Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
llifi1ll<br />
Si<br />
Journal of the American Association of <strong>Clinical</strong> <strong>Chemistry</strong><br />
Volume 35, 1989<br />
AUTHOR INDEX<br />
bbott,<br />
abe,<br />
Karen<br />
Akira;<br />
L See<br />
Yamashita,<br />
Sgoutas, Demetrios S.<br />
Swniko; Noina, Akio,<br />
552<br />
be, Kenji; Konaka, Ryusei, 1619<br />
be, Toshlo See Usui, Akihiko<br />
berus, C. See Fox, Martha; Millsap, Susan<br />
blin, Richard J., 507<br />
brahasn, Paul A. See Apple, Fred S.<br />
brahamsson, P.-A.; Andersson, C.; Bjork, T.;<br />
Ferniund, P.; Lilja, H.; Murne, A.; Weiber,<br />
H., 1497<br />
brams, Billy See Toffaletti, John<br />
bu-Farsakh, F. A.; Thajeel, A. H.; Itani, S. M.;<br />
Al-Khalily,<br />
bu-Farsakh,<br />
A. S.; Abu-Farsakh, N. A., 335<br />
N. A. See Abu-Farsakh, F. A.<br />
ckermann, H. See Blackwood, J.<br />
-; Staedter, M.; Blackwood, J.; Inbar, S.;<br />
Grenner, G., 1180<br />
damczyk, Maciej See Brashear, Jeff<br />
damson,<br />
delsteln,<br />
M.D. See Papadopoulos, N. M.<br />
Edward H. See Thornton, William<br />
H., Jr.<br />
.d1ercreutz, H.; Liewendahl, K., 1555<br />
dolphson, Janet L.; Albers, John J., 1074<br />
garwal, R. P. See McPherson, Richard A.<br />
.garwal, Veena R. See Gambhir, K. K.<br />
#.ggarwal, Suresh K. See Herold, David A.<br />
.gmon, J. See Rotenberg, Z.<br />
.gmon, Jacob See Rotenberg, Zvi; Weinberger,<br />
Itzhak<br />
Mimad, Suhail See Malik, Sohail<br />
Muardi, V. See Sadrzadeh, Sayed M. H.<br />
Mne, Risto See Panvonen, Jorma<br />
kanuma, Hiroshi See Yabuuchi, Masahiko<br />
kanuma, Yasuo See Ishibashi, Shun<br />
kers, L C. See Orsulak, P. J.<br />
-; Orsulak, P. J.; Crowley, G. T.; Arnold, L. L,<br />
1187<br />
takers, Linda C. See Orsulak, Paul J.<br />
skhavan, Hashem See Schaap, A. Paul<br />
khavan-Tafti, Hashem See Schaap, A. Paul<br />
kingbe, Olunude 0. See Koch, Thomas it<br />
-; Koch, Thomas R.; Alonsaxona, Gladys, 1107<br />
Maupovic, Petar See Graziani, Maria Stella<br />
Mbers, John J. See Adolphson, Janet L.; Lodge,<br />
Mark S.; Marcovina, Santica M., 1234<br />
-; Msrcovina, Santica M., 1357<br />
Mbertini,<br />
Mbertini,<br />
A. See Ferrari, it<br />
Alberto See Polesi, Claudio<br />
Mderaian, Frances R. See Gitehnan, Hillel J.<br />
Mexander, J. W. See Schroeder, Timothy J.<br />
Mexander, L See Peltyszyn, Stephanie;<br />
Winamer, Cathy<br />
Mexander, Nicholas M. See Roberts, Randall<br />
T.<br />
Mexander, Roy L.; Torloni, Sergio A., 1199<br />
Mexandrovich, S. See Mauck, Linda<br />
Meyasslne, H.; Duliot, M. P., 1116<br />
Ml, F. See El-Attar, Hanan M.<br />
Mi, Farouk M.; El-Attar, Hanan M., 1152<br />
M-Khalily, A. S. See Abu-Farsakh, F. A.<br />
Mlain, P. See Laine-Cessac, P.<br />
-; Turcant, A.; Premel-Cabic, A., 469<br />
Mien, L. C.; Kadijevic, Lilly; Romanschin, A. D.,<br />
2094<br />
Allin, Ronald E.; McBride, J. H.; 0th, M. K.;<br />
Rodgerson, D. 0., 1150<br />
Allison, T. See McConway, M. G.<br />
Monsazona, Gladys See Akingbe, Otumide 0.<br />
Mspector, F. See Wong, P. Y.<br />
Aitmiller, Dale H. See Parker, K. Michael<br />
-; Parker, K. Michael, 1153<br />
Altura, Burton M., 1055<br />
Alvarez, Francisco V. See Vents, Rafael<br />
Alves, Isabel Longo See Saraiva, Maria Joao<br />
Mascarenhas<br />
Alyea, K. See Witherspoon, L. It<br />
Amakawa, Tsutomu See Joukyuu, Ritsuko<br />
Ambrocio, E.; Bartlett, S.; Brady, A.;<br />
Buelteman, L.; Hammad, N., 1167<br />
Ambrose, R. See Rosano, Thomas<br />
Ainedee-Manesme, Olivier See Lambert, Willy<br />
Aniemiya, Norihiko See Kobaysshi, Isao<br />
Amino, Nobuyuki See Tamaki, Haruo<br />
Amrein, C. See Cosson, C.; Myara, I.<br />
Anand, I. See Ferrari, R.<br />
Andersen, TomE. See Rehak, Nadja N.<br />
Anderson, David J.; Rudy, Jack L., 2152<br />
Anderson, 0. See Patella, Lisa; Scott, Milda<br />
Anderson, Geoffrey; Scott, M., 1180<br />
Anderson-Mitchell, K. See Freeman, J.<br />
Andersson, C. See Abrahamsson, P.-A.<br />
Andob, Yukio See Nakashima, Koji<br />
Angback, K. See Wallinder, H.<br />
Angelova-Gateva, P.; Koev, D. J., 491<br />
Angstadt, D. S. See Witte, D. L.<br />
Anne, L See Hu, Mae<br />
Anne, Lakshmi; Kang, Sam; Forni, Theresa;<br />
Centofanti, Joan; Gottwald, Ken, 1167<br />
Annesley, Thomas M., 1337<br />
Annunziato, M. See Dakubu, S.<br />
Ansari, A.; Ghoneum, G.; Trevejo, R., 1155<br />
Anton, Soledad See Perez-Bendito, Dolores<br />
Antonarakis, Stylianos E., B4<br />
Apple, Fred S. See Eastep, Steven J.<br />
-; Benson, Peter; Abraham, Paul A.; Rosano.<br />
Thomas G.; Halstenson, Charles E., 312<br />
Applegarth, Derek A. See Harris, Heather M.<br />
Arsi, Tomiko See Imamura, Shigeyuki<br />
Aramaki, Shuichi See Hoffmann, Georg<br />
Arashima, Shin-ichiro See Yamaguchi, Akihiro<br />
Arcelloni, Cinzia See Paleari, Renata<br />
Arcuri, E. See Chiang, C. S.<br />
Arendt, Josephine See Skene, Debra J.<br />
Arevalo, Gaston, 475<br />
Arkin, Charles F. See Sughayer, Maher A.<br />
Armbruster, David A.; Green, Denise T., 323<br />
Armbruster, Franz Paul See Peters, Jorg<br />
Armbruster, MA.; Lewis, L. M., 1108<br />
Armour, C. See Napoli, K. L.<br />
Armstrong, 0. See Bronstein, I.; Voyta, J. C.<br />
Arnaud, Pierre See Speich, Michelle<br />
Arneodo, V. See Roche, D.<br />
Arnold, L L. See Akers, L. C.<br />
-; Haven, M. C.; Markin, R. S., 1197<br />
Arnold, Lyle J., Jr.; Hammond, Philip W.;<br />
Wiese, Wendy A.; Nelson, Norman C., 1588<br />
Arntsen, K. W. See Rosalki, Sidney B.<br />
Arter, T. See Detwiler, Richard; Leaky, Fred D.<br />
Arter, Thomas See Novros, Joel<br />
Artiss, J. D. See Bateson, J. E.<br />
-; Strandbergh, D. R.; Zak, B., 1159<br />
Artiss,<br />
Artur,<br />
Joseph D. See Bateson,<br />
Y. See Guemouri, Laila<br />
Joseph E.<br />
Artur, Yves See Schiele, Francoise<br />
Asai, Mario See Hirata, Rosario Dominguez<br />
Crespo<br />
Asano, Masao See Maruta, Kazuhiro<br />
Ascher, M. See Haden, B.<br />
Ash, K. 0. See Crockett, Harold; Pearson,<br />
Stephen D.; Swanson, Terry<br />
Ash, K. Owen See Pearson, Stephen D.<br />
Ashwood, E. it See Crockett, Harold<br />
Ashwood, Edward R. See Elliott, M. C.<br />
Askew, Gord; Krahn, John, 2019<br />
Aslam, M. See Moore, P.; Mundill, P.<br />
Astles, J. Rex See Tietz, Norbert W.<br />
Atger, V. See Duval, F.; Myara, I.<br />
Atherton, Nigel D., 975<br />
Attia, John; Tropak, Michael; Johnson, Paul W.;<br />
Newerly-Abranow, Wanda; Pawson, Tony;<br />
Roder, John C.; Dunn, Robert J., 717<br />
Au, J. Lai-Sim; Su, Muh-Hwan; Wientjes, M.<br />
Guillaume, 48<br />
Au, J.-X. See Yiu, Samuel C. K.<br />
Aubert, Jean-Pierre See Fontaine, Monique<br />
Aubry, Claude See Lespinas, Francis<br />
AuBuchon, J. P.; Wilkinson, J. S.; Kassapian, S.<br />
J.; Edwards, G. C., 1118<br />
Audino, Nancy See Haver, Virginia M.<br />
Auget, Jean-Louis See Speich, Michelle<br />
Aupetit, J. See Chadefaux, B.<br />
Austin, Garth E. See Morin, Leo G.<br />
Austin, Theresa M. See Horowitz, Gary L.<br />
Avenell, M. H. J. See Hahnel, R.<br />
Aversa, Catherine IL See Per, Steven R.<br />
Aw, T. C.; Koay, E. S. C.; Yuen, M., 1151<br />
Awdziej, T. See Farrenkopf, Bruce C.<br />
Awdziej, Tania N.; Blake, J.; Farrenkopf, B.;<br />
Kaufman, R. A., 1178<br />
Awni, Walid M.; Bakker, Leendert J., 2124<br />
Ayers, C. it See Boyd, James C.<br />
Aymard, Pierre See Feldmann, Delphine; Feaus,<br />
Paul D.; Moussa, Fathi<br />
Azuma, Yutaro See Maekawa, Masato<br />
-; Maekawa, Masato; Kuwabara, Yoshiko;<br />
Nakajima, Takeyuki; Taniguchi, Ken;<br />
Kanno, Takashi, 1399<br />
Baadenhuijsen, H.; Bayer, P.M.; Keller, H.;<br />
Knedel, M.; Montalbetti, N.; Brenna, S.;<br />
Prencipe, L.; Vassault, A.; Bailly, M.; Phung,<br />
H. T.; Bablok, W.; Poppe, W.; Stockmann,<br />
W., 1260<br />
Baar, Janet G. See Baker, Harold N.; Ford,<br />
Kent A.<br />
Babb, Joseph See Bernstein, Larry H.<br />
Babik, D. M. See Figard, Steve D.<br />
Bablok, W. See Baadenhuijsen, H.<br />
Bacchus, Robby A. See Frandsen, Erik K.<br />
Bachand, Steven S.; Gabor, Michael J.; Mattel,<br />
Patricia A.; O’Donnell, C. M., 1269<br />
Bachas, Leonidas G. See Barbarakis, Minas S.<br />
Bachorik, Paul S. See Cloey, Teresa; Cloey,<br />
Teresa A.; Kafonek, Stephanie<br />
-; Bradford, Reagan H.; Cole, Thomas; Frantz,<br />
Ivan; Gotto, Antonio M., Jr.; Roberta, Karen;<br />
Warnick, G. Russell; Williams, 0. Dale, 1734<br />
-; Cloey, Teresa A.. 2236<br />
<strong>Back</strong>er, Egbert T.; Harff, Gottfried A., 2190<br />
Bacon, Bonnie L; Pardue, Harry L., 360<br />
Badcock, N. R.; Leach, J. A., 889<br />
Badenoch, Jane See Baja, Renze<br />
Badenoch, Jane L; Bais, Renze, 645<br />
Baginski, P. See Khayam-Bashi, Hassan<br />
Bagneski, Kim; Koch, David D.; Haessig, Lorene<br />
K., 1129<br />
Baherji, M. See Wright, Reba K.<br />
Bailey, Kim See Painter, Pennell<br />
Bailey,<br />
Bailey,<br />
L. See Beierle, Floyd A.<br />
Mark See Donohue, Joseph<br />
Bailly, M. See Baadenhuijsen, H.<br />
Baird, F. See Witherspoon, L. R.<br />
Bais, Eenze See Badenoch, Jane L.; Branford,<br />
Susan<br />
-; Badenoch, Jane; Bayer, Peter M.; Foe, Ying;<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2343
Keller, Herbert; Roller, Peter U.; Leinberger,<br />
Robert; Weidemann, Gerhard;Rosalki,<br />
Sidney B., 317<br />
Baker, Harold N. See Ford, Kent A.<br />
-; Ford, Kent A.; Bear, Janet G.; Balay. Diane;<br />
Venetucci, Mary; Marlewaki, Debbie;<br />
Ogunro, Edward A., 1203<br />
Baker, R. See Madry, Norbert<br />
Bakke, Antony C. See Subbarao, Makam N.<br />
Bakker, Leendert J. See Awni, Walid M.<br />
Bakkeren, J. A. J. M. See Elving, L. D.<br />
Balay, Diane See Baker, Harold N.; Ford, Kent<br />
A.<br />
Baldet, L See Izembart, M.; Piechaczyk, M.<br />
Baldwin, James R.; Plesher, C. J.; Lenzo, A.,<br />
1174<br />
Bale, M. See Danielson, Susan J.; Mauck, Linda<br />
Bales, it M. See Duffy, T. H.<br />
Belle, W. See Soldin, Steven J.<br />
Ball, D. J.; Korchak, S., 1170<br />
Ball,<br />
Ball,<br />
G. DavId, 1062<br />
Michael K. See Halloran, Stephen P.<br />
Ball, Richard; Freedman, Danielle B.; Holmes,<br />
Julia C.;Midgley, John E. M.; Sheehan,<br />
Christopher P., 1891<br />
Bandi, Zoltan L; Sehoen, Irwin; Waters,<br />
Marilyn, 545<br />
-; Waters, Marilyn, 1138<br />
Bandivdekar, Atmaram H. See Tern, Tanuja H-<br />
Banerji, A. See Burrows, KeriLyn C.; Reddy.<br />
Padala V.; Shamberger, R. J.<br />
Banerji, M. See Reddy, Pedals V.<br />
Banfi, G. See Bonini, P. A.<br />
Banfl, Gluseppe; Casari, Erminia; Murone,<br />
Michelangelo; Bonini, Pier Angelo, 1545<br />
Banks. Tibor See Kapur, Bhushan M.<br />
Bankson, Daniel D. See Hghsmith, William E.<br />
-; Semroc, G.; Hofman, L F.; Silverman, L. M.,<br />
1123<br />
Bao, Constantlno 0. See Venta, Rafael<br />
Bara, J. M. Abbad See Budria, J. Ruiz<br />
Barak, Mira; Merzbach, David; Gruener,<br />
Nachman, 1467<br />
Barandica, Rob See Klonizchii, Walt<br />
Barbarakis, Minas S.; Daunert, Sylvia; Bachas,<br />
Leonidas G., 1201<br />
Barbierl, RObert L See Hankinson, Susan E.<br />
Barbour, Heather M. See Wenham, Philip R.<br />
Bardet, J. See Parvy, P.<br />
Bare, 0. See Uzan, Michel<br />
Barkey, D. See Shah, Vipin<br />
Barlow, Ellen See Felder, Robin A.<br />
Barlow, Ian M. See Harrison, Stephen P.<br />
Barnard, Geoff See Strssburger, Christian<br />
-; Kohen, Fortune; Mikola, Heikki; Lovgren,<br />
Timo, 555<br />
Barnhill, Matthew T., Jr. See Wells, David J.<br />
Barthe, Catherine; Carrere, Jacqueline;<br />
Figarella, Catherine; Guy-Crotte, Odette,<br />
1901<br />
Barthels, M. See Dati, F.<br />
Bartholomew, William K. See Katz, Paul H.<br />
Bartkowlak, Celeste D. See Carpenter, A. Betta<br />
Bartlett, S. See Ambrocio, E.<br />
Bartlett, S. M. See Reimers, T. J.<br />
Bartling, D.; Shieh, P.; Tanaka, S.; Binder, S.,<br />
1152<br />
Bartolome, Luls A. See Vents, Rafael<br />
Barton,<br />
Barton,<br />
E. See Sgoutas, D.<br />
Earl 0. See Sgoutaa, Demetrios S.<br />
Bartesch, B. See Lubec, 0.<br />
Bashani, Julie E.; Korchak, S., 1094<br />
-; Pike, S.; January, W.; Korchak, S., 1151<br />
Bastide, J.-M. See Piechaczyk, M.<br />
Basuyau, J. P.; Brunelle, Ph.; Leroy, M.; Vigier,<br />
M. P., 1194<br />
Bateson, J. E.; Artiss, J. D.; Zak, B., 1071<br />
Bateson, Joseph E.; Artisa, Joseph D.; Zak,<br />
Bennie, 1072<br />
Battaglia, Danlelle J. See Frings, Christopher<br />
S.<br />
Baudner, Siegfried See Burgi, Willy<br />
Bauler, G. See Felder, It A.<br />
Baum, John See Katz, Paul It<br />
Baum, D. See Chen, Alice<br />
Bayer, Monika F., 1144<br />
Bayer, P.M. See Baadenhuijsen, H.<br />
Bayer, Peter M. See Baja, Renze<br />
Bayhan, Aysel See Torun, Meral<br />
Baylink, D. See Hosoda, K.<br />
Baylls, Peter H. See Lewis, Helen M.<br />
Bayllss, Katherine; Kopinski, W. S.; Kueck, B.<br />
D., 1162<br />
Baynton, Robert D., 1056<br />
Bazan, Canoe, Ill See Schwartz, Joyce G.<br />
Beaman, Janine M.; Woodhead, J. Stuart. 828<br />
Bean, M. H. See Neisler, H. M.<br />
Beastall, G. H. See Linnet, Kristian; McConway,<br />
M. G.<br />
Beck, R.; Massad, A.; Liachinsky, S., 706<br />
Becker, K. K See Unni, L. K.<br />
Beckett, 0. J. See McConway, M. G.<br />
-; Foster, G. R.; Hussey, A. J.; Oliveira, D. B. G.;<br />
Donovan, J. W.; Prescott, L. F.; Proudfoot,<br />
A. T., 2186<br />
Beckett, Geoffrey J.; Hussey, Amanda J.;<br />
Laing, Ian; Howie, A. Forbes; Hayes, John<br />
D.; Strange, Richard C.; Faulder, Charles G.;<br />
Hume, Robert, 995<br />
Beck,, S. See Reason, C.<br />
Beever, K.; Bradbury, J.; Phillips, D.;<br />
McLachlan, S. M.; Pegg, C.; Goral, A.;<br />
Overbeck, W.; Feifel, G.; Smith, B. Rees,<br />
1949<br />
Baggs, Alan H. See Kunkel, Louis M.<br />
Beierle, P. See Berk, Lee; Webb, Gary<br />
Belerle, Floyd A.; Bailey, L., 1160<br />
Belchak, T. L See Fredrickson, R. A.<br />
Bell, Edward F. See Brans, Yves W.<br />
Bell, J. See Dominiczak, Marek<br />
Bell, M. See Steele, B.<br />
Bellet, N. See Freeman, J.<br />
Bellet, Neal See Hau, Po Choo;Leeder, Sydney;<br />
Rehkemper, Catherine<br />
Bellino, Linda See Demko, Paul R.<br />
Beng, C. 0. See Buttery, J. E.<br />
Bengtuon, Bengt-Ake See Nystrom, Ernst<br />
Bennett, H. J.; Gregory, B.; Kenny, M., 1129<br />
Benoit, Cheryl A. See Ricci, Mary Jo<br />
Benson, Peter See Apple, Fred S.<br />
Benson, Peter J. See Eastep, Steven J.<br />
Berg, M. See Klukas, C.; Leonard, H.<br />
Bergfeld, W. See Gupta, Manjula K.<br />
Bergman, Anders See Lindback, Bengt<br />
Bergqvist, Yngve See Eckerbom, Solveig<br />
-; Karlsson, Lisa, 1082<br />
-; Karlsson, Lisa Fohlin, tars, 2127<br />
Berk, L See Webb, Gary<br />
Berk, Lee; Beierle, F.; Webb, G.; Imperio, N.;<br />
Eby, W., 1100<br />
Bermes, Edward W. See Jandreski, Mark A.<br />
Bernadino, it See Mulberg, E.<br />
Bemnal, D. See Portoles, M.<br />
Bernard, A. M.; Lauwerya, R. It; Noel, A.;<br />
Vandeleene, B.; Lambert, A., 2141<br />
Bernard, Mark, Bonkoeki, E.; Liu, A., 1106<br />
Bernard, Serge See Orsonneau,Jean-Luc<br />
Bernstein, Larry; Rudolph, R.; Pinto, M., 1077<br />
Bernstein, Larry H.; Leukhardt-Fairfield, Carla<br />
J.; Pleban, Walter; Rudolph, Rosser, 271<br />
-; Good, I. J.; Holtzman, Golde I.; Deaton,<br />
Michael L.; Babb, Joseph, 444<br />
Berry, M. N.; Mazzachi,<br />
Peake, M. J., 817<br />
R. D.; Pejakovic, M.;<br />
Berti, Giovanni See Foesati, Piero<br />
Besemer, D. See Gibbons, I.<br />
Besemer, Diana See Urdea, Mickey S.<br />
Besse, Marie-Georges See Rogier, Herve<br />
Betebenner, Dave See Brashear, Jeff<br />
Bhalla,<br />
Bhalla,<br />
it See Chen, Yao-Tseng<br />
Ravi; Stankievic, R.; Schwartz, M. K.,<br />
1112<br />
Bhargava, A. K.; Han, Tin; Myers, M.;<br />
Fitzpatrick, J., 1079<br />
-; Myers, M. M.; Myers, L. S.; Fitzpatrick, J. E.,<br />
1102<br />
Bhargava, AK; Myers, M. M.; Petrelli, N.J.;<br />
Lele, S.; Bhattacharya, B.; Fitzpatrick, J.,<br />
1079<br />
Bhattacharya, B. See Bhargava, AK<br />
Bhayana, V.; Diamandis, E. P., 1077<br />
Blagini, A. V. See Lewis, L. M.; Vaughn, R.<br />
Blanca, Carol; Henke, J.; Hwang, D.; Meriadec,<br />
B., 1172<br />
Bidllngmaier, F. See Dablmann, N.<br />
Bled, Andree See Vernet, Michele<br />
Bielawski, C. See Muilins, Marvin<br />
Binder, S. See Bartlin, D.<br />
Bing, David H. See Williamson, Janice<br />
Biron, Marie-Philippe See Boitleux, Jean-<br />
Lou is<br />
Bissonnette, John See Swanson, J. Robert<br />
Blttlkofer, J. A.; Broenan, J. R.; Yanko, J., 1102<br />
Blxby, K See Konstantinides, Frank N.<br />
Bjork, T. See Abrahamsaon, P.-A.<br />
Black, David; Cook, Lisa, 1185<br />
Black, E.G. See Sheppard, Michael C.<br />
Black, W. See Clemens, John<br />
Black, William; Clemens, J.; Hojvat, S.;<br />
Martofano, A.; Cada, S., 1192<br />
Blackwell, Sherry See Leader, Sydney<br />
Blackwood, J. See Ackermann, H.; Padilla, A.;<br />
Staedter, M.<br />
-; Staedter, M.; Ackermann, H.; Chen, J.; Inbar,<br />
S.; Grenner, G., 1195<br />
Blackwood, J. J. See Grenner, G.<br />
Blake, D. See Rose, I. S.<br />
Blake, J. See Awdziej, Tania N.; Wilson, Job<br />
M.<br />
Blankenhomn, David H. See Graziani, Mars<br />
Stalls<br />
Blanton, J. See Lewis, L M.<br />
Blasco, Peter A. See Prior, Thomas W.<br />
Blaylock, it See Swanson, Terry<br />
Blelle, Dennis; Kamalakannan, Vedhachalai<br />
Moon, Patricia; Mak, Ken; Lohr, Steve; I<br />
Maria; Kalra, Krishan, 1148<br />
Blick, Kenneth E. See Dunn, Don J.; Parkei<br />
Michael; Passey, Richard B.<br />
-; Udwin, Michael, 1089<br />
-; Fry, Henry D.; Passey, Richard B.; Giflun<br />
Ronald L.; Parker, K. Michael, 1186<br />
Blijenberg, B. G.; Boerma, G. J. M.; Leijnae<br />
1089<br />
Blind., Eberhard See Bohler, Ulrich<br />
Bloodwomth, D. F. See Miceli, J. N.; Vroon, I<br />
H.<br />
Bloom, Jeffrey N. See Elm, Ronald J.<br />
Bluin-Hoffmann, Ellen See Hoffmann, (leo<br />
Blundell, 0. See McConway, M. G.<br />
Bodenmuller, H. See Klein, G.<br />
Bodlaender, P. See Sperling, Matthew<br />
Bodner, J. See Figard, Steve D.<br />
Bodor, Geza See Myrtle, James F.<br />
-; Wolf, Bryan A.; Hinds, Barbara; Nahm, !<br />
H.; Scott, Mitchell G., 1262<br />
Body, J. J.; Seraj, F.; Keymolen, V., 497<br />
Boehles, H. J. See Schoenau, E.<br />
Boehm, Corinne D., 1843<br />
Boerma, 0. J. M. See Blijenberg,<br />
Boeswald, W. See Schoenan, E..<br />
B. G.<br />
Boewing, B. See Schoenau, E.<br />
Bogema, Stuart C. See Ronald, Beverly A.<br />
Bohannon, J. See Wu, Yih-Shiong<br />
Bolder, Ulrich; Blind, Eberhard; Vogel, Gis<br />
Hitzler, Walter; Flentje. Dagmar; Schmb<br />
Gayk, Heinrich, 215<br />
Boitleux, Jean-Louis; Biron, Marie-Philipp<br />
Desmet, Gerard; Thomas, Daniel, 1026<br />
Bolann, Bjomn J.; Sandberg, Sverre; Digrarn<br />
Asbkorn, 1663<br />
Bollin, Ernest, Jr. See Lou, H. Philip<br />
Bonar, J. A. See McConway, M. G.<br />
Bonham, James it; Meeks, Andrew, 2253<br />
Bonini, P. A.; Pontfflo, M.; Murone, M.; Ban<br />
G., 1188<br />
Bonini, Pier Angelo See Banfi, Giuseppe<br />
Bonkoski,<br />
Bonnefont,<br />
B. See Bernard, Mark;<br />
Dominique; Legrand,<br />
Schneider,<br />
Main; Pe<br />
Jacqueline; Emerit, Jacques; Delattre,<br />
Jacques; Galli, Andre, 2054<br />
Bonnefont, J-P. See Parvy, P.<br />
Bonneton, Agnes See Pugeat, Michel<br />
Honors, Roberto See Panteghini, Mauro<br />
-; Pantehini, Mauro, 324<br />
-; Pagani, Franca; Panteghini, Mauro, 325<br />
Bonser, Jean C. See Dean, Harvey G.<br />
Bonte, H. A. See Veer, G. van der Sluijs; Vet<br />
Boone, D. Joe; Martin, M. Louise, 1087<br />
Booth, Frank See Tilzer, Lowell L.<br />
Boots, Larry See Shaw, Norman<br />
Borburgh, A. J. See Weykamp, C. W.<br />
Borden, Kim See Shaw, Norman<br />
Borden, Kimberlee See Dowel, Barry<br />
Borges, Marietta See Wortsman, Jacobo<br />
Bonmann, Priscilla See Eckfeldt, John H.<br />
Boruns, Peggy K. See Williamson, Jerry<br />
Bory, Claude; Boulieu, Roeelyne; Chantin,<br />
Christiane; Mathieu, Monique, 321<br />
Boskey, Adele L. See Bruns, David E.<br />
Bosonl, Tiziana See MeW d’Eril, Gian Vico<br />
Bottomley, Paul A.; Hardy, Christopher J.,<br />
Boulhlmez, K. See Crockett, R.<br />
Boulleu, Roselyne See Bo!y, Claude<br />
Boulter, Jim See Deneris, Even S.<br />
Bounaud, Jean-Yves See Perdrisot, Remy<br />
Bounaud, Marie-Paule See Perdrisot, Rem<br />
Bourdoux, Pierre P. See Delange, Francois<br />
Bouthillier, Daniel See Davignon, Jean<br />
Bowcock, A. See Smith, Douglas It<br />
Bowden, Don See Green, Philip<br />
Bowden, J. See Mifflin, Ted<br />
Bowden, James; Mifflin, T. E., 1076<br />
Bowen, Beta See Kessler, Jay<br />
Bowen, M. 5. See Grenner, G.<br />
Bowen, Thomas P. See Wiese, David A.<br />
Bowers, 0. N., Jr. See Krzymowski,<br />
Debra M.; Valcour, Andre<br />
G. A.; 11<br />
Bowers, George N,, Jr. See Okorodudu,<br />
Anthony 0.; Valcour, Andre A.<br />
Bowers, L. D. See Jessen, It H.<br />
2344 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
were, Larry 0., 1235, 1282<br />
wie, Lemuel J. See Dohnal, James C.<br />
Kirkpatrick, Peter P., 1355<br />
wman, C. See Patel, Niranjan<br />
yd, James C. See Felder, Robin A.<br />
Savory, M. G.; Hines, C.; Normansell, D. E.;<br />
Ayers, C. R., 1070<br />
ziniowski, D. See O’Neil, J.<br />
abham, Ewart A. See Mudarris, Ayad<br />
‘aconnier, Francois See Fesus, Paul D.<br />
‘adbury, J. See Beaver, K.<br />
‘adford, Reagan H. See Bachorik, Paul S.<br />
‘adley, Charles A.; Rogers, Michael M. .1084<br />
Dunn, Dale M.; Rogers, Michael M., 1123,<br />
1241<br />
‘adley, G. Mary See Eckfeldt, John H.<br />
‘adley, H. See Raymond, Anne<br />
‘adley, Linda See Shaw, Norman<br />
‘adstreet, K. See Demers, Laurence M.<br />
‘ady, A. See Ambrocio, E.; Freeman, J.<br />
‘ady, James A. See Spronk, Adrian M.<br />
aithwsite, Susan S.; Collins, Sonia; Prinz,<br />
Richard A.; Welch, Jami L; Winters, Gayle<br />
L., 2216<br />
undo,<br />
andt,<br />
B. See Zucchelli, G. C.<br />
B. See Schneider, L.; Sun, Lila; Villa,<br />
Barbara<br />
‘anford, Susan; Sobecki, Stan; Bais, Renze,<br />
1255<br />
us, Yves W.; Shaffer,<br />
Edward F.; Schwartz,<br />
Stanley G.; Bell,<br />
Connie A.; Martin,<br />
Lorene A., 1367<br />
antley, N. See Miceli, J. N.; Vroon, D. H.<br />
anum, Earl L See Gonchoroff, Daryl G.<br />
ashear, Jeff; Zeitvogel, Christine; Jackson,<br />
Jean; Flentge, Charles; Janulis, Lynn;<br />
Cantrell, Lois; Schmidt, Bob; Adamczyk,<br />
Maciej; Betebenner, Dave; Vaughan,<br />
Kenward, 355<br />
aunllng, 0. See Renz, M.<br />
ay, K. it See Werneke, Debra K.<br />
ay, Kurtla K.; Cerrito, M.; Broyles, D.; Hill,<br />
C.; Johnson, K.; Nunnelly, P.; Segal, A.; Van<br />
Tassel, K., 1078<br />
abant, Chantal See Pugeat, Michel<br />
eglio, Susan; Phillips, Vincent; Murthy, H.<br />
M.S., 1093<br />
Phillipe, Vincent; Murthy, H. M. S., 1093<br />
elnek, P. See Chromy, V.<br />
reitenfeld, Diane See Doumas, Basil T.<br />
anna, S. See Baadenhuijsen, H.<br />
ennan, George See Pilot, Robert L.;<br />
Zahradnik, Richard<br />
ennan, M. See Smith, Carol<br />
rent, 0. See Gault, M. H.<br />
ett, K. See Brocklehurst, D.<br />
rettfeld,<br />
Paul;<br />
Chris; Massoud, Neil; Munzenberger,<br />
Nigro, Michael; Sarnaik, Ashok;<br />
Gobrogge, Roger, 324<br />
ewater, Marge A.; Starrett, William, 1999<br />
len, Gerald See Jung, Klaus<br />
lnghurst, Cory See Wu, James T.<br />
ockas, A. J. See Crouch, CoHn<br />
ocklehurst, D.; Wilde, C. E.; Fmnbow, J. A. H.;<br />
Brett, It; Champion, A. E.; Dewhurst, D. G.,<br />
238<br />
rocks, D. G. See Schnorr, G.<br />
odeur, Garrett M., B38<br />
onstein, I. See Thorpe, G. H. G.; Voyta, J. C.<br />
Voyta, J. C.; Thorpe, G. H. G.; Kricka, L J.;<br />
Armstrong, G., 1441<br />
onstein, Irena; Voyta, John C., 1856<br />
rooks, Kiazina K; Smith, Norman B., 2100<br />
osnan, J. K. See Bittikofer, J. A.<br />
rotherton, Mary See Mahmood, Nishat<br />
own, A. See Corneliaon, L.<br />
own, K See McConway, M. G.<br />
own, Ellen D.; Rose, Alice; Craft, Neal;<br />
Seidel, Karen E.; Smith, J. C., Jr., 310<br />
own, J. M. See Cowley, D. M.; de Leacy, E. A.<br />
rown,K. See Gibbs, Judy<br />
own, Nigel N. See Do Leacy, Eric A.<br />
own, Patrice A. See Whitley, Chester B.<br />
own, Richard W. See Schwartz, Joyce G.<br />
own, Spencer A. See Patsch, Wolfgang<br />
own, W. See Butch, A.<br />
own, Warren P. See Rettmer, Rebecca L.<br />
own, Wayne S. See Butch, Anthony W.<br />
oyles, Celeste; Present, W.; Zhang, M.; Fang,<br />
X., 1187<br />
royles, D. See Bray, KUrtis It<br />
rudzlnski, A. See Lee, Sung C.<br />
runelle, Ph. See Basuyau, J. P.<br />
runs, David E. See Franquemont. Douglas W.;<br />
Mifflin, Theodore E.<br />
Boskey, Adele L.; Lieb, Wolfgang; Conway,<br />
Brian P.; Savory. John; Wills, Michael R.,<br />
183,705<br />
Bruzek, Debra See Chan, Daniel W.<br />
-; Drew, Helen; Regalado, Jacinto; Chan, Daniel<br />
W., 1188<br />
Budria, J. Ruiz; Bara, J. M. Abbad; Gonzalez, E.<br />
Fabre; Sanz, M. T. Higueras; Ostariz, J. L<br />
Serrano, 800<br />
Buelteman, L See Ambrocio, E.; Freeman, J.<br />
Buffone,<br />
Bulbley,<br />
Gregory<br />
Gregory<br />
J., 83<br />
Bartlett, 1051<br />
Bulley, M. See Remaley, A. T.<br />
Bunge, G. See Solano, Romeo<br />
Bunyagldj, C. See Wang, Tang Jang<br />
Burd, T. See Gibbons, I.<br />
Burdelski, M. See Oellerich, Michael<br />
Burgess-Cassler, Anthony; Johansen, Jon J.;<br />
Santek, David A.; Ide, Jonathan R.;<br />
Kendrick, Nancy C., 2297<br />
Burgi, Willy; Simonen, Sirkka; Baudner,<br />
Siegfried; Schmid, Karl, 1649<br />
Burke, M. Desmond, 1233<br />
Burlina, A. See Plebani, Mario<br />
Burnett, Robert W.; Itano, Masashi, 1779<br />
Burns, Washington See Lather, Barry P.<br />
Burn, Betty Jane; Kutnink, Mark A., 582<br />
Burns, Susan See Haver, Virginia M.<br />
Burrows, K. See Wright, Reba K.<br />
Burrows, KeriLyn C.; Lonardo, A.; Wright, It;<br />
Banerji, A., 1094<br />
Burtis, Carl A., 891<br />
Burton, Barbara See Shaw, Norman<br />
Burton, MB. See Kenney, J. T.<br />
Burton, Michael B. See Orsulak, Paul J.<br />
Bury, J. See Labeur, C.<br />
Busch, M. See Haden, B.<br />
Bush, 0. See Sibiia, R.<br />
Bush, Donna M. See Stevenson, Cathy C.<br />
-; Keren, David F., 1198<br />
Bush, P.; Rudy, J., 1111<br />
Butch, A.; Brown, W.; Koenig, J.; Hinds, B.;<br />
Kessler, G.; Scott, M., 1107<br />
Butch, Anthony; Shelton, M.; Matheke, M. L.;<br />
Valdes, It, Jr., 1109<br />
Butch, Anthony W.; Goodnow, Timothy T.;<br />
Brown, Wayne S.; McClellan, Adrain;<br />
Kessler, Gerald; Scott, Mitchell G., 2048<br />
Butler, Barbara A.; Taylor, W. Allen, 1102<br />
-; Taylor, W. Allen; Coper, Carol, 1103<br />
Butler, S. See Wu, Yih-Shiong<br />
Buttery, J. E.; Chamberlain, B. It; Beng, C. G.,<br />
2311<br />
Buttita, D. See Rosencrans, Robert<br />
Cada, S. See Black, William<br />
Caine., Patrick 8.; Cheung, R. M. C.; Draisey,<br />
T. F.; Yea, G. E., 1074<br />
Calamunci, K. See Woo, Charles<br />
Callis, James B., 1059<br />
Calore, James D. See DeMars, Daniel D.<br />
Calvin, J. See Monk, J.<br />
Calvo, S. See Pb, A.<br />
Cameron, J. D., 506<br />
Cameron, Oliver G. See Hariharan, M.<br />
Cami, J. See Segura, J.<br />
Camina,<br />
Camina,<br />
M. P. See Rodriguez-Segade, S.<br />
M. Felix See Rodriguez-Segade,<br />
Santiago<br />
Campbell, J. See Klukas, C.<br />
Campbell, M. See Steele, B.<br />
Campbell, W. B. See Lewis, L M.<br />
Candela, Ellen See Sadowaki, James<br />
Cannella, Giuseppe See Polesi, Claudio<br />
Cano, C.; Lykissa, E. D., 1170<br />
Cantrell, Lois See Brashear, Jeff<br />
Cao, G. See Present, Bill<br />
Caplan, Yale H.; Levine, Barry, 1794<br />
Carnyon, P. See Tercero, J. C.<br />
Cardno, Todd See Falutz, Julian<br />
Cardoni, D. See Sasse, E. A.<br />
Carey, Mary M. See Rettmer, Rebecca L.<br />
Carlaon, Ian H. See Lensmeyer, Gary L<br />
Carlson, J. See Raymond, Anne<br />
Canton, Esther See O’Connor, Daniel T.<br />
Carlyle, E. See McConway, M. G.<br />
Caro, Jose See Khazanie, Prabhaker<br />
Caroli, A. See Zucchelli, G. C.<br />
Canon, G. See Sheehan, M.<br />
Caron, Marc G. See Frielle, Thomas<br />
Carpenter, A. Betts; Bartkowiak, Celeste D.,<br />
484<br />
Carpenter, K. J.; Schelstraete, M., 2000<br />
Carreras,<br />
Carnere,<br />
L See Diaz, S.<br />
Jacqueline See Barthe, Catherine<br />
Carnico,<br />
Carrubba,<br />
Julie See Leader, Sydney<br />
J.; Doles, A.; Demeritt, S.; Levine, J.,<br />
1104<br />
Carry, Melissa See Tagari, Philip<br />
Carter, 0.; Mohr, M.; Pretty, P.; Janus, E. D.,<br />
1086<br />
Canter, G. 0. See McConway, M. G.<br />
Carter, J. See Lucas, F.<br />
Casares, Gerardo See Venta, Rafael<br />
Casari, Erminla See Banfi, Giuseppe<br />
Cassano, T. See Van Brunt, N.<br />
Cutellani, W. J. See Kazmierczak, S. C.;<br />
Khazanie, Prabhaker<br />
Castellani, William J.; Wheeler, W. S.;<br />
Kazmierczak, S.C.; Khazanie, P., 1158<br />
Caswell, A. Pd.; Russell, R. G. G., 326<br />
Catanzarlti, P. A. See Wiernik, M. D.<br />
-; Wiernik, M. D.; Swanson, B. N., 1069<br />
Cate, J. See Dyer, Deborah<br />
Catomeris, Peter; Monforte, J. R.; Thibert, It<br />
J.; Hood, I., 1176<br />
Caughlin, I See Peat, Michael A.<br />
Cavalie-Barthez, Ghlslalne See Rogier, Herve<br />
Cavalli-Sforza, IL. See Smith, Douglas R.<br />
Cavenee, Webster K., B48<br />
Cawood, A. H., 1832<br />
Cecil, M. See Wu, Yih-Shiong<br />
Ceconi, C. See Ferrari, R.<br />
Cekan, Sten Z. See Riesco, Oscar F.<br />
Cembrowski, George 8.; Lambrecht, Kristen<br />
K.; Kelly, Christine A.; Wang, Helen H., 1145<br />
Centofanti, J. See Hu, Mae; Mulberg, E.<br />
Centofanti, Joan See Anne, Lakshmi<br />
Cernosek, S. See Gage, S.<br />
Cenra, P. B. See Konstantinides, Frank N.<br />
CeiTItO, M. See Bray, Kurtis It<br />
Cervenka, Justine H. See O’Connor, Daniel T.<br />
Chadefaux, B.; Coude, M.; Hamet, M.; Aupetit,<br />
J.; Kamoun, P.. 2002<br />
Chafe, I See Gault, M. H.<br />
Cbkmkjian, Z. H. See Zachariah, N.Y.<br />
Chaleby, Kutaiba See El-Yazigi, Adnan<br />
Chalmers, A. H. See Cowley, D. M.; de Leacy, E.<br />
A.; Renouf, Judith A.<br />
Chain, B. K; Roeser, H. P.; Kamst, T. W., 2285<br />
Chamberlain, BR. See Buttery, J. E.<br />
Chambron, J. See Sapin, It<br />
Champion, A. B. See Brocklehurst, D.<br />
Chan, A. Y. W.; Swaminathan, It; Cockram, C.<br />
5., 315<br />
Chan, Daniel W. See Bruzek, Debra; Gerhardt,<br />
Gregory<br />
-; Bruzek, Debra; Rock, Robert, 1077<br />
Chan,<br />
Chan,<br />
K. See Hu, Mae<br />
Shirley See Fulton, Ann<br />
Chandler, C. See Crouch, CoHn<br />
Chandler, Wayne L. See Fine, James S.<br />
-; too, Swee-Chin; Nguyen, Son V.; Schmer,<br />
Gottfried;<br />
Chang, Agnes<br />
Stratton, John R., 787<br />
See Chou, Peter P.; Longhurst,<br />
Sharon<br />
Chang, J. See Kaseman, Deborah; Reilley,<br />
Therese<br />
Chang, L See Present, Bill<br />
Chantin, Chnistlane See Bory, Claude<br />
Chapelle, J, P. See El Allaf, Msgdeleine<br />
Chapelle, Jean-Paul; El Ailaf, M., 1120<br />
Chapman, Donna, 1068<br />
Chapman, J. F. See Levtzow, C. B.; Phillips, J.<br />
Chapman, itS. See Linnet, Kristian;<br />
McConway, M. G.<br />
Charleson, Stella See Tagari, Philip<br />
Charnas, I See Papadopoulos, N. M.<br />
Chasnoff, Ira J.; Lewis, Douglas E.; Griffith,<br />
Dan R.; Wiley, Steven, 1276<br />
Chaudhary, A. K. See Kalra, J.<br />
Chaumont, B. See Doria, Manuel, Jr.<br />
Cheek, J. H. See Zachariah, N. Y.<br />
Chen, Alice; Baum, D., 1130<br />
-;Goga,V.;Contis,L., 1162<br />
Chess, C. W. See Fu, J. C.<br />
Chen, Hso-Zhu See Geng, Jian-Guo<br />
Chen, Huel-Mei; Lifschitz, Carlo. H., 74<br />
Chen, Hul-Li See Wu, Alan H. B.<br />
Chen, I. See Sperling, Matthew<br />
Chen, J. See Blackwood, J.<br />
Chen, K. See Khayam-Bashi, Hasaan<br />
Chen, Katherine; Khayam-Bashi, H.; Gerard,<br />
S.; Hernandez, C.; tin, S. J., 1146<br />
Chen, Kwok-MIng See Crest, Michael H.<br />
Chen, I See Present, Bill<br />
Chen, Shu-Mal See Kuo, Cheng-Deng<br />
Chess, Y. M. See Sardesai, Sudha<br />
Chen, Yao-Tseng; Bhalla, It; Schwartz, M. K.,<br />
1117<br />
Cheng, A. J. See Fu, J. C.<br />
Cheng, C.; Farrenkopf, B.; Jerome, H.; Kaufman,<br />
R.A., 1178<br />
Cheng, C. Yan See Silvestrini, Bruno<br />
Cheng, K. Steve; fries, Julian J.; Girardot,<br />
Clemencia, 1144<br />
Cheng, M. See Rosenthal, Philip<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2345
Cheng. M. H. See Huang, W. T.<br />
Cheng, MI See Sarosi, David<br />
Cheng, Mary<br />
Teodosio.<br />
H.; Wong, H. T.; Hutchins, S. W.;<br />
F.; Restrepo, L.; Vu, T. H.; Huang,<br />
W. Y.; Lipsey, Allen I., 1109,1238<br />
Cheng, P. J. See Chin, Bruce G.<br />
Cheng, S. See Williams, Michael<br />
Chernow, Bart, 1054<br />
Chesler,<br />
Chesler,<br />
K. See Kroll, M. H.<br />
Ruth See KroU, Martin H.<br />
Cheung, C. K.; Cockram, C. S.; Yeung, V. T. F.;<br />
Swaminathan, R., 1672<br />
-; Lao, T.; Swaminathan, R., 1978<br />
Cheung, Kee; Hinds, John A.; Duffy, Patrick,<br />
295<br />
Cheung, Peter W., 1060<br />
Cheung, K. Pd. C. See Calnes, Patrick S.<br />
Chiang, Benjamin N. See Kuo, Cheng-Deng<br />
Chiang, Betty T. See Rehak, Nadja N.<br />
Chiang, C. S. See Cooper, M.; Tsunokawa, M.<br />
-; Grove, T.; Cooper, M.; Cuan, J.; Kowalski, A.;<br />
Parcells, K.; Tsunokawa M.; Rosenberg, M.;<br />
Arcuri, E.; Franklin, S.; mith, T.; Debouck,<br />
C.. 946<br />
Chlappetta, B. See Gates, Teresa; Melerski,<br />
JamesJ.<br />
Chiappetta, Enrico See Thacker, Susan<br />
Childers, David See Motika, Deborah<br />
Chin, Bruce G.; Cheng, P. J.; Cortes, G.; Globis,<br />
C.; Murza, B.; Kirchick, H. J., 1206<br />
Chisnall, W. N. See tim, Chew W.<br />
Cho, Hiroko; lijima, S.; Shiba, K.; Nakao, M.;<br />
Shiba, A.; Suzuki, K.; Toda, T.; Ohashi, M.,<br />
1083<br />
Chou, H. Dasgupta, See Amitava<br />
Chou, Peter P. See Longhurst, Sharon<br />
-; A.; King, Brenda; Chang, Toms, Rick Agnes;<br />
Longhurst, Sharon, 1099<br />
-; Toms, Rick A.; King, Brenda; Chang, Agnes;<br />
Longhurst, Sharon; Young, Maitland, 1099<br />
Chretien, J. See Thuan, N. T. Leuquang<br />
Chretien, P. B. See Huang, C. M.<br />
Christensen,<br />
Christensen,<br />
S. See Wu, James T.<br />
Stig Engkjaer See Engbaek,<br />
Frode<br />
Christenson, Robert H.; Toffaletti, John;<br />
Ohman, Magnus; Clemmenson, Peter M.;<br />
Wagner, Galen S.; Silverman, Lawrence M.,<br />
1124<br />
Ohman, Magnus; Clemmensen, Peter M.;<br />
Wagner, Galen S., 1125<br />
-; Ohman, E. Magnus; Clemmensen, Peter;<br />
Grande, Peer; Toffaletti, John; Silverman,<br />
Lawrence M.; Volimer, Robin T.; Wagner,<br />
Galen S., 2179<br />
Chnistofide., N. See Sheehan, C.<br />
Christy, P. See Paxton, Helene<br />
Chromy, V.; Breinek, P.; Sklepkova,<br />
Valendinova, M., 191<br />
A.;<br />
Chubb, S. A. P.; Hutchison, A., 326<br />
Chul, Shlu Ron; Wan, Koon Chin Lain,<br />
Christopher Was Kei; Lewis. W. H.P..<br />
Chung, B. See Houts, Robyn<br />
1770<br />
Chung, B. S. See Corneliaon, L<br />
Chung, Byung S. See Hsu, Po Choo<br />
Chung, Byung Book; Valdez, Johnny; Pease,<br />
John, 1166<br />
Church, W. See Howard, P.<br />
Churchill, Alison See Skene, Debra J.<br />
Chute, Christopher G. See Hankinson,<br />
Claniniboli, G. See Paci, Anna<br />
Susan E.<br />
Clanimboli, Giullano See Paci, Anna<br />
Cibull, Deanna See Stevenson, Cathy C.<br />
Ciucci, C. See Houts, Robyn<br />
Ciuti, K; Rinaldi, Graziella, 1562<br />
Clabe, A. See Crockett, R.<br />
Clague, Alan B. See De Leacy, Eric A.<br />
Clark, I See Sheehan, M.<br />
Clark,<br />
Clark,<br />
Larry<br />
Mary<br />
W.; Johnston, Sue, 1099<br />
M.; Sarosi, Elaine; Haden, Bill,<br />
1085<br />
Clark, P. See Lauderdale, V.<br />
Clark, It. See Sgoutas, D.<br />
Clark, Timothy See Hannan, Charles J., Jr.<br />
Clarke, Lorne A. See Harris, Heather M.<br />
Clarke, M. See Watson, I. D.<br />
Clayson, Kathleen J. See Fine, James S.<br />
Clemens, J. See Black, Wills<br />
Wesley<br />
,Schmidt,<br />
Clemens, John; Black, W.; Holmes, Earle W.;<br />
Hojvat, S., 1095<br />
Clement, Denial See Do Buyzere, Marc I<br />
Clemmensen, Peter See Christenson, Robert H.<br />
Clemmensen, Peter M. See Christenson, Robert<br />
H.<br />
Clemmenson, Peter Pd. See Christenson, Robert<br />
H.<br />
2346 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />
Clenc, C. See Ruelland, A.<br />
Clerico, A. See Paci, Anna; Zucchelli, G. C.<br />
Clerico, Aldo See Gianspietro, Ottavio; Paci,<br />
Anna<br />
Cline, Martin J., 1057<br />
Cloarec, I See Ruelland, A.<br />
Cloey, Teresa; Bachorik, Paul S.; Kwiterovich,<br />
P., 1069<br />
Cloey, Teresa A. See Bachorik, Paul S.<br />
-; Bachorik, Paul S., 1390<br />
Clyne, Jennifer See Urdea, Mickey S.<br />
Cobb, M. See Gibbons, I.<br />
Cocci, F. See Paci, Anna<br />
Cocci, Franca See Paci, Anna<br />
Cocker, J.; Wilson, H. K., 506<br />
Cockram, C. S. See Chan, A. Y. W.; Cheung, C.<br />
K.<br />
Coderre, James A. See Stock, John L.<br />
Cohen, Jacques, 1064<br />
Cole, K. See Prinsen, Johanna<br />
Cole, Thomas See Bachorik, Paul S.<br />
Coleman, Graham See Fulton, Ann<br />
Cohn, I See Hu, Mae<br />
Coilet-Cassart, D.; Limet, J. N.; Van Krieken,<br />
L.; Do Hertogh, R., 141<br />
Collie, Pd. J. See Santulli, M. J.<br />
Collins,<br />
Collins,<br />
K. Scott See Thompson, James D.<br />
S. See Elkhalifa, Mohained; Sloan, Chris<br />
Collins, Sonla See Braithwaite, Susan S.<br />
Colllnsworth, W. 1,1096<br />
CoIwell, Mark; Halsey, John F., 1252<br />
Comerci, C. See Klukaa, C.<br />
Comerford, A. See Gault, M. H.<br />
Comstock, George W. See Hsing, Ann W.<br />
Cone, Edward J.; Dickerson, Sandra, 1171<br />
Congest,<br />
Connelly,<br />
M. See Segura, J.<br />
I See Lasky, Fred D.<br />
Connolly, John See Deneris, Evan S.<br />
Contis, I See Chen, Alice<br />
Converse, Joan; Klee, G., 1160<br />
Conway, Brian P. See Bruns, David E.<br />
Cook, B. See Thomson, S.<br />
Cook, G. See Woo, Charles<br />
Cook, Lisa See Black, David<br />
Cooper, Carol See Butler, Barbara A.<br />
Cooper, Carol Pd. See Russell, John C.; Zibrat,<br />
Steven J.<br />
Cooper, G. K. See Moomman, Stacy; Myers, Gary<br />
L.<br />
Cooper, Katherine See Teas, Michael Y.<br />
Cooper, M. See Chiang C. S.<br />
-; Grove, T.; Chiang, C. S.; Rosenberg, M.;<br />
Franklin, S.; Debouck, C., 1191<br />
Copas, Pleas See Painter, Pennell<br />
Cope, June See Painter, Pennell<br />
Copeland, Kenneth; Yatscoff, It; Thliveris, J.;<br />
Honcharik, N., 1164<br />
Copeland, Kenneth K.; Yatacoff, Randall W.,<br />
1551<br />
Coppola, J. See Kubasik, N. P.<br />
Copur, Sitki; Kus, Sezal; Kars, Ayse; Renda,<br />
Nurten; Tekuzman, Gulten; Firat, Dincer,<br />
1968<br />
Corbin, Debra K.; Keenan, Edward J., 1148<br />
Condy, P.See Kubasik, N. P.; Thompson, F.<br />
Condy, P. A. See Kubasik, N. P.<br />
Conlna, 0.1 See Mills, G. A.<br />
Cornelison, I; Lam, X.; Brown, A.; Chung, B.<br />
S.; Tanimoto, L.; Valdez, J.; Wood, J., 1173<br />
Contes, 0. See Chin, Bruce G.<br />
Coson, C. See Myara, I.<br />
-; Myara, I.; Guillemain, It; Amrein, C.;<br />
Dreyfus, 0.; Moatti, N., 492<br />
Costa, B. See Joven, J.<br />
Costa, Pedro P. See Samaiva, Maria Joao<br />
Mascarenhas<br />
Costello, K. See Papadopoulos, N. M.;<br />
Papadopoulos, Nicholas M.<br />
Costello, K. Pd. See Shah, Vpin<br />
Costello, Rene See Pascali, Enzo<br />
-; Papadopoulos, Nick M., 186<br />
Coude, M. See Chadefaux, B.<br />
Coulam, Carolyn B. See Ng, Ronald H.<br />
Covault, H. P. See Schmidt, Wesley<br />
Cowley, 0. Pd. See de Leacy, E. A.<br />
-; McWhinney, B. C.; Brown, J. M.; Chalmers,<br />
A.H.,23<br />
Cox, N. H. See Dominiczak, Marek<br />
Cox, Timothy M. See Whitaker, Katrine B.<br />
Coyle, P.; Rofe, A. M.; Renfeng, F., 1806<br />
Craft, Neal See Brown, Ellen D.<br />
Crawford, A. See Wieringa, G. E.<br />
Creer, Michael H.; Lou, Brad W. C.; Jones,<br />
James D.; Chen, Kwok-Ming, 684<br />
Crisafulli, T. See Gates, Teresa<br />
Crissfulll, Terry See Thacker, Susan<br />
Crisan, D.; Diven, W. F.; Hartle, K.; Osborne, P.<br />
T.; Mason, L., 1854<br />
Cnisan, Domnita; Howrie, D. L.; Fricker, F. J.;<br />
Lower, D., 1163<br />
Cnitaer, John See Ng, Ronald H.<br />
Crockett, Harold; Knight, J. A.; Ashwood, E. F<br />
Ash, K. 0., 1069<br />
Crockett, K.; Boulhimez, K.; Velez, L.; Clabe, A<br />
La Moigne, F., 1132<br />
Crosby, Lisa E.; Krouwer, Jan 5., 1187<br />
Cnossin,<br />
Crouch,<br />
Kathryn 1,738<br />
Colin; Chandler, C.; Dent, A. H.;<br />
Glover, J.; Brockas, A. J., 1207<br />
Crowley, G. T. See Akers, IC.<br />
Cruschelll, Lorella See Gianspietro, Ottavio<br />
Crystal, Dali. See Fleisher, Martin<br />
Caako, G.; Zweig, M. H.; Glickman, J.; Ruddel,<br />
M.; Kestner, J., 1143<br />
Caako, Gyorgy; Zweig, Mark H.; Glickman,<br />
Janice; Kestner, Jane; Ruddel, Mark, 102<br />
-; Zweig, Mark H.; Glickman, Janice; Ruddel,<br />
Mark; Kestner, Jane, 1655<br />
Cuan, J. See Chiang, C. S.<br />
Cuccia, Claudlo See Panteghini, Mauro<br />
Culileron, Claude-Yve. See Pugeat, Michel<br />
Cummings, Steven T. See Fraser,<br />
Curran, S. See Perel, J. M.<br />
Callum 0.<br />
Curtis, George C. See Hartharan, M.<br />
Cvoniacec, D,; Stavljenic, A.; Vukelic, B., 2142<br />
Czaban, J. See Liffman, S.<br />
Czichos, A. See Rena, M.<br />
Dabe, Irwin See Hannan, Charles J., Jr.<br />
Daft, Michael C. See Wolf, Bryan A.<br />
Daggett, S. See Detwiler, Richard<br />
Dahlke, Lisa See Larsen, Sandra<br />
Dahlmann, N.; Bidlingnsaier, F., 2339<br />
Dahm, Pd. See Oster, 0.<br />
Dakubu, S.; Tovey, M.; Annunziato, M.;<br />
Whiteley, G.; Grenner, G., 1195<br />
Dalke, D. See Villa, Barbara<br />
Dallas, B. H. See Lim, Chew W.<br />
D’Amato, David See Kambli, Vijaykant B.<br />
Damodaran, K. See Khan, Shalsta; Narang,<br />
Rama<br />
Daneshvar, I<br />
Daniel, Molly<br />
See Smith, Douglas It<br />
See Wang, Hann-Ping<br />
Danielson, S. See Mauck, Linda<br />
Danielson, Susan J.; Mauck, L.; Hilborn, D.;<br />
Bale, M.; Engebrecht, R., 1200<br />
Dasgupta, Amltava See Malik, Sohail;<br />
Rosenzweig, I. Bruce<br />
-; Nakamura, Aurea; Doria, Lorna; Dennen,<br />
David, 323<br />
-; Chou, H.; Saldana, 5., 1144<br />
-; Dean, It; Dennen, D. A., 1176<br />
Dati, F.; Pelzer, H.; Barthels, M.; Egbring, It;<br />
Norfolk, D.; Tripodi, A.; Ten Cate, J. W.;<br />
Sturk,A., 1163<br />
Datl, Francesco; Lammers, M.; Metzmann, E.;<br />
Marcovina, S.; Redaelli, G., 1072<br />
Daufeldt, J. A. See Harrison, H. H.<br />
Daunert, Sylvia See Barbarakis, Mines S.<br />
Davidson, K See Rotenberg, Z.<br />
Davidson, Ehud See Rotenberg, Zvi;<br />
Weinberger, Itzhak<br />
Davidson, Kenneth See Sadowski, James<br />
Davignon, Jean; Fortin, Louis-Jacques;<br />
Tremblay, Michel; Bouthillier, Daniel;<br />
Nestruck, A. Christine, 495<br />
Davis, Holly A. See Rettmer, Rebecca L.<br />
Davis, K. See Smith, Douglas It<br />
Davitt, Christine See Gerhardt, Gregory<br />
Davouzadeh, Faegh See Wang, Hann-Ping<br />
Dawson-Hughes, Bess See Sokoll, tori J.<br />
Day, K. See Ishii, S.<br />
Day, Kevin K., 1178<br />
Deacon, Pd. C. See Rose, 1.S.<br />
Dean, Harvey G.; Bonaer, Jean C.; Gent, J. Pa<br />
1945<br />
Dean, K. See Dasgupta, Amitava<br />
Dear, P.R. F.; Henderson, M. J., 338<br />
Deaton, Michael 1 See Bernstein, Larry H.<br />
Dc Block, Jan See Dillen, Lieve<br />
DeBoen, 0. See Solano, Romeo<br />
Debouck, C. See Chiang, C. S.; Cooper, M.<br />
Do Bnoe, Marc E. See D’Haese, Patrick C.<br />
de Bruyne, Jan J.; Meijer, Gert W., 1263<br />
Dc Buyzere, Marc See Delange, Joris;<br />
Robbreeht, Johan<br />
Dc Buyzere, Marc I See Robbrecht, Johan H.<br />
-; Dc Scheerder, Ivan K.; Delanghe, Joris R.;<br />
Robbrecht, Johan H.; Clement, Denis L.;<br />
Wieme, Roger J., 246<br />
Dechaud, H.; Lejeune, H.; Garoscio-Cholet, M.;<br />
Mallein, It; Pugeat, M., 1609<br />
Dechaud, Henri See Pugeat, Michel<br />
Decker, Scott See Thompson, James D.<br />
de Costa,<br />
Defesche,<br />
Anna See Gaillard, M. Christine<br />
Charles 1 See Wortsman, Jacobo<br />
Defreese, James See Donohue, Joseph
gan, Paolo; Montagnoli, Giorgio; Wild,<br />
Christopher P., 2308<br />
egand, Pierre See Fontaine, Monigue<br />
a Bean, Karen E. C.; Woroniecka, Urszula D.,<br />
888<br />
ehennin, Louis, 532<br />
Hertogh, K. See Collet-Cassart, D.<br />
a Jong, J. G. N.; Wevers, It A.; Laarakkers, C.;<br />
Poorthuis, B. J. H. M., 1472<br />
a Rand, John; Dunlap, Larry; Hall, Terry D.,<br />
2110<br />
a Rat Angelino, C. Pd. See Elvin#{231}, L. D.<br />
elange, Francolse; Bourdoux, Pierre P., 710<br />
elange, Jonis; Do Slypere, Jean-Paul; Do<br />
Buyzere, Marc; Robbrecht, Johan; Wieme,<br />
Roger; Vermeulen, Alex, 1802<br />
elanghe, Jonis See Robbrecht, Johan<br />
elanghe, Jonls K. See Do Buyzere, Marc I;<br />
Robbrecht, Johan H.<br />
ala Tome, K, See Segura. J.<br />
elattre, Jacques See Bonnefont, Dominique<br />
elaurentis, M. See Hout, Robyn<br />
eLaurentis, Mark See Hsu, Po Choo;<br />
Rehkemper, Catherine<br />
el Carlo, F. See Doria, Manuel, Jr.<br />
elea, A. See Carrubba, J.; Ostrovaky, Irene<br />
elsa, A. C. See Garland, D. L.<br />
a Leacy, B. A.; Cowley, D. M., 1482<br />
-; Cowley, D. M.; Brown, J. M.; McWhinney, B.<br />
C.; Chalmers, A. H., 1541<br />
e Leacy, Eric A.; Brown, Nigel N.; Clague,<br />
Alan E., 1772<br />
e Leenheer, Andre P. See Lambert, Willy E.<br />
cLays, K. See Pollet, D. B.<br />
elgado, L See Enriquez, John L, Sr.<br />
elivonla-Papadopoulos, Maria, 1058<br />
elpuech, Patrick; Desch, Gerard; Fructus,<br />
Fabienne, 166<br />
el Rio, K. See Rodriguez-Segade, S.<br />
el Rio, Kamon See Rodriguez-Segade,<br />
Santiago<br />
eltour, G. See lzembart, M.<br />
elVeccbio, M. See Reilley, Therese<br />
elwlche,<br />
a Masker,<br />
J. P. See Galanti L. M.<br />
Gerhardus A. ee Franck, Paul F.<br />
H.<br />
emacker, Pierre N.M., 701<br />
eMsrco, Curtis See Mahmood, Nishat<br />
e Maria, K. See Zucchelli, G. C.<br />
eMars, Daniel D.; Katzmann, Jerry A.;<br />
Kimlinger, Terry K.; Calore, James D.;<br />
Tracy, Russell P., 766<br />
emenltt, 8. See Carrubba, J.<br />
emens, Laurence M.; Hicks, P.; Bradstreet, It,<br />
1120<br />
-; Hicks, Patti, 1196<br />
emko, Paul K.; Welch, Robin; Bellino, Linda;<br />
Griben, Denise; Young, C. C.; Winarte,<br />
Handani, 1091<br />
emshar,<br />
enaro,<br />
H. P. See Wang, Stephen T.<br />
Frank See Spector, Stephan A.<br />
enenis, Evan S.; Boulter, Jim; Connolly, John;<br />
Wads, Etsuko; Wads, Keiji; Goldman, Dan;<br />
Swanson, Larry W.; Patrick, Jim;<br />
Heinemann, Steve, 731<br />
cagIer, M. See Metzmann, E.<br />
eNicola, D. See Leaky, F. D.<br />
ennen, D. A. See Dasgupta, Aniitava<br />
ennen, David See Dasgupta, Amitava<br />
ennen, David A. See Kurschinski, Douglas T.<br />
e Nobel, B. See Elving, L. D.<br />
ason, D. D. See Haasan, F. Michael<br />
nt, A. See Sheehan, C.<br />
at, A. H. See Crouch, Cohn<br />
nton, KB. See Kazmierczak, S.C.<br />
Paulo, J. Raymond, Jr.; Simpson, Sylvia 0.;<br />
Folstein, Susan; Folstein, Marshal F., B28<br />
Potter, Werner See Dillen, Lieve<br />
‘Eril, Glanvico Melzl See Franciotta, Diego<br />
Michele<br />
e Roose, Joseph B. See Lambert, Willy E.<br />
esch, Genard See Dolpuech, Patrick<br />
s Scheerder, Ivan See Robbrecht, Johan<br />
e Scheerder, Ivan K. See Do Buyzere, Marc I<br />
e8hon, P. See Reason, C.<br />
-; Reason, C., 1094<br />
e Silva, LV. K.; Rotenberg, a, 2016<br />
esllva, Renuka See Schaap, A. Paul<br />
e Slypere, Jean-Paul Delange, See Joris<br />
esnaet, Gerard See Boitleux, Jean-Louis<br />
etweUer, G. See Howanitz, P. J.<br />
etwllen, Richard; Arter, T.; Daggett, S.;<br />
Pricker, It, 1098<br />
eutsch, Dale 6. See Duncan, Wayne P.<br />
ewhurst, D. G. See Brocklehurst, D.<br />
Zwaan, Chris See Giesen, Peter LA.<br />
‘Haese, Patrick C.; Lamberts, Ludwig V.; Do<br />
Broe, Marc E., 884<br />
Dhiranl, Nasreen See Molnar, Larry A.<br />
Diamandis, B. P. See Bhayana, V.; Khosravi, M.<br />
J.; Reichatein, E.; Shankaran, P.; Tan, A.,<br />
491<br />
-; Papanastasiou-Diamandi, A.; Lustig, V.;<br />
Khosravi,M.J.;Tan,A., 1117<br />
Diamandis, Elefthenlos P.; Papanastasiou-<br />
Diamandi, A.; Lustig, Viiam; Khosravi,<br />
Mohammad J.; Tan, Alan, 1915<br />
Diamond, Constance See Yeo, Kiang-Teck<br />
flax, K. See Khan, Shaista<br />
Dlaz, S.; Rose, H., 1066<br />
-; Hirsch, C.; Dubinsky, E.; Dudley, A. W., Jr.,<br />
1096<br />
Carreras, L., 1096<br />
-; Rose, H., 1096<br />
Dlaz, S. K. See Singh, Jagat<br />
Dlcamelll, K. F. See Sasse, E. A.<br />
Dicker, P. See Edwards, S.<br />
Dickerson, Sandra See Cone, Edward J.<br />
Dickey, D. See Graham, D.; Thompson, F.<br />
Didry, Jean Rene See Mousse, Fathi<br />
Dletzler, David N. See Landt, Yvonne<br />
Digranes, Asbjorn See Bolann, Bjorn J.<br />
Dllena,<br />
Difien,<br />
B. A.; White, G. H., 1543<br />
Lieve; Dc Block, Jan; Van Lear, Lutyart;<br />
Do Potter, Werner, 1934<br />
Dillon, K. See Gibbons,!.<br />
Di Mario, F. See Plebani, Mario<br />
Di Marlo Umberto See Sensi, Maurizio<br />
Dion, K, ee Lessard, F.<br />
Dlorio, Alfred F. See Shah, Vipin D.<br />
-;Haminer,P., 1117<br />
DlPaola, J. See Wimmer, Cathy<br />
-; Tyma, D.; Gharavi, A.; Mercer, W., 1207<br />
DlPaola, Joseph See Salinas, Roealia<br />
-; Salinas, Roealia; Mercer, Wayne, 1205<br />
Dives, W. F. See Crisan, D.<br />
Djulbegovic, Benjamin See Paaic, Resad<br />
Dnlstrlan, Ann M.; Greenberg, E. J.; Schwartz,<br />
D.; Smith, C.; Schwartz, M. K., 1080<br />
Doetsch, K. See Rifaj, Nader<br />
Dohnal, James C.; Bowie, Lemuel J., 1091<br />
Dolan, P. A.; Psnnington, C. D.; Yost, D. A., 1857<br />
Dolci, Alberto; Parlaveechia, Mariella; Mangili,<br />
Ruggero; Marcovina, Santica, 1209<br />
Doman, Joseef See Karadi, Istvan<br />
Domenici, Michael See Hsu, Po Choo<br />
Dominlczak, Marek; Bell, J.; Cox, N.H.;<br />
McCruden, D.; Jones, S. K.; Ong-Tone, L.;<br />
Finlay, A. Y.; Prier, B. M., 1137<br />
Donahoe, Mark; Hall, K.; Luxton, A., 1202<br />
Donis-Keller, H. See Smith, Douglas It<br />
Donis-Keller, Helen See Green, Philip<br />
Donnachie, KM.; Seccombe, D. W.; Urquhart,<br />
N. I.; Scudamore, C. H.; Shackleton, C. R.;<br />
Foreward, A. D.; Erb, 5., 899<br />
Donnelly, James G.; Soldin, S. J., 1167<br />
Donner, J. K See Tadepalli, Sarvamanagala<br />
Donohus, Joseph; Bailey, Mark; Gray, Robert;<br />
Holen, James; Huang, Tung-Ming; Keevan,<br />
James; Mattimiro, Chris; Putterman, Caryn;<br />
Stalder, Arnold; Dofreese, James, 1874<br />
Donovan, J. W. See Beckett, G. J.<br />
Doptis, P. See Van Brunt, N.<br />
D’Onazlo, Paul, 1232<br />
DorIa, LSee Doria, Manuel, Jr.<br />
Doria, Lomna See Dasgupta, Amitava<br />
Doria, M. J. See Harrison, H. H.<br />
Doria, Manuel,<br />
Schwemin,<br />
Jr.; Jove, M.; Molloy, S.;<br />
D.; Doria, L; Chawnont, B.; Del<br />
Carlo, F., 1085<br />
Donizzi, K,; Tagliaro, F., 1185<br />
Doss, K. See Marlewski, D.<br />
Dotchev, Dotcho C. See Svinarov, Dobrin A.<br />
Douet, Philippe See Orsonneau, Jean-Luc<br />
Douglas, J. See Marlewaki, D.<br />
Doumas, Basil T.; Hause, Lawrence L.;<br />
Simuncak, David M.; Breitenfeld, Diane,<br />
Dove, Janet 18cc Prior, Thomas W.<br />
151<br />
Dowdey, A.B.C. See Putnam, ItS.<br />
Dowel, Barry; Borden, Kimberlee; Shaw,<br />
Norm, 1192<br />
Dow.ett, M. See Pearce, S.<br />
Dralsey, T. F. See Caines, Patrick S.<br />
Draper, Karl A. See Whitley, Chester B.<br />
Drapem, Karl A. See Whitley, Chester B.<br />
Drew, Helen See Bruzek, Debra<br />
Dreyfus, 6. See Coeson, C.; Myara, L<br />
Dnueke, T. See Duval, F.<br />
D’Souza,, J. See Kubasik, N. P.<br />
D’Souza, J. P. See Kubasik, N. P.<br />
Dubin, Stuart B., 612<br />
Dublnsky, B. See Diaz, S.<br />
Dublnsky, Eli See Hirsch, Carl<br />
Dubler, Robert See Thacker, Susan<br />
Dubols, P. See Galanti, L M.<br />
DuCharme, L See Eble, K. S.<br />
Dudley, A. W., Jr. See Diaz, S.; Singh. J,; Singh,<br />
Jagat<br />
Duevel, J. See Oeilersch, Michael<br />
Dudley,<br />
Dudman,<br />
Alden<br />
N. P.<br />
W., Jr.<br />
B. See<br />
See Singh,<br />
Wang, X.<br />
J.<br />
L<br />
Duff, Henry J. See Sheldon, Robert S.<br />
Duffy, Patrick See Cheung, Kee<br />
Duffy, T. H.; Bales, R. M., 1079<br />
Dufour, D. Robert See Podiasek, Stanley J.<br />
Dufour, Lucienne See Moussa, Fathi<br />
Duggal, Rita N. See Newman, Edward S.<br />
Duggan, P. Flnbarr See O’Leary, Niall<br />
Dub, Show-Hong; Koch, Thomas It, 1182<br />
Duliot, M. P. See Aleyassine, H.<br />
Dummel, Robert See Zimmermann, Linda<br />
Dun, Huijun See Shoji, Shin’ichi<br />
Duncan, M. See Raymond, Anne<br />
Duncan, Marilyn; Prinsen, J.; Mitchell, G.;<br />
Trundle, D.; Hale, W., 1143<br />
Duncan, Wayne P.; Deutsch, Dale G., 1279<br />
Dunk., Louis, Jr. See Fan, Titan S.; Kish,<br />
Linda; Ku, Che-An; Sciotto-Brown, Susan;<br />
Zinimermann, Linda<br />
Dunlap, Larry See de Kanel, John<br />
Dunn, Dale M. See Bradley, Charles A.<br />
Dunn, Don J.; Bhick, Kenneth E.; Gillwn,<br />
Ronald 1, 1138<br />
Dunn, Robert J. See Attia, John<br />
Dupuy, Georges See Leapinas, Francis<br />
Dutton, Charyl M. See Whitley, Chester B.<br />
Duty, Gale See Passey, Richard B.<br />
Duval, F.; Frommherz, K.; Atger, V.; Drueke, T.;<br />
Lacour, B., 963<br />
Dyer, Deborah; Cate, J.; Skogen, W., 1184<br />
Dyer, K. See Shihabi, Z.<br />
Earl, LA. See Haven, M. C.<br />
-; Studts, D. J.; Markin, R. S., 1072<br />
-; Timko, D. M.; Markin, R. S., 1153<br />
Earl, Robert A. See Haven, Mary C.<br />
Earnhardt, Kimberly See Snouwaert, John N.<br />
Eastep, Steven J.; Benson, Peter J.; Presse,<br />
Lynne M.; Apple, Fred S., 333<br />
Eastman, Creswell J. See Novick, David M.<br />
Eble, K. 8.; Rynning, M.; Hutten, P.; Nelson, L.,<br />
1193<br />
-; DuChsrme, I; Stojak, J., 1193<br />
Eby, W. See Bark, Lee; Webb, Gary<br />
Echizen, Hirotoshi; Itoh, Roichi; Ishizaki,<br />
Takashi,64<br />
Eckehinan, W. C. See Jagoda, E.<br />
Eckenbom, Solveig; Bergqvist, Yngve, 2253<br />
Eckfeldt, John H.; Semi, Chris; Bormann,<br />
Priscilla; Bradley, 0. Mary, 1804<br />
Edo., Thomas K See Thornton, William H., Jr.<br />
Edinboro, Leslie B,; Hall, Karen V.; Pokhis,<br />
Alphonse, 1176<br />
Edwards, B. See Thorpe, G. H. G.<br />
Edwards, B. M. See Ostrow, D. H.<br />
Edwards, G. C. See AuBuchon, J. P.<br />
Edwards, Paul; Liu, Peter K. S.; Rose, G. Alan,<br />
241<br />
Edwards, K. See Koh, Tung Ruiz, Eliseo<br />
Edwards, S.; Moon, C.; Dicker, P.; Shepherd, H.,<br />
1080<br />
Edwards, W. See McConway, M. G.<br />
Egbents, J. See Wijnands, J. B. G.<br />
Egbnlng, K. See Dati, F.<br />
Egensperger, H. See Van Brunt, N.<br />
Eggertien, Robert See Lindstedt, Gorse<br />
Ehlen., 6. See Ferris, Robert J.<br />
Ehrenkranz, Joel K. I See Person, Nils B.<br />
Ehrmeyer, S. See Laessig, Ronald<br />
Elsenbeng, Paul K,; Shaw, David; Schsab,<br />
Colleen; Jaffe, Allan S., 440<br />
Ekin, Ronald J. See Kroll, Martin H.<br />
Eklndjian, 0.6.8cc Roche, D.; Thuan, N. T.<br />
Leuquang<br />
Ekina, Roger<br />
510<br />
Nelson, Jerald C.; Tomei, Ray T.,<br />
-; Tikanoja, Sari; Liewendahi, Kristian, 708<br />
El Allaf,<br />
El AIls!,<br />
Pd. See Chapelle, Jean-Paul<br />
Magdelelne; Chapelle, J. P., 1120<br />
El-Attar, Hanan M. See Ali, Farouk M.<br />
-;Shobokshi,O.;Ali,F., 1186<br />
Ella, Ronald J. See Hoeseini, Jeanette M.<br />
-; Hosseini, Jeanette M.; Ruddel, Mark, 1114<br />
-; Hosseini, Jeanette M.; Yang, Xiu Ying, 1115<br />
-; Hoeseini, Jeanette M.; Ruddel, Mark;<br />
Rubinow, David, 1115<br />
-; Bloom, Jeffrey N.; Herman, David C.; Shiva,<br />
Clara A.; Ruddel, Mark; Nussenblatt, Robert<br />
B.; Palestine, Alan G., 1159<br />
-;Ruddel,MarkE., 1182<br />
Elkhallfa, Mohamed; Collins, S.; Karcher, It;<br />
Epstein, E.; Kiechle, F. L., 1124<br />
Ellertz, Gina See Lindstedt, Gorse<br />
CLINICALCHEMISTRY. Vol. 35, No. 12, 1989 2347
Elliot, K.; Watson, I. D.; Stewart, M. J., 1352<br />
Elliot, R. L See Werneke, Debra K.<br />
Elliott, M. C.; Gordon, Wiffiam H.; Aahwood,<br />
EdwardR., 1120<br />
Elliott, K. L. See Konrath, J. G.<br />
Ellis, Graham; Holland, F. John; Makela,<br />
Sinikka K., 1150<br />
El Shanii, Said See Spiehier, Vine<br />
Bison, M. See Kusilek, Lesa D.<br />
Elving, L. D.; Bakkeren, J. A. J. M.; Jensen, M.<br />
J. H.; do Kat Angelino, C. M.; de Nobel, E.;<br />
van Munster, P. J. J., 308<br />
El-Yazigi, Adnan; Chaleby, Kutaiba; Martin,<br />
Cazemiro R., 848<br />
Emancipator, K.; Kroll, M. H., 1161<br />
Emerit, Jacques See Bonnefont, Dominique<br />
Endo, Takeahi See Kobayashi, Isao<br />
Endres, David B.; Villanueva, It; Sharp, C.;<br />
Singer, F., 1148<br />
Engbaek, Frode; Christensen, Stig Engkjaer;<br />
Jespersen, Bente, 93<br />
Engebrecht, K. See Danielson, Susan J.<br />
Engel, W. D. See Karl, Johann<br />
English, Trevor N. See Novick, David M.<br />
Enrlquez, John I., Sr.; Keniston, R.; Delgado. L,<br />
1136<br />
Epstein, K See Elkhalifa, Mohamed; Karcher,<br />
Raymond<br />
Epstein, Emanuel See Seharer, Katharine A.<br />
Erb, K, B. See Lewis, L M.<br />
Erb, S. See Donnachie, E. M.<br />
Erickson, Katherine See Kricka, Larry J.<br />
Eniksson, Lars See Hansson, Lena<br />
Esajas, M. See Wijnands, J. B. 0.<br />
Espina, Virginia See Faynor, Steven M.<br />
Esposito, Linda See Nicoison, Ruth E.<br />
Ethier, Diane See Tagari, Philip<br />
Evans, 0.0., 897<br />
Evans, I. See Prinsen, Johanna<br />
Evans, John See Painter, Pennell<br />
Fagglsn, D. See Plebani, Mario<br />
Fagin, A. See Miyada, D. S.<br />
Falkensson, Marianne; Jones, Wayne; Sorbo,<br />
Bo,918<br />
Falutz, Julian; Tsoukas, Chris; Cardno, Todd,<br />
704<br />
Pan, Der-Fong; Ke, Shu-Wen; Singh, Madhuri;<br />
Hartsock, Robert J., 1142<br />
Fan, Titan S.; Lentrichia, Brian B.; Solan,<br />
Vishnu; Sheiman, Mark I.; Dunka, Louis, Jr.,<br />
1171<br />
Fang, X. See Broyles, Celeste<br />
Fardin, E. See Marcovina, Santica<br />
Parley, John K,; Kyeyune-Nyombi, Eru;<br />
Tarbaux, Nanine M.; HaU, Susan L.; Strong,<br />
Donna D., 223<br />
Farmer, MG. See Zoha, Steven J.<br />
Farrance, I. See Rowbwy, D.<br />
Farrant, Robert K. See Philhpou, George<br />
Farrenkopf, B. See Awdziej, Tania N.; Cheng C.<br />
Farrenkopf, Bruce C.; Mylott, G.; Awdziej, T.;<br />
Kaufman, It A., 1178<br />
Farzami, B., 1557<br />
Fasullo, Frank J., Jr.; FrItsche, Herbert A., Jr.;<br />
Liu, Frank J.; Hamilton, Robert G., 364<br />
Faulder, Charles 0. See Beckett, Geoffrey J.<br />
Faynor, Steven M.; Eapina, Virginia, 1180<br />
Felfel, G. See Beever, K.<br />
Feild, Margaret See Thompson, James D.<br />
Fold, Ronald See Roberts, Pamela<br />
-; Roberta, Pamela, 1081<br />
Fold, Ronald D. See Nuwayhid, Naziha F.;<br />
Punzalan, Rubio It<br />
Feldbruegge, Donald See Tee, Martina<br />
Felder, K. A.; Holl, It W.; Martha, P., Jr.;<br />
Bauler, G.; Hellman, P.; Wills, M. It;<br />
Thorner, M. 0., 1423<br />
Felder, Robin A., 1051<br />
-; Roberts, Ruth; Barlow, Ellen; Boyd, James C.,<br />
1200<br />
Feldmann, Delphlne; Flandrois, Christine;<br />
Jardel, Alain; Phan, Tuyet-Minh; Aymard,<br />
Pierre, 864<br />
Fell, Anthony F. See Kirk, Elaine M.<br />
Fell, 0.8. See Fraser, W. D.<br />
Fehnayer, Gabriel Werner See Fucha, Dietmar<br />
Felmayer, Gabriele Werner See Fuchs,<br />
Dietmar<br />
Fenton, John See Motika, Deborah<br />
Ferber,!. See Lee, Sung C.<br />
Ferdeghini, M. See Pilo, A.<br />
Fernio, Isabella See Paleari, Renata<br />
Fernandez, P. See Vasdev, Sudesh<br />
Forniund, P. See Abrahamsson, P.-A.<br />
Ferran,M.E.;Lucas,F., 1111<br />
Ferrari, K.; Ceconi, C.; Signorini, C.; Anand, L;<br />
Harris, P.; Albertini, A., 331<br />
Ferrari, Roberto See Polesi, Claudio<br />
Femre, C. See Huuet, J.<br />
Ferreira, Victoria M.; Pastore, Denise, 1105<br />
Ferris, Robert J.; Ehlers, G., 1131<br />
Ferron, Liliane See Manca, Dino<br />
Fessas, Phedon See Giannoulaki, Elefteria E.<br />
Fesus, Paul D.; Preasac, Monique; Braconnier,<br />
Francois; Ayinard, Pierre, 481<br />
Feuillu, A. See Goujet, B.<br />
Field, Patricia H. See Stanton, Noel V.<br />
Fields, S. See Kaseman, Deborah; Reilley,<br />
Therese<br />
Figard, Steve D.; Bodner, J.; Babik, D. M.;<br />
Mlyniec, D.; Simpson, B.; Ogunro, E. A.,<br />
1147<br />
Figarella, Catherine See Barthe, Catherine<br />
Fiomena, Carol Ann, 1158,1795<br />
Finbow, J. A. H. See Brocklehurst, D.<br />
Finding, James W. See Raff, Hershel<br />
Fine, James S.; Chandler, Wayne L.; Clayson,<br />
Kathleen J., 2018<br />
Fine, Joan-Marina See Lefrere, Jean-Jacques<br />
Fink, Louis M. See Taylor, E. Howard<br />
Finlay, A. Y. See Dominiczak, Merck<br />
Flnlayson, J. See McConway, M. 0.<br />
Finn, Martha F. See Folan, John<br />
Finneran, J. See Staedter, M.<br />
Firat, Dincer See Copur, Sitki<br />
First, Pd. K, See Schroeder, Timothy J.<br />
Flschberg, B. See Kaseman, Deborah; Reilley,<br />
Therese<br />
Fischer, Johan; Verbruggen, Bert; Weasels,<br />
Hans; Haenen, Clemens, 483<br />
Fisher, Catherine See Rehkemper, Catherine<br />
Fisher, Delbert A. See Pandian, M. R.<br />
Fitzgerald, A. See Rowbury, D.<br />
Fitzgerald, D.; Richter, D.; Richards, J.;<br />
Hemker,<br />
Fitzpatrick,<br />
S.; Jawed, J.; Wegfahrt, P., 1140<br />
D. A.; Law, W. T.; Pasqua, J., 1133<br />
Fitzpatrick, J. See Bhargava, A. K.; Bhargava,<br />
AK<br />
Fitzpatrick, J. K See Bhargava, A. K.<br />
Flanagan, K. J.; Ruprah, M., 1342<br />
Flandrois, Christine See Feldinann,<br />
Flatow, B. See Fleisher, Martin<br />
Delphine<br />
Fleisher, Martin; Flatow, B.; Schwartz, M. K.,<br />
1128<br />
-; Gladstone, Michael; Crystal, Della; Schwartz,<br />
Morton K., 1532<br />
Flendnig, J. Guns See Gieaen, Peter L A.<br />
Flentge, Charles See Brashear, Jeff<br />
Ftentje, Dsgmar See Bohler, Ulrich<br />
Plom, Kenny J., 1087<br />
Floreani, A. See Plebani, Mario<br />
Floreani, M. See Kiang, W.<br />
Flye, M. Wayne See Wolf, Bryan<br />
Foglia, J. P. See Perel, J. M.<br />
A.<br />
-; Perel, J. M.; Lin, F. C.; Narayanan, S., 1185<br />
Fohlin, Lan See Bergqvist, Yngve<br />
Folan, John; Gosling, James P.; Finn,<br />
Fottrell, Patrick F., 569<br />
Martha F.;<br />
Folena-Wasserman, 0.5cc Tsunokawa,<br />
Foley, Thomas See Louderback, Allan<br />
M.<br />
Follett, Edward A. C. See Sinclair, David<br />
Folatein, Marshal F. See DoPaulo, J. Raymond,<br />
Jr.<br />
Folsteln, Susan See DoPaulo, J. Raymond, Jr.<br />
Folts, M. M. See Fredrickson, R A.<br />
Fontaine, Monique; Porchet, Nicole; Largffliere,<br />
Claude; Marrakchi, Slaheddine; Lhermitte,<br />
Michel; Aubert, Jean-Pierre; Degand, Pierre,<br />
2148<br />
Foo, A. Ylug See Rosalki, Sidney B.<br />
Foo, Ying See Bais, Renze<br />
Ford, Kent A. See Baker, Harold N.<br />
-; Baker, Harold N.; Bear, Janet G.; Belay,<br />
Diane; Marlewaki, Deborah; Venetucci,<br />
Mary; Ogunro. Edward A.. 2333<br />
Foneward, A. D. See Donnachie, E. M.<br />
Forman, Donald T. See Highamith. William E.<br />
Fomni, Theresa See Anne, Lakshmi<br />
Foranian, Rodney W. See Muffin, Theodore E.<br />
Fortin,<br />
Fossatl,<br />
Louis-Jacques<br />
Nero; Ponti,<br />
See Davignon, Jean<br />
Maurizi ,Principe,<br />
Lorenzo; Tarenghi, Giordano, 173<br />
-; Sirtoil, Melanie; Tarenghi, Giordano;<br />
Glachetti, Martino; Berti, Giovanni, 2212<br />
Foster, O.K. See Beckett, G. J.<br />
Fotiou, F.; Piper, M., 1073<br />
Fottrell, Patrick F. See Folan, John; Howard,<br />
Katrina; Power, Michael J.<br />
Fowlkes, Dana M. See Snouwaert, John N.<br />
Fox, J. Lawrence; Klasa, Michael, 1838<br />
Fox, M. See Thompson, F.; Vasilakis, Jeanne<br />
Fox, Martha; Vasilakie, J.; Thompson, F.; Pelch,<br />
D.; Haden, B.; Powers, M.; Aberin, C.; flano,<br />
V.; Noriyuki, I.; MiUsap, S., 1088<br />
Fraij, Bassam M., 658<br />
France, Laura A. See Whitley, Chester B.<br />
Franciotta, Diego Michele; D’Eril, Gianvico<br />
Melzi, 337<br />
Franck, Paul F. H.; de Meeker, Gerhardus A.;<br />
Moolenaar, Abraham J., 1995<br />
Frandsen, Erik K.; Bacchus, Bobby A.; Moaz,<br />
Ahmed A.; Sabagh, Tahir, 712<br />
Frandsen, Niels Jorgen; McNair, Peter, 1986<br />
Frank, Alison See Larsen, Sandra<br />
Frank, Kathy See Kress, Barry C.<br />
Franklin, S. See Chiang, C. S.; Cooper, M.<br />
Franquemont, Douglas W.; Sutphen, James I<br />
Herold, David A.; Bruns, David E., 1158<br />
-; Sutphen, James L.; Herold, David A.; Brum<br />
DavidE., 1760<br />
Frantz, Ivan See Bachorik, Paul S.<br />
Fraser, Callum G. See Stolarek, Iwona<br />
-; Cummings, Steven T.; Wilkinson, Stephen<br />
Neville, Ronald 0.; Knox, James D. E.; Ho<br />
Olga; MacWalter, Ronald S., 783<br />
-; Lott, John A., 1553<br />
Fraser, W. D.; Taggart, D. P.; Fell, G. S.; Lyon<br />
T. D. B.; Wheatley, D.; Garden, 0. J.;<br />
Shenkin, A., 2243<br />
Frazer, I. H. See Renouf, Judith A.<br />
Fredrickson, K. A.; Belchak, T. L; Foltz, M. I<br />
Loeschen, B. J.; Profitt, J. A.; Yoder, J. M.<br />
Morris, D. L,, 1140<br />
Freedman, Danielle B. See Ball, Richard<br />
Freeman, J.; Hsu, J.; Lopez, B.; Visor, J.;<br />
Messenger, H.; Wong, E.; Buelteman, L;<br />
Mills, A.; Brady. A.; Hu, M.; Anderson-<br />
Mitchell, K.; Bellet, N., 1180<br />
Freier, C. See Kan, Brenda<br />
Freier, Esther F. See Hanson, Naomi Quest<br />
Press, G.; Vignon, F.; Pau, B.; Paolucci, F.;<br />
Rochefort, H., 234<br />
Freiss, Gllles See Rogier, Herve<br />
Fricker, F. J. See Crisan, Domnita<br />
Fnicker,<br />
Fniddell,<br />
K. See Detwiler, Richard<br />
Colleen S. See Oldhem, Robert K.<br />
Fridrich, Leo; Szekeres, Thomas; Hartter,<br />
Engelbert; Sehweighofer, Franz; Gassner,<br />
Alfred; Laczkovic, Azel, 435<br />
Fniedberg, M. See Shihabi, Z.<br />
Friedman, K. J. See Prior, T. W.<br />
Friedmann, Kenneth J. See Prior, Thomas W<br />
Pride, Thomas; Caron, Marc G.; Lefkowitz,<br />
RobertJ., 721<br />
Frier, B. Pd. See Dominiczak, Marek<br />
Fries, P. See Keller, Charles H.<br />
Fninga, Christopher S.; Battaglia, Danielle J.;<br />
White, Robert M., 891<br />
Fritsche, E. T. See Holzberg, Roni A.<br />
Frltsche,<br />
Fritsche,<br />
B. A. See Shahangian, S.<br />
Herbert A., Jr. See Fasullo, Frank<br />
Jr.; Shahangian, Shahram<br />
Frommherz, K. See Duval, F.<br />
Fruchart, J. C. See Steinmetz, A.<br />
Fructus, Fabienne See Delpuech, Patrick<br />
Fry, Henry D. See Blick, Kenneth<br />
Fu, J. C. See Hong, X. Q.<br />
-; Cheng, A. J.; Chen, C. W.; Lu,<br />
E.<br />
W.; Lam, K.<br />
W., 1079<br />
Fu, Maria See Bleile, Dennis<br />
Pu, Paul; Zic, V.; Tanimoto, L.; Gorsky, J., 109<br />
Fuchs, Dietmar See Reibnegger, Gilbert<br />
-; Spire, Thomas J.; Heusen, Arno; Reibnegge<br />
Gilbert; Werner, Ernst It; Felmayer,<br />
Gabriele Werner; Wachter, Helmut, 1748<br />
-; Heusen, Arno; Reibnegger, Gilbert; Werner,<br />
Ernst R.; Felmayer, Gabriel Werner<br />
Wachter, Helmut, 2158<br />
-; Milstein, Sheldon; Kramer, Alexander;<br />
Reibnegger, Gilbert; Werner, Ernst It;<br />
Goedert, James J.; Kaufman, Seymor;<br />
Wachter, Helmut, 2305<br />
Fuchs, J. See Rotenberg, Z.<br />
Fuchg, Jacob See Rotenberg, Zvi; Weinberger,<br />
Itzhak<br />
Fuentes-Ardeniu See Juan-Pereira, L.<br />
Fuentes-Arderlu, X. See Huguet, J.<br />
-; Lott, John A., 1552<br />
Fujimoto, Takashi; Tsuda, Yoshiko; Tawa,<br />
Riichi; Hirose, Shingo. 867<br />
Fujita, Keisuke See Maruta, Kazuhiro<br />
Fukuda, Chisako; lijima, Kenji; Nakamura,<br />
Katsumi, 1897<br />
F’ukushi, Masaru See Yamaguchi, Akihiro<br />
Fukuyama, Yachiyo See Miure, Masakazu<br />
FUkUZUIni, Kieko See Terayame, Hiroahi<br />
Fulton, Ann; Chan, Shirley; Coleman, Graham<br />
641<br />
Fulton, T. K, See Smith, Douglas It<br />
Furuya, Shin See Kuroiwa, Ketsumaea<br />
Gabor, Michael J. See Bachand, Steven S.;<br />
King, David L.<br />
2348 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
thor, Mike; Martel, P.; O’Donnell, C. M., 1173<br />
Ige, Carole L See Schwartz, Joyce 0.<br />
ige, S.; Seymour, D.; Valenta, It; Cernosek, S.,<br />
1197<br />
ihi, W. A. See Papadopoulos, N. M.<br />
illlard, M. Christine; von Arb, Marianne; de<br />
Costs, Anna; Kilroe-Smith, Terence A., 1535<br />
danti, L M.; Delwiche, J. P.; Dubois, P.;<br />
Somville, M. A.; Pouthier, F.; Prignot, J., 496<br />
ilbraith, Linda V. See Leunj. Fred Y.<br />
Jablonsky,<br />
Henderson,<br />
George; Leung, Fred Y.;<br />
A. Ralph, 1116<br />
dlagher, S. K.; Johnson, L. K.; Milne, D. B.,<br />
369<br />
illi, Andre See Bonnefont, Dominique<br />
dliher, 0.See Sun, Lila<br />
dloway, Eric See Sinclair, David<br />
dteau, M. M. See Vincent-Viry, Monique<br />
unbhir, K, K.; Agarwal, Veena It, 1128<br />
lines, David E., 1055<br />
Innon, Allison; Teramoto, Y.; Knapp, S.;<br />
Tran, K.; Langton, B., 1079<br />
ircia, Marcel See Rogier, Herve<br />
ircia, Maria See Kurschinski, Douglas T.<br />
irden, 0. J. See Fraser, W. D.<br />
inland, D. L; Garland, T. E.; Delee, A. C., 1104<br />
inland, T. E. See Garland, D. L.<br />
iroscio-Cholet, Pd. See Dechaud, H.<br />
irrett, Patricia E. See Sullinger, Jana<br />
my, Philip J., 1061<br />
Irver, Fred A. See Moscoso, Hugo<br />
macon, Felix; Molina, Ernesto, 191<br />
m, T. See Leaky, F. D.<br />
laser, F. See Sapin, It<br />
masner, Alfred See Fridrich, Leo<br />
mat,Michael J. See Scott, Mitchell G.<br />
stes, Teresa See Thacker, Susan<br />
Crisafulli, T.; Chiappetta, E.; Jenkins, M.,<br />
1174<br />
itti, V. See Tamagno, B.<br />
ml, M. H. Chafe, L; Comerford, A.; Jenkins,<br />
M.; Hayden, K.; Vasdev, S.; Longerich, L.,<br />
1133<br />
Longerich, L.; Brent, D.; Johnson, D.;<br />
Johnson, E., 1150<br />
iwoski, J. Pd.; Walsh, D., 2140<br />
sijo, Sofia A. See Vents, Rafael<br />
slder, Frank B. See Shahangien, Shehram<br />
ing, Jian-Guo; Chen, Hso-Zhu; Yang, Yi-<br />
Feng; Qian, Zhong-Hao; Thong, Li-Ming, 96<br />
mi, J. Paul See Dean, Harvey G.<br />
mntzer, W. See Madry, Norbert<br />
sorge, P.M.; Sheet, J. M., 179<br />
sorge, William J. See Ricci, Mary Jo<br />
srard, S. See Chen, Katherine; Khayam-Bashi,<br />
Hasaan<br />
irasiniova, Natalija S.; Stekiova, Irma V.;<br />
Tuuminen, Tamara, 2112<br />
irber, M. See Klein, G.<br />
Ire, Jeffrey A. See Stevenson, Cathy C.<br />
mrhardt, Gregory; Davitt, Christine; Chan,<br />
Daniel W., 1554<br />
irmino, G. G. See Reeders, S. T.<br />
maravi, A. See DiPaola, J.<br />
moneum, G. See Ansari, A.<br />
acobiul, B. See Unni, L. K.<br />
senpietro,<br />
Lorelle;<br />
Ottavio; Clerico,<br />
Penno, Giuseppe;<br />
Aldo; Cruschelli,<br />
Nevalesi, Renzo,<br />
1560<br />
annouleki, Elefteria E. See Kalpexis,<br />
Dimitrios L.<br />
Kalpexis, Dimitrios L.; Tentas, Constantinos;<br />
Femsas, Phedon, 396<br />
bbons, L; Gorin, M.; Yassinzadeh, Z.;<br />
Peerson, P.; Besemer, D.; Dillon, K.; Burd,<br />
T.; Rillnian, R.; Smoluk, G.; Cobb, M., 1869<br />
bbs, Judy; Root, D.; Brown, K., 1190<br />
bbs, K. A. See McBride, L J.<br />
bIer, W, B. See Lewis, L. M.<br />
bean, S. See Murphy, Allan<br />
dwani, G. See Gupta, Manjula K.<br />
Lesen, Peter L A.; Peltenburg, Henny G.; de<br />
Zwaen, Chris; Janson, Piet C. W.; Flendrig,<br />
J. Guus; Hermens, Wim Th., 279<br />
ibent, S. See Witherspoon. L It<br />
Ilespie, David See Thompson, James D.<br />
llespie, G. A. J. See Reeders, S. T.<br />
llham, Sherni L See Schwartz, Joyce 0.<br />
Ilinor, K. See Okorodudu, A. 0.<br />
Ilum, Konald ISee Blick, Kenneth E.; Dunn,<br />
Don J.; Passey, Richard B.<br />
Llmore, B. See Myers, Gary L.<br />
Strap,<br />
nising,<br />
L See Putnam, It S.<br />
Peter; Nexo, Ebba, 1447<br />
ordano, Donna J., 1096<br />
rand, Yves See Tegari, Philip<br />
rardot, Clemencia See Cheng, K. Steve<br />
Gin, S. See Petersen, J. It<br />
Gitelnian, Hillel J.; Alderman, Frances R., 1517<br />
Glechetti, Martino See Fosseti, Piero<br />
Gladding, D. See Shah, Vipin<br />
Gladstone, Michael See Fleisher, Martin<br />
Glen, A. C. A. See McConway, M. 0.<br />
Glees, U. See Kruse-Jarres, J. D.<br />
Glick, M. See Rushkowski, Janet<br />
Glick, Melvin See Ryder, Kenneth<br />
-; Glick, Starla; Ryder, Kenneth W., 1108<br />
-; Glick, Sterla; Ryder, Kenneth W., 1160<br />
Gllck, Melvin K,; Ryder, Kenneth W.; Glick,<br />
Starle J.; Woods, John R., 837<br />
Glick, Starla See Glick, Melvin; Ryder. Kenneth<br />
Glick, Starla J. See Glick, Melvin R.<br />
Glickinan, J. See Cssko, G.<br />
Glickman, Janice See Csako, Gyorgy<br />
Globis, C. See Chin, Bruce G.<br />
Glover, J. See Crouch, Cohn<br />
Gobnogge, Koger See Brettfeld, Chris<br />
Goedert, James J. See Fucha, Dietmar<br />
Goga, V.5cc Chen, Alice<br />
Goldberg, N. See Prinsen, Johanna<br />
Goldenbeng, David M. See Hansen, Hans J.;<br />
Newman, Edward S.<br />
Goldensoph, C. K. See Tadepalli,<br />
Sarvacnanagala<br />
Goldman, Dan See Deneris, Even S.<br />
Goldsmith, Barbara M.; Troyanosky, Deborah;<br />
Hanges, Lisa, 1168<br />
Goldstein, P. J. See Manimekalai, S.; Sundarem,<br />
Shan G.<br />
Goldstein, Phiffip J.; Sundarem, G. S.;<br />
Manimekslai, S., 1157<br />
Golubjatnikov, Rjunik See Shaw, Norman<br />
Gomez-Hens. Agustina See Perez-Bendito,<br />
Dolores<br />
Gonchoroff, Daryl G.See Sehoenau, E.<br />
-; Branum, Earl L.; O’Brien, John F., 29<br />
Gonzalez, B. Fabre See Budria, J. Ruiz<br />
Good, I. J. See Bernstein, Larry H.<br />
Goodman, D. B. P. See Remeley, A. T.<br />
Goodman, H. See McCormick, C.<br />
Goodnow, Timothy T. See Butch, Anthony W.<br />
Goral, A. See Beever, K.<br />
Gordon, C. See Sadrzadeh, Sayed M. H.<br />
Gordon, Pd. See Smith, Carol<br />
Gordon, William<br />
Goren, Marshall<br />
H. See Elliott, M. C.<br />
P.; Li, Jacki T. L., 1110<br />
Gorin, M. See Gibbons,!.<br />
Gonman, E.G. See Newman, D. J.<br />
Gornet, Terrie G.See Wu, Alan H. B.<br />
Goraky, J. See Fu, Paul<br />
Gosling, James P. See Folan, John; Howard,<br />
Ketrina; Power, Michael J.<br />
Goth, Laszlo; Meszaros, Istvan; Scheller,<br />
Gyory, 1793<br />
Gotoh, Hiroshl; Hegihare, Masako; Nagatsu,<br />
Toehihsru; Iweta, Hisashi; Miura, Tskayuki,<br />
1016<br />
Gotto, Antonio M., Jr. See Bachorik, Paul S.;<br />
Patsch, Wolfgang<br />
Gottwald, K. See Hu, Mae<br />
Gottwald, Ken See Anne, Lakehmi<br />
Gouget, B.; Gourmelin, Y.; Feuillu, A.;<br />
Truchaud, A., 1133<br />
Gould, S. A. See Sehgal, Lakshman It<br />
Gourmehin, Y. See Gouget, B.<br />
Graham, B. See Mulberg, E.<br />
Graham, D.; Thompson, F.; Dickey, D., 1088<br />
Gram, Jorgen; Jespersen, Jorgen, 52<br />
Grande, Peer See Christenson, Robert H.<br />
Grandjean, Philippe,<br />
Gray, L See Winkles,<br />
1055<br />
J. W.<br />
Gray, Kichard W. See Lemann, Jacob, Jr.<br />
Gray, Kobert See Donohue, Joseph<br />
Gray, T. A. See Kennedy, R. Lee<br />
Grazia Do Roasi, Maria See Sensi, Maurizio<br />
Graziani, Maria Stella; Lippi, Ugo; Veasenelli,<br />
Corrado; Blankenhorn, David H.; Alsupovic,<br />
Peter, 1266<br />
Green, Denise T. See Armbruster, David A.<br />
Green, Eric D. See Scott, Mitchell G.<br />
Green, Judy L See Parker, K. Michael<br />
Green, Philip; Helms, Cynthia; Weiffenbach,<br />
Barbara; Stephens, Karen; Keith, Tim;<br />
Bowden, Don; Smith, Doug; Donis-Keller,<br />
Helen, B33<br />
Greenberg, B. J. See Dnistrian, Ann M.<br />
Greenberg, N. See Van Brunt, N.<br />
Gregg, K. E. See Huang, C. M.<br />
Gregory, B. See Bennett, H. J.<br />
Gregory,<br />
Grenner,<br />
Maudry See Ryan, Francis<br />
0. See Ackermann, H.; Bleckwood, J.;<br />
Dakubu, S.; Medry, Norbert; Padilla, A.;<br />
Staedter, M.<br />
-; Inbar, S.; Meneghmni, F. A.; Long, E. W.;<br />
Yamartino, E. J., Jr.; Bowen, M. S.;<br />
Blackwood, J. J.; Padille, A. J.; Mareteky, D.;<br />
Stsedter, M., 1865<br />
Grenot, Catherine See Pugeet, Michel<br />
Greuner, A. M. See Kropf, J.<br />
Grevel, J. See Napoli, K. L<br />
Grey, Joseph B. See Miles, Andrew<br />
Gniben, Denise See Domko, Paul It<br />
Griesser, H. W. See Kessler, Anne-Ch.<br />
Griffith, Dan K. See Chasnoff, Ire J.<br />
Griffiths, H. See Price, A.<br />
Griffiths, Huw See Kennedy, R. Lee; Price,<br />
Alun<br />
Grinatead, Gregory F., 1998<br />
Grinsted, J. See Wendrup, Jesper<br />
Gross, Susan F.; Hernandez, Carol; Weeks,<br />
Marilyn; Havranek, Lauren; Tono, Mary;<br />
Khayam-Bashi, H., 1183<br />
Grove, T. See Chiang, C. S.; Cooper, M.;<br />
Tsunokawe, M.<br />
Gruemer, Banns-Dieter See Prior, Thomas W.<br />
Gruemer, Hans-Dieter See Weiasbecker, Karen<br />
A.<br />
Gruener, Nachman See Barek, Mba<br />
Gruenent, D.C. See Smith, Douglas It<br />
Grutzmeier, Sven; von Schenck, Henning, 461<br />
Guadagno, Philip See Puleo, Peter K.<br />
Guadagno, Philip A. See Puleo, Peter R.<br />
Gusach, K, See Portoles, M.<br />
Gubata, Paul; Lefebvre, R. Craig, 1098<br />
Guemouni, Laila; Penn, R.; Artur, Y.; Mm, A.;<br />
Siest.G., 1126<br />
Guglielmotti, Angelo See Silvestrini, Bruno<br />
Guilbaud. Jean-Charles See Macart, Michel<br />
Guillemain, K, See Cosson, C.; Myare, L<br />
Gunter, Elaine W. See Myrick, James E.;<br />
Parsons, Patrick J.; Stanton, Noel V.<br />
-; Turner, Weyman E.; Huff, Dan L., 1601<br />
Gunzler, V. See Schnorr, G.<br />
Gupta, M. Pd. See Somani, B. L.<br />
Gupta, Manjula K.; Seifarth, K.; Redmond, G.<br />
P.; Gidwani, G.; Bergfeld, W., 1143<br />
Gutierrez, Alda; Rifai, N.; Holly, It, 1066<br />
Gutlerrez, M. Carmen See Perez-Bendito,<br />
Dolores<br />
Gutman, Steven!. See Katz, Paul R.<br />
Guy, Jennifer See Shew, Norman<br />
Guy-Crotte, Odette See Barthe, Catherine<br />
Haanen, Clemens See Fischer, Johan<br />
Hachmann, H. See Schnorr, G.; Schnorr, Gerd<br />
K.<br />
Hacisalihoglu, Ayse See Torun, Meral<br />
Haddow, James K See Knight, George J.<br />
Haden, B. See Fox, Martha; Mwrhead, C.;<br />
Thompson, F.; Vasilakis, Jeanne; Williams,<br />
Michael<br />
-; VenWinkle, M.; Scott, M.; Busch, M.; Ascher,<br />
M.; Thorstensson, It, 1204<br />
Haden, BW See Clark, Mary M.<br />
Haessig, Lorene K. See Bagneski, Kim<br />
Hafkenscheid, J. C. M.; van den Berg-Bosman,<br />
H. T. It; Hessels, M., 1790<br />
Hage, David S.; Taylor, Bob; Schryver, Pet; Keo,<br />
PamC., 1210<br />
Hagele, B. 0.; Kratzer, M.; Schaich, E.;<br />
Reuscher, E., 188<br />
Hagihara, Masako See Gotoh, Hiroehi<br />
Hagiwara, Kohjl See Konno, Norimichi<br />
Hahnel, B. See Hahnel, R.<br />
Hahnel, K.; Avenell, M. H. J.; Hahnel, E., 2226<br />
Hahnel, Koland See Masters, AM<br />
Haight, Pd. See Rosenthal, P.<br />
Haines, Dale See Thompson, James D.<br />
Hajnl-Mezghanl, Selma See Riesco, Oscar F.<br />
Halbert, Sheridan A., 1059<br />
Hale, W. See Duncan, Marilyn<br />
Hall, D. See Lee, Sung C.<br />
Hall, K. See Donehoe, Mark<br />
Hail,<br />
Hail,<br />
Karen V. See Edinboro,<br />
Pd. See Neisler, H. M.<br />
Leslie E.<br />
Hall, Margot See Panteghini, Mauro<br />
Hail, K, See Ishii, S.<br />
Hail, K, L See Rosenthal, Philip<br />
Hall, Susan L See Farley, John It<br />
Hail, Terry D. See de Kanel, John<br />
Halloran, Stephen P.; Bell, Michael K.; Watson,<br />
Anita, 1268<br />
Halonen, Tuija See Suonp#{227}A, Mikko<br />
Halsey, John F. See Colwell, Mark<br />
Halatead, K. See Van Brunt, N.<br />
Halstenson, Charles K See Apple, Fred S.<br />
Halveraon, Kevin See Melik, Soheil<br />
Hamet, M. See Chadefaux, B.<br />
Hamilton, Marilyn See Mifflin, Theodore E.<br />
Hamilton, RobertO. See Fasullo, Frank J., Jr.<br />
Hamilton, Robert W.; Hopkins, Marbry B., III;<br />
Shihabi, Z. K., 1713<br />
Hamilton-Smith, S. See Sarosi, David<br />
Hammad, N. See Ambrocio, E.<br />
CLINICALCHEMISTRY. Vol. 35, No. 12, 1989 2349
H.nunarstrom, M. See Sgoutes, D.<br />
Hammarstrom, Margareta See Sgoutas,<br />
Demetrios S.<br />
Hammer, M. K., 193<br />
Hammer, P. See Diorio, Alfred F.<br />
Hammer, Peggy A. See Shah, Vipin D.<br />
Hammond, Philip W. See Arnold, Lyle J., Jr.<br />
Han, Tin See Bhargeva, A. K.<br />
Hand, C. W. See Smith, K. F.<br />
Ranges, Usa See Goldsmith, Barbara M.<br />
Hsnfrhiaon, Susan E.; London, Stephanie J.;<br />
Chute, Christopher G.; Barbieri, Robert L;<br />
Jones, Level; Kaplan, Lawrence A.; Sacks,<br />
Frank M.; Stsmpfer, Meir J., 2313<br />
Hanks,<br />
JTannn,<br />
B. See Wells, David<br />
Charles J., Jr.; Kettler, Thomas;<br />
Debe, Irwin; Clark, Timothy, 1998<br />
Hannsnt, ME. See Unni, L K.<br />
Hannon, W. Harry See Jewel, Sandra E.;<br />
Myrick, James E.<br />
Hansen, Hans J. See Newman, Edward S.<br />
-; LaFontaine, George; Newman, Edward S.;<br />
Schwartz, Morton K.; Malkin, Aaron;<br />
Mojzisik, Kethy, Martin, Edward W.;<br />
Goldenberg, David M., 146<br />
Hansen, Joel B. See Lau, H. Philip<br />
Hansen, S. It; HoIm, J., 1721<br />
Hanson, Naomi Quast; Freier, Esther F., 1538<br />
Hanison, Lena; Petersson, Jean; Eriksson, Lees;<br />
Olin, Ake, 537<br />
Hardy, Christopher J. See Bottomley, Paul A.<br />
Hardy, Robert; Ng, R. H.; Sparks, K.; Statland,<br />
B. K.; Kent, S.; Valdes, K., Jr., 1102<br />
Harel, Danlela See Weinberger, Itahak<br />
Harell, D. See Rotenberg Z.<br />
Harff, Gottfnled A. See <strong>Back</strong>er, Egbert T.<br />
Harlharan, M.; VanNoord, Ted; Cameron,<br />
Oliver G.; Curtis, George C.; Ostrow, David<br />
G., 202<br />
-; VanNoord, T.; Singh, S.; Kindt, E.; Kronfol,<br />
Z., 1138<br />
Hanker, Carol C. See Wu, Alan H. B.<br />
Rarkness, Dianne; Whitlow, Karen; Schreiber,<br />
WillianiE., 2144<br />
Harper, J. D.; Mertel, P.; O’Donnell, C. M., 1087<br />
Harris, Heather Pd.; Applegarth, Derek A.;<br />
Clarke, Lorne A.; Wong, Jonathan, 703<br />
Harris, P. See Ferrari, R.<br />
Harrison, H. H.; Miller, K. L.; Powell, D.; Tang,<br />
C. L.; Daufeldt, J. A., 1083<br />
-; Doria, M. J.; Shaw, S. T., 1122<br />
Harrison, Stephen P.; Barlow, Ian M., 1980<br />
flarthus, H.P. See Schnorr, Gerd K.<br />
Hartle, K. See Crmsan, D.<br />
Hartley, T. F. See Nordin, B. E. C.<br />
Hartmann,<br />
Hartsock,<br />
A. B. See Myers, Gary L.<br />
Robert J. See Fan, Der-Fong<br />
Hartter, Engelbert See Fridrich, Leo<br />
Harvey, Sheryl See Lee, Theodore T.<br />
Hasegawa, K. See Hosoda, K.<br />
Hasegawa, T. See Matsuura, Tsuneski<br />
Hasegawa, Takaakl See Ohshima, Taeyuki<br />
Hashimoto, Takuma; Matsubara, Fujiteugu;<br />
Takeda, Ryoyu, 2153<br />
Haskins, C. See Woo, Jannie<br />
Hassan, F. Michael See Wermeling, Joseph K.<br />
-; Pesce, A. J.; Warner, A.; Denson, D. D., 1182<br />
Hasselberg, Stephen; Mauck, It.; Neslon, D.,<br />
1120<br />
Hasaemer, D. See Laeasig. Ronald<br />
Hassemer, David J.; Wiebe, Donald A.; Kramer,<br />
Tim, 1068<br />
-; Hill, Barbara M.; Wilber, Laura, 1068<br />
Hassett, J. See Leaky, Fred D.; Mauck, Linda<br />
Hauptiorenz, Susanne See Wencker, Marion<br />
Hause, Lawrence L See Doumas, Basil T.<br />
Hausen, Arno See Fuchs, Dietmar; Reibnegger,<br />
Gilbert<br />
Havelick, J. See Medry, Norbert<br />
Haven, MC.<br />
ItC.<br />
See Arnold, L. It.; Schiebout-Clark,<br />
-; Sobeski, It. M.; Earl, It A.; Markin, It S.,<br />
1183<br />
Haven, Mary C. See Orsulak, Paul J.<br />
-; Sobeski, Linda M.; Earl, Robert A.; Markin,<br />
Rodney S., 564<br />
Haver, Virginia M.; Audino, Nancy; Burns,<br />
Susan; Nelson, Margaret, 138<br />
Havranek,<br />
Hayashi,<br />
Lauren See Gross, Susan F.<br />
Tokishi See Tsuchiya, Hironori<br />
Hayden, C. See Present, Bill<br />
Hayden, K. See Gault, M. H.<br />
Hayes, John D. See Beckett, Geoffrey J.<br />
Hazzard, William K,, 1062<br />
Head, T. See Prinaen, Johanna<br />
Heard, Gregory S. See Weissbecker, Karen A.<br />
Heath, D. A. See Ratcliffe, W. A.<br />
Heerspink, W. See Zwart, Albert<br />
2350 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />
Heikklla, Jarmo See Hemniila, llkka<br />
Helm, C. See Renz, M.<br />
Helnemann, Steve See Deneris, Evan S.<br />
Helnzerling, K. H. See Kusilek, Less D.<br />
Helrd, Wiiliam C., 1237<br />
Helse, H. M. See Kruae.Jarres, J. D.<br />
Helss, 0. See Rifai, Nader<br />
Hejtmanclk, J. Fielding See Silverman,<br />
Lawrence M.<br />
Heilerstein, M. See Khayam-Bashi, Hasssn<br />
HelIman, P. See Felder, R. A.<br />
Helms, Cynthia See Green, Philip<br />
Hemans, Bert See Klotzsch, Sigrid<br />
Heminger, L See Sperling, Matthew<br />
Hemker, S. See Fitz#{231}erald, D.<br />
Hemmila, llkka; Heikkila, Jarmo; Leivo, Pekka,<br />
1206<br />
Henderson, A. K. See Smith, Deborah A.<br />
Henderson, A. Ralph See Galbraith, Linda V.;<br />
Leung,<br />
Henderson,<br />
Fred Y.; Smith, Deborah A.<br />
Pd. J. See Deer, P.R. F., 1043<br />
Henderson, K. W. See Rose, L S.<br />
Hendnlks, D.; Scharpe, S.; van Sande, M.;<br />
Lommaert, M. P., 177<br />
Henke, J. See Bianca, Carol<br />
Henny, Joseph; Tarailo, P.; Schiele, F.; Siest, 0.,<br />
1126<br />
Henocque, Genevieve See Macart, Michel<br />
Henry, Joseph F. See Hutchens, T. William<br />
Henton, D. See Rosenthal, P.; Rosenthal, Philip<br />
Herber, Shirley A. See Schwartz, Joyce G.<br />
Herberger, John See Lipset, Joel<br />
Herbertson, K. See McConwey, M. 0.<br />
Herman, David C. See Elm, Ronald J.<br />
Hermens, Wim Tb. See Giesen, Peter LA.<br />
Hernandez, C. See Chen, Katherine<br />
Hernandez, Carol See Gross, Susan F.<br />
Herold, David A. See Franquemont, Douglas W.<br />
Aggarwal, Suresh K.; Kinter, Michael; Wills,<br />
Michael R.; Savory, John, 1113<br />
Heron, Diane See Malik, Sohall<br />
Henshman, J. M. See Vowels, J. A.<br />
Herzog, K. H. See Schoensu, B.<br />
Hess, Allan D., 1235<br />
Heasels, Pd. See Hafkenscheid, J. C. M.<br />
Hess, Arpad See Karedi, Istvan<br />
Hewitt, C. D. See Winborne, K.<br />
-; Innes, D. J.; Savory, J.; Wills, M. R., 1777<br />
Heyndrlckz, L See Pollet, D. E.<br />
Hicks, J. Pd.See Ioeefsohn, Mariet<br />
Hicks, P. See Demers, Laurence M.<br />
Hicks, Patti See Demers, Laurence M.<br />
Higashi, Yasuko See Yoshioka, Shinichi<br />
Higgins, Trefor, 1801<br />
Hlghsmlth, W. K; Swift, M.; Perry, T.;<br />
Silverman, L. M.; Knowles, M., 1077<br />
Hlghsmlth, W. Edward, Jr.; Perry, Tenly R.;<br />
Prior, Thomas W.; Silverman, Lawrence M.,<br />
1260<br />
Hlghsmlth, William B.; Bankson, Daniel D.;<br />
Formen, Donald T., 1151<br />
Hilborn, D. See Danielson, Susan J.<br />
Hill, B. See Laessig, Ronald<br />
Hill, Barbara M. See Hassemer, David J.<br />
Hill, C. See Bray, Kurtis K.<br />
Hill, Roger J. See Sheldon, Robert S.<br />
Hlllman,<br />
HhlImi,,<br />
K. See Gibbons, I.<br />
Richard B. See Wyatt, David T.<br />
Hillock, K. See Webb, Gary<br />
Hlnberg, I. See Poon, K.<br />
Hinds, B. See Butch, A.<br />
Hinds, Barbara See Bodor, Geza; Myrtle, James<br />
F.<br />
Hinds, John A. See Cheung, Kee<br />
Hines, C. See Boyd, James C.<br />
Hlnz, V.S. See 83cc, G. G.<br />
Hirano, Tetsuo See Miura, Mesakazu<br />
Hirata, Mario Hiroyukl See Hirata, Roeenio<br />
Dominguez<br />
Hlrata, Roearlo<br />
Crespo<br />
Domlnguez Crespo; Hireta,<br />
Mario Hiroyuki; Stzufaldi, Bruno; Poesik,<br />
Rafael Abraao; Asai, Mario, 1385<br />
Hlrayama, Toshiakl See Imemura, Shigeyuki<br />
Hirokawa, Junichi See Konno, Noriniichi<br />
Hircee, Shingo See Fujimoto, Takashi<br />
Hirsch,<br />
Hirsch,<br />
C. See Diaz, S.<br />
Carl; Yu, Gordon; Dubiusky, Eli, 1100<br />
Hlsae, Nobuo See Mashige, Fumiko<br />
Hissami, Obuld, 1094<br />
Hltzler, Walter See Bohler, Ulrich<br />
Ho, Hsu-T.o See Wang, Henn-Ping<br />
Ho, Olta See Fraser, Callum G.<br />
Hoch, K. See Wilson, John M.<br />
Hoffman, Eric P. See Kunkel, Louis M.<br />
Hoffmann, Georg; Aramaki, Shuichi; Blum-<br />
Hoffmann, Ellen; Nyhan, William L;<br />
Sweetman, Lawrence, 587<br />
Hofman, J. A. See Meulenberg, P. M. M.<br />
Hofmsn, K. See Wong, P. Y.<br />
Hofmsn, L F. See Bankson,<br />
Hojvat, 8. See Black, With<br />
Daniel D.<br />
, Clemens, John;<br />
Schmidt, Wesley<br />
Holden, K. D.; Silverman, L. M., 1084<br />
Holen, James See Donohue, Joseph<br />
Boll, K, W. See Felder, It A.<br />
Hoiland, F. John See Ellis, Graham<br />
Hollander, Lorl See Inloes, Roger; Klonizchii,<br />
Walt<br />
-; Rinnie, Shernie; Worthy, Tom, 1141<br />
Holly, K, See Gutierrez, Aide<br />
Holm, J. See Hansen, S. I.<br />
Holmes, Earle W. See Clemens, John<br />
Holmes, Julia C. See Ball, Richard<br />
Bolt, David W. See Johnston, Atholl, 1236<br />
-; Johnston, Athoil, 1332<br />
Bolt, John A. See Russell, John C.; Zibrat,<br />
Steven J.<br />
Holtzman, Golde I. See Bernstein, Larry H.<br />
Holzberg, K. See Ponte, K.<br />
Holzberg, Koni A.; Sommer, M.; Moekaiski, %i<br />
B.; Fnitsche, E. T., 1104<br />
Honcharik, N. See Copeland, Kenneth<br />
Honda, T. See Matsuura, Tsuneaki<br />
Hong, X. Q.;Wong, M. M.; Pu, J. C., 1137<br />
Hood, I. See Cetomeris, Peter<br />
Hopkins, Marbry B., Ill See Hamilton, Robei<br />
W.<br />
Horenzy, M. J. See Peck, M.<br />
Hornick, Laurel J. See Lemann, Jacob, Jr.<br />
Horowits, Gary L See Yeo, Kiang-Teck; Yeo,<br />
Klang-Teck<br />
-; Austin, Theresa M.; Yeo, Kiang.Teck, 1128<br />
Hortin, G. L See Rosenblum, J. L<br />
Hortin, Glen L See Landt, Michael<br />
Hoshino, Yoshlyukl See Tsuchiya, Hironori<br />
Hosoda, K.; Kubota, T.; Hasegawa, R.;<br />
Wakabayashi, K., 1208<br />
-; Yamaji, ‘I’.; Baylink, D., 1208<br />
Hosseini, Jeanette M. See Elm, Ronald J.<br />
-; Yang, Xiu Ying; Elm, Ronald J., 1404<br />
Bouts, Robyn; Chung, B.; Ciucci, C.; Wood, J.;<br />
Delaurentis, M.; Valdez, J., 1167<br />
Howanltz, P. J.; Steindel, S. J.; Schifman, K. F<br />
Detweiler, G., 1160<br />
Howard, Katnina; Kane, Marian; Madden,<br />
Alden; Gosling, James P.; Fottrell, Patrick<br />
F., 2044<br />
Howard, P.; Jenny, R.; Church, W.; Tracy, R.,<br />
1161<br />
Howey, Jacqueline E. A. See Stolarek, Iwona<br />
Howie, A. Forbes See Beckett, Geoffrey J.<br />
Howrie, D. L See Crisan, Domnita<br />
Hsla, Karen See Spector, Stephen A.<br />
Hslao, Ray J. See O’Connor, Daniel T.<br />
Hsleh, C.-Y. See Pan, Jie<br />
Hslng, Ann W.; Comstock, George W.; Polk, B.<br />
Frank, 2145<br />
Hsu, J. See Freeman, J.<br />
Hsu, M. Y. See Sun, Lila<br />
Hsu, Po Choo; Domenici, Michael; Schulksnip,<br />
Kirk; Ballet, Neal; Chung, Bynng S.;<br />
DeLaurentis, Mark; Valdez, Johnny, 1141<br />
Han, S. See Keller, Charles H.<br />
Hen, Yu-Chu See Jeevenandem, Malayeppa<br />
Ba, M. See Freemen, J.<br />
Ru, Mae; Anne, L; Cohn, It.; Laungani, D.;<br />
Chan, K.; Gottwald, K.; Centofanti, J., 1164<br />
Huang, C. M.; Zweig, Mark, 125<br />
-; Kraft, H. G.; Gregg, It K., 1070<br />
-; Gregg. K. K., 1070, 1070<br />
-; Peck, G. L.; Chretien, P. B.; Ruddel, M.,.1OF<br />
Huang, H. M. See Wei, J. S.<br />
Huang, Tung-Ming See Donohue, Joseph<br />
Huang, W. T.; Cheng, M. H.; Wong, H. T.;<br />
Lipsey, A. I., 1183<br />
Huang, W. Y. See Cheng, Mary H.<br />
Hubbard, Elizabeth See Mifflin, Theodore E.<br />
Huchital, Michael See Kish, Linde; Sciotto-<br />
Brown, Susan; Zimmermann, Linde<br />
Hudson, C. See Weingand, Kurt<br />
Hudson, T. See Klukas, C.; Leonard, H.<br />
Huff, Dan L See Gunter, Elaine W.<br />
Huff, Daniel See Persona, Patrick J.<br />
Hughes, B. See Liffxnan, S.<br />
Hughes, J.; Weston, S.; Montague, D.; Summei<br />
M.; Shepherd, H.; Shepherd, B., 1149<br />
Hughes, J. I. See Shahangian, S.<br />
Hughes, John I. See Shehangian, Shahram<br />
Huguet, J.; Fuentes-Ardeniu, X.; Ferre, C., 1264<br />
Hulanicki, Adam See Lewandoweki, Ryszsrd<br />
Hnhm.rn., W. C. See Maceani, F.<br />
Huinbert, H. See Vernillet, L.<br />
Hume, Robert See Beckett, Geoffrey J.<br />
Hunkapiller, MW. See McBride, L J.<br />
Hunter,<br />
Hunrell,<br />
Thomas<br />
Yumlna;<br />
See Mabmood, Nishat<br />
Spiehler. Vine, 1175
sken, Brigitta C. P. See Leeuwenkamp.<br />
Oscar K.<br />
isey, A. J. See Beckett, G. J.<br />
isey, Amanda J. See Beckett, Geoffrey J.<br />
ehens, T. William; Henry, Joseph F.; Yip,<br />
Tei.Tung, 1928<br />
Lchlns, S. W. See Cheng, Mary H.<br />
Ichison, A. See Chubb, S. A. P.; McConway,<br />
M. G.<br />
ichison, James S. See Zabnadnik, Richard<br />
Lteu, P. See Eble, K. S.<br />
ang, D. See Bianca, Carol<br />
‘ang, N. See Phillips, E.<br />
e, J. K See toeefsohn, Mariet<br />
in, John E.; Soldin, S. J., 1167<br />
an, Jayson, 1083,1086<br />
nez, J. See Lucas, F.<br />
Jonathan K. See Burgess-Cassler, Anthony<br />
ku, Y. See Sorin, T.<br />
i,M. See Nekamure, Masekazu<br />
ma, Kenji See Fukuda, Chiseko<br />
ma, S. See Cho, Hiroko<br />
ama, K. See Mizuochi, E.<br />
ao,V. See Fox, Martha; Millsap, Susan<br />
y, P. See Reddy, Padala V.<br />
ii, Hirokazu See Wekui, Hideki<br />
emura, Shigeyukl; Hirayama, Toshieki; Arai,<br />
Tomiko; Tekso, Kyoji; Miseki, Hideo, 1126<br />
penio, N. See Bark, Lee<br />
ar, 8. See Ackermann, H.; Blackwood, J.;<br />
Grenner, G.; Padilla, A.; Steedter, M.<br />
lniksons, Andris; Schwartz, Joyce, G., 899<br />
ass, Koger; Hollander, Lori; Thut, Laurel;<br />
Picone, Teresa; Pflager, Ceroi, Zoccohi, Mike;<br />
Worthy, Tom, 1191<br />
tee, D. J. See Hewitt, C. D.<br />
nnou, Pinelopi C.; Konstentianos, Dimitrios<br />
G., 1492<br />
efsohn, Mariet; Rifai, N.; Hyde, J. E.; Soldin,<br />
S. J., 1156<br />
Soldin, S. J.; Hicks, J. M., 1168<br />
ce, H., Jr. See Ostrow, D. H.<br />
Hisami See Matsumoto, Kojiro<br />
as, Julian J. See Cheng, K. Steve<br />
ih, Glenn K. See Snyder, Andrew M.<br />
Madden, Thomas M.; Snyder, Thomas D.;<br />
Snyder. Andrew M., 1196<br />
ala, Kerttu See Koekinen, Pertti<br />
ksson, A. See Keller, Charles H.<br />
ibashi, Shun; Yemada, Nobuhiro; Shimeno,<br />
Hitoshi; Tekaku, Fumimaro; Akanuma,<br />
Yasuo; Munese, Toshio, 808<br />
Ida, Osamu; Kihire, Koji; Tsukamoto,<br />
Yusuke; Marumo, Fumiaki, 127<br />
ii, S.; Day, K.; Newton, M.; Hall, K., 1097<br />
imorl, Yoahio; Koyama, M.; Rokugewe, K.;<br />
Motoda, S.; Mateuda, H., 1204<br />
Izaki, Takashi See Echizen, Hirotosbi<br />
I, Akira See Nakashijna, Koji<br />
iii, S. M. See Abu-Fersakh, F. A.<br />
no, Masashi See Burnett, Robert W.<br />
h, Hideaki See Wakui, Hideki<br />
h, Roichi See Echizen, Hirotoshi<br />
kawa, Yoshinoni See Matsude, Akihiko<br />
e,W. Michael See Russell, John C.<br />
eta, Hisashi See Gotoh, Hiroshi<br />
eta, Jihel; Suga, Tetuya, 794<br />
mbart, M.; Sale, M.; Baldet, L;<br />
Schiuniberger, hi.; Deltour, G., 2137<br />
lonsky, George See Galbraith, Linda V.;<br />
Leung, Fred Y.<br />
k, Khona See Rettmer, Rebecca L<br />
*son,<br />
kson,<br />
J. See Shihabi, Z.<br />
J. S. See Kusilek, Lees D.<br />
kson, Jean See Brasheer, Jeff<br />
kson, Kathryn See Jenny, Richard W.<br />
kson, S. See Ryder, K.<br />
rfe, Allan S. See Eisenberg, Paul R.<br />
gods, E. See Reins, A.; Tsey, H.<br />
Tsay, H.; Mantha, S.; Ogan, M.; Stouffer, B.;<br />
Raise, A.; Turebi, N.; Tu, J.; Eckelman, W.<br />
C., 1189<br />
n, C. See Schinitz, J.<br />
n, Chandra See Navazi, Weleska<br />
ii, Narish See Spiehier, Vine<br />
kobi, Peter<br />
let, Pierre<br />
See Knivoy, Norberto<br />
See Perdrisot, Remy<br />
nani, Azim; Pudek, Morris; Schreiber,<br />
Wffliam K., 471<br />
nbou, Robert C. See Snouwaert,<br />
flies, S. K. See Phillipou, G.<br />
John N.<br />
nes, Steve K. See Phiffipou, George<br />
flatsch, G. See Knuse-Jarres, J. D.<br />
sdreski, Mark A.; Bermes, Edward W.;<br />
Leischner, Relph; Kahn, Stephen E., 1547<br />
netschek, Kobert J., 1089<br />
flsen, M. J. H. See Elving, L D.<br />
n, Piet C. W. See Giesen, Peter It. A.<br />
Jansson, Jan-Hakan; Norberg, Bo; Nilsson,<br />
Torbjorn K., 1544<br />
Janason, Svante See Lundberg, Per-Arne<br />
January, W. See Beshem, Julie E,<br />
Janulis, Lynn See Breshear, Jeff<br />
Janus, E. D. See Carter, G.<br />
Jarausch, J.; Lehmann, P.; Rietz, P., 1098<br />
Jardei, Main See Feldmann, Delphine<br />
Jauneau, Monique See Vernet, Michehe<br />
Jawad, J. See Fitzgerald, D.<br />
Jaynes, PatrIck, 1240<br />
Jeevansndsm, Malayappa; Hsu, Yu-Chu;<br />
Remiss, Lois; Schiller, William It, 2228<br />
Jeffcoate, S. L See Pearce, S.<br />
Jenkins, M. See Gates, Teresa; Gault, M. H.<br />
Jennings, T. See Van Brunt, N.<br />
Jenny, K. See Howard, P.<br />
Jenny, Richard W,; Jackson, Kathryn, 1184<br />
Jensen, Mogens Krogh See Rasmussen,<br />
Karsten<br />
Jerome, H. See Cheng, C.<br />
Jespersen, Bente See Engbaek, Frode<br />
Jespersen, Jorgen See Gram, Jorgen<br />
Jessen, K. H.; Killeen, A. A.; Bowers, L D., 1142<br />
Jeweil, Sandra B.; Slazyk, William J.; Smith, S.<br />
Jay; Hannon, W. Harry, 1701<br />
Jeyasinghem, M.D.; Pratt, 0. E.; Rooprai, H.<br />
K., 2129<br />
Johsnsen, Jon J. See Burgess-Cessler, Anthony<br />
Johanson, N. See Lee, Sung C.<br />
Johsnsson, Pie-Marie See Lindstedt, Goran<br />
Johno, Ikuo See Ohshima, Taeyuki<br />
Johnson, A. Myron See Ledue, Thomas B.<br />
Johnson, Andrew Myron; Ritchie, Robert F.;<br />
Ledue, Thomas B., 1268<br />
Johnson, Andrew W. See Rosslki, Sidney B.<br />
Johnson, Catherine See Skogerboe, Kristen J.<br />
Johnson, D. See Gault, M. H.<br />
Johnson, E. See Gault, M. H.<br />
Johnson, G. F. See Nuwayhid, N. F.<br />
Johnson, George F. See Nuweyhid, Naziha F.;<br />
Punzalan, Rubio It; Smith, Karen<br />
Johnson, J. See Morin, Leo G.<br />
Johnson, J. T. See Neisler, H. M.; Panteghini,<br />
Mauro<br />
Johnson, James K See Morn, Leo G.<br />
Johnson, K. See Bray, Kurtie It<br />
Johnson, L K. See Gallagher, S. K.<br />
Johnson, Pam M. See Perkins, Sherry L.<br />
Johnson, Paul W. See Attia, John<br />
Johnston, Atholl See Holt, David W.<br />
-; Marsden, Joanne T.; Holt, David W., 1309<br />
Johnston, D. See Lucas, F.<br />
Johnston, Dennis A. See Shahanjian. Shehram<br />
Johnston, Sue See Clark, Larry W.<br />
Jolley, Michael B., 1239<br />
Jones, A. W.; Jonsson, K-A; Jorfeldt, It., 400<br />
Jones, Carolee See Leeder, Sydney<br />
Jones, Christopher B.; Wians, Frank H., Jr.;<br />
Martinez, Luis A.; Merritt, Gerald J., 1394<br />
Jones, James D. See Creer, Michael H.<br />
Jones, Karen J., 1174<br />
Jones, Lovell See Hankinson, Susan E,<br />
Jones, S. K. See Dominiczak, Marek<br />
Jones, S. K. See Ratclffe, W. A.<br />
Jones, Wayne See Falkensson, Marianne<br />
Jonsson, K-A See Jones, A. W.<br />
Jonza, J. See Kubasik, N. P.; Thompson, F.<br />
Jordan, N.M. See Silver, M. K.<br />
Jordening, H. See Wandrup, Jesper<br />
Jorfeldt, L See Jones, A. W.<br />
Joseph, K. See Kropf, J.<br />
Joseph, R. See Phillips, E.; Sibilie, R.<br />
Joukyuu, Ritsuko; Mizuno, Shigeki; Amakawa,<br />
Tsutomu; Tsukeds, Toshihiko; Nishima,<br />
Toshihir Kitemura, Motoshi, 687<br />
Joustra, M.; Nilsson, Ingegerd, 1109<br />
Jove, M. See Doria, Manuel, Jr.<br />
Joven, J.; Vilelle, E.; Costa, B.; Turner,<br />
Richart, C.; Mesana, L., 813<br />
P.R.;<br />
Juan-Pereira, L; Fuentes-Ardeniu, 1544<br />
Jung,<br />
-; Pergande,<br />
Klaus; Nickel,<br />
Monika;<br />
Erika, 336<br />
Klotzek, Silke, 1955<br />
-; Bnien, Gerald; Kirschner, Peter; Schroder,<br />
Kersten; Schmiedel, Thomas, 2000<br />
Juste, Patrick See Klotzsch, Signid<br />
Kadijevic, Lilly See Allen, It. C.<br />
Kafonek, Stephanie; Bechorik, Paul S.;<br />
Kwiterovich, Peter 0., Jr., 380<br />
Kahsn, J. See Wellinder, H.<br />
Kahn, Sidney N., 508<br />
Kahn, Stephen E. See Jandreski, Mark A.<br />
Kahhan, Satish C. See Shoup, Vernon A.<br />
KaHn. Marcia F. See Novick, David M.<br />
Kallner,<br />
Kalpazis,<br />
Anders, 1803<br />
Dimitnios L See Giannoulaki,<br />
Elefteria E.<br />
-; Giennoulaki, Elefteria E., 844<br />
Kaira, J.; Chaudhary, A. K.; Massey, K. L.;<br />
Prasad,K., 1137<br />
Kaira, Krishan<br />
Kzm.tak*nnzn,<br />
See BIde, Dennis<br />
Vedhachalam See Bleile,<br />
Dennis<br />
Kambli, Vijaykant B.; D’Amato, David;<br />
Reynoso, Gustavo, 1156<br />
Kammerer, K. C. See Lopez, C.<br />
Kamoun, P. See Chadefaux, B.; Parvy, P.<br />
-; Rabier, D., 1267<br />
Kampa, logo 5., 1165<br />
Kamst, T. W. See Cham, B. E.<br />
Ran, Brenda See Rigault, Marie Y.<br />
-; Freier, C., 1082<br />
Kanba, Shigenobu See Matsumoto, Kojiro<br />
Kane, Marlan See Howard, Katrine<br />
Kaneda, N. See Watszu, V.<br />
Rang, Sam See Anne, Lakshmi<br />
Kanno, Takashi See Azuma, Yutaro; Maekawa,<br />
Maseto<br />
Kao, Pal See Klee, George<br />
Kao, Pal C. See Hage, David S.<br />
Kapadia, P. See Petersen, J. It<br />
Kaplan, J. C. See Orsuisk, P. J.<br />
Kaplan, Lawrence A. See Hankinson, Susan E.;<br />
Russell, John C.; Stain, Even A.<br />
Miller, Judith A.; Stampfer, Meir; Romieu,<br />
Isebelle; Stein, Evan A.. 1114<br />
Kaplan, M. See Kusilek, Less D.<br />
Kapmeyer, W. See Metzmann, E.<br />
Kapmeyer, Wolfgang H.; Metzmann, Erwin,<br />
1092, 1092<br />
Kapsalls, A. See Scheffel, J.<br />
Kapur, Bhushan M.; Banks, Tibor, 1185<br />
Kapyaho, Kirsti See Svens, Elvor<br />
Karadi, Iatvan; Romics, Laszlo; Pals, Gabor;<br />
Doman, Jozsef; Kaszss, lions; Hesz, Arpad;<br />
Kostner, Gerhard hi., 2121<br />
Karasawa, Kouji See Shoji, Shin’ichi<br />
Karcher, K. See Elkhalife, Mohamed; Sloan,<br />
Chris<br />
Karcher, Raymond; Scharer, K.; Epstein, E.;<br />
Kiechle, F. L., 1124<br />
Karcher, Raymond B. See Scharer, Katharine<br />
A.<br />
Range, W. H.; Weiner, E. J.; Rogers, E. J.;<br />
Nicolosi, It J., 1790<br />
Karl, Johann; Kerscher, It.; Engel, W. D.;<br />
Ziegenhorn, J., 1067<br />
Karisson, Lisa See Bergqvist. Yngve<br />
Karmen, Arthur See Murthy, Vadiraja V.<br />
Kars, Ay.e See Copur, Sitki<br />
Karuza, Jurgis See Katz, Paul It<br />
Kasemsn, Deborah; Stamy, K.; Fields, S.;<br />
Usategui-Gomez, M.; Reilley, T.; Kaufman,<br />
R.A.,1121<br />
Chang, J.; Wenk-Salamone, K.; Fischberg, E.;<br />
Usatagui-Gomez, M.; Kaufman, It A., 1121<br />
Kassapian, S. J. See AuBuchon, J. P.<br />
Kaszas, Hona See Karadi, Istvan<br />
Kataoka, Mikiko See Matsuda, Akihiko<br />
Ratayama, Katsuhiro See Kuroiwa,<br />
Kate, Kanefusa See Usui, Akihiko<br />
Katsumasa<br />
Katoh, Kazuo See Yabuuchi, Masehiko<br />
Katz, Paul K.; Gutman, Steven I.; Richmen,<br />
Gary Karuza, Jurgis; Bartholomew, William<br />
R.; Baum, John, 466<br />
Katz, Paula See Zoccol, Michael A.<br />
Katzn,znn, Jerry A. See DeMars, Daniel D.<br />
Kaufman, J. See Villa, Barbara<br />
Kaufman, K. A. See Awdziej, Tame N.; Cheng,<br />
C.; Ferrenkopf, Bruce C.; Ksseman,<br />
Deborah; Keihley, Therese; Rosenfield,<br />
Henry- Zaunczkoswki, Denise<br />
Kaufman, Seymor See Fuchs, Dietmar<br />
Kawajiri, Yoshiko See Yoshioka, Shinichi<br />
Kawamura, Kenya<br />
Kazmlerczak, S.C.<br />
See Mon. Mikio<br />
See Castellani, William J.;<br />
Van Lente, F.<br />
-; Castellani, W. J.; Denton, E. E., 1106<br />
Kazmierczak, Steven C. See Rosalki, Sidney B.<br />
Van Lente, Frederick, 251<br />
Ke, Shu-Wen See Fan, Der-Fon<br />
Keefe, M. It See Rosenthal, Phihp<br />
Keenan, Edward J. See Corbin, Debra K.<br />
Keevan, James See Donohue, Joseph<br />
Keir, Geoffrey See Luxton, Richard W.<br />
Keith, Tim See Green, Philip<br />
Kelier, Charles H.; Fries, P.; Kline, E.; Kucera,<br />
K.; Hsu, S.; Isaksson, A.; Neider, K., 1142<br />
Keller, H. See Baadenhuijsen, H.<br />
Keller, H.P. See Vernillet, L<br />
Keller, Herbert See Bais, Renze<br />
Kelly, A. See McIntosh, S. J.<br />
Kelly, Christine A. See Cembrowski, George S.<br />
Kelner, Michael J. See Roberts, Randall T.<br />
Kendrick, Nancy C. See Burgess-Cessler,<br />
Anthony<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2351
Keniston, IL See Enriquez, John I., Sr.<br />
Kennedy, Annette See Prabhaksran, Victor M.<br />
Kennedy, K. Lee; Grifliths, Huw; Gray, T. A.,<br />
1882<br />
Kenney, J. T.; Orsulek, P. J.; Kolodner, K. M.;<br />
Burton, M. E., 2134<br />
Kenny, M. See Bennett, H. J.<br />
Kenny. Margaret, 1241<br />
Kenny, Margaret A. See Malik, Sohail<br />
Kenny, Terry See Swenson, J. Robert<br />
Kent, S. See Hardy, Robert<br />
Keren, David F. See Bush, Donna M.; Register,<br />
Loretts J.<br />
Kerscher, L. See Karl, Johann<br />
Kessler, Anne-Ch.; Griesser, H. W.; Willnow, P.;<br />
Kueppers,R., 1141<br />
Kessler, G. See Butch, A.<br />
Kessler, Gerald See Butch, Anthony W.<br />
Kessler, Jay; Warlck-Yates, Kathy; Bowen,<br />
Bets, 1097<br />
Kessner, Art See Navazi, Waleske<br />
Keatner, J. See Cseko, G.<br />
Kestner, Jane See Csako, Gyorgy<br />
Ketchum, Catherine H. See Russell, John C.<br />
Kettler, Thomas See Hennan, Charles J., Jr.<br />
Keymolen, V. See Body, J. J.<br />
Key.er, H. See Petersen, J. It<br />
Khadempour, M. Hassan; Ofulue, A. Felix;<br />
Thurlbeck, William M., 1150<br />
Khan, S. See Petersen, J. K.<br />
Khsn, Shaista; Damoderan, K.; Diaz, It,<br />
Khsakhntan, N. K. See Krause, J. S.<br />
1198<br />
Khanna, Pyare See Klonizcbii, Walt; Zoccoli,<br />
Michael A.<br />
Khayam-Bashl, H. See Chen, Katherine; Gross,<br />
Susan F.<br />
Khayani-Bashl, Hsssan; Gerard, S.; Bagineki,<br />
P.; Hellerstein, M.; Chen, K., 1136<br />
Khazanle,<br />
lCh.v.-ie,<br />
P. See Castellani, William J.<br />
Prabhsker; Sinhe, Madhur; Caro,<br />
Jose; Silverman, Jan F.; Castellani, W. J.,<br />
1146<br />
Khosravl, M. J. See Diamandis, E. P.; Tan, A.<br />
-; Diemandis, E. P., 181<br />
-; Diamandis, E. P., 1138<br />
-; Sudsbuzy, It, 2251<br />
Khosravl, Mohammad J. See Diamandis,<br />
Eleftherios P.<br />
Khurl, Shuknl F. See Lum, Gifford<br />
Klsng, W.; Mimme, L.; Swenson, S.; Floreani,<br />
M., 1090<br />
Kiechle, F. L See Elkhalife, Mohamed; Karcher,<br />
Raymond; Sloan, Chris<br />
Kiechle, Frederick L See Scharer, Katharine<br />
A.<br />
Kiefer, Charles K. See Moecoso, Hugo<br />
Kihira, Koji See Ishida, Osamu<br />
Kilbeeney, J. See Wang, TanJang<br />
Khhleen, A. A. See Jessen, B. H.<br />
-;Orr,H.T., 1075<br />
Kllroe-Smith, Terence A. See Geillard, M.<br />
Christine<br />
Kim, Sook-Chia See Nandedksr, Arvind K. N.<br />
Kimlinger, Terry K. See Dehiars, Daniel D.<br />
Kimura, Mieko See Mateude, Akihiko<br />
Kimura, Motoko See Tameki, Haruo<br />
Kindt, E. See Heriharen, hi.<br />
King, Brenda See Chou, Peter P.; Longhurst,<br />
Sharon<br />
King, David L; Gabor, Michael J.; Martel,<br />
Patricia A.; O’Donnell, C. Michael, 163<br />
King, J. S., 198, 344, 517, 715,905, 1271, 1565,<br />
1812, 2023, 2161, 2259, 2340<br />
Klnter, Michael See Herold, David A.<br />
Kir, Sedef See Torun, Meral<br />
Kirchick, H. J. See Chin, Bruce G.<br />
Kirk, Elaine<br />
Kirkpatrick,<br />
M.; Fell, Anthony F., 1288<br />
Peter P. See Bowie, Lemuel J.<br />
Kirschner, Peter See Jung, Klaus<br />
Kish, Linda; Lin, Yuh-Nan; Huchitel, Michael;<br />
Solan, Vishnu; Sheiman, Mark; Dunks,<br />
Louis, Jr., 1172<br />
Kissinger, Peter T., 1240<br />
Kitamura, Motoshi See Joukyuu, Riteuko<br />
Kitszawa, Shikifumi See Ohahima, Taeyuki<br />
Kiasa, Michael See Fox, J. Lawrence<br />
Klaus, Eric M.; McComb, Robert B., 2158<br />
KIss, G. See Converse, Joan<br />
Kiss, G. G.; Preissner, C. M.; Hinz, V.S., 1147<br />
Kiss, George; Preiesner, Carol; Schryver,<br />
Patricia; Taylor, Robert; Kao, Psi, 1147<br />
Klee, George G.; Post, Gregory, 1362<br />
Klein, G. See Rizzotti, P.<br />
Bodenmuiler, H.; Gerber, M., 1089<br />
Kline, B. See Keller, Charles H.<br />
Kline, Michael<br />
Kloepter, Hans<br />
J. See Muffin, Theodore<br />
See Warnick, G. Russell<br />
E.<br />
2352 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />
Kionizchil, Walt; Barendice, Rob; Hollander,<br />
Lori; Worthy, Tom, 1141<br />
-; Khenna, Pyare, 1171<br />
Klotzek, Silke See Jung, Klaus<br />
Klotmch, S. See Levy, S.<br />
Klotzsch, Sigrid; Hemams, Bert; Juste, Patrick,<br />
1105<br />
Klukas, C. See Leonard, H.<br />
-; Comerci, C.; Campbell, J.; Hudson, T.;<br />
Williems, M.; Berg, M.; Kozel, P., 1194<br />
Knapp, S. See Gammon, Allison<br />
Knedel, M. See Beadenhuijeen, H.<br />
Knepil, Janusz; McPhillips, Mary, 181<br />
Knight, George J.; Palomaki, Glenn E.; Lee,<br />
Dale H.; Haddow, James E., 1036<br />
Knight,<br />
Knight,<br />
J. A. See Crockett, Harold<br />
William See Wang, Hamm-Ping<br />
Knowles, M. See Highamith, W. E.<br />
Knox, James D. E. See Fraser, Callum G.<br />
Koay, E. S.C. See Aw, T. C.<br />
Kobayeshi, lsao; Amemiya, Norihiko; Endo,<br />
Takeshi; Okuyama, Kohji; Tamura, Kohji;<br />
Kume, Shoji, 1644<br />
Kobayashi, Kunlo; Ogasehara, Naomi;<br />
Sskoguchi, Takafumi; Taniuchi, Koji;<br />
Metsuoka, Akira, 177<br />
Kobayashi, Ryoji See Wakui, Hideki<br />
Koch, D. D. See Pauley, Scott D.<br />
Koch, David D. See Begneski, Kim; Larsen,<br />
Sandra; Tee, Martina<br />
Koch, Thomas IL See Akimgbe, Olumide 0.;<br />
Duh, Show-Hong<br />
-; Akimgbe, Olumide 0.; Neelkantan, N. V.;<br />
Vickery, D. K.; Naccarato, W. F., 1145<br />
-; Platoff, Gennady E., 1182<br />
Koch, W. See Kus, Debra hi.<br />
Koda, Naoya See Yamegucbi, Shuichi<br />
Koenig, J. See Butch, A.<br />
Koenig, John W. See Wolf, Bryan A.<br />
Koepf, S. M. See McBride, L. J.<br />
Koev, D. J. See Angelova-Gateve, P.<br />
Koffl, Agnes See Macart, Michel<br />
Koh, T. See Ruiz, Eliseo<br />
Koh, Tung; Ruiz, E.; Edwards, K., 1084<br />
Kohen, Fortune See Bernard, Geoff;<br />
Strasburger, Christien<br />
Kohl, HH; Tsai, LL; Uhn, J; Miller, DL, 1077<br />
Kohno, H. See Sorin, T.<br />
Koivisto, Velkko See Suhonen, Lauri<br />
Kolberg, Janice See Urdea, Mickey S.<br />
Koiler, D. E. See Zarembka, F. It<br />
Koller, P. U.. 186<br />
Roller, Peter U. See Baja, Renze<br />
Kolodner, K. M. See Kenney, J. T.<br />
Komachi, Y. See Nekemura, Masakazu<br />
Komiyania, Atsuahi See Shoji, Shin’ichi<br />
Konaka, Kyusei See Abe, Kenji<br />
Konings, C. H. See van Heeften, T. W.<br />
Konishi, M. See Nakamura, Masakezu<br />
Konno, Nonimichi; Hirokawe, Jumichi; Tsuji,<br />
Mesehiro; Hegiwara, Kohji; Taguchi, Hideo;<br />
Murakami, Shigeki; Teguchi, Shizuko, 159<br />
Konrath, J. G.; Manderino, G. L.; Przywara, L.<br />
W.; Elliott, K. L., 1078<br />
Konstantisnos, Dimitnios G. See Ioannou,<br />
Pinelopi C.<br />
Konstantinides, Frank N.; Mitchell, D. It;<br />
Bixby, B..; Singh, It K.; Li, J. C.; Cerra, F. B.,<br />
178<br />
Koottathep,<br />
Kopinaki,<br />
S. See Singksmani, It<br />
W. S. See Bayliss, Katherine<br />
Konchak, S. See Ball, D. J.; Bashem, Julie E.<br />
Korley, Victoria See Tagari, Philip<br />
Koskinen, Pertti; lrjala. Kerttu, 327<br />
Kost, Gerald J. See Wiese. David A., 1232<br />
Kostner, Gerhard M. See Karadi, Ietvan<br />
Kothari, Kanchan; Sivaprased, N.; Mani, It S.,<br />
701<br />
Kowaiski, A. See Cbiamg, C. S.<br />
Kowarski, Avinosm See Strasburger, Christian<br />
Koyama, M. See Ishimori, Yoshio<br />
Kozel, P. See Klukas, C.; Leonard, H.<br />
Kraft, H. G. See Huang, C. M.<br />
Krahn, John See Askew, Gord; Prosser, Connie<br />
Kramer, Alexander See Fuchs, Dietmar<br />
Kramer, Fred Russell See Lomeli, Hilda<br />
Kramer, Tim See Hassemer, David J.<br />
Kramp, W. J.; Nevill, J. It.; McCusker, L. M.;<br />
Larsen, F. It., 1194<br />
Kratzer, M. See 1-Isgele, E. 0.<br />
Krause, J. S.; Khankhamian, N. K., 494<br />
Krauza, C. See Leaky, Fred D.<br />
Kress, Barry C.; Frank, Kathy; Leverett,<br />
Lenore; Norton, Kurt; Sweet, Michael, 1197<br />
Krlcka, L J. See Bronstein, I.; Thorpe, G. H. G.;<br />
Voyta, J. C.<br />
Krlcka, Larry J.; Erickson, Katherine; Wilding,<br />
Peter, 1065<br />
-; Erickson, Katherine; Mullen, James; Wildini<br />
Peter, 1112, 1239<br />
Krivoy, Norberto; Jakobi, Peter; Weissman,<br />
Amir; Zimmer, Eten Z., 192<br />
-; Jakobi, Peter, 895<br />
Kroil, M. H. See Emancipator, K.<br />
-; Chesler, K., 1066<br />
Kroll, Martin H.; Chesler, Ruth; Ekin, Ronald<br />
J., 1523<br />
Kronfol, Z. See Hariharan, M.<br />
Kronlck, MN. See McBride, It. J.<br />
Kropf, J.; Gressner, A. M.; Joseph, K., 1540<br />
Marx, A. hi.; Gressner, A. M., 2144<br />
Krouwer, Jan S. See Crosby, Lisa E.; Schlain,<br />
Brian, 901<br />
Kruse-Jarnes, J. D.; Janatach, G.; Glees, U.;<br />
Msrbsch, It; Heise, H. M., 1854<br />
Krystal, Gerald; Lam, Vivian; Schreiber,<br />
William E., 860<br />
Krzymow.ki, GA.; Valcour, A. A.; Onoroski,<br />
M.; McComb, It M.; Bowers, G. N., Jr., 111<br />
Ku, Che-An; Lentrichia, Brian B.; Solan,<br />
Vishnu; Sheiman, Mark I.; Dunks, Louis, Ji<br />
1171<br />
Kubasik, N. See Peck, M.; Thompson, F.<br />
Kubasik, N. P.; Cordy, P. A.; Murray, C.; Maye<br />
T. K.; D’Souza, J. P., 1107<br />
-; Cordy, P.; Jonza, J.; Mayer, T.; D’Souze, J.,<br />
1108<br />
-; Xander, S. A.; Coppola, J.; Mayer, T. K.;<br />
D’Souza, J. P., 1125<br />
-; Cordy, P. A.; Meyer, T. K.; D’Souza, J. P.,<br />
1125<br />
Kubo, Hiroeki See Matsumoto, Kojiro<br />
Kubota, T. See Hosoda, K.<br />
Kucera, K. See Keller, Charles H.<br />
Kueck, B. D. See Bayliss, Katherine<br />
Kueppers, K. See Kessler, Anne-Ch.<br />
Kuhlman, J. See Vasiliades, John<br />
Kulig, K. See Sinh, J.; Singh, Jagat<br />
Kulig, Kim See Smgh, J.<br />
Kuine, Shoji See Kobeyashi, Isao<br />
Kunkel, Louis M.; Beggs, Alan H.; Hoffman,<br />
Eric P., B21<br />
Kuo, Cheng-Deng; Wu, Wen-Guey; Wang, Jia-<br />
Horng; Chen, Shu-Mai; Chiemg, Benjamin<br />
N., 667<br />
Kupferschmidt, Reinhard See Schmid, Raine<br />
-; Schmid, Rainer W., 1313<br />
Kurata, K. See Mizuochi, E.<br />
Kunoiwa, Katsumasa; Katayame, Kateuhiro;<br />
Miura, Toshihide; Nagasawa, Takeshi;<br />
Ohsawa, Susumu; Yoshida, Toshihiko;<br />
Furuya, Shin, 1117<br />
-; Neketsuyama. Shuichi; Kateyame, Keteuhii<br />
Nagasewa, Tekeahi, 2169<br />
Kurschinski, Douglas T.; Dennen, David A.;<br />
Garcia, Merle, Scamu, Angelo M., 2156<br />
Kurtz, K. See Smith, Carol<br />
Kus, Debra M.; Miller, B..; Bowers, G. N., Jr.;<br />
Koch,W., 1130<br />
Kus, Sezal See Copur, Sitki<br />
Kusilek, Lesa D.; Jackson, J. S.; Kaplan, hi.;<br />
Elson, M.; Heinzerling, K. H., 1191<br />
Kutnink, Mark A. See Burn, Betty Jane<br />
Kuwabara, Yoshiko See Azuma, Yutaro<br />
Kuwana, Tomomi; Sugita, Osamu; Yakata,<br />
Minoru, 179<br />
Kwant, G.; Oeseburg, B.; Zijlstra, W. G., 773<br />
Kwant, Gerard See Oeseburj, Berend<br />
Kwiterovich, P. See Cloey, Teresa<br />
Kwlterovich, Peter 0., Jr. See Kafonek,<br />
Stephanie<br />
Kyeyune-Nyombi, Era See Farley, John R.<br />
Kyler, Mary Kay See Lott, John A.<br />
Laarakkers, C. See de Jong, J. G. N.<br />
Labbe, Robert F. See Rettmer, Rebecca L.;<br />
Skogerboe, Kristen J.<br />
Labeur, C.; Michiels, G.; Bury, J.; Usher, D. C.;<br />
Kosseneu, hi., 1380<br />
Lacher, D. A., 330<br />
Lachman, Mary F.; Romeo, K.; hicComb, K. il<br />
499<br />
Lacour, B. See Duval, F.<br />
Laczkovlc, Axel See Fridrich, Leo<br />
Ladd, Don See Leeder, Sydney<br />
Ladenson, J. H. See Silva, D. P., Jr.<br />
Ladenaon, Jack H. See Lendt, Yvonne; Olesen<br />
Hennik; Scott, Mitchell G., 904<br />
Ladouceur, P. See Muirhead, C.<br />
Ledouceur, Pete See Roberts, Pamela<br />
Leessig, Konald; Ehrmeyer, S.; Lanphesr, B.;<br />
Hill, B.; Hassemer, D., 1088<br />
LaFontaine, George See Hansen, Hans J.<br />
Lame, Seppo See Peavonen, Jorma<br />
Laine-Cessec, P.; Turcant, A.; Allain, P., 77<br />
Laing, Ian See Beckett, Geoffrey J.<br />
Lake, Mitcheil S.; Ruby, Stephen G., 1067
alouel, Jean-Marc See Wu, Lily L.<br />
alouel, J.-M. See Wu, Lily L.<br />
am, Christopher Wai Kel See Chui, Shiu Hon<br />
em,K. W. See Fu, J. C.<br />
am, Vivian See Krystal, Gerald<br />
am, X. See Cornelison, L<br />
amb, S. V. See Reimers, T. J.<br />
ambert, A. See Bernard, A. M.<br />
ambert, Willy B.; Yousef, Mohammed A.; Van<br />
Liedekerke, Beatrijs M.; De Rooee, Joseph<br />
Be Leenheer, Andre P., 298<br />
-; Vanneste, Lutgert; De Leenheer, Andre P.;<br />
Amedee-Menesme, Ohvier, 671<br />
imberts, Ludwig V. See D’Haese, Patrick C.<br />
ambin, Patrick See Lefrere, Jean-Jacques<br />
ambrecht, Kristen K. See Cembrowski,<br />
George S.<br />
siemens, M. See Deti, Frenceeco<br />
mndicho, Del See MaUl, Soheil<br />
andmark, Knud See Urdel, Petter<br />
sndt, M. See Roeenblum, J. L.<br />
sndt, Michael; Hortin, Glen L; Smith, Carl H.,<br />
889<br />
sndt, Y. See Sllva, D. P., Jr.<br />
sndt, Yvonne; Valdys, Hemant C.; Porter,<br />
Sharon E.; Dietzler, David N.; Ledenson,<br />
Jack H., 985<br />
engan, C. E. See Watson, I. D.<br />
ington, B. See Gannon, Allison<br />
lngton, Simon K. See O’Leary, Thomas Denis<br />
snphear, B. See Lsessig, Ronald<br />
so, T. See Cheung, C. K.<br />
argilliere, Claude See Fontaine, Monique<br />
ersen,<br />
men,<br />
F. L See Kramp, W. J.<br />
Sandra; Frank, Alison; Dehike, Lisa;<br />
Koch, David D., 1100<br />
Lease See Nelson, Nine, Ohman, Stan<br />
ash, J. M. See Ward, Kory M.<br />
asky, F. D.; Zapoticznyj, W.; Gaas, T.;<br />
DeNicola, D., 1134<br />
esky, Fred D.; Arter, T.; Connelly, L; Hassett,<br />
J.; Kreuza, C.; Warren, K.; Wrenberg, A.,<br />
1132<br />
atner, Barry P.; Sksle, Jeffery S.; Burns,<br />
Weshing#{231}on, 1965<br />
Cu, Brad W. C. See Creer, Michael H.<br />
su, H.P. See Neelkantan, N. V.; Zohe, Steven<br />
J.<br />
su, H. Philip; Miller, Warren K.; Hansen, JosI<br />
B.; Bollin, Ernest, Jr., 1860<br />
euderdele, V.; Clark, P.; Roszak, D.; Wong, B.,<br />
1075<br />
eungani, D. See Hu, Mae<br />
iutz, H. U. See Oellerich, Michael<br />
euwerya, iLK. See Bernard, A. hi.<br />
ew, W. T. See Fitzpatrick, D. A.; Silver, M. It<br />
Iwson, G. J. See Quigley, hi. It<br />
lyte, K. See Moore, P.<br />
ea, Dale H. See Knight, George J.<br />
each, J. A. See Badcock, N. It<br />
eal-Khouri, Susana See Lum, Gifford<br />
eavltt, Lynda F. See Ledue, Thomas<br />
Bigot, J. F. See Vernillet, L.<br />
B.<br />
,due, Thomas B. See Johnson, Andrew Myron<br />
Poulin, Sue B..;Lesvitt, Lynda F.; Johnson, A.<br />
Myron, 2001<br />
C. See Zecbaniah, N. Y.<br />
ie, C. K. See Vaughn, R.<br />
C. K, See Rosenthal, Philip<br />
C.-Y. G. See Pan, Jie<br />
J. See Lee, Sung C.<br />
e, Martha See Wyatt, David T.<br />
Sung C., 900<br />
Johanson, N.; Lee. J.; Brudzinski, A.; Hall, D.;<br />
Mess, L; Ferber, I.; Orf, J., 1164<br />
ie, Theodore T.; Sullivan, Susan; Harvey,<br />
Sheryl, 1198<br />
eder, Sydney; Blackwell, Sherry; Ladd, Don;<br />
Yein, Fred; Carrion,<br />
Bellet, Neal, 1166<br />
Julie; Jones, Carolee;<br />
euwenkamp, Oscar K.; van der VijLh, Willem<br />
J. F.; Husken, Brigitte C. P.; Lips, Paul;<br />
Netelenbos, J. Coen, 1911<br />
febvre, K. Craig See Gubata, Paul<br />
,fkowitz, Robert J. See Frielle, Thomas<br />
,frere, Jean-Jacques; Fine, Jean-Menus;<br />
Marneux, Micheine; Lambin, Patrick;<br />
Salmon, Charles, 338<br />
gene, S. See Prinsen, Johanne<br />
grand, Alain See Bonnefont, Dominique;<br />
Peynet, Jacqueline<br />
gras, B. See Ruelland, A.<br />
hmenn, P. See Jarausch, J.<br />
,brer, Michael, 1180<br />
htinen, Matti See Paavonen, Jorme<br />
hto, Math See Peavonen, Jorme<br />
ijnse, B. See Blijenberg, B. G.<br />
Inberger. K. See Wielinger, H.<br />
Leinberger, Robert See Bale, Renze<br />
L.eischner, Ralph See Jandreski, Mark A.<br />
Leivo, Pekks See Hemmila, llkka<br />
Lejeune, H. See Dechaud, H.<br />
Lejeune, Henve See Pugeat, Michel<br />
Lele, S. See Bhergava, AK<br />
Leleux, J. See Sentulli, M. J.<br />
Leloux, Mirjam S.; Mees, R. A. A., 1183<br />
Lernann, Jacob, Jr.; Hornick, Laurel J.; Pleuss,<br />
Joan A.; Grey, Richard W., 2107<br />
La Moigne, F. See Crockett, It<br />
Lensmeyer, Gary L; Wiebe, Donald A.; Carlson,<br />
Ian H., 59<br />
Lentrichia, Brian B. See Fan, ‘l’itan S.; Ku,<br />
Che-An<br />
Lenzo, A. See Baldwin, James It<br />
Leonard, Deborah K.; Li, Philip K., 1128<br />
Leonard, H.; Klukes, C.; Williams, M.; Berg, M.;<br />
Kozel, P.; Hudson, T., 1194<br />
Leong, Denis A., 1053<br />
Lequang, N. T. See Roche, D.<br />
Leroy, M. See Basuyau, J. P.<br />
Lertora, Juan J. L See Kicci, Mary J0<br />
Leshner, Robert T. See Prior, Thomas W.<br />
Lesi, Carlo See Melzi d’Eril, Gian Vico<br />
Leslie, P. See Tibi, L.<br />
Lespinas, Francis; Dupuy, Georges; Revol,<br />
Francoise; Aubry, Claude, 654<br />
Lessard,F.;Dion,R., 2116<br />
Leukhardt-Falrfleld, Carla J. See Bernstein,<br />
Larry H.<br />
Leung, Fred Y. See Galbreith, Linde V.<br />
-; Galbraith, Linde V.; Jablonsky, George;<br />
Henderson, A. Ralph, 1435<br />
Leveno, K. See Putnam, R. S.<br />
Leverett, Lenore See Kress, Benny C.<br />
Levine,<br />
Levine,<br />
Berry See Caplsm, Yale H.<br />
J. See Carrubba, J.; Levy, S.<br />
Levine, R. See Levy, S.<br />
Levunson, Stanley S. See Smith, Michael P.<br />
Levtzow, C. B.; Chapman, J. F.; Parker, N. C.;<br />
McDade, M., 1086<br />
Levy, 0. A. See Yiu, Samuel C. K.<br />
Levy, S.; Levine, J.; Levine, R.; Klotzsch, S., 1130<br />
Lewendowski, Ryszard; Sokalski, Tomesz;<br />
Hulanicki, Adam, 2146<br />
Lewis, Douglas It See Chssnoff, Ira J.<br />
Omori, Erin; Nishio, Junko; Schnoll, Sidney<br />
H., 1186<br />
Lewis, Helen M.; Ratcliffe, Wendy A.; Stott,<br />
Richard A. W.; Wilkins, Martin R.; Baylis,<br />
Peter H., 953<br />
Lewis, L M. See Armbruster, M. A.; Vaughn, It<br />
-; Gibler, W. B.; Erb, It E.; Vaughn, R.; Biagini,<br />
A. V.; Campbell, W. B.; Blanton, J., 1125<br />
Lewis, W. H. P. See Chin, Shiu Hon<br />
Lewko, Walter M. See Oldham, Robert K.<br />
Lhermltte, Michel See Fontaine, Monique<br />
LI, J. C. See Konstantinides, Frank N.<br />
LI, Jacki T. L See Goren, Marshall P.<br />
LI, Mingen G.; Madappelly, hiathew hi., 2330<br />
LI, Philip K. See Leonard, Deborah It; Nagy,<br />
Mary P.<br />
Li, Z. M. See O’Grady, hi.<br />
Liaw, Yun-Fan See Yeh, Chau-Ti<br />
Lieb, Wolfgang See Brums, David -<br />
Liewendahl, K. See Adlercneutz, H.<br />
Liewendshl, Kristlan See Ekins, Roger<br />
Liffnian, S.; Pizza, T.; Qureshi, H.; Czaben, J.;<br />
Hughes, E.; Schwartz, D., 1112<br />
Llfechitz, Carlo. H. See Chen, Huei-Mei<br />
Lilja, H. See Abrahameson, P.-A.<br />
LIe, Chew W.; Dallas, B. H.; Chisnall, W. N.,<br />
1085<br />
Llmet, J. N. See Collet-Cssssnt, D.<br />
LIn, F. C. See Foglia, J. P.; Perel, J. hi.<br />
Lin, S. J. See Chen, Katherine<br />
Lie, Yuh-Nan See Kish, Linda; Sciotto-Brown,<br />
Susan; Zimmermann, Linde<br />
LInareHl, Louis 0. See Nelson, Jereld C.<br />
Llndhack, Bengt; Bergman, Anders, 835<br />
Lindsay, G. See Watson, I. D.<br />
Lindsay, W. See Wilson, John hi.<br />
Llndstedt, Goren See Lundberg, Per-Anne;<br />
Nystrom, Ernst<br />
-; Lundberg, Per-Arne; Johamsson, Pie-Marie;<br />
Eggerteen. Robert; Ellertz, Gina; Nystrom,<br />
Ernst, 1557<br />
Lhnnet, KristIan, 284, 1416<br />
-; hicConway, hi. G.; Chapman, R. S.; Beastall,<br />
G.H., 1805<br />
Lippi, Ugo See Graziani, Marie Stalls<br />
Lips, Paul See Leeuwenkamp, Oscar B..<br />
Upset, Joel; Mansbach, Lillian; Herberger,<br />
John, 1201<br />
Lipsey, A. I. See Huang, W. T.<br />
Lipsey, Allen I. See Cheng, Many H.<br />
Lischinsky, S. See Beck, R.<br />
LIu, A. See Bernard, Mark; Schneider, L.<br />
LIu, Frank J. See Fasullo, Frank J., Jr.<br />
Uu, Peter K. S. See Edwards, Paul<br />
Lizardi, Paul M. See Lomei, Hilda<br />
Lloyd, Cynthia; Travis, James, 1971<br />
Lochmulier, Charles H., 1052<br />
Lockitch, GIllian, 1241<br />
Lodato, D. See Relyee, Noel hi.<br />
Lodge, Mark S.; Albere, John J., 1073<br />
Loeschen, B. J. See Fredrickson, It A.<br />
Loeschen, Barbara J. See Sommer, Ronald G.<br />
Lohff, M. See Sibilia, It<br />
Lohr, Steve See Bleile, Dennis<br />
Lojo, S. See Rodriguez-Segade, S.<br />
Lojo, Santiago See Rodriguez.Segade, Santiago<br />
Lomeli, Hilda; Tyagi, Sanjay; Pritchard, Cynthia<br />
G.; Lizardi, Paul M.; Kramer, Fred Russell,<br />
1826<br />
Lommaert, M. P. See Hendriks, D.<br />
Lonardo, A. See Burrows, KeriLyn C.; Reddy,<br />
Pedals V.<br />
London, Stephanie J. See Hankinson, Susan E.<br />
Long, E. W. See Grenner, G.<br />
Longerich, L See Gault, M. H.<br />
Longhuret, Sharon See Chou, Peter P.<br />
-; Chou, Peter P.; Toms, Rick A.; King, Brenda;<br />
Chang, Agnes, 1099<br />
Leo, Swee-Chun See Chandler, Wayne L<br />
Lopez, B. See Freeman, J.<br />
Lopez, C.; Lykissa, E. D.; Kammerer, R. C., 1169<br />
Lopez-Otln, Carlo. See Vents, Rafael<br />
Lou, John A. See Fraser, Callum G.; Fuentes-<br />
Arderiu, X.; Lu, Carrie J.; Warren, Patricia,<br />
201<br />
-; Manning, Neal It; Kyler, Mary Kay, 347<br />
Warren, Patricia, 1766<br />
Lotti, Gaetano See Musso, Netale It<br />
Louderback, Allan; Foley, Thomas, 1086<br />
Louderback, Allen L.; Palmer, John J., 1087<br />
Love, James B., Jr., 1067<br />
Lovell, Mark A., B43<br />
-; hiifflin, Theodore B.., 1816<br />
Lovell, Mark Alan See Silverman, Lawrence<br />
Lovgren, Timo See Barnard, Geoff<br />
hi.<br />
Lower, D. See Crisan, Domnita<br />
Lu, Carrie J.; Lott, John A., 1090<br />
Lu, W. See Fu, J. C.<br />
Lubec, G.; Sehmid, It; Bantosch, B.; Sensi, M.,<br />
2254<br />
Lucas, F. See Fernan, hi. E.; Steele, B.<br />
-; Johnston, D.; Sewell, R.; Shukia, R.; Carter,<br />
J.; Ibanez, J., 1156<br />
Lucco, L See Singh, J.<br />
Lum, Gifford; Leel-Khouri, Susana, 639<br />
-; Marquardt, Carolyn; Khuri, Shukni F., 664<br />
Lundberg, Per-Anne See Lindetedt, Goran<br />
-; Lindstedt, Goran; Jansson, Svante; Tisell,<br />
Lars-Erik, 340<br />
Lundqulst, Per; Sorbo, Bo, 617<br />
Lunec, J. See Winkles,<br />
Lustenbergor, Patrick<br />
J. W.<br />
See Orsonnesu, Jean-<br />
Luc<br />
Lustgarten, J. See Sundaram, Sham G.<br />
Lustgarten, J. A.; Wenk, It B..; Noel, S., 1067<br />
Lustig, V. See Diamendis, B.. P.<br />
Lustig, Villain See Diamandis, Eleftherios P.<br />
Luxton, A. See Donahoe, Mark<br />
Luxton, Richard W.; Petal, Prague; Keir,<br />
Geoffrey; Thompson, Edward J., 1731<br />
Lykls.a, B. D. See Cano, C.; Lopez, C.<br />
Lykissa, Ernest D., 1169<br />
Lynch, Braden See Zoccoli, Michael A.<br />
Lynch, Michael J., 1188<br />
Lyon, T. D. B. See Fraser, W. D.<br />
Mass, L See Lee, Sung C.<br />
Mabbett, S.; McIntyre, A.; Thomp.on, W.;<br />
hiontaue, D., 1149<br />
Macart, Michel; Koffi, Agnes; Henocque,<br />
Genevieve; Mathieu, Jean-Francois;<br />
Guilbaud, Jean-Charles, 211<br />
Maccan, F.; Hulsmann, W. C., 711<br />
Maclejko, James J. See Smith, Michael P.<br />
Macloazek, J. See Ostrow, D. H.<br />
MacKenzie, A. See Wong, T.<br />
MacWalter, Ronald S. See Fraser, Celluin G.<br />
Madappally, Mathew M. See Li, Mingen G.<br />
Madden, Alden See Howard, Ketrina<br />
Madden, Thomas M. See Irish, Glenn R.<br />
Madry, Norbert; Senftner, H. J.; Gentzer, W.;<br />
Palermo, M.; Pothier, S.; Baker, K.;<br />
Havelick, J.; Grenner, G., 1195<br />
Meeda, M. See Uji, Y.<br />
Meekawa, Masato See Azuma, Yutaro<br />
-; Sugiura, Koseku; Azums, Yutaro; Kanno,<br />
Takashi, 897<br />
Mae., K. A. A. See Leloux, Mirjam S.<br />
Magglo, Vincent L See Mynick, James E.<br />
Magglore, Jack See O’Connor, Brian<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2353
Magnotti, Ralph A., Jr.; Stephens, Gregory W.;<br />
Rogers, Rick K.; Peace, Amadeo J., 1371<br />
Mahaffey, K. See Sibilia, R.<br />
Mahan, J. D. See Ward, Kory M.<br />
Mahan, John D. See Wailer, Kathy V.<br />
Mahinood, Nishat; Srebro, Sonia; McCarthy,<br />
M; Brotherton, Mary; Hunter, Thomas;<br />
DeMarco, Curtis, 1095<br />
Mahoney, John See Van Kessel, Antonius L.<br />
Mahuzier, 0. See Thuen, N. T. Leuquang<br />
Maler, K. S. See Pauley, Scott D.<br />
Mak, Ken See Bleile, Dennis<br />
Makela, Sinikka K. See Ellis, Graham<br />
Maklnen, Malja-Lilsa; Pettersson, Kim;<br />
Suonpaa, Mikko, 1205<br />
Malecker, James K. See Oldhem, Robert K.<br />
Malik, Sohail; Kenny, Margaret A.; Landicho,<br />
Del; Heron, Diane; Helverson, Kevin;<br />
Dasgupta, Amitava; Ahmad, Suhsil, 1157<br />
Malkin, Aaron See Hansen, Hans J.<br />
Mallein, K. See Dechaud, H.<br />
Malloy, D. See Pexton, Helene<br />
Maluf, Karen See Passey, Richard B.<br />
Manca, Dm0; Ferron, Liliene; Weber, Jean-<br />
Philippe, 601<br />
Manderino, G. L See Konrath, J. G.<br />
Manganello, Jeanne See O’Connor, Brian<br />
Mangil, Ruggeno See Dolci, Alberto<br />
Manguni, B. W., 503<br />
Mani, H. S. See Kotheni, Kanchan<br />
Manimekalai, S. See Goldstein, Philip J.;<br />
Sundaram, Sham G.<br />
-; Unni, S.; Sundarem, G. S.; Goldstein, P. J.,<br />
1140<br />
Manning, J. See Murphy, Allan<br />
Manning, Neal K. See Lott, John A.<br />
Manning, Wayne See Zoccoli, Michael A.<br />
Mansbach, Lillian<br />
Mantero, Giovanni<br />
See Lipeet, Joel<br />
See Polesi, Claudio<br />
Mantha, S. See Jagoda, E.; Raise, A.; Tsay, H.<br />
-; Tsay, H.; Tu, J., 1190<br />
Marbach, K. See Kruse-Jarres, J. D.<br />
Marcovina, S. See Dati, Francesco<br />
Marcovina, Santica See Dolci, Alberto<br />
-; Zoppo, A.; Parlavecchie, M.; Fardin, E., 1163<br />
Marcovina, Santlca M. See Albers, John J.<br />
-; Albers, John J., 2009<br />
Maretsky, D. See Grenner, G.; Padilla, A.;<br />
Staedter, hi.<br />
Markin, R. S. See Arnold, L. L.; Earl, R. A.;<br />
Haven, hi. C.; Schiebout-Clerk, K. C.<br />
Markin, Rodney S. See Haven, Mary C.<br />
Marlewski, D.; Douglas, J.; Sacha, P.; Ogunro,<br />
E.;Doss,R., 1146<br />
Marlewski,<br />
Marlewski,<br />
Debbie See Baker, Harold N.<br />
Deborah See Ford, Kent A.<br />
Marneux, Micheline See Lefrere, Jean-Jacques<br />
Marquardt, Carolyn See Lum, Gifford<br />
Marrakchi, Slaheddine See Fontaine, Monique<br />
Marsden, Joanne T. See Johnston, Athoil<br />
Marsh, K. See Woo, Jannie<br />
Marshall, Thomas See Williams, John<br />
Martel, P. See Gabor, Mike; Harper, J. D.<br />
Martel, Patricia A. See Bechand, Steven S.;<br />
King, David L.<br />
Martha, P., Jr. See Felder, R. A.<br />
Martin, Cazemiro R. See El-Yazigi, Adnen<br />
Martin, Edward W. See Hansen, Hans J.<br />
Martin, J. K. See Moore, P.<br />
Martin,<br />
Martin,<br />
Lorene A. See Brans, Yves W.<br />
M. LouIse See Boone, D. Joe<br />
Martinez, Luis A. See Jones, Christopher E.<br />
Martofano, A. See Black, William<br />
Marumo, Funiiaki See Ishida, Osamu<br />
Maruta, Kazuhiro; Teradaira, Ryo; Watsnabe,<br />
Noriyuki; Nagetsu, Toshiharu; Asano,<br />
Maeao; Yamamoto, Katsunobu; Matsumoto,<br />
Takatoshi; Shionoya, Yoshihiko; Fujita,<br />
Kelsuke, 1694<br />
Marx, A. M. See Kropf, J.<br />
Masana, L. See Joven, J.<br />
Mashige, Fumiko; Hisae, Nobuo; Toyota,<br />
Sechiko; Yoshinoya, Sadeyoshi; Ohkubo,<br />
Akiyuki, 2322<br />
Masiero, M. See Plebeni, Mario<br />
Masini, S. See Zucchelli, G. C.<br />
Mason, L See Crisan, D.<br />
Masover, B. See Mulberg, E.<br />
Messed, A. See Beck, R.<br />
Massey, K. L See Kalra, J.<br />
Massoubre, Catherine See Orsonneau, Jean-<br />
Luc<br />
Massoud, Nell See Brettfeld, Chris<br />
Masters, AM; Hahnel, Roland, 979<br />
Masude, Minoru See Yebuuchi, Mesehiko<br />
Masulli, I. S. See Zoha, Steven J.<br />
Matamoros, H. A. See Reimers, T. J.<br />
Matheke, M. L See Butch, Anthony<br />
Matheke, Mary Lou See Reason, Craig<br />
Mathias, Dietgen See Peters, Jorg<br />
Mathieu, Jean-Francols See Macart, Michel<br />
Mathleu, Monique See Bony, Claude<br />
Mathisen, Mary L; Vessella, Robert L., 1092<br />
Matsubara, Fujitsugu See Hashimoto, Takuma<br />
Matsuda, Akihiko; Kimure, Mieko; Kateoke,<br />
Mikiko; Ohkuma, Shin-ichi; Sato, Makoto;<br />
Itokawa, Yoshinori, 1939<br />
Matsuda, H. See Ishimori, Yoshio<br />
Matsumoto, Kojiro; Kanbe, Shigenobu; Kuhn,<br />
Hiroaki; Yegi, Gohei; In, Hiseini; Yuki,<br />
Hideteke, 453<br />
Matsumoto, Takatoshi See Maruta, Kazuhino<br />
Matsuoka, Akira See Kobayeshi, Kunio<br />
Metsuura, Tsuneaki; Hasegewa, T.; Tanaka, K.;<br />
Shibeta, H.; Honda, T., 1082<br />
Matsuzaki, Hiroko See Miura, Masakezu<br />
Mattimiro, Chris See Donohue, Joseph<br />
Maturen, Andrew See Nice, Allen; O’Connor,<br />
Brian<br />
Meuck, L. See Danielson, Susan J.; Hasselberg,<br />
Stephen<br />
Mauck, Linda; Alexandrovich, S.; Bale, M.;<br />
Danielson, S.; Hassett, J.; Sundberg, hi.;<br />
Widener, J., 1200<br />
Meugh, K. Se. Sperling, Matthew<br />
Mexon, H. See Sperling, Matthew<br />
Mayer, T. See Kubasik, N. P.<br />
Mayer, T. K. See Kubasik, N. P.<br />
Mayfield, C. See Singh, Jagat<br />
Mayrand, P. E. See McBride, L J.<br />
Mazzachi, K. D. See Berry, hi. N.<br />
McBlain, William A. See Molnar, Larry A.<br />
McBride, J. H. See Aim, Ronald B..; Schotters,<br />
S. B.<br />
McBride, James H.; Rodgerson, Denis 0., 1356<br />
-; Rodgerson, Denis 0.; Park, Sue S.; Reyes, Ana<br />
F., 1726<br />
McBride, L J.; Koepf, S. M.; Gibbs, R. A.;<br />
Salser, W.; Mayrend, P. E.; Hunkapiller, M.<br />
W.; Kronick, hi. N., 2196<br />
McCallum, Theresa See Picone, Teresa<br />
McCarthy,<br />
McClellan,<br />
M. See Mahmood, Nishat<br />
Adrain See Butch, Anthony W.<br />
McClure, K. Dale See Watkins, Michael<br />
McComb, H. B. See Lachmen, Mary F.; Valcour,<br />
Andre<br />
McComb, K. M. See Knzymowski, G. A.<br />
McComb, Robert B. See Klaus, Eric M.;<br />
Okorodudu, Anthony 0.; Valcour, Andre A.<br />
McConwey, M. G. See Linnet, Kristian<br />
-; Chapman, It S.; Beastall, G. H.; Brown, E.;<br />
Tilhnan, J.; Bonar, J. A.; Hutchison, A.;<br />
Allison, T.; Finlayson, J.; Weston, B.;<br />
Beckett. G. J.; Canter. G. D.; Carlyle, B..;<br />
Henbenteon, B..; Blundell, G.; Edwards, W.;<br />
Glen, A. C. A.; Reid, A., 289<br />
McCord, Joe M., 1050<br />
McCormick, C.; Shihabi, Z., 1122<br />
-; Shihabi, Z ; Goodman, H., 1137<br />
McCormick, Michael I See Sun, Yi<br />
McCruden, D. See Dominiczek, Marek<br />
McCusker, L M. See Kramp, W. J.<br />
McDade, M. See Levtzow, C. B. -<br />
McDowell, Ian F. W.; Wisdom, G. Brian;<br />
Trimble, Elisabeth K., 2070<br />
McGinley, M. H. See Schottens, S. B.<br />
McGinnis, S. See Silver, hi. It<br />
McIntosh, S. J.; Watson, I. D.; Kelly, A.;<br />
Stewart, hi. J., 1353<br />
McIntyre, A. See Mabbett, S.<br />
McKenzie, Sheila See Sinclair, David<br />
McLachlan, R., 478<br />
McLachlan, S. M. See Beaver, K.<br />
McLaughlin, Kathleen See Skogerboe, Kristen<br />
J.<br />
McMahan, C. Alex See Schwartz, Joyce G.<br />
McMurray, H. 0. See Rifai, Nader<br />
McNair, Peter See Frandsen, Niels Jorgen<br />
McNally, A. J. See Siemon, Peggy<br />
McNainara, Judith K., 1234<br />
McPherson, Richard A. See Podiesek, Stanley<br />
J.; Podlesek, Stanley J.<br />
-; Aganwal, K. P.; Scott, Joan R.; Podlasek,<br />
Stanley J., 1076<br />
McPhillip., Mary See Knepil, Janusz<br />
McWhinney, B.C. See Cowley, D. M.; de Leacy,<br />
E. A.<br />
Medcalf, E. See Newman, D. J.<br />
Me., A. V. See Wang, P. Y.<br />
Meeks,<br />
Meijer,<br />
Andrew See Bonham, James R.<br />
Gert W. See de Bruyne, Jan J.<br />
Meleraki, James J.; Chiappetta, B..; Spells, M.;<br />
Ramsey,J., 1174<br />
Mellbning, Goran See Nilsson, Torbjorn K.<br />
Melzi d’Bnil, Glen Vico; Bosoni, Tiziana; Lesi,<br />
Carlo, 2142<br />
Meneghini, F. A. See Grenner, G.<br />
Meng, Xianzhong See Pippenger, C. F.<br />
Meola, John K. See Persons, Patrick J.<br />
Mercer, W. See DiPeola, J.; Peltyszyn,<br />
Stephanie; Wimimer, Cathy<br />
Mercer, Wayne See DiPaola, Joseph; Salinas,<br />
Rosalie<br />
Meriadec, B. See Bianca, Carol<br />
Merritt, Gerald J. See Jones, Christopher E.<br />
Merritt, Russell J., 1060,1238<br />
Merzbach, David See Barak, Mire<br />
Messenger, H. See Freemin, J.<br />
Messing, Bernard See Peynet, Jacqueline<br />
Meszaros, Istvan See Goth, Laszlo<br />
Metzler, M.; Pierre, K., 1071<br />
Metzmann, B. See Dati, Francesco<br />
-; Schmidt, B.; Dengler, M.; Kapmeyer, W.,<br />
1091<br />
Metzmann, Erwin See Kepmeyer, Wolfgang H.<br />
Meulenberg, P.M. M.; Hofmen, J. A., 168<br />
Miceli, J. N. See Vroon, D. H.<br />
-; Vroon, D. H.; Bloodworth, D. F.; Brantley, N.<br />
Tackett, E. B.; Wellington, Pat, 1165<br />
Miceli, Joseph N., 1240<br />
Michalski, 1, 1112<br />
Michiels, G. See Labeur, C.<br />
Mldgley, J. See Sheehan, C.<br />
Midgley, John B. M. See Ball, Richard<br />
Mlfflin, T. E. See Bowden, James<br />
Mifflin, Ted; Bowden, J.; Walton, 5., 1076<br />
Mifflin, Theodore E. See Lovell, Mark A.<br />
-; Hamilton, Marilyn; Hubbard, Elizabeth;<br />
Kline, Michael J.; Bruns, David E., 110<br />
-; Foremen, Rodney W.; Bruns, David F., 1651,<br />
1819<br />
Migueres, ML See Thuan, N. T. Leuqueng<br />
Mikola, Heikkl See Barnard, Geoff<br />
Miles, Andrew; Philbrick, David B.. S.; Grey,<br />
JosephE., 514<br />
Miller, Barbara B.; Turner, Wayman E., 1756<br />
Mliler, Dayton T. See Mynick, James E.<br />
Miller, DL See Kohl, HH<br />
Miller, JudIth A. See Kaplan, Lawrence A.<br />
Miller, K. L. See Harrison, H. H.<br />
Miller, R. See Kus, Debra hi.<br />
Mifier, R. C. See Pauley, Scott D.<br />
Miller, W. Greg See Tetrault, Gregory A.;<br />
Weiesbecker, Karen A.<br />
Miller, Warren K. See Lau, H. Philip<br />
Miller, Wayne See Shew, Norman<br />
Mills, A. See Freeman, J.<br />
Mills, A. J. See Prabhakaran, Victor hi.<br />
Mills, 0. A.; Walker, V.; Coma, D. L, 673<br />
Mills, Graham A. See Walker, Vaierie<br />
MIllsap, S. See Fox, Martha<br />
Millsep, Susan; Powers,<br />
V.; Abenin, C., 1103<br />
hi.; Noriyuki, I.; llama,<br />
Milne, D. B. See Gallagher, S. K.<br />
Milstein, Sheldon See Fuchs, Dietmar<br />
Mimes, I See Kieng, W.<br />
Mien, A. See Guemouri, Leila<br />
Mlsaki, Hldeo See Imamuna, Shigeyuki<br />
Mitchell, D. R. See Konstantinides, Frank N.<br />
Mitchell, 0. See Duncan, Marilyn<br />
Mitsunioto, H. See Solano, Romeo<br />
Miura, Akira B. See Wakui, Hideki<br />
Miura, Masakszu; Fukuyama, Yechiyo; Hirano,<br />
Tetsuo; Matsuzaki, Hiroko, 1995<br />
Miura, Takayuki See Gotoh, Hiroehi<br />
Miura, Toshihide See Kuroiwa, Katsumesa<br />
Miya, Terry See Wu, James T.<br />
Miyada, D. S.; Fegin, A.; Ocaniz, J.; Vezini, N. D.,<br />
1134<br />
-; Fagin, A.; Pinkie, H.; Ocaniz, J.; Vazini, N. D.,<br />
2325<br />
Miyagi, Kouichi See Shoji, Shin’ichi<br />
Mlyai, KIyoshi See Tamaki, Henuo<br />
Mlzokemi, M. See Sorin, T.<br />
Mlzuno, Shigeki See Joukyuu, Riteuko<br />
Mizuochl, E.; Yamaneshi, H.; Obata, K.; Takai,<br />
M.; Iinuma,K.;Kureta,K., 1192<br />
Mizushima, Yoshikiyo See Yamaguchi, Akihiro<br />
Mlyniec, D. See Figand, StaveD.<br />
Moatti, N. See Cosaon, C.; Myers, L<br />
Moawad, Atef H. See Zibret, Steven J.<br />
Moaz, Aheed A. See Fnandsen, Erik K.<br />
Moelby, Lam See Rasmussen, Kersten<br />
Mohr, M. See Center, G.<br />
Mojzislk, Kathy See Hansen, Hens J.<br />
Molina, Ernesto See Gascon, Felix<br />
Moll, Willi See Wencker, Marion<br />
Molloy, S. See Doria, Manuel, Jr.<br />
Molnar, Larry A.; Dhirani, Nasreen; Tram, Kim:<br />
McBlain, William A., 824<br />
Molyneux, Angus See Rowbotham, Lynn<br />
Monforte, J. H. See Cetomeris, Peter<br />
Monk, J.; Calvin, J.; Price, C. P.; Wreghitt, T. G.<br />
431<br />
2354 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
lontagnoli, Giorglo See Degan, Paolo<br />
lontague, D. See Hughes, J.; Mabbett, S.<br />
lontalbettl, N. See Baedenhuijsen, H.<br />
lontero, A. See Singh, J.<br />
loolenaar, Abraham J. See Franck, Paul F. H.<br />
loon, C. See Edwards, S.; Mumdill, P.<br />
loon, Patricia See Bleile, Denmis<br />
loom, F.M. I; Simpson, D., 1782<br />
bore, Gordon P., 1849<br />
loom, K. See Putnam, K. S.<br />
bore, P.; Layte, K.; Aslem, M.; Martin, J. K.,<br />
1149<br />
loom, K. B. See Okorodudu, A. 0.<br />
loorman, Stacy; Winn, C. I; Myers, G. I;<br />
Cooper, 0. R., 1073<br />
lorales, A. See Soldin, Steven J.; Stone, Judy<br />
lorales, Antonio See Rifai, Nader<br />
lorano, Susanne See Senei, Meurizio<br />
bomno, Kuben F. See Tilzer, Lowell I<br />
borgan, Craig See Pandian, M. H.<br />
Ion, Mlkio; Kawamura, Kenye, 1127<br />
brim, Leo 0.; Austin, Garth E.; Rodey, Glenn<br />
E.; Johnson, James E., 1039<br />
-; Austin, Garth E.; Rodey, G.; Johnson, J., 1154<br />
lornis, Brian See Rowbotham, Lynn<br />
bornis, Brian W. See Price, Mum<br />
bornis, D. I See Fredrickson, K. A.<br />
lonris, David L See Somnier, Ronald G.<br />
bornlsett, Joel D. See Petech, Wolfgang<br />
bortler, Eric See Robbrecht, Johan<br />
bosca, Andrea See Paleari, Renete<br />
boscoso, Hugo; Shyamala, M.; Kiefer, Charles<br />
B..; Garver, Fred A., 2066<br />
loses,<br />
loses,<br />
G. C. See Smith, Deborah A.<br />
Godfrey C. See Smith, Deborah A.<br />
lo.k.khl, W. B. See Holzberg, Roni A.<br />
loskie, Laura A. See Newman, Edward S.<br />
loss, Donald W. See Whitaker, Katrine B.<br />
-; Whitaker, Katrine B.; hiunno, Alastair J., 896<br />
loss, 0.5. See Sehgal, Lakshman K.<br />
lotika, Deborah; Childers, David; Fenton,<br />
John, 1068<br />
lotin, Jean See Pugeat, Michel<br />
lotoda, S. See Ishiinori, Yoehio<br />
louisa, Fathi; Dufour, Lucienne; Didry, Jean<br />
Rene; Aymard, Pierre, 874<br />
boyer, Thomas P., 1815<br />
ludarris, Ayad; Brabhem, Ewart A., 1164<br />
lueggler, Paul See Subbarso, hiakam N.<br />
luirhead, C.; Ladouceur, P.; Pierre, K.; Heden,<br />
B.; Seislove, J.; Purcell, 0., 1110<br />
luirhead, C. L See Vasilakis, Jeanne<br />
lukharjee, A. See Zacherieh, N.Y.<br />
lulbeng, E.; Masover, B.; Graham, B.;<br />
Bernedino, H.; Silva, K.; Centofanti, J., 1173<br />
Lullen, James See Kricke, Larry J.<br />
bullies, Marvin; Spanien, M.; Bielawski, C.,<br />
1095<br />
lundlll, P.; Moon, C.; Aslam, M., 1149<br />
lunro, Alastair J. See Moss, Donald W.<br />
lunzenberger, Paul See Brettfeld, Chris<br />
lurakami, Shigeki See Konmo, Norimichi<br />
lures., Mituya See Usui, Akihiko<br />
lures., Toshlo See Ishibeshi, Shun<br />
lure., A. See Abrahamsson, P.-A.<br />
lurone, M. See Bonini, P. A.<br />
lurone, Michelangelo See Banfi, Giuseppe<br />
lurphy, Allan; Manning, J.; Gibson, S., 1091<br />
Furray, C. See Kubasik, N. P.<br />
Furthy, H. MS. See Breglio, Susan; Staples,<br />
Mark; Watkins, Michael; Zen, Geraldine Tun<br />
Lurthy, Vadiraja V.; Kermen, Arthur, 1115<br />
-; Kaninen, Arthur, 1190<br />
Lurza, B. See Chin, Bruce G.<br />
[mao, Natal. K.; Vergassola, Claudio; Pende,<br />
Aldo; Lotti, Gaetano, 1975<br />
[yarn, I. See Coeson, C.<br />
-; Atger, V.; Coeson, C.; Guillemain, K.; Amnein,<br />
C.; Dryfus, G.; Moatti,<br />
(yer,, 0.1 See Moorman,<br />
N., 1258<br />
Stacy<br />
[yen, Gary I; Schap, F. D.; Smith, S. J.;<br />
Cooper, 0. K.; Hantmann, A. E.; Gilmore, B.;<br />
Ray, D. H., 1073<br />
yen, IS. See Bhargeve, A. K.<br />
[yen, M. See Bhergeve, A. K.<br />
Lyers,M. M. See Bhargava, A. K.; Bhargava,<br />
[ylott, G. See Ferrenkopf, Bruce C.<br />
lyre, S. A. See Schroeder, Timothy J.<br />
[yrick, James E.; Gunter, Elaine W.; Maggio,<br />
Vincent L; Miller, Dayton T.; Hannon, W.<br />
Harry, 37<br />
yrti,, James F.; Bodor, Geza; Wolf, Bryan A.;<br />
Hinds, Barbara; Nahm, Moon H.; Scott,<br />
Mitchell 0., 2154<br />
accarato, W. F. See Koch, Thomas K.<br />
agasawa, Takeshi See Kuroiwa, Katsumasa<br />
Nagatsu, Toshiharu See Gotoh, Hinoshi;<br />
Maruta, Kazuhiro<br />
Nagy, Mary P.; Li, Philip K., 1168<br />
Nahm, Moon H. See Bodor, Geza; Myrtle, James<br />
F.<br />
Nail, Bharat See O’Connor, Brian<br />
Naka, Keilchl See Shimojo, Nobuo<br />
Nakajlina, Chiaki See Shimojo, Nobuo<br />
Nakajinia, Takeyukl See Azume, Yutaro<br />
Nakamoto, Yasushi See Wakui, Hideki<br />
Nakainura, Aurea See Dasgupte, Amitava<br />
Nakamura, Katsumi See Fukuda, Chisako<br />
Nakamura, M. See Sonin, T.<br />
Nakaniura, Muakazu; Seth, S.; Konishi, M.;<br />
lide, M.; Komachi, Y., 1065<br />
Nakamura, Masao See Shoji, Shin’ichI<br />
Nakamura,<br />
Nakamura,<br />
Robert<br />
Tsun.o<br />
M., 1239<br />
See Yebuucbi, Mesahiko<br />
Nakao, M. See Cho, Hiroko<br />
Nakashima, Koji; Nishizaki, Osamu; Andoh,<br />
Yukio; Takei, Hitoshi; Itei, Akira; Yoshida,<br />
Yukio, 958<br />
Nakatsuyama, Shuichi See Kuroiwa,<br />
Ketsumasa<br />
Nance, Walter B. See Weissbecker, Karen A.<br />
Nandedkar, Arvind K. N.; Kim, Sook-Chie,<br />
1135<br />
Napoil, K. I; Grevel, J.; Armour, C., 1186<br />
Narang, Emma; Damodaran, K.; Rao, J., 1200<br />
Narayanan, S. See Foglia, J. P.; Perel, J. M.<br />
Nargessl, H. D.; Sverlow, K.; Schneider, D.;<br />
Ralston, S., 1198<br />
Naudin, Claude See Vernet, Michele<br />
Nevalesi, Kenzo See Giampietro, Ottevio<br />
Navazl, Waleska; Keasner, Art; Jam, Chandre,<br />
1106<br />
Nealon, D. See Hasselberg, Stephen<br />
Neary, K. H., 2336<br />
Need, A. 0. See Nordin, B. E. C.<br />
Neelkantan, N. V. See Koch, Thomas K.; Zohe,<br />
Steven J.<br />
-; Weston, S.; Lou, H. P., 1202<br />
Neely, H. See Witherspoon, I K.<br />
Neglia, Joseph P. See Whitley, Chester B.<br />
Neider,<br />
Neisler,<br />
K. See Keller, Charles H.<br />
H. M.; Bean, M. H.; Thompson, W. R.;<br />
Johnson, J. T.; Hall, M.; Pittington, J.;<br />
Smith, J. L., 1136<br />
Nelsl,r, Mike See Panteghini, Meuro<br />
Nelson, Jerald C. See Ekins, Roger; Pandian,<br />
M. K.<br />
-; Tomei, Ray T., 541<br />
-; Linerelli, Louis G.; Pandian, M. K., 1257<br />
Nelson, I See Eble, K. S.<br />
Nelson, Margaret See Hever, Virginia M.<br />
Nelson, Nine; Ohman, Stan; Lareson, Lease, 486<br />
Nelson, Norman C. See Arnold, Lyle J., Jr.<br />
Nestruck, A. Christine See Devignon, Jean<br />
Netelenbos, J. Coon See Leeuwenkamp, Oscar<br />
K.<br />
Neuenhofer, S. See Schnomr, Gerd K.<br />
Nevill,<br />
Neville,<br />
J. I See Kramp, W. J.<br />
Ronald G. See Fraser, Callum 0.<br />
Newerly-Abranow, Wanda See Attia, John<br />
Newman, D. J., hiedcalf, E.; Gorinan, E.G.;<br />
Price, C. P., 1205<br />
Newman, Edward S. See Hansen, Hans J.<br />
-; Moskie, Laura A.; Duggal, Rita N.;<br />
Goldenberg, David M.; Hansen, Hens J.,<br />
1743<br />
Newman, Howard A. I., 1234<br />
Newton, M. See Iehii, S.<br />
Newton, M. K. See Rosenthal, Philip<br />
Nexo, Ebbs See Gimsing, Peter<br />
Ng, H.-T. See Pan, Jie<br />
Ng, K. H. See Hardy, Robert<br />
Ng, Ronald H.; Sparks, Katherine; Statland,<br />
BernardE., 1106<br />
-; Coulam, Carolyn B.; Trout, Neil; Cnitser,<br />
John; Stetland, Bernard E., 1144<br />
-; Sparks, Katherine; Statland, Bernard B., 1159<br />
Nguyen, Son V. See Chandler, Wayne L<br />
Nguyen, Thuy; Wernick, 0. Russell, 1086<br />
Nice, Allen; Meturen, Andrew, 1542<br />
Nicholson, J. See Winborne, K.<br />
Nicholson, James H.P.; Savory, M. Geraldine;<br />
Savory, John; Wills, Michael K., 488<br />
Nicholson, John F., 1238<br />
Nickel, Erika See Jung, Klaus<br />
Nicoloal,<br />
Nicolson,<br />
K. J. See Karge, W. H.<br />
Ruth B.; Reilly, Christopher P.;<br />
Pannall, Peter K.; Esposito, Linde, Wellby,<br />
Maurice I, 931<br />
Nigro, Michael See Brettfeld, Chris<br />
Nilsson, Ingegerd See Joustra, M.<br />
Nilsson, Torbjorn K. See Jansson, Jan.Hakan<br />
-; hiellbring, Goran, 1999<br />
Nlshlna, Toshihlro See Joukynu, Ritauko<br />
Nlshlo, Junko See Lewis, Douglas #{163}<br />
Nishizaki, Oseinu See Nakaahiina, Koji<br />
Noedel, M. See Peat, Michael A.<br />
Noel, A. See Bernard, A. M.<br />
Noel, S. See Lustgarten, J. A.<br />
Noller, Hans G., 1209, 1209<br />
Noma, A. See Uji, Y.<br />
Noma, Aklo See Abe, Akina<br />
Nomoto, Shozo See Shoji, Shin’ichi<br />
Norb.rg, Be See Janseon, Jan-Hakan<br />
Nondin, B. B. C.; Need, A. 0.; Hartley, T. F.;<br />
Philcox, J. C.; Wilcox, hi.; Thomas, D. W., 14<br />
Norfolk, D. See Deti, F.<br />
Noriyukl, I. See Fox, Martha; Millsap, Susan<br />
Nonmansell, D. B. See Boyd, James C.<br />
Norton, Carol See Kej, Robert<br />
Norton, Gary See Novros, Joel<br />
Norton, Kurt See Knees, Berry C.<br />
Noun, N. See Peltyszyn, Stephanie; Wimmer,<br />
Cathy<br />
Novick, David M.; Poretsky, Leonid; Kalin,<br />
Marcia F.; English, Trevor N.; Ruxton,<br />
David; Eastman, Creswell J., 1807<br />
Novros, Joel; Norton, Gary; Arter, Thomas;<br />
Shenklin, Nora, 1101<br />
Nunneily, P. See Bray, Kurtis K.<br />
Nuss.nblatt, Robert B. See Elm, Ronald J.<br />
Nustad, Kjeil See Peus, Elisabeth<br />
Nuwayhid, N. F.; Johnson, G. F., 1179<br />
Nuwayhid, Naziha F.; Johnson, George F.; Feld,<br />
Ronald D., 1526<br />
Nyberg, S. See Phillips, E.<br />
Nyhan, William I See Hoffmenm, Georg<br />
Nystrom, Ernst See Lindstedt, Conan<br />
-; Lindstedt, Goran; Rudenstam, Carl-Magnus;<br />
Bengtsaon, Bengt-Ake; Tisell, Lars-Erik,<br />
1019<br />
Obata, K. See Mizuochi, F.<br />
Ob.nley, Larry W. See Sun, Yi<br />
O’Brien, John F. See Gonchoroff, Daryl 0.;<br />
Schosnau, B..<br />
O’Brien, Maureen See Sedowski, James<br />
Obst, Joachlm, 1208<br />
Ocanlz,J. See Miyade, D. S.<br />
O’Conneil, Kathleen M., 1233<br />
O’Connor, Brian; Manganello, Jeanne;<br />
Pacholski, Janet; Roth, Diethuld; Maggiore,<br />
Jack; Quale, Marguerite; Naik, Bharet;<br />
Maturen, Andrew, 2250<br />
O’Connor, Daniel T.; Pandian, M. K.; Canlton,<br />
Father; Cervenke, Justine H.; Hsiao, Ray J.,<br />
1631<br />
Od,il, William D. See Zahradnik, Richard<br />
O’Donnell, C. M. See Bachend, Steven S.;<br />
Gabor, Mike; Harper, J. D.<br />
O’Donnell, C. Michael See King, Devid L.<br />
0.1, T. See Ryder, K.<br />
0.lert, B. See Oster, 0.<br />
0.llerich, Michael; Burdelski, M.; Louts, H. U.;<br />
Rodeck, B.; Duevel, J., 1135<br />
Oeseburg, B. See Kwant, 0.<br />
Oeseburg, Berend; Kwant, Gerard, 515<br />
Ofulue, A. Felix See Khadempoun, M. Hassan<br />
Ogan, M. See Jagoda, E.<br />
Ogasahara, Naomi See Kobeyashi, Kunio<br />
O’Grady, MS.. Peck, hi.<br />
-;Li,Z.M., 1069<br />
Ogunro, B. See Marlewski, D.<br />
Ogunro, B. A. See Figard, Steve D.<br />
Ogunro, Edward A. See Baker, Harold N.; Ford,<br />
Kent A.<br />
Ohasbi, M. See Cho, Hiroko<br />
Obkubo, Aklyukl See Mashige, Fumiko<br />
Ohkuma, Shin-ichi See Matsuda, Akihiko<br />
Ohean, B. Magnus See Christenson, Robert H.<br />
Ohman, Magnus See Christenson, Robert H.<br />
Ohmin, Stan; Lersson, Lease, 900<br />
Obese, Stan See Nelson, Nina<br />
Ohsewa,<br />
Ohshlma,<br />
Susumu See Kuroiwa,<br />
Ta.yukl; Hasegewa,<br />
Katsumese<br />
Takaeki; Johno,<br />
Ikuo; Kitazawa, Shikifumi, 1722<br />
Ohtani, Shigeru See Tsuchiya, Hinonori<br />
Ohyanagi, Kazuhiko See Yamaguchi, Akihiro<br />
Okab.,<br />
Okada,<br />
H. See Uji, Y.<br />
Kunlo See Shimojo, Nobuo<br />
Okaniwa, K. See Yamaseli, Mesehiko<br />
Okorodudu, A. 0.; Gillmor, H.; Onoroski, hi.;<br />
Parker, L.; Moore, K. F., 1555<br />
Okorodudu, Anthony 0.; Pelletier, Peter R.;<br />
Valcour, Andre A.; Bowers, George N., Jr.;<br />
McComb, Robert B., 153<br />
Okuda, Klyoshl See Shimojo Nobuo<br />
Okuyama, Kohjl See Kobayashi, Isao<br />
Oldham, Robert K.; Maleckar, James K.;<br />
Friddell, Colleen S.; Lewko, Walter hi.;<br />
West, William H.; Yennelli, John K., 1576<br />
O’Leary, Niall; Pembroke, Anthony; Duggan, P.<br />
Finbarr, 510<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2355
O’Leary, Thomas Denis; Langton, Simon R.,<br />
1697<br />
Olesen, Henrik; Ladenson, Jack H., 189<br />
Olin, Ake See Hansson, Lena<br />
Oliveira, D. B. G. See Beckett, G. J.<br />
Olivier, Frencoise See Vernet, Michele<br />
Olley, A. See Rosencrens, Robert<br />
Olson, II. M. See Sun, Lilla; Walters, S.<br />
Omorl, Erie See Lewis, Douglas E.<br />
O’Neil, J.; Bozimowski, D., 1125<br />
Ong-Tone, I See Dominiczak, Marek<br />
Onica, D. See Wallinder, H.<br />
Onoroski, M. See Krzymowski, G. A.;<br />
Okorodudu, A. 0.<br />
Opheini, K. E. See Sadrzadeh, Sayed hi. H.<br />
Oppenheimer, J. See Woo, Jennie<br />
Oppermann, M. See Patal, Ninanjan<br />
Orf, J. See Lee, Sung C.<br />
Orf, J. W. See Tadepalli, Servamanagala<br />
Origenes, Maurice I, Jr. See Rettmer,<br />
Rebecca L<br />
Orr, H. T. See Killeen, A. A.<br />
Orsonneau, Jean-Luc; Douet, Philippe;<br />
Massoubre, Catherine; Lustenberger,<br />
Patrick; Bernard, Serge, 2233<br />
Orsulak, P. J. See Akers, L. C.; Kenney, J. T.;<br />
Schiebout-Clark, K. C.<br />
-; Akere, I C.; Kaplan, J. C., 1184<br />
Orsulak, Paul J.; Haven, Mary C.; Burton,<br />
Michael E.; Akers, Linda C., 1318<br />
Osawa, Hisao; Yoshino, Fumio; Yamada,<br />
Akefumi, 1133<br />
Osborne, James W. See Sun, Yi<br />
Osborne, P. T. See Crisan, D.<br />
Osonio, R. Vex; Vilaninho, 1,2338<br />
Ostariz, J. I Serrano See Budnia, J. Ruiz<br />
(later, 0.; Dabm, hi.; Oelert, H.; Pnellwitz, W.,<br />
851<br />
Ostrovsky, Irene; Delea, A.; Stesiw, K.;<br />
Santiago, I., 1104<br />
Ostrow, D. H.; Trace, H., Jr.; Macioszek, J.;<br />
Swanson, S. M.; Edwards, B. M., 1193<br />
Ostrow, David G.See Hariharan, hi.<br />
Ota, M. K. See Allin, Ronald F.<br />
Ou, Ching-Nan See Rognerud, Cheryl;<br />
Rognerud, Cheryl L.<br />
-;Rognerud,CherylL, 1164<br />
Overbeck, W. See Beever, K.<br />
Peavonen, Jorma; Lehtinen, Matti; Lehto,<br />
Maili; Lame, Seppo; Aine, Risto; Rasanen,<br />
Liise; Stanman, Ulf-Hekan, 869<br />
Pacholski. Janet See O’Connor, Brian<br />
Paci, Anna; Cocci, F.; Piras, F.; Ciariinboli, G.;<br />
Clenico, A., 1140<br />
-; Cocci, Fnanca; Piras, Francesca; Cianimboh,<br />
Giuliano; Clerico. Aldo, 2093<br />
Padilla, A.; Maretsky, D.; Blackwood, J.; Inbar,<br />
S.; Grenner, G., 1196<br />
Padilla, A. J. See Grenner, G.<br />
Pagan!, Franca See Bonora, Roberto;<br />
Panteghini, Mauro<br />
Painter, Pennell; Evens, John; Cope, June;<br />
Bailey, Kim; Smith, Jane; Whaley, Tammy,<br />
1136<br />
Evans, John; Copas, Pleas; Smith, Jane; Cope,<br />
June, 1143<br />
Paleani, Renata; Arcelloni, Cinzia; Paroni, Kite;<br />
Fermo, Isabella; hiosca, Andrea, 425<br />
Palermo,<br />
Palestine,<br />
M. See Madry, Norbert<br />
Alan 0. See Elm, Ronald J.<br />
Palmer, Adele, 1154<br />
Palmer, J. See Peck, hi.<br />
Palmer, John J. See Louderback, Allan I<br />
Palomaki, Glenn E. See Knight, George J.<br />
Palo., Gebor See Karadi, Istvan<br />
Pen, Jie; Ng, H.-T.; Heieh, C.-Y.; Lee, C.-Y. 0.,<br />
1081<br />
Pandian, M. IL See Nelson, Jerald C.; O’Connor,<br />
Daniel T.; Tercero, J. C.<br />
-; Morgan, Craig; Nelson, Jerald C.; Fisher,<br />
Delbert A., 1150<br />
Pang, E. See Singh, Jagat<br />
Pannall, Peter R. See Nicolson, Ruth F.<br />
Panteghini, Mauro See Bonora, Roberto<br />
-; Pagani, Franca, 180<br />
-; Pagani, Franca, 417<br />
-; Bonore, Roberto; Pagani, Franca; Hall,<br />
hiargot; Neisler, Mike; Johnson, J. T., 901<br />
-; Pagani, Franca; Cuccia, Claudia, 909<br />
-; Pagani, Franca, 1116<br />
-; Pagani, Franca, 1264<br />
Peolucci, F. See Freiss, G.<br />
Peolucci, Francis See Rogier, Herve<br />
Papedimitriou, Dimitri C. See Wortsman,<br />
Jacobo<br />
Papadopoulos, N. M.; Costello, R.; Charnas, L.;<br />
Adamson, hi. D.; Gahl, W. A., 2231<br />
2356 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />
Papadopoulos, Nicholas M.; Costello, R., 1085<br />
Papedopoulos, Nick M. See Costello, Rene;<br />
Pascal!, Enzo<br />
Pepanastasiou-Diamandi, A. See Diamandis, E.<br />
P.; Diamandis, Eleftherios P.<br />
Pappas, Alex A. See Taylor, F. Howard<br />
Patuet, K, J. See Santulli, M. J.<br />
-; Santulli, hi.; Penson, J., 1105<br />
Parcells, K. See Chiang, C. S.<br />
Pardue, Harry I See Bacon, Bonnie L.<br />
Park, Sue S. See McBride, James H.<br />
Parker, K, Michael See Aitmiller, Dale H.;<br />
Blick, Kenneth F.<br />
-; Green, Judi L.; Aitmiller, Dale H.; Blick,<br />
Kenneth E., 1184,1238<br />
Parker. I See Okorodudu, A. 0.<br />
Parker, N. C. See Levtzow, C. B.<br />
Pankkinen, Jaakko, 1638<br />
Parlavecchla, M. See Marcovina, Santica<br />
Parlavecchla, Manlella See Dolci, Alberto<br />
Paroni, Rita See Peleari, Renata<br />
Parra, H. J. See Steinmetz, A.<br />
Parsons, Patrick J. See Stanton, Noel V.<br />
-; Stanton, Noel V.; Gunter, Elaine W.; Huff,<br />
Daniel; Meola, John R.; Reilly, Andrew A.,<br />
2059<br />
Parvy, P.; Bardet, J.; Rabier, D.; Bonnefont, J-<br />
P.; Kamoun, P., 178<br />
Pascal!, Enzo; Pezzoli, Antonio; Costello, Rene;<br />
Papadopoulos, Nick M., 1550<br />
Pasic, limed; Djulbegovic, Benjamin; Wittliff,<br />
JamesL., 2317<br />
Pasqua, J. See Fitzpatrick, D. A.<br />
Pusey, Richard B. See Blick, Kenneth E.<br />
-; Maluf, Karen; Smith, James; Gillum, Ronald<br />
L., 1099<br />
-; Duty, Gale; Blick, Kenneth E.; Gillum,<br />
Ronald L., 1157<br />
Pastore, Denise See Ferreira, Victoria M.<br />
Petal, Niranjan; Opperniann, hi.; Bowman, C.,<br />
1199<br />
Petal, Pragna See Luzton, Richard W.<br />
Patella, Lisa; Anderson, 0,, 1102<br />
Patrick, A. W. See Tibi, L.<br />
Patrick, Jim See Deneris, Even S.<br />
Patsch, Josef K. See Patech, Wolfgang<br />
Patscb, Wolfgang; Brown, Spencer A.;<br />
Morrisett, Joel D.; Gotto, Antonio hi., Jr.;<br />
Patech, Josef K., 265<br />
Patton, Phillip E., 1063<br />
Pen, B. See Freiss, G.; Piechaczyk, M.<br />
Pan, Bernard See Rogier, Herve<br />
Pauley, Carol See Werner, Mario<br />
Pauley, Scott D.; Miller, K. C.; Maier, K. S.;<br />
Roes, S. J.; Koch, D. D., 1142<br />
Paus, Elisabeth; Nusted, Kjell. 2034<br />
Pavlls-Jenklns, Lynn See Spronk, Adrian hi.<br />
Pawson, Tony See Attia, John<br />
Paxton, Helene; Christy, P.; hialloy, D., 1201<br />
Paz, J. M. See Rodriguez-Segade, S.<br />
Paz, J. Manuel See Rodniguez-Segade, Santiago<br />
Peake, M. J. See Berry, M N.<br />
Pearce, S.; Dowsett, M.; Jeffcoate, S. L, 632<br />
Pearson, Stephen D.; Ash, K. Owen; Urry,<br />
Francis hi., 636<br />
-; Wu, J. T., 1082<br />
-; Ash, K. 0.; Urry, F.M., 1163<br />
-; Wu, James T., 1997<br />
Pease, John See Chuog, Byung Soak<br />
Peat, J. J. See Peat, Michael A.<br />
Peat, Michael A.; Pino, J. A.; Caughlin, L.;<br />
Noedel, hi.; Peat, J. J., 1185<br />
Peck, 0.1 See Huang, C. M.<br />
Peck, M.; O’Gredy, M.; Sanghvi, A.; Horenzy, M.<br />
J.; Kubasik, N.; Palmer, J., 1101<br />
Peck, William A., 1053<br />
Pedd.cord, K. Michael, 691<br />
Pesters, D. See Pallet, D. E.<br />
Pegg, C. See Beever, K.<br />
Pejakovic, M. See Berry, hi. N.<br />
Pekary, A. B. See Vowels, J. A.<br />
Pelcb, D. See Fox, Martha<br />
Peiletier, Peter ft. See Okorodudu, Anthony 0.<br />
Peltenburg, Henny G. See Giesen, Peter LA.<br />
Peltyszyn, Stephanie; Alexander, L.; Mercer,<br />
W.; Noun!, N.; Wimmer, C., 1111<br />
-; Alexander, L.; Noun, N.; Mercer, W.;<br />
Wimmer, C., 1207<br />
Pelzer, H. See Dati, F.<br />
Pembroke, Anthony See O’Leary, Niall<br />
Pende, Aldo See Musso, Natale K.<br />
Penders, T. J. See Weykamp, C. W.<br />
Pennington, C. D. See Dolan, P. A.<br />
Penno, Giuseppe See Giampietro, Ottavio<br />
Penson, J. See Paquet,<br />
Penta, K. See Steedter,<br />
R. J.<br />
M.<br />
Per, Steven H.; Averse, Catherine K.; Situ,<br />
Alexander F., 1859<br />
Perdnisot, Remy; Bounaud, Manie-Paule;<br />
Bounaud, Jean-Yves; Jellet,<br />
Perel, J. M. See Foglia, J. P.<br />
Pierre, 115<br />
-; Foglia, J. P.; Curran, S.; Lin, F. C.;<br />
Narayenan, 5., 1175<br />
-; Stiller, K. L; Cunran, S.; Lin, F. C.;<br />
Narayanen, S., 1179<br />
Perez-Bendito, Dolores; Gomez-Hens.<br />
Agustina; Gutierrez, M. Carmen; Anton,<br />
Soledad, 230<br />
Pergande, Monika See Jung, Klaus<br />
Perkins, Sherry 1; Johnson, Pam M., 1508<br />
Perrin,<br />
Perrot,<br />
K. See Guemouni, Laila<br />
Daniel See Pugeat, hiichei<br />
Perry,<br />
Perry,<br />
T. See Highamith, W. E.<br />
Tenly R. See Highamith, W. Edward, Jr,<br />
Perryman, M. B. See Puleo, Peter K.<br />
Perryman, M. Benjamin See Puleo, Peter K.<br />
Person, Nil. B.; Ehrenknanz, Joel ILL, 1181<br />
Pesce, A. J. See Hassan, F. Michael; Schroeder,<br />
Timothy J.; Wermeling, J. K.<br />
Pesce, Amadeo J. See hiagnotti, Ralph A., Jr.;<br />
Wermeling, Joseph R.<br />
Peace, Michael<br />
Pete, Philomena<br />
A., 1232<br />
M. See Sgoutes, Demetrios S.<br />
Peter, James B. See Sevall, J. Sanders; Young,<br />
Karen K. Y.<br />
Peters, Barbara See Peters, Jorg<br />
Peters, Jeffrey I See Wu, James T.<br />
Peters, Jorg; Schmidt-Gayk, Heinnich; Peters,<br />
Barbara; Armbruster, Franz Paul;<br />
Quentmeier, Armin; Mathias, Dietger, 573<br />
Peters, P. See Sgoutes, D.<br />
Petersen, J. R.; Kapadie, P., 1197<br />
-;Gini,S.,1201<br />
-; Khan, S.; Keyser, H., 1203<br />
Peterson, P. See Gibbons, L<br />
Peterson, Timothy B. See Sun, Vi<br />
Petersson, Jean See Hausson, Lens<br />
Petrelli, N.J. See Bhargava, AK<br />
Pettersson, Kim See Makinen, Maije-Liisa;<br />
Suonpal, Mikko<br />
Pevet, Paul See Skene, Debra J.<br />
Peynet, Jacqueline See Bonnefont, Dominique<br />
-; Legrand, Alsin; Messing, Bernard; Thuillier,<br />
Francois; Rousselet, Francois, 674<br />
Pezzoll, Antonio See Pascali, Enzo<br />
Pflager, Carol See Inloes, Roger; Picone, Teres<br />
Pham, Q.See Rifai, Nader<br />
Pham, Quynbchl; Rifai, N.; Soldin, S. J., 1066<br />
Phan, Tuyet-Mlnh See Feldmann, Delphine<br />
Philbrick, David H. S. See Miles, Andrew<br />
Philcox, J. C. See Nordin, B. B.. C.<br />
Phillipou, G.; James, S. K.; Seeborn, C. J.;<br />
Phillips, P. J., 456<br />
Phillipou, George; Farnant. Robert K.; Phiffips<br />
Patrick J., 2017<br />
-; James, Steve K.; Seaborn, Chris J.; Phillips,<br />
Patrick J., 2019<br />
Phillips, D. See Bsever, K.<br />
Phillips, E.; Hwang, N.; Joseph, K.; Nyberg, S.,<br />
1131<br />
Phillips, J. C.; Chapman, J. F., 1072<br />
Phillips, M. J. See Yiu, Samuel C. K.<br />
Phillips, P. J. See Phillipou, G.<br />
Phillips, Patrick J. See Phillipou, George<br />
Phillips, Vincent See Breglio, Susan<br />
Phung, H. T. See Baadenhuijsen, H.<br />
Picone, Teresa See Inloes, Roger<br />
-; McCallwn, Theresa; Pflager, Carol; Zoccoli,<br />
Michael A., 1171<br />
Piechaczyk, M.; Baldet, L; Peu, B.; Bastide, J.<br />
M., 422<br />
Pleper, Robert K. See Wu, James T.<br />
Pierre, K. See Metzler, M.; Muirheed, C.<br />
Pike, S. See Basham, Julie F.<br />
Pb, A. See Zucchelli, G. C.<br />
-; Zucchelli, 0. C.; Calvo, S.; Ferdeghini, M.,<br />
1209<br />
Pilot, Robert 1; Brennan, George; Zehrednik,<br />
Richard, 1206<br />
Pino, J. A. See Peat, Michael A.<br />
Pinto, M. See Bernstein, Larry<br />
Piper, M. See Fotiou, F.<br />
Plppenger, C. See Solano, Romeo<br />
Pipp.nger, C. E.; hieng, Xienzhong; Van Lamt<br />
Frederick; Rothnen, A. David, 1173, 1348<br />
Piras, F. See Pad, Anna<br />
Pinas, Francesca See Paci, Anna<br />
PinkIe, H. See Miyada, D. S.<br />
Plea, M. See Schottare, S. B.<br />
Pittington, J. See Neisler, H. M.<br />
Pizza, T. See Liffman, S.<br />
Platoff, Gennady E. See Koch, Thomas R.<br />
Plaut, David; Steed, Linda, 1110<br />
Pleban, Walter See Bernstein, Larry H.<br />
Plebani, Mario; Faggian, D.; Masiero, hi.; Di<br />
Mario, F.; Burlns, A., 1126
-; Faggian, D.; Floreani, A.; Masiero, hi.;<br />
Bunlina, A., 1134<br />
lesher, C. J. See Baldwin, James K.<br />
leuse, Joan A. See Lemann, Jacob, Jr.<br />
lotke, B. D. See Zarembka, F. K.<br />
odlesek, Stanley J.; Dufour, D. Robert;<br />
McPherson, Richard A., 1763<br />
odlasek, Stanley J. See McPherson, Richard<br />
A.<br />
-; McPherson, Richard A., 69<br />
-; McPherson, Richard A., 1119<br />
oklis, Alphonse See Edinboro, Leslie F.<br />
olaniec, Julie See Reason, Craig<br />
olesi, Claudlo; Rodella, Anna; Mantero,<br />
Giovanni; Cannella, Giuaeppe; Ferrari,<br />
Roberto; Albertini, Alberto, 1431<br />
olk, B. Frank See Hsing, Ann W.<br />
ollet, D. B..; Pesters, D.; Warmenbol, H.;<br />
Vastmans, I; Saman, B.; Heyndrickx, I; Do<br />
Lays, K.; Vsnderborght, B.; Wauters, C.; Van<br />
Heuverswyn, H., 1204<br />
onte, K.; Holzberg, K., 1130<br />
onti, Maunlzlo See Foesati, Piero<br />
ontllio, M. See Bonini, P. A.<br />
Oon, Mm Kwong See Wang, Shih Yung<br />
oon, H.; Hinberg, I., 1108<br />
-; Hinberg, I., 1161<br />
oorthuls, B. J. H. M. See de Jong, J. 0. N.<br />
oppe, W. See Baadenhuijsen, H.<br />
orchet, Nicole See Fontaine, Monique<br />
oretsky, Leonid See Novick, David hi.<br />
orter, S. K. See Silva, D. P., Jr.<br />
orter, Sharon E. See Landt, Yvonne<br />
orioles, M.; Bernal, D.; Guasch, R., 1117<br />
oslilico, James T. See Stock, John I<br />
ossik, Rafael Abraao See Hirata, Rosanio<br />
Dominguez Crespo<br />
ost, Gregory See Klee, George G.<br />
othier, S. See Madry, Norbert<br />
ottathil, H. See Siemon, Peggy<br />
oulin, Sue B. See Ledue, Thomas B.<br />
outhier, F. See Galanti, L. hi.<br />
owell, D. See Harrison, H. H.<br />
‘ower, Michael J.; Gosling, James P.; Fottrell,<br />
Patrick F., 1408<br />
-; Fottrell, Patrick F., 2087<br />
owers, M. See Fox, Martha; Milleep, Susan<br />
rabhakaran, V. M. See Vasdev, Sudesh<br />
rabhakaran, Victor M.; Whelan, Vern C.;<br />
Mills, A. J.; Kennedy, Annette, 1075<br />
rasad, K. See Kaira, J.<br />
ratt, O.K. See Jeyasingham, M.D.<br />
‘reese, Lynne M. See Eastep, Steven J.<br />
‘reissner,<br />
reissner,<br />
C. M. See Klee, G. 0.<br />
Carol See Klee, George<br />
‘rellwitz, W. See (later, 0.<br />
remel-Cabic, A. See Allain, P.<br />
‘rencipe, I See Baedenhuijsen, H.<br />
‘rescott, I F. See Beckett, G. J.<br />
‘resent, Bifi; Hayden, C.; Chang, L.; Chen, L.;<br />
Ceo, 0., 1204<br />
‘resent, W. See Broyles, Celeate<br />
ress, Richard D.; Wilding, Peter, 2219<br />
ressac, Monique See Fesus, Paul D.<br />
retty, P. See Canter, 0.<br />
ribor, Hugo C., 1233<br />
‘ricci, Flavie See Sensi, Meunizio<br />
‘rice, A.; Griffaths, H., 2017<br />
rice, Alun; Gniffiths, Huw; Morris, Brian W.,<br />
275<br />
rice, C. P. See Monk, J.; Newman, D. J.<br />
‘rignot, J. See Gelanti, I M.<br />
‘rihoda, Thomas J. See Schwartz, Joyce 0.<br />
‘rmncipe, Lorenzo See Fossati, Piero<br />
rninsen,<br />
[Anne<br />
J. See Duncan, Marilyn; Raymond,<br />
rlnsen, Johanna; Evans, I.; Heed, T.; Cole, K.;<br />
Legere, S.; Rushkowski, J.; Trundle, D.;<br />
Goldberg, N., 1135<br />
rrinz,<br />
‘nor,<br />
Richard A. See Braithwaite, Susan S.<br />
T. W.; Friedman, K. J.; Silverman, I M.,<br />
1075<br />
‘nor, Thomas W. See Highsmith, W. Edward,<br />
Jr.<br />
F-;Blasco, Peter A.; Dove, Janet L.; Leshner,<br />
Robert T.; Gruemer, Hanns-Dietar, 679<br />
-; Fniedmenn, Kenneth J.; Silverman, Lawrence<br />
hi., 1256<br />
nitchard, Cynthia G. See Lomeli, Hilda<br />
rrofitt, J. A. See Fredrickson, K. A.<br />
trosser, Connie; Krehn, John, 2336<br />
‘roudfoot, A. T. See Beckett, 0. J.<br />
truemer, J. M. See Wermeling, J. K.<br />
truemer,<br />
rzywara,<br />
Jane M. See Wermeling, Joseph<br />
LW. See Konrath, J. G.<br />
K.<br />
!uckett, ID. See Tadepalli, Sarvamanagala<br />
udek. Morris See Jainani, Azim<br />
Pugeat, M. See Dechaud, H.<br />
Pugeat, Michel; Bonneton, Agnes; Perrot,<br />
Daniel; Rocle-Nicolas, Brigitte; Lejeune,<br />
Herve; Grenot, Cetherine; Decheud, Henri;<br />
Brebent, Chantal; hiotin, Jean; Cuilleron,<br />
Claude-Yves, 1675<br />
Puleo, Peter ft.; Guedagno, Phili , Scheel, M.;<br />
Roberts, R.; Perryman, hi. B., 1119<br />
-; Guadagno, Philip A.; Roberts, Robert;<br />
Perryman, hi. Benjamin, 1452<br />
Punter,<br />
Pun,.alai,<br />
J. See Schnorr, G.<br />
Rubio ft.; Johnson, George F.; Feld,<br />
RoneldD., 1112<br />
Purcell, G. See Muinhead, C.<br />
Puschendorf, Bernd See Wencker, Marion<br />
Putnam, R. S.; Dowdey, A. B. C.; Van Dreal, P.;<br />
Moore, K.; Gilstrap, L.; Leveno, K., 1136<br />
Puttermen, Caryn See Donahue, Joseph<br />
Qian, Zhong-Hao See Geng, Jian-Guo<br />
Quale, Marguerite See O’Connor, Brian<br />
Quentmeler, Aninin See Peters, Jorg<br />
Quigley, M. K.; Lawson, 0. J., 507<br />
Quinn, K. See Tadepalli, Sarvamanagala<br />
Quinton, Paul M., 726<br />
Qureshi, H. See Liffman, S.<br />
Ream, Shanthi; Vrebel, Done M., 339<br />
Rabler, D. See Kamoun, P.; Pervy, P.<br />
Raff, Hershel; Finding, James W., 596<br />
Rainey, Petrie M., 1165<br />
Relay., Vidmantaa A. See Rohner, Charles;<br />
Rosenzweig, I. Bruce<br />
Ralston, S. See Nargeasi, K. D.<br />
Ramias, Lois See Jeevanandam, Malayappa<br />
Ramsey, J. See Melerski, James J.<br />
Rao, J. See Narang, Rema<br />
Raaanen, Lila. See Paavonen, Jorms<br />
Rasmussen, Karsten, 260,2271<br />
-; Moelby, Lane; Jensen, hiogens Krogh, 2277<br />
Ratdliffe, W. A.; Heath, D. A.; Ryan, hi.; Jones,<br />
S.R., 1957<br />
Ratcllffe, Wendy A. See Lewis, Helen M.<br />
Rauscher, B. See Hagele, E. 0.<br />
Ray, D. H. See hiyers, Gary L.<br />
Ray, K. See Williams, Michael<br />
Raymond, Anne; Bradley, H.; Sinipkins, F.;<br />
Trundle, D., 1105<br />
-; Duncan, hi.; Carlson, J.; Pnineen, J.; Trundle,<br />
D., 1139<br />
Raynaud, Florence See Skene, Debra J.<br />
Ream, Linda See Wu, James T.<br />
Reason, C. See DeShon, P.<br />
-; DeShon, P.; Becks, 5., 1094<br />
Reason, Craig; Polaniec, Julie; Matheke, Mary<br />
Lou, 1118<br />
Recio, Carmen See Recio, Fernando<br />
Redo, Fernando; Redo, Carmen, 1127<br />
Redaelli, G. See Dati, Francesco<br />
Reddy, Padala V.; fley, P.; Banerji, A.; Lonardo,<br />
A., 1170<br />
-; hey, P.; Benerji, hi.; Banerji, A.; Lonardo, A.,<br />
1170<br />
Redmond, G. P. See Gupta, Manjula K.<br />
Reeders, S. T.; Germino, G. G.; Gillespie, G. A.<br />
J., B13<br />
Regalado, Jacinto See Bruzek, Debra<br />
Register, Loretta J.; Keren, David F., 2016<br />
Rehak, Nadja N.; Chiang, Betty T., 1031<br />
-; Andersen, Tom F., 1538<br />
Rehkemper, Catherine; Fisher, Catherine;<br />
DeLaurentis, Mark; Ballet, Neal, 1141<br />
Roibnegger, Gilbert See Fuchs, Dietmar<br />
-; Fuchs, Dietmar; Hausen, Ama; Werner, Ernst<br />
K.; Werner-Felmayer, Gabniele; Wachter,<br />
Helmut, 990<br />
-; Fuchs, Dietmar; Hausen, Arno; Werner, Ernst<br />
R.; Wemner-Felmayer, Gebriele; Wechter,<br />
Helmut, 2157<br />
Reich.teln, B. See Shankaran, P.<br />
-; Diamandis, E. P., 1139<br />
Reid, A. See McConwey, M. G.<br />
Reid, S. See Shackleton, C. H. L.<br />
Reilley, T. See Kaseman, Deborah<br />
Reffley, Therese; Fields, S.; Stamy, K.;<br />
Del Vecchio, M.; Chang, J.; Fischberg, E.;<br />
Kaufman, K. A., 1122<br />
Reilly, Andrew A. See Parsons, Patrick J.<br />
Reffly, Christopher P. See Nicolson, Ruth B..<br />
Reimer, Keith A., 1049<br />
Relniers, T. J.; Matamoros, K. A.; Bartlett, S.<br />
hi.; Lamb, S. V., 1133<br />
Roles, A. See Jagoda, F.; Tsay, H.<br />
-; Stouffer, B.; Tesy, H.; Jagoda, E.; Mantha, S.;<br />
Tunebi, N.; Tu, J., 1189<br />
Rej, Robert; Norton, Carol, 1069<br />
Relyea, Noel M., 1169<br />
-; Lodato, D., 1169<br />
Remaley, A. T.; Builey, hi.; Senior, hi. B.;<br />
Goodman, D. B. P., 1259<br />
Remaley, Alan T.; Wilding, Peter, 2261<br />
Renda, Nurten See Copur, Sitki<br />
Renfeng, F. See Coyle, P.<br />
Renouf, Judith A.; Wood, Amends; Frazer, I.<br />
H.; Thong, Y. H.; Chalmers, A. H., 1478<br />
Renz, M.; Helm, C.; Breunlmg, 0.; Czichos, A.;<br />
Wieland, C.; Seelig, H. P., 1861<br />
Resnick, Lowrence M., 1054<br />
Restrepo, L. See Cheng, Mary H.<br />
Retsum, Helga; Ueland, Per Magne; Svardel,<br />
Aebjorn Martin, 1921<br />
Rettmer, Rebecca I; Davis, Holly A.; Carey,<br />
Mary hi.; Jack, Rhona Labbe, Robert F.,<br />
1113<br />
-; Origenes, Maurice I, Jr.; Brown, Warren P.;<br />
Labbe, Robert F., 1114<br />
Revenant, Marie-Claude See Vernet, Michele<br />
Revol, Francoise See Lespinas, Francis<br />
Hayes, Ana F. See McBride, James H.<br />
Reynoso, Gustavo See Kambli, Vijeykant B.<br />
Rhode., M. See Wells, David<br />
Ricci, Mary Jo; Benoit, Cheryl A.; Lertora, Juan<br />
J. I; George, William J., 1809<br />
Rice, D. See Shihabi, Z.<br />
Richards, J. See Fitzgerald, D.<br />
Richardson, Douglas K. See Russell, John C.<br />
Richant, C. See Joven, J.<br />
Riche, I. See Vincent-Viry, Monique<br />
Rlchman, Gary See Katz, Paul K.<br />
Richter,<br />
Ridnoun,<br />
D. See Fitzgerald, D.<br />
Michelle D. See Whitley, Chester B.<br />
Riesco, Oscar F.; Hejri-Mezghani, Selma;<br />
Cekan, Stem Z., 1680<br />
Rletz, P. See Jarausch, J.<br />
Rifal, N. See Gutierrez, Aide; Iosefsohn, Mariet<br />
Pham, Quynhchi<br />
Rifal, Nader; Heiss, 0.; Doetech, K., 1065<br />
-; Pham, Q.; hicMurnay, K. G., 1066<br />
-; Morales, Antonio, 1189<br />
-; Morales, Antonio, 1996<br />
Rigault, Marie Y.; Ken, Brenda, 1092<br />
Rinaldi, Grazieila See Ciuti, R<br />
Rinker, Alan D.; Tietz, Norbert W., 1799<br />
Rinnie, Sherrie See Hollander, Loni<br />
Ritchie, Robert F. See Johnson, Andrew Myron<br />
Rizzotti, P.; Rozza, F.; Klein, G., 1090<br />
Robbrecht, Joban See Delange, Joris<br />
-; Do Buyzere, Marc; Dolanghe, Joris; Do<br />
Scheerder, Ivan; Mortier, Eric;<br />
Vanderschueren, Serge, 898<br />
Robbrecht, Johan H. See Do Buyzere, Marc L.<br />
-; Do Buyzere, Marc I; Dolanghe, Joris K., 1540<br />
Roberts, K., 1093<br />
Roberts, Karen See Bachorik, Paul S.<br />
Roberts, Pamela See Felci, Ronald<br />
-; Feld, Ronald; Ladouceur, Pete, 1128<br />
Roberts, Pamela I See Smith, Karen<br />
Roberta, R. See Puleo, Peter K.<br />
Roberts, Randall T.; Kelner, Michael<br />
Alexander, Nicholas M., 1124<br />
J.;<br />
Roberts, Robert See Puleo, Peter K., 1050<br />
Roberts, Ruth See Felder, Robin A.<br />
Robinson, P. See Ryder, K.<br />
Roche, D. See Thuan, N. T. Leuquang<br />
-; Arneodo, V.; Lequeng, N. T.; Skindjien, 0.0.,<br />
Rochefort, H. See Freiss, 0.<br />
Rochefort, Henri See Rojier, Herve<br />
Rock, Robert See Chan, Daniel W.<br />
Rocle-Nicolas, Brigitte See Pugeet, Michel<br />
Rodeck, B. See Oellerich, Michael<br />
Rodella, Anna See Polesi, Claudio<br />
Roder, John C. See Attla, John<br />
Rodey, 0. See Morin, Leo G.<br />
Rodey, Glenn B. See hiorin, Leo G.<br />
Rodgerson, D. 0. See Aim, Ronald E.;<br />
Schotters, S. B.<br />
Rodgerson, DenI. 0. See McBride, James H.<br />
Rodriguex-Segade, S.; Lojo, S.; Camina, hi. F.;<br />
Paz, J. hi.; Del Rio, K., 1556<br />
Rodnlguez-Segade, Santiago; Lojo, Santiago;<br />
Camina, hi. Felix; Paz, J. Manuel; Del Rio,<br />
Remon, 134<br />
Roeser, H. P. See Chain, B. E.<br />
Rote, A. M. See Coyle, P.<br />
Rogers, E. J. See Karge, W. H.<br />
Rogers, K. See Sibilia, K.<br />
Rogers, I See Schmidt, Wesley<br />
Rogers, Linda C.; Smith, F. A., 1103<br />
Rogers, Michael M. See Bradley, Charles A.<br />
Rogers, Rick K. See Ma#{231}aotti,Ralph A., Jr.<br />
Rogler, Herve; Freise, Gillee; Bases, Marie-<br />
Georges; Cavslie-Barthez, Ghislaine; Garcia,<br />
Marcel; Pau, Bernard; Rochefort, Henri;<br />
Peolucci, Francis, 81<br />
Rognerud, Cheryl; Ou, Ching-Nan, 1164<br />
Rognerud, Cheryl I See Ou, Ching-Nan<br />
-; Ou, Ching-Nan, 857<br />
CLINICALCHEMISTRY, Vol.35, No. 12, 1989 2357
Rohdewald, Peter See Schaefer, Hans Guenter<br />
Rohner, Charles; Raisys, Vidmantas A., 1177<br />
Rome, Risto See Tunpeinen, Ursula<br />
Rokahr, B. See Woo, Jannie<br />
Rokugawa, K. See Ishimori, Yoshio<br />
Romano, Louis J. See Schaap, A. Paul<br />
Romanschln, A. D. See Allen, L. C.<br />
Romeo, K. See Lschman, Mary F.<br />
Romics, Laazlo See Karadi, Istvan<br />
Romleu, Isabeile See Kaplan, Lawrence A.<br />
Ronald, Beverly A.; Bogeme, Stuart C., 1177<br />
Roopral, H. K. See Jeyasingham, M. D.<br />
Root, D. See Gibbs, Judy<br />
Ro.alkl, Sidney B. See Baja, Renze<br />
-; Kazmierczak, Steven C.; Van Lente,<br />
Frederick, 187<br />
-; Foo, A. Ying, 513<br />
-; Foo, A. Ying; Amnteen, K. W., 702<br />
-; Foo, A. Ying; Johnson. Andrew W., 707<br />
Rosano, Thomas; Yadegari, P.; Swift, T.; Wu, A.;<br />
Ambrose, K., 1132<br />
Rosano, Thomas 0. See Apple, Fred S.<br />
Rose, Alice See Brown, Ellen D.<br />
Rose, 0. Alan See Edwards, Paul<br />
Rose, H. See Dlaz, S.<br />
Roes, I. S.; Young, G. P.; St. John, D. J. B.;<br />
Deacon, M. C.; Blake, D.; Henderson, K. W.,<br />
2290<br />
Rosen, A. I See Sehgal, Lakshmen K.<br />
Rosenberg, Jonathan 8., 1571<br />
Rosenberg, M. See Chiang, C. S.; Cooper, hi.;<br />
Tsunokawe, hi.<br />
Rosenblum, J. I; Stahlschmidt, G. E.; Landt,<br />
M.; Hortin, G. L; Vaidys, H. C.; SOya, D. P.,<br />
Jr.;Smith,C.H., 1123<br />
Rosencrans, Robert; Buttita, D.; Olley, A.;<br />
Semna, F., 1090<br />
Rosenfeld, Louis, 521<br />
Rosenfleld, H. See Zeunczkoswki, Denise<br />
Rosenfleld, Henry; Kaufman, K. A., 1129<br />
Rosenthal, P.; Height, M.; Henton, D., 1151<br />
Rosenthal, Philip; Keefe, M. I.; Henton, D.;<br />
Cheng, hi.; Lee, C. K.; Hall, K. L.; Newton,<br />
hi. K., 1095<br />
Rosenzweig, I. Bruce; Dasgupte, Amitave;<br />
Turgeon, Jeanne; Raisys, Vidmantas A., 1177<br />
Ross, S. J. See Pauley, Scott D.<br />
Rosseneu, M. See Labeun, C.<br />
Roszak, D. See Lauderdale, V.<br />
Rotenberg, Z. See De Silve, L. V. K.<br />
-; Weinberger, I.; Davidson, F.; Fucha, J.;<br />
Harell, D.; Agmon, J., 871<br />
Rotenberg, Zvi See Weinberger, htzhak<br />
-; Weinberger, Itzhak; Sagie, Alex; Fucha, Jacob;<br />
Davidson, Ehud; Sperling, Oded; Agmon,<br />
Jacob, 301<br />
Roth, Diethild See O’Connor, Brian<br />
Rothner, A. David See Pippenger, C. E.<br />
Roussel, G. See Thuan, N. T. Leuqueng<br />
Rousselet, Francols See Peynet, Jacqueline<br />
Rowbotham, Lynn; Molyneux, Angus; Morris,<br />
Brian, 513<br />
Rowbury, D.; Fanrence, h.; Fitzgerald, A., 1552<br />
Rozza, F. See Rizzotti, P.<br />
Rubinow, David See Elm, Ronald J.<br />
Ruby, Stephen G. See Lake, Mitchell S.<br />
Ruddel, M. See Csako, G.; Huang, C. M.<br />
Ruddel, Mark See Csako, Gyorgy; FIn, Ronald<br />
J.<br />
Ruddel, Mark K. See Elm, Ronald J.<br />
Rudenstam, Carl-Magnus See Nystrom, Ernst<br />
Rudolph, K. See Bernstein, Larry<br />
Rudolph, Raiser See Bernstein, Lenny H.<br />
Rudy, J. See Bush, P.<br />
Rudy, Jack K..See Anderson, David J., 509<br />
Ruelland, A.; Clerc, C.; Legras, B.; Cloerec, I,<br />
2155<br />
Rulz, K See Koh, Tun&<br />
Hula, Eliseo; Koh, T.; Edwards, K., 1084<br />
Rulz, Jean-Charles See Vernet, hiichele<br />
Running, Joyce A. See Urdes, Mickey S.<br />
Ruprah, M. See Flanagan, K. J.<br />
Ru.hkowski, J. See Prinsen, Johanna<br />
Rushkowski, Janet; Trundle, D.; Glick, hi.,<br />
1098<br />
Russell, John C. See Zibrat, Steven J.<br />
-; Cooper, Carol hi.; Ketchum, Catherine H.;<br />
Torday, John S.; Richardson, Douglas K.;<br />
Halt, John A.; Kaplan, Lawrence A.;<br />
Swanson, J. Robert; Lyle, W. Michael, 1005<br />
-; Cooper, Carol hi.; Ketchum, Catherine H.;<br />
Torday, John S.; Richardson, Douglas<br />
Holt, John A.; Kaplan, Lawrence A.;<br />
K.;<br />
Swenson, J. Robert; lyle, W. Michael, 1075<br />
Russell, K. 0. G. See Caswell, A. hi.<br />
Rutten, WimP. F. See van Rijn, Jan L. hi. L.<br />
Rutterford, Mary See Smith, K. F.<br />
Ruxton, David See Novick, David hi.<br />
Ryan, Diane F. See Zibrat, Steven J.<br />
Ryan, Francis; Scott, Deborah; Gregory,<br />
Maudry; Turner, Marshall, 1123<br />
Ryan, M. See Ratcliffe, W. A.<br />
Ryder, K.; Oei, T.; Robinson, P.; Jackson, S.;<br />
Taylor, D.; Whang, K., 1130<br />
Ryder, Kenneth; Glick, Starla; Glick, Melvin,<br />
1155<br />
Ryder, Kenneth W. See Glick, Melvin; Glick,<br />
Melvin K.<br />
Rynning, M. See Eble, K. S.<br />
Sabagh, Taliir See Frandsen, Erik K.<br />
Sacha, P. See hiarlewski, D.<br />
Sacks, Frank M. See Hankinson, Susan F.<br />
Sadowskl, James; Davidson, Kenneth; O’Brien,<br />
Maureen; Candela, Ellen, 1162<br />
Sadrzadeh, Sayed M. H.; Ainardi, V.; Gordon,<br />
C.; Tartaglione, T.; Opheim, K. E., 1181<br />
Sagie, Alex See Rotenberg, Zvi<br />
Salle, H. See Steinmetz, A.<br />
Sakai, Y. See Uji, Y.<br />
Sakoguchi, Takafumi See Kobayashi, Kunio<br />
Sala, M. See Izembart, hi.<br />
Saldana, S. See Dasgupta, Amiteva<br />
Salinas, H. See Wimmer, Cathy<br />
Salinas, Rosalla See DiPaola, Joseph<br />
DiPaola, Joseph; Mercer, Wayne, 1205<br />
Salmon, Charles See Lefrere, Jean-Jacques<br />
Salser, W. See McBride, L. J.<br />
Semen, E. See Pallet, D. E.<br />
Sampson, C. See Vasdev, Sudesh<br />
Sanchez, Agustin C. See Venta, Rafael<br />
Sanchez-Pescador, Ray See Urdea, Mickey S.<br />
Sandberg, Sverre See Bolann, Bjorn J.<br />
Sanghvi,<br />
Santek,<br />
A. See Peck, hi.<br />
David A. See Burgese-Caealer, Anthony<br />
Santiago, L See Ostrovsky, Irene<br />
Santulli, M. See Paquet, K. J.<br />
Santulli, M. J.; Paquet, K. J.; Collie, M. J.;<br />
Leleux, J., 1104<br />
Sans, M. T. Higuenas See Budria, J. Ruiz<br />
Sapin, K.; Gasser, F.; Chambron, J., 888<br />
Saraiva, Maria Joao Mascanenhas; Alves,<br />
Isabel Longo; Costa, Pedro P., 1033<br />
Sardesai, Sudha; Chen, Y. hi.; Vaughn, C. B.,<br />
1081<br />
Sarnaik, Ashok See Brettfeld, Chris<br />
Sarosi, David; Hamilton-Smith, S.; Cheng, hi.<br />
L., 1101<br />
Sarosi, Elaine See Clark, Many hi.<br />
Sasaki, Masabide, 1052<br />
Saso, Luciano See Silvestrini, Bruno<br />
Sasse, B. A.; Cardoni, D.; Dicamelli, K. F., 2140<br />
Sate, K. See Sorin, T.<br />
Sato, Makoto See Matsuda, Akihiko<br />
Sato, S. See Nakamura, Maeakazu<br />
Savory, J. See Hewitt, C. D.; Winbomne, K.<br />
Savory, John See Brune, David<br />
David A.; Nicholson, James<br />
E.; Herold,<br />
K. P.<br />
Savory, M. G. See Boyd, James C.; Winbomne, K.<br />
Savory, M. Geraldine See Nicholson, James K.<br />
P.<br />
Scanu, Angelo M. See Kunechinski, Douglas T.<br />
Scano, J. See Shihabi, Z.<br />
Schaab, Coileen See Eisenberg, Paul K.<br />
Schaap, A. Paul; Akhavan-Tafti, Hashem;<br />
Desilva, Renuka, 1201<br />
-; Akhavan, Hashem; Romano, Louis J., 1863<br />
Schaefer, Hans Guenter; Rohdewald, Peter,<br />
821<br />
Schaich, K. See Hagele, E. 0.<br />
Schap, F. D. See Myers, Gary L.<br />
Scharer, K. See Karcher, Raymond<br />
Scharer, Katharine A.; Karcher, Raymond F.;<br />
Epstein, Emanuel; Kiechle, Frederick L.,<br />
2250<br />
Scharpe, S. See Hendriks, D.<br />
Scheel, M. See Puleo, Peter K.<br />
Scheffel, J.; Wiesner, D.; Kapsalis, A.; Traylor,<br />
D.; Susrez, A., 1210<br />
Scheller, Gyorgy See Goth, Laszlo<br />
Schel.traete, M. See Carpenter,<br />
Schiebout-Clark, B.C.; Haven,<br />
K. J.<br />
hi. C.; Orsulak,<br />
P. J.; Markin, K. S., 1146<br />
Schiele, F. See Henny, Joseph<br />
Schiele, Francolse; Antur, Yves; Varasteh,<br />
Abdolreza; Weilman, Maria; Siest, Gerard,<br />
926<br />
Schifman, K. B. See Howanitz, P. J.<br />
Schiller, William H. See Jeevanandam,<br />
Malayeppe<br />
Schlain, Brian; Knouwer, Jan S., 2118<br />
Schlumberger, M. See Izembert, hi.<br />
Schmer, Gottfried See Chandler, Wayne L.<br />
Schmid, Karl See Bungi, Willy<br />
Schmid, K. See Lubec, G.<br />
Schmid, Rainer; Kupferschmidt, Reinhand, 1352<br />
Schmld, Rainer W. See Kupferschmidt,<br />
Reinherd<br />
Schmidt, B. See Metzmann, F.<br />
Schmidt, Bob See Brashear, Jeff<br />
Schmidt, Linda S. See Spronk, Adrian hi.<br />
Schmidt, N. A. See Weykamp, C. W.<br />
Schmidt, Nico A. See van Rijn, Jan L hi. L<br />
Schmidt, Wesley; Clemens, J.; Rogers, L.;<br />
Covault, H.P.; Hojvet, S., 1152<br />
Schmldt-Gayk, Heinnich See Bohler, Ulrich;<br />
Peters, Jorg<br />
Schmledel, Thomas See Jung, Klaus<br />
Schmltz,J.;Jain,C.;Stockert,L., 1131<br />
Schneider, D. See Nargessi, R. D.<br />
Schneider, I; Liu, A.; Bonkoski, F.; Brendt, B.<br />
1181<br />
Schnoil, Sidney H. See Lewis, Douglas F.<br />
Schnorr, G.; Brocks, D. G.; Gunzler, V.;<br />
Hachmann, H.; Punter, J., 1188<br />
Schnorr, Gerd K.; Hachmann, H.; Harthus, H.<br />
P.; Neuenhofer, S.; Walter, 0., 1188<br />
Schoen, Irwin See Bandi, Zolten L.<br />
Schoenau, K; Boeswald, W.; Wanner, K.;<br />
Herzog, K. H.; Boewing, B.; Boehies, H. J.;<br />
Stahr, K., 1888<br />
-; Herzog, K. H.; Gonchoroff, Daryl 0.; O’Brie:<br />
John F., 2255<br />
Schotters, S. B.; McBride, J. H.; Rodgerson, D<br />
0.; McGinley, hi. H.; Pisa, hi., 1109<br />
Schrelber, William K. See Harkness, Dianne;<br />
Jamani, Azini; Knystel, Gerald<br />
Schroder, Karaten See Jun, Klaus<br />
Schroeder, Timothy J.; Weiskittel, P.; Pesce,<br />
J.; Myre, S. A.; Alexander, J. W.; First, Ml<br />
1176<br />
Schryver, Pat See Hage, David S.<br />
Schryver, Patricia See Klee, George<br />
Schulkamp, Kirk See Heu, Pa Choo<br />
Schwartz, Connie A. See Brens, Yves W.<br />
Schwartz, D. See Dnietnian, Ann hi.; Liffman,<br />
S.; Smith, Carol<br />
Schwartz, Joyce, G. See Indriksons, Andris<br />
-; Brown, Richard W.; hicMahan, C. Alex; Gai<br />
Carole L; Herber, Shirley A., 130<br />
-; Bazan, Cabs, Ill; Gage, Carole L; Prihoda,<br />
Thomas J.; Gillhani, Sherni L, 651<br />
Schwartz, M. K. See Bhalla, Ravi; Chen, Yao-<br />
Tseng Dnistrian, Ann M.; Fleisher, Mantis<br />
Smith, Carol<br />
Schwartz, Morton K. See Fleisher, Martin;<br />
Hansen, Hans J.<br />
Schweighofer, Franz See Fridnich,<br />
Schweitzer, J. K. See Witte, D. L<br />
Leo<br />
Schwenzin, D. See Doris, Manuel, Jr.<br />
Sciotto-Brown, Susan; Lin, Yuh-Nan; Huchit<br />
Michael; Sheiinan, Mark; Dunks, Louis, Jr<br />
1172<br />
Scott, Deborah See Ryan, Francis<br />
Scott,<br />
Scott,<br />
Joan H. See McPherson, Richard A.<br />
M. See Anderson, Geoffrey Butch, A.;<br />
Haden, B.<br />
Scott, Milda; Anderson, G., 1103<br />
Scott, Mitchell G. See Bodor, Geza; Butch,<br />
Anthony W.; Myrtle, James F.; Wolf, Bryai<br />
A.<br />
-; Ladenean, Jack H.; Green, Eric D.; Gast,<br />
Michael J., 620<br />
Scriven, Anthony J.; Tapley, Elizabeth hi., 15<br />
Scudamore, C. H. See Donnachie, E. hi.<br />
Seaborn, C. J. See Phillipou, G.<br />
Seaborn, Chris J. See Phillqou, George<br />
Seamonds, Bette; Strasser, B. L.; Tuhy, P. M.,<br />
1202<br />
Seccombe, D. W. See Donnachie, E. hi.<br />
Seelig, H. P. See Rena, M.<br />
Sefraoui, M. See Stainmetz, A.<br />
Segal, A. See Bray, Kurtis R.<br />
Segers, M. F. G. See Thomas, C. hi. G.<br />
Segura, J.; de Ia Torre, K.; Congost, hi.; Cami,<br />
879<br />
Sehgal, H. L See Sehgal, Lakshmen K.<br />
Sehgal, Lakshman 1K.;Sehgal, H. L.; Rosen, A<br />
L.; Gould, S. A.; Moss, G.S., 1155<br />
Seldel, Karen E. See Brown, Ellen D.<br />
Seifarth, K. See Gupta, Manjula K.<br />
Seislove, J. See Muinhead, C.<br />
Selzlnger, Bernd K., B25<br />
Semroc, G. See Bankeon, Daniel D.<br />
Senftner, H. J. See Madry, Norbert<br />
Senior, M. B. See Remaley, A. T.<br />
Senn, Chris See Eckfeldt, John H.<br />
Seoul,<br />
Sensi,<br />
M. See Lubec, 0.<br />
Maurlzio; Pricci, Flavia; Grazis De Roe<br />
Maria, Moreno, Susanne; Di MarIo,<br />
Umberto, 384<br />
Sephel, Gregory C. See Smith, Mary Carole<br />
Saraj, F. See Body, J. J.<br />
Serna, F. See Rosencrane, Robert<br />
2358 CLINICALCHEMISTRY, Vol.35, No. 12, 1989
,ta, F. See Tamagno, B.<br />
‘vaIl, J. Sanders; Peter, James B., 1076<br />
,verson, Suzanne L See Whitley, Chester<br />
,well, K. See Lucas, F.<br />
B.<br />
,ymour, D. See Gage, S.<br />
routes, D.; Clank, R.; Sgoutas, S., 1145<br />
Barton, E.; Hammarstrom, hi.; Peters, P.;<br />
Sgoutas,S., 1145<br />
routes, Demetrioe<br />
Hammarstrom,<br />
S.; Barton, Earl G.;<br />
Margareta; Pete, Philomena<br />
hi.; Sgoutas, Sandra A., 1785<br />
Abbott, Karen L, 2251<br />
routes, S. See Sgoutas, D.<br />
loutas, Sandra A. See Sgoutas, Demetris<br />
teckleton, C. H. L.; Reid, S., 1906<br />
S.<br />
tackleton, C. K. See Donnachie, E. M.<br />
tee, M. See Staedter, hi.<br />
teffer, Stanley G. See Brans, Yvee W.<br />
teb, V. See Yen, Sg.Erh<br />
teh, Vipin; Gladding, D.; Costello, K. M.;<br />
Barkey, D., 1162<br />
teh, Vipin D.; Yen, Shing-Erh; Diorio, Alfred<br />
F.; Hammer, Peggy A., 493, 1801,2157,2337<br />
tekanglan, S.; Fritache, H. A.; Hughes, J. I.,<br />
1080<br />
tehangian, Shahnam; Friteche, Herbert A.,<br />
Jr.; Hughes, John I.; Gelder, Frank B., 405<br />
Friteche, Herbert A., Jr.; Hughes, John I.;<br />
Johnston, Dennis A., 972<br />
teler, Robert C., 1058<br />
iamberger, K. J.; Banerji,<br />
Benerji, A., 1118<br />
A., 1113<br />
hankanan, P.; Reichatein, F.; Diamandie, F. P.,<br />
1153<br />
hanklin, Nora See Novms, Joel<br />
liapino, Sander 8., 1063<br />
harp, C. See Endres, David B.<br />
mw, David See Eisenberg, Paul R.<br />
law, Leslie M., 5,1235,1299<br />
law, Norm See Dowell, Barry<br />
law, Norman; Guy, Jennifer; Borden, Kim;<br />
Golubjetnikov, Rjunik; Bradley, Linda;<br />
Boots, Larry; Burton, Barbara; Miller,<br />
Wayne, 1192<br />
law, S. T. See Harrison, H. H.<br />
heat, J. M. See George, P.M.<br />
heehan, C.; Chnistofides, N.; Dent, A.; Midgley,<br />
J., 1148<br />
heehan, Christopher P. See Ball, Richard<br />
heehan, M.; Caron, 0.; Clark, L, 1103<br />
heiman, Mark See Kish, Linde; Sciotto-Brown,<br />
Susan; Zimmermenn, Linde<br />
heiman, Mark I. See Fan, Titan S.; Ku, Che.<br />
An<br />
heldon, Robert S.; Hill, Roger J.; Duff, Henry<br />
J., 748<br />
helton, M. See Butch, Anthony<br />
henkin, A. See Fraser, W. D.<br />
hepherd, B. See Hughes, J.<br />
hepherd, H. See Edwards, S.; Hughes, J.<br />
heppard, Michael C.; Black, F. G., 1142<br />
herman, W. M. See Ward, Kory M.<br />
heth, Anil K. See Tern, Tanuja K.<br />
heth, Nandini A. See Teni, Tenuja K.<br />
bibs, A. See Cho, Hinako<br />
hiba, K. See Cho, Hinoko<br />
hibata, H. See Matsuura, Tsuneaki; Yshikawa,<br />
Kazuaki<br />
hieh, P. See Bartling, D.<br />
bleak, Shu-Chu See Ting, Stanford W.<br />
Ting, W. K., 1111<br />
hihabi, Z. See McCormick, C.<br />
-; Rice, D.; Dyer, K., 1122<br />
-; Scero, J.; Jackson, J.; Friedberg, hi., 1203<br />
hihabi, 7.. K. See Hamilton, Robert W.<br />
himano, Hitoehi See Ishibeshi, Shun<br />
bimizu, Noriko See Terayama, Hiroshi<br />
bijuixu, K. See Yen, Shing-Erh<br />
himizu, Yoehlo See Yamauchi, Akihiro<br />
Itimojo, Nobuo; Naka, Keiichi; Nakajima,<br />
Chiaki; Yoshikawa, Chikao; Okuda, Kiyshi;<br />
Okada, Kunio, 1992<br />
hionoya, Yoehlhlko See Marute, Kazuhino<br />
hirahase, Y. See Watazu, Y.<br />
hobokshi, 0. See FI-Attar, Hanan M.<br />
boil, Shin’ichl; Komiyama, Atsushi;<br />
Nakamure, Maseo; Nomoto, Shozo, 1264<br />
-; Karasawa, Kouji; hiiyagi, Kouichi; Dun,<br />
Huijun, 2254<br />
bort, 6. See Uzan, Michel<br />
hoop,<br />
huey,<br />
Vernon<br />
Denise<br />
A.; Kalhan,<br />
F. See Tietz,<br />
Satish C., 495<br />
Norbert W.<br />
hukla, K. See Lucas, F.<br />
huler, S.F. See Witherspoon, L. R.<br />
hyaniala, M. See Moscoso, Hugo<br />
hyu, W. C. See Wei, J. S.<br />
ihiha, H.; Lohff, M.; Bush, D.; Rogers, K.;<br />
Joseph, R., 1106<br />
-; Lohff, M.; Bush, D.; Maheffey, K.; Joseph, R,<br />
1158<br />
Slemon, Peggy; Pottathil, K.; Usategui, M.;<br />
McNally, A. J., 1195<br />
Sleet, G. See Guemouni, Laila; Henny, Joseph;<br />
Vincent.Viry, Mornque<br />
Siest, Gerard See Schiele, Francoise<br />
Sigmund,<br />
Signorini,<br />
D. See Wermeling,<br />
C. See Ferrari, R.<br />
J. K.<br />
Silva, D. P., Jr. See Roeenblum, J. L.<br />
-; Landt, Y.; Porter, S.F.; Ladenson, J. H., 1203<br />
Silva, K. See Mulberg, F.<br />
Silver, M. K.; McGinnis, S.; Jordan, N.M.; Law,<br />
W.T., 1074<br />
Silverman, Jan F. See Khazanie, Prabhaker<br />
Silverman, L M. See Bankson, Daniel D.;<br />
Highemith, W. F.; Holden, K. D.; Prior, T.<br />
W.<br />
Silverman, Lawrence M. See Christenson,<br />
Robert H.; Highamith, W. Edward, Jr.; Prior,<br />
Thomas W.<br />
-; Hejtmancik, J. Fielding; Thibodeeu, Stephen<br />
N.; Lovell, Mark Alan, B53<br />
Silvestnini, Bruno; Guglielmotti, Angelo; Saso,<br />
Luciano; Cheng, C. Yen, 2207<br />
Slmbeye, A. G. A., 1081<br />
Simmons, M. See Wu, Yih-Shiong<br />
Slmonen, Sirkka See Bungi, Willy<br />
Slmpklna, F. See Raymond, Anne<br />
Simpson, B. See Figard, Steve D.<br />
Simpson, D. See Moore, F. M. L.<br />
Simpson, Sylvia G. See DePaulo, J. Raymond,<br />
Jr.<br />
Simsek, Bolkan See Torun, Meral<br />
Simuncak, David M. See Doumas, Basil T.<br />
Sinclair, David; Galloway, Eric; McKenzie,<br />
Sheila; Follett, Edward A. C.; Wallace,<br />
Leeley, 1669<br />
Sine, H. K See Wu, Yih.Shio<br />
Singer, F. See Endres, David<br />
Sl,igh, J.; Dudley, Alden W., Jr.; Montaro, A.;<br />
Kulig,K., 1073<br />
-; Kulig, Kim; Dudley, A. W., Jr.; Lucco, L.,<br />
1115<br />
Slngh, Jagat; Dudley, A. W., Jr.; Pang, E.; Kulig,<br />
K.; Mayfield, C., 1145<br />
-; Dudley, A. W., Jr.; Diaz, S. K.; Kulig, K., 1154<br />
Slngh, Madhuni See Fan, Der.Fong<br />
Slngh, K. K. See Konstantinides, Frank N.<br />
Slngh, S. See Haniharan, hi.<br />
Singkamani, R.; Koottethep, S.; Supapang, A.;<br />
Thurnham, D. I., 513<br />
Sinba, Madhur See Khazanie, Prabhaker<br />
Sinha, K. See Somani, B. L.<br />
Sinnecker, Gernot, 1253<br />
Sirtoll, Melanie See Foseati, Piero<br />
Site, Alexander F. See Per, Steven K.<br />
Sivaprasad, N. See Kothani, Kanchan<br />
Shale, Jeftery S. See Latner, Benny P.<br />
Skene, Debra J.; Churchill, Alison; Raynaud,<br />
Florence; Pevet, Paul; Arendt, Josephine,<br />
1749<br />
Sklepkova, A. See Chromy, V.<br />
Skogen, W. See Dyer, Deborah<br />
Skogerboe, Kristen J.; McLaughlin, Kathleen;<br />
Labbe, Robert F., 1114<br />
-; Johnson, Catherine; Labbe, Robert F., 1157<br />
Skonier, John K See Snouwaert, John N.<br />
Slaby, K. See Wright, Robs K.<br />
Slazyk, William J. See Jewel, Sandra E.<br />
Sliva, Clara A. See Elm, Ronald J.<br />
Sloan, Chris; Collins, S.; Karcher, K.; Kiechle, F.<br />
L., 1159<br />
Smith, A. F. See Tibi, L.<br />
Smith, B. Re.. See Beaver, K.<br />
Smith, C. See Dnistrien, Ann M.<br />
Smith, C. H. See Rosenblum, J. L.<br />
Smith, Carl H. See Landt, Michael<br />
Smith, Carol; Schwartz, D.; Kurtz, R.; Brennan,<br />
hi.; Gordon, M.; Schwartz, hi. K., 1078<br />
Smith, Deborah A.; Henderson, A. Ralph, 509<br />
-; Moses, 0. C.; Henderson, A. K., 1116<br />
-; Henderson, A. Ralph, 1127<br />
-; Moses, Godfrey C.; Henderson, A. Ralph,<br />
1774<br />
Smith, Doug See Green, Philip<br />
Smith, Douglas K.; Fulton, T. K.; Swain, P.;<br />
Bowcock, A.; Daneshvar, L; Traver, C.;<br />
Gruenert, D.C.; Davis, R.; Cavelli-Sforza, L.<br />
L.; Donis-Keller, H., B17<br />
Smith, K See Wilson, John M.<br />
Smith, F. A. See Rogers, Linda C.<br />
Smith, J. C., Jr. See Brown, Ellen D.<br />
Smith, J. L. See Neisler, H. hi.<br />
Smith, James See Passey, Richard B.<br />
Smith, Jane See Painter, Pennell<br />
Smith, Joyce K.; Woo, Jannie, 1179<br />
Smith, Karen; Roberts, Pamela L; Johnson,<br />
George F., 1083<br />
Smith, Mary Carole; Sephel, Gregory C., 1156<br />
Smith, Michael P.; Levinson, Stanley S.;<br />
Maciejko, James J., 1074<br />
Smith, Norman B. See Brooks, Klezina E.<br />
Smith, K. F.; Rutterford, Mary; Hand, C. W.,<br />
1175<br />
Smith, S. J. See Myers, Gary L.<br />
Smith, S. Jay See Jewel, Sandra E.<br />
Smith, T. See Chiang, C. S.<br />
Smith, Wendell C. See Sportsman, J. Richard<br />
Smoluk,<br />
Sneath,<br />
G. See Gibbons, I.<br />
Tom See Spiehler, Vms<br />
Sninsky, John J., 1058<br />
Snouwaert, John N.; Jambou, Robert C.;<br />
Skonier, John E.; Earnhardt, Kimberly;<br />
Stebbina, John K.; Fowlkes, Dana M., B7<br />
Snyder, Andrew M. See Irish, Glenn K.<br />
Irish, Glenn K.; Snyder, Thomas D., 1197<br />
Snyder, Thomas D. See Irish, Glenn K.; Snyder,<br />
Andrew M.<br />
Sobecki, Stan See Branford, Susan<br />
Sobeski, L M. See Haven, hi. C.<br />
Sobeski, Linda M. See Haven, Mary C.<br />
Sokalski, Tomasz See Lewandowski, Ryszard<br />
Sokoll, Lon J.; Dawson.Hughes, Bess, 328<br />
Solan, Vishnu See Fan, Titan S.; Kish, Linde;<br />
Ku, Che-An<br />
Solano, Romeo; Pippenger, C.; Bunge, G.;<br />
Miteumoto, H.; DeBoer, 0., 1173<br />
Soldin, S. J. See Donnelly, James 0.; Hyde, John<br />
E.; Iosefsohn, Mariet; Pham, Quynhchi;<br />
Stone, Judy<br />
Soldin, Steven J. See Stone, Judith A.<br />
-; Morales, A.; Velasquez, hi. T.; Belfe, W., 1136<br />
Solomon, Judy See Wynn, Annette<br />
Somani, B. L; Sinha, K.; Gupta, M. M., 497<br />
Sommer, M. See Holzberg, Roni A.<br />
Sommer, Ronald G.; Loeschen, Barbara J.;<br />
Morris, David L., 1166<br />
Somville, M. A. See Galanti, L. M.<br />
Soonemaker, K. See Witherspoon, L. R.<br />
Sorbo, Be See Falkenseon, Marianne; Lundquist,<br />
Per<br />
Sorin, T.; Ifuku, Y.; Sato, K.; Kohno, H.;<br />
Mizokemi, hi.; Tokude, H.; Nekamure, hi.;<br />
Yamamoto, hi., 1206<br />
Spain, Mark See Wamnick, G. Russell<br />
Spanier, M. See hiullins, Marvin<br />
Sparks, K. See Hardy, Robert<br />
Sparks, Katherine See Ng, Ronald H.<br />
Spaven, F. F. See Zoha, Steven J.<br />
Spector, Deborah H. See Spector, Stephen A.<br />
Spector, Stephen A.; Hale, Karen; Denaro,<br />
Frank; Spector, Deborah H., 1581<br />
Spelcb, Michelle; Auget, Jean-Louis; Arnaud,<br />
Pierre, 833<br />
Spells, M. See Melerski, James J.<br />
Sperllng, Matthew; Chen, L; Heminger, L;<br />
Maxon, H.; Maugh, K.; Bodlaender, P., 1160<br />
Sperling, Oded See Rotenberg, Zvi<br />
Spichiger, Ursula E.; Vonderschmitt, Dieter J.,<br />
448<br />
Splehler, Vine See Hurrell, Yumina<br />
-; Wilson, Howard; El Shami, Said; Snesth,<br />
Tom; Jam, Narish, 1175<br />
Spiekerman, Michael, 1147<br />
Spire, Thomas J. See Fuchs, Dietmar<br />
Sportsman, J. Richard; Smith, Wendell C.;<br />
Wisely, Carl L., 1623<br />
Spronk, Adrian M.; Pavlis-Jenkins, Lynn;<br />
Schmidt, Linda S.; Taskar, Suhas; Brady,<br />
James A., 1193<br />
Srebro, Some See Mehznood, Nishat<br />
Staedter, M. See Ackermann, H.; Blackwood, J.;<br />
Grenner, G.<br />
-; Maretaky, D.; Finneren, J.; Penta, K.; Shee,<br />
M.; Inbar, S.; Blackwood, J.; Grenner, G.,<br />
1196<br />
Stahlschmidt, G. K. See Roeenbluxn, J. L.<br />
Stalder, Arnold See Donahue, Joseph<br />
Stampfer, Mein See Kaplan, Lawrence A.<br />
Stampfer, Meir J. See Hankineon, Susan F.<br />
Stamy, K. See Kasemen, Deborah; Reilley,<br />
Therese<br />
Stankievic, K. See Rhalle, Ravi<br />
Stanton, Noel V. See Parsons, Patrick J.<br />
-; Gunter, Elaine W.; Parsons, Patrick J.; Field,<br />
Patricia H., 2104<br />
Staples, Mark See Zen, Geraldine Tun<br />
-; Zen, Geraldine Tun; Munthy, H. hi. S., 1190<br />
Starrett, William See Brewster, Mange A.<br />
Stasiw, K. See Ostrovsky, Irene<br />
Statland, B. E. See Hardy, Robert<br />
Statland, Bernard E. See Ng, Ronald H.<br />
Stavljenlc, A. See Cvoriscec, D.<br />
Stebbins, John K. See Snouwsert, John N.<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2359
Steed, Linda See Plaut, David<br />
Steele, B.; Bell, M.; Campbell, hi.; Lucas, F.,<br />
1123<br />
Steffes, Michael W., 1237<br />
Stehr, K. See Schoenau, F.<br />
Stein, Kvau A. See Kaplan, Lawrence A.<br />
-; Wilson, Pamela; Kaplan, Lawrence A., 1203<br />
Steinberg, William M. See Werner, Mario<br />
Steindel, S. J. See Howanitz, P. J.<br />
Steinmetz, A.; Salle, K.; Sefraoui, M.; Parre, H.<br />
J.; Fruchart,<br />
Stekiova, Irma<br />
J. C., 671<br />
v.a.. Gerasimova, Netalija S.<br />
Stenman, Ulf-Hakan See Paevonen, Jorma;<br />
Suhonen, Lauri; Turpeinen, Ursula<br />
Stephens, Gregory W. See Magnotti, Ralph A.,<br />
Jr.<br />
Stephens, Karen See Green, Philip<br />
Stevenson, Cathy C.; Cibull, Deanna; Gere,<br />
Jeffrey A.; Bush, Donna M., 1179<br />
Stewart, M. J. See Elliot, K.; McIntosh, S. J.;<br />
Watson, I. D.<br />
Stiller, K. L See Perel, J. hi.<br />
St. John, D. J. B. See Roe., I.S.<br />
Stock, John L; Coderre, James A.; Posillico,<br />
JamesT., 18<br />
Stockert, L See Schmitz, J.<br />
Stockmann, W. See Baadenhuijsen, H.<br />
Stojak, J. See Eble, K. S.<br />
Stolarek, Iwona; Hawey, Jacqueline E. A.;<br />
Fraser, Callum G., 560<br />
Stone, Judith A.; Soldin, Steven J., 1326<br />
Stone, Judy; Morales, A.; Soldin, S. J., 1168<br />
Stott, Richard A. W. See Lewis, Helen hi.<br />
Stouffer, B. See Jagode, F.; Reise, A.; Tsay, H.<br />
Strandbergh, D. K. See Arties, J. D.<br />
Strange. Richard C. See Beckett, Geoffrey J.<br />
Strasberg, Paula, 1512<br />
Strasburger, Christian; Barnard, Geoff; Toldo,<br />
Lure; Zarmi, Bstya; Zadik, Zvi; Kowarski,<br />
Avinoam; Kohen, Fortune, 913<br />
Strasser, B. L See Seamonde, Bette<br />
Stratton, John K. See Chandler, Wayne L<br />
Streeter, B. See Wu, Lily L.<br />
Strong, Donna D. See Farley, John K.<br />
Strong, Wllliam B., 1061<br />
Strufaldi, Bruno See Hinata, Rosaria<br />
Dominguez Crespo<br />
Studts, U. J. See Earl, R. A.<br />
Stork, A. See Dati, F.<br />
Su, Muh-Hwan See Au, J. Lai-Sim<br />
Suarez, A. See Scheffel, J.<br />
Subbarao, Makam N.; Bakke, Antony C., 1153<br />
-; hiueggler, Paul, 1181<br />
Sudsbury, K. See Khosravi, hi. J.<br />
Suga, Tetuya See Iwate, Jihel<br />
Sughayer, Maher A.; Arkin,<br />
Sugita, Osamu See Kuwana,<br />
Charles F.. 1794<br />
Tomomi<br />
Sugiura, Ko.aku See Maekawe, Masato<br />
Suhonen, Lauri; Stanman, Ulf-Hakan; Koivisto,<br />
Veikko; Teramo, Karl, 922<br />
Suit, Paula See Van Lente, Frederick<br />
Sullinger, Jane; Garrett, Patricia F., 2223<br />
Sullivan, Susan See Lee, Theodore T.<br />
Summers, M. See Hughes, J.<br />
Sun, C. See Wong, P. Y.<br />
Sun, Lila; Galliher, G.; Tueak, R.; Brandt,<br />
Hsu, hi. Y.; Olson, H. hi., 1071<br />
B.;<br />
Sun, Yi; Peterson, Timothy E.; McCormick,<br />
Michael L.; Oberley, Larry W.; Osborne,<br />
James W., 1265<br />
Sundarain, G. S. See hienimekalni, S.<br />
Sundaram, Shan G.; Lustgartan, J.; Wenk, R.<br />
F.;Manimekalai, S.; Thilakavathi, S.;<br />
Goldstein, P. J., 1118<br />
Sundarem, G.S. See Goldstein, Phillip J.<br />
Sundberg, M. See Mauck, Linda<br />
Suonpaa, Mikko See hiakinen, Maija-Liisa<br />
-; Halonen, Tuija; Pettareson, Kim, 1205<br />
Supapang, A. See Singkamani, R.<br />
Sutphen, James L. See Franquemont, Douglas<br />
Suzuki, K. See Cho, Hiroko<br />
Svardal, Asbjorn Martin See Retsum, Helga<br />
Svens, Elvor; Kapyaho, Kirsti; Tanner, Pirjo;<br />
Weber, T. H., 662<br />
Sverlow, K. See Nargessi, R. D.<br />
Svlnarov, Dobrin A.; Dotchev, Dotcho<br />
Swain, P. See Smith, Douglas R.<br />
C., 1615<br />
Swaminathan, R. See Chan, A. Y. W.; Cheung,<br />
C. K.<br />
Swanson, B. N. See Catanzariti, P. A.; Wiernik,<br />
M.D.<br />
Swanson, J. Robert See Russell, John C.<br />
Kenny, Terry; Bissonnetta, John, 1193<br />
Swanson, Larry W. See Deneris, Even S.<br />
Swanson, S. See Kieng, W.<br />
Swanson, S. M. See Oetrow, D. H.<br />
Swanson, Terry; Blaylock, R.; Ash, K. 0., 1100<br />
Sweet, Michael See Kress, Barry C.<br />
Sweetman, Lawrence See Hoffmann, Georg<br />
Swift, M. See Highamith, W. F.<br />
Swift, T. See Roseno, Thomas<br />
Szekeres, Thomas See Fridrich, Leo<br />
Tackett, K. B. See Miceli, J. N.; Vroon, D. H.<br />
Tadepalli, Sarvamanagala; Quinn, R.; Puckett,<br />
L. D.; Onf, J. W.; Goldensoph, C. R.; Donner,<br />
J.E., 1187<br />
Tagari, Philip; Ethier, Diane; Carry, Melissa;<br />
Korley, Victoria; Chanleson, Stalla; Girard,<br />
Yves; Zamboni, Robert, 388<br />
Taggart, D. P. See Fraser, W. D.<br />
Tagliaro, F. See Donizzi, R.<br />
Taguchi, Hideo See Kanno, Norimichi<br />
Taguchi, Shizuko See Komno, Norimichi<br />
Takagi, Nobubiko See Tsuchiya, Hironori<br />
Takai, M. See hiizuochi, E.<br />
Takaku, Fumim.ro See Ishibashi, Shun<br />
Takao, Kyoji See Imamura, Shigeyuki<br />
Takasugi, Nobuo See Yamaguchi, Akihiro<br />
Takeda, Ryoyu See Hashinioto, Takuma<br />
Takei, Hitoshi See Nakashima, Koji<br />
Takeuchi, Fiji See Usui, Akihiko<br />
Talwar, D. See Watson, I. D.<br />
Tamagno, B.; Gatti, V.; Sets, F., 1539<br />
Tamaki, Haruo; Amino, Nobuyuki; Kixnura,<br />
Motoko; Miyal, Kiyoshi, 1252<br />
Tamura, Kohji See Kabeyashi, Isao<br />
Tan, A. See Diamandis, F. P.<br />
-; Khosravi, M. J.; Diamendis, E. P., 1139<br />
Tan, Alan See Diamandis, Eleftherios P.<br />
Tanaka, K. See Matsuura, Tsuneaki; Yoshikawa,<br />
Kazuaki<br />
Tanaka, Minoru See Usui, Akihiko<br />
Tanaka, S. See Bantling, D.<br />
Tang, C. L See Harrison, H. H.<br />
Taniguchi, Ken See Azuma, Yutaro<br />
Tanimoto, L See Cornelison, L.; Fu, Paul<br />
Tanluchi, Koji See Kobayashi, Kunio<br />
Tanner, Pirjo See Svens, Elvor<br />
Tapley, Elizabeth M. See Scriven, Anthony J.<br />
Tarailo, P. See Henny, Joseph<br />
Tarbaux, Nanine M. See Farley, John R.<br />
Tareoghi, Giordano See Fossati, Piero<br />
Tartaglione, T. See Sadrzsdeh, Sayed M. H.<br />
Tas, Sinan, 256<br />
Taskar, Subas See Spronk, Adrian M.<br />
Tataumi, Mikio See Teuchiya, Hironori<br />
Tawa, Rilchi See Fujimoto, Takashi<br />
Taylor. Bob See Hage, David S.<br />
Taylor, D. See Ryder, K.<br />
Taylor, E. Howard; Fink, Louis M.; Pappas,<br />
Alex A., 710<br />
Taylor, G. See Wang, P. Y.<br />
Taylor,<br />
Taylor,<br />
Robert See Klee, George<br />
W. Allen See Butler, Barbara A.<br />
Tekuzman, Gulten See Copur, Sitki<br />
Ten Cate, J. W. See Dati, F.<br />
Tern, Tanuja K.; Banclivdekar, Atmaram H.;<br />
Sheth, Anil R.; Sheth, Nandini A., 1376<br />
Tentas, Constentinos See Giannoulaki,<br />
Elefteria F.<br />
Teodosio, F. See Cheng, Mary H.<br />
Teredaira, Ryo See Maruta, Kazuhiro<br />
Teramo, Karl See Suhonem, Lauri<br />
Teramoto, Y. See Gannon, Allison<br />
Terayama, Hhroshi; Shimizu,<br />
Fukuzumi, Rieko, 2202<br />
Noriko;<br />
Tercero, J. C.; Pandian, hi. K.; Cerayon, P.,<br />
1208<br />
Tetrault, Gregory A.; Miller, W. Greg, 1065<br />
Thacker, Susan; Dubler, Robert; Wang, Neil;<br />
Walling, John; Chiappetta, Enrico; Gates,<br />
Teresa; Crisafulli, Terry, 1176<br />
Thajeel, A. H. See Abu-Fareakh, F. A.<br />
Them, Sock Ying See Wang, Shih Yung<br />
Thibert, K. J. See Catomeris, Peter<br />
Thibodeau, Stephen N. See Silverman,<br />
Lawrence M., 1057<br />
Thilakavatbi, S. See Sundaram, Shan G.<br />
Thliveris, J. See Copeland, Kenneth<br />
Thomas, C. M. G.; Segers, hi. F. G., 1791<br />
Thomas,<br />
Thomas,<br />
U. W. See Nordim, B. F. C.<br />
Daniel See Boitleux, Jean-Louis<br />
Thomas, Stanley M. See Tilzer, Lowell L.<br />
Thompson,<br />
Thompson,<br />
Edward J. See Luxton, Richard W.<br />
F. See Fox, Martha; Graham, D.<br />
-; Fox, hi.; Heden, B.; Vasilakis, J.; Dickey, D.;<br />
Cordy, P.; Jonza, J.; Kubasik, N., 1088<br />
Thompson, James D.; Decker, Scott; Haimes,<br />
Dale; Collins, R. Scott; Feild, Margaret;<br />
Gillespie, David, 1878<br />
Thompson, W. See Mebbett, S.<br />
Thompson, W. H. See Neisler, H. M.<br />
Thomson, S.; Wallace, A. hi.; Cook, B., 1706<br />
Thong, Y. H. See Renouf, Judith A.<br />
Thorner, MO. See Felder, K. A.<br />
Thornton, William H., Jr.; Adelstein, Edward<br />
H.; Roes, Thomas E., 459<br />
Thorpe, 0. H. 0. See Bronstein, I.; Voyte, J. C.<br />
-; Bronstein, I.; Knicka, L. J.; Edwards, B.;<br />
Voyta, J. C., 2319<br />
Thorstensson, K. See Haden, B.<br />
Thuan, N. T. Leuquang; hiigueres, M. L.;<br />
Roche, D.; Rouseel, 0.; hiahuzier, G.;<br />
Chretien, J.; Ekindjian, 0. G., 1456<br />
Thuillier, Francois See Peynet, Jacqueline<br />
Thurlbeck. William M. See Khadempour, M.<br />
Hassan<br />
Thunnham, U. I. See Singkamanm, K.<br />
Thut, Laurel See mb.., Roger<br />
Tibi, L; Patrick, A. W.; Leslie, P.; Taft, A. D.;<br />
Smith, A. F., 1427<br />
Tietz, Norbert W. See Rinker, Alan D.<br />
-; Astles, J. Rex; Shuey, Denise F., 1688<br />
Tikanoja, Sari See Ekins, Roger<br />
Tillman, J. See hicConway, hi. 0.<br />
Tilzer, Lowell L; Moreno, Ruben F.; Booth,<br />
Frank; Wilbur, Stephen; Thomas, Stanley<br />
hi.,2147<br />
Tiniko, U. M. See Earl, K. A.<br />
Ting, Stanford W.; Shiesh, Shu-Chu; Yang, Ch<br />
Fang, 1155<br />
Ting, W. K. See Shiesh, Shu-Chu<br />
Tlsell, Lars-Erik See Lundberg, Per-Anne;<br />
Nystrom, Ernst<br />
Tizio,<br />
Toda,<br />
T. See Wimmer, Cathy<br />
T. See Cho, Hiroko<br />
Toffaletti, John See Christenson, Robert H.<br />
-; Abrams, Billy, 935<br />
-; Abrams, Billy, 1131<br />
Toft, A. D. See Tibi, L.<br />
Tokuda, H. See Sorin, T.<br />
Toldo, Luce See Straeburger, Christian<br />
Tom, K. See Watkins, Michael<br />
Tomasik, J. See Walters, S.<br />
Tomei, Ray T. See Ekine, Roger; Nelson, Jerald<br />
C.<br />
Toms, Kick A. See Chou, Peter P.; Longhunst,<br />
Sharon<br />
Tono, Mary See Gross, Susan F.<br />
Torday, John S. See Russell, John C.<br />
Torloni, Sergio A. See Alexander, Roy L.<br />
Torun, Meral; Hacisalihoglu, Ayse; Kin, Sedef;<br />
Simsek, Bolkan, 1263<br />
-; Bayhan, Aysel; Yentur, Gulderen, 1792<br />
Tovey, M. See Dakubu, S.<br />
Toyota, Sachiko See Mashige, Fumiko<br />
Tracy, R. See Howard, P.<br />
Tracy, Russell P. See Dehiars, Daniel D.<br />
Tran,<br />
Tran,<br />
K. See Gennon, Allison<br />
Kini See hiolnar, Larry A.<br />
Trever, C. See Smith, Douglas K.<br />
Traverse, William See Yea, KIeng-Teck<br />
Travis, James See Lloyd, Cynthia<br />
Traylor, D. See Scheffel, J.<br />
Tremblay, Michel See Davignan, Jean<br />
Trevejo, K. See Aneani, A.<br />
Trimble, Elisabeth K. See McDowell, Ian F. W<br />
Tripodi,<br />
Tropak,<br />
A. See Dati, F.<br />
Michael See Attia, John<br />
Trout, Neil See Ng, Ronald H.<br />
Troyanosky, Deborah See Goldsmith, Barbara<br />
M.<br />
Truchaud, A. See Gouget, B.<br />
Trujillo, G. See Woo, Charles<br />
Trundle, U. See Duncan, Marilyn; Prinsen,<br />
Johanna; Raymond, Anne; Rushkowski,<br />
Janet<br />
Trundle, Diana S., 1237<br />
Tsai, LL See Kohl, HH<br />
Tsai, Michael Y.; Cooper, Katherine, 1989<br />
Tsay, H. See Jagoda, F.; Mantha, S.; Reiss, A.<br />
-; Reise, A.; Stouffer, B.; Mantha, S.; Turabi, S<br />
Jegoda, F.; Tu, J., 1189<br />
Tse, Mertlna; Feldbruegge, Donald; Wiebe,<br />
Donald; Koch, David D., 1068<br />
Tsoukas,<br />
Tsuchiya,<br />
Chris See Falutz, Julian<br />
Hiz’onorl; Hayeshi, Tokishi; Tatsum<br />
Mikio; Hoshino, Yoshiyuki; Ohtani, Shigert<br />
Takagi, Nobuhiko, 43<br />
Tsuda, Yoshiko See Fujimoto, Takeshi<br />
Tsuji, A. See Uji, Y.<br />
Tsuji, Masahiro See Konno, Norimichi<br />
Tsukada, Toshihiko See Joukyuu, Ritsuko<br />
Tsukeda, Yuteka See Yoshioka, Shinichi<br />
Tsukenioto, Yusuke See Ishida, Osamu<br />
Tsunokawa, M. See Chiang, C. S.<br />
-; Chiang, C. S.; Grove, T.; Folena-Wasserman,<br />
0.; Rosenberg, M., 1191<br />
Tu, J. See Jagoda, F.; hientha, S.; Reiss, A.;<br />
Tsay, H.<br />
Tuhy, P. M. See Seamonds, Bette; Zoha, Steven<br />
J.<br />
Turabi, N. See Jagoda, F.; Reiss, A.; Tsay, H.<br />
2360 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
1’urcant, A. See Allain, P.; Laine-Cessec, P.<br />
Turgeon, Jeanne See Rosenzweig, I. Bruce<br />
Turk, John W. See Wolf, Bryan A.<br />
Turner, Marshall See Ryan, Francis<br />
Turner, P. K. See Joven, J.<br />
Turner, Wayman K. See Gunter, Elaine W.;<br />
Miller, Barbara B.<br />
I’urpelnen, Ursula; Stenman, Ulf-Hekan;<br />
Rome, Risto, 33<br />
Tusak, K. See Sun, Lila<br />
Tuumlnen, Tamara See Gerasimova, Natslija S.<br />
Tvede, K. See Wendrup, Jesper<br />
Tyagi, Sanjay See Lomeli, Hilda<br />
Tyma, D. See DiPaole, J.<br />
Uchimaru, U. See Won, P. Y.<br />
Udwin, Michael See Bhck, Kenneth E.<br />
Ueland, Per Magne See Retsum, Helga<br />
Uemura, M. See Yemasaki, Mesehiko<br />
Uji, Y.; Okebe, H.; Sakai, Y.; Noma, A.; Meede,<br />
hi.; Tsuji, A., 325<br />
Ullman, Edwin F., 1239<br />
Ulm, J See Kohl, RH<br />
Unni, L K.; Hannant, hi. F.; Becker, R. E.;<br />
Giecobini, F., 292<br />
Unni, S. See Manimekalai, S.<br />
Urdal,<br />
Urdea,<br />
Petter; Landmark, Knud, 1559<br />
Mickey S.; Kolberg, Janice; Clyne,<br />
Jennifer; Running, Joyce A.; Besemer,<br />
Diana; Warner, Brian; Senchez-Pescedor,<br />
Ray, 1571<br />
Urquhart, N. L See Donnachie, E. M.<br />
Urry, F.M. See Pearson, Stephen D.<br />
Urry, Francis M. See Pearson, Stephen D.<br />
Usatagul-Gomez, M. See Kasemen, Deborah<br />
Usategui, M. See Siemon, Peggy<br />
Usategul-Gomez, M. See Kaseman, Deborah<br />
Usher, D.C. See Labeur, C.<br />
Usui, Akihiko; Kato, Kanefusa; Abe, Toshio;<br />
Murase, Mituya; Tanaka, Minoru; Takeuchi,<br />
Eij, 1942<br />
Uzan, Mlchel; Short, 0.; Bare, 0., 1092<br />
Valdya, H. C. See Rosenblum, J. L<br />
Valcour, A. A. See Krzymowski, G. A.<br />
Valcour, Andre; Bowers, 0. N., Jr.; McComb, K.<br />
B., 1119<br />
Valcour, Andre A. See Okorodudu, Anthony 0.<br />
-; Bowers, George N., Jr.; hicComb, Robert B.,<br />
939<br />
Valdes, R., Jr. See Butch, Anthony; Hardy,<br />
Robert<br />
Valdez, J. See Cornelison, L; Haute, Robyn<br />
Valdez, Johnny See Chung, Byung Sook; Hsu,<br />
Po Choo<br />
Valdya, Hemant C. See Lsndt, Yvonne<br />
Valendinova, M. See Chromy, V.<br />
Valenta, K. See Gage, S.<br />
Van Brunt, N.; Egensperger, H.; Greenberg, N.;<br />
Halstead, K.; Cassano, T.; Doptis, P.;<br />
Jennings, T., 1101<br />
van do Galseyde, J. F. See Weykemp, C. W.<br />
Vandeleene, B. See Bernard, A. hi.<br />
van den Berg-Bosnian, H. T. K. See<br />
Hafkenscheid, J. C. hi.<br />
Vanderborght, B. See Pallet, D. F.<br />
Vanderschueren, Serge See Robbrecht, Jahan<br />
van der Sluljs Veer, G. See Vermes, I.<br />
van der Vljgh, Willem J. F. See Leeuwenkamp,<br />
Oscar R.<br />
Van Dreal, P. See Putnam, K. S.<br />
van Haeften, T. W.; Konings, C. H., 1024<br />
Van Heuverswyn, H. See Pallet, D. F.<br />
Van Kesel, Antonius L; Mahoney, John, 1131<br />
Van Krleken, L. See Collet-Cassant, D.<br />
Van Lear, Lutyart See Dillen, Lieve<br />
Van Lente, F.; Kazmierczak, S.C., 1542<br />
Van Lente, Frederick See Kazmierczak, Steven<br />
C.; Pippenger, C. F.; Rosalki, Sidney B., 1233<br />
-; Suit, Paula, 2326<br />
Van Liedekerke, Beatrijs M. See Lambert,<br />
Willy E.<br />
van Munstor, P. J. J. See Elving, L. D.<br />
Vanneste, Lutgart See Lambert, Willy F.<br />
VanNoord, T. See Heriharan, M.<br />
VanNoord, Ted See Harihanan, M.<br />
van Ru, Andre M. See Wade, Chris K.<br />
van Rijn, Jan L M. L; Schmidt, Nico A.;<br />
Rutten, WimP. F., 840<br />
van Sande, M. See Hendniks, D.<br />
Van Tassel, K. See Bray, Kurtis K.<br />
Van Winkle, M. See Haden, B.<br />
van Zanten, A. P. See Weber, J. A.<br />
Varastoh, Abdolreza See Schiele, Francoise<br />
Vasdev, S. See Gault, M. H.<br />
Vasdev, Sudesh; Fernandez, P.; Prabhakaran, V.<br />
hi.; Sampson, C., 1138<br />
Vasilakis, J. See Fox, Martha; Thompson, F.<br />
Vasilakis, Jeanne; Muirhead, C. L.; Fox, M.;<br />
Haden,B., 1126<br />
Vasiliedes, John; Kuhlman, J., 1168<br />
Vassaneili, Corrado See Graziani, Maria Stalls<br />
Vassault, A. See Baedenhuijsen, H.<br />
Vastmans, L See Pallet, D. F.<br />
Vaughan, Kenward See Brashear, Jeff<br />
Vaughn, C. B. See Serdesai, Sudha<br />
Vaughn, K. See Lewis, L. M.<br />
-; Lewis, L hi.; Biagini, A. V.; Lee, C. K., 1108<br />
-;Lewis,L.hi., 1159<br />
Vaziri, N. D. See Miyade, D. S.<br />
Veer, G. van der Sluijs; Vermes, I.; Bonta, H.<br />
A., 493<br />
Velasquez, MT. See Soldin, Steven J.<br />
Velez, L See Crockett, R.<br />
Venetucci, Mary See Baker, Harold N.; Ford,<br />
Kent A.<br />
Vente, Rafael; Geijo, Sofia A.; Sanchez, Agustin<br />
C.; Bao, Constentino G.; Bartolame, Luis A.;<br />
Casanes, Gerardo; Lopez-Otin, Carlos;<br />
Alvarez, Frencisco V., 2003<br />
Verbruggen, Bert See Fischer, Johan<br />
Vergassola, Cleudio See Musso, Natale R.<br />
Vermes, I. See Veer, G. van der Sluijs<br />
-; van den Sluijs Veer, G.; Bonta, H. A., 1139<br />
Vermeulen, Alex<br />
Vernet, Michele;<br />
See Delange, Joris<br />
Revenant, Marie-Claude;<br />
Bird, Andree; Naudin, Claude; Jauneau,<br />
Monique; Olivier, Frencoise; Ruiz, Jean-<br />
Charles, 672<br />
Vernillet, L; Keller, H. P.; Le Bigot, J. F.;<br />
Huinbert, H., 608<br />
Vessella, Robert I See Mathisen, Mary L.<br />
Vickery, D. K. See Koch, Thomas R.<br />
Vigier, M. P. See Basuyau, J. P.<br />
Vignon, F. See Freiss, G.<br />
Vllarinho, I See Osorio, K. Vex<br />
Vilelle, E. See Joven, J.<br />
Villa,<br />
Villa,<br />
B. See Williams, Michael<br />
Barbara; Brandt, B.; Dalke, D.; Kaufman,<br />
J., 1109<br />
Villanueva, K. See F,ndres, David B.<br />
Vincent-Viry, Monique; Riche, L; Siest, 0.;<br />
Galteau, hi. M., 1184<br />
Visor, J. See Freeman, J.<br />
Vogel, Gisela See Bobber, Ulnich<br />
Vogt, B. W.; Ziegsnhorn,<br />
Volke, Teresa McMlllen<br />
J., 1110<br />
See Warnick, G.<br />
Russell<br />
Volimer, Robin T. See Christenson, Robert H.<br />
von Arb, Marianne See Gaillard, hi. Christine<br />
Vonderschmitt, Dieter J. See Spichiger, Ursula<br />
F.<br />
von Schenck, Henning See Grutzmeier, Sven<br />
Vowels, J. A.; Pekary, A. F.; Hershman, J. hi.,<br />
1147<br />
Voyte, J. C. See Bronstein, I.; Thorpe, G. H. G.<br />
-; Bronstein, I.; Thorpe, G. H. G.; Kricka, L. J.;<br />
Armstrong, G., 1190<br />
Voyta, John C. See Bronstein, Irena<br />
Vrabel, Dene M. See Raam, Shanthi<br />
Vroon, U. H. See Miceli, J. N.<br />
-; Miceli, J. N.; Bloodworth, D. F.; Brantley, N.;<br />
Tackett, F. B.; Wellington, P., 1165<br />
Vu, T. H. See Cheng, Mary H.<br />
Vukelic, B. See Cvoriscec, D.<br />
Wachter, Helmut See Fuchs, Dietmar;<br />
Reibnegger, Gilbert<br />
Wade, Etsuko See Deneris, EvanS.<br />
Wade, Keiji See Deneris, Even S.<br />
Wade, Chris K.; van Rij, Andre hi., 336<br />
Wagner, Galen S. See Christenson, Robert H.<br />
Wakabayashi, K. See Hosoda, K.<br />
Wakui, Hideki; Kobayashi, Ryoji; Itoh, Hideaki;<br />
Imsi, Hirokazu; Nakemoto, Yasushi; Miura,<br />
Akira B., 577<br />
Waldenlind, L. See Wallinder,<br />
Walker, V. See Mills, G. A.<br />
H.<br />
Walker, Valerie; Mills, Gnaham A., 1460<br />
Wallace,<br />
Wallece,<br />
A. M. See Thomson, S.<br />
Lesley See Sinclair, David<br />
Wailer, Kathy V.; Ward, Kary M.; Mahan, John<br />
D.; Wismatt, Dorothy K., 755<br />
Wallinder, H.; Angback, K.; Kshan, J.; Onica,<br />
D.; Waldenlind, L, 328<br />
Walling,<br />
Walloch,<br />
John<br />
Jami<br />
See Thacker, Susan<br />
I See Braithwaite, Susan S.<br />
Walsh, D. See Gawoski, J. M.<br />
Walter, G. See Schnorn, Gerd K.<br />
Walters, S.; Tomasik, J.; Olson, H. M., 1071<br />
Walton, S. See Mifflin, Ted<br />
Wan, Koon Ching See Chui, Shiu Hon<br />
Wandrup, J., 2027<br />
Wandrup, Jesper; Tvede, K.; Grinsted, J.;<br />
Jordening,H.,<br />
Wang, Henn-Ping;<br />
1740<br />
Ho, Hsu-Tso; Davouzadeb,<br />
Feegh; Wang, Huie, 1189<br />
-; Daniel, hiolly; Williams, Barbara; Knight,<br />
William, 1192<br />
Wang, Helen H. See Cembrowski, George S.<br />
Wang, Huie See Wang, Hann-Ping<br />
Wang, J. See Wang, X. L.<br />
Wang, Jia-Horng See Kuo, Cheng-Deng<br />
Wang, Neil See Thacker, Susan<br />
Wang, Shib Yung; Them, Sock Ying; Poon, Mm<br />
Kwong, 329<br />
Wang, Stephen T.; Demshar, H. P., 1152<br />
Wang, Tang Jang; Kilheeney, J.; Weaver, R.;<br />
Bunyagidj, C., 1198<br />
Wang, X. I; Dudman, N. P. B.; Wilcken, D. F.<br />
L., 1000<br />
-; Dudman, N. P. B.; Wang, J.; Wilcken, D. E.<br />
L., 2082<br />
Wang, Yue Hue See Wu, Lai Wen<br />
Wanner, K. See Schoenau, F.<br />
Ward, Kory M. See Wailer, Kathy V.<br />
-; Mahan, J. D.; Sherman, W. M.; Lash, J. hi.,<br />
1135<br />
Warlick-Yates, Kathy See Kessler, Jay<br />
Warmenbol, H. See Pallet, D. F.<br />
Warner, A. See Hassen, F. Michael<br />
Warner, Ann See Wermeling, Joseph R., 648<br />
Warner, Brian See Urdea, Mickey S.<br />
Warnick, 0. Russell See Bachonik, Paul S.;<br />
Nguyen, Thuy; Wu, Lily L.<br />
-; Spain, Mark; Kloepfer, Hens; Volke, Teresa<br />
Mchiillan, 409, 1235<br />
Warnik, K. See Wu, Lily L.<br />
Warren, K. See Lasky, Fred D.<br />
Warren, Patricia See Lott, John A.<br />
-; Lott, John A., 1090<br />
Watanebe, Norlyuki See Maruta, Kazuhiro<br />
Watazu,Y.;Shinahase,Y.; Keneda, N., 1127<br />
Waters, Marilyn See Bandi, Zoltan L.<br />
Watkins, Michael; Munthy, H. M. S.; McClure,<br />
K. Dale; Tom, K., 1140<br />
Watman, N. See Woo, Jannie<br />
Watson, Anita See Halloran, Stephen P.<br />
Watson, I. D. See Elliot, K.; Mcintosh, S. J.<br />
-; Langen, C. F.; Stewart, hi. J., 1353<br />
-; Clarke, M.; Stewart, hi. J.; Lindsay, G.;<br />
Talwar,D., 1354<br />
Watts, Nelson B., 1236<br />
Wauters, C. See Pallet, D. F.<br />
Weaver, K. See Wang, Tang Jang<br />
Webb,<br />
Webb,<br />
G. See Berk, Lee<br />
Gary; Beierle, F.; Berk, L.; Hillock, K.;<br />
Eby, W., 1097<br />
Weber, J. A.; van Zanten, A. P., 2143<br />
Weber, Jean-Philippe See Menca, Dma<br />
Weber, T. H. See Svens, Elvor<br />
Weeks, Marilyn See Gross, Susan F.<br />
Wegfahrt, P. See Fitzgerald, D.<br />
Wei, J. S.; Huang, H. M.; Shyu, W. C.; Wu, C. S.,<br />
2247<br />
Wei, Jeng S. See Yeh, Chau-Ting<br />
Weiber, H. See Abrahamsson, P.-A.<br />
Weldemenn, Gerhard See Baja, Rsnze<br />
Weiffenbach, Barbara See Green, Philip<br />
Weinberger, I. See Rotenberg, Z.<br />
Weinberger, Itzhak See Rotenberg, Zvi<br />
-; Fucha, Jacob; Rotenberg, Zvi; Davidson,<br />
Ehud; Hard, Daniels; Agmon, Jacob, 414<br />
Weiner, E. J. See Karge, W. H.<br />
Weingand,<br />
Weiskittel,<br />
Kurt; Hudson, C., 1134<br />
P. See Schroeder, Timothy J.<br />
Weissbecker, Karen A.; Gruemer, Hans-Dieter;<br />
Heard, Gregory S.; Miller, W. Gregory;<br />
Nance,<br />
Welssman,<br />
Walter F.; Wolf, Barry, 831<br />
Amir See Krivoy, Norberto<br />
Welch, Robin See Demka, Paul R.<br />
WelIby, Maurice I See Nicolson, Ruth F.<br />
Wellington, P. See Vroon, D. H.<br />
Wellington, Pat See Miceli, J. N.<br />
Wellmen, Maria See Schiele, Frencaise<br />
Wells, David; Ranks, B.; Rhodes, M., 1165<br />
Wells, David J.; Barnhill, Matthew T., Jr., 2241<br />
Wenoker, Marion; Hauptiorenz. Susanne;<br />
Willi; Puschendorf, Bernd, 1519<br />
Moll,<br />
Wenhain, Philip K.; Barboun, Heather M., 895<br />
Wenk, K. K. See Lustgarten, J. A.; Sundaram,<br />
ShanG.<br />
Wenk-Salamone, K. See Kaseman, Deborah<br />
Wermeling, J. it; Pruemer, J. hi.; Sigmund, D.;<br />
Peace, A. J., 1182<br />
Wermeling, Joseph K.; Pruemer, Jane hi.;<br />
Hassan, F. Michael; Warner, Ann; Peace,<br />
AmadeoJ., 1011<br />
Werneke, Debra K.; Elliot, K. L.; Bray, K. R.,<br />
1078<br />
Werner, Ernst K. See Fucha, Dietmar;<br />
Reibnegger, Gilbert<br />
Werner, Mario; Steinberg, William M.; Pauley,<br />
Carol, 967<br />
Werner-Felmayer, Gabriele See Reibnegger,<br />
Gilbert<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2361
Weasels, Hans See Fischer, Johan<br />
West, William H. See Oldham, Robert K.<br />
Weston, R See McConway, M. G.<br />
Weston, S. See Hughes, J.; Neelkanten, N. V.<br />
Wevers, K. A. See de Jong, J. G. N.<br />
Weykamp, C. W.; Pendera, T. J.; Schmidt, N. A.;<br />
Borburgh, A. J.; van de Galseyde, J. F.;<br />
Wolthers, B. J., 2281<br />
Whaley, Tammy See Painter, Pennell<br />
Wheng, F. See Ryder, K.<br />
Wheatley, U. See Fraser, W. D.<br />
Wheeler, W. S. See Castalleni, William J.<br />
Whelan, Vern C. See Prabhakaran, Victor M.<br />
Whitaker, Katrine B. See Moss, Donald W.<br />
-; Cox, Timothy hi.; Moss, Donald W., 86<br />
White, G. H. See Dilena, B. A.<br />
White, Paul F., 1056<br />
White, Robert M. See Fringe, Christopher S.<br />
White, Y. See Wu, Yih-Shiong<br />
Whiteley, 0. See Dekubu, S.<br />
Whitley, Chester B.; Ridnour, Michelle D.;<br />
Draper, Karl A.; Dutton, Cheryl M.; Neglia,<br />
Joseph P., 374<br />
-; Draper, Karl A.; Dutton, Cheryl hi.; Brown,<br />
Patrice A.; Severson, Suzanne L.; France,<br />
Laura A., 2074<br />
Whltlow, Karen See Harkness, Dianne<br />
Wiana, Frank H., Jr. See Jones, Christopher E.<br />
Widener, J. See Mauck, Linda<br />
Wiebe, Donald See Tee, Martins<br />
Wiebe, Donald A. See Hassemer, David J.;<br />
Lensmeyer, Gary L.<br />
Wieland, C. See Renz, hi.<br />
Wielinger, H.; Leinberger, K.; Zimmermann, 0.,<br />
1161<br />
Wleme, Roger See Delange, Joris<br />
Wieme, Roger J. See De Buyzere, Marc L.<br />
Wientjes, M. Guillaume See Au, J. Lai-Sim<br />
Wieringa, G. K.; Crawford, A., 2146<br />
Wiernik, M.D. See Catanzariti, P. A.<br />
-; Catanzaniti, P. A.; Swanson, B. N., 1119<br />
Wiese, David A.; Bowen, Thomas P.; Kost,<br />
Gerald J., 1098<br />
Wiese, Wendy A. See Arnold, Lyle J., Jr.<br />
Wiesner, D. See Scheffel, J.<br />
Wijnends, J. B. 0.; Esajas, hi.; Egberts, J., 706<br />
Wijono, Mercy, 1177<br />
Wilber, Laura See Hassemer, David J.<br />
Wilbur, Stephen See Tilzer, Lowell L.<br />
Wilcken, U.K. I See Wang, X. L.<br />
Wilcox, M. See Nordin, B. E. C.<br />
Wild, Christopher P. See Degan, Peolo<br />
Wilde, C. K. See Brocklehurst, D.<br />
Wilding, Peter See Kricka, Larry J.; Press,<br />
Richard D.; Remaley, Alan T.<br />
Wilkins, Martin It. See Lewis, Helen M.<br />
Wilkinson, J. 8. See Auliuchan, J. P.<br />
Wilkinson, Stephen P. See Fraser, Cailum G.<br />
Willey, Steven See Chasnoff, Ira J.<br />
Williams, Barbara See Wang, Hann-Ping<br />
Williams,<br />
Williams,<br />
Bernadine K. See Yeo, Kiang-Teck<br />
John; Williams, Katherine hi.;<br />
Marshall, Thomas, 206<br />
Williams, Katherine M. See Williams, John<br />
Williams, M. See Klukaa, C.; Leonard, H.<br />
Williams, Michael; Villa, B.; Ray, F.; Cheng, S.;<br />
Haden,B., 1132<br />
Williams, 0. Dale See Bachorik, Paul S.<br />
Williams, K. K. See Wu, Lily L.<br />
Williams, Roger K. See Wu, Lily L.<br />
Williamson, Janice; Bing, David H., 1208<br />
Williamson, Jerry; Borum, Peggy R., 1161<br />
Williamson, Robert, 2165<br />
Wifinow, P. See Kessler, Anne-Ch.<br />
Wills, MR. See Felder, K. A.; Hewitt, C. D.;<br />
Winborne, K.<br />
Wills, Michael R. See Bruns, David E.; Herold,<br />
David A.; Nicholson, James K. P.<br />
Wilson, H. K. See Cocker, J.<br />
Wilson, Howard See Spiehier, Vine<br />
Wilson, John M.; Hoch, K.; Blake, J.; Lindsay,<br />
W.; Smith, F., 1178<br />
Wilson, I See Wu, James T.<br />
Wilson, Pamela See Stain, Even A.<br />
Wimmer,<br />
Wimmer,<br />
C. See Peltyszyn, Stephanie<br />
Cathy; Alexander, L.; Mercer, W.;<br />
Noun, N.; Tizia, T., 1207<br />
-; DiPaola, J.; hiercer, W.; Noun, N.; Salinas,<br />
R., 1207<br />
Winarte, Handeni See Demko, Paul R.<br />
Winborne, K.; Nicholson, J.; Savory, M. G.;<br />
Hewitt, C. D.; Wills, hi. K.; Savory, J., 1114<br />
Windy, Carl L. See Sportsman, J. Richard<br />
Winkel, Per, 1595<br />
Winkles, J. W.; Lunec, J.; Gray, L., 303<br />
Winn, C. I See Moorman, Stacy<br />
Winters, Geyle I See Braithwaite, Susan S.<br />
Winters, Robert K. See Young, Karen K. V.<br />
Wisdom, G. Brian See McDowell, Ian F. W.<br />
Wlsmett, Dorothy K. See Weller, Kathy V.<br />
Witherapoon, lit; Shuler, S. E.; Neely, H.;<br />
Soonemaker, R.; Alyea, K.; Gilbert, S.; Baird,<br />
F., 1191<br />
Witte, U. I; Angstadt, D. S.; Schweitzer, J. K.,<br />
1148<br />
Wittliff, James L. See Pasic, Resad<br />
Wolf, Barry See Weissbecker, Karen A.<br />
Wolf, Bryan A. See Bodor, Geze; Myrtle, James<br />
F.<br />
-; Daft, Michael C.; Koenig, John W.; Flye, hi.<br />
Wayne; Turk, John W.; Scott, Mitchell G.,<br />
120<br />
Wolthers, B. J. See Weykamp, C. W.<br />
Wang, B. See Lauderdale, V.<br />
Wang, K. See Freeman, J.<br />
Wong, H. T. See Cheng, Mary H.; Huang, W. T.<br />
Wang, Jonathan See Harris, Heather M.<br />
Wong, M. M. See Hong, X. Q.<br />
Wang, P. Y.; Mee, A. V.; Sun, C.; Hofman, K.;<br />
Taylor, G.; Uchimaru, D.; Alspector, F., 1195<br />
Wong, Steven H. Y., 1240, 1293<br />
Wang, T.; MacKenzie, A., 1110<br />
Wong, William H., 1115<br />
Woo, Charles; Trujillo, G.; Cook, G.; Calaniunci,<br />
K.,1172<br />
Woo, Jannie See Smith, Joyce E.<br />
-; Haskins, C.; Oppenheimer, J.; Watman, N.;<br />
Rokahr, B.; Marsh, K., 1122<br />
Wood, Amanda See Renouf, Judith A.<br />
Wood, J. See Cornelison, L.; Houts, Robyn<br />
Woodheed, J. Stuart See Beaman, Janine hi.<br />
Woods, John K. See Glick, Melvin R.<br />
Woroniecka, Ursznle D. See de Haen, Karen E.<br />
C.<br />
Worthy, Tom See Hollander, Lan; Inloes, Roger;<br />
Klonizchii, Walt<br />
Worton, Ronald G., 519<br />
Wortsman, Jacobo; Papadimitriou, Dimitri C.;<br />
Barges, Marietta; Defesche, Charles L., 90<br />
Wreghitt, T. G. See Monk, J.<br />
Wrenberg, A. See Leaky, Fred D.<br />
Wright, K. See Burrows, KeriLyn C.<br />
Wright, Reba K.; Burrows, K.; Baherji, hi.;<br />
Slaby,R., 1170<br />
Wu, A. See Rosano, Thomas<br />
Wu, Alan H. B., 7<br />
-;Gornet,TerrieG., 1121<br />
-; Gornet, Ternie G.; Marker, Carol C.; Chen,<br />
Hui-Li, 1752<br />
Wu, C. S. See Wei, J. S.<br />
Wu, J. T. See Pearson, Stephen D.<br />
Wu, James T. See Pearson, Stephen D.; Wu, Lily<br />
L.<br />
-; Pieper, Robert K.; Wu, Lily H.; Peters,<br />
Jeffrey L., 778<br />
-; Ream, Linda; Miya, Terry, 1100<br />
-; Wilson, L.; Christensen, S., 1152<br />
-; Bringhurst, Cony, 1196<br />
Wu, Lai Wen; Wang, Yue Hue.<br />
Wu, Lily H. See Wu, James T.<br />
1355<br />
Wu, Lily I; Streeter, B.; Williams, R. R.;<br />
Lalouel, J.-M.; Wernik, K., 1071<br />
-; Wannick, G. Russell;Wu, James T.; Williams,<br />
Roger R.; Lalouel, Jean-Marc, 1486<br />
Wu, T..W. See Yiu, Samuel C. K.<br />
Wu, Wen-Guey See Kuo, Cheng-Deng<br />
Wu, Yih-Shiong; Bohannon, J.; White, V.; Cecil,<br />
hi.; Butler, S.; Simmons, M.; Sine, H. E.,<br />
1119<br />
-; Cecil, hi.; Bohannon, J.; Simmons, hi.; Sine,<br />
H.E., 1154<br />
Wyatt, David T.; Lee, Martha; Hillman, Richard<br />
E., 2173<br />
Wynn, Annette; Solomon, Judy, 1088<br />
Xander, S. A. See Kubasik, N. P.<br />
Yabuuchi, Masahiko; Masuda, Minoru; Katoh,<br />
Kazuo; Nakamura, Tsuneo; Akanunia,<br />
Hiroshi, 2039<br />
Yadegari, P. See Ensano, Thomas<br />
Yogi, Gohei See Matsumoto, Kojiro<br />
Yakata, Minoru See Kuwana, Tomomi<br />
Yamada, Akefumi See Osawa, Hisao<br />
Yameda, Nobuhiro See Ishibashi, Shun<br />
Yamaguchi, Akihiro; Fukushi, hiasaru;<br />
Mizushime, Yoshikiyo; Shimizu, Yoshia;<br />
Takasugi, Nobuo; Arashima, Shin-ichiro;<br />
Ohyanagi, Kazuhiko, 1962<br />
Yamaguchi, Shuichi; Koda, Naoya; Yamamoto,<br />
Hideaki, 1806<br />
Yamaji, T. See Hosoda, K.<br />
Yameinoto, Hideaki See Yamaguchi, Shuichi<br />
Yamemoto, Katsunobu See Maruta, Kazuhiro<br />
Yamamoto, M. See Sonin, T.<br />
Yanianashi, H. See Mizuochi, E.<br />
Yamartino, E. J., Jr. See Grenner, G.<br />
Yamasaki, Masabiko; Uemura, M.; Okaniwa,<br />
K., 1187<br />
Yamashita, Sumiko See Abe, Akira<br />
Yang, Chi-Faug See Ting, Stanford W.<br />
Yang, Xiu Ying See Elm, Ronald J.; Hoeseini,<br />
Jeanette hi.<br />
Yang, Yi-Peng See Geng, Jian-Guo<br />
Yanko, J. See Bittikofer, J. A.<br />
Yannelli, John K. See Oldham, Robert K.<br />
Yassinzadeh, Z. See Gibbons, I.<br />
Yatscoff, K. See Copeland, Kenneth<br />
Yatscoff Randall W. See Copeland, Kenneth K.<br />
Yea, G. K. See Caines, Patrick S.<br />
Yeb, Chau-Ting; Wei, Jeng S.; Liaw, Yun-Fan,<br />
1684<br />
Yein, Fred See Leeder, Sydney<br />
Yen, Shing-Erh See Shah, Vipin D.<br />
-; Shimizu, K.; Shah, V., 1121<br />
Yentur, Gulderen See Town, Meral<br />
Yea, Kiang-Teck See Horowitz, Gary L.<br />
-; Diamond, Constance; Williams, Bernadine E.;<br />
Horowitz, Gary L., 1093<br />
Yea, Klang-Teck; Traverse, Willi ,Horowitz,<br />
GaryL., 1504<br />
Yeung, V. T. F. See Cheung, C. K.<br />
Yip, Tal-Tung See Hutchens, T. William<br />
Ylu, Samuel C. K.; Wu, T.-W.; Levy, 0. A.; Au,<br />
J.-X.; Phillips, hi. J., 1137<br />
Yoder, J. M. See Fredrickson, K. A.<br />
Yoshida, Toshihiko See Kunoiwa, Ketsumasa<br />
Yoshida, Yuklo See Naksahima, Kaji<br />
Yoshlkawa, Chikao See Shimojo, Nobuo<br />
Yoshikawa, Kezuaki; Tanaka, K.; Shibate, H.,<br />
1082<br />
Yoshino, Funno See Osewa, Hisao<br />
Yosbinoya,<br />
Yoshloka,<br />
Sadayoshi See Mashige, Fumiko<br />
Shinichi; Kawajini, Yoshiko; Higashi,<br />
Yasuko; Tsukada, Yutaka, 1175<br />
Yost, D. A. See Dolan, P. A.<br />
Young, C. C. See Demko, Paul K.<br />
Young, G. P. See Rose, L S.<br />
Young, Karen K. Y.; Winters, Robert F.; Peter,<br />
James B., 1076<br />
Young, Keith See Zoccoli, Michael A.<br />
Young,<br />
Yousef,<br />
Maitland See Chou, Peter P.<br />
Mohammed A. See Lambert, Willy F.<br />
Yu, Gordon See Hirsch, Carl<br />
Yuen, M. See Aw, T. C.<br />
Yuki, Hidetake See Matsumoto, Kajiro<br />
Zecharieli, N.Y.; Lee, C.; Cheek, J. H.;<br />
Chakmskjian, Z. H.; Mukharjee, A., 1080<br />
Zadik, Zvi See Stnasbunger, Christian<br />
Zahradnik, Richard See Pilot, Robert L.<br />
-; Brennan, George; Hutchison, James S.; Odd,<br />
William D., 804<br />
Zak, B. See Artiss, J. D.; Batason, J. F.<br />
Zak, Bennie See Bateson, Joseph F.<br />
ZaIIIbOnI, Robert See Tagari, Philip<br />
Zen, Geraldine Tue See Staples, Mark<br />
-; Staples, Mark; hiurthy, H. hi. 5., 1093<br />
Zapoticznyj, W. See Lasky, F. D.<br />
Zarembka, F. F.; Koller, D. F.; Plotka, E. D., 143<br />
Zarnil, Batya See Strasburger, Christian<br />
Zaunczkoswki, Denise; Rosenfield, H.;<br />
Kaufman, K. A., 1129<br />
Zeltvogel, Christine See Brashear, Jeff<br />
Zheng, M. See Broyles, Celeste<br />
Zhichu, Cui, 630<br />
Thong, Li-Ming See Geng, Jien-Guo<br />
Zibrat, Steven J.; Halt, John A.; Ryan, Diane F.;<br />
Russell, John C.; Cooper, Carol hi.; Moewad,<br />
Atef H., 1107<br />
Zic, V. See Fu, Paul<br />
Ziegenhorn, J. See Karl, Johann; yogI, 5. W.<br />
Zijlstra, W. G. See Kwent, G.<br />
Ziinmer, Etan L See Knivoy, Norberto<br />
Zimmermann,<br />
Zimmermann,<br />
G. See Wielinger, H.<br />
Linda; Lin, Yuh-Nen; Dummel,<br />
Robert; Huchital, Michael; Sheiman, Mark;<br />
Dunka, Louis, Jr., 1172<br />
Zoccoli, Michael A. See Picone, Teresa<br />
-; Young, Keith; Katz, Paula; Lynch, Braden;<br />
Manning, Wayne; Kbanne, Pyare, 1095<br />
Zoccoli, Mike See Inloes, Roger<br />
Zoha, Steven J.; Neelkantan, N. V.; Lau, H. P.;<br />
Masulli, I. S.; Spaven, F. F.; Tuhy, P.M.;<br />
Fanner, M. G., 1202<br />
Zoppo, A. See Marcovina, Santica<br />
Zuccbelli, G. C. See Pilo, A.<br />
-; Clenico, A.; Dc Mania, K.; Pilo, A.; Masini, S.;<br />
Caroli, A.; Brando, B., 1155<br />
Zwart, Albert; Heerspink, W., 1163<br />
Zweig, M. H. See Csako, G.<br />
Zweig, Mark See Huang, C. hi.<br />
Zweig, Mark H. See Cseko, Gyorgy<br />
2362 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
Volume 35, 1989<br />
SUBJECT INDEX<br />
A, abstractof meetingpaper<br />
CR,casereport<br />
CC,caseconference<br />
E, editorial<br />
H, history<br />
KEY TOABBREVIATiONS<br />
L, letter<br />
0, opinion<br />
obit, obituary<br />
A, review<br />
S,symposiumpaper<br />
SN,scientificnote<br />
SR,special report<br />
TB, technical brief<br />
AACC<br />
See also History<br />
AACC award winners, 1989,1565<br />
41st natL mtg., abstracts of papers, 1065<br />
41st netL mtg., industry-sponsored workshops,<br />
1242<br />
41st natL mtg., plenary session, 1048<br />
41st natl. mtg., roundtables, 1225<br />
41st natl. mtg., scientific program, 1045<br />
41st natl. mtg., selected topics, 1232<br />
41st natl. mtg., symposia abstracts, 1049<br />
41st natL mtg., workshops, 1211<br />
Abused drugs<br />
activation energies detd. for drugs of<br />
abuse-their use in projecting product shelflife<br />
(A), 1180<br />
adaptation of drugs of abuse testing to<br />
Synchron CX#{149}4 and CX’5 cm. analyzers<br />
(A), 1178<br />
adaptatian of Syva assays for drugs of abuse on<br />
the Olympus Reply lab, analyzer (A), 1174<br />
adaption of Syva EMIT d.a.u.n assays to the<br />
570 Alliance cm. chem. analyzer (A), 1170<br />
edulterants intended to cause false negatives in<br />
urine screens for marijuana or cocaine use<br />
(A), 1175<br />
amphetamine, methamphetamime quant.<br />
confirmation procedure by GCIMS (A), 1169<br />
anal. of cocaine metabolitas in urine:<br />
comparison of TDx FPIA cocaine metebolite<br />
assay with GCIMS (A), 1186<br />
benzodiazepines identified by capillary gas<br />
chrometog.-msss spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs., 1394<br />
calibrators containing 11-nor-9-THC-9-<br />
canboxylic acid for use with Syva EMIl’<br />
cannabinoid assays (A), 1173<br />
cocaine end pregnancy chin. end toxicoL<br />
implications fan the neonate(S), 1276<br />
cost-effective<br />
performed<br />
EMrr method for qual. d.e.u.<br />
on Cobas Mire (A), 1168<br />
delte-9-THC and delta-9-THC-canboxylic in<br />
serum by quant. GC/MS (A), 1170<br />
detection limit of the TDx fluorescence<br />
polarization immunoassay extended far<br />
benzoylecgonine in urine (SN), 2110<br />
detn. of cocaine metabolite, ecgonine methyl<br />
ester in urine, by gas chromatog. with N-<br />
selective detector (A), 1168<br />
development of EMil’ drugs of abuse assay for<br />
amphetamine/methamphetamine in urine on<br />
the ETS’5 system (A), 1180<br />
drug testing in sports-the 1988 Olympics end<br />
beyond (A), 1056<br />
emetine identified in urine by HPLC, with<br />
fluorescence and ultrevialet/diode array<br />
detection, in a patient with candiomyopethy<br />
(CR), 499<br />
EMIT convenient twa-reagent system for drug<br />
of abuse testing on most common chem.<br />
analyzers (A), 1167<br />
evain. of Abbott AD,” analyzer in traditional<br />
and nontraditional markets (A), 1174<br />
evaln. of Abbott MTD,’ drug anal, system (A),<br />
1185<br />
evaln. of Abbott TD, for drugs of abuse<br />
testing in a field environment (A), 1179<br />
evaln. of Boehninger Mannheim/Hitachi 717<br />
for routine drug of abuse testing (A), 1165<br />
eveln. of combined cocaine/opiate screening<br />
procedure on Abbott labs. TDx (A), 1165<br />
evaln. of screening method bias for five drugs<br />
of abuse classes (A), 1102<br />
evaln. of Syva EMIl’ d.a.u. appins. on 550<br />
Express (A), 1170<br />
evaln. of the TDx and ADx methadone<br />
immunoassays (TB), 1794<br />
evaln. of TLC technique for detection of<br />
opiates in urine (A), 1173<br />
evaln. of urine temp. measurement methods to<br />
screen urine specimens for drug testing (A),<br />
1181<br />
evaln. of vitreous fluid as a specimen for drug<br />
abuse testing (A), 1181<br />
five cannabinoid immunoassay systems<br />
compared at the screening threshold of 100<br />
ig/L (SN), 2241<br />
high-volume Syva EMIT drug testing on<br />
multiple Epoe analyzers interfaced to a<br />
central computer system (A), 1166<br />
improved GC/MS drug detection with chem.<br />
ionization mass spectrametry and ion trap<br />
detection (A), 1180<br />
intercornelations between direct and total<br />
plasma pyridoxal 5’ phosphate and social<br />
and therapeutic drug use, and health status<br />
(A), 1138<br />
interference of common household chemicals in<br />
immunoassays for drugs of abuse (SN), 648<br />
measurements of clonazepam and lorazepam<br />
by HPLC using solid-phase extn. (A), 1183<br />
mechanism of false-negative urine cannabinoid<br />
immunoassay screens by Visine’5 eyednaps<br />
(SN), 636<br />
(A), 1163<br />
melanin and other indole compds. do not cause<br />
false-positive cannabinoid assay results (L),<br />
1809<br />
methadone and thynoid-function tests (L),<br />
1807<br />
multiple drugs of abuse detection by FPIA<br />
using TDx reagent mixture (A), 1164<br />
performance characteristics of automated<br />
random-access analyzer Cobas Mira5 for<br />
measurement of drugs of abuse (A), 1097<br />
proficiency testing on drugs of abuse: one<br />
year’s experience in Spain (SN), 879<br />
rhabdamyolysis in a case of free-base cocaine<br />
(“crack”) overdose (CR), 1547<br />
status of drugs-of-abuse blind testing in urine:<br />
an AACC study (SR), 891<br />
use of GC/IRIMS for high-confidence identifn.<br />
of drugs (S), 1279<br />
use of Sentry’5 drug control in evaluating<br />
performance of TDx drugs of abuse<br />
screening near NIDA cutoff concns, (A), 1103<br />
Aceteminophen<br />
acetaminophen as substrate for peroxidase (A),<br />
1122<br />
enzymatic sahicylata and acetaminophen anal.<br />
on Monarch 2000 (A), 1185<br />
evaln. of serum acetaminophen and tricycic<br />
antidepressants assays on the Abbott AD,”<br />
drug detection system (A), 1102<br />
Acetoacetate<br />
kinetic mess, of ketone bodies (L), 1263<br />
multipoint kinetic simultaneous mess, of<br />
combined concns, of acetoecetate--<br />
hydnoxybutyrata and lactate-pyruvata (SN),<br />
1526<br />
Acetylated hemoglobin<br />
liq.-chnomatog. detn. of acetylated Hb, 33<br />
Acetylator phenotype<br />
simplified, rapid test for scetylator<br />
phenatyping by use of the peak height ratio<br />
of two urinary caffeine metabohites (SN), 848<br />
Acetylcholine<br />
immunoenzymometnic assay for antibody<br />
against human acetylchohine receptor using<br />
precoated microtitar plate and receptor<br />
isolated from normal leg muscle (A), 1196<br />
Acetylprocalnamide<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare IF”: detn. of serum N-<br />
acetylprocainamide, theophylline, and<br />
phenytoin (A), 1178<br />
Acidosis<br />
assessing metabolic acidosis (L), 338<br />
calculated HCO3- or total C02?, 1697<br />
effects of in viva and in vitro production of<br />
lactic acid on ionized, protein-bound, and<br />
complex-bound Ca in blood, 935<br />
“stat” measurements of L-lectate in whole<br />
blood and CSF assessed (SN), 1740<br />
Acid phosphatase<br />
characterization of 2,6-dichloro.4-nitrophenyl<br />
phosphate as a substrata for acid<br />
phosphatase (A), 1119<br />
detn. of acid phosphatase in serum with 2,6-<br />
dichloro-4-acetylphenyl phosphate substrata<br />
(A), 1117<br />
distribution of proetatic acid phoephatase in<br />
benign end malignant diseases determined<br />
by Magiwel’5 enzyme immunoassay (A), 1079<br />
evaln. of kinetic method for prostatic acid<br />
phosphatase with use of self-indicating<br />
substrate, 2,6-dichloro-4-nitrophenyl<br />
phosphate, 939<br />
factors affecting a cyanogen bromide-based<br />
assay of thiamin, 2173<br />
immunoessey of band 5 (“tantrate-resistent”)<br />
acid phosphatase involving use of antiporcine<br />
utarofernin antibodies, 86<br />
PAP and PSA as markers of proetatic<br />
carcinoma (A), 1191<br />
ref. intervals far two bone-derived enzyme<br />
activities in serum: bone isoenzyme of elk.<br />
phosphatase and tartrate-resistant acid<br />
phosphatase (TB), 180<br />
stabilizer effect on cancn. of serum pnostatic<br />
acid phosphatase (A), 1118<br />
Acquired immune deficiency syndrome<br />
See also HIV<br />
depressed activities of punine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
development of a confirmatory enzyme-linked<br />
iinmunosorbent assay for HIV-1 antibodies,<br />
946<br />
follow-up of monoclonal gammopathies in<br />
asymptomatic HI V-infected subjects (L), 338<br />
molecular probes used to detect<br />
cytomegalovinus and human<br />
immunodeflciency virus (5), 1581<br />
neoptarin mess. in serum, tissue culture<br />
supernatas by competitive enzyme-linked<br />
iinmunosorbant assay, 1467<br />
ohigoclonal bending detected by urinary<br />
protein electrophoresis and immunofixation<br />
in two patients with AIDS end proteinunia<br />
(CR), 1795<br />
ohigoclanal immunoglobulins in HIV infection,<br />
1669<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2363
quant. EIA for detn. of tumor necrosis factoralpha<br />
(A), 1187<br />
serum prealbumin levels in normal individuals<br />
of various age; and in patients with AIDS (A),<br />
1115<br />
serum Zn in homosexual men (L), 704<br />
specific routine detn. of 3’-azido-3’.<br />
deoxythymidine in plasma by<br />
semieutomated liq. chnamatog. (5), 1313<br />
urinary neopterin concns. vs total neopterins<br />
for chin, utility (SN), 2305<br />
Acromegaly<br />
somatotrapin as mess. by a twa-site timeresolved<br />
immunofluorometric assay, 913<br />
ACTH<br />
See Corticotropin<br />
Acute abdominal disease<br />
pancreatic amylase in serum for differential<br />
diagnosis of acute pancreatitis, acute<br />
abdominal diseases (TB), 2142<br />
Acute-phase proteins<br />
changes in serum acute-phase proteins in<br />
patients with dermatologic diseases (A), 1084<br />
Adamantyl 1,2-dioxetane phosphate<br />
chemiluminescent assay of alk. phosphatase<br />
applied in an ultrasensitive enzyme<br />
immunoassay of thyrotropin (A), 1190<br />
1441<br />
chemilumineacent enzyme immunoassay of a-<br />
fetoprotein with edamantyl dioxetane<br />
phenyl phosphate as substrate (SN), 2319<br />
Adenoelne<br />
adenosine and dopamine simultaneously deed.<br />
in urine by reversed-phase HPLC, with online<br />
meas. of uv ebsorbance end electrochem.<br />
detection, 64<br />
Adenosine deaminase<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
Adenosine kinase<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
Adhesion molecules<br />
cell and substrata adhesion molecules in<br />
embryonic end neural development (S), 738<br />
Adrenal disorders<br />
direct detn. of 4 sulfates and 7 glucunonides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” hiq. chromatog., 794<br />
Adrenergic receptors<br />
properties of the th- and 2-adrenergic receptor<br />
subtypes revealed by molec. cloning (5), 721<br />
Advanced analytical concepts<br />
See Oak Ridge Conference<br />
Affinity blotting<br />
monoclonal immunoghobuhins: affinity<br />
for law concne. in serum (SN), 478<br />
blatting<br />
Aflatoxins<br />
time-resolved fluoroimmunoassay of aflatoxins<br />
(SN), 2308<br />
Age-related effects<br />
See Sex- and age-related effects<br />
AIDS<br />
See Acquired immune deficiency syndrome,<br />
HIV<br />
Alanine aminotransferase<br />
ALT reagent with thionicotinamide adenine<br />
dinucleotide (S), 1857<br />
evaln. of the IFCC Ref. Method for alanine<br />
aminotransferase: spurious blank ALT acty.<br />
due to contamination of D-alanine with L-<br />
alanine; recommendations for a correction<br />
(SN), 153<br />
high alanine aminotransferase activities in<br />
plasma, hearts in patients with acute<br />
myocardial infarction, 279<br />
high.M, (“biiary”) isoenzyme of elk.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
mess. of glutathione S-transferase B1 in plasma<br />
after birth asphyxia: early indication of<br />
hepatoceilular damage, 995<br />
plasma glutathione S-transfersse and F protein<br />
are mare sensitive than alanine<br />
aminotransferase as markers of<br />
acetaminophen-induced liver damage, 2186<br />
ratio of serum aspartate to alanine<br />
aminotransferase as a prognostic index in<br />
pediatric liver disease (A), 1151<br />
system to standardize ALT cutoff actys. (A),<br />
1118<br />
Albumin<br />
accuracy of total protein and albumin system<br />
specific values for SMA, SMAC-3, RA-1000,<br />
Assist, and Demand compared with the ref.<br />
method far T. protein and a comparative<br />
method for albumin (A), 1104<br />
direct, indirect techniques for free thyraxin<br />
compared in patients with nonthyroidal<br />
illness. II. effect of prealbumin, albumin,<br />
tbyroxin-binding globulin, 1655<br />
effect of albumin on results for free-thyraxin<br />
index as estd. by total T4tF3 uptake ratio<br />
(L),706<br />
effect of serum albumin on displacement of<br />
phenytoin by ceftriaxone end nafcuilin (A),<br />
1176<br />
evaln. of immunochem. methods for detg. low<br />
cancns. of albumin in urine (A), 1209<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns. (CR), 333<br />
interaction between pyridine nucleotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme.linked enzymes (SN), 2129<br />
longitudinal study of thyroid function in<br />
pregnancy, 275<br />
law-normal cancns. of free thyraxin in serum in<br />
late pregnancy: physiol. fact, not tech.<br />
artefact,<br />
microplate<br />
1891<br />
mess, of urinary albumin,<br />
creatinine, 1371<br />
monoclonal antibodies evald. far use in<br />
screening far conjugates of human serum alb.<br />
and pyridoxal 5’-P04 (SN), 1756<br />
more on albumin end thyroid hormones (L),<br />
2017<br />
nonprotein components of urine interfere with<br />
colorimetry of urinary albumin with<br />
bromphenol blue (L), 336<br />
usefulness of data on albumin and prealbumin<br />
concns. in detg. effectiveness of nutrit., 271<br />
Albuminurie<br />
albuminunia and progression of diabetic<br />
nephropathy (A), 1237<br />
automated measurement of microalbuminunis<br />
with a microcentrifugal analyzer (A), 1084<br />
calorimetric screening method for<br />
microalbuminuria: intra-individual<br />
variability for untimed day specimens (L),<br />
2019<br />
high incidence of false-positive albuminurla<br />
results with the Micro-Bumintest’5 (TB),<br />
1252<br />
microelbuminuria in dlabetes mellitus: mare on<br />
urine storage and accuracy of calorimetry<br />
(L), 1560<br />
micnoalbuminuria in rats and humans (A),<br />
1137<br />
rapid assays far microalbuminunia on two<br />
analyzers (A), 1196<br />
screening for microalbuminuria in patients<br />
with diabetes: frozen storage of urine<br />
samples decreases their albumin content<br />
(SN), 308<br />
screening for microalbuniinuria with a rapid,<br />
low-cost calorimetric assay (SN), 456<br />
Albuterol<br />
albuterol: transdermal absorption and<br />
f’mgerprick blood-sample contamination<br />
from nebulizers (TB), 889<br />
Alcaptonurla<br />
homogentisic acid deed. in biol. fluids by<br />
}IPLC (SN), 321<br />
Alcohol<br />
See also Alcoholism, Ethanol<br />
alcohol detection by microdiffusion (L), 1269<br />
bedside diagnosis of alcohol intoxn. with a<br />
pocket-size breath-alcohol device: sampling<br />
from unconscious subjects and specificity for<br />
ethanol, 918<br />
differences between capillary and venous<br />
blood-alcohol concns. as a function of time<br />
after drinking, with emphasis on sampling<br />
variations in left vs right arm, 400<br />
serum mitochondrial aspartate<br />
aminotransferase acty.: not useful as marker<br />
of excessive alcohol consumption in an<br />
unselected population, 926<br />
Alcoholism<br />
liq.-chromstog. detn. of acetylated Hb, 33<br />
measurement of carbohydrate-deficient<br />
transferrin, biochem. marker for alcohol<br />
disease (A), 1109<br />
signif. of low serum urea N concns. (SN), 639<br />
Alkaline phosphetase<br />
elk. phosphatase acty. from osteosarcoma cell<br />
line SaOS-2: isoenzyme std. for quantifying<br />
skeletal elk. phosphatase acty. in serum, 223<br />
elk. phosphetese isoenzyme mystery (L), 707<br />
elk. phosphatase isoenzymes in plasma in<br />
hyperthyroidism, 1427<br />
alk. phosphatase isoenzymes of liver and bone<br />
origin are incompletely resolved by wheatgerm-lectin<br />
affinity chromatog., 29<br />
elk. phosphatase of possible renal origin<br />
identified in plasma after colchicine overdose<br />
(L),702<br />
biliary elk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-cellulose:<br />
appin. to detection of hepetobilisny diseases,<br />
1684<br />
chemiluminescent assay af elk. phosphatase<br />
applied in an ultrasensitive enzyme<br />
immunoassay of thyrotropin (A), 1190<br />
chemiluminescent substrates far elk.<br />
phosphatase: application to ultrasensitive<br />
enzyme-linked immunoassays and DNA<br />
probes (A), 1201<br />
(S), 1863<br />
conflicting results of liq.-chromatog. detns. of<br />
elk. phosphatase isoenzymes (L), 2255<br />
differences between alk. phosphatase activities<br />
in serum end lyophilized controls in AMP<br />
buffer explained (L), 510<br />
effect of Triton X-100 an pptn. of biiary<br />
phoephatase by wheat-germ lectin (L), 513<br />
evaln. of a photometric assay for detn. of<br />
human bone elk. phosphatase (A), 1089<br />
high-M, (“biiery”) isoenzyme of elk.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
hypomagnesemia and low elk. phosphatase<br />
acty. in patients’ serum after cardiac surgery<br />
(SN), 664<br />
identn, of Salmonella app. with an alkaline<br />
phosphatase-labeled oligonucleotide probe:<br />
comparison with standard biochem. identn.<br />
techniques<br />
measurement<br />
(A), 1075<br />
of elk. phosphatase acty. by<br />
Kodak Ektachem 700 XR analyzer compared<br />
with other routine anal, methods (TB), 328<br />
ref. intervals for two bone-derived enzyme<br />
activities in serum: bone isoenzyme of alk.<br />
phosphatase and tartrate-resistent acid<br />
phosphatase (TB), 180<br />
short- and long-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
siahidase from different sources compared for<br />
electrophoretically sepg. serum elk.<br />
phosphatase fractions from liver end bone<br />
(SN), 1955<br />
Stratus automated creatine kinase-MB essay<br />
evald.: identn. and eliinn. of falsely increased<br />
results assocd. with a high-M, form of elk.<br />
phosphatase, 2048<br />
sugar-chain anal, of elk. phosphatese by lectin<br />
affinity chromatog. in serum from a patient<br />
with oeteosancoma (TB), 179<br />
Alkaptonuris<br />
anal. far homogentisic acid by NMR<br />
spectrometry<br />
(L), 1806<br />
on diagnosis of alkaptonunie<br />
Allergy<br />
mess, of urinary leukatnienes by reversedphase<br />
hiq. chromatog. and RIA, 388<br />
response of allergic and normal persons to<br />
sulfiting agents in wine: detn. of urinary<br />
thiosulfeta excretion (TB), 1792<br />
Aluminoxamine<br />
indirect mess, of deaferniaxamine<br />
chelated cmps. aluminoxamine<br />
and its<br />
and<br />
fernioxamine by Zeeman at. absorp.<br />
spectrom. (SN), 884<br />
Aluminum<br />
critical appraisal of methods for Al-monitoring<br />
program (A), 1114<br />
electrothermal at. absorp. spectrom. detn, of<br />
Al: serum matrix effects eliminated (SN),<br />
1517<br />
micro-quantity tissue digestion for metal<br />
measurements by use of a microwave aciddigestion<br />
bomb (SN), 488<br />
Alxheimer’s disease<br />
detn. of physostigmine in plasma and CSFby<br />
hiq. chnamatog. with electrochem. detection<br />
(SN), 292<br />
American Board of <strong>Clinical</strong> <strong>Chemistry</strong><br />
See ABCC<br />
Amidolytic activity<br />
functional, immunolog. of a2-<br />
cancns.<br />
macroglobulin compared in plasma of<br />
subjects without ai-protease inhibitor<br />
defIciency<br />
Amikacin<br />
(SN), 1535<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare II” analyzer; detn, of serum<br />
amikacin, gentamicin, and tobramycm (A),<br />
1178<br />
2364 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
Amino acids<br />
amino acid anal, for nutritional assessment by<br />
Pica-Tag HPLC: precision studies, ref.<br />
ranges, and correlations with ion-exchange<br />
method (A), 1113<br />
detn. of branched-chain amino acids and<br />
tynosine in serum in various hepatic diseases,<br />
and its chin, usefulness, 1399<br />
fully automated fluorescence assay far detg.<br />
total homocystaine in plasma, 1921<br />
new pitfall in plasma amino acid analysis (TB),<br />
178<br />
proton NMR studies of plasma to determine<br />
metab. status of patients with adult resp.<br />
distress syndrome (SN), 667<br />
therapeutic agents affecting amino acid<br />
chrometograms (TB), 1999<br />
Aminolevulinic acid<br />
i-aminalevulinic acid in plasma by free amino<br />
acid anal. (TB), 1998<br />
Anilnotransferases<br />
See also specific enzymes<br />
modified IFCC reagents for ALT and AST<br />
tasting on Ciba Corning 550 Express (A),<br />
1118<br />
serum apo-aminotransferases reassociate<br />
equally well with pyridoxal 5’-P04 in water<br />
or buffer (TB), 1790<br />
Amiodarone<br />
amiodarone and the thyroid function (R), 1882<br />
Ammonia<br />
evaln, of Abbott hiq. NH3 assay (A), 1103<br />
Amniotic fluid<br />
amniotic fluid lameilan bodies characterized by<br />
resistive-pulse counting: relation to measures<br />
of fetal lung maturity, 612<br />
eveln. of PG-Numeric’S test for semiautomated<br />
anal, of phosphatidylglycerol in<br />
amniotic fluid (A), 1072<br />
improved staining of thin-layer chnomatognams<br />
of amniotic fluid phosphohipids (TB), 1539<br />
IMx’5 AFP, automated microparticle<br />
immunoassay far AFP: performance<br />
characteristics and chin, studies (A), 1192<br />
multicenter evaln. of TDx test far assessing<br />
fetal hung maturity, 1005<br />
phospholipid surface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal, of the value of pptn. with cold acetone,<br />
800<br />
tumor markers in seminal plasma and amniotic<br />
fluid (A), 1079<br />
Amperometry<br />
See also Ehectrochemical detection<br />
“stat” measurements of L-lactata in whole<br />
blood and CSF assessed (SN), 1740<br />
Amphetamine<br />
AD,.” amphetamine class assay (A), 1174<br />
amphetamine, methamphetamine quant.<br />
confirmation procedure by GC/MS (A), 1169<br />
development of drugs of abuse assay for<br />
amphetaniine/methamphetamine in urine on<br />
the El’S”' system (A), 1180<br />
false-positive urine amphetamine screen with<br />
ritodnine (TB), 1542<br />
ranitidine and high concns. of<br />
phenyh,pnapanolamine cross react in the EMIT<br />
manaclonal<br />
amphetamine/methamphetamine assay<br />
(TB), 1998<br />
relative operating characteristic curves used to<br />
compare drug screening immunoasseys<br />
amphetamine and methamphetamine<br />
for<br />
(A),<br />
1175<br />
Amylase<br />
a-amylase detn. with the Reflotron reagent<br />
carrier system: use of whole blood, plasma,<br />
and serum, and effect of isoenzymes (SN),<br />
317<br />
anal, of a.amylase isoenzymes by automated<br />
isoelectric focusing (SN), 2116<br />
diagnostic value of measuring pancreatic hipase<br />
and the P3 isoform of pancreatic amylase<br />
isoenzyme in serum of hospitalized<br />
hyperamylasemic patients, 417<br />
effect of forced diuresis on urinary excretion of<br />
pancreatic amylase (A), 1127<br />
hyperamylasemia and a-amylase isoenzymes in<br />
acute liver congestion due to cardiac<br />
circulatory failure (TB), 1793<br />
immobilized anti-salivary amylase antibody<br />
interacts with macroamylases: implications<br />
for use in a pancreatic amylase assay to<br />
distinguish niacroamylasemia from acute<br />
pancreatitis, 1651<br />
immunocatahytic assay af pancreatic a-amylase<br />
in serum and urine with a specific<br />
monoclonal antibody (SN), 662<br />
immunolog.-derived pancreatic amylase,<br />
pancreatic hpase, and total amylase<br />
compared as predictors of pancreatic<br />
inflammation (TB), 1542<br />
measuring canboxypeptidase A acty. with a<br />
centnif. analyzer: anal, and chin.<br />
considerations, 251<br />
mechanism of action of pancreatic end salivary<br />
a-amylase on 4,6-ethyhidene-a-4-<br />
nitraphenylmaltoheptaoside substrate (L),<br />
methodoL and din. multicenter evaln, of<br />
specific pancreatic a.amylase assay based on<br />
a double monoclonal antibody technique (A),<br />
1090<br />
methods compared for detg. total ecty. and<br />
isoenzymes of amylase in serum (SN), 645<br />
pancreatic amylase in serum for differential<br />
diagnosis of acute pancreatitis, acute<br />
abdominal diseases (TB), 2142<br />
pancreatic amyhase mess, in serum by use of a<br />
monoclonal antibody immunochem.<br />
immobilized to a solid phase, 110<br />
pancreatic isoamyhase: direct assay based on<br />
efficient capture by a monoclonal antibody<br />
(A), 1123<br />
performance of Reflotron amylase and<br />
biirubin test methods in two physicians<br />
office labs. (A), 1093<br />
Reflotron amylase: eveln. of new dry-chem. test<br />
for the Reflotron (A), 1096<br />
serum P.amylase detn. using monoclonal<br />
antibody (A), 1127<br />
staining method for use in electrophoretic<br />
detn, of amylase isoenzymes in serum (SN),<br />
2322<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
time-resolved immunofluorometric assay of<br />
human pancreatic amylase in serum (A),<br />
1117<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamylase in serum, with use of<br />
two monoclonel antibodies, 1915<br />
urine appln. far Abbott Spectrum and VP<br />
using Abbott hiq. amylase reagent (A), 1102<br />
Amyloid A<br />
confusion of apolipoprotain E phenotyping by<br />
serum amyhoid A (TB), 671<br />
Anaesthesia<br />
morphine monitoring for an anaesthesia pain<br />
service (A), 1182<br />
Analgesic drugs<br />
newer approaches in management of acute pain<br />
(A), 1056<br />
Analytical error<br />
See also Variation, source of<br />
acceptable anal. error: different opinion (L),<br />
1553<br />
alpha-fetoprotein assay and abnormal values<br />
(A), 1157<br />
characterization of sulfasalazine’s interference<br />
in mess. of conj. bihirubin with the Ektachem<br />
slide (SN), 1760<br />
choosing qual.-control systems to detect max.<br />
chin, allowable anal, errors, 284<br />
circulating antibodies to mouse monoclonal<br />
immunoglobulins caused false-positive<br />
results in two-site assay for alphafetoprotein<br />
(L), 2339<br />
citrate interference in assays of total Ca in<br />
serum (TB), 2140<br />
CK-MM interference with an<br />
immunoenzymometric method for quantn. of<br />
CK-MB in serum (L), 901<br />
CK-unrelatad serum component identified<br />
CK isoenzyme anal, using Helena Rep<br />
in<br />
system (A), 1117<br />
chin, important<br />
measurement<br />
interference of sulfasalazine<br />
of conjugated bilirubin by<br />
in<br />
Ektachem slide method (A), 1158<br />
counting errors: effect on immunoassay<br />
precision, 1362<br />
differences between elk. phosphatase activities<br />
in serum and lyophilized controls in AMP<br />
buffer explained (L), 510<br />
differences between values for plasma and<br />
serum in tests performed in the Ektachem<br />
700 XR analyzer, and evaln. of “plasma<br />
separator tubes (PST)” (SN), 151<br />
differentiating between sensitivity and limit of<br />
detection (L), 509<br />
disturbance of the detn, of Hb concn. in<br />
patients with high leukocyte counts (L), 515<br />
effect of measurement wavelength on<br />
fructosamine results (L), 1552<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerlex cortisol, Biodata testosterone (SN),<br />
641<br />
effect on results of temp. at which Reflotron#{149}<br />
strips are stored (L), 186<br />
effects of various serum proteins on quantn. of<br />
fructosamine (SN), 134<br />
estimation of true values in RhAs, 1680<br />
evaln, of Gilford <strong>Chemistry</strong> Control<br />
interference with the chloride method in the<br />
Beckman Synchron CX3 analyzer:<br />
cumulative effect of Br an Cl- results (TB),<br />
1538<br />
factitiously high Na activities in the<br />
Ektachem 400 awing to interferences by high<br />
gamma-globulin condos. (CR), 333<br />
falsely elevated hgG indices in CSF of<br />
plasmapheresed patients (A), 1158<br />
falsely hih values for serum testosterone by<br />
“direct’ assay (A), 1142<br />
false-positive urine amphetamine screen with<br />
ritodrine (TB), 1542<br />
hazard of commercial antiserum crossreactivity<br />
in monoclonel gammopathy eveln,<br />
(L),2016<br />
Indocyanine Green interference in the Kodak<br />
Ektachem detn, of total bihirubin (L), 899<br />
indole compounds do not cause false positives<br />
with the TDx cannabinoid assay (TB), 323<br />
interference of common household chemicals in<br />
immunoassays far drugs of abuse (SN), 648<br />
interference of coumarin therapy with the<br />
“Heptast” owing to declining prothrombin<br />
concns. (SN), 483<br />
interference of plasma expanders in detn. of<br />
total protein (TB), 2143<br />
interferences of human anti-mouse antibodies<br />
in mouse monoclonal antibody-based<br />
immunoassays (A), 1188<br />
interference with mess, of intact parathynin in<br />
serum from renal dialysis patients (TB),<br />
1543<br />
interlab. study of blood-gas anal.: dependence<br />
of Poi end pcce results on atmospheric<br />
pressure (SN), 1779<br />
investigation of protoporphyrin IX std.<br />
materials used in ecid-exth, methods;<br />
proposed correction for the millimolar<br />
absorptivity of protoporphyrin IX, 1601<br />
labile enzyme in fresh serum interferes with<br />
assay of carboxypeptidase N (TB), 177<br />
mechanism of false-negative urine cannabinoid<br />
immunoaasay screens by Visine”' eyedrops<br />
(SN), 636<br />
(A), 1163<br />
more on “hook effects” in immunometric<br />
assays for prostate-specific antigen (L), 1262<br />
multi-factor designs. II. design for identifying<br />
instruments with sample-to-sample<br />
carryover end drift (SN), 2118<br />
murine monoclonel antibody adsorbed onto<br />
vinylidene j’luanide floccules used to<br />
eliminate antibody interference in<br />
“sandwich”-type immunoassays (SN), 1743<br />
nitromethane interferes in assay for creatinine<br />
by Jaff#{233} reaction (SN), 1772<br />
nonprotein components of urine interfere with<br />
calorimetry of urinary albumin with<br />
bromphenol blue (L), 336<br />
oxalate is overestd. in elk. unines collected<br />
during administration of HC032 with no<br />
specimen pH adjustment (SN), 2107<br />
quantn. of x-and X-containing<br />
immunoglobulins by rate nephelametry’.<br />
comparison of two comm. reagent antisera<br />
(A), 1198<br />
ranitidine and high concns. of<br />
phenylpropanolamine cross react in the EMIl’<br />
monoclonal<br />
amphetamine/methamphetamine assay<br />
(TB), 1998<br />
relative potency of commercial calibrators far<br />
fructosamine, and their effect on mess, of<br />
fructosamine in serum (L), 712<br />
reliable mess. of circulating immune complex<br />
depends on stable, accurate ref. material (L),<br />
1555<br />
serum Mg as effected by drugs (L), 506<br />
standard deviation errors in spreadsheet<br />
statistics (A), 1087<br />
standn. of a commercial (Boehniner<br />
Mannheim Diagnostics) enzymic method for<br />
cholesterol, 409<br />
technique-induced errors in two popular blood<br />
glucose reagent strips (A), 1156<br />
therapeutic agents affecting amino acid<br />
chromatognams (TB), 1999<br />
CLINICALCHEMISTRY, Vol.35, No. 12, 1989 2365
Anaphylaxis<br />
mess, of urinary leukotrienes by reversedphase<br />
liq. chromatog. and RIA, 388<br />
Androgens<br />
measurement of free testosterone and free<br />
androgen index by use of sex-hormonebinding<br />
globulin concns,<br />
(fluoroimmunoassay) in hirsutism (A), 1143<br />
plasma conjugated endrogens as digitalis-like<br />
factors ins dialysis-dependent male (A),<br />
1150<br />
Androstenedione<br />
1251RhA for androstenedione in serum end in<br />
blood-spot-samples from neonates, 1706<br />
Anemia<br />
reliability of detn, of whole-blood 02 affinity<br />
with blood-gas enalyzers and multiwavelength<br />
oximetars, 773<br />
Anglotensin-converting enzyme<br />
specific enzyme immunoassey for measuring<br />
new angiotensin-converting enzyme<br />
inhibitor, SQ 29,852, in plasma; comparison<br />
with SQ 29,852 RIA (A), 1190<br />
Animal models of disease<br />
See Veterinary chemistry<br />
Anion gap<br />
improved method for calcg. Ce fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
Antlarrhythmlc drugs<br />
amiodarone and the thyroid function (R), 1882<br />
entiarrhythmic drugs and the cardiac Na<br />
channel: current models (5), 748<br />
concurrent mess. of flecainide acetate and<br />
propranolol by normal-phase liq. chromatog.<br />
(SN), 857<br />
relevance of pharmecokinetics to monitoring<br />
new antiarrhythmics (S), 1332<br />
simultaneous deth. of lidocaine and its<br />
metabohite (MEGX), mexiletine,<br />
disopynimide, and quinidine in serum by<br />
HPLC (A), 1355<br />
Antibiotics<br />
See also specific antibiotic of interest<br />
estn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
Anticoagulants<br />
correction of instrument- and reagent-based<br />
differences in detn. of the int. normalized<br />
ratio fat monitoring anticoagulant therapy<br />
(SN), 840<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
simultaneous “sandwich” enzyme<br />
immunoassay for protein C using monoclonal<br />
antibodies (A), 1208<br />
specific RIA for measuring new thromboxane<br />
antagonist, SQ 30,741, in plasma (A), 1189<br />
Anticonvulsant<br />
antiepileptic<br />
drugs<br />
drug monitoring by FPIA and gas<br />
chromatography (A), 1208<br />
automated HPLC of anticonvulsants: cost<br />
assessment (A), 1353<br />
implications of near-patient testing at an<br />
anticonvulsant clinic (A), 1352<br />
simult, liq.-chnomatog. detn, of some<br />
bronchodilators, anticonvulsants,<br />
chioramphenicol, and hypnotic agents, with<br />
Chromosorb P columns used for sample<br />
prepn., 1615<br />
Antidepressants<br />
See also Tricyclic antidepressants<br />
issues in methodology and applns. for ther.<br />
monitoring of entidepressants (S), 1318<br />
new method for monitoring fluvoxamine in<br />
human plasma by HPLC with uv detection<br />
(A), 1185<br />
Antiepileptic drugs<br />
See Anticonvulsant drugs<br />
Antipyrine -<br />
antipyrine interferes with chem, detn. of Br m<br />
simultaneous estn. of total body H20 and<br />
extracellular H20, 1367<br />
Antlthrombin<br />
increased concns. of heparmn cofactar II in<br />
diabetic patients, and possible effects on<br />
thrombin inhibition assay of antithrombin<br />
111,52<br />
Antitrypsin -<br />
screening far deficiency of a,-proteinase<br />
inhibitor (SN), 1971<br />
Apolipoproteins<br />
adaptation of serum apolipoproteins A-h and B<br />
immunoturbidimetric assays<br />
737 Autoanelyzer (A), 1069<br />
on the Hitachi<br />
alpha slow-moving HDL subfraction in serum<br />
of a patient with radiation enteritis and<br />
peritoneal carcinosis (CR), 674<br />
apolipoprotein<br />
characterizing<br />
E isofarm anal. in<br />
atherogenic risk (A), 1235<br />
apolipoprotein E isoforms in patients with<br />
hypertrophic candiomyapathy (A), 1070<br />
epolipoprotein E phenotype deed. by agarose<br />
gel electrofocusing, immunoblotting, 2070<br />
candidate Ref. Method for measurement of<br />
apolipoprotein B-100 evaln. of a<br />
monoclonal-antibody-based enzyme-linked<br />
immunosorbent assay (A), 1073<br />
calorimetric detn. of non-enzymaticaily<br />
glyceted spolipoprotein B (A), 1074<br />
comparative measurements of apohipoprotein<br />
B by immunonephelometry and radial<br />
immunodiffusion (A), 1069<br />
comparison of serum apolipoprotain<br />
measurements end serum hpid parameters<br />
(A), 1067<br />
concns. of lipids, apolipoproteins in patients<br />
with chin, well-controlled insulin-dependent<br />
and non-insulin-dependent diabetes, 813<br />
confusion of apolipoprotein E phenotyping by<br />
serum amyloid A (TB), 671<br />
designing a reliable calibrator for<br />
nephelometnic apo A-hand B assays (A),<br />
1073<br />
development of a receptor assay for measuring<br />
serum “active” epolipoprotein B-100 concn,<br />
(A), 1066<br />
effect of glycation of low-density hipoprotein on<br />
immunolog. deth. of apolipoprotein B (SN),<br />
2219<br />
enzyme-linked immunosorbent assay of<br />
apolipopratein B in blood spotted onto filter<br />
paper, suitable for neonatal screening, 1000<br />
eveln, of assays far apolipoprotein A-I and B<br />
on TurbiTimer (A), 1072<br />
evaln, of matrix effects of lyophilized pools on<br />
apolipoprotein B immunoasseys (A), 1074<br />
extrapolation of lipoprotein ref. limits to<br />
epolipoprotein measurements (A), 1070<br />
HUP-lipid program: apohipoprotein A-hand B<br />
and the spa B/apo A-I ratio (A), 1065<br />
immunoturbidimetric detn. of apolipoprotemn<br />
A-h and B on Hitachi analyzers (A), 1067<br />
implications for mess, of pre- high-density<br />
lipoprotein (free apo A-I) by ultracentrifn.<br />
(L),2336<br />
influence of end-stage renal failure on concns.<br />
of free apolipoprotein A-i in serum, 963<br />
mess, of apolipoprotein B in plasma from<br />
hyperhipidemic subjects treated with<br />
chohestyramine or placebo: differential<br />
effects of storage at -70 #{176}C, 380<br />
measurements of apolipoprotein A-I and B in<br />
normal individuals end in survivors of<br />
myocardial infarction (A), 1073<br />
mechanisms responsible for increasing<br />
immunoreactivity of apolipoprotein A.I with<br />
storage: role of oxidn., 2082<br />
rate immunonephelometry, radial<br />
immunodiffusion compared for<br />
apolipoproteins Al and B assay (SN), 2236<br />
serum lipid and epolipoprotein changes in<br />
normal pregnancy (A), 1066<br />
standn. of epohipoprotein Band A-h mess. (R),<br />
1357<br />
stendn. of immunochem. detn, of<br />
apolipoproteins A-I and B: report on IFCC<br />
meeting on standn. of apolipoprotein A-I and<br />
B measurements (basis for future<br />
consensus), Vienna, Austria, April 18-19,<br />
1989 (SE), 2009<br />
strong ssaocn, of a single nucheotide<br />
substitution in the 3’-untranslated region of<br />
the apolipoprotain-CIU gene with common<br />
hypertrighyceridemia in Arabs, 256<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
Arachidonic acid<br />
mess, of urinary leukotrienes by reversedphase<br />
liq. chramatog. and RIA, 388<br />
Argimne<br />
arginine pharmacokinetics assessed with an<br />
enzymatic assay adapted to a centrif.<br />
analyzer (SN), 1024<br />
Argininosuccinate synthetase<br />
HPLC for argininosuccinate synthetase (A),<br />
1117<br />
Arteriosclerosis<br />
atherosclerosis and the cholesterol connection:<br />
evolution of a cm. appln. (R), 521<br />
distribn, of thiobarbitunic acid-reactive<br />
substances in lipoprotains, proteins in serum,<br />
2054<br />
lipoprotein(a): enetic marker for<br />
atherosclerosis (A), 1234<br />
lipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monoclonel<br />
antibodies, 1380<br />
plasma lipoprotein(a) and the Friedewald<br />
formula (L), 2156<br />
role of Mg in etiology of cardiovascular disease<br />
(A), 1055<br />
serum lipoproteins and coronarographic<br />
features (L), 1266<br />
Artificial intelligence<br />
artificial intelligence program for<br />
interpretation of raw data from automated<br />
hemotol. instruments (A), 1089<br />
Aspartate aminotransferase<br />
effect of therapeutic coronary reperfusion on<br />
serum aspartete aminotransferase<br />
isoenzymes<br />
myocardial<br />
in patients with acute<br />
infarction (A), 1116<br />
effects of therapeutic coronary reperfusion on<br />
aspartate aminotransferase isoenzynies in<br />
sera of patients with acute myocardial<br />
infarct, 909<br />
high-M, (“biliary”) isoenzyme of alt.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
increases in aspartate aminotransferase,<br />
creatine kinase in hemorrhagic shock and<br />
encephalopathy syndrome (L), 2253<br />
ratio of serum aspartate to alanine<br />
aminotransferase as a prognostic index in<br />
pediatric liver disease (A), 1151<br />
selective proteoiytic measurement of serum m-<br />
AS’l’ (A), 1127<br />
serum mitochondrial aspartate<br />
aminotransferase acty.: not useful as marker<br />
of excessive alcohol consumption in en<br />
unselected population, 926<br />
Aspirin<br />
See Selicylate<br />
Atherogenesla<br />
effect of glycation of how-density lipoprotein on<br />
immunohog. deth. of apolipoprotein B (SN),<br />
2219<br />
Atherosclerosis<br />
See Arteriosclerosis<br />
Atomic absorption spectrometry<br />
See also Atomic absorption spectroscopy,<br />
Atomic absorption spectrophotometry<br />
at. absorption spectrom. detn. of Se in blood<br />
components, 537<br />
concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
851<br />
electrothermal at. abeorp. spectrom. detn. of<br />
Al: serum matrix effects eliminated (SN),<br />
1517<br />
improved detn, of Vain biol. fluids by<br />
electrotherm. at. absorption spectrom. (SN),<br />
127<br />
indirect mess, of desfernioxamine<br />
chelated cmps. aluminoxamine<br />
end its<br />
and<br />
fernioxamine by Zeeman at. absorp.<br />
spectram. (SN), 884<br />
micro-quantity tissue digestion for metal<br />
measurements by use of a microwave aciddigestion<br />
bomb (SN), 488<br />
quantn. of Sr in plasma and urine with<br />
flameless at. abeorp. spectrom., 1911<br />
Atomic absorption .pectrophotometry<br />
enzymatic assay of Mg through glucokinase<br />
actn. (SN), 2212<br />
evaln, of urine metals control using at.<br />
absorption spectrophotom. (A), 1177<br />
fast, stable method for harvesting leukocytes<br />
far measuring intracellular Mg (SN), 1986<br />
quantn. Mn in lymphocytes to assess Mn<br />
nutrit. status,<br />
sensitive, direct<br />
1939<br />
calorimetry of Cu in serum,<br />
552<br />
ATP<br />
platelet-derived ATP may contribute to<br />
measured concn, of inorg. pyrophosphate in<br />
serum (TB), 326<br />
Atrial natriuretic peptide<br />
development and validn. of a two-site<br />
immunoradiometric assay for atrial<br />
natriuretic factor in unextracted plasma, 953<br />
heart disorders and concentrations of directly<br />
measured atrial natriuretic peptide in<br />
plasma, 435<br />
improved RIA of atrial natriuretic peptide in<br />
plasma, 1431<br />
influence of blood pressure, heart rate, age, and<br />
sex on concns, of atrial natriuretic factor end<br />
cyclic GMP (SN), 1519<br />
Autoantibodies<br />
autoantibodies to lactate dehydnogenase in<br />
serum identified by use of immobilized<br />
Protein G and immobilized jacalin, a<br />
jackfruit lectin, 2190<br />
highly sensitive assays of autoantibodies to<br />
2366 CLINICALCHEMISTRY,Vol.35, No. 12, 1989
thyroglobulin, thyroid peroxidase, 1949<br />
meas, of autoimmune response against collagen<br />
types 1,111, and N by enzyme-linked<br />
immunosorbent assay, and appln. in<br />
infective endocarditis, 246<br />
sensitive radiobinding assay for measuring<br />
autoantibodies to thynoperoxidase in human<br />
serum (A), 1208<br />
streptokinase binds to lactate dehydrogenase<br />
subunit.M, which shares en epitope with<br />
plasminagen, 69<br />
Autoimmune disease<br />
amiodarone and the thyroid function (R), 1882<br />
changes in concanavalin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
cobalamin-binding capacity of haptocorrin and<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
ELISA method to measure antibodies to<br />
cardiolipin and phosphatidylserine (A), 1207<br />
expression of the major human<br />
ribonucleoprotein (RNP) autoantigens in E.<br />
coli end their use in an EIA for screening<br />
sera from patients with autoimmune diseases<br />
(S), 1861<br />
mess, of autoimmune response against collagen<br />
types 1,111, and N by enzyme-linked<br />
immunoeorbent assay, and appln. in<br />
infective endocarditis, 246<br />
Automated analyzers<br />
See Continuous-flow analysis, Discrete<br />
analysis, etc.<br />
Autoradiography<br />
evaln. of biotinylated (Blugene’)<br />
labeled cDNA probes of $-<br />
vs<br />
glucocerebrosidase: rd. sensitivities in<br />
genamic and other systems (SN), 1512<br />
Avidin-biotin interaction<br />
biotin-avidin-based<br />
immunosorbent<br />
solid-phase enzyme-linked<br />
assay for human serum IgE<br />
(A), 1192<br />
biotin-specific binders to probe charge effects<br />
in enzyme immunoassays (A), 1201<br />
immunoradiometry of carcinoembryomc<br />
antigen with use of avidin-biotin labeling,<br />
573<br />
immunoradiometry of corticotropin with use of<br />
avidin-biotin sepn., 804<br />
quanta. of biotin in serum by competition with<br />
solid-phase biotin for binding to<br />
peroxidase-avidin conjugate (SN), 1721<br />
Awards<br />
See AACC<br />
Azidodeoxythymidine<br />
adaptation of ZDV-Trac’ for simultaneous<br />
monitoring of AZT and G-AZT (A), 1187<br />
sensitive and rapid HPLC procedure for<br />
measuring zidovudine (AZT) in serum (A),<br />
1181<br />
specific routine detn. of 3’-azido-3’-<br />
deoxythymidine in plasma by<br />
semiautomated liq. chromatog. (S), 1313<br />
Bacteria<br />
identn. of Salmonella spp. with an alkaline<br />
phosphatase-labeled oligonucheotide probe:<br />
comparison with standard biochem. identn.<br />
techniques (A), 1075<br />
Barbiturates<br />
See also specific barbiturate of interest<br />
BASO-DALT<br />
See Electrophoresis, twa-dimensional<br />
Beckman Conference<br />
introduction (S), B3<br />
panel discussion (5), B53<br />
Bence Jones protein<br />
Bence Jones proteins in urine of patients with<br />
multiple sclerosis (L), 1550<br />
Benzodiazepines<br />
assay for benzodiazepines on the ADS”<br />
analyzer (A), 1174<br />
measurement of benzodiazepines in urine by<br />
double-antibody RIA (A), 1175<br />
measurements of clonazepam end lorazepam<br />
by HPLC using solid-phase extn, (A), 1183<br />
Benzophenones<br />
benzodiazepines identified by capillary gas<br />
chnamatog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs., 1394<br />
Benzoylecgonine<br />
cocaine and pregnancy: chin. and toxicol.<br />
implications for the neonate (5), 1276<br />
detection limit of the TDx fluorescence<br />
polarization immunoassay extended for<br />
benzoylecgonine in urine (SN), 2110<br />
Bicarbonate<br />
calculated HCO or total C02?, 1697<br />
development of dry powder bicarbonate<br />
reagent on Boehringer Mannheim/Hitachi<br />
analyzers (A), 1154<br />
improved method for celcg. Ca fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
kinetic evaln. of HCO assay system (A), 1112<br />
Bichromatic analysis<br />
adaption of Syva EMIT d.a,u.’ assays to the<br />
570 Alliance chin. chem, analyzer (A), 1170<br />
appln. of three turbidimetric immunoglobulin<br />
assays, IgG, IgA, and 1gM, to the Express 550<br />
analyzer (A), 1095<br />
bichromatic sample-blank methodologies for<br />
Dacos, Dacos XL (A), 1156<br />
bichromatics for total protein detn. (A), 1159<br />
cardiac enzyme measurement with Eur.<br />
reagents using Ciba Corning 550 Express’”<br />
(A), 1118<br />
evaln. of a Hg-free Cl reagent on Technicon<br />
Assist’” and RA-100’” systems (A), 1105<br />
evaln. of the 570 alliance cm. chem. analyzer<br />
and Ciba Corning Diagnostics reagents (A),<br />
1094<br />
Fe detn. using CIBA Corning 550 Express<br />
analyzer (A), 1113<br />
modified IFCC reagents for ALT and AST<br />
tasting on Ciba Corning 550 Express (A),<br />
1118<br />
performance characteristics of Ciba Corning<br />
Diagnostic single liq. Mg reagent on the<br />
Express 550(A), 1094<br />
Bile acids<br />
bile acid-binding activity of diethylaminoethyl<br />
dextran in healthy subjects and in primary<br />
biliary cirrhosis (A), 1134<br />
enzymic mess. of total bile acids adapted to the<br />
Cobss Fara centrif. analyzer (TB), 1538<br />
Bihirubin<br />
biliary elk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-cellulose:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
characterization of sulfasalazine’s interference<br />
in mess, of conj. bilirubin with the Ektschem<br />
slide (SN), 1760<br />
chin, important interference of sulfasalazine in<br />
measurement of conjugated bilirubin by<br />
Ektachem slide method (A), 1158<br />
delta and conjugated bilirubins as predictors of<br />
early liver allograft rejection are unaffected<br />
by cytomegalovirus infection (A), 1137<br />
detn. of biirubin in neonatal serum with<br />
Abbott A-Gent5 neonatal bilirubin reagent<br />
(A), 1151<br />
detn. of total bihirubin in serum using an<br />
improved liq. total bilirubin reagent (A),<br />
1094<br />
effect of hemoglobinemia on biirubin assays<br />
on Kodak Ektachem 700 and<br />
Bihirubinometar (A), 1157<br />
evaln. of total and direct bilirubin assays on<br />
the Beckman Astra and Synchron CX5 and<br />
Kodak Ektachem systems in comparison<br />
with HPLC bihirubin measurements (A),<br />
1095<br />
Indocyanine Green interference in the Kodak<br />
Ektachem detn. of total bihirubin (L), 899<br />
Monoject Amber Samplett.e free of bihirubin<br />
photolysis (TB), 889<br />
one-step protocol for assays of total and direct<br />
bihirubin with stable combined reagents<br />
(SN), 173<br />
performance of Reflotron amylase and<br />
bilirubin test methods in two physicians<br />
office labs. (A), 1093<br />
three direct spectrophotometric methods for<br />
detn. of total bilirubin in neonatal and adult<br />
serum, adapted to the Technicon RA-1000<br />
analyzer (SN), 1980<br />
total bihirubin bias: is accuracy more important<br />
than consistency? (A), 1128<br />
total digoxin-like immunoreactive<br />
total biirubin concn., and birth<br />
factor(s),<br />
wt. in<br />
neonates (L), 192<br />
unreliable visual estn. of incidence and amount<br />
of turbidity, hemolysis, and icterus in serum<br />
from hospitalized patients (SN), 837<br />
Bioassay<br />
ultrasensitive bioassay of thyrotropin (TB),<br />
1252<br />
Bioengineered proteins<br />
deveL of a vector system for expression of<br />
bioengineered proteins (S), B7<br />
Biological variation<br />
See Variation,<br />
Bioluminescence<br />
source of<br />
assay<br />
chemi- and bioluminescent immunoassays (A),<br />
1239<br />
Biometry<br />
See Statistics<br />
Biotin<br />
See Avidin-biotin<br />
Biotinidase<br />
automated procedure for mess, of biotinidase<br />
acty. in serum (SN), 831<br />
kinetic detn. of serum biotinidase using a<br />
unique chromogenic substrate (A), 1151<br />
Bipolar affective disorder<br />
genetics of bipolar affective disorder: chin.<br />
implications (5), B28<br />
Birth asphyxia<br />
mess, of glutathione S-transferase B, in plasma<br />
after birth asphyxia: early indication of<br />
hepatocellular damage, 995<br />
Birth defects<br />
See Heritable disorders, Genetics<br />
Blood gases<br />
calculated HCO3- or total C02?, 1697<br />
evaln, of Biotrol bicarbonate reagent on Abbott<br />
Spectrum (A), 1091<br />
evaln. of Biotrol bicarbonate reagent on Roche<br />
Cobas Mira (A), 1092<br />
evaln, of GEM-6 in-line blood gas analyzer (A),<br />
1108<br />
influence of blood 02 tension on dipstick<br />
glucose detns. (L), 1268<br />
interinstrument comparison in P02 between<br />
tonometared whole blood and<br />
perfluorocarbon (A), 1131<br />
interinstrument differences in P02<br />
measurement on four recent blood gas<br />
analyzers (A), 1133<br />
intarlab. study of blood.gss anal.: dependence<br />
of P02 and pco2 results on atmospheric<br />
pressure (SN), 1779<br />
organic acids and drug interference in<br />
measurement of CO2 concn. by Kodak<br />
Ektachem 700(A), 1156<br />
performance evaln, of Corning 288 and Nova<br />
Stat Profile 1 blood gas systems (A), 1093<br />
recent developments in blood ss and<br />
electrolyte measurements with electrochem.<br />
sensors<br />
reliability<br />
(A), 1232<br />
of detn, of whole-blood 02 affinity<br />
with blood-gas analyzers and multiwavelength<br />
oximeters, 773<br />
reliability of temp. correction algorithms for<br />
assessing blood gas parameters at
Separation of Individual Compound Classes,<br />
2258<br />
Measurement of Oxygen by Membrane-<br />
Covered Probes, 194<br />
Medical Decision Making, 2020<br />
Medical Toxicology-Diagnosis and Treatment<br />
of Human Poisoning, 195<br />
Molecular Luminescence Spectroscopy:<br />
Methods and Applications: Part 2, 342<br />
Nonisotopic Immunoessay, 2160<br />
Otto FaIn. America’s First <strong>Clinical</strong><br />
Biochemist, 1810<br />
Peptide Hormones as Prohormones:<br />
Processing, Biological Activity,<br />
Pharmacology, 2258<br />
Recent Advances in Thin-Layer<br />
Chromatography, 342<br />
A Software Program far Immunoassay Data<br />
Handling, 1564<br />
Brain<br />
estn. of brain lesion size based on quantifying<br />
CK-BB in serum (L), 2018<br />
HPLC anal. of brain and plasma for octanoic,<br />
decanoic acids, 1945<br />
rapid, reliable in vivo assays of phosphate<br />
metabolites by NMR, 392<br />
serum creatine kinase isoenzyme BB: poor<br />
index to size of various brain lesions (SN),<br />
651<br />
Breast<br />
comparison of CA- 15 and steroid receptors in<br />
cancerous and adjacent noncancerous tissue<br />
of the breast (A), 1080<br />
immunahistochem. studies utilizing<br />
monoclonel and polyclonel antibodies to c-<br />
erbB-2 protein (A), 1079<br />
IMx’” BCM, automated microparticle enzyme<br />
immunoassay for breast cancer mucin (A),<br />
1078<br />
incidence of elevation of tumor markers CA-<br />
549, CA-15.3, end CEA in sera of breast<br />
cancer patients (A), 1078<br />
measurement of estrogen and progesterone<br />
receptors in breast tumors using steroidbinding<br />
assays and monoclonal enzyme<br />
immunoassays (A), 1138<br />
use of CEA, CA 15-3, and sialic acid in<br />
evaluating din, course of breast cancer<br />
patients (A), 1080<br />
Breast milk<br />
detn. of protein concn, in human breast milk<br />
using Coomassie Brilliant Blue on the Cobas<br />
Fare centrifugal analyzer (A), 1082<br />
total protein detd. in breast milk by use of<br />
Coomassie Brilliant Blue and centrif, anal,<br />
(SN), 2127<br />
Breath analysis<br />
confirmatory<br />
Brodifacouni<br />
breath ethanol testing (A), 1184<br />
brodifacoum (super warfarmn) poisoning: lab,<br />
methods for assessment of vit. K antagonism<br />
(A), 1162<br />
Bromide<br />
entipyrine interferes with chem. detn. of Br- in<br />
simultaneous estn. of total body H20 and<br />
extracellular H20, 1367<br />
effect of Br- on ion-specific electrodes in the<br />
Hitachi 736 (A), 1161<br />
evaln. of Gilford <strong>Chemistry</strong> Control<br />
interference with the chloride method in the<br />
Beckman Synchran CX3 analyzer:<br />
cumulative effect of Br an Cl results (TB),<br />
1538<br />
Bronchodilators<br />
simult. liq.-chromatog. detn, of some<br />
bronchodilators, anticonvulsants,<br />
chloraniphenicol, and hypnotic agents, with<br />
Chromosorb P columns used for sample<br />
prepn., 1615<br />
Cachectin<br />
See Tumor necrosis factor<br />
Caffeine<br />
caffeine interference eliminated in HPLC detn,<br />
of urinary nicotine and cotinine, 1456<br />
direct HPLC detn. of theophyiline,<br />
theophylline analogs, and caffeine in plasma<br />
with an ISRP (Pinkerton) column (A). 1185<br />
simplified, rapid test for acetylator<br />
phenotyping by use of the peak height ratio<br />
of two urinary caffeine metabolites (SN), 848<br />
Calciferin<br />
calciferin and cathepsmn D-like acid protease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
Calcinosis<br />
tumoral cslcinosi& seasonal biochem. studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
Calcitonin<br />
osteoporosis 1989 (A), 1053<br />
Calcium<br />
elk. phosphatase isoenzymes in plasma in<br />
hyperthyroidism, 1427<br />
Ca content of healthy erythrocytes (L), 1264<br />
Cs metab. in hypertension (A), 1054<br />
citrate interference in assays of total Ca in<br />
serum (TB), 2140<br />
critical anal, and din, aspects of ionized Cain<br />
neonates (R), 2027<br />
effect of citrate on urinary excretion of Ca and<br />
oxalata: relevance to Ca oxalate<br />
nephrohithiasis, 23<br />
effect of hematocrit and added heparin on Ca2<br />
in capillary blood from neonates (SN), 486<br />
effect of oral citrate on Ca absorption after oral<br />
load of Ca phosphate (TB), 1541<br />
effects of in vivo and in vitro production of<br />
lactic acid an ionized, protein-bound, and<br />
complex-bound Cain blood, 935<br />
effects on ionized Ca by different heparin<br />
preparations measured in ICA 2 analyzer<br />
(A), 1128<br />
improved method for calcg. Ca fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
increased Ca uptake in vascular tissue by<br />
plasma of salt-induced hypertensive DahI<br />
rats (A), 1138<br />
modern trends in image analysis (A), 1053<br />
NCCLS evaln. protocols EP-5 (precision), EP-<br />
6 (linearity), end EP-lO (preliminary<br />
evaluation) tested with en unsuitable Ca<br />
method (AAS) (A), 1099<br />
new liquid Ca reagent for Abbott Spectrum5<br />
(A), 1094<br />
new method for detg. bound and ionized Cain<br />
serum (TB), 491<br />
no relation between colorectal cancer and<br />
concns. of Cain serum (L), 1263<br />
quantn. of Sr in plasma and urine with<br />
flameless at. absorp. spectrom., 1911<br />
relation between plasma cholesterol and total<br />
and ionized Ca concns. in serum from<br />
poetmenopausal women (TB), 328<br />
statis, interpretn. of concns. of Mg, Zn, Ca, K,<br />
choleatarols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
tumorel calcinosis: seasonal biochem, studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
urine Ca anal, using Beckman Synchron CX3<br />
and Synchron CX5 din, systems (A), 1132<br />
Calcium-binding protein<br />
RIA of oateocalcin with polyclonal and<br />
monoclonal antibodies, 1408<br />
solid-phase enzymaimmunoassay for<br />
osteocalcin<br />
monoclonal<br />
in serum or plasma, with use of a<br />
antibody, 2087<br />
Calculous disease<br />
determinants of carbonate apatite in renal<br />
calculi (A), 1133<br />
effect of citrate on urinary excretion of Ca and<br />
oxalate: relevance to Ca oxalate<br />
nephrolithiasis, 23<br />
electrophoresis gel model for Ca oxalate<br />
crystallization (A), 1130<br />
enzymatic detn. of urinary axalate (SN), 2330<br />
enzymatic method for oxalate automated with<br />
the Cobas Fare centrif. analyzer (SN), 2094<br />
excretion of urinary enzymes after<br />
extracorporeal shock-wave lithotripsy (TB),<br />
2000<br />
oxalate is overestd, in elk. urines collected<br />
during administration of HCO3-2 with no<br />
specimen pH adjustment (SN), 2107<br />
sepn., identn. of urinary proteins and atonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate-polyacrylamide gel electrophoresis<br />
(SN), 658<br />
Calibration materials<br />
See Control materials, Quality control<br />
Cancer<br />
elk. phosphatase acty. from osteosarcoma cell<br />
line SaOS-2: isoenzyme std, for quantifying<br />
skeletal elk. phosphatase acty. in serum, 223<br />
alpha slow-moving HDL subfraction in serum<br />
of a patient with radiation enteritis end<br />
peritoneal carcinosis (CR), 674<br />
anal. sensitivity of prostate-specific antigen<br />
Tandem#{149}-E enzyme immunometric assay<br />
(A), 1078<br />
assay of “intact” parathyrin in the immediate<br />
and long-term postoperative follow-up of<br />
patients treated for hyperparathyraidism or<br />
thyroid tumor (L), 340<br />
benign transient hyperphosphatasemia in an<br />
adult with malignant lymphoma (L), 897<br />
biliary elk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-cellulose:<br />
appln. to detection of hepatobiliary diseases,<br />
1684<br />
calciferin and cathepsin D-like acid protease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
CA195, marker for colorectal cancer (A), 1077<br />
chemiluminescent enzyme immunoassay of a-<br />
fetoprotein with adamantyl diaxetane<br />
phenyl phosphate as substrate (SN), 2319<br />
cm, signif. of genetic rearrangements in<br />
neuroblastomas (S), B38<br />
cobalamin-binding capacity of haptocorrin and<br />
transcobelamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
Coloscreen VPI teat kit evald, for detection of<br />
fecal occult blood, 156<br />
comparison of CA-15 and steroid receptors in<br />
cancerous and adjacent noncanceraus tissue<br />
of the breast (A), 1080<br />
concns, of tumor-associated trypsin inhibitor<br />
and C-reactive protein in serum in acute<br />
pelvic inflammatory disease (SN), 869<br />
creatine kinase and lactate dehydrogenase<br />
isoenzymes in serum and tissues of patients<br />
with stomach adenocarcinoma, 1385<br />
decreased dehydroepiandrosterane sulfate in<br />
pigmented nodular adrenal dysplasia (SN),<br />
2216<br />
detn, of a2-macroglobulin-trypsin complex<br />
with a new synthetic substrate, 2169<br />
detn, of the allyl lysophospholipid derivative<br />
ET-18-OCH3, a new antineophastic drug, in<br />
plasma, 821<br />
direct detn. of 4 sulfates and 7 glucuronides<br />
17-ozystaroids in urine by fluorescence<br />
of<br />
“high-performance” liq. chromatog., 794<br />
discordant hCG measurements ins patient<br />
with carcinoma (TB), 1259<br />
distribution of prostatid acid phosphatase in<br />
benign and malignant diseases determined<br />
by Magiwel’” enzyme immunoassay (A), 1079<br />
DNA binding differences of active and inactive<br />
platinum anticancer drugs shown by agarose<br />
electrophoresis of restriction endonuchease<br />
fragments of drug-treated DNA (A), 1077<br />
estrogen end progesterone receptor assays,<br />
the EIA method (Abbott), of low-speed<br />
by<br />
supernates of breast-cancer homogenates<br />
(SN), 2226<br />
evaln, of human-serum-based tumor marker<br />
control by comm. available RIA and EIA test<br />
kits (A), 1068<br />
extn. of intracellular nucleosides and<br />
nucleotides with acetonitrile, 48<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN),<br />
fundamental mechanisms<br />
166 -<br />
of tumorigenesis in<br />
the nervous system: isoln. and charactern. of<br />
genes assocd. with hered. farms of cancer (S),<br />
B25<br />
grand round at Sahlgren’s Hospital:<br />
hypercelcemia ins patient with mammary<br />
carcinoma; metastases or primary<br />
hyperparathyroidism? (CC), 1019<br />
fl-hCG vs intact hCG assays in detection of<br />
trophoblastic disease (CR), 1799<br />
high serum ferritin level and its significance in<br />
cancer (A), 1081<br />
immunoassay for estrogen receptor does not<br />
detect inactivated receptor (SN), 824<br />
immunoassey of band 5 (“tartrate-resistant”)<br />
acid phosphatase involving use of antiporcine<br />
utaroferrmn antibodies, 86<br />
immunohistochem, studies utilizing<br />
monoclonal and polyclonal antibodies to c-<br />
erbB-2 protein (A), 1079<br />
immunoradiometry of a’y- and y’y-enohase<br />
(neuron-specific enolase), with use of<br />
monochonal antibodies and magnetizable<br />
polymer particles, 2034<br />
IMx’” BCM, automated micropartiche enzyme<br />
immunoessay for breast cancer mucin (A),<br />
1078<br />
incidence of elevation of tumor markers CA-<br />
549, CA-15.3, and CEA in sara of breast<br />
cancer patients (A), 1078<br />
influence of O.C.T. embedding compd. on<br />
detns, of estrogen and pragestin receptors in<br />
breast cancer (SN), 2317<br />
lactate dehydrogenase isoenzyme pattern in<br />
sara in malignant diseases, 396<br />
lactate dehydrogenase isoenzyme patterns m<br />
serum in metastatic liver disease (SN), 871<br />
loss of heterozygosity in stages of malignancy<br />
(S), B48<br />
2368 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
measurement of estrogen and progesterone<br />
receptors in breast tumors using steroidbinding<br />
assays and monoclonel enzyme<br />
immunoassays (A), 1138<br />
measuring decision values for prostate-specific<br />
antigen in serum (A), 1077<br />
measuring tissue factor (Factor HI) acty. in<br />
plasma, 1897<br />
methods for detg. “reference chenes” from<br />
serial measurements: plasma lipid-bound<br />
sialic acid, 972<br />
2-microglobulin and immune activation (L),<br />
2158<br />
molecular genetics of leukemia and lymphoma<br />
(S),B43<br />
neopterin meas. in serum, tissue culture<br />
supernates by competitive enzyme-linked<br />
immunosorbant assay, 1467<br />
no relation between colorectal cancer and<br />
concns. of Ca in serum (L), 1263<br />
pancreatic oncofetal antigen and carbohydrate<br />
antigen 19-9 in sera of patients with<br />
pancreatic cancer, 405<br />
PAP end PSA as markers of prostatic<br />
carcinoma (A), 1191<br />
partial charectern, of an abnormal lactate<br />
dehydrogenase isoenzyme, LDH-lex, in<br />
serum from a patient with hepatocellular<br />
carcinoma (SN), 844<br />
prelim, chin. evaln. of an ovarian cancer<br />
marker-CA 215 (A), 1081<br />
preliminary appraisal of a PR-EIA kit for<br />
quantifying progesterone receptors in breastcancer<br />
tissue (L), 339<br />
prostatic inhibin-hike peptide in urine of<br />
prostatic cancer patients, meas, by enzymelinked<br />
immunosorbent assay, 1376<br />
proto-oncogene abnormalities in human cancer<br />
(A), 1057<br />
relative importance of estrogen and<br />
progesterone receptor assays as prognostic<br />
indicators in primary breast cancer: shortterm<br />
study, 238<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasla, and assessment of<br />
effects of organ failure, 1631<br />
RIA of -microseminaprotein, a prostaticsecreted<br />
protein in acre of men and women,<br />
1497<br />
serum creatine kinase isoenzyme BB: poor<br />
index to size of various brain lesions (SN),<br />
651<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoassays<br />
of carcinoembryonic antigen (SN), 146<br />
sugar-chain anal, of elk. phosphatase by lectin<br />
affinity chromatog. in serum from a patient<br />
with osteosarcoma (TB), 179<br />
tumor-derived activated cells: prehim. lab, and<br />
din, results (5), 1576<br />
two-site immunoenzymometric assay of 52-kDa<br />
pro-cathepsin D; use in breast diseases, 234<br />
two-site immunoenzymometry of 52-kDa<br />
cathepsin D in cytosols of breast-cancer<br />
tissues, 81<br />
two-site IRMA far detn, of urinary<br />
cytakeratin-18; apphicn. to management of<br />
bladder cancer (A), 1198<br />
use of CEA, CA 15-3, and sialic acid in<br />
evaluating cm, course of breast cancer<br />
patients (A), 1080<br />
Cannablnoids<br />
calibrators containing 11-nor--THC-9-<br />
carboxylic acid far use with Syva EMIT#{176}<br />
cannabinoid assays (A), 1173<br />
comparison of Abbott TDx FPIA for<br />
cannabinoids with GC/MS (A), 1185<br />
delta-9-THC and delta-9-THC-carboxylic in<br />
serum by quant. GC/MS (A), 1170<br />
five cannabinoid immunoessey systems<br />
compared at the screening threshold of 100<br />
ig/L (SN), 2241<br />
indole compounds do not cause false_positives<br />
with the TDx cannabinoid assay (TB), 323<br />
mechanism of false-negative urine cannabinoid<br />
immunoassay screens by Visin&M eyedrops<br />
(SN), 636<br />
(A), 1163<br />
melanin and other indole compds. do not cause<br />
false-positive cannabinoid assay results (L),<br />
1809<br />
sample preparation for thin-layer chromatog.<br />
anal, for 11-nor-9-tatrahydrocannabinoh-9-<br />
carboxylic acid in urine (SN), 163<br />
Carbamazepine<br />
differing results far carbamazepine between<br />
ace and TDx (A), 1182<br />
EMIT mess, of carbamazepine, phenobarbital,<br />
and theophyllline in the “Monarch” centrif.<br />
analyzer (L), 895<br />
latex-based immunoassay for detn. of<br />
carbamazepine with IL Monarch” chem.<br />
system (A), 1171<br />
Syva EMITS convenience pack assays for<br />
carbamazepine and tobramycin on the Cobas<br />
Mira analyzer (A), 1173<br />
Carbon dioxide<br />
calculated HC0 or total C02?, 1697<br />
Carbon monoxide<br />
reliability of detn. of whole-blood 02 affinity<br />
with blood-gas analyzers and multiwavelength<br />
oximeters, 773<br />
Carboxyhemoglobin<br />
spectrophotometric stat detn. of HbCO in<br />
microsamples (A), 1163<br />
Carboxypeptidase<br />
labile enzyme in fresh serum interferes with<br />
assay of carboxypeptidase N (TB), 177<br />
measuring carboxypeptidsse A acty. with a<br />
centrif. analyzer anal, and din.<br />
considerations, 251<br />
Carcinoembryonic<br />
immunometric<br />
antigen<br />
assay for carcinoembryonic<br />
antigen based on enhanced luminescence<br />
(A), 1080<br />
immunoradiometry of carcinoembryonic<br />
antigen with use of avidin-biotin labeling,<br />
573<br />
incidence of elevation of tumor markers CA-<br />
549, CA-15.3, and CEA in acre of breast<br />
cancer patients (A), 1078<br />
solid-phase time-resolved immunofluorometric<br />
assay for carcinoembryonic antigen (A), 1077<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoassays<br />
of carcinoembryonic antigen (SN), 146<br />
use of CEA, CA 15-3, and sialic acid in<br />
evaluating din, course of breast cancer<br />
patients (A), 1080<br />
Carcinoma<br />
measurement of sialic acid in squamous cell<br />
carcinoma patients (anal canal and cervix)<br />
by an automated Cobas-Mira procedure (A),<br />
1079<br />
Cardiac disease<br />
See Heart disease<br />
Cardiac glycosides<br />
detection of poisoning by plant-origin cardiac<br />
glycoside with the Abbott TDx analyzer<br />
(SN), 295<br />
Cardiolipin<br />
ELISA method to measure antibodies to<br />
cardiohipin and phosphatidylserine (A), 1207<br />
Carnitine<br />
(acyl)carnitine<br />
erythrocytes,<br />
distribution between plasma,<br />
and leukocytes in blood (L),<br />
711<br />
ref. values for creatine, creatinine, and<br />
carnitine are lower in vegetarians (L), 1802<br />
Carotenoids<br />
butylated hydroxytoluene in the mobile phase<br />
increases sensitivity in carotenoids<br />
chromatog. (L), 513<br />
concns, of carotanoids, retinol, and tocopherol<br />
in plasma aftera meal (SN), 310<br />
transport conditions and stability<br />
markers in blood (SN), 2313<br />
of biochem.<br />
Catecholamines<br />
comparison of HPLC and radioenzymatic assay<br />
for plasma catecholamines (A), 1100<br />
Cathepsin<br />
twa-site immunoenzymometry of 52-kDe<br />
cathepsin D in cytosols of breast-cancer<br />
tissues, 81<br />
Cathepsin-llke acid protease<br />
calciferin and cathepsin D-like acid protease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
CEDIA<br />
cloned enzyme donor immunoassay of serum<br />
digoxin (A), 1190<br />
performance of CEDIA’ ‘1’4MAb and T-uptake<br />
assays on Technicon RA-1000’ (A), 1191<br />
Cell surface modulation<br />
cell and substrate adhesion molecules in<br />
embryonic and neural development (5), 738<br />
Centrifugal<br />
analyzer<br />
arginine pharmacokinetics assessed with an<br />
enzymatic assay adapted to a centrif,<br />
analyzer (SN), 1024<br />
assays for immunoglobulins on the Cobas Mire<br />
analyzer (A), 1197<br />
automated enhanced<br />
rheumatoid factors<br />
latex agglutn, assay for<br />
in serum (SN), 303<br />
automated measurement of microalbuminuria<br />
with a microcentrifugal analyzer (A), 1084<br />
automated methods far din, assay of<br />
superoxide dismutase and glutathione<br />
peroxidase in human plasma and<br />
erythrocytes using a Cobas Bio centrifugal<br />
analyser (A), 1126<br />
automated micromethod for measuring free<br />
fatty acids in plasma/serum (SN), 2228<br />
din, performance of the EMIT vancomycin<br />
assay (SN), 1504<br />
cost-effective assays for use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoinin serum (SN) 1782<br />
detn, of protein concn. in human breast milk<br />
using Coomassie Brilliant Blue on the Cobas<br />
Fara centrifugal analyzer (A), 1082<br />
development of apphicn. protocols for EMIT<br />
vancomycin assay on the Syva Autolab’”<br />
instrument system and for Cobss Mira<br />
analyzer (A), 1167<br />
development of automated latex agglutination<br />
immunoassay for proceinainide for IL<br />
Monarch’ chem. system (A), 1171<br />
development of latex-based tobramycin<br />
immunoassay for the IL Monarch” chem.<br />
system (A), 1172<br />
dimethylniethylene blue-based spectrophotom,<br />
of glycoeaminoglycans in untreated urine:<br />
rapid screening for mucopolysaccharidos,<br />
1472<br />
EMIT ethanol assays for use on Cobas Mira<br />
and Cobas Bio analyzers (A), 1166<br />
EMIT mess, of carbamazepine, phenobarbitaj,<br />
and theophyliline in the “Monarch” centrif,<br />
analyzer (L), 895<br />
EMIT’” serum thyroid hormone uptake assay<br />
for use on Cobas Mire and Cobas Bjo<br />
analyzers (A), 1141<br />
enzymatic assay of Mg through glucokinase<br />
actn. (SN), 2212<br />
enzymatic<br />
enzymatic<br />
detn. of K in serum, 817<br />
method for lactate in whole blood<br />
adapted to the Cobas Bio (TB), 324<br />
enzymatic method for oxalata automated with<br />
the Cobas Fara centrif. analyzer (SN), 2094<br />
enzymatic theophyllmne assay an Cobas-Mira<br />
(A), 1102<br />
enzymic assay of sahicylate adapted to the<br />
Monarch centrifugal<br />
enzymic mess, of total<br />
analyzer (TB), 326<br />
bile acids adapted to the<br />
Cobas Fare centrif, analyzer (TB), 1538<br />
evaln. of Biotrol bicarbonate reagent on Roche<br />
Cobas Mira (A), 1092<br />
evaln. of PG-Numeric’” test for semiautomated<br />
anal, of phosphatidylglycerol in<br />
amniotic fluid (A), 1072<br />
evaln. of theophylline rotor for DuPont Analyst<br />
(A), 1108<br />
four fluorescence polarization immunoassays<br />
for therapeutic drug monitoring evald., 138<br />
immunometric assay for digoxin adapted to<br />
Roche Cobas Fara centrifugal analyzer (A),<br />
1166<br />
immunoturbidimetry of prealbumin<br />
(transthyretin) in a microcentrifugal<br />
analyzer (TB), 178<br />
improved pyrogallol red-Mo method for detg.<br />
total urinary protein (SN), 2233<br />
improved urinary oxalate method for a centrif.<br />
analyzer (L), 1806<br />
kinetic mess, of ketone bodies (L), 1263<br />
latex agglutination inhibition immunoassay for<br />
gentamicmn on the IL Monarch’” chem,<br />
system (A), 1172<br />
latex agglutination inhibition immunoassay for<br />
quinidine on the IL Monarch’” chem. system<br />
(A), 1172<br />
latex-based immunoassay for detn. of<br />
carbamazepine with IL Monarch’” chem.<br />
system (A), 1171<br />
measurement of fructoaamine using nitroblue<br />
tetrazohium on IL Multistat end comparison<br />
with Hb A1 in diabetic patients (A), 1146<br />
measurement of sialic acid in squamous cell<br />
carcinoma patients (anal canal and cervix)<br />
by an automated<br />
1079<br />
Cobas-Mira procedure (A),<br />
measuring carboxypeptidase A acty. with a<br />
centrif. analyzer anal, and chin.<br />
considerations, 251<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2369
modified EMITS thyroxin assay for use on<br />
Cobas Mire and Cobss Bio analyzers (A),<br />
1141<br />
modifn. and automation of whole-blood CN<br />
assay (A), 1177<br />
multipoint kinetic simultaneous mess. of<br />
combined concns. of acetoacetate--<br />
hydroxybutyrata and lactate-pyruvate (SN),<br />
1526<br />
neonatal phenyhalanine screening using the<br />
Encore centrifugal analyzer (A), 1153<br />
pancreatic amylase in serum for differential<br />
diagnosis of acute pancreatitis, acute<br />
abdominal diseases (TB), 2142<br />
pyruvate mess, in whole blood with the Cobss<br />
Bio analyzer (TB), 325<br />
safe, easy removal of Cobas Bio sample cups<br />
(L), 2156<br />
serum valproic acid detn, on Cobas<br />
centrifugal analyzer (A), 1178<br />
BioFP<br />
single-channel glycerol-blanked triglyceride<br />
method adapted to the Cobas Fara (A), 1067<br />
Syva EMITS digoxin assay utilizing on-line pretreatment,<br />
for use on Cobss Mira analyzer<br />
(A), 1167<br />
total protein detd. in breast milk by use of<br />
Coomassie Brilliant Blue and centrif. anal.<br />
(SN), 2127<br />
Centrifugal ultrafiltration<br />
three methods compared for estg. testosterone<br />
and estradiol not bound to sex-hormonebinding<br />
lobulin (SN), 632<br />
Centrifugation, two-dimensional<br />
creatine kinase and lactate dehydrogenase in<br />
whole blood, plasma, and serum determined<br />
with Abbott’s Vision system (A), 1125<br />
creatine kinase assay by Abbott Vision system<br />
(A), 1125<br />
Cerebrospinal fluid<br />
appln. of a silver-binding assay to detn, of<br />
protein in CSF (SN), 860<br />
Biotrol urine proteins reagent using pyrogallol<br />
red-Mo complex (A), 1082<br />
chin. applns. for quent. a and X light chain<br />
detns.<br />
cystatin<br />
(A), 1084<br />
C quantn. in CSF (TB), 179<br />
detn. of physostigmine in plasma and CSF by<br />
hiq. chromatog with electrochem. detection<br />
(SN), 292<br />
estn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
eveln. and performance characteristics of<br />
Paramax anal, system for detg. spinal fluid<br />
and urine protein with hiq. Coomassie Blue<br />
user-defined chem. (A), 1112<br />
evaln. of Kodak<br />
(A), 1090<br />
slides for CSF protein assays<br />
falsely elevated IgG indices in CSF of<br />
plasmapheresed patients (A), 1158<br />
micro-method for total protein in CSF, using<br />
benzethonium chloride in microtitar plate<br />
wells (SN), 1731<br />
more on ohigoclonal bands and diagnosis of<br />
multiple sclerosis (L), 337<br />
performance characteristics of CSF protein on<br />
Paramax (A), 1084<br />
sensitive and specific procedure for detecting<br />
ohigoclonal bending in CSF by agarose gel<br />
electrophoresis (A), 1082<br />
(TB), 1997<br />
simplified screening of populations at risk for<br />
tranathyretin Metwsssocd. familial<br />
amyloidatic polyneuropathy (SN), 1033<br />
“stat” measurements of L-hactate in whole<br />
blood and CSF assessed (SN), 1740<br />
three methods for demonstration of oligoclanal<br />
bands of IgG in CSF compared (A), 1085<br />
Ceruloplasmin<br />
measurement of human ceruloplasmin by its<br />
oxidase acty. using 4,4’-<br />
bis(dimethylamino)diphenylamine (A), 1082<br />
short- and long-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
CF antigen<br />
isolation of “cystic fibrosis protein” from<br />
serum, 1901<br />
Chemical-sensitive field effect transistors<br />
update on CHEMFET sensors for patient<br />
monitoring (A), 1060<br />
Cheinllunainescence<br />
appin. of a rapid non-radioisotopic nucleic acid<br />
anal. system to the detection of sexually<br />
transmitted disease-causing organisms end<br />
assocd. antimicrobial resistances (5), 1571<br />
assay formats involving acridinium-esterlabeled<br />
DNA probes (5), 1588<br />
chemilumescence receptor assay for vit. B12<br />
(A), 1194<br />
chemiluminescence receptor assay for folete<br />
(A), 1194<br />
chemiluminescent assay of elk. phosphatase<br />
applied in an ultrssensitive enzyme<br />
immunoassay of thyrotrapin (A), 1190<br />
chemiluminescent detection of herpes simplex<br />
virus I DNA in blot and in-situ hybridization<br />
assays (S), 1856<br />
chemiluminescent detn. of nonesterified fatty<br />
acids in serum (TB), 325<br />
chemiluminescent substrates for elk.<br />
phosphatase: application to ultrasensitive<br />
enzyme-linked immunoassays and DNA<br />
probes (A), 1201<br />
(5), 1863<br />
comparison of sample preparation techniques<br />
for measurement of total N in stool and food<br />
samples by chemiluminescence (A), 1114<br />
enhanced luminescence competitive<br />
immunoassay for anti-HIV (A), 1207<br />
role of rapid immunoassays for urgent detns, of<br />
creatine kinase isoenzyme MB (SN), 1752<br />
Chemlluminescence enzyme lmmunoassay<br />
chemiluminescent enzyme immunoassay of a-<br />
fetoprotein with adamantyl dioxetane<br />
phenyl phosphate as substrata (SN), 2319<br />
Chemllumlnescence immunoasaay<br />
chemi- and bioluminescent immunoassays (A),<br />
1239<br />
chemiluminescent assay for total serum IgE<br />
(A), 1194<br />
chemiluminescent assay of elk. phosphatase<br />
applied in an ultrasensitive enzyme<br />
immunoassay of thyrotropin, 1441<br />
diagnostic efficacy of Magic Lite intact<br />
parathyrin assay (A), 1187<br />
evaln. of chemiluminescent immunoassay for<br />
deth. of serum peptide hormones (A), 1206<br />
evaln. of ultrasensitive chemiluminescent<br />
thyrotropin assay (A), 1139<br />
measurement of thyrotrapin and T4 by new<br />
luminescence immunoassay LIA-MAT (A),<br />
1209<br />
measuring creatine kinase MB isoenzyme ins<br />
maintenance hemodialysis popn,:<br />
chemiluminometric immunoassay end<br />
electrophoresis compared (SN), 1965<br />
monoclonal chemiluminesceut digoxui assay<br />
(A), 1194<br />
quantn, of progesterone in human serum using<br />
the Amerhita system (A), 1205<br />
two-point calibration of immunoassays in the<br />
Ciba Coming Magic Lita system (A), 1188<br />
use of affinity chromatog. in developing<br />
chemiluminescent-labeled antibodies for a<br />
parathyrin immunometric assay (A), 1210<br />
Chimerlc antibodies<br />
genetically engineered antibodies (S), 1849<br />
Chloride<br />
enzymatic Cl method far the EMDS Easy ST<br />
analyzer (A), 1133<br />
evaln. of a Hg-free Cl reagent on Technicon<br />
Assist’” and RA-100’” systems (A), 1105<br />
evaln, of Gilford <strong>Chemistry</strong> Control<br />
interference with the chloride method in the<br />
Beckman Synchron CX3 analyzer:<br />
cumulative effect of Br-an C1 results (TB),<br />
1538<br />
influence of aspirin on in vitro direct<br />
potantiometry of Cl in serum (TB), 2146<br />
nonniercurimetric spectrophotometric assay<br />
for Chin blood serum (A), 1129<br />
rapid detn. of C1 in serum using a cyclic<br />
voltammetric method (A), 1133<br />
Chlorophenoxy herbicides<br />
HPLC mess, of chlorophenozy herbicides,<br />
bromoxynil, and ioxynil, in bioL specimens<br />
to aid diagnosis of acute poisoning(S), 1342<br />
Cholesterol<br />
accuracy, precision of anal, for total cholesterol<br />
as measured with the Reflotron cholesterol<br />
method (SN), 1734<br />
accurate cholesterol results by modn. of Roche<br />
enzymatic method parameters (A), 1068<br />
atherosclerosis and the cholesterol connection:<br />
evolution of a chin. apphn. (R), 521<br />
CAP-CDC cholesterol ref. materials study (A),<br />
1073<br />
cholesterol measurement in grossly hipemic<br />
specimens (A), 1072<br />
cholesterol standardization for 13 years by<br />
CDC and Japanese cholesterol levels (A),<br />
1065<br />
comparison of Technicon Chem-1 HDL<br />
cholesterol method with ppth, and<br />
ultracentrifugetion methods (A), 1066<br />
comparison testing of lot-to-lot variance in<br />
Reflotron dry reagent strip method of<br />
cholesterol measurement (A), 1098<br />
concns. of lipids, apolipoproteins in patients<br />
with chin, well-controlled insulin-dependent<br />
and non-insulin-dependent diabetes, 813<br />
cyclosporine does not interfere in total and<br />
high-density lipoprotain cholesterol mess.<br />
with use of enzymatic cholesterol assays<br />
(TB), 2251<br />
development of enzymic ref. equiv. method for<br />
total cholesterol (A), 1071<br />
diagnosis of recessive X-linked ichthyosis:<br />
quantitative HPLC/mass spect. anal. of<br />
plasma for cholesterol sulfate, 1906<br />
dual-pptn. method evald, for mess, of<br />
cholesterol in high-density hipoprotein<br />
subfractions HDL2 and HDL3 in plasma, 265<br />
effect of lyophiln. on results of five enzymic<br />
methods for cbolestarol (SN), 1523<br />
enzymatic deth. of total cholesterol in<br />
gallstones (SN), 2247<br />
evaln, of Beckman cholesterol reagents by a<br />
nath. cholesterol ref. method lab. (A), 1068<br />
evaln. of cholesterol mess, with the Beckman<br />
System 700 Analyzer in the Centers for<br />
Disease Control-NatL Heart, Lung and<br />
Blood Institute Lipid Standn, Program<br />
(TB), 1790<br />
evain. of the Kodak Ektachem HDL<br />
cholesterol kit on the Kodak Ektachem 700<br />
analyzer (A), 1069<br />
external assessment of lab, cholesterol<br />
measurements using patients specimens (A),<br />
1069<br />
improved accuracy of cholesterol values<br />
obtained by Synchron AS#{149} calibrator setpoint<br />
modn. as evidenced in patient<br />
correlation to Abell-Kendell ref. method (A),<br />
1071<br />
influence of end-stage renal failure on concns.<br />
of free apolipoprotain A-i in serum, 963<br />
interhospital lab. comparison of total and highdensity<br />
hipoprotain cholesterol assays (A),<br />
1075<br />
Lp(a) hipoprotein concn. in serum of patients<br />
with heavy proteinuria of different origin<br />
(SN), 2121<br />
performance evaln, of Ciba Corning<br />
Diagnostics HDL cholesterol reagent on the<br />
Impact 400E (A), 1094<br />
polyacryhamide gel electrophoresis used in a<br />
critical study of ppth. reagents for<br />
quantifying MDL cholesterol (TB), 1254<br />
rapid micro-scale proced. for detn, of total lipid<br />
profile, 1486<br />
regional interlab. standn. of serum cholesterol,<br />
HDL cholesterol, and triglycerides (A), 1065<br />
relation between plasma cholesterol and total<br />
and ionized Ca concns. in serum from<br />
postmenopausal women (TB), 328<br />
screening of serum cholesterol end HDL<br />
cholesterol using the E.M. Diagnostic<br />
Systems EASY ST analyzer (A), 1074<br />
standn, of a commercial (Boehringer<br />
Mannheim Diagnostics) enzymic method for<br />
cholesterol, 409<br />
statis. interpretn. of concns, of Mg, Zn, Ca, K,<br />
cholesterols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
study of lyophilization effect on enzymatic<br />
methods for cholesterol (A), 1066<br />
Synchron CX’” 4/5 system meets cholesterol<br />
accuracy goals of nath. cholesterol education<br />
program (A), 1071<br />
transport conditions and stability of biochem,<br />
markers in blood (SN), 2313<br />
twa-center evaln, of physician’s office chem.<br />
analyzer (Clinistat) for cholesterol anal. (A),<br />
1102<br />
whole-blood quality-control materiel for<br />
Reflatron#{149} assays of cholesterol (TB), 1255<br />
Wisconsin cholesterol study-assessment of<br />
lab, performance (A), 1068<br />
workshop to improve total cholesterol anal.<br />
(A), 1067<br />
Cholesteryl ester transfer protein<br />
alpha slow-moving MDL subfraction in serum<br />
of a patient with radiation enteritis<br />
peritoneal carcinosis (CR), 674<br />
and<br />
Cholinesterase<br />
adaptation of six DGKC enzymes and<br />
cholinestarase to Synchran CX’5 at 30#{176}C<br />
and 37#{176}C (A), 1126<br />
2370 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
automated detn, of cholinestarase acty. in<br />
plasma and erythrocytes by flow-injection<br />
anal,, and eppln. to identify subjects<br />
sensitive to succinylchohine, 77<br />
detn. of physostigmine in plasma and CSF by<br />
liq. chromatog. with electrochem. detection<br />
(SN), 292<br />
devehpment of Kodak Ektachem thin-film<br />
assay for serum chohinesterase (A), 1120<br />
Hitachi 717 procedure for dibucaine inhibition<br />
phenotyping of chohinestarase variants (A),<br />
1120<br />
Chorlocarcinoina<br />
fl-hCG vs intact hCG assays in detection of<br />
trophoblastic<br />
Choriogonadotropin<br />
disease (CR), 1799<br />
algorithm for testing and reportin serum<br />
choriagonadotropin at chin, signif. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
assay for human choriogonadotropin using<br />
higand and enti-ligand system (A), 1093<br />
chariogonadotrapin discriminatory zone and<br />
ultrasonograpliy (L), 2019<br />
chin, significant decision levels of hCG (L),<br />
1801<br />
comparison of intact and beta-subunit hCG<br />
levels in maternal serum with normal end<br />
aborting prenancy (A), 1136<br />
comparison of intact and beta subunit hCG<br />
levels in paired serum end urine samples (A),<br />
1143<br />
confusion about the discriminatory zone and<br />
choriogonadotropin stds, (L), 2336<br />
discordant hCG measurements in a patient<br />
with carcinoma (TB), 1259<br />
evaln. of Baxter Dade Stratus as a stat method.<br />
for human choriogonadotropin, digoxin, and<br />
digitoxin (A), 1111<br />
evaln. of human choriogonadotropin on Abbott<br />
IMx automated immunoassay systems (A),<br />
1099<br />
fl-hCG vs intact hCG assays in detection of<br />
trophoblastic disease (CR), 1799<br />
quant. hCG for the stat lab. (A), 1100<br />
quantn. of choriogonadotropin: differential<br />
cross-reactivities of free hCG fl-subunit with<br />
eight different monoclonal antibody-based<br />
hCG and (hCG + fi) “sandwich”-type assays<br />
(TB), 1791<br />
quanth. of free and whole molecule fl-hCG in<br />
an automated fluorescence immunoassay<br />
(A), 1147<br />
quanth. of hCG and its fl-subunit in the<br />
Amerlite system (A), 1205<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
solid-phase immunochemiluminometric assay<br />
for human choriogonadotropin (A), 1147<br />
three nonisotopic methods for human<br />
choriogonadotropin evald. (TB), 1545<br />
Chromaffin granules<br />
enzyme-linked immunoeorbent assay for<br />
chromogranin A, 1934<br />
Chromatofocusing<br />
chromatofocusing and isoelectric focusing in<br />
immobilized pH gradients compared<br />
characterization of Hb variants, 425<br />
far<br />
Chromatography, affinity<br />
adenosine end dopamine simultaneously deed.<br />
in urine by reversed-phase HPLC, with online<br />
meas, of uv absorbance end electrochem.<br />
detection, 64<br />
elk. phoephatase isoenzymes of liver and bone<br />
origin are incompletely resolved by wheatgerm-lectin<br />
affinity chromatog., 29<br />
liq.-chromatog. deth. of acetylatad Mb, 33<br />
precision of mess, of glycated Hb by affinity<br />
chromatog. on regenerated columns (L), 191<br />
ref. range of glycated Hb in nandiabetic<br />
persons possessing Mb S by affinity<br />
chromatog.<br />
sugar-chain<br />
(A), 1162<br />
anal, of elk. phosphatase by hectin<br />
affinity chromatog. in serum from a patient<br />
with osteosarcoma (TB), 179<br />
use of affinity chromatog. in developing<br />
chemiluminescent-lebeled<br />
parathyrin immunometric<br />
antibodies for a<br />
assay (A), 1210<br />
Chromatography, capifiary gas<br />
fluoxetine and narfluoxetine detn. in serum by<br />
capillary GC-ECD with solid-phase extn.<br />
(A), 1169<br />
long-chain aliphatic fatty acids end phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
phytanic acid, pristanic acid, and very-longchain<br />
fatty acid methyl esters mess.<br />
simultaneously by capillary gas chromatog.<br />
(L),703<br />
steroid profile for urine: ref. values, 2281<br />
system far toxicoL screening by capillary gas<br />
chrometog. with use of a drug retention<br />
index based on Ni-containing ref. cmpds.,<br />
601<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
Chromatography, cation-exchange<br />
fully automated fluorescence assay for detg.<br />
total homocysteine in plasma, 1921<br />
interlab, evaln. of isocratic HPLC method for<br />
creatinine in serum (A), 1132<br />
liq.-chromatog, detn, of acetylated Mb, 33<br />
stability of hemoglobins A, F, 5, and C in dried<br />
neonatal whole-blood samples when<br />
analyzed by cation-exchange HPLC (A),<br />
1152<br />
Chromatography, column<br />
therapeutic agents effecting amino acid<br />
chromatograms (TB), 1999<br />
Chromatography, gas<br />
quantn. of halothane by headspsce gas<br />
chrometog.<br />
Chromatography,<br />
(A), 1173<br />
gas-liquid<br />
detn. of cocaine metabohita, ecgonine methyl<br />
ester in urine, by gas chromatog. with N-<br />
selective detector (A), 1168<br />
simple enzymatic method for detg. 1,5-<br />
anhydro-D-glucitol in plasma for diagnosis of<br />
Chromatography, ion-exchange<br />
simple enzymatic method for detg. 1,5-<br />
anhydro-D-glucitol in plasma for diagnosis of<br />
diabetes, 2039<br />
simplified anal, for glycated Hb by ionexchange<br />
chromatog. (L), 2253<br />
Chromatography, liquid<br />
anal, of supplemented vit, K1 (20) in serum<br />
microsamples by solid-phase extrn. end<br />
narrow-bore HPLC with multichannel uv<br />
detection (S), 1288<br />
anal. performance of AACC Creatinine Study<br />
Group HPLC method (A), 1104<br />
assessment of renal function by inulin<br />
clearance: comparison with creatinine<br />
clearance as deed, enzymatically (SN), 312<br />
automated detn, of drugs in serum by columnswitching<br />
tetracycic<br />
HPLC. IV. sepn. of tricycic<br />
antidepressants end their<br />
and<br />
metabolitas (SN), 453<br />
automated fluoroimmunoassay of theophylline<br />
and vaiproic acid by flow-injection anal, with<br />
use of HPLC (SN), 469<br />
automated HPLC of anticonvulsents: cost<br />
assessment (A), 1353<br />
biliary elk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-ceilulose:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
butylatad hydroxytoluene in the mobile phase<br />
increases sensitivity in carotenoids<br />
chromatog. (L), 513<br />
caffeine interference eliminated in HPLC detn,<br />
of urinary nicotine and cotinine, 1456<br />
concurrent mess, of flecainide acetate and<br />
prapranolol by normal-phase liq. chromatog,<br />
(SN), 857<br />
conflicting results of hiq.-chromatog. detns. of<br />
elk. phosphatase isoenzymes (L), 2255<br />
creatine kinase isoforms in ischemic heart<br />
disease (R), 7<br />
cyclosporin A mess, in plasma in various<br />
transplant types by HPLC and RIA (A),<br />
1356<br />
cyclosporine measured in plasma from patients<br />
with various transplants: HPLC and RIA<br />
with a specific monoclonal antibody<br />
compared (SN), 1726<br />
detn, of physostigmine in plasma and CSF by<br />
hiq. chromatog. with electrochem. detection<br />
(SN), 292<br />
deth. of serum desipramine and 2-<br />
hydroxydesipramine for pharmacokinetic<br />
applns, by HPLC with uv detection (SN),<br />
2134<br />
diagnosis of recessive X-linked ichthyosis:<br />
quantitative HPLC/mass sped, anal, of<br />
plasma for cholesterol sulfate, 1906<br />
direct detn. of 4 sulfates and 7 glucuronides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” liq. chromatog., 794<br />
distribn, of cyclosporin A metabolites among<br />
plasma and cells in whole blood: effect of<br />
temp., hematocrit, and metabolite concn,, 59<br />
emetine identified in urine by HPLC, with<br />
fluorescence and ultraviolet/diode array<br />
detection, in a patient with cardiomyopathy<br />
(CR), 499<br />
estimation of true values in RIAs, 1680<br />
fluorescence polarn. immunoassay of urinary 5-<br />
hydroxy-3-indoleacetic acid, 355<br />
free 3-methoxy-4-hydroxyphenylghycol deed, in<br />
plasma by liq. chromatog. with coulometric<br />
detection, 202<br />
high-M, (“biliary”) isoenzyme of elk.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
HPLC anal, for serotonin and tryptamine<br />
excreted in urine after oral loading with L-<br />
tryptophan, 43<br />
HPLC anal, of brain end plasma for octanaic,<br />
decanoic acids, 1945<br />
HPLC detn. of hemoglobin A1, in the presence<br />
of the fast hemoglobin I-Philadelphia (TB),<br />
494<br />
HPLC deth. of L-tryptophan in serum end<br />
urine (A), 1115<br />
HPLC/mass spectrom.: state of the art for the<br />
drug anal, lab. (S), 1282<br />
HPLC meas. of chlorophenoxy herbicides,<br />
bromoxynil, end ioxynil, in bioL specimens<br />
to aid diagnosis of acute poisoning(S), 1342<br />
HPLC meas. of phenylalanme by direct<br />
injection of plasma onto en internal-surface<br />
reversed-phase silica support, 975<br />
HPLC using diode array detection (A), 1240<br />
hiq. chromato. assay for free and<br />
transthyretin-bound retinal-binding protein<br />
in serum, 582<br />
liq.-chromatog. assay of urinary<br />
porphobilinogen (SN), 471<br />
hiq.-chromatog. detn, of acetylated Mb, 33<br />
liquid chromatog./electrochem.: in uivo deths.<br />
with microdialysis sampling probes (A), 1240<br />
liquid-chromatog. method for indomethacin<br />
and other inflammatory drugs (A), 1164<br />
loss of porphyrins from soln, during anal.:<br />
effect of sample pH and matrix on porphyrin<br />
qusntn, in urine by HPLC (SN), 1508<br />
measurements of clonazepam and lorazepam<br />
by HPLC using solid-phase extn, (A), 1183<br />
new method for monitoring fluvoxamine in<br />
human plasma by I-IPLC with uv detection<br />
(A), 1185<br />
new pitfall in plasma amino acid analysis (TB),<br />
178<br />
polyamines assayed by HPLC with<br />
electrochem. detection after post-column<br />
reaction with immobilized polyamine<br />
oxidase, 1694<br />
prepn. of fecal samples for assay of volatile<br />
fatty acids by gas-hiq. chromatog. and<br />
HPLC, 74<br />
quantn. of urinary porphyrins by liq.<br />
chromatog. after oxidn, of porphyrinogens,<br />
1619<br />
resolution of issues in HPLC anal, of urinary<br />
porphyrmns (A), 1157<br />
sensitive and rapid HPLC procedure for<br />
measuring zidovudine (AZT) in serum (A),<br />
1181<br />
simple hiq.-chromatog. method for vit. B6 cmps.<br />
in plasma, 241<br />
simultaneous detn. of lidocaine and its<br />
metabolite (MEGX), mexiletine,<br />
disopyrimide, and quinidine in serum by<br />
HPLC (A), 1355<br />
simultaneous deth. of pentoxifylline and three<br />
metabohites in bioL fluids by liq. chromatog.<br />
(SN), 298<br />
simultaneous liq.-chromatog, detn. of vit. K1,<br />
vit, E in serum, 2285<br />
simult. hiq.-chromatog. detn. of same<br />
bronchodilators, enticonvulsants,<br />
chloramphenicol, and hypnotic agents, with<br />
Chromoeorb P columns used for sample<br />
prepn., 1615<br />
specific routine detn. of 3’-azido-3’-<br />
deoxythymidine in plasma by<br />
semiautomated hiq. chromatog. (5), 1313<br />
supercritical fluid end microbore liquid<br />
chromatog. for din, anal, (A), 1240<br />
supercritical fluid chrometog. and microbore<br />
hiq. chromatog. for drug anal. (S), 1293<br />
two-site immunochemiluminametric assay of<br />
intact parathyrin with use of a tracer peptide<br />
purified by reversed-phase hg. chromatog.,<br />
215<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2371
urinary 5-hydroxyindoleacetic acid by HPLC<br />
with electrochem. detection (L), 507<br />
urine free cortisol in depressed patients<br />
assayed by HPLC (A), 1138<br />
whole-blood cyclosporin A: comparison of<br />
monoclonal antibody RIA with HPLC (A),<br />
1100<br />
Chromatography, reversed-phase<br />
See also Chromatography, liquid<br />
adenosine and dopamine simultaneously deed.<br />
in urine by reversed-phase HPLC, with online<br />
mess, of uv absorbance and electrochem,<br />
detection, 64<br />
amino acid anal. for nutritional assessment by<br />
Pico-Tag HPLC: precision studies, ref.<br />
ranges, and correlations with ian-exchange<br />
method (A), 1113<br />
i-eminolevulinic acid in plasma by free amino<br />
acid anal. (TB), 1998<br />
anal. of mexiletine stereoisomers in serum by<br />
HPLC with a chiral column (A), 1178<br />
anal. of urinary metanephrines of patients<br />
treated with antihypertensive a-methyldopa<br />
(Ahdomet) (A), 1138<br />
antipyrmne, indocyanine green, and lorazepam<br />
deed, in plasma by HPLC (SN), 2124<br />
detn. of cyclosporine in plasma: specific RIA<br />
with a monoclonal antibody and liq.<br />
chromatog. compared, 608<br />
deth. of trans-phylloquinone in children’s<br />
serum (SN), 874<br />
detn, of tyramine in plasma by ian-pair extn.<br />
and reversed-phase liquid chromatog. with<br />
electrochem. detection (A), 1152<br />
direct deth. of 4 sulfates and 7 glucuronides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” liq. chromatog., 794<br />
direct HPLC detn, of theophylline,<br />
theophyhline analogs, and caffeine in plasma<br />
with en ISRP (Pinkerton) column (A), 1185<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes end porphyrins, 2290<br />
encainide and metabohite anal, in serum or<br />
plasma using reversed-phase HPLC (A),<br />
1177<br />
exth. of intracellular nucleosides and<br />
nucheotides with acetonitrile, 48<br />
HPLC for argininosuccinate synthetese (A),<br />
1117<br />
liq. chromato. assay for free and -<br />
transthyretin-bound retinal-binding protein<br />
in serum, 582<br />
hiq.-chromatog. monitoring of cytosine<br />
arabinoside<br />
arabinoside,<br />
and its metabolite,<br />
in serum, 1011<br />
uracil<br />
meas, of urinary leukotrienes by reversedphase<br />
hiq. chromatog. end RIA, 388<br />
polyamines assayed by HPLC with<br />
ehectrochem. detection after post-column<br />
reaction with immobilized polyamine<br />
oxidase, 1694<br />
quantn. of urinary porphyrins by liq.<br />
chromatog. after oxidn, of porphyrinogens,<br />
1619<br />
reversed-phase HPLC sepn. of plasma<br />
norepinephrine, epinephrine, and dopamine,<br />
with 3-electrode coulometric detection (SN),<br />
1975<br />
simultaneous detn, of pentoxifylline and three<br />
metabohites in biol. fluids by liq. chromatog.<br />
(SN), 298<br />
Chromatography, size-exclusion<br />
hiq. chromato. assay for free and<br />
transthyretm-bound retinal-binding protein<br />
in serum, 582<br />
Chromatography, supercritical fluid<br />
hybrid chrometog. methodologies for drug<br />
anal.-GC-MS,<br />
supercritical<br />
LC-MS, MS-MS. and<br />
fluid chromatography-MS (A),<br />
1055<br />
supercritical fluid chromatog. and microbore<br />
liq. chromatog. for drug anal. (5), 1293<br />
Chromatography, thin-layer<br />
detn. of the allyl lysophospholipid derivative<br />
ET-18-OCH3, a new antineoplastic drug, in<br />
plasma, 821<br />
evaln. of TLC technique for detection of<br />
opiates in urine (A), 1173<br />
improved staining of thin-layer chromatograms<br />
of amniotic fluid phosphohipids (TB), 1539<br />
phospholipid surface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal, of the value of pptn. with cold acetone,<br />
800<br />
rapid thin-layer chromatog. semiquantification<br />
of morphine in urine via dabsylation:<br />
comparison with EMIT and thin-layer<br />
chromatog.-iodoplatinate methods (TB), 329<br />
sample preparation for thin-layer chromatog.<br />
anal. for 11-nor-9-tetrahydrocannabinol-9-<br />
carboxylic acid in urine (SN), 163<br />
thin-layer chromatog. of free porphyrins for<br />
diagnosis of porphyria (SN), 1043<br />
Chromatography, two-dimensional<br />
encainide by HPLC-simplified 2-D<br />
chromatog.<br />
1177<br />
to eliminate interferences (A),<br />
Cbromogranin<br />
enzyme-linked<br />
A<br />
immunosorbent assay for<br />
chromogrenin A, 1934<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
Chylomicrons<br />
strong assocn. of a single nucleotide<br />
substitution in the 3’-untranslated region of<br />
the apolipoprotein-Clil gene with common<br />
hypertriglyceridemia in Arabs, 256<br />
Chymotrypein<br />
fecal chymotrypsin: suitable test for diagnosing<br />
pancreatic insufficiency (A), 1090<br />
Circadlan<br />
rhythm<br />
circadien variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
Clrcannual rhythms<br />
tumoral calcinosis: seasonal biochem, studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
Cirrhosis<br />
bile acid-binding activity of diethylaminoethyl<br />
dextran in healthy subjects and in primary<br />
biliary cirrhosis (A), 1134<br />
buliary elk. phospbatase measured by minicolumn<br />
chromatog. on DEAE-cellulose:<br />
appln. to detection of hepatobiliary diseases,<br />
1684<br />
calciferin and cathepsin D-ike acid pratease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
Citrate<br />
citrate interference in assays of total Ca in<br />
serum (TB), 2140<br />
effect of citrate on urinary excretion of Ca end<br />
oxalate: relevance to Ca oxalate<br />
nephrolithiasis, 23<br />
effect of oral citrate on Ca absorption after oral<br />
load of Ca phosphate (TB), 1541<br />
Clearance, renal<br />
See also Creatinine<br />
<strong>Clinical</strong> Chemist, The<br />
198,344,517,715,905, 1271, 1565, 1812,2023,<br />
2161, 2259,2340<br />
<strong>Clinical</strong><br />
chemistry<br />
appln. of expert systems in the cm. lab. (R),<br />
1595<br />
bial. variability of 26 cm. chem. analytes in the<br />
elderly, 783<br />
mal. genetics end the transformation of cm.<br />
chem, (5), 2165<br />
regulatory<br />
evaln, (SR), 691<br />
Clotting<br />
See Coagulation<br />
Coagulation<br />
anal, of supplemented<br />
model for chin, labs.: an empirical<br />
vit, K1 (20) in serum<br />
microsamphes by solid-phase extrn, and<br />
narrow-bore HPLC with multichanneh uv<br />
detection (S), 1288<br />
brodifacoum (super warfarin) poisoning lab.<br />
methods for assessment of vit. K antagonism<br />
(A), 1162<br />
correction of instrument- and reagent-based<br />
differences in deth. of the int, normalized<br />
ratio for monitoring anticoagulant therapy<br />
(SN), 840<br />
development of human factor VII ELISA:<br />
preliminary studies (A), 1161<br />
enzyme immunoassay for quantn. of<br />
thrombin-antithrombin III<br />
complex-multicenter evsln. (A), 1163<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
increased concns. of heparin cofactor II in<br />
diabetic patients, and possible effects on<br />
thrombin inhibition assay of antithrombin<br />
111,52<br />
measuring tissue factor (Factor III) acty. in<br />
plasma, 1897<br />
monitoring lysis of fully cross-linked fibrin<br />
clots with comm. D-dimer test (A), 1161<br />
new chromogenic substrate for detn, of<br />
prothrombin time with the Reflotron5 (A),<br />
1161<br />
optimized microturbidimetric assay for<br />
fibrinogen, 211<br />
standn, of methods for meas. plasminogen<br />
activator inhibitor acty. in plasma, 787<br />
Cobalamin<br />
cobalamin-binding capacity of haptocarrin and<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
high prevalence of atrophic gastritis in the<br />
elderly: implications for health-associated<br />
ref. limits for cobalamin in serum (L), 1557<br />
methyimalanic acid. I. concns. in serum and<br />
urinary excretion in normal subjects after<br />
feeding and during fasting, and after loading<br />
with protein, fat, sugar, isoleucine, valine,<br />
2271<br />
methylmalonic acid. II. relation between<br />
concns, in serum and urinary excretion, and<br />
the correln. between serum cobalamin and<br />
accumulation of methylmalonic acid, 2277<br />
solid-phase sample extn. for rapid detn. of<br />
methyimalonic acid in serum, urine by stable<br />
isotope dilution, 260<br />
Cobalamin-binding proteins<br />
cobalamin-binding capacity of haptocorrin and<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
Cocaine<br />
anal, of cocaine metabohites in urine:<br />
comparison of TDx FPIA cocaine metabolite<br />
assay with GCIMS (A), 1186<br />
cocaine and pregnancr cm. and toxicol.<br />
implications for the neonate (5), 1276<br />
detn, of cocaine metabohite, ecgonine methyl<br />
ester in urine, by gas chromatog. with N-<br />
selective detector (A), 1168<br />
urine screening for cocaine use with ELISA and<br />
confirmation with GC/MS (A), 1171<br />
Codeine<br />
simultaneous quantn. of morphine, codeine,<br />
and 06-monoacetyl morphine by gas<br />
chromatog. mass spectrom. (A), 1355<br />
Collagen<br />
collagen-linked fluorescence in skin biopsy<br />
specimens from young insulin-dependent<br />
diabetic patients (A), 1137<br />
mess, of autoimmune response against collagen<br />
types 1,111, and IV by enzyme-linked<br />
immunosorbent assay, and appln. in<br />
infective endocarditis, 246<br />
Colorinietry<br />
See also Spectrophotometry<br />
antipyrine interferes with chem, detn. of Br<br />
simultaneous estn. of total body H20 end<br />
in<br />
extracellular H20, 1367<br />
assessment of renal function by inuhin<br />
clearance: comparison with creatinine<br />
clearance as deed. enzymatically (SN), 312<br />
Biotrol urine proteins<br />
red-Mo complex (A), 1082<br />
colorimetric detn. of non-enzymatically<br />
glycated apohipoprotein B (A), 1074<br />
calorimetric screening method for<br />
reagent using pyrogallol<br />
microalbuminuria: intra-individual<br />
variability for untimed day specimens (L),<br />
2019<br />
detn. of a2-macroglobulin-trypsin<br />
with a new synthetic substrate,<br />
complex<br />
2169<br />
enzymic urea asseT. new cohorimetric method<br />
based on H202 mess. (SN), 654<br />
fluorescence polarn. immunoassay of urinary 5-<br />
hydroxy-3-indoleacetic acid, 355<br />
improved colorimetric fructosamine assay (A),<br />
1110<br />
measurement of human cerulophasmin by its<br />
oxidase acty. using 4,4’-<br />
bis(dimethylamina)diphenylamine (A), 1082<br />
microalbuminuria in diabetes mellitus: more on<br />
urine storage and accuracy of colarimetry<br />
(L), 1560<br />
new liquid Ca reagent for Abbott Spectrums<br />
(A), 1094<br />
one-step protocol for assays of total and direct<br />
bihirubin with stable combined reagents<br />
(SN), 173<br />
performance characteristics of a Mg procedure<br />
for the Olympus AU5000 series of chem,<br />
analyzers (A), 1089<br />
performance of Technicon cohorimetric K<br />
method on the RA-100 system (A), 1130<br />
quant. measurement of urinary cystine by<br />
nitroprusside reaction (A), 1152<br />
rapid detn. of toxic CN- concns, in blood, 617<br />
2372 CLINICAL CHEMISTRY,Vol. 35, No. 12, 1989
screening for microalbuminuria with a rapid,<br />
low-cost calorimetric assay (SN), 456<br />
sensitive, direct calorimetry of Cu in serum,<br />
552<br />
Wako UV colorimetric pancreatic lipase assay<br />
with 1,2-dihinoleoylglycerol as substrate<br />
evald. (TB), 1540<br />
Complement<br />
complement activation in plasma donors (A),<br />
1155<br />
complement C4 sUbtypes and psoriasis (TB),<br />
2142<br />
immunochem. detn. of C4b-binding protein in<br />
human plasma (A), 1163<br />
serum proteins, immunoglobuhin, and<br />
complement (C3 & C4) levels in Down’s<br />
syndrome in Kuwait sample (A), 1081<br />
Computers<br />
appln. of Quality Management System<br />
microcomputer qual.-control program in the<br />
RIA/endocrine lab. (A), 1086<br />
automation end interpretation of quentn.<br />
antibodies to therapeutic proteins,<br />
of<br />
illustrated with somatotrapin, 1623<br />
chin, evaln. of Beckman “Interlinkn Systems<br />
Director” interfacing the Syncbron CX 5 and<br />
Synchron AS analyzers (A), 1088<br />
computerized interpretation of Toxi-Lab<br />
chromatograms (A), 1087<br />
computerized model for automating collection<br />
of field data (A), 1088<br />
computerized quant. anal, of Coomassie-Bluestained<br />
serum proteins sepd. by twodimensional<br />
electrophoresia, 2297<br />
evaln, of Beckman Interhink’s custom<br />
formatting far reporting glucose tolerance<br />
test results (A), 1088<br />
evaln. of Beckman Interlinkn Systems<br />
Director-software version 3.0 interfacing one<br />
Synchron CX3 and one Synchron CX 5<br />
(A), 1088<br />
high-volume Syva EMIl’ drug testing on<br />
multiple Rpos analyzers interfaced to a<br />
central computer system (A), 1166<br />
integrated computer-controlled lab. anal. and<br />
reporting system incorporating the Olympus<br />
AU5031 (A). 1086<br />
knowledge-based systems in a comm. lab.<br />
setting (A), 1233<br />
Concanavalin<br />
changes in concanavahin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
Congenital adrenal hyperplasia<br />
assessment of screening program for congenital<br />
adrenal hyperplasia in Portugal based on<br />
antibody-coated tube RIA for 17a-OH<br />
progesterone (L), 2338<br />
1-RIA for endrostenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
Congenital disorders<br />
See Heritable disorders<br />
Continuous-flow analysis<br />
accuracy of total protein and albumin system<br />
specific values for SMA, SMAC-3, RA-1000,<br />
Assist, and Demand compared with the ref.<br />
method forT, protein and a comparative<br />
method for albumin (A), 1104<br />
automated deth. of urinary Nat, K, Cl,<br />
urea, and creatinine without sample diln.<br />
with the “RAT-XT” (SN), 481<br />
automated procedure for meas, of biotinidsse<br />
acty. in serum (SN), 831<br />
Control materials<br />
activation energies deed. for drugs of<br />
abuse-their use in projecting product shelflife<br />
(A), 1180<br />
evaln, of human-serum-based tumor marker<br />
control by comm. available<br />
kits (A), 1068<br />
RIA and EIA test<br />
evaln. of hiq. quality-control<br />
of fructosamine in human<br />
material for detn.<br />
serum (A), 1106<br />
evain. of liquid immunology control using the<br />
Beckman Array (A), 1154<br />
evaln. of urine metals control using at.<br />
absorption spectrophotom. (A), 1177<br />
interinstrument comparison in poe between<br />
tonometared whole blood and<br />
perfluorocarbon (A), 1131<br />
interlab. comparison of control materials for<br />
use with hematofluorameters, 2059<br />
reflectometric evaln. of Quantimetrix urine<br />
dipstick controls (A), 1108<br />
serum-based quality control fluids and<br />
calibrators: lyophihization vs vacuum-drying?<br />
(A), 1101<br />
use of Sentry<br />
performance<br />
drug control in evaluating<br />
of TDx drugs of abuse<br />
screening near NIDA cutoff concns. (A), 1103<br />
Copper<br />
changes in Fe, Zn, Cu concns. in serum and in<br />
their binding to transport proteins after<br />
cholecystectomy, cardiac surgery (SN), 2243<br />
interactions of Cu with some analytes in serum<br />
(L),335<br />
sensitive, direct calorimetry of Cu in serum,<br />
552<br />
Coproporphyrin<br />
quantn. of urinary porphyrins by hiq.<br />
chramatog. after oxidn. of porphyrmnagens,<br />
1619<br />
rapid detn. of uroporphyrin and<br />
coproporphyrmns in urine using secondderivative<br />
spectroscopy (A), 1132<br />
Coronary angioplasty<br />
creetine kinase isoforms in ischemic heart<br />
disease (R), 7<br />
Corrections<br />
670, 2257<br />
Corticosterold-binding globulin<br />
decreased immunoreecty. and binding acty. of<br />
corticosteroid-binding globulin in serum in<br />
septic shock, 1675<br />
Corticotrophn -<br />
evaln. of high sensitivity corticatropin<br />
immunorediometric assay (A), 1146<br />
immunoradiometry of corticatrapin with use of<br />
avidin-biotin sepn., 804<br />
new immunoradiometric assay for<br />
corticotropin evald, in normal subjects and<br />
patients with Cushing’s syndrome, 596<br />
parallel assays of -endorphin end ACTH in<br />
Cushing’s patients undergoing petrosal<br />
studies (A), 1145<br />
Cortisol<br />
decreased immunareacty. and binding acty. of<br />
corticostaroid-binding globulin in serum in<br />
septic shock, 1675<br />
detn, of FSH, LH, and cortisoh with automated<br />
enzyme immunoassays (A), 1141<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerhex cortisol, Biodata testosterone (SN),<br />
641<br />
evaln. of an RIA of urinary cortisol without<br />
extrn. (SN), 125<br />
reservations regarding assessment of data<br />
obtained with commercialiy available<br />
cortisol RIA kite (L), 2153<br />
solid-phase non-isotopic immunassay for<br />
quantn. of cortisol in serum (A), 1201<br />
urine free cortisol in depressed patients<br />
assayed by HPLC (A), 1138<br />
Cotinine<br />
caffeine interference eliminated in HPLC detn,<br />
of urinary nicotine end cotinine, 1456<br />
exposure to environmental tobacco smoke<br />
measured by cotinine I-RIA (SN), 1036<br />
Coulometry<br />
detn. of trans-phylloquinone in children’s<br />
serum (SN), 874<br />
free 3-methoxy-4-hydroxyphenylglycol deed. in<br />
plasma by liq. chromatog. with coulometric<br />
detection, 202<br />
reversed-phase HPLC sepn. of plasma<br />
norepinephrine, epinephrine, and dapamine,<br />
with 3-electrode coulametric detection (SN),<br />
1975<br />
Counterimmunoelectrophoresis<br />
See Immunoelectrophoresis<br />
Coupled-enzyme method -<br />
Hb peroxidase arty. for coupled enzymatic<br />
reactions (A), 1122<br />
C-peptide<br />
improved RIA of C-peptide and its appln. ins<br />
multiyear study, 37<br />
C-reactive protein<br />
See also Acute-phase proteins<br />
concns, of tumor-associated trypsin inhibitor<br />
and C-reactive protein in serum in acute<br />
pelvic inflammatory disease (SN), 869<br />
decreased immunareacty. and binding acty. of<br />
corticosteroid-binding globulin in serum in<br />
septic shock, 1675<br />
erythrocyte sedimentation rate and C-reactive<br />
protein compared in the elderly (SN), 466<br />
evaln, of a particle-enhanced immunoassay for<br />
quantifyingC-reactive protein (TB), 2001<br />
evaln. of the Tina-quant immunoturbiditnetric<br />
method for C-reactive protein on the Hitachi<br />
705 (A), 1081<br />
four immunochem, methods compared for<br />
mess. C-reactive protein in plasma (SN), 461<br />
method comparison for C-reactive protein<br />
comparing the Array’ protein system from<br />
Beckman to the Behring BNA (A), 1085<br />
nephelometric detn. of C-reactive protein (A),<br />
1197<br />
sensitive turbidimetric<br />
of C-reactive protein<br />
immunoassay for detn.<br />
in serum (A), 1082<br />
simultaneous detn. of serum neopterin and C-<br />
reactive protein as markers of infection in<br />
heart-transplant recipients (TB), 1258<br />
Creatine<br />
ref. values for creatine, creatinine, and<br />
carnitine are lower in vegetarians (L), 1802<br />
Creatine kinase<br />
appin. of Magic’ Lite<br />
immunochemiluminometric method for<br />
measurement of creatine kinase-MB in blood<br />
spots (A), 1123<br />
cardiac isoenzyme (CK-MM isoform) assays for<br />
early detection of acute myocardial<br />
infarction: comparison of immunometric and<br />
ehectrophoretic systems (A), 1117<br />
changes in creatine kinase acty. in acute<br />
myocerdial infarction, 414<br />
changes in isoform patterns end stability of<br />
CK-MB during storage (A), 1120<br />
characteristics of creatine kinase-MB and MB<br />
isoforms in serum after reperfusion in acute<br />
myocard. infarct, 2179<br />
CK-MM interference with en<br />
imenunoenzymometric method far quanta. of<br />
CK-MB in serum (L), 901<br />
CK-unrelated serum component identified in<br />
CK isoenzyme anal. using Helena Rep<br />
system (A), 1117<br />
cm. and anal. evaln. of different methods for<br />
mess, of creatine kinase isoenzyme MB (SN),<br />
130<br />
cm. comparison of Helena REP vs Kodak<br />
Ektachem creatine kinase MB slide in<br />
patients with suspected acute myocardial<br />
infarction (A), 1125<br />
comparison of automated vs manual<br />
ehectraphoresis system far creatine kinase<br />
isoenzymes (A), 1106<br />
comparison of Kodak CK-MB assay with CK<br />
isoenzyme electropharesis (A), 1123<br />
comparison of Stratus and Roche methods for<br />
CK-MB deth. (A), 1124<br />
concordance of creatine kinase-MB arty. and<br />
mass, 440<br />
creatine kinase and lactate dehydrogenase in<br />
whole blood, plasma, and serum determined<br />
with Abbott’s Vision system (A), 1125<br />
creatine kinase and lactate dehydrogenase<br />
isoenzymes in serum and tissues of patients<br />
with stomach adenocarcinoma, 1385<br />
creatine kinase and lactate dehydrogenase<br />
isoenzyme utilization: cut-off values for<br />
fractionation based on total CK activity, and<br />
monitoring of ordering patterns in 334<br />
intensive-care-unit patients (A), 1122<br />
creetine kinsse assay by Abbott Vision’ system<br />
(A), 1125<br />
creatine kinase isoforms in ischemic heart<br />
disease (R), 7<br />
creatine kinase MB isoenzyme in<br />
rhabdomyosarcoma (L), 896<br />
detection of serum CK-MB iaoforms by RIA<br />
(A), 1121<br />
development of a second-generation Isomune<br />
CK’assay(A), 1121<br />
diagnosis of acute myocardial infarction from<br />
two measurements of creatine kinase<br />
isoenzyme MB with use of nonparametric<br />
probability estn., 444<br />
diagnosis of acute myacardial infarct, when<br />
skel. muscle damage is present: a caveat<br />
regarding use of creatine kinase isoenzymes<br />
(L),705<br />
diagnostic performances of CK-MB assays by<br />
Du Pont and by Ciba-Corning compared (A),<br />
1122<br />
diagnostic utility of serum total creatine kinase<br />
and creatine kinase-2 in myocardiel<br />
infarction re-evaluated, 1435<br />
elevated CK-MB in a patient with pelvic<br />
sarcoma (A), 1124<br />
EMDS test pack CK-MB immunoassay<br />
immunoinhibition with anti-CK-M antibody<br />
(A), 1115<br />
estn. of brain lesion size based on quantifying<br />
CK-BB in serum (L), 2018<br />
evaln, of automated CK-MB mass assay (A),<br />
1107<br />
evaln, of Dade Stratus<br />
1090<br />
for detn. of CK-MB (A),<br />
eveln. of immunoenzymatic assay for CK-MB<br />
using the Icon format (A), 1121<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2373
evolution of serum CK-MB isoforms after<br />
acute myocardial infarction (A), 1120<br />
four assays for creatine kinase MB compared<br />
(A), 1124<br />
heterogeneity of serum creatine<br />
isoenzyme MM in myocardiel<br />
kinase<br />
infarction:<br />
din, significance and poet-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
high incidence of appearance end/or<br />
diaapperance of macro CK type in hosp.<br />
population<br />
IgA-CK-BB<br />
(A), 1123<br />
complex with CK-MB<br />
ehectrophoretic mobility can lead to<br />
erroneous diagnosis of acute myocard.<br />
infarct. (CR), 2003<br />
immunoaffinity purifn. of creatine kinase-MB<br />
from human, dog, end rabbit heart with use<br />
of monoclonal antibody specific for CK-MB,<br />
985<br />
immunochemical vs electrophoretic CK-MB<br />
deths. in early detection of acute myocardial<br />
infarction (A), 1125<br />
immunochem. test for CK-MB isoforms (L),<br />
2157<br />
increases in aspartete aminotransferase,<br />
creatine kinase in hemorrhagic shock and<br />
encepbalopathy syndrome (L), 2253<br />
interference of macro-creatine kinase in detn.<br />
of CK-MB in serum with the Kodak<br />
Ektachem (L), 2155<br />
is electrophoresis a ref. method for CK-MB in<br />
comparison with an immunoenzymometric<br />
method? (L), 900<br />
isoenzymes and isoforms of CK: what is the<br />
score? (E), 201<br />
measurement of creatine kinase MB by the<br />
Baxter Stratus fluorometric analyzer (A),<br />
1123<br />
measuring creatine kinase MB isoenzyme in a<br />
maintenance hemodialysis popn.:<br />
chemiluminometric immunoassay and<br />
electrophoresis<br />
more on methods<br />
compared (SN), 1965<br />
for CK-MB (L), 899<br />
rapid purifn. of creatine kinase MB isoenzyme<br />
on preparative polyacrylamide slabs, 96<br />
rapid, quant. immunoassay for creatine kinase-<br />
MB using Tandem Icon’ QSR technology<br />
(A), 1197<br />
rapid, specific method for CK-MB using<br />
Tandem Icon OSR CK-MB reagents (A),<br />
1120<br />
rate of release of CK isoforms into serum of<br />
patients with myocardial infarction treated<br />
with thrombolysis (L), 1264<br />
reproducibility of creatine kinase isoenzyme<br />
electrophoresis (L), 710<br />
role of CK subforms in thrombolytic therapy<br />
early diagnosis and assessment of efficacy<br />
(A), 1050<br />
role of rapid immunoassays for urgent detns. of<br />
creatine kinase isoenzyene MB (SN), 1752<br />
S-lOOa,, protein in blood and urine during<br />
open-heart surgery, 1942<br />
scheme for detecting elevated CK-MB in<br />
children (A), 1109<br />
sensitive, rapid assay of subforms of crestine<br />
kinase MB in plasma, 1452<br />
sepn. of the CK-MM isoforms by the Paragon’<br />
agarose gel electrophoreais system (A), 1101<br />
serum creatine kinase in primary hypothermia<br />
(L),2254<br />
serum creatine kinase isoenzyme BB: poor<br />
index to size of various brain lesions (SN),<br />
651<br />
single-vial screening assay for creatine kinase-<br />
MB (A), 1122<br />
statis, interpreth. of concns. of Mg, Zn, Ca, K,<br />
cholesterols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
Stratus automated creatine kinase-MB assay<br />
evald.: identn. and emmn. of falsely increased<br />
results assocd. with a high-M, farm of elk.<br />
phosphatase, 2048<br />
two kits for CK-MM isoforms evald. for early<br />
recognition of acute myocardial infarction<br />
(TB), 493<br />
use of creatine kinase MB isoforms for<br />
predicting myocardial reperfusion (A), 1125<br />
variation in decision thresholds for CK and<br />
CK-2 in myocardial infarction (A), 1116<br />
Creatinine<br />
anal, performance of AACC Creatinine Study<br />
Group HPLC method (A), 1104<br />
assessment of renal function by inulin<br />
clearance: comparison with creatinine<br />
clearance as deed. enzymatically (SN), 312<br />
automated detn. of urinary Na, K, Cl, P,,<br />
urea, and creatinine without sample diln.<br />
with the “RAT-XT” (SN), 481<br />
interlab. evaln. of isocratic HPLC method for<br />
creatinine in serum (A), 1132<br />
kinetic study of the Jaffe reaction for<br />
crsatinine in serum: 2. evaln. of buffered<br />
reagent and comparison of different dataprocessing<br />
options, 360<br />
micraplate mess, of urinary albumin,<br />
creatinine, 1371<br />
modifn. of Kodak Ektachem<br />
creatinine to substantially<br />
smde far<br />
reduce<br />
interference from lidocaine metabolite (A),<br />
1098<br />
new commercial method for enzymatic detn. of<br />
creatinine in serum and urine eveld:<br />
camper son with a kinetic Jaff#{233} method and<br />
- isotope diln.-mass spectrometry (SN), 835<br />
nitromethane interferes in assay for creatinine<br />
by Jaff#{233} reaction (SN), 1772<br />
ref. values for creetine, creatimne, and<br />
carnitine are lower in vegetarians (L), 1802<br />
renal function assessed by serum creatinine<br />
and creatinine clearance: ghomerular<br />
filtration rate estd. by four procedures (SN),<br />
2326<br />
Creatinine clearance<br />
renal function assessed by serum creatinine<br />
and creatinine clearance: glamerular<br />
filtration rate esed. by four procedures (SN),<br />
2326<br />
Cross reactivity<br />
See antigen-antibody system of interest<br />
Cryolnununoglobulins<br />
148 cryoimniunoglobulins characterized by<br />
cryocrit, immunoelectraphoresis, and<br />
immunonephelometry (A), 1083<br />
Cushing’. syndrome<br />
decreased dehydroepiandrosterone sulfate in<br />
pigmented nodular adrenal dysplasia (SN),<br />
2216<br />
Cutoff value<br />
chin, significant decision levels of hCG (L),<br />
1801<br />
creatine kinase and lactate dehydrogenase<br />
isoenzyme utilization: cut-off values far<br />
fractionation based on total CK activity, and<br />
monitoring of ordering patterns in 334<br />
intensive-care-unit patients (A), 1122<br />
detection limit of the Tl)x fluorescence<br />
polarization immunoassay extended for<br />
benzoylecgonine in urine (SN), 2110<br />
empirically deed. Pb-poisoning screening cutoff<br />
for the Protofluor-Z hematofluorometer<br />
(SN), 2104<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN), 166<br />
measuring carboxypeptidase A arty. with a<br />
centrif. analyzer: anal, end chin.<br />
considerations, 251<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
system to standardize ALT cutoff sctys. (A),<br />
1118<br />
Cyanide<br />
modifn. and automation of whale-blood CN<br />
assay (A), 1177<br />
rapid detn. of toxic CN- concns. in blood, 617<br />
Cyanocobalamin<br />
See Vitamin B12<br />
Cyclic GMP<br />
influence of blood pressure, heart rate, age, end<br />
sex on concns. of atrial natriuretic factor and<br />
cyclic GMP (SN), 1519<br />
Cycho.porine<br />
adv. in cyclosporine pharmacol., measurement,<br />
and ther. monitoring (S), 1299<br />
automated assay specific for #{231}yclosporine<br />
whole blood, with use of a Cr02 particle<br />
column (5), 1860<br />
calibration of 1I immunoassay measuring<br />
cyclosporin A (TB), 181<br />
calibration problems with the<br />
immunoassay for cyclosporin A (L), 1551<br />
comparison of assay methods far a new<br />
strategy for cyclosporine monitoring (A),<br />
1186<br />
comparison of cyclosporine assays in pediatric<br />
patients receiving organ transplants (A),<br />
1168<br />
comparison<br />
methods:<br />
of cyclosporine immunoassay<br />
examination of rejection and<br />
nephrotoxic episodes in liver transplantation<br />
(A), 1183<br />
comparison of four methods for measurement<br />
of cyclosporin (A), 1186<br />
concn, dependence and mechanism of the<br />
immunosuppressive activity of cyclosporine<br />
(A), 1235<br />
continuing need for qual. assessment of<br />
cyclosporine measurement (5), 1309<br />
cyclosporin A meas. in plasma in various<br />
transplant types by HPLC and RIA (A),<br />
1356<br />
cyclosporine concns, in blood after liver<br />
transplanth.: correlation<br />
results with chin, events,<br />
of immunoasaay<br />
564<br />
cyclosporine does not interfere in total and<br />
high-density lipoprotein cholesterol meas,<br />
with use of enzymatic cholesterol assays<br />
(TB), 2251<br />
cyclosporine measured in plasma from patients<br />
with various transplants: HPLC and RIA<br />
with a specific monoclonsi antibody<br />
compared (SN), 1726<br />
cyclosporine metabolism impeded/blocked by<br />
co-administration of phenobarbital (A), 1160<br />
cyclosporine monitoring (E), 5<br />
cyclosporine pharmacokinetics with<br />
concomitant ketoconazole therapy (A), 1176<br />
deth, of cyclosporine in plasma specific RIA<br />
with a monoclonal antibody and mq.<br />
chromatog. compared, 608<br />
distribn, of cyclosporin A metabolites among<br />
plasma and cells in whale blood: effect of<br />
temp., hematocrit, and metabolite concn., 59<br />
impact of meal timing on bioavailability of<br />
cycloeporine in CsA-treated renal allograft<br />
recipients post-transplantation (A), 1179<br />
isolation, characterization, and pharmacoL<br />
arty. of cyclosporine metabolites (A), 1235<br />
mess, of cycloeporine concns, in whole blood:<br />
HPLC and 83A with a specific monoclonal<br />
antibody end 8H- or iesIlabeled ligand<br />
compared (SN), 120<br />
new directions in cyclosporine monitoring (A),<br />
1235<br />
nonselective measurements of cyclosporin A in<br />
transplant patient specimens by RIA a<br />
monoclonal antibody and 1251tracer (A),<br />
1164<br />
pharmacokinetics and biotransformation of<br />
cyclosporine metabolite, M-17 (A), 1164<br />
qual. assurance of cyclosporine measurements:<br />
comparison of current methods (A), 1236<br />
receptor assay for cyclosporine acty. in whole<br />
blood (A), 1167<br />
sensitivity of CYCLO-Trac SP (specific<br />
monoclonal immunoassay for cyclosporin A)<br />
(L),900<br />
whole-blood cyclosporin A: comparison of<br />
monoclonsl<br />
1100<br />
antibody RIA with HPLC (A),<br />
Cystatin<br />
cystatin C quantn. in CSF (TB), 179<br />
Cystic fibrosis<br />
defective epitheliel ion transport in cystic<br />
fibrosis (5), 726<br />
genetic heterogeneity at the cystic fibrosis<br />
locus (A), 1077<br />
high-Mr (“biliary”) isoenzyme of elk.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
isolation of “cystic fibrosis protein” from<br />
serum, 1901<br />
update on cystic fibrosis: a molecular approach<br />
(A), 1057<br />
use of the polymerase chain reaction for<br />
simultaneous anal, of two Pst I<br />
polymorphisms linked to cystic fibrosis<br />
(TB), 1260<br />
Cystine<br />
quant. measurement of urinary cystine by<br />
nitroprusside reaction (A), 1152<br />
Cytochrome c<br />
interaction between pyridine nucleotide<br />
coenxymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
Cytokeratin-18<br />
two-site IRMA for deth, of urinary<br />
cytokeratin-18; applicn. to management of<br />
bladder cancer (A), 1198<br />
Cytomegalovirus<br />
molecular probes used to detect<br />
cytomegelovirus and human<br />
iminunodeficiency virus (5), 1581<br />
Cytosine arabino.ide<br />
documentation of cytosine arabinoside<br />
using drug monitoring (A), 1182<br />
toxicity<br />
2374 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
liq.-chromatog. monitoring a! cytosine<br />
arabinoside and its metabohite, uracil<br />
arabinoside, in serum, 1011<br />
Data handling<br />
algorithmic-driven lab, testing in a primary<br />
care setting (A), 1233<br />
automation and interpretation of quantn. of<br />
antibodies to therapeutic proteins,<br />
illustrated with somatotropin, 1623<br />
biol. variation of urinary N-acetyl-fl-Dglucoseminidase:<br />
practical and chin.<br />
implications, 560<br />
comparison of ref. standard and standard curve<br />
data-reduction methods for NMI’ low-end<br />
sensitive TSH IRMA (A), 1187<br />
CV at the detection limit (L), 901<br />
determining “ref. changes” for serial<br />
measurements of plasma lipid-bound sialic<br />
acid (A), 1080<br />
detn, of the lower limit of detection (L), 2152<br />
generalized likelihood ratio concept and<br />
logistic regression anal, for multiple<br />
diagnostic categories, 990<br />
methods for detg. “reference changes” from<br />
serial measurements: plasma lipid-bound<br />
sielic acid, 972<br />
reservations regarding assessment of data<br />
obtained with commercially available<br />
cortisol RIA kits (L), 2153<br />
sampling distribn, of skewness and kurtosis<br />
(TB), 330<br />
use of algorithms to achieve cost containment<br />
in a chin, lab. (A), 1233<br />
Data processing<br />
artificial intelligence program for<br />
interpretation of raw data from automated<br />
hemotoL instruments (A), 1089<br />
kinetic study of the Jaff#{233} reaction for<br />
creatinine in serum: 2. evahn. of buffered<br />
reagent and comparison of different dataprocessing<br />
options, 360<br />
Decanoic acid<br />
HPLC anal, of brain and plasma for octenoic,<br />
decanoic acids, 1945<br />
Dehydroepiandrosterone sulfate<br />
decreased dehydroepiandrosterone sulfate in<br />
pigmented nodular adrenal dysplasia (SN),<br />
2216<br />
solid-phase enzyme immunoassay of serum<br />
DHEA-S (A), 1197<br />
Densitometry<br />
See also Reflection densitometry<br />
detection of Duchenne/Becker muscular<br />
dystrophy carriers by densitometric scanning<br />
(TB), 1256<br />
deth. of the allyl lysophospholipid derivative<br />
ET-18-0CH, a new antineophastic drug, in<br />
plasma, 821<br />
Depression<br />
free 3-methoxy-4-hydroxyphenylghycoh deed, in<br />
plasma by liq. chromatog. with coulometric<br />
detection, 202<br />
urine free cortisol in depressed patients<br />
assayed by HPLC (A), 1138<br />
Desferrioxamine<br />
indirect mess, of desferrioxamine and its<br />
chelated cmpa. aluminoxamine and<br />
ferrioxamine by Zeeman at. absorp.<br />
spectrom. (SN), 884<br />
Dextran<br />
interference of plasma expanders in detn. of<br />
total protein (TB), 2143<br />
Diabetes<br />
albuminuria and progression of diabetic<br />
nephropathy (A), 1237<br />
assessin metabolic acidosis (L), 338<br />
biol, variation of urinary N-acetyl-$-Dglucosaminidase:<br />
practical and din.<br />
implications, 560<br />
chin. evaln, of fructosainine assay for screening<br />
for diabetes mellitus (A), 1096<br />
collagen-linked fluorescence in skin biopsy<br />
specimens from young insulin-dependent<br />
diabetic patients (A), 1137<br />
composition of very-low-density lipoproteins in<br />
nan-insulin-dependent diabetes, 808<br />
concns. of lipids, apohipoprotains in patients<br />
with din, well-controlled insulin-dependent<br />
and non-insulin-dependent diabetes, 813<br />
correin, of HbAic, glycated serum proteins and<br />
albumin, and fructosamine with 24-h glucose<br />
profile of insulin-dependent pregnant<br />
diabetics, 922<br />
detn. of usefulness of fructosamine assay for<br />
diagnosis of diabetes (A), 1145<br />
diabetes mellitus: diagnosis and screening (A),<br />
1236<br />
D-lysine effectively decreases non-enzymic<br />
glycation of proteins in vitro, 384<br />
effect of din, apparent recent change in<br />
glycemic control on serum fructosamine (A),<br />
1136<br />
effect of exercise training on glycemic control,<br />
kidney function, and renal ultrastructure in<br />
obese (diabetic) Zucker rats (A), 1135<br />
effect of glycation of low-density lipoprotain on<br />
immunohog. detn. of apolipoprotein B (SN),<br />
2219<br />
effects of various serum proteins on quantn. of<br />
fructosamine (SN), 134<br />
enzyme immunoassay of Hb Ak: anal.<br />
characteristics and din, performance in<br />
diabetes mellitus, with and without uremia,<br />
93<br />
fructosamine and IgA: no correln. in nondiabetics<br />
(L), 1558<br />
fructosamine as routine parameter in diabetes<br />
diagnosis (A), 1098<br />
glycatad Hb and fructosamine measurements<br />
in assessing glycemic control (A), 1236<br />
glycatad Hb in fractionated erythrocytes, 958<br />
increased concns. of heparin cofactor II in<br />
diabetic patients, and possible effects on<br />
thrombin inhibition assay of antithrombin<br />
III, 52<br />
measurement of fructosamine using nitroblue<br />
tatrazolium on IL Multistat and comparison<br />
with Hb A1, in diabetic patients (A), 1146<br />
microalbuminuria in diabetes mellitus: more on<br />
urine storage and accuracy of calorimetry<br />
(L), 1560<br />
microalbuminuria in rats and humans (A),<br />
1137<br />
microphata mess. of urinary albumin,<br />
creatinine, 1371<br />
nonenzymic glycation of human<br />
immunoglobulins does not impair their<br />
immunoreactivity (A), 1154<br />
oral glucose tolerance test does not provide a<br />
uniform stimulus to pancreatic islets in<br />
pregnancy, 1482<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
screenin for microalbuminuria in patients<br />
with diabetes: frozen storage of urine<br />
samples decreases their albumin content<br />
(SN), 308<br />
screening for microalbuiniiiuria with a rapid,<br />
how-cost calorimetric assay (SN), 456<br />
simple enzymatic method for detg. 1,5-<br />
anhydro-D-glucitol in plasma for diagnosis of<br />
diabetes, 2039<br />
transferrin in urine of non-insulin-dependent<br />
diabetics: marker for early complications?,<br />
1672<br />
variables involved in evaluating maternal<br />
serum alpha.fetoprotein: albumin, total<br />
protein and fructosamine (A), 1159<br />
Dialysis patients<br />
See also Hemodialysis<br />
plasma conjugated androgens as digitalis-like<br />
factors in a dialysis-dependent male (A),<br />
1150<br />
Dibucaine<br />
Hitachi 717 procedure for dibucaine inhibition<br />
phenotyping of cholinestarase variants (A),<br />
1120<br />
Diet-related effects<br />
effect of ingestion of hemoprotains on fecal<br />
excretion of hemes and porphyrmns, 2290<br />
methyhmalonic acid. I. concns. in serum and<br />
urinary excretion in normal subjects after<br />
feeding and during fasting, and after loading<br />
with protein, fat, sugar, isoleucine, valine,<br />
2271<br />
Digitalis<br />
plasma conjugated androgens as digitalis-like<br />
factors in a dialysis-dependent male (A),<br />
1150<br />
radioreceptor assay for endogenous digitalislike<br />
substances using microsomal fractions<br />
from human placenta (A), 1140<br />
specific binding of cardiac glycoside drugs and<br />
endogenous digitalis-like substances to<br />
particulate membrane fractions from<br />
placenta, 2093<br />
Digitoxin<br />
evaln. of Baxter Dade Stratus as a stat method.<br />
for human choriogonadotropin, digoxin, and<br />
diitoxin (A), 1111<br />
Digoxin<br />
apphn. of Microgenics CEDIAIN digoxin assay to<br />
the EN! Gemstar’” (A), 1171<br />
cloned enzyme donor immunoassay of serum<br />
digoxin (A), 1190<br />
comparison of free digoxin and total dioxin:<br />
extant of interference from digoxin-like<br />
immunoreactive substances in a fluorescence<br />
polarn, assay (TB), 323<br />
digoxin anal, using Abbott’s digoxin NXT<br />
system (A), 1164<br />
digoxin drug-drug interactions investigated<br />
with a human myocardial NaIK-ATPase<br />
radioreceptor assay (A), 1168<br />
digoxin immune Feb (Digibind’) markedly<br />
affects results of immunoassays for digoxin<br />
(A), 1165<br />
digoxin-like immunoreactive substances in<br />
post-liver transplantation patients with<br />
positive fluid balance (A), 1144<br />
digoxin-like immunoreectivity in neonates and<br />
infants minimized by centrifugal<br />
ultrafiltration and FPIA (A), 1163<br />
dry-strip immunametric assay for digoxin on<br />
the AmesiN seralyzer’ (A), 1168<br />
elimination of total digoxin from a patient in<br />
chronic renal failure post-Fab fragment<br />
(Digibind) therapy (A), 1179<br />
endogenous digoxin measured by receptor<br />
assay in normotensive and hypertensive<br />
subjects (A), 1135<br />
evaln. of a dry reagent digoxin immunometric<br />
assay on a physician’s office analyzer (A),<br />
1109<br />
evaln. of Baxter Dade Stratus as a stat method.<br />
for human choriogonadotropin, digoxin, and<br />
digitoxin (A), 1111<br />
evaln. of Becton<br />
immunoassay<br />
Dickinson Affinity’<br />
system (A), 1107<br />
immunometric assay for digoxin adapted to<br />
Roche Cobas Fare centrifugal analyzer (A),<br />
1166<br />
kinetic behavior of digoxin-hike -<br />
immunoreactive substances during<br />
ultrafiltration studies (A), 1157<br />
measurement of serum digoxin using CEDIA<br />
reagents and the RA-1000 (A), 1183<br />
monoclonal chemiluminescent digoxin assay<br />
(A), 1194<br />
performance of CEDIA Digoxin R assay on<br />
Technicon RA-1000’ chem. analyzer (Al,<br />
1171<br />
physician office eveln. of Chinimate’ digoxin<br />
and theophylhine systems (A), 1099<br />
sequential changes in cross reactivity of antidigaxin<br />
antibodies during immunization (A),<br />
1186<br />
storage temp. and concns. of digozin-hike<br />
immunoreactive factor(s) in plasma (L), 895<br />
Syva EMIT digoxin assay utilizing on-line pretreatment,<br />
for use on Cobas Mire analyzer<br />
(A), 1167<br />
thin-film immunochem. measurement of<br />
digoxin in human serum (A), 1200<br />
total digoxin-hike immunoreactive factor(s),<br />
total bilirubin concn., and birth wt. in<br />
neonates (L), 192<br />
update on digoxin (S), 1326<br />
Dthydroneopterin<br />
urinary neopterin concns. vs total neopterins<br />
for chin, utility (SN), 2305<br />
Dimethyl sulfoxide - -<br />
detection of dimethyl sulfoxide in urine using a<br />
modified Toxilab’ procedure (A), 1165<br />
Diode array spectrometry<br />
HPLC using diode array detection (A), 1240<br />
Dipeptidyl peptidase<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidase IV in synovial fluid<br />
from patients with rheumatoid and<br />
ostaoarthritis, 1016<br />
evaln. of leukocyte-associated dipeptidyl<br />
peptidase IV enzyme in normal and<br />
immunodeficient conditions (A), 1153<br />
Dipsticks<br />
See also Test stripe<br />
implications of probability anal, for<br />
interpreting results of leukocyte esterase and<br />
nitrite test stips, 1663<br />
underestn. of urinary glucose by an automated<br />
dipstick analyzer based on glucose oxidase<br />
with I as indicator chromogen (L), 1804<br />
Discrete analysis -<br />
See also analyte of interest, Instrumentation,<br />
Random-access analysis, etc.<br />
assay of glucose-6-phosphate dehydrogensse<br />
acty. in blood on the Hitachi 737, with<br />
simultaneous detn. of Hb (A), 1119 -<br />
automated assay specific for cyclosporine m<br />
whole blood, with use of a Cr02 particle<br />
column (S), 1860<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2375
estn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
evaln. of Boehringer Mannheim/Hitachi 717<br />
for routine drug of abuse testing (A), 1165<br />
evain, of Boehringer MannheimfHitachi 717<br />
for routine TDM (A), 1165<br />
evaln. of Hitachi 736 chem. analyzer (A), 1109<br />
evaln, of single-reagent Mg procedure on the<br />
Hitachi 737 (A), 1128<br />
measurement of methotrexate on Du Pont ace<br />
discrete din, analyzer (A), 1169<br />
measurement of vancomycin on the Du Pont<br />
ace’ discrete chin, analyzer (A), 1169<br />
stat TDEF capability on Dacos’ XL (A), 1111<br />
Diurnal variation<br />
circadien variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
I-RIA for androstanedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
DNA<br />
automated DNA sequencing methods involving<br />
polymerase chain reaction, 2196<br />
detection of HIV proviral DNA in peripheral<br />
blood mononuclear cells by polymerase chain<br />
reaction (A), 1076<br />
DNA binding differences of active and inactive<br />
platinum anticancer drugs shown by agarose<br />
electrophoresis of restriction endonuclease<br />
fragments of drug-treated DNA (A), 1077<br />
purifn., characterization of intact hactoferrin<br />
found in the urine of human milk.fed<br />
preterm infants, 1928<br />
quanth. of residual DNA in biol. products (S),<br />
1859<br />
DNA fingerprinting<br />
DNA fingerprinting (S), 1832<br />
DNA fingerprinting procedure in the chin, lab.<br />
(A), 1076<br />
DNA fingerprinting with nonradioactive gene<br />
probes (TB), 2147<br />
identn. of locus-specific VNTR sequences in<br />
forensic samples (A), 1058<br />
DNA probes<br />
assay formats involving acridinium-esterlabeled<br />
DNA probes (S), 1588<br />
carrier detection and characterization of gene<br />
deletions in Duchenne and Becker muscular<br />
dystrophy utilizing dystrophin cDNA probes<br />
(A), 1075<br />
chemihuminescent substrates for elk.<br />
phosphatase: application to ultrasensitive<br />
enzyme-linked immunoassays and DNA<br />
probes (A), 1201<br />
(S), 1863<br />
din, lab, use of a semi-automated DNA probe<br />
system (A), 1076<br />
DNA probes for carrier identn.<br />
muscular dystrophy (E), 519<br />
in Duchenne<br />
DNA probes used in detecting carriers of<br />
Duchenne muscular dystrophy: selected case<br />
studies (CR), 679<br />
evaln. of biotinylated (Blugene”) vs<br />
labeled cDNA probes of -<br />
glucocerebrosidase: rel, sensitivities in<br />
genomic and other systems (SN), 1512<br />
genetic heterogeneity at the cystic fibrosis<br />
locus (A), 1077<br />
identh. of Saimonella<br />
phosphstase-labeled<br />
app. with an alkaline<br />
oligonucleotide probe:<br />
comparison with standard biochem. identh.<br />
techniques (A), 1075<br />
use and apphns. of nucleic acid probes in the<br />
chin, lab. (S), 1819<br />
use of DNA probes and complement<br />
phenotyping for diagnosis and carrier<br />
detection in families with steroid 21-<br />
hydroxylase deficiency (A), 1075<br />
Dopainine<br />
adenosine and dopamine simultaneously deed.<br />
in urine by reversed-phase HPLC, with online<br />
meas, of uv absorbance and electrochem.<br />
detection, 64<br />
reversed-phase HPLC sepn. of plasma<br />
norepinephrine, epinephrine, and dopamine,<br />
with 3-electrode coulometric detection (SN),<br />
1975<br />
Down’s<br />
syndrome<br />
chemiluminescent enzyme ‘immunoassay of a-<br />
fetoprotein with adamantyl dioxetane<br />
phenyl phosphate as substrate (SN), 2319<br />
evaln, of Abbott IMx immunoassay analyzer<br />
for maternal serum alpha-fetoprotein<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
maternal serum estriol in screening for Down’s<br />
syndrome: significance of high SD for the<br />
population (A), 1193<br />
serum proteins, immunoglobulin, and<br />
complement (C3 & C4) levels in Down’s<br />
syndrome in Kuwait sample (A), 1081<br />
Drug assay<br />
See also rpecific drug of interest, Abused<br />
drugs, Toxicology<br />
adaptation of ZDV-Trac”' for simultaneous<br />
monitoring of AZT and G-AZT (A), 1187<br />
adaption of Syva EMIT’ TDM assays to the 550<br />
Express (A), 1170<br />
appln. of the Syva EMIT quant. therapeutic<br />
drug assays to Roche Cobas Mire”' analyzer<br />
(A), 1184<br />
chin, lab. evaln. of Clinimata’” digoxin,<br />
theophyhine, phenytoin, phenobarbital, and<br />
carbamazepine systems (A), 1103<br />
computerized interpretation of Taxi-Lab<br />
chromatograms (A), 1087<br />
cost-effective essays for use in monitoring<br />
csrbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
detn. of serum desipramine and 2-<br />
hydroxydesipramine for pharmacokinetic<br />
applns. by HPLC with uv detection (SN),<br />
2134<br />
effect of gel separator tubes on specimens for<br />
therapeutic drug anal, (A), 1182<br />
effect of serum albumin on displacement of<br />
phenytoin by ceftriaxone and nafcillin (A),<br />
1176<br />
evaln. of Boehringer Mannheim/Hitachi 717<br />
for routine TDM (A), 1165<br />
evaln. of Syva ETS and Abbott AD, urine drug<br />
screening immunoassay analyzers (A), 1176<br />
evaln. of TDM available on the DuPont<br />
Dimension (A), 1096<br />
GC-NPD and GC.MS anal. of comm. available<br />
Taxi-Disc’<br />
HPLC/mass<br />
drugs (A), 1184<br />
spectrom.: state of the art for the<br />
drug anal. lab. (S), 1282<br />
hybrid chromatog. methodologies for drug<br />
anal.-GC-MS, LC-MS, MS-MS, and<br />
supercritical fluid chromatography-MS (A),<br />
1055<br />
identn, of some typical a-blockers (bisoprolol,<br />
betaxolol) and propefenone in biol.<br />
specimens: applicn. to doping anal. (A), 1183<br />
hiq.-chromatog. monitoring of cytosine<br />
arabinoeide and its metabolita, uracil<br />
arabinoside, in serum, 1011<br />
liquid-chromatog. method for indomethacin<br />
and other inflammatory drugs (A), 1164<br />
patient-side immunoasssy system with a<br />
singhe-use cartridge for measuring analytes<br />
in blood(S), 1869<br />
performance of theophylline, gentamicin,<br />
tobramycin, phenytoin, and digoxin reagents<br />
on the Beckman Synchron CXn4 (A), 1181<br />
ranitidine and high concns. of<br />
phenylpropanolamine<br />
monoclonal<br />
cross react in the EMIT<br />
amphetamine/methamphetaniine assay<br />
(TB), 1998<br />
simult. liq.-chromatog. detn. of some<br />
bronchodilators, anticanvulsants,<br />
chloramphenicol, and hypnotic agents, with<br />
Chromosorb P columns used for sample<br />
prepn,, 1615<br />
specific RIA for measuring prsvastatin in<br />
human serum (A), 1189<br />
specific RIA for measuring SQ 31,765 in human<br />
serum (A), 1189<br />
strategies for sample prepn. with use of solidphase<br />
extrn. in TDM of basic drugs (A), 1352<br />
supercritical fluid cbromatog. and microbore<br />
liq. chromatog. for drug anal. (S), 1293<br />
system for toxicoL screening by capillary gas<br />
chromatog. with use of a drug retention<br />
index based on Ni-containing ref. cmpds.,<br />
601<br />
use of GC/IR/MS for high-confidence identifn.<br />
of drugs (S), 1279<br />
variations in protein binding of drugs in<br />
plasma, serum (SN), 1722<br />
versatile, efficient system for extracting drugs<br />
from urine for gas chromatog./mass<br />
spectrom. anal. (SN), 2100<br />
Drug dependence<br />
See Abused drugs, Drug assay, Toxicology<br />
Drug metabolism<br />
antiarrhythmic drugs and the cardiac Na<br />
channel: current models (S), 748<br />
oxidation phenotype, comparison between<br />
debrisoquine and dextromethorphan tests<br />
(A), 1184<br />
Drug<br />
monitoring<br />
cydlosporine monitoring (E), 5<br />
fluorescence polarn. iminunoaaaay of<br />
gentamicin or netilmicin in bhood spotted on<br />
filter paper (SN), 867<br />
four fluorescence polarization immunoassays<br />
for therapeutic drug monitoring evald., 138<br />
Drugs of abuse<br />
See Abused drugs<br />
Duchenne muscular dystrophy<br />
DNA probes for carrier identn. in Duchenne<br />
muscular dystrophy (E), 519<br />
DNA probes used in detecting carriers of<br />
Duchenne muscular dystroph selected case<br />
studies (CR), 679<br />
Dumping syndrome<br />
oral glucose tolerance test does not provide a<br />
uniform stimulus to pancreatic islets in<br />
pregnancy, 1482<br />
Dwarfism<br />
somatotropin as mess. by a twa-site timeresolved<br />
immunofluorometric assay, 913<br />
Dye-binding procedures<br />
micro-method for total protein in CSF, using<br />
benzethonium chloride in microtiter plate<br />
wells (SN), 1731<br />
new highly sensitive dye-forming system for<br />
immunostaining (A), 1187<br />
nonprotein components of urine interfere with<br />
colorimetry of urinary albumin with<br />
bromphenol blue (L), 336<br />
total protein deed. ‘inbreast milk by use of<br />
Coomassie Brilliant Blue and centrif. anal.<br />
(SN), 2127<br />
Dysfibrogenemias<br />
optimized microturbidimetric assay for<br />
fibrinogen,<br />
Dystrophln<br />
211<br />
carrier detection and characterization of gene<br />
deletions in Duchenne and Becker muscular<br />
dystrophy utilizing dystrophin cDNA probes<br />
(A), 1075<br />
Economics of laboratory operation<br />
binding of labeled thyroxin analog to serum<br />
proteins evald. after RIA of free thyroxin<br />
(SN), 475<br />
calculation of charges for erroneous results<br />
caused by interfering substances in an outpatient<br />
chem. lab. (A), 1155<br />
concurrent mess. of flecainide acetate and<br />
propranolol by normal-phase liq. chromatog.<br />
(SN), 857<br />
two-point calibration of immunoassays in the<br />
Ciba Corning Magic Lita system (A), 1188<br />
use of algorithms to achieve cost containment<br />
in a chin, lab. (A), 1233<br />
Ectopic pregnancy<br />
algorithm for tasting and reportinq serum<br />
choriogonadotropin at din, signif. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
Effects of Disease on <strong>Clinical</strong> Laboratory<br />
Tests, 2nd. edn.<br />
2161<br />
Ektachem<br />
See Multilayer film analysis<br />
Ehectrochemical detection<br />
bedside diagnosis of alcohol intoxn, with a<br />
pocket-size breath-alcohol device: saxniling<br />
from unconscious subjects and specificity for<br />
ethanol, 918<br />
detn. of physostigmine in plasma and CSF by<br />
liq. chromatog. with electrochem. detection<br />
(SN), 292<br />
detn. of tyrainine in plasma by ion-pair extn.<br />
and reversed-phase liquid chromatog. with<br />
electrochem. detection (A), 1152<br />
recent developments in blood as and<br />
electrolyte measurements with electrochem.<br />
sensors (A), 1232<br />
Electrochemical<br />
See Ion-selective<br />
techniques<br />
electrodes, Electrochemistry,<br />
Potantiometry<br />
Electrodes<br />
See Ion-selective electrodes<br />
Electrofocusing<br />
apolipoprotein E phenotype deed. by agarose<br />
gel electrofocusing, immunoblotting, 2070<br />
Electroimmunoassay<br />
four immunochem, methods compared for<br />
mess. C-reactive protein in plasma (SN), 461<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
Electrolyte, transport<br />
defective epithehial ion transport in cystic<br />
fibrosis (S), 726<br />
Electrolytes<br />
See also specific electrolyte of interest<br />
antiarrhythmic drugs and the cardiac Na<br />
channel: current models (S), 748<br />
automated detn. of urinary Nsf, K, Cl, P.<br />
urea, and creatinine without samphe diln.<br />
with the “RAT-XT” (SN), 481<br />
2376 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
detn. of Mg2 in granulocytes, 1404<br />
enzymatic assay of Mg through glucokinase<br />
actn. (SN), 2212<br />
enzymatic detn, of K in serum, 817<br />
evaln. of Nova 12: whole-blood and serum<br />
electrolyte, glucose, and BUN analyzer (A),<br />
1128<br />
fast, stable method for harvesting leukocytes<br />
for measuring intracellular M (SN), 1986<br />
fluorometry of Mg2 in serum with 2-hydroxy-<br />
1-naphthaldehyde salicyloylhydrazone, 1492<br />
improvement in Synchron CX’-3 electrolyte<br />
performance by use of an enzymatic cleaner<br />
(A), 1097<br />
performance characteristics of Na, K, and Chin<br />
urine on the Paramax analytical system’ (A),<br />
1131<br />
performance evaln, of Corning 288 and Nova<br />
Stat Profile 1 blood gas systems (A), 1093<br />
recent developments in blood gas and<br />
electrolyte measurements with electrochem,<br />
sensors (A), 1232<br />
simultaneous deth. of urea, glucose, Na, K, Cl,<br />
and total CO2 in undlluted human serum<br />
using an electrode-based automated analyzer<br />
(A), 1091<br />
transient increase of sweat electrolyte concns.<br />
associated with environmental deprivation<br />
(A), 1153<br />
Ehectrophoresls<br />
is electrophoresis a ref. method for CK-MB in<br />
comparison with an immunoenzymometric<br />
method? (L), 900<br />
Electrophoreels, agarose<br />
reproducibility of creatine kinase isoenzyme<br />
electrophoresis (L), 710<br />
Electrophoresls, agarose gel<br />
agarose gel ehectrophoresis, and a chaotropic<br />
method compared for lactate dehydrogenase<br />
isoenzyme-1 (TB), 2250<br />
comparison of automated vs manual<br />
ehectrophoreais system for creetine kinase<br />
isoenzymes (A), 1106<br />
ehectrophoresis gel model far Ca oxalate<br />
crystallization (A), 1130<br />
electrophoretic examin. of proteinuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
evaln, of Paragon high-resolution<br />
electropboresis system (A), 1088<br />
field evaln. of Paramax’ Plus anaL system with<br />
Closed Container Sampling”' (A), 1106<br />
IgA-CK-BB complex with CK-MB<br />
ehectrophoretic mobility can lead to<br />
erroneous diagnosis of acute myocard.<br />
infarct. (CR), 2003<br />
lactate dehydrogenase isoenzyme pattern in<br />
sera in malignant diseases, 396<br />
measuring creatine kinase MB isoenzyme in a<br />
maintenance hemodialysis popn.:<br />
chemiluminometric immunoassay and<br />
electrophoresis compared (SN), 1965<br />
sensitive and specific procedure for detecting<br />
oligochonal banding in CSF by agarose gel<br />
electrophoresis (A), 1082<br />
(TB), 1997<br />
sepn. of the CK-MM isoforms by the Paragon’<br />
agarose gel electrophoresis system (A), 1101<br />
serum glycated -lipoprotein deed, by agarose<br />
gel electrophoresis with nitroblue<br />
tetrazolium<br />
Ehectrophoreals,<br />
coloration<br />
cellulose<br />
(TB), 177<br />
acetate<br />
diagnostic value of measuring pancreatic lipase<br />
and the P3 isoform of pancreatic amyhase<br />
isoenzyme in serum of hospitalized<br />
hyperamyhasemic patients, 417<br />
intra-individual variation of electrophoretic<br />
serum protein fractions (TB), 1544<br />
sialidase from different sources compared for<br />
electrophoretically sepg. serum alk.<br />
phosphatase fractions from liver and bone<br />
(SN), 1955<br />
staining method far use in ehectrophoretic<br />
detn. of amylase isoenzymes in serum (SN),<br />
2322<br />
Electrophoresis, gel<br />
lactate dehydrogenase isoenzyme campn. of<br />
platelets (SN), 2325<br />
quantn. of glycated Rb by alkaline gel<br />
electrophoresis: the Paragon system (A),<br />
1162<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd. familial<br />
amyhoidotic pohyneuropathy (SN), 1033<br />
Electrophoresis, high-voltage<br />
creatine kinase isoforms in ischemic heart<br />
disease<br />
sensitive,<br />
(R), 7<br />
rpid assay of subforms of creatine<br />
kinase MB in plasma, 1452<br />
Ehectrophoresis, hectin affinity<br />
alk. phosphatase isoenzymes of liver and bone<br />
origin are incompletely resolved by wheatgerm-hectin<br />
affinity chromatog., 29<br />
Electrophoreals, pohyacryhanjide gel<br />
See also Electrophoresis, two-dimensional<br />
anal. of a-amyhase isoenzymes by automated<br />
isoelectric focusing (SN), 2116<br />
partial charactern. of an abnormal lactate<br />
dehydrogenase lsoenzyme, LDH-lex, in<br />
serum from a patient with hepetocellular<br />
carcinoma (SN), 844<br />
pohyacryhamide gel ehectrophoresis used in a<br />
critical study of pptn. reagents for<br />
quantifying HDL cholesterol (TB), 1254<br />
rapid purifn. of creatine kinase MB isoenzyme<br />
on preparative polyacrylamide slabs, 96<br />
sepn., identn. of urinary proteins and stonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate.-pohyacrylamide gel electrophoresis<br />
(SN), 658<br />
Electrophoreels, two-dimensional<br />
chin. applns, of high-resolution 2-D<br />
ehectropboresis of proteins: comparative<br />
anal, by 2DE of proteins in high-resolution<br />
agarose ehectrophoresis bands and current<br />
med. indications for 2DE anal, of serum<br />
proteins (A), 1083<br />
computerized quant. anal, of Coomassie-Bluestained<br />
serum proteins sepd. by twodimensional<br />
electrophoresis, 2297<br />
Electrophysiohogy<br />
antiarrhythmic drugs and the cardiac Na<br />
channel: current models (S), 748<br />
Embryonic development<br />
cell and substrata adhesion molecules in<br />
embryonic and neural development (S), 738<br />
Emergency procedure<br />
bedside diagnosis of alcohol intoxn. with a<br />
pocket-size breath-alcohol device: sampling<br />
from unconscious subjects and specificity for<br />
ethanol, 918<br />
diagnostic value of measuring pancreatic hipase<br />
and the P3 isoform of pancreatic emyhase<br />
isoenzyme in serum of hospitalized<br />
hyperamyhasemic patients, 417<br />
methods compared for detg. total acty. and<br />
isoenzymes of amylase in serum (SN), 645<br />
role of rapid immunoassays for urgent detns, of<br />
creatine kinase isoenzyme ME (SN), 1752<br />
“stat” measurements of L-lactate in whole<br />
blood and CSF assessed (SN), 1740<br />
Emetine<br />
emetine identified in urine by HPLC, with<br />
fluorescence and ultraviolet/diode array<br />
detection, in a patient with cerdiomyopathy<br />
(CR), 499<br />
EMIT<br />
See Enzyme immunoassay<br />
Emphysema<br />
functional, immunohog. concns, of a2-<br />
macroglobulin compared in plasma of<br />
subjects without a1-protease inhibitor<br />
deficiency (SN), 1535<br />
screening for deficiency of at-proteinase<br />
inhibitor (SN), 1971<br />
Encalnide<br />
encainide and metabohita anal, in serum or<br />
plasma using reversed-phase HPLC (A),<br />
1177<br />
encainide by HPLC-simphified 2-D<br />
chromatog. to eliminate interferences (A),<br />
1177<br />
Encephalopathy syndrome<br />
increases in aspartata aminotransferase,<br />
creatine kinase<br />
encephalopathy<br />
in hemorrhagic shock and<br />
syndrome (L), 2253<br />
Endocarditis<br />
meas. of autoimmune response against collagen<br />
types I, IH, and IV by enzyme-linked<br />
immunosorbent assay, and apphn. in<br />
infective endocarditis, 246<br />
Endorphin<br />
parallel assays of -endorphin and ACTH in<br />
Cushing’s patients undergoing petrosal<br />
studies (A), 1145<br />
Enolase<br />
immunoradiometry of a-y-and -enohase<br />
(neuron-specific enolase), with use of<br />
monoclonal antibodies and magnetizable<br />
polymer particles, 2034<br />
Environmental hazards<br />
new approach to etiohogic diagnosis in<br />
environmental<br />
Enzyme activity<br />
chem. poisoning (A), 1055<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidase IV in synovial fluid<br />
from patients with rheumatoid and<br />
ostaoarthritis, 1016<br />
adaptation of six DGKC enzymes and<br />
chahinesterase to Synchron CX’5 at 30#{176}C<br />
and 37#{176}C (A), 1126<br />
choice of substrate concn, in the search for<br />
abnormal enzyme acty. in tissues (L), 1267<br />
concordance of creatine kinase-MB acty. and<br />
mass, 440<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
effects of therapeutic coronary reperfusion on<br />
aspartata aminotransferase isoenzymes in<br />
sara of patients with acute myocardial<br />
infarct,, 909<br />
evaln. of kinetic method far prostatic acid<br />
phosphatase with use of self-indicating<br />
substrate, 2,6-dichhoro-4-nitrophenyh<br />
phosphate, 939<br />
interaction between pyridine nucheotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-hinked enzymes (SN), 2129<br />
macroenzymes: biochem. characterization, chin.<br />
signif., and lab, detection (R), 2261<br />
methods compared for detg. total acty. and<br />
isoenzymes of amyhase in serum (SN), 645<br />
partial charactern. of an abnormal lactate<br />
dehydrogenase isoenzyme, LDH-lex, in<br />
serum from a patient with hepatoceiluhar<br />
carcinoma (SN), 844<br />
serum mitochondrial aspartate<br />
aminotransferase acty.: not useful as marker<br />
of excessive alcohol consumption in an<br />
unselected population, 926<br />
two-site immunoenzymometry of 52-kDa<br />
cathepsin D in cytosois of breast-cancer<br />
tissues, 81<br />
valproate therapy depresses GSH-PX and<br />
SOD enzyme acty.: possible mechanism for<br />
VPA-induced idiosyncratic drug toxicity (A),<br />
1173<br />
Enzyme electrodes<br />
enzyme electrode far glucose measurement in<br />
whale blood a critical care profiling<br />
instrument (A), 1098<br />
evaln. of Nova-12 urea electrode (A), 1100<br />
use of enzyme electrodes in whole-blood<br />
measurements (A), 1233<br />
Enzyme immunoassay<br />
adaptation of drugs of abuse testing to<br />
Synchron CX’4 and CX’S din, analyzers<br />
(A), 1178<br />
adaptation of Syva assays for drugs of abuse on<br />
the Olympus Reply lab, analyzer (A), 1174<br />
adaption of Syva EMI’r’ d.a.u,”' assays to the<br />
570 Alliance chin. chem, analyzer (A), 1170<br />
adaption of Syva EMIT’ TDM assays to the 550<br />
Express (A), 1170<br />
advances in enzyme-amplified immunoassay<br />
methods (A), 1239<br />
anal. sensitivity of prostate-specific antigen<br />
Tandem’-E enzyme immunometric assay<br />
(A), 1078<br />
appln. of Microgenics CEDIAn digoxin assay to<br />
the ENI Gemstar”' (A), 1171<br />
appin. of the Syva EMIT’ quant. therapeutic<br />
drug assays to Roche Cobas Mira”' analyzer<br />
(A), 1184<br />
automated enzyme immunoessay for detecting<br />
1gM antibody to hepatitis B core antigen (A),<br />
1193<br />
automated enzyme immunoassay for detecting<br />
1gM antibody to hepatitis A virus (A), 1193<br />
automated enzyme immunoasaay for lutropin<br />
(Abbott IMx’ analyzer) (SN), 2333<br />
benzodiazepines identified by capillary gas<br />
chromatog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs., 1394<br />
biotin-avidin-based solid-phase enzyme-linked<br />
iinmunosorbent assay for human serum IgE<br />
(A), 1192<br />
biotin-specific binders to probe charge effects<br />
in enzyme immunoassays (A), 1201<br />
calibrator design considerations for Du Pont<br />
Vista”' immunoassay system (A), 1202<br />
calibrators containing 11-nor-9-THC-9-<br />
carboxyhic acid far use with Syva EMIT’<br />
cannabinoid assays (A), 1173<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2377
candidate Ref. Method for measurement of<br />
apohipoprotein B-100: evaln. of a<br />
monochonal-antibody-based enzyme-linked<br />
immunosorbent assay (A), 1073<br />
CEDIA”' total T3. a rapid homogeneous enzyme<br />
immunoassay for serum total T3 (A), 1095<br />
chemihuminescent assay of alk. phosphatase<br />
applied in an uhtrasensitive enzyme<br />
immunoassay of thyrotropin, 1441<br />
chemihuminescent substrates for alk.<br />
phosphatase: application to ultrasensitive<br />
enzyme-linked immunoassays and DNA<br />
probes (A), 1201<br />
(S), 1863<br />
circulating antibodies to mouse monoclonal<br />
iinniunoglobulins caused false-positive<br />
results in two-site assay for alphafetoprotein<br />
(L), 2339<br />
chin, performance of the EMIT vancomycin<br />
assay (SN), 1504<br />
comparison of two comm. available<br />
immunological occult blood tests and a<br />
guaiac slide test (A), 1162<br />
cost-effective assays far use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
cost-effective EMIT method for qual. d.a.u.<br />
performed an Cobas Mire (A), 1168<br />
detection of antibody to hepatitis B core<br />
antigen using automated micropartichebased<br />
EIA (A), 1193<br />
detection of hepatitis B infection in a randomly<br />
selected pediatric hospital population using<br />
an automated enzyme immunoassay far<br />
HBsAg (A), 1152<br />
detn. of FSH, LH, and cortisoh with automated<br />
enzyme immunoassays (A), 1141<br />
development of applicn. protocols for EMIT’<br />
vancomycin assay on the Syva’ Autolab”'<br />
instrument system and for Cobas Mire<br />
analyzer (A), 1167<br />
development of EMIT’ drugs of abuse assay for<br />
amphetamine/methamphetamine in urine on<br />
the ETh”' system (A), 1180<br />
development of fully automated immunoassay<br />
for hLH on the Abbott IMx’ automated<br />
immunoassay system (A), 1203<br />
development of human factor VII ELISA:<br />
preliminary studies (A), 1161<br />
direct solid-phase enzymoimmunoassay of<br />
testosterone in saliva, 2044<br />
discordant hCG measurements in a patient<br />
with carcinoma (TB),<br />
distribution of prostatic<br />
1259<br />
acid phosphatase in<br />
benign and malignant diseases determined<br />
by Magiwel”' enzyme immunoassay (A), 1079<br />
EIA for detection of RTLV-1 antibodies using<br />
a mixture of synthetic peptide and viral<br />
hysate (A), 1204<br />
ELISA method to measure antibodies to<br />
cardiolipin and phosphatidylserine (A), 1207<br />
EMIT’ convenient two-reagent system for drug<br />
of abuse tasting on most common chem.<br />
analyzers (A), 1167<br />
EMIT”' serum thyroid hormone uptake assay<br />
for use on Cobas Mire and Cobas Bio<br />
analyzers (A), 1141<br />
enhanced luminescence competitive<br />
immunoassay for anti-HIV (A), 120’?<br />
enzyme immunoassay for quantn. of IgG<br />
antibody to rubella virus in serum (A), 1092<br />
enzyme immunoassay for quantn. of<br />
thrombin-antithrombin III<br />
complex-multicentar evaln, (A), 1163<br />
enzyme immunoassay measurement of serum<br />
interheukin-2 receptor in heart-transplanted<br />
patients (A), 1155<br />
enzyme immunaassay of Hb A1,,:anal.<br />
characteristics and chin. performance in<br />
diabetes mellitus, with and without uremia,<br />
93<br />
evahn. of Abbott Commander enzyme<br />
immunoassay system for hepatitis B surface<br />
antigen and B core antibody (A), 1207<br />
evaln. of Abbott IMx immunoassay analyzer<br />
for maternal serum ahpha-fetoprotein<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
evaln, of Abbott IMx T3 assay (A), 1202<br />
evain. of a dry reagent digoxin ixnmunometric<br />
assay on a physician’s office analyzer (A),<br />
1109<br />
evahn, of automated CK-MB mass assay (A),<br />
1107<br />
evaln. of chemiluminescent immunoassay for<br />
deth. of serum peptide hormones (A), 1206<br />
evaln. of EIA for detn. of haloperidol, a<br />
neuroheptic drug, in serum (A), 1175<br />
evaln. of enzyme immunoassay kits for<br />
hepatitis B surface antigen, B surface<br />
antibody, and B core antibody (A), 1207<br />
evaln, of ferritin on Abbott IMx’ automated<br />
immunoassay systems (A), 1099<br />
evaln. of high-sensitivity TSH enzyme<br />
immunoassay reagents far use with Photon<br />
ERA (A), 1196<br />
evsln, of human choriogonadotropin on Abbott<br />
IMx’ automated immunoassay systems (A),<br />
1099<br />
evaln, of new consumer test for lutropin (A),<br />
1146<br />
evaln. of new recombinant ELISA immunoassay<br />
for detection of antibodies to HIV vs DuPont<br />
Western blot (A), 1204<br />
evaln. of Syva EMIT’ d.a,u, apphns. on 550<br />
Express (A), 1170<br />
evaln, of the Olympus P1(310 automated<br />
enzyme immunoassay system (TB), 1995<br />
evaln, of thyroid-stimulating hormone<br />
immunoassay on the IMx (A), 119’?<br />
evaln. of total T3 on Abbott IMx’ automated<br />
immunoassay systems (A), 1099<br />
expression of the major human<br />
ribonucleoprotein (RNP) autoantigens in E.<br />
coil and their use in an EIA for screening<br />
sara from patients with autoimmune diseases<br />
(S), 1861<br />
fluorometric enzyme immunoassay for<br />
measurement of free T4 using Magnisep”'<br />
Cr02 particles (A), 1202<br />
fluorometric enzyme immunoassay for<br />
measurement of total thyroxin using a<br />
reagent delivery module”' (RDM) (A), 1140<br />
fluorometric enzyme immunoassay far<br />
measurement of total T3 using Magnisep”'<br />
Cr02 particles (A), 1202<br />
functional acty. of protein S detd. with use of<br />
protein C activated by venom activator, 1644<br />
high-volume Syva EMrr’ drug tasting on<br />
multiple Epos analyzers interfaced to a<br />
central computer system (A), 1166<br />
immunoassay system for panel testing enzyme<br />
(5), 1874<br />
immunometric total thyroxin assay for use with<br />
dry reagent stripe and a reflectance<br />
photometer (A), 1140<br />
improved test for confirming antibodies to HJV<br />
using six recombinant peptides, including<br />
the intact gag gene-product, p24 (A), 1191<br />
IMi”' APP, automated micropartiche<br />
immunoassay for AFP: performance<br />
characteristics and chin, studies (A), 1192<br />
IMx”' BCM, automated micraparticle enzyme<br />
immunoassay for breast cancer mucin (A),<br />
1078<br />
IMx’ 2-microghobuhin, fully automated<br />
microparticle enzyme immunoassay (A),<br />
1192<br />
how-cost high-sensitivity diagnostic tool (A),<br />
1209<br />
Magiwel”' enzyme immunoassay for dog<br />
heartworm (Dirofiiaria immitis) infections<br />
(A), 1137<br />
measurement of antibodies to soluble CD4 by<br />
ELISA using recombinant CD4 (A), 1191<br />
measurement of estrogen and progesterone<br />
receptors in breast tumors using steroidbinding<br />
assays and monoclonal enzyme<br />
immunoassays (A), 1138<br />
measurement of methotrexate on Du Pant aca<br />
discrete cm. analyzer (A), 1169<br />
measurement of serum digoxin using CEDIA”'<br />
reagents and the RA-l000 (A), 1183<br />
measurement of vancamycin on the Du Pont<br />
ada discrete chin, analyzer (A), 1169<br />
microparticle enzyme immunoassay for<br />
measuring antibodies to hepatitis B surface<br />
antigen, IMx anti-HBs (A), 1193<br />
modified EMIT’ thyroxin assay for use on<br />
Cobas Mire and Cobas<br />
1141<br />
Bio analyzers (A),<br />
monochonal antibodies evald, for use in<br />
screening for conigstes of human serum alb.<br />
and pyridaxal 5’-P04 (SN). 1756<br />
monochonal antibody toy chain of fetal Rb<br />
used to develop an enzyme immunoassay,<br />
2066<br />
novel nonisotopic immunoassay for grkb3-<br />
microghobulin (A), 1205<br />
one-step enzyme immunoassay for free<br />
thyroxin: results with dysalbuminemic sara<br />
and one serum containing autoantibodiea to<br />
thyroxin (TB), 888<br />
overview of enzyme immunoassays (A), 1239<br />
performance characteristics and chin. eveln. of<br />
the Abbott IMx’ APP (A), 1092<br />
performance of CEDIA Digaxin R assay on<br />
Technicon RA-1000”' chem. analyzer (A),<br />
1171<br />
performance of CEDIA”' T4 MAb homogeneous<br />
enzyme immunoessay on the Olympus AU-<br />
5000 din, analyzer (A), 1141<br />
performance of Microgenics CEDIA”' thyroxin<br />
and T-uptake assays on the Ciba-Corning<br />
550 Express”' analyzer (A), 1141<br />
photometric microtitar strip technique for<br />
doctor’s office lab (A), 1209<br />
prospective study of Abbott AFP-EIA as an aid<br />
in detection of fetal neural tube defect (A),<br />
1192<br />
quant. ELA for detn. of tumor necrosis factoralpha<br />
(A), 1187<br />
quant. hCG for the stat lab. (A), 1100<br />
ranitidine and high concns. of<br />
phenyhprapanohamine cross react in the EMIT<br />
monoclonal<br />
amphetamine/methamphetamine assay<br />
(TB), 1998<br />
rapid automated detection of human 1gM<br />
antibody to hepatitis B core antigen (A),<br />
1206<br />
rapid enzyme immunoassay for visual,<br />
semiquant. detn. of hutropin in urine for<br />
ovulation prediction (A), 1148<br />
rapid self-contained immunoassay far hepatitis<br />
B surface antigen (A), 1195<br />
rapid self-contained immunoassay for human<br />
thyrotropin (A), 1195<br />
rapid, specific method for CK-MB using<br />
Tandem Icon OSR CK-MB reagents (A),<br />
1120<br />
rapid thin-layer chromatog. semiquantification<br />
of morphine in urine via dabsylation:<br />
comparison with EMIT and thin-layer<br />
chromatog.-iodoplatinate methods (TB), 329<br />
screening utility of a rapid, automated<br />
fluorescent enzyme immunosssay for HBsAg<br />
in an S.T.D. clinic (A), 1192<br />
simultaneous “sandwich” enzyme<br />
immunoassay for measuring human<br />
osteocalcin using antibodies against<br />
synthetic peptides (A), 1208<br />
simultaneous “sandwich” enzyme<br />
immunoassay for protein C using monoclonal<br />
antibodies (A), 1208<br />
solid-phase enzyme immunoassay of serum<br />
DHEA-S (A), 1197<br />
solid-phase enzyme immunoassay of serum<br />
ferritin (A), 1203<br />
solid-phase enzymoimmunoassay for<br />
osteocahcin in serum or plasma, with use of a<br />
monochonal antibody, 2087<br />
solid-phase enzymaimmunoassay of estrone in<br />
saliva, 569<br />
solid-phase non-isotopic immunassay for<br />
quantn. of cortisol in serum (A), 1201<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoassays<br />
of carcinoembryonic antigen (SN), 146<br />
specific enzyme immunoassay far measuring<br />
new angiotensin-converting enzyme<br />
inhibitor, SQ 29,852, in plasma comparison<br />
with SQ 29,852 RIA (A), 1190<br />
surface characterization of polystyrene (A),<br />
1190<br />
Syva EMIT’ convenience pack assays for<br />
carbamazepine and tobramycin on the Cobas<br />
Mira analyzer (A), 1173<br />
Syve EMIT’ digoxin assay utilizing on-line pretreatment,<br />
for use on Cobas Mire analyzer<br />
(A), 1167<br />
thin-film enzyme immunoassay for<br />
measurement of serum or plasma T4 (A),<br />
1200<br />
thin-film immunochem. measurement of<br />
digoxin in human serum (A), 1200<br />
urine screening for cocaine use with ELISA and<br />
confirmation with GC/MS<br />
Enzyme inhibition assay<br />
(A), 1171<br />
evaln. of a photometric assay for detn. of<br />
human bone alk. phosphatase (A), 1089<br />
Enzyme inhibition lmmunoassay<br />
development of a second-generation Isomune<br />
CK#{149} assay (A), 1121<br />
EMDS test pack CK-MB immunaassay<br />
immunoinhibition with anti-CK-M antibody<br />
(A), 1115<br />
2378 CLINICALCHEMISTRY, Vol. 35, No. 12, 1989
lactate dehydrogenase-1 assay using an<br />
subunit-specific, immobilized monochonal<br />
antibody (A), 1121<br />
methods compared for detg. total acty. and<br />
isoenzymes of amylase in serum (SN), 645<br />
serum P-amylase deth. using monoclonal<br />
antibody (A), 1127<br />
single-vial screening assay for creatine kinase-<br />
MB (A), 1122<br />
Enzyme-linked lnununoasaay<br />
five cannabinoid immunoaasay systems<br />
compared at the screening threshold of 100<br />
ig/L (SN), 2241<br />
immunoradiometry of carcinoembryanic<br />
antigen with use of avidin-biotin labeling,<br />
573<br />
time-resolved fluoroimmunoassay of aflatoxins<br />
(SN), 2308<br />
Enzyme-linked hnmunosorbent assay<br />
See also Enzyme immunoassay<br />
algorithm for testing and reporting serum<br />
choriogonadotropin at chin. signif. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
development of a confirmatory enzyme-linked<br />
immunosorbent assay far HIV-1 antibodies,<br />
946<br />
enzyme-linked immunoeorbent assay for<br />
chromogranin A, 1934<br />
enzyme-linked immunoaorbent assay for free<br />
thyroxin in serum (SN), 1770<br />
enzyme-linked immunosorbent assay of<br />
apolipoprotein B in blood spotted onto filter<br />
paper, suitable for neonatal screening, 1000<br />
hipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
mesa, of autoimmune response against collagen<br />
types I, III, and IV by enzyme-linked<br />
immunosorbent assay, and appln. in<br />
infective endacarditls, 246<br />
microplate meas. of urinary albumin,<br />
creatinine, 1371<br />
neopterin mess, in serum, tissue culture<br />
supernates by competitive enzyme-linked<br />
immunosorbant assay, 1467<br />
prostatic inhibin-like peptide in urine of<br />
prostatic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
rheumatoid factors deed, by fluorescence<br />
immunoassay comparison with qual. and<br />
quant. methods (SN), 464<br />
standn. of apolipoprotein B and A-I mess. (R),<br />
1357<br />
Enzyme-linked ligand sorbent assay<br />
quantn. of biotin in serum by competition with<br />
solid-phase biotin for binding to<br />
peroxidaae-avidin conjugate (SN), 1721<br />
Enzyme-multiplied lmmunoassay<br />
See Enzyme immunoassay<br />
Enzymes<br />
circadian variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
excretion of urinary enzymes after<br />
extracorporeal shock-wave hithotripsy (TB),<br />
2000<br />
urinary excretion of some proteins and<br />
enzymes during normal pregnancy (SN),<br />
1978<br />
Enzymlc methods<br />
accurate cholesterol results by modn. of Roche<br />
enzymatic method parameters (A), 1068<br />
arginine pharmacokinetics assessed with an<br />
enzymatic assay adapted to a centrif,<br />
analyzer<br />
automated<br />
(SN), 1024<br />
micromethod for measuring free<br />
fatty acids in plasma/serum (SN), 2228<br />
chemihuminescent deth. of nonestarified fatty<br />
acids in serum (TB), 325<br />
cyclosporine does not interfere in total and<br />
high-density lipoprotein cholesterol mess.<br />
with use of enzymatic cholesterol assays<br />
(TB), 2251<br />
deth. of branched-chain amino acids and<br />
tyrosine in serum in various hepatic diseases,<br />
and its chin, usefulness, 1399<br />
detn. of glucose using glucose oxidase in a<br />
fixed-time reaction (A), 1105<br />
development of enzymic ref. equiv. method for<br />
total chohesterol (A), 10’71<br />
development of liq. triglycerides-GPO reagent<br />
utilizing response-surface ca-optimization<br />
(A), 1071<br />
effect of lyophiln. on results of five enzymic<br />
methods for cholesterol (SN). 1523<br />
enzymatic assay of Mg through glucokinase<br />
actn. (SN), 2212<br />
enzymatic Cl method for the EMDS Easy ST<br />
analyzer (A), 1133<br />
enzymatic detn. of K in serum, 817<br />
enzymatic detn. of total cholesterol in<br />
gallstones (SN), 2247<br />
enzymatic deth. of urinary oxalate (SN), 2330<br />
enzymatic method for lactate in whale blood<br />
adapted to the Cobas Bio (TB), 324<br />
enzymatic method for oxalate automated with<br />
the Cobas Fare centrif, analyzer (SN), 2094<br />
enzymatic method using 1,2-diglyceride for<br />
pancreatic lipase test in serum (A), 1126<br />
enzymatic salicylate and acetaminophen anal.<br />
on Monarch 2000 (A), 1185<br />
enzymatic theophylline assay on Cobas-Mira<br />
(A), 1102<br />
enzymic assay of salicylate adapted to the<br />
Monarch centrifugal analyzer (TB), 326<br />
enzymic mess. of total bile acids adapted to the<br />
Cobas Fare centrif. analyzer (TB), 1538<br />
enzymic urea assay new colorimetric method<br />
based on H202 mess, (SN), 654<br />
evaln. of Abbott hiq. NH3 assay (A), 1103<br />
evaln. of APEC glucose analyzer method (A),<br />
1112<br />
factors affecting a cyanogen bromide-based<br />
assay of thiamin, 2173<br />
glycerol-blanked triglyceride measurement an<br />
the Hitachi 705 chem. analyzer (A), 1072<br />
increase of hypoxanthine during cardiac<br />
surgery, as measured by an indirect<br />
automated enzymatic assay (L), 898<br />
modified enzymatic approach to measure blood<br />
urea Nan the Technicon RA.1000’ (A), 1104<br />
multipoint kinetic simultaneous mess, of<br />
combined concns, of acetoacetate-l9-<br />
hydroxybutyrate and lactate-pyruvate (SN),<br />
1526<br />
new commercial method for enzymatic deth. of<br />
creatinine in serum and urine evald:<br />
comparison witha kinetic Jaff#{233} method and<br />
isotope dihn.-mass spectrometry (SN), 835<br />
pohyamines assayed by HPLC with<br />
ehectrochem. detection after poet-column<br />
reaction with immobilized pohyamine<br />
oxidase, 1694<br />
rapid micro-scale proced. for detn. of total lipid<br />
profile, 1486<br />
screening for deficiency of ai-protainase<br />
inhibitor (SN), 1971<br />
selective proteohytic measurement of serum m-<br />
AST (A), 1127<br />
simple enzymatic method for detg. 1,5-<br />
anhydro-D-glucitol in plasma for diagnosis of<br />
diabetes, 2039<br />
simultaneous detn, of urea, glucose, Na, K, Cl,<br />
and total CO2 in undiluted human serum<br />
using an electrode-based automated analyzer<br />
(A), 1091<br />
standn. of a commercial (Boehrin?er<br />
Mannheim Diagnostics) enzymac method for<br />
cholesterol, 409<br />
study of hyophilization effect on enzymatic<br />
methods for cholesterol (A), 1066<br />
test-strip method far lactate in whole blood<br />
(SN), 1992<br />
two-center evaln. of physician’s office chem.<br />
analyzer (Clinistat’) for cholesterol anal. (A),<br />
1102<br />
Enxymoimmunoassay<br />
See Enzyme immunoassay<br />
Epidemiology<br />
cholesterol standardization for 13 years by<br />
CDC and Japanese cholesterol levels (A),<br />
1065<br />
Lp(a) phenotype frequency in a normal North<br />
Am. population (A), 1070<br />
Epilepsy<br />
See also Anticonvulsant drugs<br />
HPLC anal, of brain and plasma for octanoic,<br />
decanoic<br />
Epinephrlne<br />
acids, 1945<br />
reversed-phase HPLC sepn. of plasma<br />
norepinephrine, epinephrine, and dopamine,<br />
with 3-electrode coulometric detection (SN),<br />
1975<br />
Equilibrium dialysis<br />
direct and indirect techniques for free thyroxin<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
direct, indirect techniques for free thyroxin<br />
compared in patients with nonthyroidal<br />
illness. II. effect of prealbumin, albumin,<br />
thyroxin-binding globulin, 1655<br />
Errata<br />
See Corrections<br />
Erythrocytes<br />
(acyh)carnitine distribution between plasma,<br />
erythrocytes, and leukocytes in blood (L),<br />
711<br />
automated detn. of chohinesterase acty. In<br />
plasma and erythrocytes by flow-injection<br />
anal., and apphn. to identify subjects<br />
sensitive to succinyhcholine, 77<br />
automated methods for chin, assay of<br />
superoxide dlsmutase and glutathione<br />
peroxidase in human plasma and<br />
erythrocytes using a Cobas Bio centrifugal<br />
analyser (A), 1126<br />
Ca content of healthy erythrocytes (L), 1264<br />
effect of substrate concn, on erythrocyte<br />
transketolase assay (L), 1557<br />
erythrocyte ferritin assay to fmd patients with<br />
homozygous hemochromatosls (A). 1083<br />
glycated Hb in fractionated erythrocytes, 958<br />
interaction between pyridine nucleotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
simple method to deth. human red cell viability<br />
(A), 1128<br />
stability of red cell folate after hemohysis with<br />
ascorbic acid sob. (A), 1160<br />
Erythrocyte sedimentation rate<br />
erythrocyte sedimentation rate and C-reactive<br />
protein compared in the elderly (SN), 466<br />
Erythropoletln<br />
RIA for measurement of natural and Rh<br />
erythropoietin in patient sara (A), 1191<br />
Estradlol<br />
enhanced luminescence immunoassay for<br />
estradiol (A), 1149<br />
estradiol-17 deed, in plasma by gas<br />
chromatog,-mass spectrom. with selected ion<br />
monitoring of mixed silyl<br />
ether-pertluoroacyl ester deravs. and use of<br />
various stable-isotope-labeled internal stds,,<br />
532<br />
evaln. of six direct 17$-estradioh RIA kits and<br />
comparison with an in-house extn, RIA (A),<br />
1150<br />
investigation of sex-hormone-binding globulin<br />
interference in direct RIM for testosterone<br />
and estradioh, 979<br />
one-step estradiol RIA with use of pre-reacted<br />
double-antibody system (A), 1198<br />
three methods compared for estg. testosterone<br />
and estradiol not bound to sex-hormonebinding<br />
globulin (SN), 632<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
Estriol<br />
maternal serum estriol in screeninjfor Down’s<br />
syndrome: significance of high SD for the<br />
population (A), 1193<br />
Estrogen receptors<br />
effect of ether or ketamine anesthesia on rat<br />
uterine estrogen, progesterone receptors<br />
(SN), 143<br />
estrogen and progesterone receptor assays, by<br />
the EIA method (Abbott), of low-speed<br />
supernates of breast-cancer homogenates<br />
(SN), 2226<br />
immunaassay for estrogen receptor does nat<br />
detect inactivated receptor (SN), 824<br />
measurement of estrogen and progesterone<br />
receptors in breast tumors using steroidbinding<br />
assays and monochonal enzyme<br />
immunoassays (A), 1138<br />
relative importance of estrogen and<br />
progesterone receptor assays as prognostic<br />
indicators in primary breast cancer shortterm<br />
study, 238<br />
Estrogens<br />
See also specific estrogen of interest<br />
effects of estrogen on mineral metab. in<br />
poetmenopausal women as evald. by multiple<br />
assays measuring parathyrin bloacty., 18<br />
estradiah-17$ deed, in plasma by gas<br />
chromatog.-mass spectrom. with selected ion<br />
monitoring of mixed silyl<br />
ether-perfluoroacyl ester derive, and use of<br />
various stable-isotope-labeled internal sods.,<br />
532<br />
hormonal evaln, of female infertility,<br />
reproductive disorders (CC), 620<br />
influence of OCT. embedding compd. on<br />
detns. of estrogen and progestin receptors in<br />
breast cancer (SN), 2317<br />
mess, of estrone-3-glucuronide in urine by<br />
rapid, homogeneous timeresolved<br />
fluoroimmunoassay, 665<br />
solid-phase enzymoimmunaassay of estrone in<br />
saliva, 569<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2379
Estrone<br />
mess. of estrone-3-ghucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoasssy, 555<br />
sohid-phase enzymoimmunoassay of estrone in<br />
saliva, 569<br />
Ethanol<br />
See also Alcohol<br />
confirmatory breath ethanol tasting (A), 1184<br />
EMIT’ ethanol assays for use on Cobas Mira<br />
and Cobas Bio analyzers (A), 1166<br />
evaln. of Abbott AD,” analyzer in traditional<br />
and nontraditional markets (A), 1174<br />
ET-18-OCH3<br />
detn. of the allyl lysophosphohipid derivative<br />
ET-18-OCH3, a new antineophastic drug, in<br />
phasma, 821<br />
Exercise, effects of<br />
alteration of lymphocyte subsets and endocrine<br />
response during 80 days of competitive swim<br />
training (A), 1136<br />
effect of exercise training on glycemic control,<br />
kidney function, and renal ultrastructure in<br />
obese (diabetic) Zucker rats (A), 1135<br />
effects of in vivo and in vitro production of<br />
hectic acid on ionized, protein-bound, and<br />
complex-bound Cain blood, 935<br />
heterogeneity of serum creatine<br />
isoenzyme MM in myocardial<br />
kinase<br />
infarction:<br />
chin, significance and post-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
lactate dehydrogenase in serum of patients<br />
performing an exercise test (L), 2016<br />
patterns of lactate dehydrogenase isoenzymes<br />
and 2 in serum on exercise (SN), 301<br />
I<br />
pyruvata mess, in whole blood with the Cobas<br />
Bio analyzer (TB), 325<br />
test-strip method for lactate in whole blood<br />
(SN), 1992<br />
Expert systems<br />
appln. of expert systems in the din, lab. (R),<br />
1595<br />
Exponential amplification<br />
quant. essays based on use of replicetable<br />
hybridization probes (S). 1826<br />
Extraceiluhar water<br />
antipyrine interferes with chem. detn. of Br in<br />
simultaneous estn, of total body H20 and<br />
extracellular H2O, 1367<br />
Factor III<br />
measuring tissue factor (Factor III) acty. in<br />
plasma, 1897<br />
Familial aniyloidotic polyneuropathy<br />
simplified screening of populations at risk far<br />
transthyretin Met30-asaocd. familial<br />
amyloidotic pohyneuropethy (SN), 1033<br />
Familial dy.albuniinemic hyperthyroxinemia<br />
evaln. of Amerliten VF4 method in patients<br />
with FDH and nonthyroidal illness (A), 1142<br />
Fanconi syndrome<br />
ehectrophoretic examin. of protainuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
Fatty acids<br />
See also Lipids, Triglycerides<br />
automated micromethod for measuring free<br />
fatty acids in plasma/serum (SN), 2228<br />
chemiluminescent detn. of nonesterified fatty<br />
acids in serum (TB), 325<br />
direct and indirect techniques for free thyroz.in<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
do nonesterified fatty acids displace thyroxin<br />
from its plasma binding sites in severe<br />
nonthyroidal illnesses? (A), 931<br />
effect of thyroid hormone-binding proteins and<br />
fatty acids on modified analog assays of F’1’4<br />
and FF3 in serum (L), 708<br />
hang-chain aliphatic fatty acids and phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
low-normal concns. of free thyroxin in serum in<br />
hate pregnancy- physial. fact, not tech.<br />
artefact, 1891<br />
phytanic acid, pristanic acid, and very-langchain<br />
fatty acid methyl esters mess.<br />
simultaneously by capillary gas chromatog.<br />
(L),703<br />
prepn. of fecal samples for assay of volatile<br />
fatty acids by gas-hiq. chromatog. and<br />
HPLC, 74<br />
Feces<br />
chin, effective screening of asymptomatic<br />
patients for fecal occult blood loss requires<br />
lab, assistance (L), 2337<br />
comparison of sample preparation techniques<br />
for measurement of total N in stool and food<br />
samples by chemihuminescence (A), 1114<br />
effect of ingestion of hemoprotains on fecal<br />
excretion of hemes and porphyrins, 2290<br />
fecal chymotrypsin: suitable test for diagnosing<br />
pancreatic insufficiency (A), 1090<br />
“Fecatwin Sensitive” test for fecal occult blood<br />
not intended for use without testing positives<br />
with the FECA-ELA assay (L), 1555<br />
prepn, of fecal samples for assay of volatile<br />
fatty acids by gas-hiq. chromatog. and<br />
HPLC, 74<br />
thin-layer chromatog. of free porphyrins for<br />
diagnosis of porphyria (SN), 5043<br />
Ferrioxamine<br />
indirect mess, of desferrioxamine and its<br />
chelated cmps. aluminoxamine and<br />
ferrioxamine by Zeeman at. absorp.<br />
spectrom. (SN), 884<br />
Ferritin<br />
commercially available dissociation-enhanced<br />
hanthanide t’luoroimmunoassay kit evald. for<br />
quantifying ferritin in serum (TB), 327<br />
concns, of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
851<br />
erythrocyte ferritin assay to find patients with<br />
homozygous hemochromatosis (A), 1083<br />
evaln. of ferritin on Abbott LMx’ automated<br />
immunoassay systems (A), 1099<br />
high serum ferritin level and its significance in<br />
cancer (A), 1081<br />
rapid det. of ferritin in serum by the<br />
“Stratus” fluoroenzymoinimunometric assay<br />
(TB), 672<br />
short- and lang-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
solid-phase enzyme immunoassay of serum<br />
ferritin (A), 1203<br />
solid-phase immunofluorometric assay for<br />
human serum ferritin (A), 1189<br />
Fertility<br />
high concns. of Zna2-glycoprotein and lack of<br />
a2HS-ghycoprotein in ejaculates, 1649<br />
RIA of $-microseminopratein, a prostaticsecreted<br />
protein in sara of men and women,<br />
1497<br />
Fertility studies<br />
See also Infertility<br />
embryo cryopreservation (A), 1064<br />
hormonal evaln. of female infertility,<br />
reproductive disorders (CC), 620<br />
IVF-GIFT: enhanced reproductive technol.<br />
(A), 1063<br />
meas. of estrone-3-ghucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoassay, 555<br />
ovarian stimulation monitoring (A), 1063<br />
solid-phase enzymoimmunoassay of estrone in<br />
saliva, 669<br />
Fetal status<br />
See also Amniotic fluid,<br />
Lecithin/sphingomyein ratio, etc.<br />
amniotic fluid lameilar bodies characterized by<br />
resistive-pulse counting: relation to measures<br />
of fetal lung maturity, 612<br />
automated rapid assessment of surfactant and<br />
fetal lung maturity by altered fluorescence<br />
polarization of a dye (PC16) (A), 1107<br />
comparison of tests used to assess fetal<br />
maturity (A), 1069<br />
lab. role in predicting fetal lung maturity (A),<br />
1241<br />
maternal serum estriol in screening for Down’s<br />
syndrome: significance of high SD for the<br />
population (A), 1193<br />
multicenter evaln. of TDx’ fetal hung maturity<br />
(A), 1075<br />
multicenter eveln. of TDx teat for assessing<br />
fetal lung maturity, 1005 - -<br />
phosphohipid surface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal. of the value of pptn. with cold acetone,<br />
800<br />
Fetoprotein<br />
AFP quantn. compared using a semiautomated<br />
monoclonal and a -<br />
polyclonal-monoclonal immunoenzymatic<br />
assay (A), 1200<br />
alpha-fetoprotein assay and abnormal values<br />
(A), 1157<br />
biiary all, phosphatase measured by minicolumn<br />
chromatog. on DEAR-cellulose:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
chemiluminescent enzyme immunoassay of a-<br />
fetoprotein with adamantyl dioxetane<br />
phenyh phosphate as substrate (SN), 2319<br />
circulating antibodies to mouse monochonal<br />
immunoglobulins caused false-positive<br />
results in two-site assay for alphafetoprotein<br />
(L), 2339<br />
dissocn. of immunocomplexes by ionic shock<br />
for development of immunosensors: appln. to<br />
meas. of ai-fetoprotain (SN), 1026<br />
eveln. of Abbott IMx immunoassay analyzer<br />
for maternal serum alpha-fetoprotein<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
IMx” AFP, automated micropartiche<br />
immunoassay for AFP: performance<br />
characteristics and chin, studies (A), 1192<br />
performance characteristics and din, evaln. of<br />
the Abbott IMx AFP (A), 1092<br />
prospective study of Abbott AFP-EIA as an aid<br />
in detection of fetal neural tube defect (A),<br />
1192<br />
racial and other differences of maternal serum<br />
a-fetoprotein in a large obstetrical<br />
population (A), 1136<br />
variables involved in evaluating maternal<br />
serum alpha-fetoprotein: albumin, total<br />
protein and fructosamine (A), 1159<br />
Fiber Optic sensors<br />
intravascular monitoring techniques, risks and<br />
problems (A), 1059<br />
Fibrin<br />
monitoring hysis of fully cross-linked fibrin<br />
clots with comm. D-dimer teat (A), 1161<br />
Fibrinogen<br />
optimized microturbidimetric assay for<br />
fibrinogen.<br />
Fibronectin<br />
211<br />
See also Prealbumin<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusiona (SN), 166<br />
Flame photometry<br />
enzymatic detn. of K in serum, 817<br />
Flecainide<br />
fhecainide: comparison of fluorescence<br />
polarization with HPLC (A), 1097<br />
Flow-injection analysis<br />
automated fluoroimmunoassay of theophyiline<br />
and vaiproic acid by flaw-injection anal. with<br />
use of HPLC (SN), 469<br />
Fluorescein<br />
interference by intravenous fluorescein with<br />
lab. tests (A), 1159<br />
Fluorescence immunoassay<br />
See Fhuoroimmunoassay, Immunoassay<br />
Fluorescence polarization<br />
automated rapid assessment of surfactant and<br />
fetal lung maturity by altered fluorescence<br />
polarization of a dye (PC 16) (A), 1107<br />
comparison of free digoxin and total dioxin:<br />
extent of interference from digoxin-hike<br />
immunoreactive substances in a fluorescence<br />
polarn. assay (TB), 323<br />
cost-effective assays for use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
flecainide: comparison of fluorescence<br />
polarization with HPLC (A), 1097<br />
multicenter evaln. of TDx fetal lung maturity<br />
(A), 1075<br />
multicenter evaln. of TDx test for assessing<br />
fetal hung maturity, 1005<br />
TDM assays by fluorescence polarization on<br />
Cobas Fara IITNanalyzer; detn. of serum<br />
amikacin, gentamicin, and tobramycin (A),<br />
1178<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare IITN:detn, of serum N-<br />
acetyhprocainamide, theophylline, and<br />
phenytoin (A), 1178<br />
Fluorescence polarization immunoassay<br />
AD” amphetamine class assay (A), 1174<br />
antiepieptic drug monitoring by FPIA and gas<br />
chromatography (A), 1208<br />
assay for benzodiazepines on the AD,’<br />
analyzer (A), 1174<br />
cm. performance of the EMIT vancomycin<br />
assay (SN), 1504<br />
comparison of Abbott TDx FPIA for<br />
cannabinoids with GC/MS (A), 1185<br />
cyclosporine concns. in blood after liver<br />
transplantn.: correlation of immunoassay<br />
results with chin. events, 564<br />
detection limit of the TDx fluorescence<br />
polarization immunoassay extended for<br />
benzoylecgonine in urine (SN), 2110<br />
development of TD./ADn fluorescence<br />
polarization immunoassay for detection of<br />
methadone in human urine (A), 1176<br />
digoxin-hike immunoreactivity in neonates and<br />
infants minimized by centrifugal<br />
ultrafiltration and FPIA (A), 1163<br />
2380 CLINICALCHEMISTRY, Vol. 35, No. 12, 1989
evaln. of Abbott AD,. analyzer in traditional<br />
and nontraditional markets (A), 1174<br />
evaln. of Abbott MTDX’ drug anal. system (A),<br />
1185<br />
evaln, of Abbott TD for drugs of abuse<br />
testing ins field environment (A), 1179<br />
evaln. of combined cocaine/op!ate screening<br />
procedure on Abbott labs. TDx (A), 1165<br />
evaln. of the Ames Seralyzer for therapeutic<br />
drug monitoring of phenobarbital, phenytoin<br />
(TB), 324<br />
evaln. of the Tl)x and ADx methadone<br />
immunoassays (TB), 1794<br />
five cannabinoid immunoasaay systems<br />
compared at the screening threshold of 100<br />
,&g/L (SN), 2241<br />
fluorescence polarn. immunoassay of<br />
gentainicin or netilmicin in blood spotted on<br />
filter paper (SN), 867<br />
fluorescence poharn. immunoasaay of urinary 5-<br />
hydroxy-3-indoleacetic acid, 355<br />
four fluorescence polarization immunoassays<br />
for therapeutic drug monitoring evald,, 138<br />
multiple drugs of abuse detection by FPIA<br />
using TDx reagent mixture (A), 1164<br />
prognostic value of MEGX liver-function test<br />
in transplant candidates (A), 1135<br />
serum valproic acid detn. on Cobas B1oFP<br />
centrifugal analyzer (A), 1178<br />
rluoroenzymoimmunometric assay<br />
rapid detn. of ferritin in serum by the<br />
“Stratus” fluoroenzymoimmunametric assay<br />
(TB), 672<br />
!luorobnmunoassay<br />
automated fluoroimmunoassay of theophylhine<br />
and valproic acid by flow-injection anal, with<br />
use of HPLC (SN), 469<br />
commercially available dissociation-enhanced<br />
lanthanide fluoroimmunoassay kit evald. far<br />
quantifying ferritin in serum (TB), 327<br />
development of monoclonal antibodies<br />
human myoglobin and their use in<br />
to<br />
fluorescence immunoassay (A), 1203<br />
dry-chem. multilayer element for thyroid<br />
hormone uptake assay (A), 1195<br />
dry-chem. multilayer immunoassay for total<br />
thyroxin (A), 1180<br />
dry-chem. multilayer inlmunaassay test far<br />
theophylline (A), 1196<br />
dry-chem. multihayer immunoaasay tests for<br />
phenytoin and phenabarbital (A), 1196<br />
evaln, of automated CK-MB mass assay (A),<br />
1107<br />
evaln. of automated fluorescent immunoassay<br />
far detection of HBsAg (A), 1095<br />
fluorescence immunoassays (A), 1239<br />
mess, of estrone-3-glucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoassay, 555<br />
measurement of free testosterone and free<br />
androgen index by use of sex-hormonebinding<br />
globulin concns.<br />
(fluoroimmunoassay) in hirsutism (A), 1143<br />
multilayer fluorescence immunoassay<br />
technique(S), 1865<br />
quantn. of free and whole molecule -hCG in<br />
an automated fluorescence immunoassay<br />
(A), 1147<br />
rheumatoid factors detd, by fluorescence<br />
immunoassay comparison with qual. and<br />
quant. methods (SN), 464<br />
stable liposomes for microcapeule<br />
immunoassay in human sara (A), 1204<br />
time-resolved fluorescence immunoassay<br />
system especially suited for res. applications<br />
(TB), 491<br />
time-resolved fluoroimmunoassay for<br />
measuring thyroxin-binding globulin (A),<br />
1205<br />
time-resolved fluoraimniunoassay of aflatoxins<br />
(SN),2308<br />
rluoromoiry<br />
antipyrine<br />
simultaneous<br />
interferes<br />
estn.<br />
with chem. detn. of Br<br />
of total body H20 and<br />
in<br />
extracellular H20, 1367<br />
automated DNA sequencing methods involving<br />
polymerase chain reaction, 2196<br />
calibrator design considerations for Du Pont<br />
Vista’ immunoassay system (A), 1202<br />
collagen-linked fluorescence in skin biopsy<br />
specimens from young insulin-dependent<br />
diabetic patients (A), 1137<br />
detn. of trons-phyiloquinone in children’s<br />
serum (SN), 874<br />
direct detn. of 4 sulfates and 7 glucuronides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” hiq. chromatog., 794<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyrins, 2290<br />
effect of light on reactions between N’-<br />
methylnicotinamide and methyl ketones<br />
(TB), 2000<br />
evaln, of Abbott IMx T3 assay (A), 1202<br />
evaln, of thyroid-stimulating hormone<br />
immunoassay on the IMx (A), 1197<br />
fluorometric enzyme immunoassay for<br />
measurement of free T4 using Magnisep’<br />
Cr02 particles (A), 1202<br />
fluorometric enzyme immunoassay for<br />
measurement of total thyroxin using a<br />
reagent delivery module’ (RDM) (A), 1140<br />
fluorometric enzyme immunoassay for<br />
measurement of total T3 using Magnisep’<br />
Cr02 particles (A), 1202<br />
fluorometric method for phenylalanine<br />
microplate assay adapted for<br />
phenylketonuria screening (SN), 2112<br />
fluorometry of Mg2+ in serum with 2-hydroxy-<br />
1-naphthahdehyde salicyloyhhydrszone, 1492<br />
fully automated fluorescence assay for detg.<br />
total homocysteine in plasma, 1921<br />
immunoassays for rubella antibodies (IgG and<br />
1gM) in serum using time-resolved<br />
fluorescence (A), 1153<br />
hiq. chromatog. assay for free and<br />
transthyretin.bound retinol-binding protein<br />
in serum, 582<br />
how-cost high-sensitivity diagnostic tool (A),<br />
1209<br />
measurement of creatine kinase MB by the<br />
Baxter Stratus fluorometric analyzer (A),<br />
1123<br />
microassay for screening newborns for<br />
galactosemia with use of a fluorometric<br />
microplata reader (SN), 1962<br />
modern trends in image analysis (A), 1053<br />
nonenzymatic stopped-flaw fluorimetry for<br />
direct detn. of uric acid in serum and urine,<br />
230<br />
novel nonisotopic immunoassay for grkb2-<br />
microglobulin (A), 1205<br />
quantn. of urinary porphyrins by hiq.<br />
chromatog. after oxidn, of porphyrinogens,<br />
1619<br />
rapid self-contained immunoassay for human<br />
thyrotropin (A), 1195<br />
screening utility of a rapid, automated<br />
fluorescent enzyme immunoassay for HBsAg<br />
in an S.T.D. clinic (A), 1192<br />
simultaneous liq.-chramatog. detn. of vit. K1,<br />
vit. E in serum, 2285<br />
two-site IRMA for detn, of urinary<br />
cytokeratin-18; epplicn. to management of<br />
bladder cancer (A), 1198<br />
Fluorouracil<br />
extn, of intracellular nucleoeides and<br />
nucheotides with acetonitrile, 48<br />
Fluoxetine<br />
fluoxetine and norfluoxetine detn. in serum by<br />
capillary GC-ECD with solid-phase extn.<br />
(A), 1169<br />
fluozetine inhibition of imipramine<br />
metabolism (A), 1180<br />
Fluvoxamine<br />
new method for monitoring fluvoxamine in<br />
human plasma by RPLC with uv detection<br />
(A), 1185<br />
Folate<br />
See also specific fohate of interest<br />
chemilumineacence receptor assay for fohate<br />
(A), 1194<br />
stability of red cell fohate after hemohysis with<br />
ascorbic<br />
Fohic acid<br />
acid sohn. (A), 1160<br />
See Fohate<br />
Follitropin<br />
assay far human follitropin using higand and<br />
anti-higand system (A), 1190<br />
detn. of FSH, LH, and cortisol with automated<br />
enzyme immunoassays (A), 1141<br />
development of solid-phase FSH IRMA (A),<br />
1201<br />
fully automated essay for human folliclestimulating<br />
hormone on the Abbott IMx’<br />
automated immunoassay system (A), 1142<br />
time-resolved immunofluorometry of<br />
fohhitropin in serum (TB), 181<br />
(A), 1138<br />
Forensic medicine<br />
benzodiazepines identified by capillary gas<br />
chromatog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs,, 1394<br />
confirmatory breath ethanol testing (A), 1184<br />
degree of lipid peroxidation in postmortem<br />
blood of tire victims (A), 1176<br />
DNA fingerprinting(S), 1832<br />
evaln, of vitreous fluid as a specimen for drug<br />
abuse testing (A), 1181<br />
five cannabinoid immunoassay systems<br />
compared at the screening threshold of 100<br />
g/L (SN), 2241<br />
identn, of locus-specific VNTR sequences in<br />
forensic samples (A), 1058<br />
F protein<br />
plasma glutathione S-transferase and F protein<br />
are mare sensitive than alanine<br />
aminotransferase as markers of<br />
acetaminophen-induced liver damage, 2186<br />
Fructosamine<br />
din, evaln. of fructosamine assay for screening<br />
for diabetes mellitus (A), 1096<br />
correln, of 14bAi, glycated serum proteins and<br />
albumin, and fructosamine with 24-h glucose<br />
profile of insulin-dependent pregnant<br />
diabetics, 922<br />
detergent enhances interference of urete in<br />
detns, of fructosamine (L), 1803<br />
detn, of usefulness of fructosamine assay far<br />
diagnosis of diabetes (A). 1145<br />
effect of chin. apparent recent change in<br />
glycemic control on serum fructosamine (A),<br />
1136<br />
effect of measurement wavelength<br />
fructosamine results (L), 1582<br />
on<br />
effects of various serum proteins on quantn. of<br />
fructosamine (SN), 134<br />
evaln. of liq. quality-control material for detn.<br />
of fructosaniine in human serum (A), 1106<br />
fructosamine and IgA: no correln, in nondiabetics<br />
(L), 1556<br />
fructoeamine as routine parameter in diabetes<br />
diagnosis (A), 1098<br />
fructosamine assay modified far estn. of<br />
glycated Rb (TB), 497<br />
fructosamine: matrix problems with stds. based<br />
on protein matrices (L), 191<br />
glycated Hb and fructosamine measurements<br />
in assessing glycemic control (A), 1236<br />
glycated Hb in fractionated erythrocytes, 958<br />
improved colorimetric fructosamine assay (A),<br />
1110<br />
D-hysine effectively decreases nan-enzymic<br />
glycation of proteins in vitro, 384<br />
measurement of fructosamine using nitroblue<br />
tetrazohum on IL Multistat and comparison<br />
with Hb A1 in diabetic patients (A), 1146<br />
relative potency of commercial calibrators for<br />
fructosamine, and their effect on mess. of<br />
fructosamine in serum (L), 712<br />
Galactosemia<br />
microassay for screening newborns for<br />
galactosemia with use of a fluorometric<br />
microphate reader (SN), 1962<br />
Gallstones<br />
enzymatic detn. of total cholesterol in<br />
gallstones (SN), 2247<br />
Gammopathie.<br />
See also Monoclonal gammopathies<br />
Gas<br />
See Blood gases, Breath analysis<br />
Gas chromatography<br />
cost-effective assays for use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
use of GC/IR/MS for high-confidence identifn.<br />
of drugs(S), 1279<br />
Gas chromatography, capillary<br />
benzodiszepines identified by capillary gas<br />
chromatog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs., 1394<br />
Gas chromatography/mass ipectrometry<br />
amphetamine, methamphetamine quant.<br />
confirmation procedure by GCIMS (A), 1169<br />
biochem, contribution to diagnosis and study<br />
of a new case of D-glyceric acidemia/aciduria<br />
(CR), 2148<br />
din, steroid profiles by GC/MS (A), 1142<br />
comparison of Abbott TDx FPIA for<br />
cannabinoids with GC/MS (A), 1185<br />
delta-9-THC and delta-9-THC-carboxyhic in<br />
serum by quant. GC/MS (A), 1170<br />
estrsdiol-17$ detd. in plasma by gas<br />
chromatog.-mass spectrom. with selected ion<br />
monitoring of mixed sihyl<br />
ether-perfluoroscyl ester derive, and use of<br />
various stable-isotope-labeled internal sods.,<br />
532<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2381
GC-NPD and GC-MS anal, of comm. available<br />
Toxi-Disc drugs (A), 1184<br />
identn, of some typical -bhockers (bisoprohol,<br />
betaxolol) and prapafenone in bioL<br />
specimens: applicn. to doping anal. (A), 1183<br />
improved GCIMS drug detection with chem.<br />
ionization mass spectrometry and ion trap<br />
detection (A), 1180<br />
isotope diln, GC-MS of metals at trace levels in<br />
biol. samples (A), 1113<br />
quant anal. for org. acids in biol, samples:<br />
batch isolation followed by gas<br />
chromatog.-mass spectrom. anal., 587<br />
simultaneous qusntn. of morphine, codeine,<br />
and 06-monoacetyl morphine by gas<br />
chromatog. mass spectrom. (A), 1355<br />
urinary org. acid excretion by premature<br />
babies,<br />
versatile,<br />
1460<br />
efficient system for extracting drugs<br />
from urine for gas chromatog./mass<br />
spectrom. anal. (SN), 2100<br />
Gastrltls<br />
high prevalence of atrophic gastritis in the<br />
elderly: implications for health-associated<br />
ref. limits for cobalamin in serum (L), 1557<br />
Gastroduodenal ulcers<br />
pepsin and pepsinogen group I levels in human<br />
gastroduodenal biopsies (A), 1126<br />
Gaucher’. disease<br />
immunoassay of band 5 (“tartrate-resistant”)<br />
acid phosphatase involving use of antiporcine<br />
uteroferrin antibodies, 86<br />
GELLAB<br />
See Ehectrophoresis, twa-dimensional<br />
Gene probes<br />
DNA fingerprinting with nonradioactive gene<br />
probes (TB), 2147<br />
Gene synthesis<br />
genetically engineered antibodies (5), 1849<br />
Genetic engineering<br />
genetically engineered antibodies (S), 1849<br />
Genetics<br />
See also Heritable disorders<br />
carrier detection and characterization of gene<br />
deletions in Duchenne and Becker muscular<br />
dystrophy utilizing dystrophin cDNA probes<br />
(A), 1075<br />
cm. signif. of genetic rearrangements in<br />
neuroblastomas (5), B38<br />
construction of a linkage map of the human<br />
gename, and its apphn. to mapping genetic<br />
diseases (5), 833<br />
cystic fibrosis: diagnostic testing and the<br />
search for the gene (5), B17<br />
DNA flngerprintmg (5), 1832<br />
erythrocyte ferritin assay to find patients with<br />
homozygous hemochromatosis (A), 1083<br />
fundamental mechanisms of tumorigenesis in<br />
the nervous system: isoln, and charactern, of<br />
genes assocd, with hered. forms of cancer (S),<br />
825<br />
genes encoding neuronal nicotinic<br />
acetylchohine receptors (S), 731<br />
genetic heterogeneity at the cystic fibrosis<br />
locus (A), 1077<br />
genetics of bipolar affective disorder: chin.<br />
implications (5), B28<br />
lipoprotain(a): genetic marker for<br />
atherosclerosis (A), 1234<br />
loss of heterozygosity in stages of malignancy<br />
(S). B48<br />
Lp(a) phenotype frequency in a normal North<br />
Am: population (A), 1070<br />
mapping the locus of autosomal dominant<br />
polycystic kidney disease: diagnostic eppln.<br />
mole, genetics of Duchenne and Becker<br />
muscular dystrophy emphasis on improved<br />
diagnosis (S), B21<br />
molecular genetics of leukemia and lymphoma<br />
(S),B43<br />
moL genetics and the transformation of cm.<br />
chem, (S), 2165<br />
oxidation phenotype, comparison between<br />
debrisoquine and dextromethorphan tests<br />
(A), 1184<br />
recombinant DNA technoL in diagnosis of<br />
genetic disorders(S), 84<br />
strong assocn, of a single nucheotide<br />
substitution in the 3’-untranslated region of<br />
the apohipoprotein.CIII gene with common<br />
hypertrighyceridemia in Arabs, 256<br />
use of DNA probes and complement<br />
phenotyping for diagnosis and carrier<br />
detection in families with steroid 21-<br />
hydroxylase deficiency (A), 1075<br />
Gentamicin<br />
fluorescence poharn. immunoassay of<br />
gentamicin or netilmicin in blood spotted on<br />
filter paper (SN), 867<br />
latex agglutination inhibition immunoassay for<br />
gentamicin on the IL Monarch’ chem.<br />
system (A), 1172<br />
quality assurance study of gentamicin usage<br />
and monitoring ins children’s hospital (A),<br />
1167<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare 1P5 analyzer; detn. of serum<br />
amikacin, gentamicin, and tobramycin (A),<br />
1178<br />
Technicon tobramycin and gentamicin: secondgeneration,<br />
improved methods on the RA-<br />
1000 system (A), 1172<br />
Geriatric chemistry<br />
bioL variability of 26 din. chem. analytes in the<br />
elderly, 783<br />
chin. chem. ref,-intervals for healthy elderly<br />
(A), 1061<br />
erythrocyte sedimentation rate and C-reactive<br />
protein compared in the elderly (SN), 466<br />
geriatric ther, drug monitoring: special<br />
considerations(S), 1337<br />
Gigantism<br />
somatotropin as mess. by a two-site timeresolved<br />
immunofluorometric assay, 913<br />
Globulins<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns,<br />
Glomerular filtration rate<br />
(CR), 333<br />
renal function assessed by serum creatinine<br />
and creatinine clearance: glomerular<br />
filtration rate estd. by four procedures (SN),<br />
2326<br />
Glucitol<br />
simple enzymatic method for detg. 1,5-<br />
anhydro-D-ghucitol in plasma for diagnosis of<br />
diabetes, 2039<br />
Glucocerebrosldsse<br />
evaln. of biotinylated (Blugene’) vs 32p<br />
labeled cDNA probes of -<br />
glucocerebrosidase: rel. sensitivities in<br />
genomic and other systems (SN), 1512<br />
Glucosaminidase<br />
bioL variation of urinary N.acetyh--Dglucosaminidase:<br />
practical and din.<br />
implications, 560<br />
intra-individual biol. variation in the N-acetyl-<br />
$-glucosaminidsse/creatininium ratio for<br />
first morning urine (TB), 1256<br />
Glucose<br />
accuracy, precision, and chin, reliability of three<br />
capillary blood glucose monitors (A), 1135<br />
aqueous-based glucose control solos. for use<br />
with glucose reagent-strips and meters (L),<br />
2017<br />
deth, of glucose using glucose oxidase<br />
fixed-time reaction (A), 1105<br />
in a<br />
effectiveness of NsF as a preservative of blood<br />
glucose (SN), 315<br />
effects of glucose on spectraphotometric detn,<br />
of blood D-xylose (A), 1156<br />
enzyme electrode for glucose measurement<br />
whole blood with a critical care profiling<br />
in<br />
instrument (A), 1098<br />
evaln. of APEC glucose analyzer method (A),<br />
1112<br />
evaln, of Beckman Interhink’s custom<br />
formatting for reporting glucose tolerance<br />
test results (A), 1088<br />
evaln. of Litescan “One Touch” glucometer far<br />
a hoep. bedside glucose monitoring program<br />
(A), 1107<br />
evaln. of Nova 12: whale-blood and serum<br />
electrolyte, glucose, and BUN analyzer (A),<br />
1128<br />
individual home glucose meters evalusted by<br />
routine chin. lab, methods (A), 1142<br />
influence of blood 02 tension on dipstick<br />
glucose detns. (L), 1268<br />
qua!. control of glucose monitors outside the<br />
chin, lab.: use of commercial nonhuman<br />
erythrocyte prepns. supplemented with<br />
glucose (L), 509<br />
quality-control program for evaluating and<br />
monitoring multiple-site reflectance glucose<br />
analyses (A), 1160<br />
reagenthess detn, of glucose and other<br />
constituents in blood by ATR-FT-IRspectroscapy<br />
(5), 1854<br />
relationship between plasma and whole-blood<br />
glucose during the glucose tolerance test (A),<br />
1127<br />
reliable bedside glucose tasting ins hospital<br />
(A), 1237<br />
simultansous detn, of urea, glucose, Na, K, Cl,<br />
and total CO2 in undiluted human serum<br />
using an electrode-based automated analyzer<br />
(A), 1091<br />
technique-induced errors in two popular blood<br />
glucose reagent strips (A), 1156<br />
underestn. of urinary glucose by an automated<br />
dipstick analyzer based on glucose oxidase<br />
with has indicator chromogen (L), 1804<br />
Glucose-6-phosphate dehydrogensse<br />
assay of glucose-S-phosphate dehydrngenase<br />
acty. in blood on the Hitachi 737, with<br />
simultaneous detn. of Hb (A), 1119<br />
Glucose tolerance test<br />
oral glucose tolerance test does not provide a<br />
uniform stimulus to pancreatic islets in<br />
pregnancy, 1482<br />
relationship between plasma and whole-blood<br />
glucose during the glucose tolerance test (A),<br />
1127<br />
Glutsmyhtransfersse<br />
high-M, (“biliary”) isoenzyme of alk,<br />
phosphataae and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
Ghutathioue peroxidsse<br />
automated methods for chin, assay of<br />
superoxide dismutase and ghutethione<br />
peroxidase in human plasma and<br />
erythrocytes using a Cobas Bia centrifugal<br />
analyser (A), 1126<br />
Glutathione synthetase deficiency<br />
pyroghutamic acidemia in an adult (CR), 684<br />
Glutathione S-transferase<br />
mess, of glutathione S-transferase B1 in plasma<br />
after birth asphyxia: early indication of<br />
hepatocellular damage, 995<br />
plasma glutathione S-transferaae and F protein<br />
are more sensitive than alanine<br />
aminotransferase as markers of<br />
acetaminophen-induced liver damage, 2186<br />
Glycated albumin<br />
correhn. of HbAic, glycated serum proteins and<br />
albumin, and fructosamine with 24-h glucose<br />
profile of insulin-dependent pregnant<br />
diabetics, 922<br />
Ghycated hemoglobin<br />
enzyme immunoassay of Hb Air: anal.<br />
characteristics and chin, performance in<br />
diabetes mellitus, with and without uremia,<br />
93<br />
fructosamine assay modified for estn. of<br />
glycated Rb (TB), 497<br />
glycated Hb and fructosamine measurements<br />
in assesaing glycemic control (A), 1236<br />
glycated Rb in fractionated erythrocytes, 958<br />
HPLC detn. of hemoglobin A1,,in the presence<br />
of the fast hemoglobin I-Philadelphia (TB),<br />
494<br />
liq.-chromatog. detn. of acetylated Rb, 33<br />
precision of mess. of glycated Rb by affinity<br />
chromatog. on regenerated columns (L), 191<br />
quantn. of glycated Hb by alkaline gel<br />
ehectrophoresis: the Paragon system (A),<br />
1162<br />
ref. range of glycated Hb in nondiabetic<br />
persons possessing Rb S by affmity<br />
chromatog. (A), 1162<br />
simplified anal, for glycated Hb by ionexchange<br />
chromatog. (L), 2253<br />
Glycated<br />
lipoprotein<br />
effect of ghycation of law-density lipoprotein on<br />
immunolog. detn. of apohipoprotein B (SN),<br />
2219<br />
serum glycated $-lipoprotein detd. by agarose<br />
gel ehectrophoresis with nitroblue<br />
tatrazohium coloration (TB), 177<br />
Glycated lysine<br />
does the effective diminution of nonenzymatic<br />
glycation by D-lysine really highlight its<br />
potential use in viva? (L), 2254<br />
Glycated proteins<br />
colorimetric detn. of non-enzymatically<br />
glycated apolipoprotein B (A), 1074<br />
correln, of HbAic, glycated serum proteins and<br />
albumin, and fructosamine with 24-h glucose<br />
profile of insulin-dependent pregnant<br />
diabetics, 922<br />
l).hysine effectively decreases non-enzymic<br />
glycation of proteins in vitro, 384<br />
nonenzymic glycation of immunoghobulins does<br />
not impair their immunoreactivity (SN),<br />
1039<br />
Glyceric acldemia<br />
biochem. contribution to diagnosis and study<br />
of a new case of D-ghyceric acidemia/aciduria<br />
(CR), 2148<br />
2382 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
Glycohemoghobin<br />
See Glycated hemoglobin<br />
Glycoprotems<br />
apphn. of a silver-binding assay to detn. of<br />
protein in CSF (SN), 860<br />
changes in concanavalin A-reactive proteins in<br />
mflammatory disorders, 2207<br />
decreased immunoreacty. and binding acty. of<br />
corticosteroid.binding globulin in serum in<br />
septic shock, 1675<br />
detecting serum acidic range glycoproteins<br />
using isoehectric focusing on cellulose acetate<br />
mambranes<br />
high condos,<br />
(A), 1083<br />
of Zna2-glycoprotein and lack of<br />
a2HS-ghycopratein in ejaculates, 1649<br />
high-yield purifn. of the complex-farming<br />
glycoprotein in urine, 577<br />
two-site immunoenzymometry of 52.kDa<br />
cathepsin Din cytosols of breast-cancer<br />
tissues, 81<br />
Ihycosaminoghycans<br />
diagnostic test for mucopolysaccharidosis I.<br />
direct method for quantg. excessive urinary<br />
glycosaininoglycan excretion, 374<br />
diagnostic test for mucopolysaccharidosis. II.<br />
rapid quantn. of ghycosaminoghycan in urine<br />
samples one paper matrix, 2074<br />
dimethylmethylene blue-based spectrophotom.<br />
of glycosaminoghycana in untreated urine:<br />
rapid screening for mucopolysaccharidoses,<br />
1472<br />
lyoxa1<br />
glyoxal: an artefact from metronidazohe and<br />
glyoxylic acid in urinary org. acid anal. (TB),<br />
673<br />
Ryoxylic acid<br />
glyoxal: an artefact from metronidazohe and<br />
glyoxylic acid in urinary org. acid anal. (TB),<br />
673<br />
onadotroplns<br />
RIA of -microseminoprotein, a prostatic.<br />
secreted protein in sera of men and women,<br />
1497<br />
3ranuhocyte.<br />
detn. of Mg2+ in granulocytes, 1404<br />
rowth hormone<br />
changes of growth-related hormones and<br />
growth factors following pneumanectomy’ I.<br />
growth hormone (A), 1150<br />
aloperidoh<br />
evain. of EIA for detn, of hahoperidoh, a<br />
neuroheptic drug, in serum (A), 1175<br />
how-dose monitoring of haloperidol (A), 1179<br />
alothane<br />
quantn. of halothane by headspace gsa<br />
chromatog. (A), 1173<br />
hlaptocorrin<br />
cobalamin-binding capacity of haptocorrin and<br />
transcobalsmin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
lieart disease<br />
See also Myocardial infarction<br />
antiarrhythniic drugs and the cardiac Na<br />
channel: current models(S), 748<br />
apolipoprotein E isoform anal, in<br />
characterizin[atherogenic risk (A), 1235<br />
epolipoprotein E isoforms in patients with<br />
hypertrophic cerdiomyopethy (A), 1070<br />
concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
851<br />
creatine kinase isoforms in ischemic heart<br />
disease (R), 7<br />
diagnostic utility of serum total creatine kinase<br />
and creatine kinase-2 in myocardial<br />
infarction re-evaluated, 1435<br />
duah-pptn. method evald. for mess, of<br />
cholesterol in high-density lipoprotein<br />
subfractions HDL2 and HDL3 in plasma, 265<br />
emetine identified in urine by HPLC, with<br />
fluorescence and ultraviolet/diode array<br />
detection, in a patient with cerdiomyopathy<br />
(CR), 499<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN), 166<br />
heterogeneity of serum creatine kinase<br />
isoenzyme MM in myocardial infarction:<br />
chin. significance and post-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
high alanine aminotransferase activities in<br />
plasma, hearts in patients with acute<br />
nyocardial infarction, 279<br />
HUP-lipid program: apolipoprotain A-I and B<br />
and the apo B/apo A-I ratio (A), 1065<br />
hypomagnesemia and how alk. phosphatase<br />
acty. in patients’<br />
(SN), 664<br />
serum after cardiac surgery<br />
immunochem. test for CK-MB isoforms (L),<br />
2157<br />
increase of hypoxanthine during cardiac<br />
surgery, as measured by an indirect<br />
automated enzymatic assay (L), 898<br />
LDL heterogeneity relationships between<br />
particle size and coronary disease (A), 1234<br />
lipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monoclonal<br />
antibodies, 1380<br />
mess, of autoimmune response against collagen<br />
types I, Ill, and IV by enzyme-linked<br />
immunosorbent assay, and appln. in<br />
infective endocarditia, 246<br />
mess, of urinary heukotrienes by reversedphase<br />
liq. chromatog. and RIA, 388<br />
optimized microturbidimetric assay for<br />
fibrinogen, 211<br />
patterns of lactate dehydrogenase isoenzymes 1<br />
and 2 in serum on exercise (SN), 301<br />
role of Mg in etiology of cardiovascular disease<br />
(A), 1055<br />
S-100a0 protein in blood and urine during<br />
open-heart<br />
simultaneous<br />
surgery, 1942<br />
detn. of pentoxifylline and three<br />
metabolites in bioL fluids by hiq. chromatog.<br />
(SN), 298<br />
specific binding of cardiac glycoside drugs and<br />
endogenous digitalis’like substances to<br />
particulate membrane fractions from<br />
placenta, 2093<br />
statis. interpretn. of concns, of Mg, Zn, Ca, K,<br />
cholesterols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
streptokinase binds to lactate dehydrogenase<br />
subunit-M, which shares an epitope with<br />
plasminogen, 69<br />
strong aasocn, of a single nucleotide<br />
substitution in the 3’-untranslated region of<br />
the apolipoprotein-CIhI gene with common<br />
hypertriglyceridemia in Arabs, 256<br />
update on digoxin (5), 1326<br />
Heart disorders<br />
heart disorders and concentrations of directly<br />
measured atriah natriuretic peptide in<br />
plasma, 435<br />
Heart transplant<br />
ohigoclonal banding in serum from hearttransplant<br />
recipients, 431<br />
serum prolactin as a rejection marker in heart<br />
transplantn. (TB), 492<br />
simultaneous deth. of serum neopterin and C-<br />
reactive protein as markers of infection in<br />
heart-transplant recipients (TB), 1258<br />
Hemsgglutination<br />
passive hemagglutinetion assay for HIV<br />
antibody screening (Retrocell HIV#{149}) (A),<br />
1210<br />
Hematocrit<br />
effect of hematocrit and added heparmn on Ca2<br />
in capillary blood from neonates (SN), 486<br />
Hematofluorometers<br />
empirically detd. Pb-poisoning screening cutoff<br />
for the Prototluor-Z hematofluorometer<br />
(SN), 2104<br />
interlab, comparison of control materials for<br />
use with hematofluorometers, 2059<br />
Hematology<br />
artificial intelligence program for<br />
interpretation of raw data from automated<br />
hemotol, instruments (A), 1089<br />
correction factors for extracorporeal pump<br />
hemodihution: evaln, using an in-vitro model<br />
(A), 1158<br />
performance evaln. of Corning 288 and Nova<br />
Stat Profile 1 blood gas systems (A), 1093<br />
Heme<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyria, 2290<br />
empirically detd, Pb-poisoning screening cutoff<br />
for the Protofluor-Z hematofluorometer<br />
(SN), 2104<br />
interaction between pyridine nucleotide<br />
coenaymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
Zn protoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Hemochromatosis<br />
erythrocyte ferritin assay to fmd patients with<br />
homozygous hemochromatosia (A), 1083<br />
Hemodlahysis<br />
See also Dialysis patients<br />
critical appraisal of methods for Al-monitoring<br />
program (A), 1114<br />
improved detn. of Vain bioL fluids by<br />
electratherm, at. absorption spectrom. (SN),<br />
127<br />
interference with mess, of intact parathyrin in<br />
serum from renal dialysis patients (TB),<br />
1543<br />
measuring creatine kinaae MB isoenzyme in a<br />
maintenance hemodialysia popn.:<br />
chemiluminometric immunoassay and<br />
electrophoresis compared (SN), 1965<br />
serum paratbyroid hormone in hemodialysis<br />
patients (A), 1140<br />
Hemoglobin<br />
See also Glycated hemoglobin<br />
apphn. of a silver-binding assay to detn. of<br />
protein in CSF (SN), 860<br />
assay of glucose-6-phosphate dehydrogenase<br />
ecty. in blood on the Hitachi 737, with<br />
simultaneous detn. of Rb (A), 1119<br />
automated detn. of chohinesterase ecty. in<br />
plasma and erythrocytes by flow’injection<br />
anal., and eppln. to identify<br />
sensitive to succinylchaline,<br />
subjects<br />
77<br />
disturbance of the detn. of Hb concn, in<br />
patients with high heukocyte counts (L), 515<br />
effect of hemoglobinemia on bilirubin assays<br />
on Kodak Ektachem 700 and<br />
Bilirubinometer (A), 1157<br />
evain. of dry-chem, analyzer, the Chinistat, for<br />
blood Hb and serum or plasma constituents<br />
(A), 1108<br />
Hb peroxidase acty. for coupled enzymatic<br />
reactions (A), 1122<br />
interaction between pyridine nucheotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-hinked enzymes (SN), 2129<br />
liq.-chromatog. detn, of acetylated Hb, 33<br />
monoclonal antibody to ‘y chain of fetal Hb<br />
used to develop an enzyme immunoassay,<br />
2066<br />
patient-side immunoassay system withs<br />
single-use cartridge for measuring analytes<br />
in blood (5), 1869<br />
reliability of detn, of whole-blood 0 affinity<br />
with blood-gas analyzers and multiwavelength<br />
oximeters, 773<br />
unreliable visual estn, of incidence and amount<br />
of turbidity, hemohysis, and icterus in serum<br />
from hospitalized patients (SN), 837<br />
unusual band on Rb electrophoresis produced<br />
by a monoclonal immunoghobulin in serum<br />
(TB), 1794<br />
unusual band that binds Rb after<br />
ultracentrifn. of hemolyzed plasma<br />
hipoprotein sepn. (TB), 495<br />
for<br />
Hemogloblnopathles<br />
prenatal diagnosis of hemoglobinopathies by<br />
using pohymeraae chain reaction and allelespecific<br />
ohgonucleotide probes (S), 1854<br />
Hemoglobinuria<br />
(Wake Forest University Case Conference):<br />
myoglobinurie, hemoghobinuria, acute renal<br />
failure (CC), 1713<br />
Hemoglobin variants<br />
chromatofocusing and isoelectric focusing in<br />
immobilized pH gradients compared for<br />
characterization of Rb variants, 425<br />
nephelometric method for quantitating HbF<br />
(A), 1199<br />
stability of hemoglobins A, F, 5, and C in dried<br />
neonatal whole-blood samples when<br />
analyzed by cation-exchange RPLC (A),<br />
1152<br />
Hemoproteins<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyria, 2290<br />
Hemorrhagic disease<br />
anal, of supplemented vit. Ki (20) in serum<br />
microeamples by solid-phase extrn. and<br />
narrow-bare HPLC with multichannel uv<br />
detection (5), 1288<br />
Hemorrhagic shock<br />
increases in aspartata aminatransferaae,<br />
creatine kinase in hemorrhagic shock and<br />
encephalopathy syndrome (L), 2253<br />
Heparin<br />
effect of hematocrit end added heparin on Ca2<br />
in capillary blood from neonates (SN), 486<br />
increased concns. of heparmncofactor II in<br />
diabetic patients, and possible effects on<br />
thrombin inhibition assay of antithrombin<br />
111,52<br />
Hepatic disease<br />
See also Liver disease<br />
Hepatitis<br />
calciferin and cathepsin D-hike acid protease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
generalized likelihood ratio concept and<br />
logistic regression anal, for multiple<br />
diagnostic categories, 990<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2383
Hepatitis A<br />
automated enzyme immunoassay for detecting<br />
1gM antibody to hepatitis A virus (A), 1193<br />
rapid diagnostic tasting for simultaneous<br />
detection of acute and remote hepatitis A<br />
infection (A), 1198<br />
Hepatitis B<br />
automated enzyme immunoassay for detecting<br />
1gM antibody to hepatitis B core antigen (A),<br />
1193<br />
detection of antibody to hepatitis B core<br />
antigen using automated microparticlebased<br />
EIA (A), 1193<br />
detection of hepatitis B infection in a randomly<br />
selected pediatric hospital population using<br />
an automated enzyme<br />
1-IBsAg (A), 1152<br />
immunoassay for<br />
rapid automated detection of human 1gM<br />
antibody to hepatitis B core antigen (A),<br />
1206<br />
Hepatitis B surface antigen<br />
automated latex photometric immunoassay for<br />
detection of hepatitis B surface antigen (A),<br />
1206<br />
evaln. of Abbott Commander enzyme<br />
immunoassay system for hepatitis B surface<br />
antigen and B core antibody (A), 1207<br />
evaln. of automated fluorescent immunoassay<br />
for detection of HBsAg (A), 1095<br />
evahn. of enzyme immunoassay kits for<br />
hepatitis B surface antigen, B surface<br />
antibody, and B core antibody (A), 1207<br />
microparticle enzyme immunoassay for<br />
measuring antibodies to hepatitis B surface<br />
antigen, IMx anti-HBs (A), 1193<br />
rapid self-contained immunoassay for hepatitis<br />
B surface antigen (A), 1195<br />
rapid semiquant. teat for hepatitis B surface<br />
antigen using the Icon#{149} Reader’ (A), 1198<br />
screening utility of a rapid, automated<br />
fluorescent enzyme immunoassay for HBsAg<br />
in an S.T.D. clinic (A), 1192<br />
Hepatobiiary disorders<br />
signif. of low serum urea N concns. (SN), 639<br />
Heritable disorders<br />
See also Genetics<br />
automated detn, of cholinesterase acty. in<br />
plasma and erythrocytes by flow-injection<br />
anal,, and appln. to identify subjects<br />
sensitive to succinylcholine, 77<br />
automated procedure for mess, of biotinidase<br />
acty. in serum (SN), 831<br />
biochem. contribution to diagnosis and study<br />
of a new case of D-glyceric acidemia/aciduria<br />
(CR), 2148<br />
construction of a linkage map of the human<br />
genome, and its apphn. to mapping genetic<br />
diseases (S), B33<br />
cystic fibrosis: diagnostic testing<br />
search far the gene (S), B17<br />
and the<br />
detection of Duchenne/Becker muscular<br />
dystrophy carriers by densitometric scanning<br />
(TB), 1256<br />
diagnosis of recessive X-linked ichthyosis:<br />
quantitative HPLC/mass spect. anal. of<br />
plasma for cholesterol sulfate, 1906<br />
diagnostic test for mucopolyssccharidoais. II.<br />
rapid quantn. of ghycosammnoghycan in urine<br />
samples on a paper matrix, 2074<br />
discordant<br />
globulin<br />
RIA results for thyroxin-binding<br />
(TBG): new indicator of variant<br />
TBG molecules with decreased affinity for<br />
thyroxin (TB). 1257<br />
DNA probes for carrier identn, in Duchenne<br />
muscular dystrophy (E), 519<br />
DNA probes used in detecting carriers of<br />
Duchenne muscular dystrophy: selected case<br />
studies (CR), 679<br />
enzymatic detn. of urinary oxalate (SN), 2330<br />
fundamental mechanisms of tumorigenesis in<br />
the nervous system: isoln. and charactern. of<br />
genes assocd. with hered, forms of cancer (5),<br />
B25<br />
genetics of bipolar affective disorder: chin.<br />
implications (S), B28<br />
hered. complete deficiency of lactate<br />
dehydrogenase H-subunit (CR), 687<br />
high-M, (“bihiary”) isoenzyme of elk.<br />
phoaphataae and the diagnosis of liver<br />
dysfunction<br />
homogentisic<br />
in cystic fibrosis, 1888<br />
acid detd. in bioL fluids by<br />
HPLC (SN), 321<br />
HPLC anal, of brain and plasma for octanoic,<br />
decanoic acids, 1945<br />
l-RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
isolation of “cystic fibrosis protein” from<br />
serum, 1901<br />
lang-chain aliphetic fatty acids and phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
mapping the hocus of autosomal dominant<br />
polycystic kidney disease: diagnostic appln.<br />
(S),B13<br />
microassay for screening newborns for<br />
galactoeemia with use of a fluorometric<br />
microplate reader (SN), 1962<br />
mohec. genetics of Duchenne and Becker<br />
muscular dystrophy: emphasis on improved<br />
diagnosis (S), B21<br />
mol. genetics and the transformation of chin.<br />
chem. (5), 2165<br />
pyroghutamic acidemia in an adult (CR), 684<br />
screening for deficiency of ai-proteinase<br />
inhibitor (SN), 1971<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd. familial<br />
amyloidotic pohyneuropathy (SN), 1033<br />
somatotropin as mess, by a two-site timeresolved<br />
immunotluorometric assay, 913<br />
sources of imprecision in screening for<br />
congenital hypothyroidism: anal. of 9 y of<br />
performance data, 1701<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
use of DNA probes and complement<br />
phenotyping for diagnosis and carrier<br />
detection in families with steroid 21-<br />
hydroxylase deficiency (A), 1075<br />
use of pohymerase chain reaction far diagnosis<br />
of inherited disorders(S),<br />
use of the polymerase chain<br />
1843<br />
reaction for<br />
simultaneous anal. of two Pst I<br />
polymorphisms linked to cystic fibrosis<br />
(TB), 1260<br />
Herpes simplex virus<br />
chemiluminescent detection of herpes simplex<br />
virus I DNA in blot and in-situ hybridization<br />
assays(S), 1856<br />
“High-performance” chromatography<br />
See Chromatogaphy, liquid<br />
“High-pressure chromatography<br />
See Chromatography, liquid<br />
Hirsutism<br />
measurement of free testosterone and free<br />
androgen index by use of sex-hormonebinding<br />
globulin concns.<br />
(fluoroimmunoassay) in hirsutism (A), 1143<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
Histocompatibihity complex<br />
fi2-microglobulin and immune activation (L),<br />
2158<br />
HIV<br />
See also Acquired immunodeficiency<br />
syndrome<br />
anal. of serum antibodies to HIV using a<br />
multiple synthetic antigen-coated test strip<br />
(A), 1204<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
detection of HIV praviral DNA in peripheral<br />
blood mononuclear cells by polymerase chain<br />
reaction (A), 1076<br />
detection of HIV-1 RNA by polymerase chain<br />
reaction (A), 1076<br />
development of a confirmatory enzyme-linked<br />
immunoeorbent assay for HIV-1 antibodies,<br />
946<br />
ELb. for detection of HTLV-1 antibodies using<br />
a mixture of synthetic peptide and viral<br />
hysate (A), 1204<br />
enhanced luminescence competitive<br />
inimunoassay for anti-HIV (A), 1207<br />
evahn. of leukocyte-associated dipeptidyl<br />
peptidase IV enzyme in normal and<br />
immunodeficient conditions (A), 1153<br />
evahn, of new recombinant ELISA immunoassay<br />
far detection of antibodies to HIV vs DuPont<br />
Western blot (A), 1204<br />
improved test for confirming antibodies to HIV<br />
using six recombinant peptides, including<br />
the intact gag gene-product, p24 (A), 1191<br />
molecular probes used to detect<br />
cytomegalovirus and human<br />
immunodeficiency virus (5), 1581<br />
neopterin as a predictive marker for disease<br />
progression in human immunodeficiency<br />
virus type 1 infection (SN), 1746<br />
ohigochonal immunoglobuhins in HIV infection,<br />
1669<br />
passive hemagglutination assay for HIV<br />
antibody screening (Retroceil HIV) (A),<br />
1210<br />
specific routine detn, of 3’-azido-3’-<br />
deoxythymidine in plasma by<br />
semiautomated hiq. chromatog. (5), 1313<br />
urinary neopterin concns. vs total neoptenns<br />
for chin, utility (SN), 2305<br />
Homocystelne<br />
fully automated fluorescence assay far detg.<br />
total homocysteine in plasma, 1921<br />
rapid detn. of total homocysteine in plasma<br />
(TB), 2002<br />
Homogentisic acid<br />
anal, for homogentisic acid by NMR<br />
spectrometry on diagnosis of alkaptonuria<br />
(L), 1806<br />
homogentisic acid detd. in bioL fluids by<br />
HPLC (SN), 321<br />
Homosexuality<br />
serum Zn in homosexual men (L), 704<br />
Hormones<br />
See also specific hormone of interest<br />
alteration of lymphocyte subsets and endocrine<br />
response during 80 days of competitive swim<br />
training (A), 1136<br />
effect of repeated freezing and thawinjon<br />
vitamins and hormones in serum (1 B), 2145<br />
effects of hemolysis and storage on quanth. of<br />
hormones in blood samples from animals<br />
(A), 1133<br />
evaln, of chemiluminescent immunoassay for<br />
deth. of serum peptide hormones (A), 1206<br />
sample treatment for long-distance transport<br />
of plasma far hormone assay (TB), 331<br />
HPLC<br />
See Chromatography, liquid; or analyte of<br />
interest<br />
Human Immunodeficiency virus<br />
See RN, Acquired immunodeficiency<br />
syndrome<br />
Hurler’s<br />
syndrome<br />
diagnostic test far mucopohysaccharidosis I.<br />
direct method for quantg. excessive urinary<br />
glycosaminoglycan excretion, 374<br />
Hydatidiform mole<br />
algorithm for testing and reporting serum<br />
choriogonsdotropin at chin, signif. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
Hydroxyapatite<br />
tumoral cahcinosis: seasonal biochem. studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
Hydroxybutyrate<br />
kinetic mess, of ketone bodies (L), 1263<br />
multipoint kinetic simultaneous mess, of<br />
combined cancns, of acetoacetate-fihydroxybutyrate<br />
and lactate-pyruvate (SN),<br />
1526<br />
Hydroxyindoleacetic acid<br />
fluorescence poharn. immunoaasay of urinary<br />
hydraxy-3.indoheacetic acid, 356<br />
5-<br />
urinary 5-hydroxyindoleacetic acid by HPLC<br />
with electrochem. detection (L), 507<br />
2-Hydroxy-1-naphthaldehyde<br />
salicyloylhydrazone<br />
fluorometry of Mg2<br />
1-naphthaldehyde<br />
in serum with 2-hydroxysalicyloylhydrazone,<br />
1492<br />
Hydroxyprogesterone<br />
assessment of screening program for congenital<br />
adrenal hyperplasia in Portugal based on<br />
antibody-coated tube RIA for 17a-OH<br />
progesterone (L), 2338<br />
Hydroxyvitamin D<br />
25-hydroxyvitamin D and 1,25-<br />
dihydroxyvitamin D detd. in serum by<br />
“SPE-octadecyl (C18)” coL extraction and<br />
radioassay (TB), 1995<br />
Hyperamylssemla<br />
diagnostic value of measuring pancreatic lipase<br />
and the P3 isoform of pancreatic amylase<br />
isoenzyme in serum of hospitalized<br />
hyperamyhasemic patients, 417<br />
hyperamylasemia and a.amylase isoenzymes in<br />
acute liver congestion due to cardiac<br />
circulatory failure (TB), 1793<br />
Hypercalcenila<br />
grand round at Sahlgren’s Hospital:<br />
hypercalcemia in a patient with mammary<br />
carcinoma; metastases or primary<br />
hyperparathyroidism? (CC), 1019<br />
Hypercholesterolemia<br />
See also Heart disease, Hyperhipidemia<br />
Hyperlipidemia<br />
apolipoprotein E phenotype detd, by agaroae<br />
gel electrofocusing, immunoblotting, 2070<br />
cholesterol measurement in grossly hipemic<br />
specimens (A), 1072<br />
mess. of apohipoprotein B in plasma from<br />
hyperhipidemic subjects treated with<br />
2384 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
cholestyramine or placebo: differential<br />
effects of storage at -70 0C, 380<br />
simultaneous liq.-chromatog. detn. of vit. K1,<br />
vit. E in serum, 2285<br />
Hypermagnesemia<br />
frequency of hypo- and hypermagnesemia for<br />
each chin, service in four teaching hospitals<br />
(A), 1130<br />
Hyperoxaluria<br />
simple liq.-chromatog.<br />
in plasma, 241<br />
method for vit. B6 cmps.<br />
Hyperparathyroidism<br />
assay of “intact” parathyrin in the immediate<br />
and hong-term postoperative follow-up of<br />
patients treated for hyperparathyroidism or<br />
thyroid tumor (L), 340<br />
effects of estrogen on mineral metab, in<br />
poetmenopauaal women as evald. by multiple<br />
assays measuring parathyrin bioacty.,<br />
grand round at Sahlgren’s Hospital:<br />
18<br />
hypercalcemia in a patient with mammary<br />
carcinoma; metaatases or primary<br />
hyperparathyroidism? (CC), 1019<br />
two-site immunochemiluminometric assay of<br />
intact parathyrin with use of a tracer peptide<br />
purified by reversed-phase lig. chromatog.,<br />
215<br />
Hyperphosphatssemia<br />
benign transient hyperphosphatasemia in an<br />
adult with malignant hymphoma (L), 897<br />
Hyperphosphatemic tumoral calcinosis<br />
tumoral calcinosis: seasonal biochem. studies<br />
and chem, studies of eyelid lesion (CR), 183<br />
Hypertension<br />
anal, of urinary metanephrines of patients<br />
treated with antihypertensive a-methyhdopa<br />
(Aldomet) (A), 1138<br />
Ca metab. in hypertension (A), 1054<br />
endogenous digoxin measured by receptor<br />
assay in normotensive and hypertensive<br />
subjects (A), 1135<br />
increased Ca uptake in vascular tissue by<br />
plasma of salt-induced hypertensive Dahh<br />
rats (A), 1138<br />
role of Mg in etiology of cardiovascular disease<br />
(A), 1055<br />
Hyperthyroidism<br />
elk. phosphatase isoenzymes in plasma in<br />
hyperthyroidism, 1427<br />
increased laminin concns. in serum in<br />
hyperthyroidism (TB), 1540<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
Hypertriglyceridemia<br />
strong assocn, of a single nucleotide<br />
substitution in the 3’-untranslated region of<br />
the apolipoprotain-CIlI gene with common<br />
hypertriglyceridemia in Arabs, 256<br />
Hypnotic agents<br />
simult. liq.-chromatog. detn. of some<br />
bronchodilators, anticonvulaants,<br />
chloramphenicoh, and hypnotic agents, with<br />
Chromosorb P columns used for sample<br />
prepn., 1615<br />
Hypocahcemia<br />
critical anal. and chin. aspects of ionized Cain<br />
neonates (R), 2027<br />
Hypomagnesemia<br />
frequency of hypo- and hypermagnesemia for<br />
each cm. service in four teaching hospitals<br />
(A), 1130<br />
Hypoparathyroidism<br />
effects of estrogen on mineral metab. in<br />
postmenopausal women as evald, by multiple<br />
assays measuring parathyrin bioacty., 18<br />
Hypothalamic-pituitary-adrenal<br />
system<br />
immunoradiometry of corticotropin with use of<br />
avidin-biotin sepn., 804<br />
Hypothermia<br />
serum creatine kinaae in primary hypothermia<br />
(L), 2254<br />
Hypothyroidism<br />
neonatal screening far congenital<br />
hypothyroidism with LKB Delfia neonatal<br />
TSH kit (A), 1152<br />
sources of imprecision in screening for<br />
congenital hypothyroidism: anal. of 9 y of<br />
performance data, 1701<br />
Hypoxanthine<br />
increase of hypoxanthine during cardiac<br />
surgery, as measured by an indirect<br />
automated enzymatic assay (L), 898<br />
Hypoxia<br />
effects of in viva and in vitro production of<br />
lactic acid on ionized, protein-bound, and<br />
complex-bound Ca in blood, 935<br />
Ichthyosis<br />
diagnosis of recessive X-hinked ichthyosis:<br />
quantitative HPLC/mass spect. anal. of<br />
plasma for cholesterol sulfate, 1906<br />
IFCC<br />
standn, of immunochem. detn. of<br />
apolipoproteins A-I and B: report on IFCC<br />
meeting on standn. of apohipoprotein A-I and<br />
B measurements (basis for future<br />
consensus), Vienna, Austria, April 18-19,<br />
1989 (SR), 2009<br />
Ig<br />
See Immunoghobulins<br />
Imipramine<br />
fluoxetine inhibition of imipramine<br />
metabolism (A), 1180<br />
Immobilized metal affinity chromatography<br />
purifn., characterization of intact lactoferrin<br />
found in the urine of human milk-fed<br />
preterm infants, 1928<br />
Immune<br />
complexes<br />
reliable mess. of circulating immune complex<br />
depends on stable, accurate ref. material (L),<br />
1555<br />
Immune response<br />
leukotriene B4 is measurable in serum of<br />
smokers and nonsmokers (SN), 459<br />
Immunoassay<br />
See also Immunoinetric assay, specific type of<br />
assay<br />
calibration problems with the I<br />
immunoasaay for cychosporin A (L), 1551<br />
cyclosporine cancns. in blood after liver<br />
transplantn.: correlation of immunoassay<br />
results with chin, events, 564<br />
diajnosis of infertility:<br />
SpermCheck’”-immunoassey for detection<br />
of anti-sperm antibodies (A), 1140<br />
digoxin anal, using Abbott’s digoxin NXT<br />
system (A), 1164<br />
estrediol-17$ detd, in plasma by gas<br />
chromatog.-mass spectrom. with selected ian<br />
monitoring of mixed silyl<br />
ether-perfluoroacyh ester derivs. and use of<br />
various stable-isotope-labeled internal sods.,<br />
532<br />
eveln. of Affinity’” automated immunoassay<br />
system (A), 1188<br />
evaln, of Becton Dickinson Affinity’”<br />
immunoasaay system (A), 1107<br />
evaln. of matrix effects of hyophilized pools on<br />
apolipopratein B immunoassays (A), 1074<br />
evaln, of the TDx and ADx methadone<br />
immunoassays (TB), 1794<br />
immunoaaaay for estrogen receptor does not<br />
detect inactivated receptor (SN), 824<br />
immunoassays for rubella antibodies (IgG and<br />
1gM) in serum using time-resolved<br />
fluorescence (A), 1153<br />
interferences of human anti-mouse antibodies<br />
in mouse monochonal antibody-based<br />
immunoassays (A), 1188<br />
mechanism of false-negative urine cannabinoid<br />
immunoassay screens by Visine’” eyedrops<br />
(SN), 636<br />
murmnemonoclonal antibody adsorbed onto<br />
vinylidene fluoride floccules used to<br />
eliminate antibody interference in<br />
“sandwich”-type immunoassays<br />
new highly sensitive dye-forming<br />
(SN), 1743<br />
system for<br />
immunostaining (A), 1187<br />
performance evain. of thyroid-function panel<br />
for DuPont Vista’” immunoassay system (A),<br />
1145<br />
rapid detn. of ferritin in serum by the<br />
“Stratus” fluoroenzymoimmunometric assay<br />
(TB), 672<br />
role of rapid immunoasaays for urgent detna. of<br />
creetine kinase isoenzyme MB (SN), 1752<br />
sensitivity of CYCLO-Trac SP (specific<br />
monoclonal immunoasssy for cychosporin A)<br />
(L),900<br />
sequential changes in cross reactivity of antidigoxin<br />
antibodies during immunization (A),<br />
1186<br />
shaking polystyrene beads during coating with<br />
antibody: effect on precision profile of<br />
enzyme immunoassay of triiodothyronine<br />
(L), 701<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoasaays<br />
of carcinoembryonic antigen (SN), 146<br />
Immunoblot technique<br />
apolipoprotein E phenotype detd. by agarose<br />
gel electrofocusing, immunoblatting, 2070<br />
IgG heavy-chain subclass typing of myeloma<br />
paraproteins by isoelectric focusing<br />
immunoblot anal., 364<br />
improved immunoblotting technique far Lp(a)<br />
phenotyping (A), 1070<br />
Immunocatalytic assay<br />
immunocat.ahytic assay of pancreatic a-amyhase<br />
in serum and urine with a specific<br />
monochonal antibody (SN), 662<br />
Immunochemiluminometrlc assay<br />
appin. of Magic Lita<br />
immunochemihuminometric method for<br />
measurement of creatine<br />
spots (A), 1123<br />
kinase-MB in blood<br />
chin, and anal. evaln. of different methods for<br />
mess. of creatine kinase isoenzyme MB (SN),<br />
130<br />
development and validation of<br />
immunochemiluininometric assay for whole<br />
molecule and N-terminal parathyroid<br />
hormone (A), 1147<br />
quantn. of hCG and its a-subunit in the<br />
Amerlite system (A), 1205<br />
solid-phase immunochemiluminometric assay<br />
for human choriogonadotropin<br />
two-site immunochemiluminometric<br />
1147 (A),<br />
assay of<br />
intact parathyrin with use of a tracer peptide<br />
purified by reversed-phase hg. chromatog.,<br />
215<br />
Immunochemistry<br />
See also specific analyte of interest<br />
dissocn, of immunocomptexes by ionic shock<br />
for development of immunosenaors: appln. to<br />
mess, of ai-fetoprotein (SN), 1026<br />
Immunoelectrophoresls<br />
See also specific technique of interest<br />
148 cryoimmunoglobulins characterized by<br />
cryocrit, immunoelectrophoresis, and<br />
immunonephehometry (A), 1083<br />
Immunosnzyniometric assay<br />
See also Enzyme immunoassay<br />
APP quantn. compared using a semiautomated<br />
monoclonal<br />
pohyclonal-monochonal<br />
and a<br />
immunoenzymatic<br />
assay (A), 1200<br />
anal, of serum antibodies to HIV using a<br />
multiple synthetic antigen-coated test strip<br />
(A), 1204<br />
automated assay specific for cychoeporine in<br />
whole blood, with use of a Cr02 particle<br />
column (S), 1860<br />
CK-MM interference with an<br />
immunoenzymometric method for quantn. of<br />
CE-MB in serum (L), 901<br />
evsln. of immunoenzymatic assay for CE-MB<br />
using the Icon format (A), 1121<br />
evahn. of new ELISA procedure for detecting IgG<br />
antibodies to Toxoplasma gondii (A), 1203<br />
evaln, of rapid, automated ELISA method for<br />
prolactin (A), 1188<br />
immunoenzymometric assay for antibody<br />
against human acetylcholine receptor using<br />
precoated microtiter plate and receptor<br />
isolated from normal leg muscle (A), 1196<br />
immunometric assay for digaxin adapted to<br />
Roche Cobas Fara centrifugal analyzer (A),<br />
1166<br />
is electrophoresis a ref. method for CE-MB in<br />
comparison with an immunoenzymametric<br />
method? (L), 900<br />
measurement of creetine kinase MB by the<br />
Baxter Stratus fluoromctric analyzer (A),<br />
1123<br />
pancreatic oncofetal antigen and carbohydrate<br />
antigen 19-9 in sera of patients with<br />
pancreatic cancer, 405<br />
rapid diagnostic testing for simultaneous<br />
detection of acute and remote hepatitis A<br />
infection (A), 1198<br />
rapid, quant. immunaassay for creatine kinase-<br />
MB using Tandem Icon#{149} QSR’” technology<br />
(A), 1197<br />
rapid semiquant. test for hepatitis B surface<br />
antigen using the Icon Reader’” (A), 1198<br />
role of rapid immunoassays far urgent detns. of<br />
creatine kinase isoenzyme MB (SN), 1752<br />
simultaneous mess, of total and IgAconjugated<br />
ai-microglobuhin by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
two-site immunoenzymometric assay of 52.kDa<br />
pro-cathepsin D; use in breast diseases, 234<br />
two-site immunaenzymometry of 52-kDa<br />
cathepsin D in cytosols of breast-cancer<br />
tissues, 81<br />
Immunoflxation<br />
ehectrophoretic<br />
electrophoresis<br />
examin. of proteinurie in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
CLINICALCHEMISTRY,Vol. 35, No. 12, 1989 2385
Immunofluorometric assay<br />
aberrant hectin-binding acty. of<br />
immunoglobuhin G in serum in rheumatoid<br />
arthritis, 1638<br />
direct and indirect immunofluorometry of<br />
thyrotropin<br />
immunoassay<br />
(A), 1206<br />
of neonatal hTSH in paper discs<br />
using time-resolved fluorescence (A), 1139<br />
solid-phase immunofluorometric assay for<br />
human serum ferritin (A), 1189<br />
solid-phase time-resolved immunofluorometric<br />
assay for carcinoembryonic antigen (A), 1077<br />
somatotropin as mess, by a two-site timeresolved<br />
immunofluorometric assay, 913<br />
time-resolved immunofluorometric assay for<br />
measuring human thyroglobulin (A), 1205<br />
time-resolved immunofluorometric assay for<br />
thyroxin-binding globulin in serum (A), 1139<br />
time-resolved immunofluorometric assay of<br />
human pancreatic amylaae in serum (A),<br />
1117<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamylase in serum, with use of<br />
two monoclonal antibodies, 1915<br />
time-resolved immunofluorometry of<br />
folhitropin in serum (TB), 181<br />
(A), 1138<br />
ultra-specific time-resolved<br />
immunofluorometric assay of lutropin in<br />
serum (TB), 2251<br />
use of murine monoclonah antibodies<br />
roup.relatad antigens for<br />
to blood-<br />
immunofluorescent detection of blood<br />
groups on human spermatozoa (A), 1208<br />
Immunoglobuhin-enzyme complexes<br />
high incidence of appearance and/or<br />
disapperance of macro CE type in hosp.<br />
population (A), 1123<br />
IgA-CK-BB complex with CE-MB<br />
electrophoretic mobility can lead to<br />
erroneous diagnosis of acute myocard.<br />
infarct. (CR), 2003<br />
macroenzymes: biochem. characterization, din.<br />
signif., and lab. detection (R), 2261<br />
Immunoghobuhins<br />
aberrant lectin-binding acty. of<br />
immunoghobulin G in serum in rheumatoid<br />
arthritis, 1638<br />
appln. of a silver-binding assay to detn. of<br />
protein in CS? (SN), 860<br />
appln. of three turbidimetric immunoglobuhin<br />
assays, IgG, IgA, and 1gM, to the Express 550<br />
analyzer (A), 1095<br />
assays for immunoglobulins on the Cobas Mire<br />
analyzer (A), 1197<br />
automated enzyme immunoassay for detecting<br />
1gM antibody to hepatitis B core antigen (A),<br />
1193<br />
automated enzyme immunoassay for detecting<br />
1gM antibody to hepatitis A virus (A), 1193<br />
automated nephelometric immunoassay of IgE<br />
with novel shell/core particles (A), 1092<br />
Bence Jones immunoglobulins in the urine in<br />
multiple sclerosis (L), 186<br />
biotin-avidin-based solid-phase enzyme-linked<br />
immunosorbent assay for human serum IgE<br />
(A), 1192<br />
chemiluminescent assay for total serum IgE<br />
(A), 1194<br />
circulating antibodies to mouse monoclonal<br />
immunoglobuhins caused false-positive<br />
results in two-site assay for alphafetoprotain<br />
(L), 2339<br />
comparison of 1gM antigen capture assay with<br />
standard EIA and WA methods for detecting<br />
1gM antibodies to Toxoplasma gondii (A),<br />
1201<br />
evaln. of new ELISA procedure for detecting IgG<br />
antibodies to Toxoplasma gondii (A), 1203<br />
evaln, of radial partition immunoassay for<br />
quantn. of IgE (A), 1199<br />
falsely elevated IgG indices in CSF of<br />
plasmapheresed patients (A), 1158<br />
fructosamine and IgA: no correin. in nondiabetics<br />
(L), 1556<br />
lgG heavy-chain subclass typing of myeloma<br />
paraproteins by isoelectric focusing<br />
immunoblot anal., 364<br />
immunoasaays fo, rubella antibodies (IgG and<br />
1gM) in serum using time-resolved<br />
fluorescence (A), 1153<br />
nonenzymic glycation of human<br />
immunoglobuhins does not impair their<br />
immunoreactivity (A), 1154<br />
oligoclonal immunoglobulin bands in HTLV-lassociated<br />
myelopathy (A), 1085<br />
ohigochonal immunoglobulins in HIV infection,<br />
1669<br />
quantn. of x- and A-containing<br />
immunoglobuhins by rate nephehometry:<br />
comparison of two comm. reagent antisera<br />
(A), 1198<br />
serum proteins, immunoglobulin, and<br />
complement (C3 & C4) levels in Down’s<br />
syndrome in Kuwait sample (A), 1081<br />
three methods for demonstration of oligoclonal<br />
bands of IgG in CSF compared (A), 1085<br />
unusual band on Hb electrophoresia produced<br />
by a monoclonal immunoglobuhin in serum<br />
(TB), 1794<br />
WHO/RPSP standardization of Beckman<br />
Synchron CX’”5 and correlation of Igs and<br />
transferrin to Beckman Array’” protein<br />
system (A), 1106<br />
Immunoinhibition<br />
chin, and anal. evahn. of different methods for<br />
mess, of creatine kinase isoenzyme MB (SN),<br />
130<br />
development of theophylhine assay for Abbott<br />
EPx’” system (A), 1170<br />
interference of macro-creatine kinase in detn.<br />
of CK-MB in serum with the Kodak<br />
Ektachem (L), 2155<br />
Immunology<br />
decreased immunoreacty. and binding acty. of<br />
corticosteroid-binding globulin in serum in<br />
septic shock, 1675<br />
Immunometric assay<br />
how sensitive are immunometric assays for<br />
thyrotropin?, 289<br />
more on “hook effects” in immunometric<br />
assays for prostate-specific antigen (L), 1262<br />
(L), 2154<br />
quantn. of choriogonadotropin: differential<br />
cross-reactivities of free hCG 9-subunit with<br />
assays<br />
eight different monoclonal<br />
hCG and (hCG +<br />
antibody-based<br />
fi)“sandwich”-type<br />
(TB). 1791<br />
Stratus automated creatine kinase-MB assay<br />
evald.: identn. and elimn. of falsely increased<br />
results assocd. with a high-M, form of alk.<br />
phosphatase, 2048<br />
Immunonephelometry<br />
chin. apphns. for quant. ic and A light chain<br />
detna. (A), 1084<br />
comparative measurements of apohipoprotein<br />
B by immunonephehometry and radial<br />
immunodiffusion (A), 1069<br />
148 cryoimmunoglobulins characterized by<br />
cryocrit, immunoelectrophoresis, and<br />
immunonephehometry (A), 1083<br />
effect of glycation of how-density hipoprotain on<br />
immunolog. detn. of apolipoprotein B (SN),<br />
2219<br />
hmmunopreclpliation assay<br />
pancreatic amyhase mess, in serum by use of a<br />
monoclonal antibody immunochem.<br />
immobilized to a solid phase, 110<br />
Immunoradiometric assay<br />
assay for human choriogonadotropin using<br />
ligand and anti-ligand system (A), 1093<br />
assay for human foilitropin using higand and<br />
anti-higand system (A), 1190<br />
assay for human hutropin using ligand and antihigand<br />
system (A), 1093<br />
chin, and anal. evaln. of different methods for<br />
mess. of creatine kinsse isoenzyme MB (SN),<br />
130<br />
comparison of ref. standard and standard curve<br />
data-reduction methods for NMI low-end<br />
sensitive TSH IRMA (A), 1187<br />
counting errors: effect on immunoassay<br />
precision, 1362<br />
critical evaln. of an immunoradiometric assay<br />
of sex-hormone binding globulin (TB), 2146<br />
development and vahidn, of a two-site<br />
immunoradiometric assay for atrial<br />
natriuretic factor in unextracted plasma, 953<br />
development of solid-phase FSH IRMA (A).<br />
1201<br />
discordant hCG measurements in a patient<br />
with carcinoma (TB), 1259<br />
evaln. of high sensitivity corticotropin<br />
immunoradiometric assay (A), 1146<br />
highly sensitive assays of autoantibodies to<br />
thyroghobuhin, thyroid peroxidase, 1949<br />
high-sensitivity assay for human thyrotropin<br />
using ligand and anti-ligand system (A), 1093<br />
immunoradiometry of a-y- and -enoIase<br />
(neuron-specific enohase), with use of<br />
monochonal antibodies and magnetizable<br />
polymer particles, 2034<br />
immunoradiometry of carcinoembryonic<br />
antigen with use of avidin-biotin labeling,<br />
573<br />
immunoradiometry of corticotropin with use of<br />
avidin-biotin sepn., 804<br />
influence of matrix on cancns. of somatotropin<br />
mess. in serum with commercial<br />
immunoradiometric assays, 1423<br />
IRMA for serum type III procoilagen peptide<br />
using monochonal antibodies (A), 1188<br />
labeled-antibody assay for free T4 (A), 1148<br />
new immunoradiometric assay for<br />
corticotropin evald. in normal subjects and<br />
patients with Cushing’s syndrome, 596<br />
novel inimunoradiometric assay of<br />
thyroghobulin in serum with monochonal<br />
antibodies selected for lack of crossreactivity<br />
with autoantibodies, 422<br />
pancreatic oncofetal antigen and carbohydrate<br />
antigen 19-9 in sera of patients with<br />
pancreatic cancer, 405<br />
performance, diagnostic apphn. of a two-site<br />
immunoradiometric assay for parathyrin in<br />
serum (SN), 1957<br />
simultaneous mess, of total and IgAconjugated<br />
a1-microghobulin by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
somatotropin as mess, by a two-site timeresolved<br />
immunofluorometric assay, 913<br />
two-site IRMA for detn. of urinary<br />
cytokeratin-18; apphicn. to management of<br />
bladder cancer (A), 1198<br />
Immunosensors<br />
dissocn. of immunocomplexes by ionic shock<br />
for development of immunoeensors: apphn. to<br />
mess, of aj-fetoprotam (SN), 1026<br />
Immunosuppressive drugs<br />
adv. in cyclosporine pharmacol., measurement,<br />
and ther. monitoring (S), 1299<br />
continuing need for qual. assessment of<br />
cyclosporine measurement (S), 1309<br />
distribn. of cyclosporin A metabohites among<br />
plasma and cells in whole blood: effect of<br />
tamp., hematocrit, and metabohite concn,, 59<br />
Immunoturbidiinetry<br />
adaptation of serum apolipoproteins A-I and B<br />
immunoturbidimetric assays on the I-hitachi<br />
737 Autoanahyzer (A), 1069<br />
assays for immunoghobulins on the Cobas Mire<br />
analyzer (A), 1197<br />
evaln, of assays for apolipoprotein A-I and B<br />
on TurhiTimer (A), 1072<br />
evaln, of the Tina-quant immunoturbidimetric<br />
method for C-reactive protein on the Hitachi<br />
705 (A), 1081<br />
four immunochem, methods compared for<br />
mess, C-reactive protein in plasma (SN), 461<br />
immunoturbidimetric detn. of apolipoprotein<br />
A-I and Ban Hitachi analyzers (A), 1067<br />
immunoturbidimetric technique for detn, of<br />
serum 2-microglobulin (A), 1189<br />
immunoturbidimetry of 2-microghobulin in<br />
serum (TB), 1996<br />
immunoturbidimetry of prealbumin<br />
(transthyretin) in a microcentrifugal<br />
analyzer (TB), 178<br />
immunoturbidimetry of serum protens with<br />
the Behring “Turbitimer” (TB), 2144<br />
influence of end-stage renal failure on concns.<br />
of free apohipoprotein A-i in serum, 963<br />
Inborn errors of metabolism<br />
See Heritable disorders<br />
hndoleamines<br />
fluorescence polarn. immunoassay of urinary 5-<br />
hydroxy-3-indoleacetic acid, 355<br />
Indohes<br />
indole compounds do not cause false positives<br />
with the TDx cannabinoid assay (TB), 323<br />
melanin and other indole compds. do not cause<br />
false-positive cannabinoid assay results (L),<br />
1809<br />
Indomethacin<br />
liquid-chromatog. method for indomethacin<br />
and other inflammatory drugs (A), 1164<br />
Infants<br />
See Newborns, Neonates<br />
Infection<br />
alterations in lactate dehydrogenase isoenzyme<br />
patterns after therapy with streptokinase or<br />
streptococcal infection (SN), 1763<br />
appln. of a rapid non-radiaisotopic nucleic acid<br />
anal, system to the detection of sexually<br />
transmitted disease-causing organisms and<br />
asaocd. antimicrobial resistances (5), 1571<br />
comparison of 1gM antigen capture assay with<br />
standard EIA and IFA methods for detecting<br />
2386 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
1gM antibodies to Toxoplasma gondii (A),<br />
1201<br />
delta and conjugated bilirubins as predictors<br />
early liver allograft rejection are unaffected<br />
of<br />
by cytomegalovirus infection (A), 1137<br />
detection of hepatitis B infection in a randomly<br />
selected pediatric hospital population using<br />
an automated enzyme immunoassay far<br />
HBsAg (A), 1152<br />
evaln. of new EUSA procedure for detecting IgG<br />
antibodies to Toxoplasma gondii (A), 1203<br />
implications of probability anaL for<br />
interpreting results of leukocyte esterase and<br />
nitrite test stipe, 1663<br />
neopterin as a predictive marker for disease<br />
progression in human immunodeficiency<br />
virus type 1 infection (SN), 1746<br />
oligoclonal immunoghobulin bands in HTLV-Iassociated<br />
myelopathy (A), 1085<br />
simultaneous detn. of serum neopterin and C-<br />
reactive protein as markers of infection in<br />
heart-transplant recipients (TB), 1258<br />
Infertility<br />
See also Fertility studies<br />
diagnosis of infertilit1r<br />
SpermCheck”-immunoassay far detection<br />
of anti-sperm antibodies (A), 1140<br />
hormonal evaln. of female infertility,<br />
reproductive disorders (CC), 620<br />
lab, assays in infertility diagnosis (A), 1062<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
Inflammation<br />
changes in concanavalin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
leukotriene 84 is measurable in serum of<br />
smokers and nonsmokers (SN), 459<br />
meas. of urinary leukotrienes by reversedphase<br />
hiq. chromatog. and RIA, 388<br />
Information for authors<br />
information for authors (E), 1<br />
Infrared spectroecopy<br />
enzymatic detn. of total cholesterol in<br />
gallstones (SN), 2247<br />
use of GC/IR/MS for high-confidence identifn.<br />
of drugs(S), 1279<br />
Inherited anomalies<br />
See Heritable disorders<br />
$-Inhlbin<br />
RIA of -microeeminoprotein, a prostaticsecreted<br />
protein in sara of men and women,<br />
1497<br />
Instrumentation<br />
See also Discrete analysis, Continuous-flaw<br />
analysis, etc.<br />
chin. chem, analyzer evald. by NCCLS<br />
guidelines for use ins military field lab, unit<br />
(SN), 2223<br />
evaln. of Boehringer Mannheim/Hitachi 717<br />
analyzer (A), 1096<br />
evahn. of Corning 288 analyzer (A), 1131<br />
evaln. of improved Technicon Chem 1 system<br />
(A), 1089<br />
evaln. of performance of DCL reagents on<br />
Hitachi 704 analyzer (A), 1110<br />
evaln, of the Olympus PK31O automated<br />
enzyme immunoassay system (TB), 1995<br />
multicenter evaln. of the Boehringer<br />
MannheimfHitachi 717 analysis system<br />
(TB), 1260<br />
multi-factor designs. II. design for identifying<br />
instrumente with sample-to-sample<br />
carryover and drift (SN), 2118<br />
Olympus AU 5000-alternative reagents (A),<br />
1110<br />
performance of pre-production model of<br />
Technicon’s DPA-1 analyzer for automated<br />
quantn. of IgG, IgA, 1gM, C3, C4, and<br />
apolipoproteina A and B (A), 1112<br />
recent advances in instrumentation for use in<br />
physicians’ offices and public health<br />
screening programs (A), 1232<br />
serum, plasma compared for use in 19 common<br />
chem. tests performed in the Hitachi 737<br />
analyzer (L), 1562<br />
two whole-blood multi-analyte analyzers evald.<br />
(SN), 1532<br />
Insulin<br />
evaln. of RIA kit far detn. of free insulin:<br />
effects of sample handling and storage (A),<br />
1144<br />
improved RIA of C-peptide<br />
muhtiyearstudy, 37<br />
and its appln. in a<br />
simple method for free insulin<br />
1146<br />
Interference<br />
See Analytical error; Variation, source of<br />
by a RIA kit (A),<br />
“Interferographs”<br />
re-evaln. of Reftotron, to characterize influence<br />
of drugs, hemolysate, lipemla, and bilirubin<br />
on results (A), 1160<br />
Interinstrument comparison<br />
accuracy, precision, and chin, reliability of three<br />
capillary blood glucose monitors (A), 1135<br />
interinstrument comparison in p02 between<br />
tonometered whole blood and<br />
perfluorocarbon (A), 1131<br />
Interlaboratory<br />
continuing<br />
performance<br />
need for qual. assessment of<br />
cyclosporine measurement (5), 1309<br />
development and evaln, of quality-assurance<br />
program based on interlab. comparison (A),<br />
1160<br />
interhospital lab. comparison of total and highdensity<br />
lipoprotein cholesterol assays (A),<br />
1075<br />
sources of imprecision in screening for<br />
congenital hypothyroidism: anal. of 9 y of<br />
performance data, 1701<br />
utilization of NatL Ref. System far Chin. Labs.-<br />
recommended methods for six anshytes (A),<br />
1104<br />
Wisconsin cholesterol study-assessment of<br />
lab. performance (A), 1068<br />
Interleukin<br />
enzyme immunoassay measurement of serum<br />
interheukin-2 receptor in heart-transplanted<br />
patients (A), 1155<br />
Intermethod comparison<br />
APP quantn. compared using a semiautomated<br />
monoclonal and a<br />
polyclonal-monoclonal immunoenzymatic<br />
assay (A), 1200<br />
anal. of cocaine metabolites in urine:<br />
comparison of TDx FPIA cocaine metabohite<br />
assay with GC/MS (A), 1186<br />
appraisal of twa rapid automated<br />
“supersensitive” TSH immunoessays (A),<br />
1151<br />
aspects of method comparison study that need<br />
more attention (A), 1110<br />
cardiac isoenzyme (CE-MM isoform) assays for<br />
early detection of acute myocardial<br />
infarction: comparison of immunometric and<br />
electrophoretic systems (A), 1117<br />
chin, comparison of Helena REP vs Kodak<br />
Ektachem creatine kinase MB slide in<br />
patients with suspected acute myocardial<br />
infarction (A), 1125<br />
din. evaln, of four “high-sensitivity” assays for<br />
thyratropin (A), 1145<br />
comparative measurements of apolipoprotein<br />
B by immunonephehometry and radml<br />
immunodiffusion (A), 1069<br />
comparison of agaroee gel electrophoresis<br />
immunoassay (Abbott A-GENT) for<br />
and<br />
measurement of lactate dehydrogenase<br />
isoenzyme-1 (A), 1124<br />
comparison of assay methods for a new<br />
strategy for cyclosporine monitoring (A),<br />
1186<br />
comparison of Centocor CA 19-9, Tandem-R<br />
CA 195, and Truqusnt GI (A), 1078<br />
comparison of cyclosporine immunoassay<br />
methods: examination of rejection and<br />
nephrotoxic episodes in liver transplantation<br />
(A), 1183<br />
comparison of four methods for measurement<br />
of cyclosporin (A), 1186<br />
comparison of HPLC and radioenzymatic assay<br />
for plasma catecholamines (A), 1100<br />
comparison of 1gM antigen capture assay with<br />
standard EIA and IFA methods for detecting<br />
1gM antibodies to Toxoplasma gondii (A),<br />
1201<br />
comparison of hutropin immunoreactivity in<br />
serum by RIA and time-resolved<br />
fluorescence findings in serum from normal<br />
children and those treated with LHRH<br />
analogs (A), 1150<br />
comparison of new Hybritech TSH EIA with<br />
two other high sensitivity TSH assays (A),<br />
1147<br />
comparison of Stratus and Roche methods for<br />
CE-MB detn, (A), 1124<br />
comparison of Technicon Chem-1 HDL<br />
cholesterol method with pptn. and<br />
ultracentrifugation methods (A), 1066<br />
comparison of test results of Hitachi 704 and<br />
American Monitor Perspective analyzers (A),<br />
1110<br />
comparison of tests used to assess fetal<br />
maturity (A), 1069<br />
diagnostic performances of CE-MB assays by<br />
DuPont and by Ciba-Corningcompared (A),<br />
1122<br />
differing results for carbamazepine between<br />
aca and TDx (A), 1182<br />
evaln. of immunochem. methods for detg. how<br />
concns. of albumin in urine (A), 1209<br />
evaln, of six direct l7-estradioh RIA kits and<br />
comparison with an in-house extn. EtA (A),<br />
1150<br />
evaln, of Syva ETS and Abbott AD1 urine drug<br />
screening immunoassay analyzers (A), 1176<br />
evaln. of three serum thyrotropin assays ins<br />
chin. outpatient population without other<br />
serious mess (A), 1147<br />
evaln. of total and direct bilirubin assays on<br />
the Beckman Astra and Synchron CX5 and<br />
Kodak Ektachem systems in comparison<br />
with HPLC bilirubin measurements (A),<br />
1095<br />
evaln. of unsaturated Fe-binding capacity on<br />
the Technicon Chem’l’” (A), 1091<br />
flecainide: comparison of fluorescence<br />
polarization with HPLC (A), 1097<br />
four assays for creatine kinase MB compared<br />
(A), 1124<br />
four nonisotopic immunoassays of free<br />
thyroxin evahd. (SN), 115<br />
four sensitive thyrotropin assays compared (A),<br />
1145<br />
immunochemical vs electrophoretic CE-MB<br />
detns. in early detection of acute myocsrdiah<br />
infarction (A), 1125<br />
mess, of cychosporine concns. in whole blood:<br />
HPLC and RIA with a specific monochonal<br />
antibody and 3H- or issllabeled ligand<br />
compared (SN), 120<br />
method comparison for C-reactive protein<br />
comparing the Array protein system from<br />
Beckman to the Behring BNA (A), 1085<br />
method-dependent correlation of major<br />
thyroxin-binding proteins with serum F?4 in<br />
patients with nonthyroidal illness (A), 1143<br />
performance evaln. of Corning 288 and Nova<br />
Stat Profile 1 blood gas systems (A), 1093<br />
qual. assurance of cyclosporine measurements:<br />
comparison of current methods (A), 1236<br />
relative operating characteristic curves used to<br />
compare drug screening immunoassays for<br />
amphetamine and methamphetamine (A),<br />
1175<br />
renal function assessed by serum creatinine<br />
and creatinine clearance: ghomeruhar<br />
filtration rate estd. by four procedures (SN),<br />
2326<br />
three methods for demonstration of ohigochonal<br />
bands of IG in CSF compared (A), 1085<br />
total bilirubm bias: is accuracy more important<br />
than consistency? (A), 1128<br />
whole-blood cychoeporin A. comparison of<br />
monoclonal antibody RIA with HPLC (A),<br />
1100<br />
International Federation of <strong>Clinical</strong><br />
<strong>Chemistry</strong><br />
See tFCC<br />
Intra-individual variation<br />
intra-individual variability of blood Mg<br />
parameters with time (A), 1114<br />
intra-individual variation of electrophoretic<br />
serum protein fractions (TB), 1544<br />
Intralaboratory performance<br />
sources of imprecision in screening far<br />
congenital hypothyroidism: anaL of 9 y of<br />
performance data, 1701<br />
Inulin<br />
assessment of renal function by inulin<br />
clearance: comparison with creatinine<br />
clearance as detd, enzymatically (SN), 312<br />
Iodine<br />
moderate I deficiency, possible explanation for<br />
inverse relation between cord serum<br />
thyrotropin and birth weight in a normal<br />
Kenyan popn. (L), 710<br />
Ion-selective electrodes<br />
effect of Br on ion-specific electrodes in the<br />
Hitachi 736(A), 1161<br />
effects on ionized Ca by different heparin<br />
preparations measured in ICA 2 analyzer<br />
(A), 1128<br />
enzymatic detn, of K in serum, 817<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns. (CR), 333<br />
new method for detg. bound and ionized Cain<br />
serum (TB), 491<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2387
performance characteristics of Na, K, and Cl in<br />
urine on the Paramax analytical system#{149} (A),<br />
1131<br />
role of new whole-blood anal, techniques in<br />
critical care (A), 1232<br />
simultaneous detn, of urea, glucose, Na, K, Cl,<br />
and total CO2 in undiluted human serum<br />
using an electrode-based automated analyzer<br />
(A), 1091<br />
use of enzyme electrodes in whole-blood<br />
measurements (A), 1233<br />
Ion transport<br />
defective epithelial ion transport in cystic<br />
fibrosis (S), 726<br />
Iron<br />
anal. performance of Kodak Ektachem chin.<br />
chem. slides (Fe) (A), 1101<br />
changes in Fe, Zn, Cu concns. in serum and in<br />
their binding to transport proteins after<br />
cholecystectomy, cardiac surgery (SN), 2243<br />
Fe detn. using CIBA Corning 550 Express<br />
analyzer (A), 1113<br />
investigation of protoporphyrin IX sod.<br />
materials used in acid-extn. methods;<br />
proposed correction for the millimohar<br />
absorptivity of protoporphyrin IX, 1601<br />
nath. ref. system for serum Fe: evaln, and use of<br />
proposed guidelines for detn. of serum Fe<br />
compared with a method in daily service (A),<br />
1113<br />
performance of the KOdak iron and total ironbinding<br />
capacity methods (TB), 2250<br />
pretreatment of sara before coulometric anal.<br />
maximizes recovery for serum Fe and TIBC<br />
(A), 1131<br />
Zn protoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Iron-binding capacity<br />
evaln, of unsaturated Fe-binding capacity on<br />
the Technicon Chemhln (A), 1091<br />
performance of the Kodak iron and total ironbinding<br />
capacity methods (TB), 2250<br />
pretreatment of sara before coulometric anal.<br />
maximizes recovery for serum Fe and TIBC<br />
(A), 1131<br />
Ischemia<br />
free radical ablation for organ preservation (A),<br />
1051<br />
Isoamylase<br />
pancreatic amylase meas. in serum by use of a<br />
monoclonal antibody immunochem.<br />
immobilized toe solid phase, 110<br />
P3 isoamylase accompanying renal<br />
insufficiency (L), 187<br />
ISO-DALT<br />
See Electrophoresis, two-dimensional<br />
Isoelectric focusing<br />
See also Electrophoresis, two-dimensional<br />
anal, of a-amylase isoenzymes by automated<br />
isoehectric focusing (SN), 2116<br />
chromatofocusing and isoelectric focusing in<br />
immobilized pH gradients compared for<br />
characterization of Hb variants, 425<br />
complement C4 allotypes and psoriasis (TB),<br />
2142<br />
creatine kinase isoforms in ischemic heart<br />
disease<br />
detecting<br />
(R), 7<br />
serum acidic range ghycaproteins<br />
using isoehectric focusing on cellulose acetate<br />
mambranea (A), 1083<br />
IgG heavy-chain subclass typing of myelama<br />
paraprateins by isoehectric focusing<br />
immunoblot anal., 364<br />
ohigochonal immunoglobuhins in HIV infection,<br />
1669<br />
Isoenzymes<br />
See also enzyme of interest<br />
agarose gel ehectrophoresis, and a chaotropic<br />
method compared for lactate dehydrogenase<br />
isoenzyme-1 (TB), 2250<br />
alk. phosphatase isoenzyme mystery (L), 707<br />
alk. phoaphatase isoenzymes in plasma in<br />
hyperthyroidism, 1427<br />
elk. phoephatase isoenzymes of liver and bone<br />
origin are incompletely resolved by wheatgerm-lectin<br />
affinity chromatog., 29<br />
alterations in lactate dehydrogenase isoenzyme<br />
patterns after therapy with streptokinase or<br />
streptococcal infection (SN), 1763<br />
a-amylsse detn. with the Reflotron reagent<br />
carrier system: use of whole blood, plasma,<br />
and serum, and effect of isoenzymes (SN),<br />
317<br />
anal, of a-amyhase isoenzymes by automated<br />
isoelectric focusing (SN), 2116<br />
appln. of Magic Lite<br />
immunochemiluminometric method far<br />
measurement of creatine kinase-MB in blood<br />
spots (A), 1123<br />
bihiary alk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-celluhoee:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
cardiac isoenzyme (CK-MM isoform) assays for<br />
early detection of acute myocardial<br />
infarction: comparison of immunometric and<br />
ehectrophoretic systems (A), 1117<br />
changes in isoform patterns and stability of<br />
CK-MB during storage (A), 1120<br />
CE-MM interference with an<br />
immunoenzymometric method for quantn. of<br />
CE-MB in serum (L), 901<br />
CE-unrelated serum component identified in<br />
CK isoenzyme anal, using Helena Rep<br />
system (A), 1117<br />
cliii. and anal. evaln, of different methods for<br />
meas. of creatine kinase isoenzyme MB (SN),<br />
130<br />
cm, comparison of Helena REP vs Kodak<br />
Ektachem creatine kunase MB slide in<br />
patients with suspected acute myocardial<br />
mfarction (A), 1125<br />
comparison of agarose gel electraphoresis and<br />
immunoassay (Abbott A-GENT) for<br />
measurement of lactate dehydrogenase<br />
isoenzyme-1 (A), 1124<br />
comparison of automated vs manual<br />
electrophoresis system for creatine kinase<br />
isoenzymes (A), 1106<br />
comparison of KOdak CE-MB assay with CE<br />
isoenzyme electrophoresis (A), 1123<br />
comparison of Stratus and Roche methods for<br />
CK-MB detn, (A), 1124<br />
concordance of creatine kinase-MB acty. and<br />
mass, 440<br />
conflicting results of hiq.-chromatog. detns. of<br />
alk, phoephatase isoenzymes (L), 2255<br />
creatine kunase and lactate dehydrogenase<br />
isoenzymes in serum and tissues of patients<br />
with stomach adenocarcinoma, 1385<br />
creatine kinase and lactate dehydrogenase<br />
isoenzyme utilization: cut-off values for<br />
fractionation based on total CK activity, and<br />
monitoring of ordering patterns in 334<br />
intensive-care-unit patients (A), 1122<br />
creatine kunase isoforms in ischemic heart<br />
disease (R), 7<br />
creatine kinase MB isoenzyme in<br />
rhabdamyosarcoma (L), 896<br />
detection of serum CE-MB isoforms by RIA<br />
(A), 1121<br />
diagnosis of acute myocardial infarction from<br />
two measurements of creatine kunase<br />
isoenzyme MB with use of nonparametric<br />
probability estn., 444<br />
diagnosis of acute myocardial infarct, when<br />
skel, muscle damage is present: a caveat<br />
regarding use of creatine kinase isoenzymes<br />
(L), 705<br />
diagnostic performances of CK-MB assays by<br />
Du Pont and by Ciba-Corning compared (A),<br />
1122<br />
diagnostic value of measuring pancreatic hipase<br />
and the P3 isoform of pancreatic amylase<br />
isoenzyme in serum of hospitalized<br />
hyperamylasemic patients, 417<br />
ECG evidence of myocardial infarction without<br />
cardiac isoenzymes abnormalities (A), 1116<br />
effect of forced diuresis on urinary excretion of<br />
pancreatic amyhase (A), 112’7<br />
effect of therapeutic coronary reperfusion on<br />
serum aspartate aminotransferase<br />
isoenzymes in patients with acute<br />
myocardial infarction (A), 1116<br />
effects of therapeutic coronary reperfusion on<br />
aspartate aminotransferase isoenzymes in<br />
sara of patients with acute myocardial<br />
infarct,, 909<br />
elevated CE-MB ins patient with pelvic<br />
sarcoma (A), 1124<br />
EMDS test pack CK-MB immunoassay:<br />
immunoinhibition with anti-CE-M antibody<br />
(A), 1115<br />
estn, of brain lesion size based on quantifying<br />
CE-BB in serum (L), 2018<br />
evahn. of a photometric assay far detn. of<br />
human bone elk. phosphatase (A), 1089<br />
evaln. of automated CE-MB mass assay (A),<br />
1107<br />
evaln, of Dade Stratus for detn, of CK-MB (A),<br />
1090<br />
evahn. of immunoenzymatic assay for CE-MB<br />
using the Icon format (A), 1121<br />
evolution of serum CK-MB isoforms after<br />
acute myocardial infarction (A), 1120<br />
four assays for creatine kinase MB compared<br />
(A), 1124<br />
hered. complete deficiency of lactate<br />
dehydrogenase H-subunit (CR), 687<br />
heterogeneity of serum creatine kinase<br />
isoenzyme MM in myocardial infarction:<br />
chin, significance and poet-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
high-M, (“biliary”) isoenzyme of alk.<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
hypereanylasemia and a-amylase isoenzymes in<br />
acute liver congestion due to cardiac<br />
circulatory failure (TB), 1793<br />
immunoaffinity<br />
from human,<br />
purifn. of creatune kunase-MB<br />
dog, and rabbit heart with use<br />
of monoclonal antibody specific for CE-MB,<br />
985<br />
immunoassay of band 5 (“tartrate-resistant”)<br />
acid phosphatase involving use of antiporcine<br />
uteroferrin antibodies, 86<br />
immunochemical vs electrophoretic CE-MB<br />
detns, in early detection of acute myocardial<br />
infarction (A), 1125<br />
is electraphoresis a ref. method for CK-MB in<br />
comparison with an immunoenzymometric<br />
method? (L), 900<br />
isoenzymes and isoforms of CE: what is the<br />
score? (E), 201<br />
lactate dehydrogenase and its isoenzymes in<br />
serum in multiple myehoma (SN), 1968<br />
lactate dehydrogenase-1 assay using an M-<br />
subunit-specific, immobilized monoclonal<br />
antibody (A), 1121<br />
lactate dehydrogenase isoenzyme compn. of<br />
platelets (SN), 2325<br />
lactate dehydrogenase isoenzyme 1:<br />
development of automated chem, method<br />
(A), 1119<br />
lactate dehydrogenase isoenzyme pattern in<br />
sara in malignant diseases, 396<br />
lactate dehydrogenase isoenzyme patterns in<br />
serum in metastetic liver disease (SN), 871<br />
measurement of creatine kinase MB by the<br />
Baxter Stratus fluorometric analyzer (A),<br />
1123<br />
measurement of lactate dehydrogenase using<br />
purified human placental LD isoenzyme-5<br />
(A), 1116<br />
measuring crestine kinase MB isoenzyme in a<br />
maintenance hemodialysis popn.:<br />
chemiluminometric immunoassay and<br />
ehectrophoresis compared (SN), 1965<br />
methodol. and din, multicenter evaln. of<br />
specific pancreatic a-amylase assay based on<br />
a double monochonal antibody technique (A),<br />
1090<br />
methods compared for detg. total acty. and<br />
isoenzymes of axnylase in serum (SN), 645<br />
more on methods for CK-MB (L), 899<br />
pancreatic isoamyhase: direct assay based on<br />
efficient capture by a monochonal antibody<br />
(A), 1123<br />
partial charectern. of an abnormal lactate<br />
dehydrogenase isoenzyme, LDH-lex, in<br />
serum from a patient with hepatocellular<br />
carcinoma (SN), 844<br />
patterns of lactate dehydrogenase isoenzymes 1<br />
and 2 in serum on exercise (SN), 301<br />
platelet LDH isoenzymes (A), 1134<br />
purified hyophihized lactate dehydragenase<br />
isoenzyme 5 used in a study of measuring<br />
LDH acty. (SN), 1774<br />
rapid purifn. of creatine kunaseMB isaenzyme<br />
on preparative pohyacryhamide slabs, 96<br />
rapid, quant. inimunoassay for creatine kinase-<br />
MB using Tandem Icon QSR technology<br />
(A), 1197<br />
rap!d,specific method for CE-MB using<br />
Tandem Icon OSR CK-MB reagents (A),<br />
1120<br />
reproducibility of creatine kinase isoenzyme<br />
electrophoresis (L), 710<br />
role of rapid immunoassays for urgent detns. of<br />
creatine kinase isoenzyme MB (SN), 1752<br />
S-lOOa,, protein in blood and urine during<br />
open-heart surgery, 1942<br />
scheme for detecting elevated CE-MB in<br />
children (A), 1109<br />
sensitive, rapid assay of subforms of creatine<br />
kinase MB in plasma, 1452<br />
serum creatine kinase isoenzyme BB: poor<br />
index to size of various brain lesions (SN),<br />
651<br />
2388 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
serum P-amyhase detn. using monochonal<br />
antibody (A), 1127<br />
sialidase from different sources compared for<br />
electrophoretically sepg. serum alk.<br />
phosphatase fractions from liver and bone<br />
(SN), 1955<br />
single-vial screening assay for creatine kinase-<br />
MB (A), 1122<br />
staining method for use in ehectrophoretic<br />
detn. of amyhase isoenzymes in serum (SN),<br />
2322<br />
standn. of nomenclature in chin. chem. (L),<br />
1552<br />
statis, intarpretn. of concns. of Mg, Zn, Ca, K,<br />
cholesterols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
Stratus automated creatine kinase-MB assay<br />
evald,: identn, and ehimn. of falsely increased<br />
results assocd. with a high-M, form of alk,<br />
phosphatase, 2048<br />
time-resolved immunofluorometric assay of<br />
human pancreatic amylase in serum (A),<br />
1117<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamylase in serum, with use of<br />
two monoclonal antibodies, 1915<br />
use of creatine kinase MB isoforms for<br />
predicting myocardial reperfusion (A), 1125<br />
variability in serum lactate dehydrogenase<br />
acty. and isoenzyme patterns induced by<br />
streptokinase (A), 1119<br />
variation in decision thresholds for CK and<br />
CK-2 in myocardial infarction (A), 1116<br />
Jaff#{233} reaction<br />
See Creatinine<br />
Ketoconazole<br />
cyclosporine pharmacokinetics with<br />
concomitant<br />
Ketoisocaproic<br />
ketoconazole<br />
acid<br />
therapy (A), 1176<br />
etabn. of a-ketoisocaproic acid in serum and<br />
plasma (TB), 495<br />
Ketone bodies<br />
kinetic mess. of ketone bodies (L), 1263<br />
Kidney disease<br />
See also Renal disease, Renal function<br />
biol, variation of urinary N-acetyh--Dghucosaminidase:<br />
practical and chin,<br />
implications, 560<br />
circadian variations and ref. intervals for same<br />
enzymes in urine of healthy children (SN),<br />
864<br />
electrophoretic examin, of proteinuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
high-yield purifn. of the complex-farming<br />
glycoprotein in urine, 577<br />
interference with meas. of intact parathyrin in<br />
serum from renal dialysis patients (TB),<br />
1543<br />
Lp(a) lipoprotein concn, in serum of patients<br />
with heavy protainuria of different origin<br />
(SN), 2121<br />
mapping the locus of autosomal dominant<br />
polycystic kidney disease: diagnostic appln.<br />
(S),B13<br />
i-microghobulun and immune activation (L),<br />
2158<br />
new technique for measuring free thyroxin in<br />
serum: multi-center study (SN), 2137<br />
P3 isoamyhase accompanying renal<br />
insufficiency (L), 187<br />
rhabdomyolysis in a case of free-base cocaine<br />
(“crack”) overdose (CR), 1547<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
urine protein 1: sex-dependent marker of<br />
tubular or glomerular dysfunction (TB),<br />
2141<br />
(Wake Forest University Case Conference):<br />
myoglobinuria, hemoglobinuria, acute renal<br />
failure (CC), 1713<br />
Kinetic analysis<br />
concn. of free thyroxin in serum during<br />
nonthyroidal ihhness-calcn. or mess,? (SN),<br />
159<br />
performance of kinetic BUN assay on<br />
BM/Hitachi 717’ (A), 1098<br />
Kinetic assays<br />
enzymatic detn. of K in serum, 817<br />
kinetic detn, of serum biotinidase using a<br />
unique chromogenic substrata (A), 1151<br />
kinetic study of the ,Jaff#{233} reaction for<br />
creatinine in serum: 2. evaln, of buffered<br />
reagent and comparison of different dataprocessing<br />
options, 360<br />
muhtipoint kinetic simultaneous mess. of<br />
combined concns. of acetoacetate--<br />
hydroxybutyrate and hactate-pyruvate (SN),<br />
1526<br />
nonenzymatic stopped-flow fluorimetry for<br />
direct detn, of uric acid in serum and urine,<br />
230<br />
Kinetic enzyme assay<br />
alk. phosphatase acty. from ostaosarcoma cell<br />
line SaOS-2: iaoenzyme sod, for quantifying<br />
skeletal elk. phosphatase acty. in serum, 223<br />
detn. of acid phosphatase in serum with 2,6-<br />
dichhoro-4-acetylphenyl phosphate substrate<br />
(A), 1117<br />
“Kit” methods<br />
algorithm for testing and reporting serum<br />
choriogonadotropin at chin. sigrnf. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
automated enzyme immunoassay for lutropin<br />
(Abbott IMx analyzer) (SN), 2333<br />
calibration of hi1 immunoassay measuring<br />
cyclosporin A (TB), 181<br />
chin, and anal. evaln. of different methods for<br />
mess. of creatine kinsse isoenzyme MB (SN),<br />
130<br />
Coloscreen VPI test kit evald. for detection of<br />
fecal occult blood, 156<br />
commercially available dissociation-enhanced<br />
hanthanide fluaroimmunoassay kit evald. for<br />
quantifying ferritin in serum (TB), 327<br />
critical evaln, of an immunoradiometric assay<br />
of sex-hormone binding globulin (TB), 2146<br />
cychosporine concns, in blood after liver<br />
trensphantn.: correlation of immunoassay<br />
results with chin, events, 564<br />
detection of poisoning by plant-origin cardiac<br />
glycoside with the Abbott TDx analyzer<br />
(SN), 295<br />
diagnostic performance of a modified freethyroxin<br />
assay in subjects with anomalies in<br />
their binding proteins (TB), 493<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerlex cortisol, Biodata testostarone (SN),<br />
641<br />
enzymatic detn. of urinary oxalate (SN), 2330<br />
enzymatic method for lactate in whole blood<br />
adapted to the Cobss Bio (TB), 324<br />
estrogen and progesterone receptor assays,<br />
the EIA method (Abbott), of low-speed<br />
by<br />
supernates of breast-cancer homogenates<br />
(SN), 2226<br />
evahn. of a particle-enhanced immunoaasay for<br />
quantifying C-reactive protein (TB), 2001<br />
evahn. of biotinyhatad (Blugene’”) vs 32p<br />
labeled cDNA probes of -<br />
ghucocerebrosidsse: rel, sensitivities in<br />
genomic and other systems (SN), 1512<br />
four nonisotopic immunoassays of free<br />
thyroxinevald. (SN), 115<br />
four sensitive thyrotropin assays critically<br />
evald., compared (SN), 1785<br />
high incidence of false-positive albuminuria<br />
results with the Micro-Bumintest’” (TB),<br />
1252<br />
influence of matrix on concns. of somatotropin<br />
mess, in serum with commercial<br />
immunoradiometric assays, 1423<br />
interference of coumarin therapy with the<br />
“Heptest” owing to declining prothrombin<br />
concns. (SN), 483<br />
mess, of cychosporine concns. in whole blood:<br />
HPLC and RIA with a specific monoclonal<br />
antibody and 3H- or ‘25I-habeled higand<br />
compared (SN), 120<br />
mechanism of false-negative urine cannabinoid<br />
immunoassay screens by VisineTMeyedrops<br />
(SN), 636<br />
methods compared for detg. total acty. and<br />
isoenzymes of amyhase in serum (SN), 645<br />
microplate mess, of urinary albumin,<br />
creatinine, 1371<br />
more on “hook effects” in immunametric<br />
assays for prostate-specific antigen (L), 2154<br />
new commercial method for enzymatic detn. of<br />
creetinine in serum and urine evald:<br />
comparison with a kinetic Jaff#{233} method and<br />
isotope diln.-mass spectrometry (SN), 835<br />
new technique for measuring free thyroxin in<br />
serum: multi-center study (SN), 2137<br />
pancreatic amylase in serum for differential<br />
diagnosis of acute pancreatitis, acute<br />
abdominal diseases (TB), 2142<br />
performance, diagnostic apphn. of a two-site<br />
immunoradiometric assay for parathyrin in<br />
serum (SN), 1957<br />
performance of the Recombigen5 HIV-1<br />
antibody latex agglutn. test (TB), 2140<br />
preliminary appraisal of a PR-EIA kit for<br />
quantifying progesterone receptors in breastcancer<br />
tissue (L), 339<br />
quantn. of choriogonadotropin: differential<br />
cross-reactivities of free hCG a-subunit with<br />
eight different monoclonal antibody-based<br />
hCG and (hCG + $) “sandwich”-type assays<br />
(TB), 1791<br />
relative potency of commercial calibrators for<br />
fructosamine, and their effect on mess, of<br />
fructosamine in serum (L), 712<br />
reservations regarding assessment of data<br />
obtained with commercialhy available<br />
cortisol RIA kits (L), 2153<br />
sensitivity of CYCLO-Trac SP (specific<br />
monoclonal immunoassay for cyclosporin A)<br />
(L),900<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoassays<br />
of carcinoembryonic antigen (SN), 146<br />
sources of imprecision in screening for<br />
congenital hypothyroidism:<br />
performance data, 1701<br />
anal, of 9 y of<br />
standn. of a commercial (Boehringer<br />
Mannheim Diagnostics) enzymtc method for<br />
cholesterol, 409<br />
three nonisotopic methods for human<br />
choriogonadotropin evald, (TB), 1545<br />
two kits for CK-MM isoforms evald. for early<br />
recognition of acute myocardial infarction<br />
(TB), 493<br />
Wako UV colorimetric pancreatic hipase assay<br />
with 1,2-dihinoleoylglycerol as substrate<br />
evald. (TB), 1540<br />
Laboratory safety<br />
field evaln. of Paramax Plus anal, system with<br />
Closed Container Sampling’” (A), 1106<br />
Lactate<br />
effects of in vivo and in vitro production of<br />
lactic acid on ionized, protein-bound, and<br />
complex-bound Ca in blood, 935<br />
enzymatic method for lactate in whole blood<br />
adapted to the Cobas Bio (TB), 324<br />
evahn. of the Kodak Ektachem din. chem.<br />
slides for lactate<br />
multipoint kinetic<br />
(A), 1132<br />
simultaneous mesa, of<br />
combined concns. of acetoacetate--<br />
hydroxybutyrate and lactate-pyruvate (SN),<br />
1526<br />
“stat” measurements of L-lactate ip whole<br />
blood and CSF assessed (SN), 1740<br />
test-strip method for lactate in whole blood<br />
(SN), 1992<br />
Lactate dehydrogenase<br />
agarose gel electrophoresis, and a chaotropic<br />
method compared for lactate dehydrogenase<br />
isoenzyme-1 (TB), 2250<br />
alterations in lactate dehydrogenase isoenzyme<br />
patterns after therapy with streptokinase or<br />
streptococcal infection (SN), 1763<br />
autoantibodies to lactate dehydrogenase in<br />
serum identified by use of immobihized<br />
Protein G and immobilized jacahin, a<br />
jackfruit lectin, 2190<br />
comparison of agarose gel electrophoresis and<br />
immunoasaay (Abbott A-GENT) for<br />
measurement of lactate dehydrogenase<br />
isoenzyme-1 (A), 1124<br />
creatine kinase<br />
whole blood,<br />
and lactate dehydrogenase in<br />
plasma, and serum determined<br />
with Abbott’s Vision system (A), 1125<br />
creatine kinase and lactate dehydrogenase<br />
isoenzymes in serum and tissues of patients<br />
with stomach adenocarcinoma, 1385<br />
creatine kinase and lactate dehydrogenase<br />
isoenzyme utilization: cut-off values for<br />
fractionation based on total CE activity, and<br />
monitoring of ordering patterns in 334<br />
intensive-care-unit patients (A), 1122<br />
hered. complete deficiency of lactate<br />
dehydrogenase H-subunit (CR), 687<br />
lactate dehydrogenase acty. of murine natural<br />
killer cells in young and old mice:<br />
implications (A), 1155<br />
lactate dehydrogenase and its isoenzymes in<br />
serum in multiple myeloma (SN), 1968<br />
lactate dehydrogenase-1 assay using an M-<br />
subunit-specific, immobilized monoclonal<br />
antibody (A), 1121<br />
lactate dehydrogenase in serum of patients<br />
performing an exercise test (L), 2016<br />
lactate dehydrogenase isoenzyme compn. of<br />
platelets (SN), 2325<br />
lactate dehydrogenase isoenzyme 1:<br />
development of automated chem. method<br />
(A), 1119<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2389
lactate dehydrogenase isoenzyme pattern in<br />
sera in malignant diseases, 396<br />
lactate dehydrogenase isoenzyme patterns in<br />
serum in metastatic liver disease (SN), 871<br />
measurement of lactate dehydrogenase using<br />
purified human placental LD isoenzyme-5<br />
(A), 1116<br />
partial charactern. of an abnormal lactate<br />
dehydrogenase isoenzyme, LDH-iex, in<br />
serum from a patient with hepatocelluhar<br />
carcinoma (SN), 844<br />
patterns of lactate dehydrogenase isoenzymes 1<br />
and 2 in serum on exercise (SN), 301<br />
platelet LDH isoenzymes (A), 1134<br />
purified lyophihized lactate dehydrogenase<br />
isoenzyme 5 used in a study of measuring<br />
LDH acty. (SN), 1774<br />
streptokinase binds to lactate dehydrogenase<br />
subunit-M, which shares an epitope with<br />
plasminogen, 69<br />
variability in serum lactate dehydrogenase<br />
acty. and isoenzyme patterns induced by<br />
streptokinase (A), 1119<br />
Lactoferrin<br />
purifn., characterization of intact lactoferrin<br />
found in the urine of human milk-fed<br />
preterm infants, 1928<br />
Lactogen<br />
turbidimetric latex immunoasaay of placental<br />
hactogen on microtiter plates, 141<br />
Laminin<br />
increased laminin concns. in serum in<br />
hyperthyroidiam (TB), 1540<br />
Laser<br />
nephelometry<br />
four immunochem. methods compared for<br />
mess. C-reactive protein in plasma (SN), 461<br />
functional, immunohog, concns, of a2-<br />
macroghobuhincompared in plasma of<br />
subjects without a1-protease inhibitor<br />
defidiency (SN), 1535<br />
screening for microalbuminuria in patients<br />
with diabetes: frozen storage of urine<br />
samples decreases their albumin content<br />
(SN), 308<br />
Latex agglutination assay<br />
automated enhanced latex agghutn. assay for<br />
rheumatoid factors in serum (SN), 303<br />
patient-side immunoassay system with a<br />
single-use cartridge for measuring analytas<br />
in blood (S), 1869<br />
performance of the Recombigen5 HP/-i<br />
antibody latex agghutn. test (TB), 2140<br />
quant. detn. of myoglobin by a latex-enhanced<br />
turbidimetric assay (A), 1091<br />
Latex agglutination immunoassay<br />
automated latex photometric immunoassay for<br />
detection of hepatitis B surface antigen (A),<br />
1206<br />
development of automated latex agglutination<br />
immunoassay for procainamide for IL<br />
Monarch’”chem, system (A), 1171<br />
latex-based immunoassay for detn. of<br />
carbamazepine with IL Monarch’” chem,<br />
system (A), 1171<br />
turbidimetric latex immunoasaay of placental<br />
lactogen on microtiter plates, 141<br />
urine protein 1: sex-dependent marker of<br />
tubular or glomerular dysfunction (TB),<br />
2141<br />
Latex agglutination inhibition assay<br />
comparison of two comm. available<br />
immunological occult blood tests and a<br />
guaiac slide test (A), 1162<br />
Latex agglutination inhibition immunoassay<br />
development of latex-based tobramycin<br />
immunoassay for the IL Monarch’” chem.<br />
system (A), 1172<br />
latex agglutination inhibition immunoassay for<br />
gentamicin on the IL Monarch’” chem.<br />
system (A), 1172<br />
latex agglutination inhibition immunoassay for<br />
quinidine on the IL Monarch’” chem. system<br />
(A), 1172<br />
poisoning<br />
empirically detd. Pb-poisoning screening cutoff<br />
for the Protofluor-Z hematofluorometer<br />
(SN), 2104<br />
interhab, comparison of control materials for<br />
use with hematofluorometers, 2059<br />
investigation of protoporphyrmn IX sod.<br />
materials used in acid-extn. methods;<br />
proposed correction for the milhimolar<br />
absorptivity of protoporphyrmn IX, 1601<br />
Lead<br />
Lecithin/sphingomyehin ratio<br />
muhticenter evaln. of TDx teat for assessing<br />
fetal lung maturity, 1005<br />
phosphohipid surface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal, of the value of pptn. with cold acetone,<br />
800<br />
usefulness of hecithin/sphingomyelin ratio and<br />
uselessness of phosphatidyhghyceroh deths. in<br />
tracheal aspirates from pretarm infants (L),<br />
706<br />
Lectins<br />
aberrant lectin-binding acty. of<br />
immunoghobulin G in serum in rheumatoid<br />
arthritis, 1638<br />
autoantibodies to lactate dehydrogenase in<br />
serum identified by use of immobilized<br />
Protein G and immobilized jacalin, a<br />
jackfruit hectin, 2190<br />
changes in concanavahin A-reactive<br />
inflammatory disorders, 2207<br />
proteins in<br />
effect of Triton X-100 on pptn. of bihiary<br />
phosphatase by wheat-germ lectin (L), 513<br />
Leukemia<br />
chin, significance of 2-microghobuhin in chronic<br />
lymphocytic leukemia and non-Hodgkins<br />
hymphoma (A), 1079<br />
extn, of intracellular nucheosides and<br />
nucheotides with acetonitrile, 48<br />
hiq,-chromatog. monitoring of cytoeine<br />
arabinoside and its metabolite, uracil<br />
arabinoside, in serum, 1011<br />
molecular genetics of leukemia and hymphoma<br />
(5), B43<br />
Leukocyte esterase<br />
implications of probability anal. for<br />
interpreting results of leukocyte esterase and<br />
nitrite teat stips, 1663<br />
Leukocytes<br />
(acyh)carnitine distribution between plasma,<br />
erythrocytes, and heukocytes in blood (L),<br />
711<br />
fast, stable method for harvesting leukocytes<br />
for measuring intracellular Mg (SN), 1986<br />
Leukotrienes<br />
leukotriene B4 is measurable in serum of<br />
smokers and nonsmokers (SN), 459<br />
mess, of urinary heukotrienes by reversedphase<br />
liq. chromatog. and RIA, 388<br />
Light-chain proteins<br />
chin, apphns. for quant. a and A light chain<br />
detns. (A), 1084<br />
normal range of a/A light-chains<br />
immunoghobuhins in 422 hospital patients<br />
(A), 1086<br />
Likelihood ratios<br />
diagnostic utility of serum total creatine kinsse<br />
and creatine kinase-2 in myocardial<br />
infarction re-evaluated, 1435<br />
generalized likelihood ratio concept and<br />
logistic regression anal, for multiple<br />
diagnostic categories, 990<br />
Lipase<br />
diagnostic value of measuring pancreatic Lipase<br />
and the P3 isoform of pancreatic amyhase<br />
isoenzyme in serum of hospitalized<br />
hyperamyhasemic patients, 417<br />
enzymatic method using 1,2-dighyceride for<br />
pancreatic lipase test in serum (A), 1126<br />
immunohog.-derived pancreatic amyhase,<br />
pancreatic hipase, and total amyhase<br />
compared as predictors of pancreatic<br />
inflammation (TB), 1542<br />
lipase acty. measured in serum by a<br />
continuous-monitoring PH-Stat<br />
technique-update, 1688<br />
measuring carboxypeptidsse A acty. with a<br />
centrif, analyzer anal, and din.<br />
considerations, 251<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
Wako UV cohorimetric pancreatic hipase assay<br />
with 1,2-dilinoleoyhghyceroh as substrate<br />
evald. (TB), 1540<br />
Lipemia<br />
effects of lipemia of Hitachi 737 measurements<br />
(A), 1159<br />
Lipids<br />
CDC/NHLBI<br />
lipid standardization<br />
program-30 years of collaboration (A), 1073<br />
comparison of serum apohipoprotein<br />
measurements and serum lipid parameters<br />
(A), 1067<br />
concns, of lipids, apohipoproteins in patients<br />
with chin, well-controlled insulin-dependent<br />
and non-insulin-dependent diabetes, 813<br />
degree of lipid peroxidation in postmortem<br />
blood of fire victims (A), 1176<br />
HUP-hipid program: apolipoprotein A-I and B<br />
and the apo B/epa A-I ratio (A), 1065<br />
managing lipids by diet, exercise, and drugs in<br />
adult patients (A), 1062<br />
managing of lipids by diet, exercise, and drugs<br />
in pediatric patients (A), 1061<br />
rapid deth. of total lipid profile using only 0.5<br />
mL of plasma (A), 1071<br />
rapid micra-scale proced. for detn. of total lipid<br />
profile, 1486<br />
serum lipid and apohipoprotein changes in<br />
normal pregnancy (A), 1066<br />
simultaneous hiq.-chromatog. detn, of vit. K1,<br />
vit. E in serum, 2285<br />
transport conditions and stability of biochem,<br />
markers in blood (SN), 2313<br />
Lipoprotein receptors<br />
development of a receptor assay for measuring<br />
serum “active” apolipoprotein B-100 concn,<br />
(A), 1066<br />
Lipoproteins<br />
alpha alow-moving HDL subfraction in serum<br />
of a patient with radiation enteritis and<br />
peritoneal carcinosis (CR), 674<br />
changes in structure and function of LDL<br />
following oxidation (A), 1234<br />
comparison of Technicon Chem-1 HDL<br />
cholesterol method with pptn. and<br />
ultracentrifugation methods (A), 1066<br />
composition of very-how-density hipoproteins in<br />
non-insulin-dependent diabetes, 808<br />
cord blood hipoprotein(a) in blacks and whites<br />
(A), 1065<br />
cychospormne does not interfere in total and<br />
high-density hipoprotein cholesterol mess,<br />
with use of enzymatic cholesterol assays<br />
(TB), 2251<br />
differential detn, of HDL-subfractions in cm.<br />
labs. (L), 701<br />
distribn. of thiobarbituric acid-reactive<br />
substances in lipoproteins, proteins in serum,<br />
2054<br />
dual-ppth. method evald, for mess. of<br />
cholesterol in high-density lipoprotein<br />
subfrections HDL2 and HDL3 in plasma, 265<br />
effect of glycation of how-density hipoprotein on<br />
immunolog. detn. of apolipoprotein B (SN),<br />
2219<br />
evaln, of the Kodak Ektachem HDL<br />
cholesterol kit on the Kodak Ektachem 700<br />
analyzer (A), 1069<br />
extrapolation of hipoprotein ref. limits to<br />
apohipoprotain measurements (A), 1070<br />
fasting vs nonfasting hipoprotain measurements<br />
(A), 1066<br />
implications for mess, of pre-fl high-density<br />
hipoprotein (free apo A-I) by ultracentrifn,<br />
(L), 2336<br />
improved immunoblotting technique for Lp(a)<br />
phenotyping (A), 1070<br />
improved methods for sepn. of total MDL and<br />
subclasses (A), 1086<br />
mnterhospital lab. comparison of total and highdensity<br />
hipoprotein cholesterol assays (A),<br />
1075<br />
LDL heterogeneity: relationships between<br />
particle size and coronary disease (A), 1234<br />
hipoprotein(a): genetic marker for<br />
atherosclerosis (A), 1234<br />
hipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
hipoprotein changes in subjects on a modified<br />
fasting regimen (A), 1068<br />
Lp(a) lipoprotein concn, in serum of patients<br />
with heavy proteinuria of different origin<br />
(SN), 2121<br />
Lp(a) phenotype frequency in a normal North<br />
Am. population (A), 1070<br />
meas. of apolipoprotein B in plasma from<br />
hyperlipidemic subjects treated with<br />
chohestyramine or placebo: differential<br />
effects of storage at -70 #{176}C, 380<br />
performance eveln, of Ciba Corning<br />
Diagnostics MDL cholesterol reagent on the<br />
Impact 400E (A), 1094<br />
plasma hipoprotein(a) and the Friedewald<br />
formula (L), 2156<br />
pohyacryhaniide gel ehectropharesis used in a<br />
critical study of ppth. reagents for<br />
quantifying HDL cholesterol (TB), 1254<br />
rapid micro-scale proced. for detn. of total lipid<br />
profile, 1486<br />
regional interlab, standn. of serum cholesterol,<br />
HDL cholesterol, and triglycerides (A), 1065<br />
screening of serum cholesterol and HDL<br />
cholesterol using the EM. Diagnostic<br />
2390 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
Systems EASY ST analyzer (A), 1074<br />
serum lipoproteins and coronarographic<br />
features (L), 1266<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
unusual band that binds Mb after<br />
ultracentrifn. of hemohyzed plasma for<br />
lipopratein sepn. (TB), 495<br />
use of adual-pptn. proced. for mess. highdensity<br />
lipoprotain 3 in normolipidemic<br />
serum, 1390<br />
ApO.Omes<br />
stable liposomes for microcapsule<br />
immunoassay in human sera (A), 1204<br />
,.ithiasls<br />
See Calculous disease<br />
aver disease<br />
See also Liver function, Hepatic disease<br />
elk. phosphatase isoenzymes in plasma in<br />
hyperthyroidism, 1427<br />
biliary alk. phosphatase measured by minicolumn<br />
chromatog. on DEAE-celluhose:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
calciferin and cathepsin D-hike acid protease in<br />
serum in acute, chronic liver injuries in rats,<br />
humans, 2202<br />
cydhosporineconcns. in blood after liver<br />
transphanth.: correlation of immunoassay<br />
results with chin, events, 564<br />
detn, of branched-chain amino acids and<br />
tyrosine in serum in various hepatic diseases,<br />
and its din, usefulness, 1399<br />
functional acty. of protein S detd. with use of<br />
protein C activated by venom activator,<br />
high-M, (“bihiary”) isoenzyme of alk.<br />
1644<br />
phosphatase and the diagnosis of liver<br />
dysfunction in cystic fibrosis, 1888<br />
lactate dehydrogenase isoenzyme patterns in<br />
serum in metastatic liver disease (SN), 871<br />
mess, of glutathione S-transferase B1 in plasma<br />
after birth asphyxim early indication of<br />
hepatocehlular damage, 995<br />
plasma glutathione S-transferase and F protein<br />
are more sensitive than alanine<br />
aminotransferase as markers of<br />
ecetaminophen-induced<br />
ratio of serum aspartate<br />
liver damage,<br />
to alanine<br />
2186<br />
aminotrensferase as a prognostic index in<br />
pediatric liver disease (A). 1151<br />
rhabdomyohysis in a case of free-base cocaine<br />
(“crack”) overdose (CR), 1547<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasie, and assessment of<br />
effects of organ failure, 1631<br />
signif. of how serum urea N concns, (SN), 639<br />
Liver function<br />
See also Liver disease<br />
antipyrine, indocyanine green, and horazepem<br />
deed, in plasma by HPLC (SN), 2124<br />
effect of hypoxia and oxygen free radicals on<br />
liver lysosomes (A), 1137<br />
prognostic value of MEGX liver-function test<br />
in transplant candidates (A), 1135<br />
Lowe’s syndrome<br />
ehectrophoretic examin. of proteinuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
Luliberin<br />
comparison of lutropin immunoreactivity in<br />
serum by RIA and time-resolved<br />
fluorescence findings in serum from normal<br />
children and those treated with LHRH<br />
analogs (A), 1150<br />
Luminescence lmmunoassay<br />
development of enhanced luminescence<br />
immunoassay for progesterone (A), 1149<br />
enhanced luminescence immunoassay for<br />
eatradiol (A), 1149<br />
enhanced luminescence immunoassay for free<br />
T3 (A), 1149<br />
immunometric assay for carcinoembryonic<br />
antigen based on enhanced luminescence<br />
(A), 1080<br />
one-step immunometric assay for TSH based<br />
on enhanced luminescence (A), 1149<br />
Lung disease<br />
bronchopulmonary dysphasia-current<br />
concepts (A), 1241<br />
changes of growth-related hormones and<br />
growth factors following pneumonectomy: I.<br />
growth hormone (A), 1150<br />
defective epithehial ion transport in cystic<br />
fibrosis (S), 726<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN), 166<br />
functional, immunohag. concns. of 02-<br />
macroglobulin compared in plasma of<br />
subjects without a1-protease inhibitor<br />
deficiency (SN), 1535<br />
proton NMR studies of plasma to determine<br />
metab. status of patients with adult reap.<br />
distress syndrome (SN), 667<br />
Lupus erythematosus<br />
See also Systemic lupus erythematosus<br />
changes in concanavalin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
Lutropin<br />
assay for human hutropin using higand and antihigand<br />
system (A), 1093<br />
automated enzyme immunoassay for hutropin<br />
(Abbott IMx analyzer) (SN), 2333<br />
comparison of hutropin immunoreactivity in<br />
serum by RIA and time-resolved<br />
fluorescence findings in serum from normal<br />
children and those treated with LHRH<br />
analogs (A), 1150<br />
detn, of FSH, LH, and cortisoh with automated<br />
enzyme immunoassays (A), 1141<br />
development of fully automated immunoassay<br />
for hLH on the Abbott IMx automated<br />
immunoassay system (A), 1203<br />
evaln. of new consumer test for hutropin (A),<br />
1146<br />
predicting ovulation in in-vitro fertilization<br />
program by monitoring lutainizing<br />
hormone/creatinine ratio in random urine<br />
samples (A), 1144<br />
rapid enzyme immunoassay far visual,<br />
semiquant. detn. of hutropin in urine for<br />
ovulation prediction (A), 1148<br />
ultra-specific time-resolved<br />
immunofluorometric assay of lutropin in<br />
serum (TB), 2251<br />
Lyme disease<br />
detecting Lyme disease, 1812<br />
Lymphocytes<br />
alteration of lymphocyte subsets and endocrine<br />
response during 80 days of competitive swim<br />
training (A), 1136<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
evaln, of heukocyte-associated dipeptidyl<br />
peptidase IV enzyme in normal and<br />
immunodeficient conditions (A), 1153<br />
quantn. Mn in lymphocytes to assess Mn<br />
nutrit. status, 1939<br />
Lymphokine-actlvated killer cells<br />
tumor-derived activated cells: prehim. lab, and<br />
din, results<br />
Lymphoma<br />
(5), 1576<br />
molecular<br />
(S),B43<br />
genetics of leukemia and lymphoma<br />
Lysine<br />
does the effective diminution of nonenzymatic<br />
glycation by D-lysine really highlight its<br />
potential use in vivo? (L), 2254<br />
Lysosomes<br />
effect of hypoxia and oxygen free radicals on<br />
liver hysosomes (A), 1137<br />
Macroamylasemia<br />
immobilized anti-salivary amylase antibody<br />
interacts with macroamylases: implications<br />
for use in a pancreatic amylase assay to<br />
distinguish macroamyhasemia from acute<br />
pancreatitia, 1651<br />
Macroenzymes<br />
See Immunoglabulin-enzyme complexes<br />
macroenzymes: biochem, characterization, cm.<br />
signif., and lab, detection (R), 2261<br />
Macroghobuhin<br />
detn, of a2-macroghobulin-trypsin complex<br />
with a new synthetic substrata, 2169<br />
functional, immunohog. concns. of 02-<br />
macroglobulin compared in plasma of<br />
subjects without ai-protease inhibitor<br />
deficiency (SN), 1535<br />
Magnesium<br />
blood Mg parameters in premenstrual<br />
syndrome (A), 1115<br />
detn, of Mg2 in granulocytea, 1404<br />
enzymatic assay of Mg through glucokinase<br />
actn. (SN), 2212<br />
evaln. of single-reagent Mg procedure on the<br />
Hitachi 737 (A), 1128<br />
fast, stable method for harvesting leukocytes<br />
for measuring intracellular Mg (SN), 1986<br />
fluorometry of Mg21’in serum with 2-hydroxy-<br />
1-nephthaldehyde salicyhoyhhydrazone, 1492<br />
frequency of hypo- and hypermagnesemia for<br />
each chin, service in four teaching hospitals<br />
(A), 1130<br />
hypomagnesemia and howelk. phosphatase<br />
acty. in patients’ serum after cardiac surgery<br />
(SN), 664<br />
intra-individual variability of blood Mg<br />
parameters with time (A), 1114<br />
meas, of Mg2 in mononuclear blood cells (L),<br />
1559<br />
modified Mg method in the aca III: ehimn. of<br />
interference by bihirubin (SN), 1031<br />
performance characteristics of a Mg procedure<br />
for the Ohympus AU5000 series of chem.<br />
analyzers (A), 1089<br />
performance<br />
Diagnostic<br />
characteristics of Ciba Corning<br />
single hiq. Mg reagent on the<br />
Express 550 (A), 1094<br />
performance of Beckman Liquid-Stat Mg<br />
reagent (A), 1131<br />
serum Mg as affected by drugs (L), 506<br />
stetis. intarpretn. of concns. of Mg, Zn, Ca, K,<br />
cholestarols, and creatine kinase isoenzymea<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
variation among units for blood cellular Mg<br />
(A), 1115<br />
Malondialdehyde<br />
distribn, of thiobarbituric acid-reactive<br />
substances in hipoprateins, proteins in serum,<br />
2054<br />
plasma malondialdehyde, lipid peroxides, and<br />
the thiobarbituric acid reaction (L), 336<br />
Manganese<br />
quanth. Mn in lymphocytes to assess Mn<br />
nutrit, status, 1939<br />
Marijuana<br />
sample preparation for thin-layer chromatog.<br />
anal. for 11-nor-9-tetrahydrocannabinol-9-<br />
carboxylic acid in urine (SN), 163<br />
Mass spectrometry<br />
automation advances in mass spectrometry<br />
(A), 1240<br />
benzodiazepines identified by capillary gas<br />
chromatog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derive., 1394<br />
diagnosis of recessive X-hinked ichthyosis:<br />
quantitative HPLC/mass spect. anal. of<br />
plasma for cholesterol sulfate, 1906<br />
HPLC/mass spectrom.: state of the art for the<br />
drug anal, lab. (S), 1282<br />
new commercial method for enzymatic<br />
creatinine in serum and urine evald:<br />
detn, of<br />
comparison with a kinetic Jaff#{233} method and<br />
isotope dihn.-mass spectrometry (SN), 835<br />
quant. anal. for org. acids in biol, samples:<br />
batch isolation followed by gas<br />
chromstog.-mass spectrom. anal,, 587<br />
simultaneous quantn. of morphine, codeine,<br />
and 06-monoacetyl morphine by gas<br />
chromatog. mass spectram. (A), 1355<br />
use of GCIIR/MS for high-confidence identifn.<br />
of drugs (S), 1279<br />
Melanin<br />
melanin and other indohe compds. do not cause<br />
false-positive cannabinoid assay results (L),<br />
1809<br />
Mehatonin<br />
salivary melstonin estn. in assessment of<br />
pmneal-gland function (L), 514<br />
Menopause<br />
effects of estrogen on mineral metab. in<br />
postmenopausal women as evald, by multiple<br />
assays measuring parathyrin bioacty., 18<br />
improved method for calcg. Ca fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
relation between plasma cholesterol and total<br />
and ionized Ca concns, in serum from<br />
postmenopausal women (TB), 328<br />
solid-phase enzymoinimunoassay of estrone in<br />
saliva, 569<br />
Menstrual cycle<br />
blood Mg parameters in premenstrual<br />
syndrome (A), 1115<br />
mess, of estrone.3-glucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoassay, 555<br />
Mental disorders<br />
free 3-methoxy-4-hydroxyphenylglycol deed, in<br />
plasma by liq. chromatog. with coulometric<br />
detection, 202<br />
Metabolic acidoals<br />
calculated HCO3’ or total C02?, 1697<br />
multipoint kinetic simultaneous mess, of<br />
combined concns, of acetoacetate--<br />
hydroxybutyrata and hactate-pyruvate (SN),<br />
1526<br />
pyroghutamic acidemia in an adult (CR), 684<br />
Metabolic disease<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
Metabolism<br />
biochem, contribution to diagnosis and study<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2391
of a new case of D-ghyceric acidemia/aciduria<br />
(CR), 2148<br />
distribn. of cychosporin A metabohites among<br />
plasma and cells in whole blood: effect of<br />
temp., hematocrit, and metabohite concn,, 59<br />
hered, complete deficiency of lactate<br />
dehydrogenase H-subunit (CR), 687<br />
methylmalonic acid, I. concns, in serum and<br />
urinary excretion in normal subjects after<br />
feeding and during fasting, and after loading<br />
with protein, fat, sugar, isoleucine, valine,<br />
2271<br />
methylmalonic acid. II. relation between<br />
concns, in serum and urinary excretion, and<br />
the correhn, between serum cobalamin and<br />
accumulation of methylmalonic acid, 2277<br />
purifn., characterization of intact Iactoferrin<br />
found in the urine of human milk-fed<br />
preterm infants, 1928<br />
rapid, reliable in viva assays of phosphate<br />
metabohites by NMR, 392<br />
simple hiq.-chromatog, method for vit, B6 cmps.<br />
in plasma, 241<br />
Metadrenaline<br />
modified method of anal, for metadrenaline in<br />
urine (L), 513<br />
Metanephrlnes<br />
anal, of urinary metanephrines of patients<br />
treated with antihypertensive a-methyhdopa<br />
(Ahdomet) (A), 1138<br />
Methadone<br />
development of TD/AD’ fluorescence<br />
polarization immunoassay for detection of<br />
methadone in human urine (A), 1176<br />
evaln, of the TDx and ADx methadone<br />
immunoassays (TB), 1794<br />
methadone and thyroid-function teats (L),<br />
1807<br />
Methainphetamine<br />
amphetamine, methamphetamine quant.<br />
confirmation procedure by GC/MS (A), 1169<br />
development of EMIT drugs of abuse assay for<br />
amphetaxnine/methamphetamine in urine on<br />
the ETS’ system (A), 1180<br />
relative operating characteristic curves used to<br />
compare drug screening immunoassays for<br />
amphetamine and methamphetamine (A),<br />
1175<br />
Methotrexate<br />
measurement of methotrexate on Du Pont aca<br />
discrete chin, analyzer (A), 1169<br />
Methoxyhydroxyphenyhglycol<br />
free 3-methoxy-4-hydroxyphenylglycol deed. in<br />
plasma by hiq. chromatog, with coulometric<br />
detection, 202<br />
Methoxytryptophol<br />
RIA of 5-methoxytryptophol in plasma (SN),<br />
1749<br />
Methylenebiachloroanihine<br />
detn, of 4,4’-methyhenebis(2-chloroaniline) in<br />
urine (L), 506<br />
Methyl ketones<br />
effect of light on reactions between N’-<br />
methylnicotinamide and methyl ketones<br />
(TB), 2000<br />
Methylmalonic acid<br />
methyhmalonic acid. I. concns. in serum and<br />
urinary excretion in normal subjects after<br />
feeding and during fasting, and after loading<br />
with protein, fat, sugar, isoleucine, valine,<br />
2271<br />
methylmalonic acid. II. relation between<br />
concns, in serum and urinary excretion, and<br />
the correln, between serum cobahemin and<br />
accumulation of methylmalonic acid, 2277<br />
solid-phase sample extn, for rapid detn, of<br />
methylmalonic acid in serum, urine by stable<br />
isotope dilution, 260<br />
Methylnicotinamide<br />
effect of light on reactions between N’-<br />
methylnicotinamide and methyl ketones<br />
(TB), 2000<br />
Mexiletine<br />
anal, of mexihetine stereoisomers in serum by<br />
HPLC with a chiral column (A), 1178<br />
Mice<br />
lactate dehydrogenase acty. of murine natural<br />
killer cells in young and old mice:<br />
implications (A), 1155<br />
Microalbuminurla<br />
See Albumin<br />
Microdiffusion<br />
alcohol detection by microdiffusion (L), 1269<br />
Microghobuhin<br />
chin, significance of 2-microglobulin in chronic<br />
hymphocytic leukemia and non-Hodgkins<br />
lymphoma (A), 1079<br />
high-yield purifn. of the complex-forming<br />
glycoprotein in urine. 577<br />
immunoturbidimetric technique for detn, of<br />
serum 2-microglobulin (A), 1189<br />
immunoturbidimetry of $2-microghobulin in<br />
serum (TB), 1996<br />
IMx z-microglobulin, fully automated<br />
micropartiche enzyme immunoassay (A),<br />
1192<br />
z-microghobuhin and immune activation (L),<br />
2158<br />
navel nonisotopic immunoasaay for grkb2-<br />
microghobuhin (A), 1205<br />
simultaneous meas. of total and IgAconjugated<br />
ai-microglobulin by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
Micropartiche capture enzyme inimunoassay<br />
fully automated assay for human folliclestimulating<br />
automated<br />
hormone on the Abbott IMx’<br />
immunoassay system (A), 1142<br />
Microplate assay<br />
direct solid-phase enzymoimmunoassay<br />
testosterone in saliva, 2044<br />
of<br />
fluorometric method for phenyhalanine<br />
microplate assay adapted for<br />
phenylketonuria screening (SN), 2112<br />
fl-Microseminoprotein<br />
RIA of -microseminoprotain, a prostaticsecreted<br />
protein in sara of men and women,<br />
1497<br />
Military medicine<br />
chin, chem, analyzer evald, by NCCLS<br />
guidelines for use in a military field lab. unit<br />
(SN), 2223<br />
Mineral metabolism<br />
effects of estrogen on mineral metab, in<br />
postmenopausal women as evald, by multiple<br />
assays measuring parathyrmn bioacty., 18<br />
Molecular biology<br />
DNA fingerprinting (S), 1832<br />
glossary for molecular biology (S), 1816<br />
Molecular genetics<br />
automated DNA sequencing methods involving<br />
pohymerase chain reaction, 2196<br />
moL genetics and the transformation of chin.<br />
chem, (S), 2165<br />
Molecular<br />
probes<br />
molecular probes used to detect<br />
cytomegahovirus and human<br />
immunodeficiency virus (S), 1581<br />
Monitoring pregnancy<br />
See also Amniotic fluld, Fetal status, etc.<br />
Monitoring therapy<br />
adv, in cychosporine pharmacoL, measurement,<br />
and ther, monitoring (S), 1299<br />
assessment of compliance status in outpatients<br />
(A), 1353<br />
bedside monitoring for neonatal intensive care<br />
patients (A), 1241<br />
continuing need for qual. assessment of<br />
cychosporine measurement (S), 1309<br />
cost-effective assays for use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
cychosporin A mess, in plasma in various<br />
transplant types by HPLC and RIA (A),<br />
1356<br />
cyclosporine concns, in blood after liver<br />
transplantn.: correlation of immunoaasay<br />
results with cm. events, 564<br />
cychosporine measured in plasma from patients<br />
with various transplants:<br />
with a specific monoclonal antibody<br />
compared (SN), 1726<br />
detn. of cychosporine in plasma: specific<br />
HPLC and RIA<br />
RIA<br />
with a monoclonal antibody and hiq.<br />
chromatog. compared, 608<br />
deth, of the allyl hysophosphohipid derivative<br />
ET-18-OCH3, a new antineophastic drug, in<br />
plasma, 821<br />
development of a confirmatory enzyme-linked<br />
immunosorbent assay for HIV-1 antibodies,<br />
946<br />
documentation of cytosine arabinoside toxicity<br />
using drug monitoring (A), 1182<br />
evaln, of Boehringer MannheimfHitachi 717<br />
for routine TDM (A), 1165<br />
evain, of the Ames Seralyzer for therapeutic<br />
drug monitoring of phenobarbitah, phenytoin<br />
(TB), 324<br />
extn, of intracellular nucheosides and<br />
nucheotides with acetonitrile, 48<br />
free 3-methoxy-4-hydroxyphenyhghycoh deed. in<br />
plasma by hiq. chromatog. with coulometric<br />
detection, 202<br />
geriatric ther. drug monitoring: special<br />
considerations (S), 1337<br />
glycated Hb in fractionated erythrocytes, 958<br />
implications of near-patient testing at an<br />
anticonvuhaent clinic (A), 1352<br />
indirect therapeutic drug monitoring by<br />
measuring monoamine oxidase actys. from<br />
platelets (A), 1175<br />
intravascular monitoring: techniques, risks and<br />
problems (A), 1059<br />
issues in methodology and apphns. for ther,<br />
monitoring of antidepressants (S), 1318<br />
lactate dehydrogenase and its isoenzymes in<br />
serum in multiple myeloma (SN), 1968<br />
lactate dehydrogenase isoenzyme pattern in<br />
sara in malignant diseases, 396<br />
hiq.-chromatog. monitoring of cytosine<br />
arabinoside and its metabohite, uracil<br />
arabinoside, in serum, 1011<br />
meas, of cychosporine concns, in whale blood:<br />
HPLC and RIA with a specific monoclonah<br />
antibody and 3H- or unIlabehed ligand<br />
compared (SN), 120<br />
measurement of methotrexate on Du Pont oca<br />
discrete din, analyzer (A), 1169<br />
morphine monitoring for an anaesthesia pain<br />
service (A), 1182<br />
new directions in cychosporine monitoring (A),<br />
1235<br />
orgn. of a chin. pharmacokinetics service (A),<br />
1354<br />
quality assurance study of gentamicin usage<br />
and monitoring in a children’s hospital (A),<br />
1167<br />
relevance of pharmecokinetics to monitoring<br />
new entiarrhythmics (S), 1332<br />
specific routine detn. of 3’-azido-3’-<br />
deoxythymidine in plasma by<br />
semiautomated liq. chromatog. (5), 1313<br />
spectroscapic systems for nan-invasive<br />
measurements (A), 1059<br />
strategies far sample prepn. with use of solidphase<br />
extrn, in TDM of basic drugs (A), 1352<br />
supercritical fluid chromatog. and microbore<br />
liq. chromatog. for drug anal. (S), 1293<br />
ther, drug monitoring in the 19904 (S), 1348<br />
update on CHEMFET sensors for patient<br />
monitoring (A), 1060<br />
update on digoxin (5), 1326<br />
variations in protein binding of drugs in<br />
plasma, serum (SN), 1722<br />
Monoamine oxidase<br />
indirect therapeutic drug monitoring by<br />
measuring monoamine oxidase ectys. from<br />
platelets (A), 1175<br />
Monoclonal antibodies<br />
elk, phosphatase isoenzymes of liver and bone<br />
origin are incompletely resolved by wheatgerm-lectin<br />
affinity chromatog., 29<br />
calibration of 1I immunoassay measuring<br />
cyclosporin A (TB), 181<br />
cyclosporine measured in plasma from patients<br />
with various transplants: HPLC and RIA<br />
with a specific monochonal antibody<br />
compared (SN), 1726<br />
detn. of cychosporine in plasma specific RIA<br />
with a monochonal antibody and liq.<br />
chromatog. compared, 608<br />
development of monochonal antibodies to<br />
human myoglobin and their use in<br />
fluorescence immunoassay (A), 1203<br />
enzyme-linked immunosorbent assay for<br />
chromogranin A, 1934<br />
evahn, of Dade Stratus for detn. of CK-MB (A),<br />
1090<br />
genetically<br />
IgG heavy-chain<br />
engineered<br />
subclass<br />
antibodies(S),<br />
typing of<br />
1849<br />
myehoma<br />
paraproteins by isoehectric focusing<br />
immunoblot anal., 364<br />
immunoaffmity purifn. of creetine kinase-MB<br />
from human, dog, and rabbit heart with use<br />
of monochonal antibody specific for CK-MB,<br />
985<br />
immunocatahytic assay of pancreatic a-amylase<br />
in serum and urine with a specific<br />
monochonal antibody (SN), 662<br />
immunochem, detn. of C4b-bindmg protein in<br />
human plasma (A), 1163<br />
immunohistochem, studies utilizing<br />
monoclonal and pohyclonal antibodies to c-<br />
erbB-2 protein (A), 1079<br />
immunoradiometry of a’- and 7’y-enalase<br />
(neuron-specific enolase), with use of<br />
monoclonal antibodies and magnetizable<br />
polymer particles, 2034<br />
interferences of human anti-mouse antibodies<br />
in mouse monoclonal antibody-based<br />
immunoassays (A), 1188<br />
hipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
mess. of cyclosporine concns, in whole blood:<br />
HPLC and ifiA with a specific monoclonal<br />
antibody and 3H- or unIhabehed higand<br />
compared (SN). 120<br />
2392 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
methodoL and chin. multicentar evaln. of<br />
specific pancreatic a-amyhase assay based on<br />
a double monoclonal antibody technique (A),<br />
1090<br />
monochonal antibodies evald, for use in<br />
screening for conjugates of human serum ahb,<br />
and pyridaxal 5’-P04 (SN), 1756<br />
monoclonal antibody to ‘y chain of fetal Hb<br />
used to develop an enzyme immunoassay,<br />
2066<br />
monochonal chemihuminescent digoxmn assay<br />
(A), 1194<br />
murmnemonochonal antibody adsorbed onto<br />
vinyhidene fluoride floccules used to<br />
eliminate antibody interference in<br />
“sandwich”-type immunoessays (SN), 1743<br />
novel immunoradiometric assay of<br />
thyroghobulin in serum with monochonal<br />
antibodies<br />
reactivity<br />
selected for lack of cross-<br />
with autoantibodies, 422<br />
pancreatic amylase mess, in serum by use of a<br />
monoclonal antibody immunochem,<br />
immobilized to a solid phase, 110<br />
pancreatic isoamylase: direct assay based on<br />
efficient capture by a monochonal antibody<br />
(A), 1123<br />
pancreatic oncofetal antigen and carbohydrate<br />
antigen 19-9 in sara of patients with<br />
pancreatic cancer, 405<br />
prehim. chin. evaln, of an ovarian cancer<br />
marker-CA 215 (A), 1081<br />
quantn. of choriogonadotropin: differential<br />
cross-reactivities of free hCG a-subunit with<br />
eight different monoclonal antibody-based<br />
hCG and (hCG<br />
(TB), 1791<br />
+ ) “sandwich”-type assays<br />
RIA of osteocalcin with pohyclonal and<br />
monochonal antibodies, 1408<br />
solid-phase enzymoimmunoassay for<br />
osteocalcin in serum or plasma, with use of a<br />
monochonal antibody, 2087<br />
solving the problem of antibody interference in<br />
commercial “sandwich”-type immunoassays<br />
of carcinoembryonic antigen (SN), 146<br />
somatotropin as mess, by a two-site timeresolved<br />
immunofluorometric assay, 913<br />
standn, of apohipoprotein B and A-I mess, (R),<br />
1357<br />
Stratus automated creatine kinase-MB assay<br />
evald,: identn, and elimn, of falsely increased<br />
results assocd, with a high-M, form of alk,<br />
phoephataae, 2048<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamylase in serum, with use of<br />
two monochonal antibodies, 1915<br />
two-site immunoenzymometry of 52-kDa<br />
cathepsin D in cytosols of breast-cancer<br />
tissues, 81<br />
use of murine monoclonal antibodies to bloodgroup-related<br />
antigens for<br />
immunofluorescent detection of blood<br />
groups on human spermatozoa (A), 1208<br />
Monochonal gammopathies<br />
follow-up of monochonah gammopathies<br />
asymptomatic HIV-infected subjects<br />
in<br />
(L), 338<br />
hazard of commercial antiserum crossreactivity<br />
in monochonal gammopathy evaln,<br />
(L), 2016<br />
mare on monochonal gammopathies<br />
quantn. of ii- and X-containing<br />
(L), 1268<br />
immunoghobulins by rate nephehometry:<br />
comparison of two comm. reagent antisera<br />
(A), 1198<br />
racial and age-related differences in incidence<br />
of monoclonal gammopathy of uncertain<br />
significance (A), 1154<br />
strategy for diagnosis of monochonal<br />
gammopathies in serum (L), 508<br />
r4onochonah immunoglobulins<br />
monochonal immunoglohuhina: affinity blotting<br />
for low concns. in serum (SN), 478<br />
t4ononuchear cells<br />
detection of HIV proviral DNA in peripheral<br />
blood mononuclear cells by polymerase chain<br />
reaction (A), 1076<br />
meas. of Mg2 in mononuclear blood cells (L),<br />
1559<br />
Morphine<br />
morphine monitoring for an anaesthesia pain<br />
service (A), 1182<br />
rapid thin-layer chromatog, semiquantification<br />
of morphine in urine via dabsylation:<br />
comparison with EMIT and thin-layer<br />
- chromatog.-iodophatinate methods (TB), 329<br />
simultaneous quantn. of morphine, codeine,<br />
and 06-manoacetyl morphine by gas<br />
chromatog,<br />
ts1ucin<br />
mass spectrom. (A), 1355<br />
IMx” BCM, automated microparticle enzyme<br />
immunoassay for breast cancer mucin (A),<br />
1078<br />
Mucopohysaccharides<br />
diagnostic test for mucopohysaccharidosis I.<br />
direct method for quantg. excessive<br />
glycosaminoghycan excretion, 374<br />
urinary<br />
Mucopohysaccharidosis<br />
diagnostic test for mucopolysaccharidosis. II.<br />
rapid quanta. of glycosaminoghycan in urine<br />
samples on a paper matrix, 2074<br />
dimethylmethyhene blue-based spectrophotom.<br />
of glycosaminoghycans in untreated urine:<br />
rapid screening for mucopohysaccharidoses,<br />
1472<br />
Multihayer film analysis<br />
anal. performance of Kodak Ektachem chin.<br />
chem, slides (Fe) (A), 1101<br />
assessment of renal function by mum<br />
clearance: comparison with creatinine<br />
clearance ss deed, enzymaticahly (SN), 312<br />
chin. important interference of sulfasalazine in<br />
measurement of conjugated bihirubin by<br />
Ektachem slide method (A), 1158<br />
comparison of Kodak CK-MB assay with CK<br />
isoenzyme electrophoresis (A), 1123<br />
development of Kodak Ektachem thin-film<br />
assay for serum cholinestarase (A), 1120<br />
differences between values for plasma and<br />
serum in tests performed in the Ektachem<br />
700 XR analyzer, and evaln, of “plasma<br />
separator tubes (PST)” (SN), 151<br />
dry-chem. multilayer immunoassay for total<br />
thyroxin (A), 1180<br />
estn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
evahn, of assay of misc. body fluids by Kodak<br />
Ektachem 700(A), 1100<br />
evahn, of dry-chem, analyzer, the Chinistat, for<br />
blood Hb and serum or plasma constituents<br />
(A), 1108<br />
evaln, of Kodak slides for CSF protein assays<br />
(A), 1090<br />
evahn, of the Kodak Ektachem chin. chem,<br />
slides for lactate (A), 1132<br />
evahn, of the Kodak Ektachem HDL<br />
cholesterol kit on the Kodak Ektachem 700<br />
analyzer (A), 1069<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns, (CR), 333<br />
feline and canine ref. ranges for the Kodak<br />
Ektachem 700 analyzer (A), 1134<br />
Indocyanine Green interference in the Kodak<br />
Ektachem detn, of total bilirubin (L), 899<br />
interference of macro-creatine kinase in detn,<br />
of CK-MB in serum with the Kodak<br />
Ektachem (L), 2155<br />
measurement of alk. phosphatase acty. by<br />
Kodak Ektachem 700 XR analyzer compared<br />
with other routine anal. methods (TB), 328<br />
modifn, of Kodak Ektachem<br />
creatinine to substantially<br />
slide for<br />
reduce<br />
interference from lidocaine metabohita (A),<br />
1098<br />
multilayer fluorescence immunoassay<br />
technique (S), 1865<br />
performance of Kodak Ektachem DT6O<br />
analyzer in dispersed hosp. settings (A), 1101<br />
performance of the Kodak iron and total ironbinding<br />
capacity methods (TB), 2250<br />
thin-film enzyme immunoassay for<br />
measurement of serum or phssma T4 (A),<br />
1200<br />
thin-film immunochem, messurement of<br />
digoxin in human serum (A), 1200<br />
Multiple myeloma<br />
lactate dehydrogenase and its isoenzymes in<br />
serum in multiple myehoma (SN), 1968<br />
Multiple sclerosis<br />
Bence Jones immunoglobulins in the urine in<br />
multiple sclerosis (L), 186<br />
Bence Jones proteins in urine of patients with<br />
multiple sclerosis (L), 1550<br />
cystatin C quantn. in CSF (TB), 179<br />
more on ohigoclonal bands and diagnosis of<br />
multiple sclerosis (L), 337<br />
Multivariate discrimination<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
Muscular dystrophy<br />
apphn. of Magic Lite<br />
immunochemihuminometric method for<br />
measurement of creatine kinase-MB in blood<br />
spots (A), 1123<br />
carrier detection and characterization of gene<br />
deletions in Duchenne and Becker muscular<br />
dystrophy utilizing dystrophin cDNA probes<br />
(A), 1075<br />
detection of Duchenne/Becker muscular<br />
dystrophy carriers by densitometric scanning<br />
(TB), 1256<br />
mohec, genetics of Duchenne and Becker<br />
muscular dystrophy: emphasis on improved<br />
diagnosis (S), B21<br />
Mycotoxicosis<br />
tissue damage assessment in T2 mycotoxicosis<br />
(A), 1135<br />
Mycotoxins<br />
time-resolved fluoroimmunoassay of aflatoxins<br />
(SN), 2308<br />
Myelin<br />
modulated adhesion: proposal for role of<br />
myelin-as8ocd. glycoprotein in myelin<br />
wrapping(S),<br />
Myehln-associated<br />
717<br />
ghycoprotehn<br />
modulated adhesion: proposal for role of<br />
myehin-assocd. glycoprotein in myehin<br />
wrapping (5), 717<br />
Myehoma<br />
IgG heavy-chain subclass typing of myehoma<br />
paraprateins by isoelectric focusing<br />
immunoblot anal., 364<br />
simultaneous mess, of total and IgAconjugated<br />
oi-microglobuhin by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
Myelopathy<br />
oligoclonal immunaghobulin bands in HTLV-Iassociated<br />
myelopathy (A), 1085<br />
Myocardiah Infarction<br />
See also Heart disease<br />
cardiac iaoenzyme (CK-MM isoform) assays for<br />
early detection of acute myocardial<br />
infarction: comparison of immunometric and<br />
ehectrophoretic systems (A), 1117<br />
changes in creatine kinase ecty. in acute<br />
myocardial infarction, 414<br />
characteristics of creatine kinase-MB and MB<br />
isoforms in serum after reperfusion in acute<br />
myocard. infarct, 2179<br />
cm. and anal, evain. of different methods for<br />
mess, of creatine kinase iaoenzyme MB (SN),<br />
130<br />
cm. comparison of Helena REP vs Kodak<br />
Ektachem creatine kinase MB slide in<br />
patients with suspected acute myocardial<br />
infarction (A), 1125<br />
creatine kinase isoforms in ischemic heart<br />
disease(R),7<br />
diagnosis of acute myocardial infarction from<br />
two measurements of creatine kinase<br />
isoenzyme MB with use of nonparametric<br />
probability estn,, 444<br />
diagnosis of acute myocardial infarct, when<br />
skeL muscle damage is present: a caveat<br />
regarding use of creatine kinase isoenzymes<br />
(L), 705<br />
diagnostic utility of serum total creatine kinase<br />
and creatine kinase-2 in myocardial<br />
infarction re-evaluated, 1435<br />
ECG evidence of myocardial infarction without<br />
cardiac isoenzymes abnormalities (A), 1116<br />
effect of therapeutic coronary reperfusian on<br />
serum aspartata aminotransferase<br />
isoenzymes in patients with acute<br />
myocardial infarction (A), 1116<br />
effects of therapeutic coronary reperfusion on<br />
aspartate aminotransferase isoenzymes in<br />
sara of patients with acute myocardial<br />
infarct,, 909<br />
evolution of serum CK-MB isofarms after<br />
acute myocardial infarction (A), 1120<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
heterogeneity of serum creatine kinase<br />
isoenzyme MM in myacardial infarction:<br />
chin. significance and post-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
high alanine aminotransferase activities in<br />
phasma, hearts in patients with acute<br />
myocardial infarction, 279<br />
IgA-CK-BB complex with CK-MB<br />
electrophoretic mobility can lead to<br />
erroneous diagnosis of acute myocard.<br />
infarct, (CR), 2003<br />
immunochemical vs ehectrophoretic CK-MB<br />
detns. in early detection of acute myocardial<br />
infarction (A), 1125<br />
measurements of apolipoprotein A-I and B in<br />
normal individuals and in survivors of<br />
myocardial infarction (A), 1073<br />
rate of release of CK isoforms into serum of<br />
patients with myocardiahinfarction treated<br />
with thrombohysis (L), 1264<br />
reducing misdiagnosis of myocardial infarct.<br />
(L), 1801<br />
role of CK subforms in thrombolytic therapy:<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2393
early diagnosis and assessment of efficacy<br />
(A), 1050<br />
role of rapid immunoasaays for urgent detns, of<br />
creatine kinase isoenzyme MB (SN), 1752<br />
sensitive, rapid assay of subforms of creatine<br />
kinase MB in plasma, 1452<br />
two kits for CK-MM isoforms evald, for early<br />
recognition of acute myocardial infarction<br />
(TB), 493<br />
use of creatine kinase MB isoforms for<br />
predicting myocardial reperfusion (A), 1125<br />
variation in decision thresholds for CK and<br />
CK-2 in myocardial infarction (A), 1116<br />
Myocardial Ischemia<br />
myocardial response to ischemia and<br />
reperfusion: effects of preconditioning on<br />
myocardial metabolism and infarction (A),<br />
1049<br />
patterns of lactate dehydrogenase isoenzymes 1<br />
and 2 in serum on exercise (SN), 301<br />
Myoghobln<br />
automated nephehometricimmunoassa)r of<br />
myoghobin with novel shell/core particles<br />
(A), 1092<br />
development of monochonal antibodies to<br />
human myoglobin and their use in<br />
fluorescence immunoassay (A), 1203<br />
interaction between pyridine nucheotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
isoln. and charactern. of myoglobin and its two<br />
major isoforms from sheep heart, 778<br />
quant. detn. of myoghobin by a latex-enhanced<br />
turbidimetric assay (A), 1091<br />
Myoglobinuria<br />
(Wake Forest University Case Conference):<br />
myoglobinuria, hemoghobinurie, acute renal<br />
failure (CC), 1713<br />
Natal chemistry<br />
See Pediatric chemistry, Newborns, Pregnancy<br />
National Committee for <strong>Clinical</strong> Laboratory<br />
Standards<br />
See NCCLS<br />
NCCLS<br />
chin, chem, analyzer evald. by NCCLS<br />
guidelines for use ins military field lab, unit<br />
(SN), 2223<br />
NCCLS evaln. protocols EP-5 (precision), EP-<br />
6 (linearity), and EP-lO (preliminary<br />
evalustion) tested with an unsuitable Ce<br />
method (AAS) (A). 1099<br />
NCCLS publications, 715, 2141<br />
Neonates<br />
See also Newborns<br />
cocaine and pregnancy: chin, and toxicol.<br />
implications for the neonate (5), 1276<br />
critical anal. and chin, aspects of ionized Cain<br />
neonates (R), 2027<br />
diagnostic test for mucopolysaccharidosis I.<br />
direct method for quantg. excessive<br />
glycosaminoghycan excretion, 374<br />
urinary<br />
diagnostic test for mucopohysaccharidosis. LI.<br />
rapid quantn. of glycosaminoghycan in urine<br />
samples on a paper matrix, 2074<br />
effect of hematocrit and added heparmn on Ca2<br />
in capillary blood from neonates (SN), 486<br />
enzyme-linked immunosorbent assay of<br />
apolipoprotein B in blood spatted onto filter<br />
paper, suitable for neonatal screening, 1000<br />
125IRLA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
hipoprotain(a) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
moderate I deficiency, possible explanation for<br />
inverse relation between cord serum<br />
thyrotropin and birth weight in a normal<br />
Kenyan popn. (L), 710<br />
purifn., characterization of intact lactoferrin<br />
found in the urine of human milk-fed<br />
pretarm infants, 1928<br />
quant. anal. for org. acids in biol, samples:<br />
batch isolation followed by gas<br />
chromatog.-mass spectrom. anal., 587<br />
screening for deficiency of aj-proteinase<br />
inhibitor (SN), 1971<br />
sources of imprecision in screening for<br />
congenital hypothyroidism: anal, of 9 y of<br />
performance data, 1701<br />
three direct spectrophotometric methods for<br />
detn. of total biirubin in neonatal and adult<br />
serum, adapted to the Technicon RA-1000<br />
analyzer (SN), 1980<br />
total digoxin-like immunoreactive factor(s),<br />
total biirubin concn., and birth wt, in<br />
neonates (L), 192<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
usefulness of lecithin/sphingomyehin ratio and<br />
uselessness of phosphatmdyhghyceroh detns. in<br />
tracheal aspirates from preterm infants (L),<br />
706<br />
Neopterin<br />
concns. of neopterin in serum<br />
renal allografts (L), 2157<br />
of recipients of<br />
generalized likelihood ratio concept and<br />
logistic regression anal, for multiple<br />
diagnostic categories, 990<br />
neopterin as a predictive marker for disease<br />
progression in human immunodeficiency<br />
virus type 1 infection (SN), 1746<br />
neopterin mess, in serum, tissue culture<br />
supernates by competitive enzyme-linked<br />
immunosorbant assay, 1467<br />
simultaneous detn. of serum neoptarin and C-<br />
reactive protein as markers of infection in<br />
heart-transplant recipients (TB), 1258<br />
urinary neopterin concns, vs total neopterins<br />
for chin. utility (SN), 2305<br />
Nephelometric Immunoassay<br />
automated nephehometric immunoassay of IgE<br />
with novel shell/core particles (A), 1092<br />
automated nephehometric immunoassay of<br />
myoghobin with novel shell/core particles<br />
(A), 1092<br />
Nephelonietry<br />
See also Rate nephelometry<br />
designing a reliable calibrator for<br />
nephehometric epa A-I and B assays (A),<br />
1073<br />
microalbuminuria in rats and humans (A),<br />
1137<br />
nephelometric detn. of C-reactive protein (A),<br />
1197<br />
nephehometricmethod for quantitating HbF<br />
(A), 1199<br />
nephehometric prealbumin assay on the BA-<br />
1000 (A), 1203<br />
rheumatoid factors deed, by fluorescence<br />
immunoassay: comparison with qual. and<br />
quant. methods (SN), 464<br />
Nephropathy<br />
albuminuria and progression of diabetic<br />
nephropathy (A), 1237<br />
effect of exercise training on glycemic control,<br />
kidney function, and renal ultrastructure in<br />
obese (diabetic) Zucker rats (A), 1135<br />
Nervous system disorders<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd. familial<br />
amyloidotic pohyneuropathy (SN), 1033<br />
Netilmicin<br />
fluorescence poharn. immunoassay of<br />
gentamicin or netilmicin<br />
filter paper (SN), 867<br />
in blood spotted on<br />
Neural development<br />
cell and substrate adhesion molecules<br />
embryonic and neural development<br />
in<br />
(S), 738<br />
Neural tube defects<br />
chemiluminescent enzyme immunoassay of a-<br />
fetoprotain with adamantyh dioxetane<br />
phenyl phosphate as substrate (SN), 2319<br />
evahn, of Abbott IMx immunoaaaay analyzer<br />
for maternal serum ahpha-fetoprotain<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
prospective study of Abbott AFP-EIA as an aid<br />
in detection of fetal neural tube defect (A),<br />
1192<br />
Neuramlnic acid<br />
See also Sialic acid<br />
methods for detg. “reference changes” from<br />
serial measurements: plasma lipid-bound<br />
sialic acid, 972<br />
Neuraminldase<br />
See Siehidase<br />
Neurobhsstoma<br />
chin. signif. of genetic rearrangements in<br />
neuroblastomas (S), B38<br />
Neurological disease<br />
HPLC anal, for serotonin and tryptamine<br />
excreted in urine after oral loading with L-<br />
tryptophan, 43<br />
Neutrophil elastase<br />
screening far deficiency of ai-proteinase<br />
inhibitor (SN), 1971<br />
Newborns<br />
See also Neonates, Pediatric chemistry<br />
anal. of supplemented vit, K1 (20) in serum<br />
microsamples by solid-phase extrn, and<br />
narrow-bore HPLC with multichannel uv<br />
detection (S), 1288<br />
antipyrine interferes with chem. detn. of Br- in<br />
simultaneous estn, of total body H20 and<br />
extracelluhar H20, 1367<br />
apphn. of Magic Lita<br />
immunochemihuminometric method for<br />
measurement of creatine kinsse-MB in blood<br />
spots (A), 1123<br />
bedside monitoring for neonatal intensive care<br />
patients (A), 1241<br />
bronchopulmanary dysphasia-current<br />
concepts (A), 1241<br />
chin. lab, team assessment of nutritional status<br />
of low-birth-wt, infants-I (A), 1237<br />
chin. lab. team assessment of nutritional status<br />
of how-birth-wt. infants-IL (A), 1238<br />
cord blood hipoprotain(s) in blacks and whites<br />
(A), 1065<br />
detn. of bihirubin in neonatal serum with<br />
Abbott A-Gent neonatal bilirubin reagent<br />
(A), 1151<br />
digoxin-hike immunoreactivity in neonates and<br />
infants minimized by centrifugal<br />
ultrafiltration and FPIA (A), 1163<br />
fluorescence poharn. immunoassay of<br />
gentamicin or netilmicin in blood spotted on<br />
filter paper (SN), 867<br />
immunoassay of neonstal hTSH in paper discs<br />
using time-resolved fluorescence (A), 1139<br />
lab, assessments of nutritional status of lowbirth-wt,<br />
infants (A), 1238<br />
microsssay for screening newborns for<br />
galactosemia with use of a fhuorometric<br />
microphate reader (SN), 1962<br />
neonatal phenyhalanine screening using the<br />
Encore centrifugal analyzer (A), 1153<br />
neonatal screening for congenital<br />
hypothyroidism with LKB Delfia<br />
TSH kit (A), 1152<br />
neonatal<br />
NMR in viva: experience in a neonatal ICU<br />
(A), 1058<br />
nutritional needs and assessment in very-law<br />
birthweight infants (A), 1060<br />
role of the lab. in management of the growing<br />
very-low-birth.wt. infant (A), 1238<br />
simultaneous hiq.-chromatog. detn. of vit. K1,<br />
vit, E in serum, 2285<br />
spectrophotometric stat detn. of HbCO in<br />
microsamphes (A), 1163<br />
stability of hemaghobins A, F, 5, and C in dried<br />
neonatal whole-blood samples when<br />
analyzed by cation-exchange HPLC (A),<br />
1152<br />
Niacin<br />
effect of light on reactions between N’-<br />
methyhnicotinamide and methyl ketones<br />
(TB), 2000<br />
Nicotine<br />
caffeine interference eliminated in HPLC detn,<br />
of urinary nicotine and cotinine, 1456<br />
Nicotinic acetylchohlne receptors<br />
genes encoding neuronal nicotinic<br />
acetylchohine receptors (5), 731<br />
Nitrogen<br />
comparison of sample preparation techniques<br />
for measurement of total N in stool and food<br />
samples by chemihuminescence (A), 1114<br />
Nomenclature<br />
glossary for molecular biology(S), 1816<br />
Nonesterified fatty acids<br />
See Fatty acids<br />
Nonthyroldah illness<br />
concn, of free thyroxin in serum during<br />
nonthyroidal ihlnesa-cahcn. or mess,? (SN),<br />
159<br />
direct and indirect techniques for free thyroxin<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
four nonisotopic immunoassays of free<br />
thyroxin evald, (SN), 115<br />
Norepinephrlne<br />
reversed-phase HPLC sepn. of plasma<br />
norepinephrine,<br />
with 3-electrode<br />
epmnephrine,<br />
coulometric<br />
and dopamine,<br />
detection (SN),<br />
1975<br />
Normal values<br />
See Reference interval<br />
Nuclear magnetic resonance<br />
anal, for homogentisic acid by NMR<br />
spectrometry on diagnosis of alkaptonuria<br />
(L), 1806<br />
NMR in vivo: experience in a neonatal LCU<br />
(A), 1058<br />
proton NMR studies of plasma to determine<br />
metab. status of patients with adult reap.<br />
distress syndrome (SN), 667<br />
rapid, reliable in vivo assays of phosphate<br />
metabohites by NMR, 392<br />
Nucleic acids<br />
appin. of a rapid non-radioisotopic nucleic acid<br />
anal. system to the detection of sexually<br />
transmitted disease-causing organisms and<br />
assocd. antimicrobial resistances (5), 1571<br />
use and applns. of nucleic acid probes in the<br />
chin. lab. (S), 1819<br />
2394 CLINICAL CHEMISTRY,Vol.35, No. 12, 1989
Nucheosides<br />
extn. of intracellular nucleosides and<br />
nucheotides with acetonitrile, 48<br />
Nucleotides<br />
extn. of intracellular nucheosides and<br />
nucheotides with acetonitrile, 48<br />
Nutritional status<br />
amino acid anal, for nutritional assessment by<br />
Pica-Tag HPLC: precision studies, ref.<br />
ranges, and correlations with ion-exchange<br />
method (A), 1113<br />
assessment of protein calorie malnutrition<br />
using serum prealbumin (A), 1112<br />
chin, lab, team assessment of nutritional status<br />
of how-birth-wt, infants-I (A), 1237<br />
chin, lab. team assessment of nutritional status<br />
of how-birth-wt. infants-IL (A), 1238<br />
concns. of carotenoids, retinal, and tocopheroh<br />
in phssma after a meal (SN), 310<br />
lab. assessments of nutritional status of howbirth-wt.<br />
nutritional<br />
infants (A), 1238<br />
needs and assessment in very-how<br />
birthweight infants (A), 1060<br />
quantn. Mn in lymphocytes to assess Mn<br />
nutrit. status, 1939<br />
serum prealbumin hevela in normal individuals<br />
of various age; and in patients with AIDS (A),<br />
1115<br />
short- and hong-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
solid-phase sample extn. for rapid detn. of<br />
methylnialonic acid in serum, urine by stable<br />
isotope dilution, 260<br />
usefulness of date on albumin and prealbumin<br />
concns, in detg. effectiveness of nutrit., 271<br />
Znprotoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Oak Ridge Conference<br />
introduction(S), 1815<br />
Occult blood<br />
cm. effective screening of asymptomatic<br />
patients for fecal occult blood loss requires<br />
lab. assistance (L), 2337<br />
Cohoscreen VPI test kit evald. for detection of<br />
fecal occult blood, 156<br />
comparison of two comm. available<br />
immunological occult blood tests and a<br />
guaiac slide test (A), 1162<br />
“Fecatwin Sensitive” test for fecal occult blood<br />
not intended for use without testing positives<br />
with the FECA-RIA assay (L), 1555<br />
Octanoic acid<br />
HPLC anal, of brain and plasma for octanoic,<br />
decanoic acids, 1945<br />
Oligoclonal bands<br />
ohigoclonal banding detected by urinary<br />
protein ehectrophoresis and immunofixation<br />
in two patients with AIDS and proteinuria<br />
(CR), 1795<br />
oligochonal banding in serum from hearttransplant<br />
recipients, 431<br />
oligochonal immunoghobulin bands in HTLV-Iassociated<br />
myelopathy (A), 1085<br />
sensitive and specific procedure for detecting<br />
ohigoclonal banding in CSF by agarose gel<br />
ehectrophoresis (A), 1082<br />
(TB), 1997<br />
three methods for demonstration of ohigochonal<br />
bends of LgG in CSF compared (A), 1085<br />
Oncogenes<br />
proto-oncogene abnormalities in human cancer<br />
(A), 1057<br />
Opiates<br />
evain. of TLC technique for detection of<br />
opiates in urine (A), 1173<br />
Organic acidopathies<br />
quant. anal, for org. acids in bioL samples:<br />
batch isolation followed by gas<br />
chromatog.-masa<br />
Organic acids<br />
spectrom. anal., 587<br />
biochem. contribution to diagnosis and study<br />
of a new case of D-glyceric acidemia/aciduria<br />
(CR), 2148<br />
calculated HCO3- or total C02?, 1697<br />
glyoxal: an artefact from metronidazole and<br />
ghyoxyhic acid in urinary org. acid anal. (TB),<br />
673<br />
organic acids and drug interference in<br />
measurement of CO2 concn, by Kodak<br />
Ektachem 700(A), 1156<br />
quant. anal. for org. acids in bioL samples:<br />
batch isolation followed by gas<br />
chromatog.-masa spectrom. anal., 587<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
Organ transplants<br />
comparison of cyclosporine assays in pediatric<br />
patients<br />
1168<br />
receiving organ transplants (A),<br />
comparison of cychosporine immunoassay<br />
methods: examination of rejection and<br />
nephrotoxic episodes in liver transplantation<br />
(A), 1183<br />
delta and conjugated bilirubins as predictors of<br />
early liver allograft rejection are unaffected<br />
by cytomegalovirus infection (A), 1137<br />
detn, of cychosporine<br />
with a monoclonal<br />
in plasma: specific<br />
antibody and hiq.<br />
RLA<br />
chromatog. compared, 608<br />
digoxin-hike immunoreactive substances in<br />
post-liver transplantation patients with<br />
positive fluid balance (A), 1144<br />
distribn, of cychosporin A metabolites among<br />
plasma and cells in whole blood: effect of<br />
temp., hematocrit, and metabohite concn,, 59<br />
enzyme immunoassay measurement of serum<br />
interleukin-2 receptor in heart-transplanted<br />
patients (A), 1155<br />
heart disorders and concentrations of directly<br />
measured atrial natriuretic peptide in<br />
plasma, 435<br />
impact of meal timing on bioavailabihity of<br />
cychosporine in CsA-treated renal allograft<br />
recipients post-transphantetion (A), 1179<br />
mess, of cyclosporine concns. in whole blood:<br />
HPLC and RIA with a specific monoclonal<br />
antibody and 3H- or ‘251-habehedhigand<br />
compared (SN), 120<br />
nonsehective measurements of cychosporin A in<br />
transplant patient specimens by RIA with a<br />
monochonal antibody and I’tracer (A),<br />
1164<br />
prognostic value of MEGX liver-function test<br />
in transplant candidates (A), 1135<br />
Ornithine decarboxylase<br />
more on ornithine decarboxyhase (L), 897<br />
Osteoarthritis<br />
activities of dipeptidyl peptidsse LI and<br />
dipeptidyl peptidase LVin synovial fluid<br />
from patients with rheumatoid and<br />
osteoarthritis, 1016<br />
Osteocalcin<br />
effects of estrogen on mineral metab, in<br />
poatmenopausal women as evald, by multiple<br />
assays measuring parathyrin bioacty., 18<br />
osteocalcin: biol. variations and ref. limits (A),<br />
1126<br />
RIA of osteocalcin with polychonal and<br />
monochonal antibodies, 1408<br />
simultaneous “sandwich” enzyme<br />
immunoassay for measuring human<br />
osteocalcin using antibodies against<br />
synthetic peptides (A), 1208<br />
solid-phase enzymoimmunoaasay for<br />
osteocalcin in serum or plasma, with use of a<br />
monochonal antibody, 2087<br />
Osteochasts<br />
immunoassay of band 5 (“tartrate-resistent”)<br />
acid phosphatase involving use of antiporcine<br />
uteroferrin antibodies, 86<br />
Osteoporosis<br />
effects of estrogen on mineral metab. in<br />
postmenopausah women as evald, by multiple<br />
assays measuring parathyrin bioacty., 18<br />
improved method for cahcg. Ca fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
osteoporosis 1989 (A), 1053<br />
solid-phase enzymoimmunoessay for<br />
osteocalcin in serum or plasma, with use of a<br />
monochonal antibody, 2087<br />
Ovulation<br />
evahn. of new consumer test for lutropin (A),<br />
1146<br />
hormonal evaln, of female infertility,<br />
reproductive disorders (CC), 620<br />
predicting ovulation in in-vitro fertilization<br />
program by monitoring huteinizing<br />
hormone/creatinine ratio in random urine<br />
samples (A), 1144<br />
rapid enzyme immunoassay for visual,<br />
semiquant. deth. of lutropin in urine for<br />
ovulation prediction (A), 1148<br />
solid-phase enzymoimmunoassay of estrone in<br />
saliva, 569<br />
Oxalate<br />
effect of citrate on urinary excretion of Ca and<br />
oxalate: relevance to Ca oxahate<br />
nephrohithissis, 23<br />
enzymatic detn, of urinary oxalate (SN), 2330<br />
enzymatic method for oxalata automated with<br />
the Cobas Fara centrif, analyzer (SN), 2094<br />
improved urinary oxalate method for a centrif.<br />
analyzer (L), 1806<br />
oxalata is overestd. in elk. urines collected<br />
during administration of HCO3 with no<br />
specimen pH adjustment (SN), 2107<br />
Oxpentifylline<br />
simultaneous detn, of pentoxifylline and three<br />
metabohites in bioh, fluids by liq. chromatog.<br />
(SN), 298<br />
Oxygen<br />
reliability of detn, of whole-blood 02 affinity<br />
with blood-gas analyzers and multiwavelength<br />
oximeters, 773<br />
Oxygen free radicals<br />
effect of hypoxia and oxygen free radicals on<br />
liver lysosomes (A), 1137<br />
free radical ablation for organ preservation (A),<br />
1051<br />
02-derived free radicals in postischemic tissue<br />
injury (A), 1050<br />
Pancreatic disease<br />
detn. of a2-macroghobulin-trypsin complex<br />
with a new synthetic substrate, 2169<br />
fecah chymotrypsin: suitable test for diagnosing<br />
pancreatic insufficiency (A), 1090<br />
immunocatalytic assay of pancreatic a-amyhase<br />
in serum and urine with a specific<br />
monochonal antibody (SN), 662<br />
immunohog.-derived pancreatic amyiase,<br />
pancreatic lipase, and total amyhase<br />
compared as predictors of pancreatic<br />
inflammation (TB), 1542<br />
mechanism of action of pancreatic and salivary<br />
a-amyhase on 4,6-ethyhidene-a-4-<br />
nitrophenyhmaltoheptaoside substrate (L),<br />
188<br />
staining method for use in ehectropharetic<br />
detn, of amyhase isoenzymes in serum (SN),<br />
2322<br />
time-resolved immunofluarometric assay of<br />
pancreatic isoamyhase in serum, with use of<br />
two monochonal antibodies, 1915<br />
Pancreatic oncofetal antigen<br />
pancreatic oncofetal antigen and carbohydrate<br />
antigen 19-9 in sera of patients with<br />
pancreatic cancer, 405<br />
Pancreatitis<br />
diagnostic value of measuring pancreatic hipase<br />
and the P3 isoform of pancreatic amyhase<br />
isoenzyme in serum of hospitalized<br />
hyperamyhasemic patients, 417<br />
hyperamyhaaemia and a-amylase isoenzymes in<br />
acute liver congestion due to cardiac<br />
circulatory failure (TB), 1793<br />
immobilized anti-salivary amyhase antibody<br />
interacts with macroamylases: implications<br />
for use in a pancreatic amylase assay to<br />
distinguish mecroamylasemia from acute<br />
pancreatitis, 1651<br />
hipase acty. measured in serum by a<br />
continuous-monitoring PH-Stat<br />
technique-update, 1688<br />
measuring carboxypeptidase A acty. with a<br />
centrif, analyzer: anal, and chin,<br />
considerations, 251<br />
methods compared for detg. total arty. and<br />
isoenzymes of amylase in serum (SN), 645<br />
pancreatic amyhase in serum for differential<br />
diagnosis of acute pancrestitis, acute<br />
abdominal diseases (TB), 2142<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamylsse in serum, with use of<br />
two monochonal antibodies, 1915<br />
Pai’aproteins<br />
hgC heavy-chain subclass typing of myehoma<br />
paraproteins by isoehectric focusing<br />
immunoblot anal,, 364<br />
strategy for diagnosis of monochonal<br />
gammopathies<br />
Parathyrin<br />
in serum (L), 508<br />
essay of “intact” parathyrin in the immediate<br />
and hong-term postoperative follow-up of<br />
patients treated for hyperparathyroidism or<br />
thyroid tumor (L), 340<br />
din, utility of intact and total immunoreactive<br />
parathyroid hormone immunoassays (A),<br />
1148<br />
development and validation of<br />
immunochemihuminometric assay for whole<br />
molecule and N-terminal parathyroid<br />
hormone (A), 1147<br />
diagnostic efficacy of Magic Lite intact<br />
parathyrin assay (A), 1187<br />
effects of estrogen on mineral metab. in<br />
postmenopausal women as evald, by multiple<br />
assays measuring parathyrin bioacty., 18<br />
interference with mess, of intact parathyrin in<br />
serum from renal dialysis patients (TB),<br />
1543<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2395
performance, diagnostic appln. of a twa-site<br />
immunoradiometric assay for parathyrin in<br />
serum (SN), 1957<br />
serum parathyroid hormone in hemodialysis<br />
patients (A), 1140<br />
twa-site immunochemiluminometric assay of<br />
intact parathyrin with use of a tracer peptide<br />
purified by reversed-phase hg. chromatog.,<br />
215<br />
use of affinity chromatog. in developing<br />
chemihuminescent-labeled antibodies for a<br />
parathyrin immunametric assay (A), 1210<br />
Particle-enhanced immunoassay<br />
evaln, of a particle-enhanced immunoassay for<br />
quantifying C-reactive protein (TB), 2001<br />
Pauclalbuminuria<br />
See Albumin<br />
Pco,<br />
See Blood gases<br />
Pediatric chemistry<br />
See also Fetal status, Heritable disorders,<br />
Neonates, Newborns<br />
anal, of supplemented vit, K1 (20) in serum<br />
microsamphes by solid-phase extrn, and<br />
narrow-bore HPLC with multichannel uv<br />
detection (S), 1288<br />
appln. of a silver-binding assay to detn. of<br />
protein in CSF (SN), 860<br />
circadian variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
comparison of cychosporine assays in pediatric<br />
patients receiving organ transplants (A),<br />
1168<br />
comparison of hutropin immunoreactivity in<br />
serum by RIA and time-resolved<br />
fluorescence fmdings in serum from normal<br />
children and those treated with LHRH<br />
analogs (A), 1150<br />
cychosporine measured in plasma from patients<br />
with various transplants: HPLC and RLA<br />
with a specific monochonal antibody<br />
compared (SN), 1726<br />
detn, of trans-phylloquinone in children’s<br />
serum (SN), 874<br />
diagnostic test for mucopolysaccharidosis I.<br />
direct method for quantg. excessive urinary<br />
glycosaminoghycan excretion, 374<br />
fluorescence polarn. immunoassay of<br />
gentamicin or netilmicin in blood spotted on<br />
filter paper (SN), 867<br />
HPLC anal. of brain and plasma far octanoic,<br />
decanoic acids, 1945<br />
1251.RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
managing of lipids by diet, exercise, and drugs<br />
in pediatric patients (A), 1061<br />
nonenzymatic stopped-flow fluorimetry for<br />
direct detn, of uric acid in serum and urine,<br />
230<br />
optimized microturbidimetric assay for<br />
fibrinogen, 211<br />
ratio of serum aspartate to alanine<br />
aminotransferase as a prognostic index in<br />
pediatric liver disease (A), 1151<br />
scheme for detecting elevated CK-MB in<br />
children (A), 1109<br />
serum phylloquinone concns. in a normal popn.<br />
of children as compared with ref. interval in<br />
adults (TB), 671<br />
transient increase of sweat electrolyte cancna,<br />
associated with environmental deprivation<br />
(A), 1153<br />
Zn protoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Pelvic inflammatory disease<br />
concns. of tumor-associated trypsin inhibitor<br />
and C-reactive protein in serum in acute<br />
pelvic inflammatory disease (SN), 869<br />
Penicilhinase<br />
prostatic inhibin-like peptide in urine of<br />
prostatic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
Pentoxlfyhhine<br />
simultaneous detn. of pentoxifylline and three<br />
metabohites in bioL fluids by hiq. chromatog.<br />
(SN), 298<br />
Pepsinogen<br />
pepsin and pepsinogen group I levels in human<br />
gastroduodenal biopsies (A), 1126<br />
Peptide hormones<br />
automation and interpretation of quantn. of<br />
antibodies to therapeutic proteins,<br />
illustrated with somatotrapin, 1623<br />
chemilumineacent assay of alk. phosphatase<br />
applied in an ultrasensitive enzyme<br />
immunoassay of thyrotropin. 1441<br />
hormonal evaln, of female infertility,<br />
reproductive disorders (CC), 620<br />
immunoradiometry of corticotropin with use of<br />
avidin-biotin sepn., 804<br />
improved RLA of atrial natriuretic peptide in<br />
plasma, 1431<br />
influence of matrix on concns, of somatotropin<br />
mess. in serum with commercial<br />
immunoradiometric assays, 1423<br />
new immunoradiometric assay for<br />
corticotropin evald, in normal subjects and<br />
patients with Cushing’s syndrome, 596<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neophssia, and assessment of<br />
effects of organ failure, 1631<br />
units for peptide hormones (L), 189<br />
Peptldes<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd, familial<br />
amyloidotic pohyneuropathy (SN), 1033<br />
simultaneous “sandwich” enzyme<br />
immunoassay for measuring human<br />
osteocaicin using antibodies against<br />
synthetic peptides (A), 1208<br />
Peritoneal carcinosis<br />
alpha slow-moving HDL subfraction in serum<br />
of a patient with radiation enteritis and<br />
peritoneal carcinosis (CR), 674<br />
Peroxidase<br />
acetaminophen as substrate for peroxidase (A),<br />
1122<br />
Hb peroxidaae acty. for coupled enzymatic<br />
reactions (A), 1122<br />
Peroxides<br />
plasma malondialdehyde, lipid peroxides, and<br />
the thiobarbituric acid reaction (L), 336<br />
Peroxisomal defects<br />
hong-chain aliphatic fatty acids and phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
pH<br />
development and evaln, of device for<br />
measuring body fluids (A), 1129<br />
hipase acty. measured in serum by a<br />
continuous-monitoring PH-Stat<br />
technique-update, 1688<br />
variations in protein binding<br />
plasma, serum (SN), 1722<br />
of drugs in<br />
Pharmacokinetics<br />
adv. in cychosporine pharmacol., measurement,<br />
and ther. monitoring<br />
antipyrine, indocyanine<br />
(5), 1299<br />
green, and horazepam<br />
detd. in plasma by HPLC (SN), 2124<br />
arginine pharmacokinetics assessed with an<br />
enzymatic assay adapted to a centrif.<br />
analyzer (SN), 1024<br />
cyclosporine metabolism impeded/blocked by<br />
co-administration of phenobarbital (A), 1160<br />
cyclosporine pharmacokinetics with<br />
concomitant ketoconazohe therapy (A), 1176<br />
detn. of physostigmine in plasma and CSF by<br />
liq. chromatog. with ehectrochem, detection<br />
(SN), 292<br />
deth. of serum deaipramine and 2-<br />
hydroxydesipramine for pharmacokinetic<br />
apphna. by HPLC with uv detection (SN),<br />
2134<br />
orgn. of a chin, pharmacokinetics service (A),<br />
1354<br />
pharmacokinetics and biotransformation of<br />
cychosporine metebohita,M-17 (A), 1164<br />
quantn. of Sr in plasma and urine with<br />
flamehess at. absorp. spectrom., 1911<br />
relevance of pharmacokinetics to monitoring<br />
new antiarrhythmics (S), 1332<br />
simultaneous detn, of pentoxifylhine and three<br />
metabolites<br />
(SN), 298<br />
Pharmacology<br />
adv. in cychosporine pharmacol.,<br />
in bioL fluids by hiq. chromatog,<br />
measurement,<br />
and ther. monitoring(S), 1299<br />
Phencycidine<br />
frequency of low-level PCP in urine specimens<br />
for drug screening (A), 1182<br />
Phenehzlne<br />
indirect therapeutic drug monitoring by<br />
measurine monoamine oxidase actys. from<br />
platelets rA), 1175<br />
Phenobarbital<br />
See also Barbiturates<br />
cychosporine metabolism impeded/blocked by<br />
co-administration of phenobarbital (A), 1160<br />
dry-chem. multilayer immunoassay tests for<br />
phenytoin and phenobarbital (A), 1196<br />
mess. of carbamazepine, phenobarbital,<br />
EMIT<br />
and theophylhline in the “Monarch” centrif,<br />
analyzer (L), 895<br />
evaln, of the Ames Seralyzer for therapeutic<br />
drug monitoring of phenobarbitah, phenytoin<br />
(TB), 324<br />
monoclonal turbidimetric<br />
phenobarbital<br />
assay for<br />
on the RA-1000’” system (A),<br />
1172<br />
Phenoxynaphthahenesulfonic<br />
acid<br />
multilayer fluorescence immunoassay<br />
technique (S), 1865<br />
Phenylalanine<br />
fluorometric method for phenylalanine<br />
microplate assay adapted for<br />
phenyhketonuria screening (SN), 2112<br />
HPLC mess, of phenylalanine by direct<br />
injection of plasma onto an internal-surface<br />
reversed-phase silica support, 975<br />
neonatal phenylalanine screening using the<br />
Encore centrifugal analyzer (A), 1153<br />
proton NMR studies of plasma to determine<br />
metab. status of patients with adult reap.<br />
distress syndrome (SN), 667<br />
Phenylketonuria<br />
fluorometric method for phenyhahanine<br />
microplate assay adapted for<br />
phenylketonuria screening (SN), 2112<br />
HPLC mess, of phenyhalanine by direct<br />
injection of plasma onto an internal-surface<br />
reversed-phase silica support, 975<br />
Phenytoin<br />
dry-chem. multihayer immunoassay tests for<br />
phenytoin and phenobarbital (A), 1196<br />
effect of serum albumin on displacement of<br />
phenytoin by ceftriaxone and nafcillin (A),<br />
1176<br />
evaln, of the Ames Seralyzer for therapeutic<br />
drug monitoring of phenobarbital, phenytoin<br />
(TB), 324<br />
four fluorescence polarization immunoassays<br />
for therapeutic drug monitoring evald,, 138<br />
TDM assays by fluorescence polarization on<br />
Cobas Fara II’”: detn, of serum N-<br />
acetylprocainamide, theophylhine,and<br />
phenytoin (A), 1178<br />
Phosphate<br />
See Phosphorus<br />
Phosphatidylglycerol<br />
evahn. of PG-Numeric’” test for semiautomated<br />
anal. of phosphatidyhghyceroh in<br />
amniotic<br />
multicenter<br />
fluid (A), 1072<br />
evahn. of TDx test for assessing<br />
fetal hung maturity, 1005<br />
usefulness of hecithin/sphingomyehin<br />
uselessness of phosphatidylghycerol<br />
ratio and<br />
detns. in<br />
tracheal aspirates from preterm infants (L),<br />
706<br />
Phosphatldylserlne<br />
ELISA method to measure antibodies to<br />
cardiohipin and phosphatidylserine (A), 1207<br />
Phospholipids<br />
improved staining of thin-layer chromatograms<br />
of amniotic fluid phosphohipids (TB), 1539<br />
phosphohipidsurface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal, of the value of pptn. with cold acetone,<br />
800<br />
Phosphorus<br />
new single-vial reagent for detn. of P with<br />
autoblanking capability (A), 1129<br />
rapid, reliable in viva essays of phosphate<br />
metabohites by NMR, 392<br />
tumoral calcinosis: seasonal biochem. studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
Phylloquinone<br />
detn. of trans-phyiloquinone in children’s<br />
serum (SN), 874<br />
serum phylloquinone concns. in a normal popn.<br />
of children as compared with ref. interval in<br />
adults (TB), 671<br />
Physician’s office testing<br />
evaln. of a dry reagent digoxin immunometric<br />
assay on a physician’s office analyzer (A),<br />
1109<br />
evahn, of Mihes Chinistat compact “dry-chem.”<br />
analyzer for physician’s office and satellite<br />
lab, testing (A), 1106<br />
performance of Reflotron amyhase and<br />
bihirubin test methods in two physicians<br />
office labs. (A), 1093<br />
photometric microtiter strip technique for<br />
doctor’s office lab (A), 1209<br />
physician office evaln, of Chininiate’” digoxin<br />
and theaphyhline systems (A), 1099<br />
recent advances in instrumentation for use in<br />
physicians’ offices and public health<br />
screening programs (A), 1232<br />
two-center evaln, of physician’s office chem.<br />
analyzer (Clinistat) for cholesterol anal. (A),<br />
1102<br />
2396 CLINICAL CHEMISTRY, Vol.35, No. 12, 1989
Physostigmine<br />
detn, of physostigmine in plasma and CSF by<br />
hiq. chromatog. with ehectrochem. detection<br />
(SN), 292<br />
Phytanic acid<br />
lang-chain aliphatic fatty acids and phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
phytanic acid, pristanic acid, and very-hongchain<br />
fatty acid methyl esters mess.<br />
simultaneously by capillary gas chromatog.<br />
(L), 703<br />
Pigmented nodular adrenal dysplasia<br />
decreased dehydroepiandrosterone sulfate in<br />
pigmented nodular adrenal dysphasia (SN),<br />
2216<br />
Pineal function<br />
salivary melatonin estn, in assessment of<br />
pineal-gland function (L), 514<br />
Pituitary<br />
new immunoradiometric assay for<br />
corticotrapin evald. in normal subjects and<br />
patients with Cushing’s syndrome, 596<br />
Phasmapheresis<br />
falsely elevated IgG indices in CSF of<br />
plssmapheresed patients (A), 1158<br />
Phasminogen<br />
streptokinase binds to lactate dehydrogenase<br />
subunit-M, which shares an epitope with<br />
plasminogen, 69<br />
Plasmlnogen activator<br />
impact of immediate acidification of blood on<br />
measurement of plasma tissue phssminogen<br />
activator (tPA) arty. in surgical patients<br />
(TB), 1999<br />
Plasminogen activator inhibitor<br />
standn, of methods for mess. phasminogen<br />
activator inhibitor acty. in plasma, 787<br />
Platelets<br />
indirect therapeutic drug monitoring by<br />
measuring monoamine oxidase actys. from<br />
platelets (A), 1175<br />
lactate dehydrogenase isoenzyme compn. of<br />
platelets (SN), 2325<br />
platelet-derived ATP may contribute to<br />
measured concn. of inorg. pyrophosphate in<br />
serum (TB), 326<br />
platelet LDH isoenzymes (A), 1134<br />
Platinum<br />
DNA binding differences of active and inactive<br />
platinum anticancer drugs shown by agarose<br />
electrophoresis of restriction endonuclease<br />
fragments of drug-treated DNA (A), 1077<br />
Pleural effusions<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN), 166<br />
P02<br />
See Blood gases<br />
Pohyamine oxidase<br />
polyamines assayed by HPLC with<br />
electrochem, detection after post-column<br />
reaction with immobilized pohyamine<br />
oxidsse, 1694<br />
Polyamines<br />
pohyaminea assayed by HPLC with<br />
electrochem. detection after post-column<br />
reaction with immobilized polyamine<br />
oxidsse, 1694<br />
Pohyamino acids<br />
surface characterization of polystyrene (A),<br />
1190<br />
Polychromatic analysis<br />
urine eppln. for Abbott Spe.trum and VP<br />
using Abbott liq. amylase reagent (A), 1102<br />
Polycystic kidney disease<br />
mapping the locus of autosomal dominant<br />
polycystic kidney disease: diagnostic appln.<br />
(S),B13<br />
Pohycystic ovarian disease<br />
steroid profile for urine: ref. values, 2281<br />
Polymerase chain reaction<br />
applicn. of polymerase chain reaction (PCR) to<br />
detection of human retroviruses (A), 1058<br />
automated DNA sequencing methods involving<br />
polymerase chain reaction, 2196<br />
detection of HIV proviral DNA in peripheral<br />
blood mononuclear cells by pohymerase chain<br />
reaction (A), 1076<br />
detection of HIV-1 RNA by pohymerase chain<br />
reaction (A), 1076<br />
evaln. of parameters that influence pohymerase<br />
chain reaction (A), 1076<br />
prenatal diagnosis of hemoghobinopathies by<br />
using pohymerase chain reaction and allelespecific<br />
ohigonucleotide probes (S), 1854<br />
use of pohymerase chain reaction for diagnosis<br />
of inherited disorders (5), 1843<br />
Porphobilinogen<br />
liq.-chromatog, assay of urinary<br />
porphobilinogen (SN), 471<br />
sensitive method of screening for urinary<br />
porphobilinogen (SN), 2311<br />
Porphyria<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyrmns, 2290<br />
hiq.-chromatog, assay of urinary<br />
porphobihinogen (SN), 471<br />
sensitive method of screening for urinary<br />
porphobihinagen (SN), 2311<br />
Porphyrinogens<br />
quantn. of urinary porphyrins by hiq.<br />
chromatog. after oxidn, of porphyrinogens,<br />
1619<br />
Porphyrins<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyrins, 2290<br />
investigation of protoporphyrin IX std.<br />
materials used in acid-extn. methods;<br />
proposed correction for the millimohar<br />
absorptivity of protoporphyrin IX, 1601<br />
loss of porphyrmns from sohn, during anal.:<br />
effect of sample pH and matrix on porphyrin<br />
quanth. in urine by HPLC (SN), 1508<br />
quantn. of urinary porphyrmns by hiq.<br />
chromatog. after oxidn. of porphyrmnogens,<br />
1619<br />
resolution of issues in HPLC anal. of urinary<br />
porphyrmns (A), 1157<br />
thin-layer chromatog. of free porphyrms for<br />
diagnosis of porphyria (SN), 1043<br />
Potassium<br />
See also Electrolytes<br />
development of human serum ref. materials to<br />
unify Na, K results in serum to their natl,<br />
ref. systems (A), 1130<br />
enzymatic detn, of K in serum, 817<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns, (CR), 333<br />
performance of Technicon calorimetric K<br />
method on the RA-100’ system (A), 1130<br />
statis. interpretn. of concns. of Mg, Zn, Ca, K,<br />
choheaterols, and creatine kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
Potentiometry<br />
See also Ehectrochemicah detection, Ionselective<br />
electrodes<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns. (CR), 333<br />
influence of aspirin on in vitro direct<br />
potentiometry of Cl- in serum (TB), 2146<br />
Power curves<br />
between-run component of variation in<br />
internal qual. control, 1416<br />
Prevastatin<br />
specific RIA for measuring pravastatin in<br />
human serum (A), 1189<br />
Prealbuniin<br />
See also Tranathyretin<br />
assessment of protein calorie malnutrition<br />
using serum prealbumin (A), 1112<br />
direct, indirect techniques for free thyroxin<br />
compared in patients with nonthyroidal<br />
illness. II. effect of prealbumin, albumin,<br />
thyroxin-binding globulin, 1655<br />
immunoturbidimetry of prealbumin<br />
(transthyretin) in a microcentrifugal<br />
analyzer (TB), 178<br />
liq. chromatog. assay for free and<br />
transthyretin-bound retinol-binding protein<br />
in serum, 582<br />
nephelometric prealbumin assay on the RA-<br />
1000 (A), 1203<br />
serum prealbumin hevels in normal individuals<br />
of various age; and in patients with AIDS (A),<br />
1115<br />
usefulness of date on albumin and prealbumin<br />
concns, in detg. effectiveness of nutrit., 271<br />
Pregnancy<br />
algorithm for testing and reporting serum<br />
choriogonadotropin at cm, signif. decision<br />
levels with use of “pregnancy test” reagents,<br />
545<br />
choriogonadotropin discriminatory zone and<br />
ultrasonography (L), 2019<br />
cocaine and pregnancy: chin, and toxicol,<br />
implications far the neonate (5), 1276<br />
comparison of intact and beta-subunit hCG<br />
levels in maternal serum with normal and<br />
aborting pregnancy (A), 1136<br />
confusion about the discriminatory zone and<br />
choriogonadotropin stds. (L), 2336<br />
correln, of HbAic, glycated serum proteins and<br />
albumin, and fructosamine with 24-h glucose<br />
profile of insulin-dependent pregnant<br />
diabetics, 922<br />
hiq.-chromatog. detn, of acetyhated Hb, 33<br />
longitudinal study of thyroid function in<br />
pregnancy, 275<br />
low-normal concna, of free thyroxin in serum in<br />
hate pregnancy physiol. fact, not tech.<br />
artefact, 1891<br />
new technique for measuring free thyroxin in<br />
serum: multi-center study (SN), 2137<br />
oral glucose tolerance test does not provide a<br />
uniform stimulus to pancreatic islets in<br />
pregnancy, 1482<br />
RLA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neophasia, and assessment of<br />
effects of organ failure, 1631<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
salivary progesterone excellently reflects free<br />
and total progesterone in plasma during<br />
pregnancy (SN), 168<br />
serum lipid and apolipoprotein changes in<br />
normal pregnancy (A), 1066<br />
standn. of methods for mess. phasminogen<br />
activator inhibitor acty. in plasma, 787<br />
“stat” measurements of L-lactate in whole<br />
blood and CSF assessed (SN), 1740<br />
three methods compared for estg. testosterone<br />
and estradiol not bound to sex-hormonebinding<br />
globulin (SN), 632<br />
urinary excretion of some proteins and<br />
enzymes during normal pregnancy (SN),<br />
1978<br />
variables involved in evaluating maternal<br />
serum alpha-fetoprotein: albumin, total<br />
protein and fructosamine (A), 1159<br />
Prenatal diagnosis<br />
See also Amniotic fluid, Fetal status, Heritable<br />
disorders<br />
chemihuminescent enzyme immunoessay of a-<br />
fetoprotein with adamantyh dioxetane<br />
phenyl phosphate as substrate (SN), 2319<br />
prenatal diagnosis of hemoghobinopathiea by<br />
using pohymerase chain reaction and allelespecific<br />
oligonucheotide probes (S), 1854<br />
use of pohymerase chain reaction for diagnosis<br />
of inherited disorders (5), 1843<br />
use of the polymerase chain reaction for<br />
simultaneous anal, of two Pst I<br />
polymorphisms linked to cystic fibrosis<br />
(TB), 1260<br />
Pristanic acid<br />
phytanic acid, pristanic acid, and very-longchain<br />
fatty acid methyl esters mess.<br />
simultaneously by capillary gas chromatog.<br />
(L), 703<br />
Probes<br />
enzymatic amplification of RNA purified from<br />
crude cell hysata by reversible target capture<br />
(5), 1878<br />
prenatal diagnosis of hemoghobinopathies by<br />
using polymerase chain reaction and allelespecific<br />
ohigonucheotide probes (S), 1854<br />
quant. assays based on use of rephicatabhe<br />
hybridization probes (S), 1826<br />
quantn. of residual DNA in biol. products (5),<br />
1859<br />
use and appins. of nucleic acid probes in the<br />
chin, lab, (S), 1819<br />
Procainamide<br />
development of automated latex agglutination<br />
immunoassay for procainamide for IL<br />
Monarch’” chem. system (A), 1171<br />
four fluorescence polarization immunoassays<br />
for therapeutic drug monitoring evald., 138<br />
Pro-cathepsin<br />
two-site immunoenzymometric assay of 52-kDe<br />
pro-cathepsin D; use in breast diseases, 234<br />
Procollagen<br />
IRMA for serum type III procohlagen peptide<br />
using monochonal antibodies (A), 1188<br />
Proficiency testing<br />
See also Interleboratory performance<br />
effectiveness of proposed CDC/HCFA criteria<br />
to assess intralab. performance through<br />
proficiency testing programs (A), 1088<br />
external assessment of lab, cholesterol<br />
measurements using patients specimens (A),<br />
1069<br />
proficiency testing in a med.-needs context (0),<br />
347<br />
proficiency tasting on drugs of abuse: one<br />
year’s experience in Spain (SN), 879<br />
use of patient samples to evaluate accuracy of<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2397
theophyhhmne proficiency tasting performance<br />
evalns, (A), 1184<br />
Progesterone<br />
development of enhanced luminescence<br />
immunoassay for progesterone (A), 1149<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerlex cortisol, Biodata testosterone (SN),<br />
641<br />
estrogen and progesterone receptor assays, by<br />
the EIA method (Abbott), of how-speed<br />
supernates of breast-cancer homogenates<br />
(SN), 2226<br />
preliminary appraisal of a PR-EIA kit for<br />
quantifying progesterone receptors in breastcancer<br />
tissue (L), 339<br />
quantn. of progesterone in human serum using<br />
the Amerhita system (A), 1205<br />
relative importance of estrogen<br />
progesterone receptor assays<br />
and<br />
as prognostic<br />
indicators in primary breast cancer shortterm<br />
study, 238<br />
salivary progesterone excellently reflects free<br />
and total progesterone in plasma during<br />
pregnancy (SN), 168<br />
Progesterone receptors<br />
effect of ether or ketamine anesthesia on rat<br />
uterine estrogen, progesterone receptors<br />
(SN), 143<br />
measurement of estrogen and progesterone<br />
receptors in breast tumors using steroidbinding<br />
assays and monoclonal enzyme<br />
immunoassays (A), 1138<br />
Progestin receptors<br />
influence of O.C.T. embedding compd. on<br />
detns. of estrogen and progestin receptors in<br />
breast cancer (SN), 2317<br />
Proinsulin<br />
improved RIA of C-peptide and its appln. in a<br />
multiyear study, 37<br />
Prolactin<br />
evaln. of rapid, automated ELISA method for<br />
prohactin (A), 1188<br />
rapid automated detn. of total prolactin on the<br />
Stratus analyzer (A), 1095<br />
serum prohactmn as a rejection marker in heart<br />
transplantn. (TB), 492<br />
Prostate<br />
evaln, of kinetic method for prostatic acid<br />
phosphatase with use of self-indicating<br />
substrate, 2,6-dichhoro-4-nitrophenyl<br />
phosphate, 939<br />
PAP and PSA as markers of proatatic<br />
carcinoma (A), 1191<br />
RIA of fl-microseminoprotein, a prostaticsecreted<br />
protein in sera of men and women,<br />
1497<br />
Prostate-specific antigen<br />
anal, sensitivity of prostate-specific antigen<br />
Tandem-E enzyme immunometric assay<br />
(A), 1078<br />
measuring decision values for prostate-specific<br />
antigen in serum (A), 1077<br />
more on “hook effects” in immunometric<br />
assays for prostate-specific antigen (L), 1262<br />
(L), 2154<br />
PAP and PSA as markers of prostatic<br />
carcinoma (A), 1191<br />
prostate-specific antigen and the female<br />
prostate (L), 507<br />
Prostatic acid phoaphatase<br />
See Acid phosphatase<br />
Prostatic inhibin-like peptide<br />
prostatic inhibin-hike peptide in urine of<br />
prostatic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
Proteinase inhibitor<br />
functional, immunalog. concns. of a2-<br />
macroghobulin compared in plasma of<br />
subjects without ai-protaase inhibitor<br />
deficiency (SN), 1535<br />
screening for deficiency of a1-proteinase<br />
inhibitor (SN), 1971<br />
Protein<br />
C<br />
functional acty. of protein S detd. with use of<br />
protein C activated by venom activator, 1644<br />
simultaneous “sandwich” enzyme<br />
immunoassay for protein C using monochonal<br />
antibodies (A), 1208<br />
Protein G<br />
autoantibodies to lactate dehydrogenase in<br />
serum identified by use of immobilized<br />
Protein G and immobilized jacalin, a<br />
jackfruit hectin, 2190<br />
Proteins<br />
accuracy of total protein and albumin system<br />
specific values for SMA, SMAc-3, RA-1000,<br />
Assist, and Demand compared with the ref.<br />
method for T. protein and a comparative<br />
method for albumin (A), 1104<br />
apphn. of a silver-binding assay to detn. of<br />
protein in CSF (SN), 860<br />
bichromatics for total protein detn, (A), 1159<br />
Biotrol urine proteins reagent using pyrogalhoh<br />
red-Mo complex (A), 1082<br />
changes in Fe, Zn, Cu concns. in serum and in<br />
their binding to transport proteins after<br />
chohecystectomy, cardiac surgery (SN), 2243<br />
din. applns. of high-resolution 2-D<br />
ehectrophoresis of proteins: comparative<br />
anal, by 2DE of proteins in high-resolution<br />
agarose electrophoresis bands and current<br />
med. indications for 2DE anal, of serum<br />
proteins (A), 1083<br />
computerized quant. anal, of Coomassie-Bhuestained<br />
serum proteins sepd. by twodimensional<br />
ehectrophoresis, 2297<br />
detn. of protein concn, in human breast milk<br />
using Coomassie Brilliant Blue on the<br />
Fara centrifugal analyzer (A), 1082<br />
Cobas<br />
distribn, of thiobarbituric acid-reactive<br />
substances in hipoprateins,proteins in serum,<br />
2054<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerhex-M progesterone,<br />
Amerlex cortisoh, Biadata testosterone (SN),<br />
641<br />
effect of thyroid hormone-binding proteins and<br />
fatty acids on modified analog assays of FT4<br />
and FT3 in serum (L), 708<br />
estn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
evaln. and performance characteristics of<br />
Paramax anal. system for detg. spinal fluid<br />
and urine protein with liq. Coomassie<br />
user-defined chem. (A), 1112<br />
Blue<br />
evahn. of Kodak slides for CSF protein assays<br />
(A), 1090<br />
evahn. of liquid immunology control using the<br />
Beckman Array (A), 1154<br />
evaln, of Paragon high-resolution<br />
electrophoresis system (A), h085<br />
functional acty. of protein S deed. with use of<br />
protein C activated by venom activator, 1644<br />
immunohistochem, studies utilizing<br />
monoclonal and pohyclonal antibodies to c-<br />
erbB-2 protein (A), 1079<br />
immunoturbidimetry of serum protens with<br />
the Behring “Turbitimer” (TB), 2144<br />
interference of plasma expanders in detn. of<br />
total protein (TB), 2143<br />
intra-individual variation of electrophoretic<br />
serum protein fractions (TB), 1544<br />
isolation of “cystic fibrosis protein” from<br />
serum, 1901<br />
isoln. and charactern. of myoglobin and its two<br />
major isoforms from sheep heart, 778<br />
micro-method for total protein in CSF, using<br />
benzethonium chloride in microtiter plate<br />
wells (SN), 1731<br />
performance characteristics of CSF protein on<br />
Paramax (A), 1084<br />
performance characteristics of urine protein on<br />
Paramax (A), 1084<br />
purifn., characterization of intact lactoferrin<br />
found in the urine of human milk-fed<br />
preterm infants, 1928<br />
S-100a0 protein in blood and urine during<br />
open-heart surgery, 1942<br />
sepn., identn, of urinary proteins and stonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate-polyacrylamide gel electrophoresis<br />
(SN), 658<br />
serum proteins, immunoghobulin, and<br />
complement (C3& C4)levels in Down’s<br />
syndrome in Kuwait sample (A), 1081<br />
simple procedure for evaluating thyroxinbinding<br />
proteins abnormalities in euthyroid<br />
hyperthyroxinemia and hypothyroxinemia<br />
(A), 1150<br />
total protein deed, in breast milk by use of<br />
Coomassie Brffliant Blue and centrif, anal.<br />
(SN), 2127<br />
urinary excretion of some proteins and<br />
enzymes during normal pregnancy (SN),<br />
1978<br />
urine protein 1: sex-dependent marker of<br />
tubular or glomerular dysfunction (TB),<br />
2141<br />
(Wake Forest University Case Conference):<br />
myoghobmnurie, hemoglobinuria, acute renal<br />
failure (CC), 1713<br />
Proteinuria<br />
electrophoretic examin. of proteinuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
improved pyrogallol red-Mo method for detg.<br />
total urinary protein (SN), 2233<br />
Lp(s) lipoprotein concn, in serum of patients<br />
with heavy proteinuria of different origin<br />
(SN), 2121<br />
ohigochonal banding detected by urinary<br />
protein electrophoresis and immunofixation<br />
in two patients with AIDS and proteinuria<br />
(CR), 1795<br />
proteinuria (R), 755<br />
Prothrombln<br />
correction of instrument- and reagent-based<br />
differences in detn, of the mt. normalized<br />
ratio for monitoring anticoagulant therapy<br />
(SN), 840<br />
interference of coumarmn therapy with the<br />
“Heptest” owing to declining prothrombin<br />
concns. (SN), 483<br />
new chromogenic substrate for detn. of<br />
prothrombin time with the Reflotron5 (A),<br />
1161<br />
Protoporphyrin<br />
effect of ingestion of hemoproteins on fecal<br />
excretion of hemes and porphyrins, 2290<br />
empirically deed. Pb-poisoning screening cutoff<br />
for the Protofluor-Z hematofluorometar<br />
(SN), 2104<br />
interhab. comparison of control materials for<br />
use with hematofluorometers, 2059<br />
investigation of protoporphyrin IX sod.<br />
materials used in ecid-exth. methods;<br />
proposed correction for the milhimohar<br />
absorptivity of protoporphyrin IX, 1601<br />
Zn protoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Psoriasls<br />
complement C4 allotypes and psoriasis (TB),<br />
2142<br />
Psychotropic drugs<br />
See also Anticonvulsant drugs, Tricychic<br />
antidepressants, etc.<br />
Pulmonary disease<br />
See Lung disease<br />
Purines<br />
depressed activities of purine enzymes in<br />
lymphocytes of patients infected with HIV,<br />
1478<br />
Pyridine nucheotide cosnzymes<br />
interaction between pyridine nucleotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
Pyridoxal phosphate<br />
intercorrehations between direct and total<br />
phasma pyridoxah 5’ phosphate and social<br />
and therapeutic drug use, and health status<br />
(A), 1136<br />
monochonal antibodies evald, for use in<br />
screening for conjugates of human serum alb.<br />
and pyridoxah 5’-P04 (SN), 1756<br />
simple hq.-chrometog. method for vit. B6 cmps.<br />
in plasma, 241<br />
Pyroglutamic acidemla<br />
pyroglutamic acidemia in an adult (CR), 684<br />
Pyrophosphate<br />
platelet-derived ATP may contribute to<br />
measured concn. of inarg. pyrophosphate in<br />
serum (TB), 326<br />
Pyruvate<br />
multipoint kinetic simultaneous mess. of<br />
combined concns, of acetoacetate-$hydroxybutyrate<br />
and hactate-pyruvate (SN),<br />
1526<br />
pyruvate mess. in whole blood with the Cobas<br />
Bia analyzer (TB), 325<br />
Pyruvate kinase<br />
enzymatic detn. of K in serum, 817<br />
Quality control<br />
allowable limit of error in cm. chem. qual.<br />
control (SN), 630<br />
apphn. of Quality Management System<br />
microcomputer quah.-cantroh program in the<br />
RIA/endocrine lab. (A), 1086<br />
between-run component of variation in<br />
internal qual. control, 1416<br />
choosing quah.-control systems to detect max.<br />
chin. allowable anal. errors, 284<br />
continuing need for qual. assessment of<br />
cyclosporine measurement (S), 1309<br />
counting errors: effect on immunoassay<br />
precision, 1362<br />
development and evaln. of quality-assurance<br />
program based on interlab. comparison (A),<br />
1160<br />
differences between alk. phosphatase activities<br />
in serum and lyophihized controls in AMP<br />
buffer explained (L). 510<br />
2398 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
evaln. of a new linearity material (A), 1096<br />
improved RIA of C-peptide and its appin. in a<br />
muhtiyear study, 37<br />
individual home glucose meters evaluated by<br />
routine chin, lab, methods (A), 1142<br />
new mt. tamp. scale of 1990 (ITS-90) (SR), 503<br />
qual. control of glucose monitors outside the<br />
chin, lab.: use of commercial nonhuman<br />
erythrocyte prepns. supplemented with<br />
glucose (L), 509<br />
quality assurance study of gentamicin usage<br />
and monitoring in a children’s hospital (A),<br />
1167<br />
quality-control program for evaluating and<br />
monitoring multiple-site reflectance glucose<br />
analyses (A), 1160<br />
quality-management approach to preventing<br />
lab, testing mistakes (A), 1087<br />
serum-based quality control fluids and<br />
calibrators: lyophilization vs vacuum-drying?<br />
(A), 1101<br />
whole-blood quality-control material for<br />
Reflotron assays of cholesterol (TB), 1255<br />
Quinidine<br />
four fluorescence polarization immunoessays<br />
for therapeutic drug monitoring evald,, 138<br />
latex agglutination inhibition immunoassay for<br />
quinidine on the IL Monarch chem. system<br />
(A), 1172<br />
Rabbits<br />
normal biochem. and hematol, values in New<br />
Zealand White rabbits (SN), 1777<br />
Race-related differences<br />
cord blood hipoprotein(a) in blacks and whites<br />
(A), 1065<br />
racial and age-related differences in incidence<br />
of monochonal gammopathy of uncertain<br />
significance (A), 1154<br />
racial and other differences of maternal serum<br />
a-fetoprotein in a large obstetrical<br />
population (A), 1136<br />
Radial immunodiffusion<br />
comparative measurements of apolipoprotein<br />
B by immunonephehometry and radial<br />
immunodiffusion (A), 1069<br />
enzyme-linked immunosorbent assay of<br />
apohipoprotein<br />
paper, suitable<br />
B in blood spotted onto filter<br />
for neonatal screening, 1000<br />
four immunochem, methods compared for<br />
mess, C-reactive protein in plasma (SN), 461<br />
high concns. of Zna2-ghycoprotain and lack of<br />
a2HS-ghycoprotein in ejaculates, 1649<br />
hipoprotein(a) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
liq. chromatog. assay for free and<br />
transthyretin-bound retinoh-binding protein<br />
in serum, 582<br />
mess, of apohipoprotein B in plasma from<br />
hyperlipidemic subjects treated with<br />
cholestyramine or placebo: differential<br />
effects of storage at -70 #{176}C, 380<br />
rate immunonephehometry, radial<br />
immunodiffusion compared for<br />
apolipoproteins Al and B assay (SN), 2236<br />
Radial partition immunoassay<br />
Baxter Stratus evaluated as anal. system (A),<br />
1111<br />
evaln, of Baxter Dade Stratus as a stat method.<br />
for human choriogonadotropin, digoxin, and<br />
digitoxin (A), 1111<br />
evaln, of radial partition immunoassay for<br />
quantn. of IgE (A), 1199<br />
rapid automated detection of human 1gM<br />
antibody to hepatitis B core antigen (A),<br />
1206<br />
rapid automated detn. of total prohactin on the<br />
Stratus analyzer (A), 1095<br />
Radiation enteritis<br />
alpha slow-moving HDL subfraction in serum<br />
of a patient with radiation entaritis and<br />
peritoneal carcinosis (CR), 674<br />
Radioassay<br />
25-hydroxyvitamin D and 1,25-<br />
dihydroxyvitamin D deed, in serum by<br />
“SPE-octadecyl (C18)” cal, extraction and<br />
radioassay (TB), 1995<br />
Radioenzymatic assay<br />
rapid detn, of total homocystemne in plasma<br />
(TB), 2002<br />
Radioimmunoassay<br />
assessment of screening program for congenital<br />
adrenal hyperplasia in Portugal based on<br />
antibody-coated tube RIA for 17a-OH<br />
progesterone (L), 2338<br />
automated enzyme immunoassay for hutropin<br />
(Abbott IMx analyzer) (SN), 2333<br />
binding of labeled thyroxin analog to serum<br />
proteins evald. after RIA of free thyroxin<br />
(SN), 475<br />
chin, utility of intact and total immunoreactive<br />
parathyroid hormone immunoassays (A),<br />
1148<br />
comparison of Centocor CA 19-9, Tandem-R<br />
CA 195, and Truquant GI (A), 1078<br />
comparison of free testosterone by analog RIA<br />
and ultrafiltration (A), 1148<br />
concn. of free thyroxmn in serum during<br />
nonthyroidal ihhness-calcn. or meas.? (SN),<br />
159<br />
counting errors: effect on immunoassay<br />
precision, 1362<br />
cyclosporin A mess, in plasma in various<br />
transplant types by HPLC and RIA (A),<br />
1356<br />
cychosporine concns. in blood after liver<br />
transplantn.: correlation of immunoassay<br />
results with chin, events, 564<br />
cyclosporine measured in plasma from patients<br />
with various transplants: HPLC and RIA<br />
with a specific monoclonal antibody<br />
compared (SN), 1726<br />
decreased immunoreacty, and binding acty. of<br />
corticosteroid-bmnding globulin in serum in<br />
septic shock, 1675<br />
detection of serum CK-MB isoforms by RIA<br />
(A), 1121<br />
detn. of cychosporine in plasma: specific<br />
with a monochonal antibody and hiq.<br />
RIA<br />
chromatog. compared, 608<br />
direct and indirect techniques for free thyroxin<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
direct detn. of free thyroxin in undiluted serum<br />
by equilibrium diahysis/RIA (L), 510<br />
direct, indirect techniques for free thyroxin<br />
compared in patients with nonthyroidal<br />
illness. II. effect of prealbumin, albumin,<br />
thyroxin-binding globulin, 1655<br />
discordant RIA results for thyroxin-binding<br />
giobuhin (TBG): new indicator of variant<br />
TBG molecules with decreased affinity for<br />
thyroxin (TB), 1257<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerhex-M progesterone,<br />
Amerhex cortisoh, Biodata testosterone (SN),<br />
641<br />
enzyme-linked immunosorbent assay for free<br />
thyroxmn in serum (SN), 1770<br />
estimation of true values in RIAs, 1680<br />
evaln, of an RIA of urinary cortisol without<br />
extrn. (SN), 125<br />
evahn. of Corning magnetic particle RIA for<br />
free T3 (A), 1207<br />
evaln. of RIA kit for detn. of free insulin:<br />
effects of sample handling and storage (A),<br />
1144<br />
evahn, of six direct 17fl-estradiol RIA kits and<br />
comparison with an in-house extn, RIA (A),<br />
1150<br />
exposure to environmental tobacco smoke<br />
measured by cotinine ‘251-RIA (SN), 1036<br />
five cannabinoid immunosssay systems<br />
compared at the screening threshold of 100<br />
ig/L (SN), 2241<br />
heart disorders and concentrations of directly<br />
measured atrial natriuretic peptide in<br />
plasma, 435<br />
improved RIA of atrial natriuretic peptide in<br />
plasma, 1431<br />
improved RIA of C-peptide and its apphn. in a<br />
multiyear study, 37<br />
influence of matrix on concns, of somatotropin<br />
mess, in serum with commercial<br />
immunoradiometric assays, 1423<br />
investigation of sex-hormone-binding globulin<br />
interference in direct RIAs for testosterone<br />
and estradiol, 979<br />
‘251-RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
heukotriene B4 is measurable in serum of<br />
smokers and nonsmokers (SN), 459<br />
low-dose monitoring of haloperidol (A), 1179<br />
mess, of cychospormne concns, in whole blood:<br />
HPLC and RIA with a specific monochonal<br />
antibody and 3H- or mnIlabehed higand<br />
compared (SN), 120<br />
mess, of urinary heukotrienes by reversedphase<br />
hiq. chromatog. and RIA, 388<br />
measurement of benzodiazepines in urine by<br />
double-antibody RIA (A), 1175<br />
neopterin mess, in serum, tissue culture<br />
supernates by competitive enzyme-linked<br />
immunosorbant assay, 1467<br />
new immunoradiometric assay for<br />
corticotropin evald. in normal subjects and<br />
patients with Cushing’s syndrome, 596<br />
nonselective measurements of cyclospormn A in<br />
transplant patient specimens by RIA with a<br />
monoclonal antibody and I-tracer (A),<br />
1164<br />
19-O-carboxymethyh ether derivative of<br />
testosterone: its immunogenicity and<br />
radiohigand for RIA of testosterone (A), 1200<br />
one-step estradiol RIA with use of pre-reacted<br />
double-antibody system (A), 1198<br />
prostatic inhibin-hike peptide in urine of<br />
prostatic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
reservations regarding assessment of data<br />
obtained with commercially available<br />
cortisol RIA kits (L), 2153<br />
RIA for measurement of natural and Rh<br />
erythropoietin in patient sera (A), 1191<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
RIA of 5-methozytryptophol in plasma (SN).<br />
1749<br />
RIA of -microseminoprotein, a prostaticsecreted<br />
protein in sera of men and women,<br />
1497<br />
RIA of osteocalcin with polychonal and<br />
monochonal antibodies, 1408<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
sensitive radiobmnding assay for measuring<br />
autoantibodies to thyroperoxidsse in human<br />
serum (A), 1208<br />
simple method for free insulin by a RIA kit (A),<br />
1146<br />
solid-phase enzymoimmunoassay for<br />
osteocalcin in serum or plasma, with use of a<br />
monoclonal antibody, 2087<br />
specific RIA for measuring new thromboxane<br />
antagonist, SQ 30,741, in plasma (A), 1189<br />
specific RIA for measuring pravastatin in<br />
human serum (A), 1189<br />
specific RIA for measuring SQ 31,765 in human<br />
serum (A), 1189<br />
turbidimetric latex immunoassay of placental<br />
lactogen on microtiter plates, 141<br />
1988 version of two-step immunoextn. assay for<br />
PT4: chin, performance (A), 1144<br />
whole-blood cychosporin A: comparison of<br />
monoclonal antibody RIA with HPLC (A),<br />
1100<br />
Radioreceptor assay<br />
digoxin drug-drug interactions investigated<br />
with a human myocardial Na’iK-ATPsse<br />
radioreceptor assay (A), 1168<br />
radioreceptor assay for endogenous digitalishike<br />
substances using microsomal fractions<br />
from human placenta (A), 1140<br />
receptor assay for cyclosporine acty. in whole<br />
blood (A), 1167<br />
Random-access analysis<br />
adaptation of drugs of abuse testing to<br />
Synchron CX4 and CX5 chin, analyzers<br />
(A), 1178<br />
adaptation of six DGKC enzymes and<br />
chohinestarase to Synchron CX5 at 30#{176}C<br />
and 37#{176}C (A), 1126<br />
adaptation of Syva assays for drugs of abuse on<br />
the Olympus Reply lab. analyzer (A), 1174<br />
adaption of Syva EMIT TDM assays to the 550<br />
Express (A), 1170<br />
automated detn. of urinary NaF, K, C1, P1,<br />
urea, and creatinine without sample dun.<br />
with the “RAT-XT” (SN), 481<br />
cardiac enzyme measurement with Eur.<br />
reagents using Ciba Corning 550 Expresstm<br />
(A), 1118<br />
din. evahn, of Beckman Synchron CX5 chem.<br />
analyzer (A), 1103<br />
dry-chem. multihayer element for thyroid<br />
hormone uptake assay (A), 1195<br />
dry-chem. muhtihayer immunoassay for total<br />
thyroxin (A), 1180<br />
dry-chem. multilayer immunoassay test for<br />
theophylline (A), 1196<br />
dry-chem. multilayer immunoassay tests for<br />
phenytoin and phenobarbital (A), 1196<br />
enzymatic detn, of K in serum, 817<br />
evaln, and performance characteristics of<br />
Paramax anal. system for detg. spinal fluid<br />
and urine protein with hiq. Coomassie Blue<br />
user-defined chem, (A), 1112<br />
evaln, of Affinitytm automated immunosssay<br />
system (A), 1188<br />
evahn, of Baxter Paramax analyzer (A), 1111<br />
CLINICAL CHEMISTRY,Vol. 35, No. 12, 1989 2399
evaln. of Beckman Synchron CX5 analyzer (A),<br />
1108<br />
evaln. of Biotrol bicarbonate reagent on Abbott<br />
Spectrum (A), 1091<br />
evain. of carryover on Synchron CX#{174}4 and<br />
CX5 (A), 1109<br />
evain. of Syva EMIT’ d.a.u. appins. on 550<br />
Express (A), 1170<br />
evahn. of TDM available on the DuPont<br />
Dimension (A), 1096<br />
evahn. of user-defined reagents on Beckman<br />
Synchron CX’ and CX5 din, systems (A),<br />
1097<br />
measurement of serum digoxin using CEDIAW<br />
reagents and the RA-1000 (A), 1183<br />
modified enzymatic approach to measure blood<br />
urea N on the Technicon RA-1000’ (A), 1104<br />
modified IFCC reagents for ALT and AST<br />
testing on Ciba Corning 550 Express (A),<br />
1118<br />
monoclonal turbidimetric assay for<br />
phenobarbitah on the RA.l000” system (A),<br />
1172<br />
nephehometric prealbumin assay on the RA-<br />
1000 (A), 1203<br />
performance characteristics of automated<br />
random-access analyzer Cobas Mira#{174} for<br />
measurement of drugs of abuse (A), 1097<br />
performance of CEDIAtm Digoxin R assay on<br />
Technicon RA1000tm chem. analyzer (A),<br />
1171<br />
performance of Technicon Chem-1#{176}1 analyzer<br />
for quant. measurement of 10 anahytes in<br />
urine (A), 1130<br />
performance of theophylline, gentamicin,<br />
tobramycin, phenytoin, and digoxin reagents<br />
on the Beckman Synchron CX’4 (A), 1181<br />
random-access technol.: evaln. of Technicon<br />
AXONtm system (A), 1105<br />
random-access technol.: evahn. of Technicon<br />
DAX’” system (A), 1104<br />
rapid self-contained immunoassay for human<br />
thyrotropin (A), 1195<br />
Synchron CXTM 4/5 system meets cholesterol<br />
accuracy goals of nath. cholesterol education<br />
program (A). 1071<br />
Technicon tobramycin and gentamicin: secondgeneration,<br />
improved methods on the RA-<br />
1000 system (A), 1172<br />
three direct spectrophotometric methods for<br />
detn. of total bihirubin in neonatal and adult<br />
serum, adapted to the Technicon RA-1000<br />
analyzer (SN), 1980<br />
urine Ca anal, using Beckman Synchron CX’3<br />
and Synchron CX5 chin, systems (A), 1132<br />
Rate immunonephelometry<br />
rate immunonephehometry, radial<br />
immunodiffusion compared for<br />
apolipoproteins Al and B assay (SN), 2236<br />
Rate nephelometry<br />
quantn. of z- and A-containing<br />
immunoglobuhins by rate nephehometry:<br />
comparison of two comm. reagent antisera<br />
(A), 1198<br />
Rats<br />
changes in concanavalin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
changes of growth-related<br />
growth factors following<br />
hormones and<br />
pneumonectomy: I.<br />
growth hormone (A), 1150<br />
genes encoding neuronah nicotinic<br />
acetyhchohine<br />
hiq. chromatog.<br />
receptors (S), 731<br />
assay for free and<br />
transthyretin-bound retinal-binding protein<br />
in serum, 582<br />
Receiver-operating characteristic curves<br />
See also Statistics<br />
diagnostic utility of serum total creatine kinase<br />
and creatine kinase-2 in myocardial<br />
infarction re-evaluated, 1435<br />
diagnostic value of measuring pancreatic lipase<br />
and the P3 isoform of pancreatic amylsse<br />
isoenzyme in serum of hospitalized<br />
hyperamylasemic patients, 417<br />
erythrocyte sedimentation rate and C-reactive<br />
protein compared in the elderly (SN), 466<br />
measuring carboxypeptidase A acty. with a<br />
centrif. analyzer: anal, and chin.<br />
considerations, 251<br />
relative operating characteristic curves used to<br />
compare drug screening immunosssays for<br />
amphetamine and methamphetamine (A),<br />
1175<br />
role of rapid immunoasssys for urgent detns. of<br />
creatine kinase isoenzyme MB (SN), 1752<br />
strategic use of individual and combined<br />
enzyme indicators for acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
Receptors<br />
effect of ether or ketamine anesthesia on rat<br />
uterine estrogen, progesterone receptors<br />
(SN), 143<br />
estrogen and progesterone receptor assays, by<br />
the EIA method (Abbott), of how-speed<br />
supernates of breast-cancer homogenates<br />
(SN), 2226<br />
genes encoding neuronal nicotinic<br />
acetyhchohine receptors (5), 731<br />
immunoenzymometric assay for antibody<br />
against human acetyhchohine receptor using<br />
precoated microtiter plate and receptor<br />
isolated from normal leg muscle (A), 1196<br />
preliminary appraisal of a PR-EIA kit for<br />
quantifying progesterone receptors in breastcancer<br />
tissue (L), 339<br />
relative importance of estrogen and<br />
progesterone receptor assays as prognostic<br />
indicators in primary breast cancer: shortterm<br />
study, 238<br />
specific binding of cardiac glycoside drugs and<br />
endogenous digitalis-hike substances to<br />
particulate membrane fractions from<br />
placenta, 2093<br />
Recombinant DNA<br />
anal, of serum antibodies to HIV using a<br />
multiple synthetic antigen-coated test strip<br />
(A), 1204<br />
antigens produced by recombinant DNA<br />
technol. (S), 1838<br />
evahn. of new recombinant ELISA immunoassay<br />
for detection of antibodies to HIV vs DuPont<br />
Western blot (A), 1204<br />
improved test for confirming antibodies to HIV<br />
using six recombinant peptides, including<br />
the intact gag gene-product, p24 (A), 1191<br />
measurement of antibodies to soluble CD4 by<br />
ELISA using recombinant CD4 (A), 1191<br />
performance of CEDIA’” T4 MAb and T-uptake<br />
assays on Technicon RA-1000’M (A), 1191<br />
recombinant DNA technol. in diagnosis of<br />
genetic disorders (5), B4<br />
update on cystic fibrosis: a molecular approach<br />
(A), 1057<br />
Recombinant RNA<br />
qusnt. assays based on use of rephicatable<br />
hybridization probes (5), 1826<br />
“Redox” reactions<br />
measurement of human ceruhoplasmin by its<br />
oxidase arty. using 4,4’-<br />
bis(dimethyhamino)diphenyhamine (A), 1082<br />
Reference interval<br />
automated enhanced latex agghutn. assay for<br />
rheumatoid factors in serum (SN), 303<br />
circadian variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
chin. chem. ref-intervals for healthy elderly<br />
(A), 1061<br />
cobalamin-bmnding capacity of haptocorrin and<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
detn. of Mg2 in granulocytes, 1404<br />
detn, of trans-phyhhoquinone in children’s<br />
serum (SN), 874<br />
diagnostic test for mucopohysaccharidosis. II.<br />
rapid quantn. of glycosaminoglycan in urine<br />
samples on a paper matrix, 2074<br />
effects of various serum proteins on quantn. of<br />
fructosamine (SN), 134<br />
enzyme-linked immunosorbent assay for<br />
chromogranin A, 1934<br />
estr.. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
immunoradiometry of corticotropin with use of<br />
avidin-biotin sepn., 804<br />
improved detn. of Va in biol, fluids by<br />
ehectrotherm. at. absorption spectrom. (SN),<br />
127<br />
improved method for calcg. Ca fractions in<br />
plasma: ref. values, effect of menopause, 14<br />
improved pyrogallol red-Mo method for detg.<br />
total urinary protein (SN), 2233<br />
‘251-RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
lactate dehydrogenase isoenzyme compn. of<br />
platelets (SN), 2325<br />
hiq.-chromatog. assay of urinary<br />
porphobihinogen (SN), 471<br />
measuring carboxypeptidaae A acty. with a<br />
centrif, analyzer: anal. and chin.<br />
considerations, 251<br />
measuring tissue factor (Factor III) acty. in<br />
plasma, 1897<br />
methods compared for detg. total acty. and<br />
isoenzymes of aznyhase in serum (SN), 645<br />
normal biochem. and hematol, values in New<br />
Zealand White rabbits (SN), 1777<br />
prepn. of fecal samples for assay of volatile<br />
fatty acids by gas-liq. chromatog. and<br />
HPLC, 74<br />
prostatic inhibin-hike peptide in urine of<br />
prostatic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
quantn. of urinary porphyrins by hiq.<br />
chromatog. after oxidn. of porphyrinogens,<br />
1619<br />
ref. intervals for hTSH by two automated<br />
ultrasensitive assays: London Diagnostics<br />
LumsTag’” and Abbott’s IMxtm (A), 1143<br />
ref. intervals for two bone-derived enzyme<br />
activities in serum: bone isoenzyme of elk.<br />
phosphatase and tartrate-resistant acid<br />
phosphatsse (TB), 180<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplssia, and assessment of<br />
effects of organ failure, 1631<br />
RIA of fl-microseminoprotein, a prostaticsecreted<br />
protein in sera of men and women,<br />
1497<br />
RIA of osteocalcin with polychonal and<br />
monochonal antibodies, 1408<br />
self-consistent set of ref. values for 23 chin.<br />
chem. anahytes, 448<br />
serum phylloquinone concns, in a normal popn.<br />
of children as compared with ref. interval in<br />
adults (TB), 671<br />
simple hiq.-chromatog. method for vit, B6 cmps.<br />
in plasma, 241<br />
solid-phase enzymoimmunoassay of estrone in<br />
saliva, 569<br />
somat.otropin as mess. by a two-site timeresolved<br />
immunofluorometric assay, 913<br />
staining method for use in ehectrophoretic<br />
detn. of amyisse isoenzymes in serum (SN),<br />
2322<br />
standn. of methods for mess, plasmmnogen<br />
activator inhibitor acty. in plasma, 787<br />
time-resolved immunofluorometric assay of<br />
pancreatic isoamyhase in serum, with use of<br />
two monoclonal antibodies, 1915<br />
two-site immunochemihuminometric assay of<br />
intact parathyrmn with use of a tracer peptide<br />
purified by reversed-phase 1mg.chromatog.,<br />
215<br />
Reference materials<br />
CAP-CDC cholesterol ref. materials study (A),<br />
1073<br />
CDC/NHLBI lipid standardization<br />
program-30 years of collaboration (A), 1073<br />
development of human serum ref. materials to<br />
unify Na, K results in serum to their nath.<br />
ref. systems (A), 1130<br />
immunoaffinity purifn. of creatine kinaae-MB<br />
from human, dog, and rabbit heart with use<br />
of monoclonal antibody specific for CR-MB,<br />
985<br />
new SRM: trace elements, 2023<br />
reliable mess, of circulating immune complex<br />
depends on stable, accurate ref. material (L),<br />
1555<br />
standn, of apohipoprotein B and A-I mess. (R),<br />
1357<br />
whole-blood quality-control material for<br />
Reflotron’ assays of cholesterol (TB), 1255<br />
Reference methods<br />
candidate Ref. Method for measurement of<br />
apolipoprotain B-100: evaln, of a<br />
monochonal-antibody-based enzyme-linked<br />
immunosorbent assay (A), 1073<br />
estimation of true values in RIAs, 1680<br />
evaln, of the IFCC Ref. Method for alanine<br />
aminotransferase: spurious blank ALT acty.<br />
due to contamination of D-alanine with L-<br />
ahanine; recommendations for a correction<br />
(SN), 153<br />
standn. of apohipoprotein B and A-I mess, (R),<br />
1357<br />
Reference values<br />
appln. of a silver-binding assay to detn, of<br />
protein in CSF (SN), 860<br />
biol. variation of urinary N-acetyh-fl-Dglucosaminidase:<br />
practical and chin.<br />
implications, 560<br />
determining “ref. changes” for serial<br />
measurements of plasma lipid-bound siahic<br />
acid (A), 1080<br />
dimethylmethyhene blue-based spectrophotom.<br />
of glycosaminoglycans in untreated urine:<br />
rapid screening for mucopohysaccharidoses,<br />
1472<br />
direct detn. of 4 sulfates and 7 glucuronides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” liq. chromatog., 794<br />
extrapolation of hipoprotein ref. limits to<br />
apohipoprotein measurements (A), 1070<br />
2400 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
feline and canine ref. ranges for the Kodak<br />
Ektachem 700 analyzer (A), 1134<br />
normal range of ic/Alight-chains<br />
immunoglobulins in 422 hospital patients<br />
(A), 1086<br />
ref. range of glycated Hb in nondiabetic<br />
persons possessing Hb S by affinity<br />
chromatog. (A), 1162<br />
ref. values for creetine, creatinine, and<br />
carnitine are lower in vegetarians (L), 1802<br />
self-consistent set of ref. values for 23 chin,<br />
chem. analytes, 448<br />
solid-phase enzymoimmunoassay for<br />
osteocalcin in serum or plasma, with use of a<br />
monochonal antibody, 2087<br />
steroid profile for urine: ref. values, 2281<br />
Reflectance photometry<br />
accuracy, preclsion of anal, for total cholesterol<br />
as measured with the Reflotron cholesterol<br />
method (SN), 1734<br />
cs-ansylase deth. with the Reflotron’ reagent<br />
carrier system: use of whole blood, plasma,<br />
and serum, and effect of isoenzymes (SN),<br />
317<br />
aqueous-based glucose control sohns. for use<br />
with glucose reagent-stripe and meters (L),<br />
2017<br />
characterization<br />
in mess, of<br />
of sulfasalazine’s<br />
conj. bihirubinwith<br />
interference<br />
the Ektachem<br />
slide (SN), 1760<br />
chin, lab. evaln, of Clinimate’” digoxin,<br />
theophylline, phenytoin, phenobarbital, and<br />
carbamazepine systems (A), 1103<br />
comparison testing of hot-to-hot variance in<br />
Reflotron dry reagent strip method<br />
cholesterol measurement (A), 1098<br />
of<br />
dry-strip immunometric assay for digoxin on<br />
the Ames’” seralyzer’ (A), 1168<br />
eatn. of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
immunoassay system for panel testing enzyme<br />
(S), 1874<br />
immunometric total thyroxin assay for use with<br />
dry reagent strips and a reflectance<br />
photometer (A), 1140<br />
new chromogenic substrate for detn. of<br />
prothrombin time with the Reflotron’ (A),<br />
1161<br />
performance of Reflotron amyhase and<br />
bihirubintest methods in two physicians<br />
office labs. (A), 1093<br />
physician office evaln, of Chinimate’ digoxin<br />
and theophyhline systems (A), 1099<br />
quality-control program for evaluating and<br />
monitoring multiple-site reflectance glucose<br />
analyses (A), 1160<br />
re-evain. of Reflotron, to characterize influence<br />
of drugs, hemohysate, hipemia, and bihirubin<br />
on results (A), 1160<br />
Reflotron amyhase: evahn. of new dry-chem. test<br />
for the Refiotron (A), 1096<br />
test-strip method for lactate in whole blood<br />
(SN), 1992<br />
Renal disease<br />
See also Kidney disease<br />
microplate mess, of urinary albumin,<br />
creatinine, 1371<br />
proteinuria (R), 755<br />
sepn., identn. of urinary proteins and stonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate-pohyacryhamide gel ehectrophoresis<br />
(SN), 658<br />
Renal failure<br />
elimination of total digoxin from a patient in<br />
chronic renal failure post-Fab fragment<br />
(Digibind) therapy (A), 1179<br />
enzyme immunoassay of Hb A1,,:anal.<br />
characteristics and chin, performance in<br />
diabetes mellitus, with and without uremia,<br />
93<br />
influence of end-stage renal failure on concns.<br />
of free apolipoprotein A-i in serum, 963<br />
(Wake Forest University Case Conference):<br />
myoghobinuria, hemaghobmnuria, acute renal<br />
failure (CC), 1713<br />
Renal function<br />
adenosine and dopamine simultaneously deed.<br />
in urine by reversed.phase HPLC, with online<br />
mess. of uv absorbance and ehectrochem,<br />
detection, 64<br />
assessment of renal function by inuhin<br />
clearance: comparison with creatinine<br />
clearance as deed. enzymatically (SN), 312<br />
RIA of -microseminoprotein, a prostaticsecreted<br />
protein in sera of men and women,<br />
1497<br />
simultaneous mess, of total and IgAconjugated<br />
a1-microglobuhmn by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
Renal transplant<br />
concns. of neopterin in serum of recipients of<br />
renal eilografts (L), 2157<br />
two-site immunochemiluminometric assay of<br />
intact parathyrmn with use of a tracer peptide<br />
purified by reversed-phase 1mg.chromatog.,<br />
215<br />
Rephicatable hybridization probes<br />
quant. assays based on use of rephicatabhe<br />
hybridization probes (S), 1826<br />
Resistive-pulse counting<br />
amniotic fluid hamellar bodies characterized by<br />
resistive-pulse counting: relation to measures<br />
of fetal lung maturity, 612<br />
Respiratory acidosis<br />
calculated HCO3- or total C02?, 1697<br />
Respiratory disorders<br />
See Lung disease<br />
Respiratory distress syndrome<br />
See Amniotic fluid, Fetal status<br />
Restriction fragment length polymorphisms<br />
construction of a linkage map of the human<br />
genome, and its apphn. to mapping genetic<br />
diseases(s), B33<br />
cystic fibrosis: diagnostic testing and the<br />
search for the gene (S), B17<br />
genetics of bipolar affective disorder: chin,<br />
implications (5), B28<br />
mapping the hocus of autosomal dominant<br />
pohycystic kidney disease: diagnostic appln.<br />
(S),B13<br />
use of the pohymerase chain reaction for<br />
simultaneous anal. of two Pst I<br />
polymorphisms linked to cystic fibrosis<br />
(TB), 1260<br />
Reticuloendothehiosis<br />
immunoassay of band 5 (“tartrate-resistant”)<br />
acid phosphatase involving use of antiporcine<br />
uteroferrin antibodies, 86<br />
Retinol<br />
concns. of carotenoids, retinol, and tocopheroh<br />
in plasma after a meal (SN), 310<br />
hiq. chromatog. assay for free and<br />
transthyretmn-bound retmnol-binding protein<br />
in serum, 582<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
Retinol-binding<br />
hiq. chromatog.<br />
protein<br />
assay for free and<br />
transthyretin-bound retinol-binding protein<br />
in serum, 582<br />
Retinopathy<br />
transferrin in urine of non-insulin-dependent<br />
diabetics: marker for early complications?,<br />
1672<br />
Retroviruses<br />
apphicn. of pohymerase chain reaction (PCR) to<br />
detection of human retroviruses (A), 1058<br />
Reversible target capture<br />
enzymatic amplification of RNA purified from<br />
crude cell lysate by reversible target capture<br />
(S), 1878<br />
quant. assays based on use of rephicateble<br />
hybridization probes (S), 1826<br />
Rhabdomyohysis<br />
rhabdomyohysis in a case of free-base cocaine<br />
(“crack”) overdose (CR), 1547<br />
Rhabdomyosarcoma<br />
creatine kinaae MB isoenzyme in<br />
rhebdomyosarcoma (L), 896<br />
Rheumatic diseases<br />
expression of the major human<br />
ribonucheoprotein (RNP) autoantigens in E.<br />
coli and their use in an EIA far screening<br />
sere from patients with autoimmune diseases<br />
(5), 1861<br />
Rheumatoid arthritis<br />
aberrant lectin-binding acty. of<br />
immunoghobulin G in serum in rheumatoid<br />
arthritis, 1638<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidase IV in synovial fluid<br />
from patients with rheumatoid and<br />
osteoarthritis, 1016<br />
changes in concanavahin A-reactive proteins in<br />
inflammatory disorders, 2207<br />
Rheumatoid factor<br />
automated enhanced latex agghutn. assay for<br />
rheumatoid factors in serum (SN), 303<br />
rheumatoid factors deed. by fluorescence<br />
immunosssay: comparison with qual. and<br />
quant. methods (SN), 464<br />
Ritodrine<br />
false-positive urine amphetamine screen with<br />
ritodrine (TB), 1542<br />
RNA<br />
detection of HIV-1 RNA by polymerase chain<br />
reaction (A), 1076<br />
enzymatic amplification of RNA purified from<br />
crude cell lysate by reversible target capture<br />
(S), 1878<br />
Robotics<br />
fully automated robotics lab, in Kochi Med.<br />
School, Japan (A), 1052<br />
state of the art in chin, lab, robotics (A), 1051<br />
use of robotics in method development (A),<br />
1052<br />
Rocket immunoelectrophoresis<br />
See Immunoehectrophoresis<br />
Rubella<br />
enzyme immunoassay for quantn. of IgG<br />
antibody to rubella virus in serum (A), 1092<br />
immunoassays for rubella antibodies (IgG and<br />
1gM) in serum using time-resolved<br />
fluorescence (A), 1153<br />
Sahicylate<br />
enzymatic salicylate and aceteminophen anal.<br />
on Monarch 2000 (A), 1185<br />
enzymic assay of salicylate adapted to the<br />
Monarch centrifugal analyzer (TB), 326<br />
influence of aspirin on in vitro direct<br />
potentiometry of C1 in serum (TB), 2146<br />
Saliva<br />
direct solid-phase enzymoimmunoassay of<br />
testosterone in saliva, 2044<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerlex cortisol. Biodata testosterone (SN),<br />
641<br />
hered. complete<br />
dehydrogenase<br />
deficiency of lactate<br />
H-subunit (CR), 687<br />
mechanism of action of pancreatic and salivary<br />
a-amyhase on 4,6-ethyhidene-a-4-<br />
nitrophenyhmaltoheptaoside substrate (L),<br />
188<br />
salivary progesterone excellently reflects free<br />
and total progesterone in plasma during<br />
pregnancy (SN), 168<br />
solid-phase enzymoimmunoassay of estrone in<br />
saliva, 569<br />
Sample collection<br />
concns. of carotenoids, retinal, and tocopherol<br />
in plasma after a meal (SN), 310<br />
liquid chromatog./electrochem.: in vivo detns.<br />
with microdialysis sampling probes (A), 1240<br />
Sample<br />
handling<br />
albuterol: transdermal absorption and<br />
fingerprick blood-sample contamination<br />
from nebulizers (TB), 889<br />
analyte stability in closed containers after 6<br />
days’ storage (A), 1158<br />
differences between capillary and venous<br />
blood-alcohol concns. as a function of time<br />
after drinking, with emphasis on sampling<br />
variations in left vs right arm, 400<br />
distribn. of cyclospormn A metahohites among<br />
plasma and cells in whole blood: effect of<br />
temp., hematocrit, and metabohite concn., 59<br />
effectiveness of NaF as a preservative of blood<br />
glucose (SN), 315<br />
effect of hematocrit end added heparmn on Ca2<br />
in capillary blood from neonates (SN), 486<br />
effect of repeated freezing and thawing on<br />
vitamins and hormones in serum (TB), 2145<br />
electrothermal at. absorp. spectrom. detn. of<br />
Al: serum matrix effects eliminated (SN),<br />
1517<br />
estimation of true values in RIAs, 1680<br />
evaln, of RIA kit for detn. of free insulin:<br />
effects of sample handling and storage (A),<br />
1144<br />
factors affecting a cyanogen bromide-based<br />
assay of thiamin, 2173<br />
fast, stable method for harvesting leukocytes<br />
for measuring intracellular Mg (SN), 1986<br />
field evaln, of Paramax’ Plus anal. system<br />
Closed Container Sampling’” (A), 1106<br />
with<br />
impact of immediate acidification of blood on<br />
measurement of plasma tissue plssmmnogen<br />
activator (tPA) acty. in surgical patients<br />
(TB), 1999<br />
influence of OCT. embedding compd. on<br />
detns. of estrogen and progestin receptors in<br />
breast cancer (SN), 2317<br />
loss of porphyrmns from soln. during anal.:<br />
effect of sample pH and matrix on porphyrin<br />
quantn. in urine by HPLC (SN), 1508<br />
meas. of apohipoprotein H in plasma from<br />
hyperhipidemic subjects treated with<br />
chohestyramine or placebo: differential<br />
effects of storage at -70 #{176}C, 380<br />
mechanisms responsible for increasing<br />
immunoreactivity of apohipoprotein A-I with<br />
storage: role of oxidn., 2082<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2401
Monoject Amber Samphettafree of bihirubin<br />
photohysis (TB), 889<br />
sample treatment for hong-distance transport<br />
of plasma for hormone assay (TB), 331<br />
screening for microalbuminuria in patients<br />
with diabetes: frozen storage of urine<br />
samples decreases their albumin content<br />
(SN), 308<br />
SDS improves recovery of free tryptophan in<br />
plasma samples deproteinized with<br />
Centrifree Micropartition Devices (A), 1161<br />
sepn., identn, of urinary proteins and stonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate-polyacryhamide gel electrophoresis<br />
(SN), 658<br />
Serum Separator Tube problems in Hitachi<br />
736/737 analyzers (L), 1554<br />
stability of red cell fohate after hemolysls with<br />
ascorbic acid soln. (A), 1160<br />
stability of sex-hormone-binding globulin in<br />
serum, plasma (TB), 1253<br />
stabilizer effect on cancn. of serum prostatic<br />
acid phosphatase (A), 1118<br />
stabn. of a’ketoisocaproic acid in serum and<br />
plasma (TB), 495<br />
standn. of apohipoprotemn B and A-I mess. (R),<br />
1357<br />
“stat” measurements of L-lactate in whole<br />
blood and CSF assessed (SN), 1740<br />
storage conditions and saliva thiocyanate<br />
cancn. (TB), 496<br />
storage temp. and concns, of digoxmn-hike<br />
immunoreactive factor(s) in plasma (L), 895<br />
study of lyophihization effect on enzymatic<br />
methods for cholesterol (A). 1066<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
unreliable visual estn, of incidence and amount<br />
of turbidity, hemohysis, and icterus in serum<br />
from hospitalized patients (SN), 837<br />
updated evaln. of Becton Dickinson Serum<br />
Separator Tube (A), 1159<br />
use of a duah-ppth. proced. for meas. highdensity<br />
lipoprotein 3 in normolipidemic<br />
serum, 1390<br />
Sample preparation<br />
differences between values for plasma and<br />
serum in tests performed in the Ektachem<br />
700 XR analyzer, and evaln. of “plasma<br />
separator tubes (PST)” (SN), 151<br />
liq.-chromatog. assay of urinary<br />
porphobihinogen (SN), 471<br />
micro-quantity tissue digestion for metal<br />
measurements by use of a microwave aciddigestion<br />
bomb (SN), 488<br />
sample preparation for thin-layer chromatog,<br />
anal, for 11-nor-9-tetrehydrocannabmnol-9-<br />
carboxyhic acid in urine (SN), 163<br />
Sample treatment<br />
evaln. of hipochear’” nonionic polymer system<br />
for removal of interfering hipemia (A), 1103<br />
pretreatment of sera before coulometric anal.<br />
maximizes recovery for serum Fe and TIBC<br />
(A), 1131<br />
San IMego Conference<br />
Third San Diego Conference on Nucleic Acid<br />
Probes, October, 1988, practical aspects of<br />
molecular probes (S), 1571<br />
Sarcoma<br />
ehevated CK-MB in a patient with pelvic<br />
sarcoma (A), 1124<br />
Screening<br />
accuracy, precision of anal, for total cholesterol<br />
as measured with the Reflotron cholesterol<br />
method (SN), 1734<br />
adulterants intended to cause false negatives in<br />
urine screens for marijuana or cocaine use<br />
(A), 1175<br />
apphn. of Magic Lite<br />
immunochemiluminometric method for<br />
measurement of creatine kinase-MB in blood<br />
spots (A), 1123<br />
assessment of screening program for congenital<br />
adrenal hyperphasia in Portugal based on<br />
antibody-coated tube RIA for 17a-OH<br />
progesterone (L), 2338<br />
automated procedure for mess, of biotinidase<br />
acty. in serum (SN), 831<br />
chin, effective screening of ssymptomatic<br />
patients for fecal occult blood loss requires<br />
lab, assistance (L), 2337<br />
calorimetric screening method for<br />
microalbuminuria: intra-individual<br />
variability for untimed day specimens (L),<br />
2019<br />
Cohoscreen VPI test kit evald. for detection of<br />
fecal occult blood, 156<br />
cost-effective EMIT method for qual. d.a.u.<br />
performed on Cobas Mire (A), 1168<br />
diabetes mehhitus: diagnosis and screening (A),<br />
1236<br />
diagnostic test for mucopohysaccharidosis I.<br />
direct method for quantg. excessive urinary<br />
glycosaminoglycan excretion, 374<br />
diagnostic test for mucopolysaccharidosis. II.<br />
rapid quantn. of ghycosaminaghycan in urine<br />
samples on a paper matrix, 2074<br />
dimethylmethyhene blue-based spectrophotom.<br />
of ghycossminoghycans in untreated urine:<br />
rapid screening for mucopohysaccharidoses,<br />
1472<br />
ehectrophoresis gel model for Ca oxalate<br />
crystallization (A), 1130<br />
EMrr convenient two-reagent system for drug<br />
of abuse testing on most common chem,<br />
analyzers (A), 1167<br />
empirically deed. Pb-poisoning screening cutoff<br />
for the Protofluor-Z hematofluorometer<br />
(SN), 2104<br />
enzyme-linked immunosorbent assay of<br />
apohipoprotein B in blood spotted onto filter<br />
paper, suitable for neonatal screening, 1000<br />
evaln. of Abbott IMx immunoassay analyzer<br />
for maternal serum alpha-fetoprotein<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
evaln. of Abbott TD,, for drugs of abuse<br />
testing in afield environment (A), 1179<br />
evaln, of combined cocaine/opiate screening<br />
procedure on Abbott labs. TDx (A), 1165<br />
evaln, of screening method bias for five drugs<br />
of abuse classes (A), 1102<br />
evaln. of Syva ETS and Abbott AD,, urine drug<br />
screening immunoassay analyzers (A), 1176<br />
evaln. of urine temp. measurement methods to<br />
screen urine specimens for drug tasting (A),<br />
1181<br />
expression of the major human<br />
ribonucheoprotein (RNP) autoantigens in E.<br />
coli and their use in an EIA for screening<br />
sera from patients with autoiinmune diseases<br />
(S), 1861<br />
false-positive urine amphetamine screen with<br />
ritodrine (TB), 1542<br />
five cannabinoid immunoassay systems<br />
compared at the screening threshold of 100<br />
,g/L (SN), 2241<br />
fluorometric method for phenylalanine<br />
microplate assay adapted for<br />
phenylketonuria screenin (SN), 2112<br />
frequency of law-level PCP in urine specimens<br />
for drug screening (A), 1182<br />
functional acty. of protein S deed, with use of<br />
protein C activated by venom activator, 1644<br />
glycated Hb in fractionated erythrocytes, 958<br />
high-volume Syva EMrr drug testing on<br />
multiple Epos analyzers interfaced to a<br />
central computer system<br />
implications of probability<br />
(A), 1166<br />
anal. for<br />
interpreting results of leukocyte esterase and<br />
nitrite test stips, 1663<br />
interlab, comparison of control materials for<br />
use with hematof1uorometers, 2059<br />
investigation of protoporphyrmn IX std.<br />
materials used in acid-extn, methods;<br />
proposed correction for the milhimohar<br />
absorptivity of protoporphyrin IX, 1601<br />
125I.RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
hipoprotein(e) quantified by an enzyme-linked<br />
immunosorbent assay with monochonal<br />
antibodies, 1380<br />
maternal serum estriol in acreenin& for Dawn’s<br />
syndrome: significance of high SD for the<br />
population (A), 1193<br />
mechanism of false-negative urine cannabinoid<br />
screens by Visine’” eyedrops<br />
immunoassay<br />
(SN), 636<br />
(A), 1163<br />
microassey for screening newborns for<br />
galactosemia with use of a fluorometric<br />
microplate reader (SN), 1962<br />
monochonal antibodies evald. for use in<br />
screening for conjugates of human serum alb.<br />
and pyridoxal 5’-P04 (SN), 1756<br />
neonatal phenylalanmne screening using the<br />
Encore centrifugal analyzer (A), 1153<br />
neonatal screening for congenital<br />
hypothyroidism with LKB Delfia neonatal<br />
TSH kit (A), 1152<br />
passive hemagglutination assay for HIV<br />
antibody screening (Retrocell HIV) (A),<br />
1210<br />
racial and other differences<br />
of maternal serum<br />
a-fetoprotein in a large obstetrical<br />
population (A), 1136<br />
recent advances in instrumentation for use in<br />
physicians’ offices and public health<br />
screening programs (A), 1232<br />
screening for deficiency of ai-proteinase<br />
inhibitor (SN), 1971<br />
screening for microalbuminuria a rapid,<br />
how-cost calorimetric assay (SN), 456<br />
screening of serum cholesterol and HDL<br />
cholesterol using the EM. Diagnostic<br />
Systems EASY ST analyzer (A), 1074<br />
screening utility of a rapid, automated<br />
fluorescent enzyme immunoassay for HBsAg<br />
in an S.T.D. clinic (A), 1192<br />
self-consistent set of ref. values for 23 chin.<br />
chem, anahytes, 448<br />
sensitive method of screening for urinary<br />
porphobihinogen (SN), 2311<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd. familial<br />
amyloidotic pohyneurapathy (SN), 1033<br />
single-vial screening assay for creatine kinase-<br />
MB (A), 1122<br />
sources of imprecision in screening for<br />
congenital hypothyroidism: anal, of 9 y of<br />
performance data, 1701<br />
stability of hemoghobins A, F, 5, and C in dried<br />
neonatal whole-blood samples when<br />
analyzed by cation-exchange HPLC (A),<br />
1152<br />
thin-layer chromatog. of free porphyrins for<br />
diagnosis of porphyria (SN), 1043<br />
time-resolved fluoroimmunoassay of aflatoxins<br />
(SN), 2308<br />
urine screening for cocaine use with ELISA and<br />
confirmation with GC/MS (A), 1171<br />
use of Sentry’” drugcontrol in evaluating<br />
performance of TDx drugs of abuse<br />
screening near NIDA cutoff concns. (A), 1103<br />
Selenium<br />
at, absorption spectrom. detn, of Se in blood<br />
components, 537<br />
Seminal fluid<br />
high concns, of Zna2.glycoprotein and lack of<br />
a2HS-glycoprotemn in ejaculates, 1649<br />
Seminal plasma<br />
prostatic inhibin-like peptide in urine of<br />
prostetic cancer patients, mess, by enzymelinked<br />
immunosorbent assay, 1376<br />
RIA of -microseminoprotein, a prostaticsecreted<br />
protein in sara of men and women,<br />
1497<br />
tumor markers in seminal plasma end amniotic<br />
fluid (A), 1079<br />
Septic shock<br />
decreased immunoreacty. and binding acty. of<br />
corticostaroid-binding globulin in serum in<br />
septic shock, 1675<br />
Serotonin<br />
HPLC anal, for serotonin and tryptamine<br />
excreted in urine after oral loading with I..<br />
tryptophan, 43<br />
Sex- and age-related effects<br />
automated detn, of chohinesterase acty. in<br />
plasma and erythrocytes by flow-injection<br />
anal., and apphn. to identify subjects<br />
sensitive to succinyhchohine, 77<br />
biol, variation of urinary N-acetyl-fl-Dglucosaminidase:<br />
practical and chin,<br />
implications, 560<br />
cobalamin-binding capacity of haptocorrin<br />
end<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
critical anal, and chin, aspects of ionized Cain<br />
neonates (R), 2027<br />
diagnostic test for mucopolysaccharidosis. II.<br />
rapid quantn. of glycosaminoglycan in urine<br />
samples on a paper matrix, 2074<br />
dimethyimethylene blue-based spectrophotom.<br />
of glycosaminoglycans in untreated urine:<br />
rapid screening for mucopolysaccharidoses,<br />
1472<br />
effect of hemetocrit and added heparmn on Ce2<br />
in capillary blood from neonates (SN), 486<br />
effects of age and sex on the interpretation of<br />
chem, test results (A), 1155<br />
enzyme-linked immunosorbent assay of<br />
apohipoprotein B in blood spotted onto filter<br />
paper, suitable for neonatal screening, 1000<br />
estn, of ref. intervals for total protein in CSF<br />
(SN), 1766<br />
geriatric ther, drug monitoring: special<br />
considerations (S), 1337<br />
influence of blood pressure, heart rate, age, and<br />
sex on concns, of atrial natriuretic<br />
cyclic GMP (SN), 1519<br />
factor and<br />
2402 CLINICALCHEMISTRY,Vol.35, No. 12, 1989
I-RIA for androstenedione in serum and in<br />
blood-spot-samples from neonates, 1706<br />
osteocalcin: bioL variations and ref. limits (A),<br />
1126<br />
quant. anal. for org. acids in biol, samples:<br />
batch isolation followed by gas<br />
chromatog.-mass spectrom. anal,, 587<br />
quantn. of urinary porphyrmns by liq.<br />
chromatog. after oxidn, of porphyrinogens,<br />
1619<br />
racial and age-related differences in incidence<br />
of monoclonal gammopathy of uncertain<br />
significance (A), 1154<br />
relation between plasma cholesterol and total<br />
and ionized Ca cancns. in serum from<br />
poetmenopausal women (TB), 328<br />
RIA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
steroid profile for urine: ref. values, 2281<br />
Sex-hormone binding globulin<br />
critical evaln. of an immunaradiometric assay<br />
of sex-hormone binding globulin (TB), 2146<br />
investigation of sex-hormone-binding globulin<br />
interference in direct RIAs for testosterone<br />
and estradioh, 979<br />
lIlA of testosterone not bound to sex-steroidbinding<br />
protein in plasma, 1609<br />
stability of sex-hormone-binding globulin in<br />
serum, plasma (TB), 1253<br />
three methods compared far estg. testosterone<br />
and estradiol not bound to sex-hormonebinding<br />
globulin (SN), 632<br />
Sexually transmitted disease-causing<br />
organisms<br />
apphn. of a rapid non-radioisotopic nucleic acid<br />
anal, system to the detection of sexually<br />
transmitted disease-causing organisms and<br />
assocd. antimicrobial resistances (S), 1571<br />
Slalic<br />
acid<br />
See also Neuraminic acid<br />
determining “ref. changes” for serial<br />
measurements lipid-bound of plasma sialic<br />
acid (A), 1080<br />
measurement of sialic acid in squamous cell<br />
carcinoma patients (anal canal and cervix)<br />
by an automated Cobas-Mira procedure (A),<br />
1079<br />
methods for detg. “reference changes” from<br />
serial measurements: plasma lipid-bound<br />
sialic acid, 972<br />
use of CEA, CA 15-3, and sialic acid in<br />
evaluating chin, course of breast cancer<br />
patients (A), 1080<br />
Slahidase<br />
apolipoprotein E phenotype deed. by agarose<br />
gel electrofocuamg, immunoblotting, 2070<br />
siahidase from different sources compared far<br />
electrophoretically sepg. serum alk,<br />
phosphatase fractions from liver and bone<br />
(SN), 1955<br />
Skin disorders<br />
changes in serum acute-phase proteins in<br />
patients with dermatologic diseases (A), 1084<br />
collagen-linked fluorescence in skin biopsy<br />
specimens from young insulin-dependent<br />
diabetic patients (A), 1137<br />
Smoking<br />
caffeine interference eliminated in HPLC detn.<br />
of urinary nicotine and cotinine, 1456<br />
exposure to environmental tobacco smoke<br />
measured by cotinine imI.RIA (SN), 1036<br />
heukotriene B4 is measurable in serum of<br />
smokers and nonsmokers (SN), 459<br />
Sodium<br />
antiarrhythmic drugs and the cardiac Na<br />
channel: current models(S), 748<br />
development of human serum ref. materials to<br />
unify Na, K results in serum to their nath,<br />
ref. systems (A), 1130<br />
factitiously high Na activities in the<br />
Ektachem 400 owing to interferences by high<br />
gamma-globulin concns, (CR), 333<br />
Solid-phase extraction<br />
strategies for samphe prepn. with use of solid.<br />
phase extrn, in TDM of basic drugs (A), 1352<br />
Somatotropin<br />
automation and interpretation of quantn. of<br />
antibodies to therapeutic proteins,<br />
illustrated with somatotropin, 1623<br />
influence of matrix on cancns. of somatotrapin<br />
mess, in serum with commercial<br />
immunoradiometric assays, 1423<br />
somatotropin as mess, bye two-site timeresolved<br />
immunofluorometric assay, 913<br />
Somatrem<br />
automation and interpretation of quantn. of<br />
antibodies to therapeutic proteins,<br />
illustrated with somatotropin, 1623<br />
Specific gravity<br />
See Relative density<br />
Specimen handling<br />
See Sample handling<br />
Spectrofluorometry<br />
See Fluorometry<br />
Spectrophotofluorometry<br />
See Fluorometry<br />
Spectrophotometry<br />
See also Atomic absorption<br />
spectrophotometry, Calorimetry<br />
automated detn. of chohinesterase acty. in<br />
plasma and erythrocytes by flow-injection<br />
anal., and apphn. to identify subjects<br />
sensitive to succinylcholine, 77<br />
dimethylmethyhene blue-based spectrophotom.<br />
of glycosaminoghycans in untreated urine:<br />
rapid screening for mucopohysaccharidoses,<br />
1472<br />
hiq.-chromatog. assay of urinary<br />
porphobihinogen (SN), 471<br />
modified Mg method in the ace III: elimn, of<br />
interference by bilirubin (SN), 1031<br />
modifn, and automation of whole-blood CN<br />
assay (A), 1177<br />
nonmercurimetric spectrophotometric assay<br />
for Chin blood serum (A), 1129<br />
apectrophotometric stat detn. of HbCO in<br />
microsamples (A), 1163<br />
three direct spectrophotometric methods for<br />
detn, of total bilirubin in neonatal and adult<br />
serum, adapted to the Technicon RA-1000<br />
analyzer (SN), 1980<br />
Spectroscopy<br />
rapid detn, of uroporphyrmn and<br />
coproporphyrins in urine using secondderivative<br />
spectroscopy (A), 1132<br />
reagentless detn, of glucose and other<br />
constituents in blood by ATR-FT-IRspectroscopy<br />
(5), 1854<br />
spectroscopic systems for non-invasive<br />
measurements (A), 1059<br />
Spermatozoa<br />
use of murine monoclonal antibodies to bloodroup-rehated<br />
antigens for<br />
immunofluorescent detection of blood<br />
groups on human spermatozoa (A), 1208<br />
Sports medicine<br />
drug testing in sports-the 1988 Olympics and<br />
beyond (A), 1056<br />
test-strip method for lactate in whole blood<br />
(SN), 1992<br />
5100 protein<br />
5- lOOa,,protein in blood and urine during<br />
open-heart surgery, 1942<br />
Standardization<br />
CDC/NHLBI lipid standardization<br />
program-30 years of collaboration (A), 1073<br />
cholesterol standardization for 13 years by<br />
CDC and Japanese cholesterol levels (A),<br />
1065<br />
designing a reliable calibrator for<br />
nephehometric apo A-I and B assays (A),<br />
1073<br />
effect of lyophihn. on results of five enzymic<br />
methods far cholesterol (SN), 1523<br />
evahn, of Beckman cholesterol reagents by a<br />
natL cholesterol ref. method lab. (A), 1068<br />
improved accuracy of cholesterol values<br />
obtained by Synchron AS calibrator setpoint<br />
modn, as evidenced in patient<br />
correlation to Abell-Kendall ref. method (A),<br />
1071<br />
influence of matrix on cancns, of somatotropin<br />
mess, in serum with commercial<br />
immunoradiometric assays, 1423<br />
investigation of protoporphyrin IX std,<br />
materials<br />
proposed<br />
used in acid-extn. methods;<br />
correction for the mihllmolar<br />
absorptivity of protoporphyrin IX, 1601<br />
new int. temp. scale of 1990 (ITS-90) (SR), 503<br />
regional interhsb, standn, of serum cholesterol,<br />
HDL cholesterol, and triglycerides (A), 1065<br />
standn, of immunochem, detn. of<br />
epohipoproteins A-I and B: report on IFCC<br />
meeting on standn, of apohipoprotein A-I and<br />
B measurements (basis for future<br />
consensus), Vienna, Austria, April 18-19,<br />
1989 (SR), 2009<br />
successful detn, of triglycerides with the CDC<br />
standardization program (A), 1074<br />
system to standardize ALT cutoff actys. (A),<br />
1118<br />
WHO/RPSP standardization of Beckman<br />
Synchron CX’”5 and correlation of Igs and<br />
transferrin to Beckman Array’” protein<br />
system (A), 1106<br />
Statistics<br />
allowable limit of error in chin. chem, qual.<br />
control (SN), 630<br />
aspects of method comparison study that need<br />
more attention (A), 1110<br />
between-run component of variation in<br />
internal quah, control, 1416<br />
counting errors: effect on immunoassay<br />
precision, 1362<br />
CV at the detection limit (L), 901<br />
detn, of the lower limit of detection (L), 2152<br />
diagnosis of acute myocardial infarction from<br />
two measurements of creatine kinase<br />
isoenzyme MB with use of nonparametric<br />
probability estn., 444<br />
generalized likelihood ratio concept and<br />
logistic regression anal. for multiple<br />
diagnostic categories, 990<br />
methods comparison-Deming regression vs<br />
linear least squares regression (A), 1086<br />
methods for detg. “reference changes” from<br />
serial measurements: plasma lipid-bound<br />
sialic acid, 972<br />
sampling distribn, of skewness and kurtosis<br />
(TB), 330<br />
standard deviation errors in spreadsheet<br />
statistics (A), 1087<br />
t-test data anal. using a Lotus 1-2-3’”<br />
spreadsheet template (A), 1087<br />
Steroid hormones<br />
estradiol-17 deed. in plasma by gas<br />
chromatog.-mass spectrom. with selected ion<br />
monitoring of mixed silyh<br />
ether-perfluoroacyl ester derivs, and use of<br />
various stable-isotope-labeled internal sIde.,<br />
532<br />
Steroid receptors<br />
See also specific steroid of interest<br />
comparison of CA-15 and steroid receptors in<br />
cancerous and adjacent noncancerous tissue<br />
of the breast (A), 1080<br />
Steroids<br />
See also specific steroid of interest<br />
chin, steroid profiles by GCIMS (A), 1142<br />
decreased dehydroepiandrosterone sulfate in<br />
pigmented nodular adrenal dysphasia (SN),<br />
2216<br />
direct detn, of 4 sulfates and 7 glucuronides of<br />
l7-oxysteroids in urine by fluorescence<br />
“high-performance” liq. chrometog., 794<br />
direct solid-phase enzymoimmunoassay of<br />
testosterone in saliva, 2044<br />
effect of salivary proteins on binding curves of<br />
three RIA kits: Amerlex-M progesterone,<br />
Amerhex cortisol, Biodata testosterone (SN),<br />
641<br />
estimation of true values in RIAs, 1680<br />
investigation of sex-hormone-binding globulin<br />
interference in direct RIAs for testosterone<br />
and estradiol, 979<br />
solid-phase enzyme immunoassay of serum<br />
DHEA-S (A), 1197<br />
steroid profile for urine: ref. values, 2281<br />
three methods compared for estg. testosterone<br />
and estradiol not bound to sex-hormonebinding<br />
globulin (SN), 632<br />
Streptokinase<br />
alterations in lactate dehydrogenase isoenzyme<br />
patterns after therapy with streptokinase or<br />
streptococcal infection (SN), 1763<br />
creatine kinase isoforms in ischemic heart<br />
disease (R), 7<br />
streptokinese binds to lactate dehydrogenase<br />
subunit-M, which shares an epitope with<br />
plasminogen, 69<br />
Strontium<br />
quantn. of Sr in plasma and urine with<br />
flamehess at, absorp. spectrom., 1911<br />
Suhfasalaxlne<br />
characterization of sulfasahazine’sinterference<br />
in mess. of conj. bihirubin with the Ektachem<br />
slide (SN), 1760<br />
chin. important interference of sulfasalazine in<br />
measurement of conjugated bihirubin by<br />
Ektachem slide method (A), 1158<br />
simplified, rapid test for acetylator<br />
phenotyping by use of the peak height ratio<br />
of two urinary caffeine metabohites (SN), 848<br />
Superoxide dismutase<br />
automated methods for chin. assay of<br />
superoxide dismutase and glutathione<br />
peroxidase in human plasma and<br />
erythrocytes using a Cobas Bio centrifugal<br />
analyser (A), 1126<br />
improved superoxide dismutase assay for chin,<br />
use (L), 1265<br />
short- and long-term variability of indices<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2403
elated to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
Surgery<br />
changes in Fe, Zn, Cu concns, in serum and in<br />
their binding to transport proteins after<br />
chohecystectomy, cardiac surgery (SN), 2243<br />
impact of immediate acidification of blood on<br />
measurement of plasma tissue plasminogen<br />
activator (tPA) acty. in surgical patients<br />
(TB), 1999<br />
mess, of autoimmune response against collagen<br />
types I, III, and IV by enzyme-linked<br />
immunosorhent assay, and appln. in<br />
infective endocarditis, 246<br />
Sweat<br />
defective epithehial ion transport in cystic<br />
fibrosis (S), 726<br />
transient increase of sweat electrolyte concns,<br />
associated with environmental deprivation<br />
(A), 1153<br />
Symposia<br />
Nath, Aced, of Chin, Biochem, Annual<br />
Symposium: “Membrane Function and<br />
Dysfunction in Health and Disease”<br />
(introduction) (S), 717<br />
Synoviah fluid<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidase IV in synovial fluid<br />
from patients with rheumatoid and<br />
osteoarthritis, 1016<br />
Target cycling<br />
molecular probes used to detect<br />
cytomegalovirus and human<br />
immunodeficiency virus (S), 1581<br />
Tears<br />
tumoral calcinosis: seasonal biochem. studies<br />
and chem. studies of eyelid lesion (CR), 183<br />
Temperature<br />
new mt. temp. scale of 1990 (ITS-90) (SR), 503<br />
reliability of temp. correction algorithms for<br />
assessing blood gas parameters at
moderate I deficiency, possible explanation for<br />
inverse relation between card serum<br />
thyrotropmn and birth weight in a normal<br />
Kenyan popn. (L), 710<br />
neonatal screening for congenital<br />
hypothyroidism with LKB Dehfia neonatal<br />
TSH kit (A), 1152<br />
one-step immunometric assay for TSH based<br />
on enhanced luminescence (A), 1149<br />
rapid self-contained immunoassay for human<br />
thyrotropin (A), 1195<br />
ref. intervals far hTSH by two automated<br />
ultrasensitive assays: London Diagnostics<br />
LumaTag’” and Abbott’s IMx’” (A), 1143<br />
sensitive TSH in “weilness programs”:<br />
participant outcomes following abnormal<br />
results (A), 1148<br />
simplified strategy for tasting thyroid function<br />
(SN), 828<br />
ultrasensitive bioassay of thyrotropin (TB),<br />
1252<br />
Thyroim<br />
binding of labeled thyroxin analog to serum<br />
proteins evald. after RIA of free thyroxin<br />
(SN), 475<br />
concn. of free thyroxin in serum during<br />
nonthyraidal illness-calcn. or meas,? (SN),<br />
159<br />
dependence of thyroxin/thyroxin-binding<br />
globulin (TBG) ratio and free thyroxin index<br />
on TBG concns,, 541<br />
diagnostic performance of a modified freethyroxin<br />
assay in subjects with anomalies in<br />
their binding proteins (TB), 493<br />
direct and indirect techniques for free thyroxin<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
direct detn. of free thyroxin in undiluted serum<br />
by equilibrium dialysis/RLA (L), 510<br />
direct, indirect techniques for free thyroxin<br />
compared in patients with nonthyroidal<br />
illness. II. effect of prealbumin, albumin,<br />
thyroxin-binding globulin, 1655<br />
discordant RIA results for thyroxin-binding<br />
globulin (TBG): new indicator of variant<br />
TBG molecules with decreased affinity far<br />
thyroxin (TB), 1257<br />
do nonesterified fatty acids displace thyroxin<br />
from its plasma binding sites in severe<br />
nonthyroidal illnesses? (A), 931<br />
dry-chem. multilayer immunoassay for total<br />
thyroxin (A), 1180<br />
effect of albumin on results for free-thyroxin<br />
index as estd.<br />
(L),706<br />
by total T4,PF3 uptake ratio<br />
effect of thyroid hormone-binding proteins and<br />
fatty acids on modified analog assays of Fl’4<br />
and FL’3in serum (L), 708<br />
enzyme-linked immunosorbent assay for free<br />
thyroxin in serum (SN), 1770<br />
evain. of Abbott IMx’” essays for thyrozin and<br />
thyroxin uptake (A), 1105<br />
evaln. of Amerhite’” FT4 method in patients<br />
with FDH and nonthyroidal illness (A), 1142<br />
fluorometric enzyme immunoassey far<br />
measurement of free T4 using Magnisep’”<br />
Cr02 particles (A), 1202<br />
fluorometric enzyme immunoassay for<br />
measurement of total thyroxin using a<br />
reagent delivery module’” (RDM) (A), 1140<br />
four nanisotopic immunoaasays of free<br />
thyroxin evald, (SN), 115<br />
immunometric total thyroxin assay for use with<br />
dry reagent strips and a reflectance<br />
photometer (A), 1140<br />
labeled-antibody assay for free T4 (A), 1148<br />
longitudinal study of thyroid function in<br />
pregnancy, 275<br />
how-normal concns, of free thyroxin in serum in<br />
late pregnancy: physiol. fact, not tech.<br />
artefact, 1891<br />
measurement of thyrotropin and T4 by new<br />
luminescence immunoassay LIA-MAT (A),<br />
1209<br />
method-dependent correlation of major<br />
thyroxin-binding proteins with serum FT4 in<br />
patients with nonthyroidal illness (A), 1143<br />
modified EMI’I’ thyroxmn assay for use on<br />
Cobas Mira and Cobas Bia analyzers (A),<br />
1141<br />
multilayer fluorescence immunoassay<br />
technique (5), 1865<br />
new technique for measuring free thyrozin in<br />
serum: multi-center study (SN), 2137<br />
one-step enzyme immunoassay for free<br />
thyroxin: results with dysalbuminemic sara<br />
and one serum containing autoantibodies to<br />
thyroxin (TB), 888<br />
performance of CEDIA’” T4 MAb and T-uptake<br />
assays on Technicon RA-1000’” (A), 1191<br />
performance of CEDIA’”<br />
enzyme immunoassay<br />
T4 MAb homogeneous<br />
on the Olympus AU-<br />
5000 chin, analyzer (A), 1141<br />
performance of Microgenics CEDIA’” thyroxin<br />
and T-uptake assays on the Ciba-Corning<br />
550 Express’” analyzer (A), 1141<br />
simple procedure for evaluating thyroxinbinding<br />
proteins abnormalities in euthyroid<br />
hyperthyroxinemia and hypothyroxinemia<br />
(A), 1150<br />
simplified strategy for testing thyroid function<br />
(SN), 828<br />
thermal mactn. of L-thyroxin, 90<br />
thin-film enzyme immunoassay for<br />
measurement of serum or plasma T4 (A),<br />
1200<br />
1988 version of two-step immunoextn. assay for<br />
FL’4: chin. performance (A), 1144<br />
Thyroxin-binding globulin<br />
dependence of thyroxmn/thyroxin-binding<br />
globulin (TBG) ratio and free thyroxmn index<br />
on TBG concns,, 541<br />
direct, indirect techniques for free thyroxin<br />
compared in patients with nonthyroidal<br />
illness. LI.effect of prealbumin, albumin,<br />
thyroxin-binding globulin, 1655<br />
discordant RIA results for thyroxin-binding<br />
giobulmn (TBG): new indicator of variant<br />
TBG molecules with decreased affinity for<br />
thyroxin (TB), 1257<br />
longitudinal study of thyroid function in<br />
pregnancy, 275<br />
how-normal concns, of free thyroxin in serum in<br />
hate pregnancy: physiol. fact, not tech.<br />
artefact, 1891<br />
time-resolved fhuoroimmunoassay for<br />
measuring thyroxin-binding globulin (A),<br />
1205<br />
time.resohved immunofluorometric assay for<br />
thyroxin-binding globulin in serum (A), 1139<br />
Thyroxin index<br />
dependence of thyroxmn/thyroxin-binding<br />
globulin (TBG) ratio and free thyroxin index<br />
on TBG concns., 541<br />
Tissue analysis<br />
at, absorption spectrom. detn. of Se in blood<br />
components, 537<br />
choice of substrate concn. in the search far<br />
abnormal enzyme acty. in tissues (L), 1267<br />
computerized quant. anal. of Coomassie-Bluestained<br />
serum proteins sepd. by twodimensional<br />
electrophoresis, 2297<br />
concns, of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
851<br />
creatine kinase and lactate dehydrogenase<br />
isoenzymes in serum and tissues of patients<br />
with stomach adenocarcinoma, 1385<br />
HPLC mess, of chlorophenoxy herbicides,<br />
bromoxynih, and ioxynil, in biol. specimens<br />
to aid diagnosis of acute poisoning(S), 1342<br />
improved superoxide dismutase assay for chin,<br />
use (L), 1265<br />
measuring carbozypeptidase A acty. with a<br />
centrif, analyzer: anal, and chin,<br />
considerations, 251<br />
micro-quantity tissue digestion for metal<br />
measurements by use of a microwave aciddigestion<br />
bomb (SN), 488<br />
rapid, reliable in viva assays of phosphate<br />
metabohites by NMR, 392<br />
RIA of circulating chromogranin A: in vitro<br />
stability, exploration of neuroendocrine<br />
character of neoplasia, and assessment of<br />
effects of organ failure, 1631<br />
two-sita immunoenzymometry of 52-kDa<br />
cathepsin D in cytoaols of breast-cancer<br />
tissues, 81<br />
‘I’issue culture<br />
neopterin mess, in serum, tissue culture<br />
supernates by competitive enzyme-linked<br />
immunosorbant assay, 1467<br />
Tissue factor<br />
measuring tissue factor (Factor III) acty. in<br />
plasma, 1897<br />
Tobramycmn<br />
development of latex-based tobramycin<br />
immunoassay for the IL Monarchiu chem.<br />
system (A), 1172<br />
Syva EMI’I convenience pack assays for<br />
carbamazepine and tobramycin on the Cobss<br />
Mire analyzer (A), 1173<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare II’” analyzer; detn. of serum<br />
amikacin, gentamicin, and tobramycin (A),<br />
1178<br />
Technicon tobramycmn and gentamicin: secondgeneration,<br />
improved methods on the RA-<br />
1000 system (A), 1172<br />
Tocopheroh<br />
concn, of tocopherol isomers in dietary oila (A),<br />
1114<br />
concna, of carotenoids, retinol, and tocopherol<br />
in plasma after a meal (SN), 310<br />
simultaneous hiq.-chromatog. detn. of vit, K,,<br />
vit. E in serum, 2285<br />
transport conditions and stability of biochem.<br />
markers in blood (SN), 2313<br />
Total body water<br />
antipyrine interferes with chem, detn. of Br in<br />
simultaneous estn. of total body H20 and<br />
extracehhular H20, 1367<br />
Toxicology<br />
alk. phosphatase of possible renal origin<br />
identified in plasma after colchicine overdose<br />
(L), 702<br />
automated detn. of chohinesterase acty. in<br />
plasma and erythrocytes by flow-injection<br />
anal,, end appln. to identify subjects<br />
sensitive to succinyhchohine, 77<br />
benzodiazepines identified by capillary gas<br />
chrometog.-mass spectrom., with specific ion<br />
screening used to detect benzophenone<br />
derivs., 1394<br />
brodifacoum (super warfarmn) poisoning: lab,<br />
methods for assessment of vit, K antagonism<br />
(A), 1162<br />
cocaine and pregnancy: din, and toxicol.<br />
implications for the neonate (S), 1276<br />
cychosporine concns. in blood after liver<br />
transplantn.: correlation of immunoassay<br />
results with chin, events, 564<br />
detection of poisoning by plant-origin cardiac<br />
ghycoeide with the Abbott TDx analyzer<br />
(SN), 295<br />
documentation of cytosine arabinoaide toxicity<br />
using drug monitoring (A), 1182<br />
does the effective diminution of nonenzymatic<br />
glycation by D-lysine really highlight its<br />
potential use in viva? (L), 2254<br />
emetine identified in urine by I-IPLC, with<br />
fluorescence and ultraviolet/diode array<br />
detection, in a patient with cardiomyopathy<br />
(CR), 499<br />
HPLC mess, of chhorophenoxy herbicides,<br />
bromoxynil, and ioxynil, in biol, specimens<br />
to aid diagnosis of acute poisoning(S), 1342<br />
interhab. comparison of control materials for<br />
use with hemetofluorometars, 2059<br />
new approach to etiohogic diagnosis in<br />
environmental chem. poisoning (A), 1055<br />
nitromethane interferes in assay for creatinine<br />
by Jaff#{233} reaction (SN), h772<br />
plasma glutathiane S.transferase and F protein<br />
are more sensitive than alanine<br />
aminotransferese as markers of<br />
acetaminophen-induced liver damage, 2186<br />
rapid detn. of toxic CN- concns, in blood, 617<br />
supercriticah fluid chromatog. and microbore<br />
hiq. chromatog. for drug anal. (5), 1293<br />
system for toxicol. screening by capillary gas<br />
chromatog. with use of a drug retention<br />
index based on Ni-containing ref. cmpds.,<br />
601<br />
ther, drug monitoring and toxicol.: issues,<br />
perspectives for the ‘804 and ‘90s: a<br />
symposium held in Chicago, IL, October 6-8,<br />
1988(5), 1273<br />
time-resolved fhuoroimmunoassay of afhatoxins<br />
(SN), 2308<br />
vahproate therapy depresses GSH-PX and<br />
SOD enzyme acty.: possible mechanism for<br />
VPA-induced idiosyncratic drug toxicity (A),<br />
1173<br />
versatihe, efficient system far extracting<br />
from urine for gas chromatog./mass<br />
drugs<br />
spectrom. anal. (SN), 2100<br />
Trace elements<br />
See also specific element of interest<br />
at, absorption spectrom. detn. of Se in blood<br />
components, 537<br />
bladder catheters and Zn contamination of<br />
urine (TB), 888<br />
changes in Fe, Zn, Cu concns. in serum and in<br />
their binding to transport proteins after<br />
cholecystectomy, cardiac surgery (SN), 2243<br />
concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
electrothermal at: absorp. spectrom. detn, of<br />
Al: serum matrix effects eliminated (SN),<br />
1517<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2405
evaln. of urine metals control using at.<br />
absorption spectrophotom. (A), 1177<br />
improved detn, of Va in hioh, fluids by<br />
ehectrotherm. at. absorption spectram. (SN),<br />
127<br />
interactions of Cu with some analytas in serum<br />
(L),335<br />
isotope diln, GC-MS of metals at trace levels in<br />
biol. samples (A), 1113<br />
micro-quantity tissue digestion for metal<br />
measurements by use of a microwave aciddigestion<br />
bomb (SN), 488<br />
quantn. Mn in lymphocytes to assess Mn<br />
nutrit. status, 1939<br />
sensitive, direct cohorimetry of Cu in serum,<br />
552<br />
serum Zn in homosexual men (L), 704<br />
short- and long-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
Transcobahamin<br />
cobalammn-binding capacity of haptocorrin and<br />
transcobalamin: age-correlated ref. intervals<br />
and values from patients, 1447<br />
Transcortin<br />
decreased immunorescty. and binding acty. of<br />
corticosteroid-binding globulin in serum in<br />
septic shock, 1675<br />
Transferrin<br />
measurement of carbohydrate-deficient<br />
transfemin, biochem. marker for alcohol<br />
disease (A), 1109<br />
short- and long-term variability of indices<br />
related to nutritional status, I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
transfemmn in urine of non-insulin-dependent<br />
diabetics: marker for early complications?,<br />
1672<br />
WHO/RPSP standardization of Beckman<br />
Synchron CX’”5 and correlation of Igs and<br />
transfemmn to Beckman Array’” protein<br />
system (A), 1106<br />
Transketolase<br />
effect of substrata concn. on erythrocyte<br />
transketohase assay (L), 1557<br />
interaction between pyridmne nucleotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-linked enzymes (SN), 2129<br />
Transthyretin<br />
See also Preahbumin<br />
hiq. chromatog. assay for free and<br />
transthyretin-bound retinal-binding protein<br />
in serum, 582<br />
simplified screening of populations at risk for<br />
transthyretin Met30-assocd. familial<br />
amyhoidotic polyneuropathy (SN), 1033<br />
Triacylglycorols<br />
See Triglycerides<br />
Tricyclic antidepressants<br />
See also Antidepressants<br />
automated detn. of drugs in serum by columnswitching<br />
HPLC. IV. sepn. of tricychic and<br />
tetracychic antidepressants and their<br />
metabohites (SN), 453<br />
detn, of serum desipramine and 2-<br />
hydroxydesipramine for pharmacokinetic<br />
apphns. by HPLC with uv detection (SN),<br />
2134<br />
evaln, of serum acetaminophen and tricychic<br />
antidepressants assays on the Abbott ADZ’”<br />
drug detection system (A), 1102<br />
Triglycerides<br />
concns. of lipids, apohipoproteins in patients<br />
with chin, well-controlled insulin-dependent<br />
and non-insulin-dependent diabetes, 813<br />
development of liq. triglycerides-GPO reagent<br />
utilizing response-surface co-optimization<br />
(A), 1071<br />
free glycerol correction for accurate detn, of<br />
plasma trichycerides in lab. animals (A), 1134<br />
glycerol-blanked triglyceride measurement on<br />
the Hitachi 705 chem. analyzer (A), 1072<br />
Lp(a) hipoprotein concn. in serum of patients<br />
with heavy proteinuria of different origin<br />
(SN), 2121<br />
rapid micro-scale proced. for detn. of total lipid<br />
profile, 1486<br />
regional interhab, standn. of serum cholesterol,<br />
HDL cholesterol, and triglycerides (A), 1065<br />
single-channel glycerol-blanked triglyceride<br />
method adapted to the Cohas Fare (A), 1067<br />
successful detn, of triglycerides with the CDC<br />
standardization program (A), 1074<br />
Triiodothyrouine<br />
CEDIA’” total T3. a rapid homogeneous enzyme<br />
immunoassay for serum total T3 (A), 1095<br />
effect of thyroid hormone-binding proteins and<br />
fatty acids on modified analog<br />
and FT3 in serum (L), 708<br />
assays of FT4<br />
enhanced luminescence immunoassay for free<br />
‘l’3(A), 1149<br />
evaln. of Abbott LMx T3 assay (A), 1202<br />
evaln. of Corning magnetic particle RIA for<br />
free T3 (A), 1207<br />
evaln. of total T3 on Abbott IMx automated<br />
immunoassay systems (A), 1099<br />
fluorometric enzyme immunoassay for,<br />
measurement<br />
Cr02 particles<br />
of total I3<br />
(A), 1202<br />
using Magnisep’”<br />
longitudinal study of thyroid function in<br />
pregnancy, 275<br />
shaking polystyrene beads during coating with<br />
antibody: effect on precision profile of<br />
enzyme immunoassay of triiodothyronine<br />
(L), 701<br />
Trypsin<br />
detn. of a2-macroghobulin-trypsin complex<br />
with a new synthetic substrate, 2169<br />
Trypsinogen<br />
strategic use of individual and combined<br />
enzyme indicators far acute pancreatitis<br />
analyzed by receiver-operator<br />
characteristics, 967<br />
Tryptamine<br />
HPLC anal, for serotonin and tryptamine<br />
excreted in urine after oral loading with L-<br />
tryptophan, 43<br />
Tryptophan<br />
HPLC detn, of L-tryptophan in serum and<br />
urine (A), 1115<br />
SDS improves recovery of free tryptophan in<br />
plasma samples deproteinized with<br />
Centrifree Micropartition Devices (A), 1161<br />
Tumor-associated trypsin inhibitor<br />
concns. of tumor-associated trypsin inhibitor<br />
and C-reactive protein in serum in acute<br />
pelvic inflammatory disease (SN), 869<br />
Tumor-derived activated cells<br />
tumor-derived activated cells: prehim. lab, and<br />
chin, results (S), 1576<br />
Tumor markers<br />
CA195, marker far cohorectal cancer (A), 1077<br />
chin, significance of 2-microglobuhin in chronic<br />
lymphocytic leukemia and non-Hodgkins<br />
lymphoma (A), 1079<br />
comparison of CA-15 and steroid receptors in<br />
cancerous and adjacent noncancerous tissue<br />
of the breast (A), 1080<br />
comparison of Centocor CA 19-9, Tandem-R<br />
CA 195, and Truquant GI (A), 1078<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusions (SN), 166<br />
immunohistochem. studies utilizing<br />
monochonal and polychonal antibodies to c-<br />
erbB-2 protein<br />
immunoradiometry<br />
(A), 1079<br />
of ay- and yy-enolase<br />
(neuron-specific enohase), with use of<br />
monoclonal antibodies and magnetizable<br />
polymer particles, 2034<br />
incidence of elevation of tumor markers CA-<br />
549, CA-15.3, and CEA in sera of breast<br />
cancer patients (A), 1078<br />
lactate dehydrogenase isoenzyme pattern in<br />
sara in malignant diseases, 396<br />
measurement of sialic acid in squamous cell<br />
carcinoma patients (anal canal and cervix)<br />
by an automated Cobas-Mira procedure (A),<br />
1079<br />
partial charactern. of an abnormal lactate<br />
dehydrogenase isoenzyme, LDH-lex, in<br />
serum from a patient with hepatocellular<br />
carcinoma (SN), 844<br />
prehim. chin. evaln. of an ovarian cancer<br />
marker-CA 215 (A), 1081<br />
prostatic inhibin-like peptide in urine of<br />
prostatic cancer patients, mess. by enzymelinked<br />
immunoaorbent assay, 1376<br />
tumor markers in seminal<br />
fluid (A), 1079<br />
two-site immunoenzymometry of 52-kfle<br />
cathepsin D in cytosols of breast-cancer<br />
tissues, 81<br />
plasma and amniotic<br />
Turbidimetric immunoassay<br />
sensitive turbidimetric immunoassay for detn.<br />
of C-reactive protein in serum (A), 1082<br />
Turbidlmetrlc inhibition imniunoassay<br />
performance of theophylline, gentemicin,<br />
tobramycin, phenytoin, and digoxin reagents<br />
on the Beckman Synchron CX’”4 (A), 1181<br />
Turbidimetry<br />
See also Rate turbidimetry<br />
appln. of three turbidimetric immunoglobuhin<br />
assays, IgG, IgA, and 1gM, to the Express 550<br />
analyzer (A), 1095<br />
diagnostic value of measuring pancreatic hipase<br />
and the P3 isoform of pancreatic amyhase<br />
isoenzyme in serum of hospitalized<br />
hyperamylasemic patients, 417<br />
monochonal turbidimetric assay for<br />
phenobarbital on the RA-1000’” system (A),<br />
1172<br />
optimized microturbidimetric assay for<br />
fibrinoen, 211<br />
patient-side immunoassay system a<br />
single-use cartridge for measuring analytes<br />
in blood (5), 1869<br />
performance characteristics of CSF protein on<br />
Paramax’ (A), 1084<br />
performance characteristics of urine protein on<br />
Paramaz<br />
rapid assays<br />
(A), 1084<br />
for microalbuminuria on two<br />
analyzers (A), 1196<br />
turbidimetric latex immunoassay of placental<br />
lactogen on microtiter plates, 141<br />
Two-dimensional centrifugatlon<br />
See Centrifugation, two-dimensional<br />
Two-dimensional electrophoresis<br />
See Electropharesis, two-dimensional<br />
Tyramine<br />
detn. of tyramine in plasma by ion-pair extn,<br />
and reversed-phase liquid chromatog. with<br />
ehectrochem, detection (A), 1152<br />
Tyrosine<br />
detn, of branched-chain amino acids and<br />
tyrosine in serum in various hepatic diseases,<br />
and its chin, usefulness, 1399<br />
Ultracentrifugation<br />
distribn, of thiobarbituric acid-reactive<br />
substances in hipoproteins, proteins in serum,<br />
2054<br />
implications for mess, of pre-$ high-density<br />
lipoprotein (free apo A-I) by ultracentrifn,<br />
(L), 2336<br />
rapid micro-scale proced. for detn, of total lipid<br />
profile, 1486<br />
unusual band that binds Hb after<br />
ultracentrifn, of hemolyzed plasma for<br />
hipoprotein sepn. (TB), 495<br />
use of a dual-pptn. proced. for mess. highdensity<br />
hipoprotem 3 in normohipidemic<br />
serum, 1390<br />
Ultrafiltration<br />
comparison<br />
and ultrafiltration<br />
of free testosterone<br />
(A), 1148<br />
by analog RIA<br />
kinetic behavior of digoxin-like<br />
immunoreactive substances during<br />
ultrafiltration studies (A), 1157<br />
Uhtrasonography<br />
choriogonadotropin discriminatory zone and<br />
ultrasonogrephy (L), 2019<br />
Uradil arablnoside<br />
hiq.-chromatog. monitoring of cytosine<br />
arabinoside and its metabolite, uradil<br />
arabinoside, in serum, 1011<br />
Urate<br />
detergent enhances interference of urate in<br />
detns, of fructosamine (L), 1803<br />
Urea<br />
automated detn. of urinary Na, K, Cl, P1,<br />
urea, and creatinine without sample diln,<br />
with the “RAT-XT” (SN), 481<br />
enzymic urea assay- new calorimetric method<br />
based on 14203 mess, (SN), 654<br />
evain, of Nova-12 urea electrode (A), 1100<br />
simultaneous detn. of urea, glucose, Na, K, Cl,<br />
and total CO2 in undiluted human serum<br />
using an electrode-based automated analyzer<br />
(A), 1091<br />
Urea nitrogen<br />
evaln, of Nova 12: whole-blood and serum<br />
electrolyte, glucose, and BUN analyzer (A),<br />
1128<br />
modified enzymatic approach to measure blood<br />
urea N on the Technicon RA-1000 (A), 1104<br />
performance of kinetic BUN assay on<br />
BM/Hitachi 717’” (A), 1098<br />
signif. of how serum urea N concns. (SN), 639<br />
Uremia<br />
improved detn. of Vain biol, fluids by<br />
ehectrotherm, at, absorption spectrom. (SN),<br />
127<br />
Uric acid<br />
nonenzymatic stopped-flow fluorimetry for<br />
direct detn, of uric acid in serum and urine,<br />
230<br />
Urine<br />
See also specific anahyte of interest<br />
adaptation of drugs of abuse testing to<br />
Synchron CX#{149}4 and CX’5 chin. analyzers<br />
(A), 1178<br />
adenosine and dopamine simultaneously detd,<br />
in urine by reversed-phase HPLC, with on-<br />
2406 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
line mess, of uv absorbance and ehectrochem,<br />
detection, 64<br />
adulterants intended to cause false negatives in<br />
urine screens for marijuana or cocaine use<br />
(A), 1175<br />
anal, of urinary metanephrines of patients<br />
treated with antihypertensive a-methyldopa<br />
(Aldomet) (A), 1138<br />
automated detn. of urinary Nat, K, C1, P,<br />
urea, and creatinine without sample diln,<br />
with the “RAT-XT” (SN), 481<br />
Bence Jones immunoghobulins in the urine in<br />
multiple sclerosis (L), 186<br />
Bence Jones proteins in urine of patients with<br />
multiple sclerosis (L), 1550<br />
biochem. contribution to diagnosis and study<br />
of a new case of D-ghyceric acidemia/aciduria<br />
(CR), 2148<br />
biol. variation of urinary N-acetyh-9-D.<br />
glucosaminidase: practical and chin.<br />
implications, 560<br />
Biotrol urine proteins reagent using pyrogallol<br />
red-Mo complex (A), 1082<br />
bladder catheters and Zn contamination of<br />
urine (TB), 888<br />
circadian variations and ref. intervals for some<br />
enzymes in urine of healthy children (SN),<br />
864<br />
chin. applns. for quant. aand Xlight chain<br />
detns. (A), 1084<br />
cocaine and pregnancy: chin, and toxicol.<br />
implications for the neonate (S), 1276<br />
cohorimetric screening method for<br />
microalbuminuriL intra-individuah<br />
variability for untimed day specimens (L),<br />
2019<br />
comparison of Abbott Tl)x FPIA for<br />
cannabinoids with GC/MS (A), 1185<br />
comparison of intact and beta subunit hCG<br />
levels in paired serum and urine samples (A),<br />
1143<br />
contamination of urine samples by test-strip<br />
measurements? (TB), 2144<br />
detection limit of the Tl)x fluorescence<br />
polarization immunoassay<br />
benzoyhecgonine in urine<br />
extended for<br />
(SN), 2110<br />
detection of dimethyl sulfoxide in urine using a<br />
modified Toxilab’ procedure (A), 1165<br />
detn. of cocaine<br />
ester in urine,<br />
metabolite, ecgonine methyl<br />
by gas chromatog. with N-<br />
selective detector (A), 1168<br />
detn. of 4,4’-methylenebis(2-chloroanihine) in<br />
urine (L), 506<br />
development of EMrr’ drugs of abuse assay for<br />
amphetamine/methamphetemine<br />
the ETS’” system (A), 1180<br />
in urine on<br />
development of’fl)./4&i) fluorescence<br />
polarization immunoassay far detection<br />
methadone in human urine (A), 1176<br />
of<br />
diagnostic test for mucopohysaccharidoeis I.<br />
direct method for quantg. excessive urinary<br />
glycosaminoghycan excretion, 374<br />
diagnostic test for mucopohysaccharidoais, II.<br />
rapid quantn. of glycosaminoghycan in urine<br />
samples on a paper matrix, 2074<br />
dimethyimethyhene blue-based spectrophotom.<br />
of glycosaminoglycens in untreated urine:<br />
rapid screening for mucopohysaccharidoses,<br />
1472<br />
direct detn. of 4 sulfates and 7 glucuronides of<br />
17-oxysteroids in urine by fluorescence<br />
“high-performance” hiq. chromatog,, 794<br />
effect of citrate on urinary excretion of Ca and<br />
oxalate: relevance to Ca oxalate<br />
nephrohithiasis, 23<br />
effect of forced diuresis on urinary excretion of<br />
pancreatic amyhase (A), 1127<br />
electrophoretic examin, of proteinurie in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
EMIl’ convenient two-reagent system for drug<br />
of abuse testing on most common chem.<br />
analyzers (A), 1167<br />
EMil’ ethanoh assays for use on Cobas Mire<br />
and Cobas Bio analyzers (A), 1166<br />
enzymatic assay of Mg through glucokinase<br />
ectn, (SN), 2212<br />
enzymatic detn, of urinary oxalate (SN), 2330<br />
enzymatic method far oxalete automated with<br />
the Cobas Fara centrif, analyzer (SN), 2094<br />
evaln. and performance characteristics of<br />
Paramax anal, system for detg. spinal fluid<br />
and urine protein with hiq. Coomassie Blue<br />
user-def’med chem, (A), 1112<br />
evaln. of Abbott MTD,,’” drug anal. system (A),<br />
1185<br />
evaln. of Abbott TDa#{149} for drugs of abuse<br />
testing in a field environment (A), 1179<br />
evaln, of an RIA of urinary cortisol without<br />
extrn, (SN), 125<br />
evein. of Boehringer Mannheim/Hitechi 717<br />
for routine drug of abuse testing (A), 1165<br />
evaln. of immunochem, methods for detg. how<br />
concns. of albumin in urine (A), 1209<br />
evaln. of TLC technique for detection of<br />
opiates in urine (A), 1173<br />
evaln, of urine metals control using at,<br />
absorption spectrophotom. (A), 1177<br />
evaln. of urine temp. measurement methods to<br />
screen urine specimens for drug testing (A),<br />
1181<br />
excretion of urinary enzymes after<br />
extracorporeal shock-wave hithotripsy (TB),<br />
2000<br />
false-positive urine amphetamine screen with<br />
ritodrine (TB), 1542<br />
five cannabinoid immunoassay systems<br />
compared at the screening threshold of 100<br />
ig/L (SN), 2241<br />
frequency of how-level PCP in urine specimens<br />
for drug screening (A), 1182<br />
glyoxal: an artefact from metronidazole and<br />
glyoxyhic acid in urinary org. acid anal. (TB),<br />
673<br />
high-volume Syve EMIT drug testing on<br />
multiple Epos analyzers interfaced to a<br />
central computer system (A), 1166<br />
high-yield purifn. of the complex-forming<br />
glycoprotein in urine, 577<br />
homogentisic acid deW, in bioh, fluids by<br />
HPLC (SN), 321<br />
HPLC anal. for serotonin and tryptamine<br />
excreted in urine after oral loading with L-<br />
tryptophan, 43<br />
HPLC detn, of L-tryptophan in serum and<br />
urine (A), 1115<br />
HPLC mess, of chlorophenoxy herbicides,<br />
bromoxynil, and ioxynil, in bioL specimens<br />
to aid diagnosis of acute poisoning(S), 1342<br />
identn, of some typical a-blockers (bisoprolol,<br />
betaxohol) and propafenone in bioL<br />
specimens: applicn. to doping anal. (A), 1183<br />
immunocatahytic assay of pancreatic a-amylase<br />
in serum and urine with a specific<br />
monochonal antibody (SN), 662<br />
implications of probability anal, for<br />
interpreting results of heukocyte esterase and<br />
nitrite test stips, 1663<br />
improved detn, of Vain biol, fluids by<br />
electrotherm, at, absorption spectrom. (SN),<br />
127<br />
improved pyrogallol red-Mo method for detg.<br />
improved urinary oxalate method for a centrif,<br />
total urinary protein (SN), 2233<br />
analyzer (L), 1806<br />
IMi’ 2-microglobulin, fully automated<br />
microparticle enzyme immunoassay (A),<br />
1192<br />
interference of common household chemicals in<br />
immunoassays for drugs of abuse (SN), 648<br />
intra-individual biol, variation in the N-acetyh-<br />
-glucosaminidase/creatininium ratio for<br />
first morning<br />
hiq.-chromatog.<br />
urine (TB), 1256<br />
assay of urinary<br />
porphobihinogen (SN), 471<br />
loss of porphyrins from soln, during anal,:<br />
effect of sample pH and matrix on porphyrin<br />
quantn. in urine by HPLC (SN), 1508<br />
mess, of estrone-3-ghucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoassey, 555<br />
mess, of urinary heukotrienes by reversed.<br />
phase liq. chromatog, and RIA, 388<br />
measurement of benzodiazepines in urine by<br />
double-antibody RIA (A), 1175<br />
mechanism of false-negative urine cannabinoid<br />
immunoassay screens by Visine’” eyedrops<br />
(SN), 636<br />
(A), 1163<br />
methylmalonic acid, I. concns, in serum and<br />
urinary excretion in normal subjects after<br />
feeding and during fasting, and after loading<br />
with protein, fat, sugar, isoheucine, valine,<br />
2271<br />
methyimalonic acid, H. relation between<br />
concns. in serum and urinary excretion, and<br />
the correln. between serum cobalamin and<br />
accumulation of methylmalonic acid, 2277<br />
microalbuminuria in diabetes mellitus: more on<br />
urine storage and accuracy of calorimetry<br />
(L), 1560<br />
microplate mess, of urinary albumin,<br />
creatinine, 1371<br />
modified method of anal, for metadrenaline in<br />
urine (L), 513<br />
new commercial method for enzymatic detn, of<br />
creatinine in serum and urine evald:<br />
comparison with a kinetic Jeff#{233} method and<br />
isotope diln.-msss apectrametry (SN), 835<br />
nonenzymatic stopped-flow fluorimetry for<br />
direct detn, of uric acid in serum and urine,<br />
230<br />
nonprotein components of urine interfere with<br />
calorimetry of urinary albumin with<br />
bromphenol blue (L), 336<br />
oligoclonal banding detected by urinary<br />
protein electrophoresis and immunoflxation<br />
in two patients with AIDS and proteinuria<br />
(CR), 1795<br />
axalate is overestri, in alk. urmnes collected<br />
during administration of HC032 with no<br />
specimen pH adjustment (SN), 2107<br />
pancreatic amylsse mess, in serum by use of a<br />
monochonal antibody immunochem,<br />
immobilized to asolid phase, 110<br />
performance characteristics of Na, K, and Cl in<br />
urine on the Paramax analytical system (A),<br />
1131<br />
performance characteristics of urine protein on<br />
Paramax’ (A), 1084<br />
performance of Beckman Liquid-Stat’ Mg<br />
reagent (A), 1131<br />
performance<br />
for quant.<br />
of Technicon Chem-1’” analyzer<br />
measurement of 10 analytes in<br />
urine (A), 1130<br />
predicting<br />
program<br />
ovulation in in-vitro fertilization<br />
by monitoring huteinizing<br />
hormone/crestinine ratio in random urine<br />
samples (A), 1144<br />
prostatic inhibin-hike peptide in urine of<br />
prostatic cancer patients, mess, by enzyme.<br />
linked immunosorbent assay, 1376<br />
proteinuria (K), 755<br />
purifn., characterization of intact lactoferrin<br />
found in the urine of human milk-fed<br />
preterm infants, 1928<br />
quant. anal, for org. acids in biol, samples:<br />
batch isolation followed by gas<br />
chromatog.-mass spectrom. anal., 587<br />
quant. measurement of urinary cystine by<br />
nitroprusside reaction (A), 1152<br />
quantn. of Sr in plasma and urine with<br />
flamehess at, absorp. spectrom., 1911<br />
quantn. of urinary porphyrins by hiq.<br />
chromatog. after oxidn, of porphyrmnogens,<br />
1619<br />
rapid assays for microalbuminuria on two<br />
analyzers (A), 1196<br />
rapid detn, of uroporphyrmn and<br />
coproporphyrins in urine using secondderivative<br />
spectroecapy (A), 1132<br />
rapid enzyme<br />
semiquant.<br />
immunoassay for visual,<br />
detn, of lutropin in urine for<br />
ovulation prediction (A), 1148<br />
rapid thin-layer chromatog. semiquantificatian<br />
of morphine in urine via dabsylation:<br />
comparison with EMIT and thin-layer<br />
chromatog,-iodoplatinate methods (TB), 329<br />
reflectometric evahn, of Quantimetrix urine<br />
dipstick controls (A), 1108<br />
renal function assessed by serum creatinine<br />
and creatinine clearance: glomerular<br />
filtration rate estal, by four procedures (SN),<br />
2326<br />
resolution of issues in HPLC anal. of urinary<br />
porphyrins (A), 1157<br />
response of allergic and normal persons to<br />
sulfiting agents in wine: detn, of urinary<br />
thiosulfate excretion (TB), 1792<br />
5-bOa,, protein in blood and urine during<br />
open-heart surgery, 1942<br />
screening for microahbuminuria in patients<br />
with diabetes: frozen storage of urine<br />
samples decreases their albumin content<br />
(SN), 308<br />
sensitive method of screening for urinary<br />
porphobihinogen (SN), 2311<br />
sepn., identn, of urinary proteins and stonematrix<br />
proteins by mini-slab Na dodecyl<br />
sulfate-polyacryhamide<br />
(SN), 658<br />
gel ehectrophoresis<br />
simple hiq.-cbromatog. method for vit. Be cmpe.<br />
in plasma, 241<br />
simplified, rapid test for acetylator<br />
phenotyping by use of the peak height ratio<br />
of two urinary caffeine metabohites (SN), 848<br />
simultaneous detn, of pentoxifyhhine and three<br />
metabohites in bioh, fluids by hiq. chromatog.<br />
(SN), 298<br />
simultaneous mess. of total and IgAconjugated<br />
a1-microglobuhin by combined<br />
immunoenzyme/immunoradiometric assay,<br />
766<br />
CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2407
solid-phase sample extn, for rapid detn. of<br />
methylmalonic acid in serum, urine by stable<br />
isotope dilution, 260<br />
status of drugs-of-abuse blind tasting in urine:<br />
an AACC study (SR), 891<br />
steroid profile for urine: ref. values, 2281<br />
thin-layer chromatog. of free porphyrins for<br />
diagnosis of porphyria (SN), 1043<br />
transferrin in urine of non-insulin-dependent<br />
diabetics: marker for early complications?,<br />
1672<br />
two-site IRMA for detn, of urinary<br />
cytokeratin-18; apphicn. to management of<br />
bladder cancer (A), 1198<br />
underestn, of urinary glucose by an automated<br />
dipstick analyzer based on glucose oxidase<br />
with has indicator chromogen (L), 1804<br />
urinary excretion of some proteins and<br />
enzymes during normal pregnancy (SN),<br />
1978<br />
urinary 5-hydroxyindoleacetic acid by HPLC<br />
with electrochem, detection (L), 507<br />
urinary neopterin concns. vs total neopterins<br />
for chin. utility (SN), 2305<br />
urinary org. acid excretion by premature<br />
babies, 1460<br />
urine apphn, for Abbott Spectrum and VP<br />
using Abbott liq. amylase reagent (A), 1102<br />
urine Ca anaL using Beckman Synchron CX3<br />
and Synchron CX5 chin, systems (A), 1132<br />
urine free cortisol in depressed patients<br />
assayed by HPLC (A), 1138<br />
urine protein 1: sex-dependent marker of<br />
tubular or glomerular dysfunction (TB),<br />
2141<br />
urine screening for cocaine use with ELISA and<br />
confirmation with GC/MS (A), 1171<br />
Urokinase<br />
effects of therapeutic coronary reperfusion on<br />
aspartate aminotransferase isoenzymes in<br />
sera of patients with acute myocardial<br />
infarct,, 909<br />
Urohithiasia<br />
See Calculous disease<br />
Uroporphyrin<br />
rapid detn. of uroporphyrmn and<br />
coproporphyrins in urine using secondderivative<br />
spectroscopy (A), 1132<br />
Uteroferrin<br />
immunoassay of band 5 (“tartrate-resistant”)<br />
acid phosphatase involving use of antiporcine<br />
utaroferrin antibodies, 86<br />
Vahproic acid<br />
automated fluoroimmunoassay of theophylline<br />
and valproic acid by (how-injection anal, with<br />
use of HPLC (SN), 489<br />
serum valproic acid detn, on Cobas Bio’FP<br />
centrifugal analyzer (A), 1178<br />
valproate therapy depresses GSH-PX and<br />
SOD enzyme acty.: possible mechanism for<br />
VPA-induced idiosyncratic drug toxicity (A),<br />
1173<br />
Vanadium<br />
improved detn. of Va in bioL fluids by<br />
electrotherm, at. absorption spectrom. (SN),<br />
127<br />
Vancomycin<br />
chin, performance of the EMIT vancomycin<br />
assay (SN), 1504<br />
detection of CDP in sera from patients on<br />
vancomycin (A), 1166<br />
development of applicn. protocols for EMfi’<br />
vancomycin assay on the Syva#{149} Autolab’”<br />
instrument system and for Cobss Mire<br />
analyzer (A), 1167<br />
measurement of vancomycin on the Du Pont<br />
aca discrete din, analyzer (A), 1169<br />
Van Slyke Society<br />
Van Slyke Society, 2259<br />
Variation, source of<br />
See also Analytical error<br />
accuracy, precision of anal, for total cholesterol<br />
as measured with the Reflotron cholesterol<br />
method (SN), 1734<br />
adulterants intended to cause false negatives in<br />
urine screens for marijuana or cocaine use<br />
(A), 1175<br />
analyte stability in closed containers after 6<br />
days’ storage (A), 1158<br />
binding of labeled thyroxin analog to serum<br />
proteins evald, after<br />
(SN), 475<br />
RIA of free thyroxin<br />
bioh, variability of 26 chin, chem. anahytes in the<br />
elderly, 783<br />
biol. variation of urinary N.acetyh.-D.<br />
glucosaminidase: practical and chin.<br />
implications, 560<br />
calibrator design considerations for Du Pont<br />
Vista’” immunoassey system (A), 1202<br />
changes in isoform patterns and stability of<br />
CK-MB during storage (A), 1120<br />
contamination of urine samples by test-strip<br />
measurements? (TB), 2144<br />
correction of instrument- and reagent-based<br />
differences in detn, of the mt. normalized<br />
ratio for monitoring anticoagulant therapy<br />
(SN), 840<br />
critical anal. and chin.aspects of ionized Ca in<br />
neonates (H), 2027<br />
cychosporine measured in plasma from patients<br />
with various transplants: HPLC and RIA<br />
with a specific monoclonal antibody<br />
compared (SN), 1726<br />
cychosporine metabolism impeded/blocked by<br />
co-administration of phenobarbital (A), 1160<br />
cyclosporine pharmacokinetics with<br />
concomitant ketoconazohe therapy (A), 1176<br />
differences between capillary and venous<br />
blood-alcohol concns, as a function of time<br />
after drinking, with emphasis on sampling<br />
variations in heft vs right arm, 400<br />
digoxin drug-drug interactions investigated<br />
with a human myocardial Na/K-ATPase<br />
redioreceptor assay (A), 1168<br />
digoxin immune Feb (Digibind) markedly<br />
affects results of immunoassays for digaxin<br />
(A), 1165<br />
effect of Bc on ian-specific electrodes in the<br />
Hitachi 736 (A), 1161<br />
effect of gel separator tubes on specimens for<br />
therapeutic drug anal. (A), 1182<br />
effect of hemoglobinemia on bilirubin assays<br />
on Kodak Ektachem 700 and<br />
Bilirubinometer (A), 1157<br />
effect of lyophiln. on results of five enzymic<br />
methods for cholesterol (SN), 1523<br />
effect of serum albumin on displacement of<br />
phenytoin by ceftriaxone and nafcillin (A),<br />
1176<br />
effects of glucose on spectrophotometric detn,<br />
of blood D-xyhose (A), 1156<br />
effects of hemohysis and storage on quantn. of<br />
hormones<br />
(A), 1133<br />
in blood samples from animals<br />
effects of hipemia of Hitachi 737 measurements<br />
(A), 1159<br />
effects of various serum proteins on quantn. of<br />
fructosamine (SN), 134<br />
effects on ionized Ca by different heparin<br />
preparations measured in ICA 2 analyzer<br />
(A), 1128<br />
evaln, of Amerhite’” F’I’4 method in patients<br />
with FDH and nonthyroidal illness (A), 1142<br />
evain, of matrix effects of lyophilized pools on<br />
apohipoprotein B immunoaasays<br />
evahn, of parameters that influence<br />
(A), 1074<br />
polymeraae<br />
chain reaction (A), 1076<br />
eveln. of RIA kit for detn, of free insulin:<br />
effects of sample handling and storage (A),<br />
1144<br />
evaln, of the IFCC Ref. Method for alanine<br />
aminotransferase: spurious blank ALT acty.<br />
due to contamination of D-alanine with L-<br />
alsnine; recommendations for a correction<br />
(SN), 153<br />
factors affecting a cyanogen bromide-based<br />
assay of thiamin, 2173<br />
fasting vs nonfasting lipoprotain measurements<br />
(A), 1066<br />
five cannabinoid immunoassay systems<br />
compared at the screening threshold of 100<br />
pg/L (SN), 2241<br />
fluoxetine inhibition of imipramine<br />
metabolism (A), 1180<br />
improvement in Synchron CX#{149}-3 electrolyte<br />
performance by use of an enzymatic cleaner<br />
(A), 1097<br />
influence of matrix on concns, of somatotropin<br />
mess, in serum with commercial<br />
immunoradiometric assays, 1423<br />
interaction between pyridmne nucheotide<br />
coenzymes and heme proteins: possible<br />
source of error in assay of activities of<br />
coenzyme-hinked enzymes (SN), 2129<br />
interference by intravenous fluorescein with<br />
lab, tests (A), 1159<br />
int’rinstrument differences in P02<br />
measurement on four recent blood gas<br />
analyzers (A), 1133<br />
intra-individual biol, variation<br />
fl-glucosaminidase/creatininium<br />
in the N-acetyh-<br />
ratio for<br />
first morning urine (TB), 1256<br />
hpoprotein changes in subjects on a modified<br />
fasting regimen (A), 1068<br />
nonenzymic glycation of immunoghobulins does<br />
not impair their immunoreactivity (SN),<br />
1039<br />
organic acids and drug interference in<br />
measurement of CO2 concn, by Kodak<br />
Ektachem 700(A), 1156<br />
patterns of lactate dehydrogenase isoenzymes 1<br />
and 2 in serum on exercise<br />
plasma conjugated androgens<br />
(SN), 301<br />
as digitalis-hike<br />
factors ins dialysis-dependent male (A),<br />
1150<br />
sequential<br />
digoxin<br />
changes in cross reactivity of anti-<br />
antibodies during immunization (A),<br />
1186<br />
short- and long-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
Stratus automated creatine kinase-MB assay<br />
evald,: identn, and ehimn, of falsely increased<br />
results assocd. with a high-M, form of alk.<br />
phosphatase, 2048<br />
thermal inactn. of L-thyroxin, 90<br />
thyroid-function tests in subjects with<br />
alterations in thyroxin-binding proteins (A),<br />
1139<br />
transport conditions and stability of biochem,<br />
markers in blood (SN), 2313<br />
variability in serum lactate dehydrogenase<br />
acty. and isoenzyme patterns induced by<br />
streptokinase (A), 1119<br />
variables involved in evaluating maternal<br />
serum alpha-fetoprotein: albumin, total<br />
protein and fructosamine (A), 1159<br />
variation among units for blood cellular Mg<br />
(A), 1115<br />
Veterinary chemistry<br />
detection of dimethyl sulfoxide in urine using a<br />
modified Toxihab procedure (A), 1165<br />
detection of poisoning by plant-origin cardiac<br />
glycoside with the Abbott TDx analyzer<br />
(SN), 295<br />
effect of ether or ketamine anesthesia on rat<br />
uterine estrogen, progesterone receptors<br />
(SN), 143<br />
effect of exercise training on glycemic control,<br />
kidney function, and renal ultrastructure in<br />
obese (diabetic) Zucker rats (A), 1135<br />
effects of hemolysis and storage on quantn. of<br />
hormones in blood samples from animals<br />
(A), 1133<br />
feline and canine ref. ranges for the Kodak<br />
Ektachem 700 analyzer (A), 1134<br />
free glycerol correction for accurate detn. of<br />
plasma triclycerides in lab. animals (A), 1134<br />
increased Ca uptake in vascular tissue by<br />
plasma of salt-induced hypertensive DahI<br />
rats (A), 1138<br />
Magiwel’” enzyme immunasssay<br />
heartworm (Dirofilaria immitis)<br />
for dog<br />
infections<br />
(A), 1137<br />
time-resolved fluoroimmunoassay of aflatoxins<br />
(SN), 2308<br />
tissue damage assessment in T2 mycotoxicosis<br />
(A), 1135<br />
Viruses<br />
applicn. of polymerase chain reaction (PCR) to<br />
detection of human retroviruses (A), 1058<br />
delta and conjugated bihirubins as predictors of<br />
early liver allograft rejection are unaffected<br />
by cytomegahavirus infection (A), 1137<br />
detection of HIV proviral DNA in peripheral<br />
blood mononuclear cells by pohymerasechain<br />
reaction (A), 1076<br />
detection of HIV-1 RNA by polymerase chain<br />
reaction (A), 1076<br />
enzyme immunoassay for quantn. of IgG<br />
antibody to rubella virus in serum (A), 1092<br />
evaln. of automated fluorescent immunoassay<br />
for detection of HBsAg (A), 1095<br />
neopterin as a predictive marker for disease<br />
progression in human immunodeficiency<br />
virus type 1 infection (SN), 1746<br />
oligoclonal immunoglobulin bands in HTLV-Iassociated<br />
myelopathy (A), 1085<br />
quant. ELA for detn. of tumor necrosis factoralpha<br />
(A), 1187<br />
Vitamin A<br />
liq. chromatog. essay for free and<br />
transthyretin-bound retinol-binding protein<br />
in serum, 582<br />
Vitamin B<br />
simple hiq.-chromathg. method for vit, Be cmps.<br />
in plasma, 241<br />
Vitamin B12<br />
chemilumescence receptor assay for vit, B12<br />
(A), 1194<br />
cobalamin-binding capacity of haptocorrin and<br />
transcobalamin: age-correlated ref. intervals<br />
2408 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
and values from patients, 1447<br />
high prevalence of atrophic gastritis in the<br />
elderly implications for health-associated<br />
ref. limits for cobahamin in serum (L), 1557<br />
methylmalonic acid, I. cancns. in serum and<br />
urinary excretion in normal subjects after<br />
feeding and<br />
with protein,<br />
during fasting,<br />
fat, sugar,<br />
and after loading<br />
isoleucine, valine,<br />
2271<br />
methyhmalonic acid. H. relation between<br />
concns. in serum and urinary excretion, and<br />
the correhn, between serum cobahamin and<br />
accumulation of methylmalonic acid, 2277<br />
solid-phase sample extn. for rapid detn, of<br />
methylmahonic acid in serum, urine by stable<br />
isotope dilution, 260<br />
Vitamin D<br />
tumoral calcinosis: seasonal biochem. studies<br />
and chem, studies of eyelid lesion (CR), 183<br />
Vitamin E<br />
simultaneous liq,-chromatog. detn, of vit. K1,<br />
vit. E in serum, 2285<br />
Vitamin K<br />
anal, of supplemented vit, K1 (20) in serum<br />
microsamples by sohid-phaseextrn, and<br />
narrow-bore HPLC with multichannel uv<br />
detection (S), 1288<br />
brodifacoum (super warfarmn) poisonin lab,<br />
methods for assessment of vit, K antagonism<br />
(A), 1162<br />
detn. of trans-phylhoquinone in children’s<br />
serum (SN), 874<br />
serum phyhloquinone concns, in a normal popn.<br />
of children as compared with ref. interval in<br />
adults (TB), 671<br />
simultaneous hiq.-chromatog. detn, of vit. K1,<br />
vit. E in serum, 2285<br />
Vitamins<br />
effect of repeated freezing and thawing on<br />
vitamins and hormones in serum (TB), 2145<br />
quantn. of biotin in serum by competition with<br />
solid-phase biotin for binding to<br />
peroxidase-avidin conjugate (SN), 1721<br />
Vitreous fluid<br />
evaln. of vitreous fluid as a specimen far drug<br />
abuse testing (A), 1181<br />
Voltammetry<br />
rapid detn. of Cl- in serum using a cyclic<br />
voltammetric method (A), 1133<br />
Waaler-Rose assay<br />
automated enhanced latex agglutn. assay for<br />
rheumatoid factors in serum (SN), 303<br />
Xylose<br />
effects of glucose on spectrophotometric detn.<br />
of blood D-xyloae (A), 1156<br />
Zinc<br />
bladder catheters and Zn contamination<br />
urine (TB), 888<br />
of<br />
changes in Fe, Zn, Cu concns, in serum and in<br />
their binding to transport proteins after<br />
cholecystectomy, cardiac surgery (SN), 2243<br />
serum Zn in homosexual men (L), 704<br />
statis. interpretn. of condos,<br />
cholesterohs, and creatine<br />
of Mg, Zn, Ce, K,<br />
kinase isoenzymes<br />
in men at different stages of ischemic heart<br />
disease (SN), 833<br />
Znprotoporphyrin/heme ratio: primary test for<br />
Fe deficiency in a pediatric population (A),<br />
1114<br />
Zonal ultracentrifugatlon<br />
dual-pptn. method evald, for meas, of<br />
cholesterol<br />
subfractions<br />
in high-density hipoprotein<br />
HDL2 and HDL3 in plasma, 265<br />
Cumulative indexes for volumes 1-18, 19-26, and 27-31 are available. Write to the Business Office, AACC.<br />
CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2409
January: pages 1-200<br />
February: pages 201-346<br />
March: pages 347-518<br />
April: pages 519-716<br />
May: pages 717-908<br />
June: pages 909-1272<br />
July: pages 1273-1 570<br />
August: pages 1571 -1814<br />
September: pages 1815-2026<br />
October: pages 2027-2164<br />
November: pages 2165-2260<br />
December: pages 2261 -2409<br />
Beckman Supplement Issue:<br />
pages B1-B54